Citrus Sinensis ID: 012761
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 457 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FE20 | 456 | Serine/threonine-protein | yes | no | 0.971 | 0.973 | 0.839 | 0.0 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.835 | 0.903 | 0.598 | 1e-137 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.892 | 0.985 | 0.580 | 1e-136 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.739 | 0.685 | 0.516 | 4e-96 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.671 | 0.626 | 0.541 | 1e-93 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.628 | 0.7 | 0.581 | 3e-92 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.689 | 0.739 | 0.519 | 8e-91 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.652 | 0.766 | 0.529 | 5e-90 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.636 | 0.706 | 0.538 | 2e-89 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.717 | 0.440 | 0.5 | 1e-88 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 772 bits (1994), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/456 (83%), Positives = 407/456 (89%), Gaps = 12/456 (2%)
Query: 1 MGCFPCFDSREDEKLNPEKEPD--DQKQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELH 58
MGCF CFDS +DEKLNP E + +KQ QPTVSNNIS LPSG ++L S++NG SKREL
Sbjct: 1 MGCFSCFDSSDDEKLNPVDESNHGQKKQSQPTVSNNISGLPSGGEKLSSKTNGGSKRELL 60
Query: 59 LPKDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR 118
LP+DG G IAA TF FRELAAAT NF P++F+GEGGFGRVYKG L+STGQVVAVKQLDR
Sbjct: 61 LPRDGLG-QIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDR 119
Query: 119 NGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 178
NGLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK
Sbjct: 120 NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 179
Query: 179 EALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238
EALDWN RMKIAAGAAKGLE+LHDKANPPVIYRDFKSSNILL+EGFHPKLSDFGLAKLGP
Sbjct: 180 EALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGP 239
Query: 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 298
GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS PHGEQ
Sbjct: 240 TGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQ 299
Query: 299 NLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358
NLV WARPLFNDRRKF KLADPRL+GR+P R LYQALAVASMCIQEQAATRPLI DVVTA
Sbjct: 300 NLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTA 359
Query: 359 LSYLANQTYDPNSHRGAGDKDDRRNRD--GAR-IFKNDEGGGSGRRWDLEGSEKEDSPRE 415
LSYLANQ YDP+ D RRNRD GAR I +ND+GGGSG ++DLEGSEKEDSPRE
Sbjct: 360 LSYLANQAYDPSK------DDSRRNRDERGARLITRNDDGGGSGSKFDLEGSEKEDSPRE 413
Query: 416 TARILNRDLERERAVAEAKMWGENLREKRRQSAQGS 451
TARILNRD+ RERAVAEAKMWGE+LREKRRQS QG+
Sbjct: 414 TARILNRDINRERAVAEAKMWGESLREKRRQSEQGT 449
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 487 bits (1253), Expect = e-137, Method: Compositional matrix adjust.
Identities = 243/406 (59%), Positives = 297/406 (73%), Gaps = 24/406 (5%)
Query: 1 MGCFPCF-------DSREDEKLN-------PEKEPDDQKQGQPTVSNNISRLPSGRDRLR 46
MGCF C ++ +D +N D++ Q S++ +++ RD
Sbjct: 1 MGCFGCSKKSSKRSETNKDTVINRKIVGGTTSVAKSDKRDDQTQPSSDSTKVSPYRDV-- 58
Query: 47 SRSNGVSKRELHLPKDGAGVNI-------AAQTFTFRELAAATKNFRPESFIGEGGFGRV 99
+ GV K + L D G+N+ AQTFTF+ELA AT NFR + F+GEGGFG+V
Sbjct: 59 NNEGGVGKED-QLSLDVKGLNLNDQVTGKKAQTFTFQELAEATGNFRSDCFLGEGGFGKV 117
Query: 100 YKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159
+KG +E QVVA+KQLDRNG+QG REF+VEVL LSL H NLV LIG+CA+GDQRLLVY
Sbjct: 118 FKGTIEKLDQVVAIKQLDRNGVQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVY 177
Query: 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNIL 219
E+MP GSLEDHLH LP K+ LDWNTRMKIAAGAA+GLEYLHD+ PPVIYRD K SNIL
Sbjct: 178 EYMPQGSLEDHLHVLPSGKKPLDWNTRMKIAAGAARGLEYLHDRMTPPVIYRDLKCSNIL 237
Query: 220 LEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVF 279
L E + PKLSDFGLAK+GP GDK+HVSTRVMGTYGYCAP+YAMTGQLT KSD+YSFGVV
Sbjct: 238 LGEDYQPKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVL 297
Query: 280 LELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVAS 339
LELITGRKAID+T+ +QNLV WARPLF DRR F K+ DP L+G+YP+RGLYQALA+++
Sbjct: 298 LELITGRKAIDNTKTRKDQNLVGWARPLFKDRRNFPKMVDPLLQGQYPVRGLYQALAISA 357
Query: 340 MCIQEQAATRPLIGDVVTALSYLANQTYDPNSHRGAGDKDDRRNRD 385
MC+QEQ RP++ DVV AL++LA+ YDPNS + K+ +RD
Sbjct: 358 MCVQEQPTMRPVVSDVVLALNFLASSKYDPNSPSSSSGKNPSFHRD 403
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 485 bits (1248), Expect = e-136, Method: Compositional matrix adjust.
Identities = 259/446 (58%), Positives = 305/446 (68%), Gaps = 38/446 (8%)
Query: 1 MGCFPCFDSREDEKLNPEKEPDDQKQGQPTVSNNISRLPSGRDRLRSRS-NGVSKRELHL 59
M CF CF E +K+ + + ++ G+ T +N P + ++ N +E+
Sbjct: 1 MNCFSCFYFHEKKKVPRDSDNSYRRNGEVTGRDNNKTHPENPKTVNEQNKNNDEDKEV-- 58
Query: 60 PKDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN 119
NIAAQTF+FRELA ATKNFR E IGEGGFGRVYKG LE TG +VAVKQLDRN
Sbjct: 59 -----TNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRN 113
Query: 120 GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE 179
GLQGN+EF+VEVLMLSLLHH +LVNLIGYCADGDQRLLVYE+M GSLEDHL DL PD+
Sbjct: 114 GLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQI 173
Query: 180 ALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239
LDW+TR++IA GAA GLEYLHDKANPPVIYRD K++NILL+ F+ KLSDFGLAKLGPV
Sbjct: 174 PLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPV 233
Query: 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN 299
GDK HVS+RVMGTYGYCAPEY TGQLT KSDVYSFGVV LELITGR+ ID+TRP EQN
Sbjct: 234 GDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQN 293
Query: 300 LVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359
LVTWA+P+F + +F +LADP LEG +P + L QA+AVA+MC+QE+A RPL+ DVVTAL
Sbjct: 294 LVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTAL 353
Query: 360 SYLANQTYDPNSHRGAGDKDDRRNRDGARIFKNDEGGGSGRRWDLEGSEKEDSPRETARI 419
+L P+ DD +DE + EDS
Sbjct: 354 GFLGTA---PDGSISVPHYDDPPQ-------PSDE------------TSVEDSVAAE--- 388
Query: 420 LNRDLERERAVAEAKMWGENLREKRR 445
ERERAVAEA WG R R
Sbjct: 389 -----ERERAVAEAMEWGVASRAHSR 409
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 352 bits (903), Expect = 4e-96, Method: Compositional matrix adjust.
Identities = 190/368 (51%), Positives = 239/368 (64%), Gaps = 30/368 (8%)
Query: 6 CFDSREDEKLNPEKEPDDQKQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELHLPKDGAG 65
C + + K EK +DQ GQ + + S S S S V EL+
Sbjct: 77 CTVTTMESKSANEKS-NDQPVGQVSSTTTTSNAES------SSSTPVISEELN------- 122
Query: 66 VNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLES---------TGQVVAVKQL 116
++ + FTF +L +T+NFRPES +GEGGFG V+KGW+E TG VAVK L
Sbjct: 123 ISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL 182
Query: 117 DRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDL 174
+ +GLQG++E+L E+ L L H NLV L+GYC + DQRLLVYEFMP GSLE+HL L
Sbjct: 183 NPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL 242
Query: 175 PPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234
P L W+ RMKIA GAAKGL +LH++A PVIYRDFK+SNILL+ ++ KLSDFGLA
Sbjct: 243 P-----LPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLA 297
Query: 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRP 294
K P K+HVSTRVMGTYGY APEY MTG LT KSDVYSFGVV LE++TGR+++D RP
Sbjct: 298 KDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 357
Query: 295 HGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGD 354
+GE NLV WARP D+R+F +L DPRLEG + I+G + +A+ C+ RP + D
Sbjct: 358 NGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSD 417
Query: 355 VVTALSYL 362
VV AL L
Sbjct: 418 VVEALKPL 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 343 bits (881), Expect = 1e-93, Method: Compositional matrix adjust.
Identities = 176/325 (54%), Positives = 225/325 (69%), Gaps = 18/325 (5%)
Query: 53 SKRELHLPKDGAGVNIAA--QTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLES---- 106
++ L P +NI + + F+F +L AT+NFRPES +GEGGFG V+KGW+E
Sbjct: 102 AESSLSTPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTA 161
Query: 107 -----TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161
TG VAVK L+ +GLQG++E+L E+ L L H NLV L+GYC + DQRLLVYEF
Sbjct: 162 PVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEF 221
Query: 162 MPLGSLEDHLH--DLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNIL 219
MP GSLE+HL LP L W+ RMKIA GAAKGL +LH++A PVIYRDFK+SNIL
Sbjct: 222 MPRGSLENHLFRRSLP-----LPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNIL 276
Query: 220 LEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVF 279
L+ ++ KLSDFGLAK P K+HVSTRVMGTYGY APEY MTG LT KSDVYSFGVV
Sbjct: 277 LDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 336
Query: 280 LELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVAS 339
LE++TGR+++D RP+GE NLV WARP D+R+F +L DPRLEG + ++G + +A+
Sbjct: 337 LEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAA 396
Query: 340 MCIQEQAATRPLIGDVVTALSYLAN 364
C+ + RP + +VV L L +
Sbjct: 397 QCLSRDSKIRPKMSEVVEVLKPLPH 421
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 339 bits (869), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 172/296 (58%), Positives = 209/296 (70%), Gaps = 9/296 (3%)
Query: 73 FTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQV------VAVKQLDRNGLQGNRE 126
FT EL TK+FRP+ +GEGGFG VYKG+++ +V VAVK L++ GLQG+RE
Sbjct: 57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHRE 116
Query: 127 FLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTR 186
+L EV L L H NLV LIGYC + D RLLVYEFM GSLE+HL L W+ R
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFR--KTTAPLSWSRR 174
Query: 187 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 246
M IA GAAKGL +LH+ A PVIYRDFK+SNILL+ + KLSDFGLAK GP GD++HVS
Sbjct: 175 MMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 233
Query: 247 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP 306
TRVMGTYGY APEY MTG LT +SDVYSFGVV LE++TGRK++D TRP EQNLV WARP
Sbjct: 234 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARP 293
Query: 307 LFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362
ND+RK ++ DPRLE +Y +R +A ++A C+ + RPL+ DVV L L
Sbjct: 294 KLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 349
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 334 bits (857), Expect = 8e-91, Method: Compositional matrix adjust.
Identities = 174/335 (51%), Positives = 227/335 (67%), Gaps = 20/335 (5%)
Query: 71 QTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLEST---------GQVVAVKQLDRNGL 121
+ FTF EL AT+NFRP+S +GEGGFG V+KGW++ T G VVAVK+L G
Sbjct: 69 KAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEGY 128
Query: 122 QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEAL 181
QG++E+L EV L L H NLV L+GYC +G+ RLLVYEFMP GSLE+HL + L
Sbjct: 129 QGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRR--GAQPL 186
Query: 182 DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241
W RMK+A GAAKGL +LHD A VIYRDFK++NILL+ F+ KLSDFGLAK GP GD
Sbjct: 187 TWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGD 245
Query: 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV 301
K+HVST+VMGT+GY APEY TG+LT KSDVYSFGVV LEL++GR+A+D ++ EQ+LV
Sbjct: 246 KTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLV 305
Query: 302 TWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 361
WA P D+RK ++ D RL G+YP +G Y A ++A C+ A RP + +V+ L
Sbjct: 306 DWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQ 365
Query: 362 LANQTYDPNSHRGAGDK----DDRRNRDGARIFKN 392
L ++ P + G G++ D R +G+ + K+
Sbjct: 366 L--ESTKPGT--GVGNRQAQIDSPRGSNGSIVQKS 396
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 332 bits (850), Expect = 5e-90, Method: Compositional matrix adjust.
Identities = 163/308 (52%), Positives = 215/308 (69%), Gaps = 10/308 (3%)
Query: 67 NIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLES---------TGQVVAVKQLD 117
N + F+ EL +AT+NFRP+S +GEGGFG V+KGW++ TG V+AVK+L+
Sbjct: 50 NANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLN 109
Query: 118 RNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD 177
+ G QG+RE+L E+ L L H NLV LIGYC + + RLLVYEFM GSLE+HL
Sbjct: 110 QEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTF 169
Query: 178 KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237
+ L WNTR+++A GAA+GL +LH+ A P VIYRDFK+SNILL+ ++ KLSDFGLA+ G
Sbjct: 170 YQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLSDFGLARDG 228
Query: 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE 297
P+GD SHVSTRVMGT GY APEY TG L+VKSDVYSFGVV LEL++GR+AID +P GE
Sbjct: 229 PMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGE 288
Query: 298 QNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357
NLV WARP ++R+ ++ DPRL+G+Y + + +A CI A +RP + ++V
Sbjct: 289 HNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVK 348
Query: 358 ALSYLANQ 365
+ L Q
Sbjct: 349 TMEELHIQ 356
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 330 bits (846), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 162/301 (53%), Positives = 213/301 (70%), Gaps = 10/301 (3%)
Query: 71 QTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLES---------TGQVVAVKQLDRNGL 121
++FTF EL AAT+NFRP+S +GEGGFG V+KGW++ TG V+AVK+L+++G
Sbjct: 55 KSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGW 114
Query: 122 QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEAL 181
QG++E+L EV L H NLV LIGYC + + RLLVYEFMP GSLE+HL + L
Sbjct: 115 QGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPL 174
Query: 182 DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241
W R+K+A GAAKGL +LH+ A VIYRDFK+SNILL+ ++ KLSDFGLAK GP GD
Sbjct: 175 SWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGD 233
Query: 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV 301
KSHVSTR+MGTYGY APEY TG LT KSDVYS+GVV LE+++GR+A+D RP GEQ LV
Sbjct: 234 KSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLV 293
Query: 302 TWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 361
WARPL ++RK ++ D RL+ +Y + + +A C+ + RP + +VV+ L +
Sbjct: 294 EWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEH 353
Query: 362 L 362
+
Sbjct: 354 I 354
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 327 bits (838), Expect = 1e-88, Method: Compositional matrix adjust.
Identities = 172/344 (50%), Positives = 224/344 (65%), Gaps = 16/344 (4%)
Query: 64 AGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG 123
A ++ +TFT EL AT F + +GEGGFGRVY+G +E G VAVK L R+
Sbjct: 328 ATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMED-GTEVAVKLLTRDNQNR 386
Query: 124 NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDW 183
+REF+ EV MLS LHH NLV LIG C +G R L+YE + GS+E HLH+ LDW
Sbjct: 387 DREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHE-----GTLDW 441
Query: 184 NTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS 243
+ R+KIA GAA+GL YLH+ +NP VI+RDFK+SN+LLE+ F PK+SDFGLA+ G +
Sbjct: 442 DARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ- 500
Query: 244 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTW 303
H+STRVMGT+GY APEYAMTG L VKSDVYS+GVV LEL+TGR+ +D ++P GE+NLVTW
Sbjct: 501 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTW 560
Query: 304 ARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363
ARPL +R +L DP L G Y + + A+ASMC+ ++ + RP +G+VV AL +
Sbjct: 561 ARPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLIY 620
Query: 364 NQTYDPNSHRGAGD---KDDRRNRDGARIFKNDEGGGSGRRWDL 404
N ++ GD + D D A FK D W+L
Sbjct: 621 N-----DADETCGDYCSQKDSSVPDSAD-FKGDLAPSDSSWWNL 658
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 457 | ||||||
| 255547614 | 461 | receptor serine-threonine protein kinase | 1.0 | 0.991 | 0.882 | 0.0 | |
| 224053527 | 462 | serine/threonine protein kinase PBS1 [Po | 1.0 | 0.989 | 0.859 | 0.0 | |
| 224075521 | 456 | serine/threonine protein kinase PBS1 [Po | 0.986 | 0.989 | 0.864 | 0.0 | |
| 449445572 | 469 | PREDICTED: serine/threonine-protein kina | 0.995 | 0.970 | 0.832 | 0.0 | |
| 225425176 | 464 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.984 | 0.844 | 0.0 | |
| 351721508 | 449 | serine/threonine-protein kinase [Glycine | 0.971 | 0.988 | 0.847 | 0.0 | |
| 149939721 | 456 | avrPphB susceptible 1 [Arabidopsis thali | 0.971 | 0.973 | 0.839 | 0.0 | |
| 15240038 | 456 | serine/threonine-protein kinase PBS1 [Ar | 0.971 | 0.973 | 0.839 | 0.0 | |
| 149939759 | 456 | avrPphB susceptible 1 [Arabidopsis lyrat | 0.971 | 0.973 | 0.839 | 0.0 | |
| 297807331 | 456 | avrPphB susceptible 1 [Arabidopsis lyrat | 0.971 | 0.973 | 0.837 | 0.0 |
| >gi|255547614|ref|XP_002514864.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223545915|gb|EEF47418.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 831 bits (2147), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/461 (88%), Positives = 429/461 (93%), Gaps = 4/461 (0%)
Query: 1 MGCFPCFDSREDEKLNPEKEPDDQKQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELHLP 60
MGCFPCFDSRE+E LNP+KE DD+KQ PT S+NIS+L SG DRLRSRSNG SKREL P
Sbjct: 1 MGCFPCFDSREEETLNPQKESDDRKQSLPTESSNISKLSSGADRLRSRSNGRSKRELPSP 60
Query: 61 KDGA--GVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR 118
KDG GVNIAAQTFTFRELAAATKNFR ESFIGEGGFGRVYKG LE+TGQVVAVKQLDR
Sbjct: 61 KDGPVPGVNIAAQTFTFRELAAATKNFRQESFIGEGGFGRVYKGLLETTGQVVAVKQLDR 120
Query: 119 NGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 178
NGLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP K
Sbjct: 121 NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPAK 180
Query: 179 EALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238
E LDWNTRM+IAAGAAKGLEYLHDKANPPVIYRDFKSSNILL+EGFHPKLSDFGLAKLGP
Sbjct: 181 EPLDWNTRMRIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGP 240
Query: 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 298
GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ
Sbjct: 241 TGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 300
Query: 299 NLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358
NLVTWARPLFNDRRKFSKLADP+L+GRYP+RGLYQALAVASMCIQEQAA RPLIGDVVTA
Sbjct: 301 NLVTWARPLFNDRRKFSKLADPQLQGRYPMRGLYQALAVASMCIQEQAAARPLIGDVVTA 360
Query: 359 LSYLANQTYDPNSHRGAGDKDDRRNRD--GARIFKNDEGGGSGRRWDLEGSEKEDSPRET 416
LSYLANQ Y+PNS ++DD+RNRD G ++ K++EGGGSGRRWDLEGSEKEDSPRET
Sbjct: 361 LSYLANQAYEPNSTGHGRERDDKRNRDERGGQLSKSEEGGGSGRRWDLEGSEKEDSPRET 420
Query: 417 ARILNRDLERERAVAEAKMWGENLREKRRQSAQGSFDGTNG 457
R+LNRDL+RERAVAEAKMWGEN REKRRQSAQGSFDG+NG
Sbjct: 421 VRMLNRDLDRERAVAEAKMWGENWREKRRQSAQGSFDGSNG 461
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053527|ref|XP_002297857.1| serine/threonine protein kinase PBS1 [Populus trichocarpa] gi|222845115|gb|EEE82662.1| serine/threonine protein kinase PBS1 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 813 bits (2101), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/462 (85%), Positives = 426/462 (92%), Gaps = 5/462 (1%)
Query: 1 MGCFPCFDSREDEKLNPEKEPDDQKQGQPTVSNNISRLPSGRDRLRSRSNG-VSKRELHL 59
MGCFPCFDSRE+E LN EK+ DD KQ PTV +NIS+L SG DRLR RSNG SKR+L
Sbjct: 1 MGCFPCFDSREEEDLNREKQSDDLKQTLPTVPSNISKLSSGSDRLRPRSNGGQSKRQLPS 60
Query: 60 PKDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN 119
PKD GVNIAAQ F FRELAAATKNF PE F+GEGGFGRVYKG LESTGQVVAVKQLDRN
Sbjct: 61 PKDAPGVNIAAQIFAFRELAAATKNFMPECFLGEGGFGRVYKGCLESTGQVVAVKQLDRN 120
Query: 120 GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE 179
GLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP+KE
Sbjct: 121 GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPEKE 180
Query: 180 ALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239
LDWNTRMKIAAGAAKGLEYLHDKA+PPVIYRDFKSSNILLEEGF+PKLSDFGLAKLGP
Sbjct: 181 PLDWNTRMKIAAGAAKGLEYLHDKASPPVIYRDFKSSNILLEEGFNPKLSDFGLAKLGPT 240
Query: 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN 299
GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST+PHG+QN
Sbjct: 241 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTQPHGQQN 300
Query: 300 LVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359
LV WARPLFNDRRKFSKLADPRL+GRYP+RGLYQALAVASMCIQEQAA RPLIGDVVTAL
Sbjct: 301 LVAWARPLFNDRRKFSKLADPRLQGRYPMRGLYQALAVASMCIQEQAAARPLIGDVVTAL 360
Query: 360 SYLANQTYDPN--SHRGAGDKDDRRNRD--GARIFKNDEGGGSGRRWDLEGSEKEDSPRE 415
SYLANQ Y+PN HRG+GD+D++R RD G ++ +N+EGGGSGRRWDL+GSEKEDSPRE
Sbjct: 361 SYLANQAYEPNGHGHRGSGDRDEKRQRDERGGQLSRNEEGGGSGRRWDLDGSEKEDSPRE 420
Query: 416 TARILNRDLERERAVAEAKMWGENLREKRRQSAQGSFDGTNG 457
TA++LNRDL+RERAVAEAKMWGEN REK+RQ+AQGSFDG+NG
Sbjct: 421 TAKMLNRDLDRERAVAEAKMWGENWREKQRQNAQGSFDGSNG 462
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224075521|ref|XP_002304664.1| serine/threonine protein kinase PBS1 [Populus trichocarpa] gi|222842096|gb|EEE79643.1| serine/threonine protein kinase PBS1 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 805 bits (2078), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/456 (86%), Positives = 420/456 (92%), Gaps = 5/456 (1%)
Query: 1 MGCFPCFDSREDEKLNPEKEPDDQKQGQPTVSNNISRLPSGRDRLRSRSNG-VSKRELHL 59
MGCF CFDSRE+EKLN EK+ D KQ P VS+NIS+L SG DR +SRSNG SKREL
Sbjct: 1 MGCFSCFDSREEEKLNQEKQSVDLKQTLPPVSSNISKLSSGADRFKSRSNGEQSKRELPS 60
Query: 60 PKDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN 119
PKD GVNIAA FTFRELAAATKNFRPE F+GEGGFGRVYKG LESTGQVVAVKQLDRN
Sbjct: 61 PKDAPGVNIAAHIFTFRELAAATKNFRPECFLGEGGFGRVYKGRLESTGQVVAVKQLDRN 120
Query: 120 GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE 179
GLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP+KE
Sbjct: 121 GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPEKE 180
Query: 180 ALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239
LDWNTRMKIAAGAA+GLEYLHDKA+PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP
Sbjct: 181 PLDWNTRMKIAAGAARGLEYLHDKASPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPT 240
Query: 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN 299
GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS+RPHGEQN
Sbjct: 241 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSSRPHGEQN 300
Query: 300 LVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359
LVTW RPLFNDRRKFSKLADPRL+GRYP+RGLYQALAVASMCIQEQAA RPLIGDVVTAL
Sbjct: 301 LVTWTRPLFNDRRKFSKLADPRLQGRYPMRGLYQALAVASMCIQEQAAARPLIGDVVTAL 360
Query: 360 SYLANQTYDPNSH--RGAGDKDDRRNRD--GARIFKNDEGGGSGRRWDLEGSEKEDSPRE 415
SYLANQ Y+PN H RG GD+D++R+R+ G ++ +N+EGGGSGR+WDL+GSEKEDSPRE
Sbjct: 361 SYLANQAYEPNGHGYRGLGDRDEKRHREERGGQLSRNEEGGGSGRKWDLDGSEKEDSPRE 420
Query: 416 TARILNRDLERERAVAEAKMWGENLREKRRQSAQGS 451
TAR+LNRDL+RERAVAEAKMWGEN REKRRQSAQGS
Sbjct: 421 TARMLNRDLDRERAVAEAKMWGENWREKRRQSAQGS 456
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449445572|ref|XP_004140546.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] gi|449487387|ref|XP_004157601.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 803 bits (2073), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/471 (83%), Positives = 422/471 (89%), Gaps = 16/471 (3%)
Query: 1 MGCFPCFDSREDEKLNPEKEPDDQKQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELHLP 60
MGCFPCFDSRE+EKLNPEKE DD KQ P V NI++LPSG D+LRS+SNG SKRE +P
Sbjct: 1 MGCFPCFDSREEEKLNPEKESDDGKQDHPMVPPNIAKLPSGIDKLRSKSNGGSKREQQIP 60
Query: 61 KDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG 120
VNI+AQTFTFRELA ATKNFRPE FIGEGGFGRVYKG LEST Q+VAVKQLDRNG
Sbjct: 61 T--PLVNISAQTFTFRELATATKNFRPECFIGEGGFGRVYKGRLESTSQIVAVKQLDRNG 118
Query: 121 LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA 180
LQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH++PP+KE
Sbjct: 119 LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHEIPPEKEP 178
Query: 181 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240
LDWNTRMKIAAGAA+GLEYLHDKANPPVIYRDFKSSNILL+EG+HPKLSDFGLAKLGPVG
Sbjct: 179 LDWNTRMKIAAGAARGLEYLHDKANPPVIYRDFKSSNILLDEGYHPKLSDFGLAKLGPVG 238
Query: 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNL 300
DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR+AIDSTRP GEQNL
Sbjct: 239 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRRAIDSTRPQGEQNL 298
Query: 301 VTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360
VTWARP FNDRR+FSKLADP+L+GRYP+RGLYQALAVASMC QEQAA RPLIGDVVTALS
Sbjct: 299 VTWARPFFNDRRRFSKLADPQLQGRYPMRGLYQALAVASMCTQEQAAARPLIGDVVTALS 358
Query: 361 YLANQTYDPNS-----------HRGAGDKDDRRNRD---GARIFKNDEGGGSGRRWDLEG 406
YLANQ+YDP+S RG+GD+D+RRNRD G + KN+EGG SGRRW L+G
Sbjct: 359 YLANQSYDPSSPSGTAAAGTAAQRGSGDRDERRNRDEKGGGGMVKNEEGGASGRRWPLDG 418
Query: 407 SEKEDSPRETARILNRDLERERAVAEAKMWGENLREKRRQSAQGSFDGTNG 457
EK+DSPRETARILNRDL+RERAVAEAKMWGEN REKRRQS QGSFDG+NG
Sbjct: 419 PEKDDSPRETARILNRDLDRERAVAEAKMWGENWREKRRQSTQGSFDGSNG 469
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225425176|ref|XP_002265076.1| PREDICTED: serine/threonine-protein kinase PBS1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 791 bits (2042), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/464 (84%), Positives = 422/464 (90%), Gaps = 7/464 (1%)
Query: 1 MGCFPCFDSREDEKLNPEKEPDDQKQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELHLP 60
MGCFPCFDSRE+EKLNP+K DD+++ V++NISRL SG DRL++R++ K+E P
Sbjct: 1 MGCFPCFDSREEEKLNPDKGRDDRRESPQMVASNISRLSSGADRLKARNSTGLKKESSGP 60
Query: 61 KDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG 120
KD +IAAQTFTFRELA ATKNF+PESFIGEGGFGRVYKG LESTGQVVAVKQLDR G
Sbjct: 61 KDVPDGHIAAQTFTFRELAVATKNFQPESFIGEGGFGRVYKGRLESTGQVVAVKQLDREG 120
Query: 121 LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA 180
LQGNREFLVEVLMLSLLHH NLVNLIGYCADG+QRLLVYEFMPLGSLEDHL DLPPDKE
Sbjct: 121 LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGEQRLLVYEFMPLGSLEDHLLDLPPDKEP 180
Query: 181 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240
LDWNTRMKIAAGAAKGLEYLHDKA+PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG
Sbjct: 181 LDWNTRMKIAAGAAKGLEYLHDKASPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240
Query: 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNL 300
DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST PHGEQNL
Sbjct: 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTLPHGEQNL 300
Query: 301 VTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360
VTWARPLFNDRRKF+KLADPRL GRYP+RGLYQALAVASMCIQEQAATRPLIGDVVTALS
Sbjct: 301 VTWARPLFNDRRKFAKLADPRLHGRYPMRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360
Query: 361 YLANQTYDPNS-----HRGAG--DKDDRRNRDGARIFKNDEGGGSGRRWDLEGSEKEDSP 413
YLANQ+YDPN+ +RG+G D+ R AR+ +N++GGGSGRRWDLEGSE+EDSP
Sbjct: 361 YLANQSYDPNAAHGHIYRGSGDRDERRNREERSARVTRNEDGGGSGRRWDLEGSEREDSP 420
Query: 414 RETARILNRDLERERAVAEAKMWGENLREKRRQSAQGSFDGTNG 457
RETAR+LNRDL+RERAVAEAKMWGEN REKRRQSAQGSFDGTNG
Sbjct: 421 RETARMLNRDLDRERAVAEAKMWGENWREKRRQSAQGSFDGTNG 464
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351721508|ref|NP_001235164.1| serine/threonine-protein kinase [Glycine max] gi|223452434|gb|ACM89544.1| serine/threonine-protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 781 bits (2018), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/459 (84%), Positives = 413/459 (89%), Gaps = 15/459 (3%)
Query: 1 MGCFPCFDS--REDEKLNPEKEPDDQKQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELH 58
MGCF CFDS +ED L P+ +P+ QP + + ISRLPSG D+LRSRSNG SKREL
Sbjct: 1 MGCFSCFDSSSKEDHNLRPQHQPN-----QP-LPSQISRLPSGADKLRSRSNGGSKRELQ 54
Query: 59 LPKDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR 118
P V IAAQTFTFRELAAATKNFRPESF+GEGGFGRVYKG LE+T Q+VAVKQLD+
Sbjct: 55 QPP--PTVQIAAQTFTFRELAAATKNFRPESFVGEGGFGRVYKGRLETTAQIVAVKQLDK 112
Query: 119 NGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 178
NGLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK
Sbjct: 113 NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 172
Query: 179 EALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238
E LDWNTRMKIA GAAKGLEYLHDKANPPVIYRDFKSSNILL+EG+HPKLSDFGLAKLGP
Sbjct: 173 EPLDWNTRMKIAVGAAKGLEYLHDKANPPVIYRDFKSSNILLDEGYHPKLSDFGLAKLGP 232
Query: 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 298
VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST+P GEQ
Sbjct: 233 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTQPQGEQ 292
Query: 299 NLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358
NLVTWARPLFNDRRKFSKLADPRL+GR+P+RGLYQALAVASMCIQE AATRPLIGDVVTA
Sbjct: 293 NLVTWARPLFNDRRKFSKLADPRLQGRFPMRGLYQALAVASMCIQESAATRPLIGDVVTA 352
Query: 359 LSYLANQTYDPNSHRGAGDKDDRRNRD--GARIFKNDEGGGSGRRWDLEGSEKEDSPRET 416
LSYLANQ YDPN +RG+ DD+RNRD G RI KNDE GGSGRRWDLEGSEK+DSPRET
Sbjct: 353 LSYLANQAYDPNGYRGS--SDDKRNRDDKGGRISKNDEAGGSGRRWDLEGSEKDDSPRET 410
Query: 417 ARILNRDLERERAVAEAKMWGENLREKRRQS-AQGSFDG 454
ARILNRDL+RERAVAEAKMWGENLR+KR+QS QGS D
Sbjct: 411 ARILNRDLDRERAVAEAKMWGENLRQKRKQSLQQGSLDA 449
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|149939721|gb|ABR46067.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939753|gb|ABR46083.1| avrPphB susceptible 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 772 bits (1994), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/456 (83%), Positives = 407/456 (89%), Gaps = 12/456 (2%)
Query: 1 MGCFPCFDSREDEKLNPEKEPD--DQKQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELH 58
MGCF CFDS +DEKLNP E + +KQ QPTVSNNIS LPSG ++L S++NG SKREL
Sbjct: 1 MGCFSCFDSSDDEKLNPVDESNHVQKKQSQPTVSNNISGLPSGGEKLSSKTNGGSKRELL 60
Query: 59 LPKDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR 118
LP+DG G IAA TF FRELAAAT NF P++F+GEGGFGRVYKG L+STGQVVAVKQLDR
Sbjct: 61 LPRDGLG-QIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDR 119
Query: 119 NGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 178
NGLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK
Sbjct: 120 NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 179
Query: 179 EALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238
EALDWN RMKIAAGAAKGLE+LHDKANPPVIYRDFKSSNILL+EGFHPKLSDFGLAKLGP
Sbjct: 180 EALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGP 239
Query: 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 298
GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS PHGEQ
Sbjct: 240 TGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQ 299
Query: 299 NLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358
NLV WARPLFNDRRKF KLADPRL+GR+P R LYQALAVASMCIQEQAATRPLI DVVTA
Sbjct: 300 NLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTA 359
Query: 359 LSYLANQTYDPNSHRGAGDKDDRRNRD--GAR-IFKNDEGGGSGRRWDLEGSEKEDSPRE 415
LSYLANQ YDP+ D RRNRD GAR I +ND+GGGSG ++DLEGSEKEDSPRE
Sbjct: 360 LSYLANQAYDPSK------DDSRRNRDERGARLITRNDDGGGSGSKFDLEGSEKEDSPRE 413
Query: 416 TARILNRDLERERAVAEAKMWGENLREKRRQSAQGS 451
TARILNRD+ RERAVAEAKMWGE+LREKRRQS QG+
Sbjct: 414 TARILNRDINRERAVAEAKMWGESLREKRRQSEQGT 449
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15240038|ref|NP_196820.1| serine/threonine-protein kinase PBS1 [Arabidopsis thaliana] gi|45477166|sp|Q9FE20.1|PBS1_ARATH RecName: Full=Serine/threonine-protein kinase PBS1; AltName: Full=AvrPphB susceptible protein 1 gi|11559838|gb|AAG38109.1|AF314176_1 protein serine/threonine kinase PBS1 [Arabidopsis thaliana] gi|13937147|gb|AAK50067.1|AF372927_1 AT5g13160/T19L5_120 [Arabidopsis thaliana] gi|9955560|emb|CAC05444.1| protein kinase-like [Arabidopsis thaliana] gi|18700256|gb|AAL77738.1| AT5g13160/T19L5_120 [Arabidopsis thaliana] gi|149939719|gb|ABR46066.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939723|gb|ABR46068.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939725|gb|ABR46069.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939727|gb|ABR46070.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939729|gb|ABR46071.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939731|gb|ABR46072.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939733|gb|ABR46073.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939735|gb|ABR46074.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939737|gb|ABR46075.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939739|gb|ABR46076.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939741|gb|ABR46077.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939743|gb|ABR46078.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939745|gb|ABR46079.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939747|gb|ABR46080.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939749|gb|ABR46081.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939751|gb|ABR46082.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939755|gb|ABR46084.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939757|gb|ABR46085.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|332004475|gb|AED91858.1| serine/threonine-protein kinase PBS1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 772 bits (1994), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/456 (83%), Positives = 407/456 (89%), Gaps = 12/456 (2%)
Query: 1 MGCFPCFDSREDEKLNPEKEPD--DQKQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELH 58
MGCF CFDS +DEKLNP E + +KQ QPTVSNNIS LPSG ++L S++NG SKREL
Sbjct: 1 MGCFSCFDSSDDEKLNPVDESNHGQKKQSQPTVSNNISGLPSGGEKLSSKTNGGSKRELL 60
Query: 59 LPKDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR 118
LP+DG G IAA TF FRELAAAT NF P++F+GEGGFGRVYKG L+STGQVVAVKQLDR
Sbjct: 61 LPRDGLG-QIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDR 119
Query: 119 NGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 178
NGLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK
Sbjct: 120 NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 179
Query: 179 EALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238
EALDWN RMKIAAGAAKGLE+LHDKANPPVIYRDFKSSNILL+EGFHPKLSDFGLAKLGP
Sbjct: 180 EALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGP 239
Query: 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 298
GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS PHGEQ
Sbjct: 240 TGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQ 299
Query: 299 NLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358
NLV WARPLFNDRRKF KLADPRL+GR+P R LYQALAVASMCIQEQAATRPLI DVVTA
Sbjct: 300 NLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTA 359
Query: 359 LSYLANQTYDPNSHRGAGDKDDRRNRD--GAR-IFKNDEGGGSGRRWDLEGSEKEDSPRE 415
LSYLANQ YDP+ D RRNRD GAR I +ND+GGGSG ++DLEGSEKEDSPRE
Sbjct: 360 LSYLANQAYDPSK------DDSRRNRDERGARLITRNDDGGGSGSKFDLEGSEKEDSPRE 413
Query: 416 TARILNRDLERERAVAEAKMWGENLREKRRQSAQGS 451
TARILNRD+ RERAVAEAKMWGE+LREKRRQS QG+
Sbjct: 414 TARILNRDINRERAVAEAKMWGESLREKRRQSEQGT 449
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|149939759|gb|ABR46086.1| avrPphB susceptible 1 [Arabidopsis lyrata] gi|149939761|gb|ABR46087.1| avrPphB susceptible 1 [Arabidopsis lyrata] gi|149939763|gb|ABR46088.1| avrPphB susceptible 1 [Arabidopsis lyrata] gi|149939765|gb|ABR46089.1| avrPphB susceptible 1 [Arabidopsis lyrata] gi|149939767|gb|ABR46090.1| avrPphB susceptible 1 [Arabidopsis lyrata] | Back alignment and taxonomy information |
|---|
Score = 765 bits (1976), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/456 (83%), Positives = 407/456 (89%), Gaps = 12/456 (2%)
Query: 1 MGCFPCFDSRED-EKLNPEKEPDDQK-QGQPTVSNNISRLPSGRDRLRSRSNGVSKRELH 58
MGCF CFDS +D EKLNP E + QK Q QPTVSNNIS LPSG ++L S++NG SKREL
Sbjct: 1 MGCFSCFDSSDDDEKLNPVVESNGQKKQPQPTVSNNISGLPSGGEKLSSKTNGGSKRELL 60
Query: 59 LPKDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR 118
LP+DG G IAA TF FRELAAAT NF P++F+GEGGFGRVYKG L+STGQVVAVKQLDR
Sbjct: 61 LPRDGLG-QIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDR 119
Query: 119 NGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 178
NGLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK
Sbjct: 120 NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 179
Query: 179 EALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238
EALDWN RMKIAAGAAKGLE+LHDKANPPVIYRDFKSSNILL+EGFHPKLSDFGLAKLGP
Sbjct: 180 EALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGP 239
Query: 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 298
GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS PHGEQ
Sbjct: 240 TGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQ 299
Query: 299 NLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358
NLV WARPLFNDRRKF KLADPRL+GR+P R LYQALAVASMCIQEQAATRPLI DVVTA
Sbjct: 300 NLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTA 359
Query: 359 LSYLANQTYDPNSHRGAGDKDDRRNRD--GAR-IFKNDEGGGSGRRWDLEGSEKEDSPRE 415
LSYLANQ YDP+ D +RNRD GAR I +ND+GGGSG ++DLEGSEKEDSPRE
Sbjct: 360 LSYLANQGYDPSK------DDSKRNRDERGARLITRNDDGGGSGSKFDLEGSEKEDSPRE 413
Query: 416 TARILNRDLERERAVAEAKMWGENLREKRRQSAQGS 451
TARILNRD+ RERAVAEAKMWGE+LREKRRQS QG+
Sbjct: 414 TARILNRDINRERAVAEAKMWGESLREKRRQSEQGT 449
|
Source: Arabidopsis lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297807331|ref|XP_002871549.1| avrPphB susceptible 1 [Arabidopsis lyrata subsp. lyrata] gi|297317386|gb|EFH47808.1| avrPphB susceptible 1 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 764 bits (1974), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/456 (83%), Positives = 406/456 (89%), Gaps = 12/456 (2%)
Query: 1 MGCFPCFDSRED-EKLNPEKEPDDQK-QGQPTVSNNISRLPSGRDRLRSRSNGVSKRELH 58
MGCF CFDS +D EKLNP E + QK Q QPTVSNNIS LPSG ++L S++NG SKREL
Sbjct: 1 MGCFSCFDSSDDDEKLNPVVESNGQKKQSQPTVSNNISGLPSGGEKLSSKTNGGSKRELL 60
Query: 59 LPKDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR 118
LP+DG G IAA TF FRELAAAT NF P++F+GEGGFGRVYKG L+STGQVVAVKQLDR
Sbjct: 61 LPRDGLG-QIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDR 119
Query: 119 NGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 178
NGLQGNREFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK
Sbjct: 120 NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 179
Query: 179 EALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238
EALDWN RMKIAAGAAKGLE+LHDKANPPVIYRDFKSSNILL+EGFHPKLSDFGLAKLGP
Sbjct: 180 EALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGP 239
Query: 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 298
GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS PHGEQ
Sbjct: 240 TGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQ 299
Query: 299 NLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358
NLV WARPLFNDRRKF KLADPRL+GR+P R LYQALAVASMCIQEQAATRPLI DVVTA
Sbjct: 300 NLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTA 359
Query: 359 LSYLANQTYDPNSHRGAGDKDDRRNRD--GAR-IFKNDEGGGSGRRWDLEGSEKEDSPRE 415
LSYLANQ YDP+ D +RNRD GAR I +ND+GGGSG ++DLEGSEKEDSPRE
Sbjct: 360 LSYLANQGYDPSK------DDSKRNRDERGARLITRNDDGGGSGSKFDLEGSEKEDSPRE 413
Query: 416 TARILNRDLERERAVAEAKMWGENLREKRRQSAQGS 451
T RILNRD+ RERAVAEAKMWGE+LREKRRQS QG+
Sbjct: 414 TGRILNRDINRERAVAEAKMWGESLREKRRQSEQGT 449
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 457 | ||||||
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.980 | 0.982 | 0.800 | 4e-193 | |
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.962 | 0.857 | 0.642 | 8.1e-147 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.781 | 0.944 | 0.677 | 2.9e-126 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.778 | 0.859 | 0.618 | 2.2e-118 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.757 | 0.896 | 0.635 | 4.9e-117 | |
| TAIR|locus:2056613 | 424 | AT2G28590 [Arabidopsis thalian | 0.814 | 0.877 | 0.583 | 2.2e-112 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.763 | 0.897 | 0.605 | 3.4e-109 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.678 | 0.853 | 0.670 | 8.1e-108 | |
| TAIR|locus:2036818 | 389 | AT1G61860 [Arabidopsis thalian | 0.776 | 0.912 | 0.591 | 5.7e-107 | |
| TAIR|locus:2075517 | 558 | AT3G02810 [Arabidopsis thalian | 0.733 | 0.600 | 0.583 | 3.1e-106 |
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1871 (663.7 bits), Expect = 4.0e-193, P = 4.0e-193
Identities = 370/462 (80%), Positives = 397/462 (85%)
Query: 1 MGCFPCFDSREDEKLNPEKEPD--DQKQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELH 58
MGCF CFDS +DEKLNP E + +KQ QPTVSNNIS LPSG ++L S++NG SKREL
Sbjct: 1 MGCFSCFDSSDDEKLNPVDESNHGQKKQSQPTVSNNISGLPSGGEKLSSKTNGGSKRELL 60
Query: 59 LPKDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR 118
LP+DG G IAA TF FRELAAAT NF P++F+GEGGFGRVYKG L+STGQVVAVKQLDR
Sbjct: 61 LPRDGLG-QIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDR 119
Query: 119 NGLQGNREFLVEXXXXXXXXXXXXXXXIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 178
NGLQGNREFLVE IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK
Sbjct: 120 NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 179
Query: 179 EALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238
EALDWN RMKIAAGAAKGLE+LHDKANPPVIYRDFKSSNILL+EGFHPKLSDFGLAKLGP
Sbjct: 180 EALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGP 239
Query: 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 298
GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS PHGEQ
Sbjct: 240 TGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQ 299
Query: 299 NLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358
NLV WARPLFNDRRKF KLADPRL+GR+P R LYQALAVASMCIQEQAATRPLI DVVTA
Sbjct: 300 NLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTA 359
Query: 359 LSYLANQTYDPNSHRGAGDKDD-RRNRD--GARIF-KNDEGGGSGRRWDLEGSEKEDSPR 414
LSYLANQ YDP+ KDD RRNRD GAR+ +ND+GGGSG ++DLEGSEKEDSPR
Sbjct: 360 LSYLANQAYDPS-------KDDSRRNRDERGARLITRNDDGGGSGSKFDLEGSEKEDSPR 412
Query: 415 ETARILNRDLERERAVAEAKMWGENLREKRRQSAQGSFDGTN 456
ETARILNRD+ RERAVAEAKMWGE+LREKRRQS QG+ + +
Sbjct: 413 ETARILNRDINRERAVAEAKMWGESLREKRRQSEQGTSESNS 454
|
|
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1434 (509.9 bits), Expect = 8.1e-147, P = 8.1e-147
Identities = 302/470 (64%), Positives = 346/470 (73%)
Query: 2 GCFPCFDSREDEKLNPE--KEPDDQKQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELHL 59
GC PCF S + + + K+ K G T S++IS D+ +SR K+EL
Sbjct: 3 GCLPCFGSSAKDAASKDSVKKELSAKDGSVTQSHHISL-----DKSKSRRGPEQKKELTA 57
Query: 60 PKDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN 119
PK+G +IAAQTFTFRELAAATKNFRPE +GEGGFGRVYKG LE+TGQ+VAVKQLDRN
Sbjct: 58 PKEGPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTGQIVAVKQLDRN 117
Query: 120 GLQGNREFLVEXXXXXXXXXXXXXXXIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE 179
GLQGNREFLVE IGYCADGDQRLLVYE+MPLGSLEDHLHDLPPDKE
Sbjct: 118 GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKE 177
Query: 180 ALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239
LDW+TRM IAAGAAKGLEYLHDKANPPVIYRD KSSNILL +G+HPKLSDFGLAKLGPV
Sbjct: 178 PLDWSTRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKLSDFGLAKLGPV 237
Query: 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN 299
GDK+HVSTRVMGTYGYCAPEYAMTGQLT+KSDVYSFGVVFLELITGRKAID+ R GE N
Sbjct: 238 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNARAPGEHN 297
Query: 300 LVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359
LV WARPLF DRRKF K+ADP L+GRYP+RGLYQALAVA+MC+QEQAATRPLIGDVVTAL
Sbjct: 298 LVAWARPLFKDRRKFPKMADPSLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTAL 357
Query: 360 SYLANQTYDPN------SHRGAGD-----KDDRRNR-DGARIFKNDEGGGSGRRWDLEGS 407
+YLA+QT+DPN S G+G +DDRR+ DG+ + D + R +
Sbjct: 358 TYLASQTFDPNAPSGQNSRSGSGPPFIRTRDDRRSLGDGSSL---DSPAETRSRLGSPAT 414
Query: 408 EKEDSP----RETARILNRDLE--RERAVAEAKMWGENLREKRRQSAQGS 451
K +SP R+ R +N E E + WG + E + +S +GS
Sbjct: 415 HK-NSPDYRRRDMVREVNAGSEGGSETGGGSGRKWGLSDLEGQ-ESQRGS 462
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1240 (441.6 bits), Expect = 2.9e-126, P = 2.9e-126
Identities = 250/369 (67%), Positives = 277/369 (75%)
Query: 1 MGCFPCFDSREDEKLNPEKEPDDQKQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELHLP 60
MG PC S + N + D K + + ++S R + S S SK H
Sbjct: 1 MGWIPC--SGKSSGRNKTRRNGDHKLDRKSSDCSVSTSEKSRAK-SSLSESKSKGSDH-- 55
Query: 61 KDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG 120
I AQTFTF ELA AT+NFR E IGEGGFGRVYKG+L ST Q A+KQLD NG
Sbjct: 56 -------IVAQTFTFSELATATRNFRKECLIGEGGFGRVYKGYLASTSQTAAIKQLDHNG 108
Query: 121 LQGNREFLVEXXXXXXXXXXXXXXXIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA 180
LQGNREFLVE IGYCADGDQRLLVYE+MPLGSLEDHLHD+ P K+
Sbjct: 109 LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQP 168
Query: 181 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240
LDWNTRMKIAAGAAKGLEYLHDK PPVIYRD K SNILL++ + PKLSDFGLAKLGPVG
Sbjct: 169 LDWNTRMKIAAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPVG 228
Query: 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNL 300
DKSHVSTRVMGTYGYCAPEYAMTGQLT+KSDVYSFGVV LE+ITGRKAIDS+R GEQNL
Sbjct: 229 DKSHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQNL 288
Query: 301 VTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360
V WARPLF DRRKFS++ADP L+G+YP RGLYQALAVA+MC+QEQ RPLI DVVTALS
Sbjct: 289 VAWARPLFKDRRKFSQMADPMLQGQYPPRGLYQALAVAAMCVQEQPNLRPLIADVVTALS 348
Query: 361 YLANQTYDP 369
YLA+Q +DP
Sbjct: 349 YLASQKFDP 357
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1129 (402.5 bits), Expect = 2.2e-118, Sum P(2) = 2.2e-118
Identities = 224/362 (61%), Positives = 266/362 (73%)
Query: 1 MGCFPCFDSREDEKLNPEKEPDDQKQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELHLP 60
M CF CF E +K+ + + ++ G+ T +N P + ++ +
Sbjct: 1 MNCFSCFYFHEKKKVPRDSDNSYRRNGEVTGRDNNKTHPENPKTVNEQNKNNDE-----D 55
Query: 61 KDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG 120
K+ NIAAQTF+FRELA ATKNFR E IGEGGFGRVYKG LE TG +VAVKQLDRNG
Sbjct: 56 KEVTN-NIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNG 114
Query: 121 LQGNREFLVEXXXXXXXXXXXXXXXIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA 180
LQGN+EF+VE IGYCADGDQRLLVYE+M GSLEDHL DL PD+
Sbjct: 115 LQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIP 174
Query: 181 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240
LDW+TR++IA GAA GLEYLHDKANPPVIYRD K++NILL+ F+ KLSDFGLAKLGPVG
Sbjct: 175 LDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVG 234
Query: 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNL 300
DK HVS+RVMGTYGYCAPEY TGQLT KSDVYSFGVV LELITGR+ ID+TRP EQNL
Sbjct: 235 DKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNL 294
Query: 301 VTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360
VTWA+P+F + +F +LADP LEG +P + L QA+AVA+MC+QE+A RPL+ DVVTAL
Sbjct: 295 VTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALG 354
Query: 361 YL 362
+L
Sbjct: 355 FL 356
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1153 (410.9 bits), Expect = 4.9e-117, P = 4.9e-117
Identities = 225/354 (63%), Positives = 277/354 (78%)
Query: 33 NNISRLPSGRDRLRSRSNGVSKREL--HLPKDGAGVNIAAQTFTFRELAAATKNFRPESF 90
NNI+ D + +++ +R + + K G G NI+A FTFREL ATKNF P++
Sbjct: 33 NNITTF----DNISFKTDSSRRRYISEEIAKLGKG-NISAHIFTFRELCVATKNFNPDNQ 87
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEXXXXXXXXXXXXXXXIGYCA 150
+GEGGFGRVYKG +E+ QVVAVKQLDRNG QGNREFLVE +GYCA
Sbjct: 88 LGEGGFGRVYKGQIETPEQVVAVKQLDRNGYQGNREFLVEVMMLSLLHHQNLVNLVGYCA 147
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEA-LDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
DGDQR+LVYE+M GSLEDHL +L +K+ LDW+TRMK+AAGAA+GLEYLH+ A+PPVI
Sbjct: 148 DGDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDTRMKVAAGAARGLEYLHETADPPVI 207
Query: 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVK 269
YRDFK+SNILL+E F+PKLSDFGLAK+GP G ++HVSTRVMGTYGYCAPEYA+TGQLTVK
Sbjct: 208 YRDFKASNILLDEEFNPKLSDFGLAKVGPTGGETHVSTRVMGTYGYCAPEYALTGQLTVK 267
Query: 270 SDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIR 329
SDVYSFGVVFLE+ITGR+ ID+T+P EQNLVTWA PLF DRRKF+ +ADP LEG+YPI+
Sbjct: 268 SDVYSFGVVFLEMITGRRVIDTTKPTEEQNLVTWASPLFKDRRKFTLMADPLLEGKYPIK 327
Query: 330 GLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNSHRGAGDKDDRRN 383
GLYQALAVA+MC+QE+AATRP++ DVVTAL YLA + + G++++ +
Sbjct: 328 GLYQALAVAAMCLQEEAATRPMMSDVVTALEYLAVTKTEEDGQTVEGEEEEEED 381
|
|
| TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1109 (395.4 bits), Expect = 2.2e-112, P = 2.2e-112
Identities = 230/394 (58%), Positives = 275/394 (69%)
Query: 1 MGCF---PCFDSREDEKLNPEKEPDDQKQGQPTVSNNISRL--PSGRDRLR-SRSNGVSK 54
MGCF P + R D K + +K TV+ N +L PS D L+ S VSK
Sbjct: 1 MGCFGRTPKSNKRSDTKTTKNNDFTPKKL---TVNANRDKLTQPSS-DCLKVSICGDVSK 56
Query: 55 ----RELHLPKDGAGVNIA-------AQTFTFRELAAATKNFRPESFIGEGGFGRVYKGW 103
++ L D N+ AQTFTF EL+ +T NF+ + F+GEGGFG+VYKG+
Sbjct: 57 EIVTKKDQLALDAKDTNVEDEVIVKKAQTFTFEELSVSTGNFKSDCFLGEGGFGKVYKGF 116
Query: 104 LESTGQVVAVKQLDRNGLQGNREFLVEXXXXXXXXXXXXXXXIGYCADGDQRLLVYEFMP 163
+E QVVA+KQLDRNG QG REF+VE IG+CA+G QRLLVYE+MP
Sbjct: 117 IEKINQVVAIKQLDRNGAQGIREFVVEVLTLSLADHPNLVKLIGFCAEGVQRLLVYEYMP 176
Query: 164 LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG 223
LGSL++HLHDLP K L WNTRMKIAAGAA+GLEYLHD PPVIYRD K SNIL++EG
Sbjct: 177 LGSLDNHLHDLPSGKNPLAWNTRMKIAAGAARGLEYLHDTMKPPVIYRDLKCSNILIDEG 236
Query: 224 FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELI 283
+H KLSDFGLAK+GP G ++HVSTRVMGTYGYCAP+YA+TGQLT KSDVYSFGVV LELI
Sbjct: 237 YHAKLSDFGLAKVGPRGSETHVSTRVMGTYGYCAPDYALTGQLTFKSDVYSFGVVLLELI 296
Query: 284 TGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQ 343
TGRKA D+TR Q+LV WA PLF DR+ F K+ DP LEG YP+RGLYQALA+A+MC+Q
Sbjct: 297 TGRKAYDNTRTRNHQSLVEWANPLFKDRKNFKKMVDPLLEGDYPVRGLYQALAIAAMCVQ 356
Query: 344 EQAATRPLIGDVVTALSYLANQTYDPNSHRGAGD 377
EQ + RP+I DVV AL +LA+ YD SHR D
Sbjct: 357 EQPSMRPVIADVVMALDHLASSKYD-RSHRQKQD 389
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1079 (384.9 bits), Expect = 3.4e-109, P = 3.4e-109
Identities = 218/360 (60%), Positives = 263/360 (73%)
Query: 16 NPEKEPDDQKQGQPTVSNNISRLPSGRDRLRS-RSNGVSKRELHLPKDGAGVNIAAQTFT 74
N +E + P N+ R + R ++ + + G +K PK NI A++F
Sbjct: 11 NKSRENEGSSMAAPYEQQNLPR--NDRRQITTWEAVGTNKES---PK-----NIKAKSFK 60
Query: 75 FRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEXXXX 134
FRELA AT +FR E IGEGGFGRVYKG +E TGQVVAVKQLDRNGLQGNREFLVE
Sbjct: 61 FRELATATNSFRQEFLIGEGGFGRVYKGKMEKTGQVVAVKQLDRNGLQGNREFLVEIFRL 120
Query: 135 XXXXXXXXXXXIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAA 194
IGYC DGDQRLLV+EFMPLGSLEDHL D+ ++ LDWN+R++IA GAA
Sbjct: 121 SLLHHPNLANLIGYCLDGDQRLLVHEFMPLGSLEDHLLDVVVGQQPLDWNSRIRIALGAA 180
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 254
KGLEYLH+KANPPVIYRDFKSSNILL F KLSDFGLAKLG VGD +VS+RV+GTYG
Sbjct: 181 KGLEYLHEKANPPVIYRDFKSSNILLNVDFDAKLSDFGLAKLGSVGDTQNVSSRVVGTYG 240
Query: 255 YCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314
YCAPEY TGQLTVKSDVYSFGVV LELITG++ ID+TRP EQNLVTWA+P+F + +F
Sbjct: 241 YCAPEYHKTGQLTVKSDVYSFGVVLLELITGKRVIDTTRPCHEQNLVTWAQPIFREPNRF 300
Query: 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNSHRG 374
+LADP L+G +P + L QA+A+A+MC+QE+ RPLI DVVTALS+++ +T P+ G
Sbjct: 301 PELADPLLQGEFPEKSLNQAVAIAAMCLQEEPIVRPLISDVVTALSFMSTETGSPSGLTG 360
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1066 (380.3 bits), Expect = 8.1e-108, P = 8.1e-108
Identities = 208/310 (67%), Positives = 239/310 (77%)
Query: 62 DGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL 121
+G N+ A+ FTFRELA ATKNFR E IGEGGFGRVYKG LE+ QVVAVKQLDRNGL
Sbjct: 24 NGPSNNMGARIFTFRELATATKNFRQECLIGEGGFGRVYKGKLENPAQVVAVKQLDRNGL 83
Query: 122 QGNREFLVEXXXXXXXXXXXXXXXIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEAL 181
QG REFLVE IGYCADGDQRLLVYE+MPLGSLEDHL DL P ++ L
Sbjct: 84 QGQREFLVEVLMLSLLHHRNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLLDLEPGQKPL 143
Query: 182 DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241
DWNTR+KIA GAAKG+EYLHD+A+PPVIYRD KSSNILL+ + KLSDFGLAKLGPVGD
Sbjct: 144 DWNTRIKIALGAAKGIEYLHDEADPPVIYRDLKSSNILLDPEYVAKLSDFGLAKLGPVGD 203
Query: 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV 301
HVS+RVMGTYGYCAPEY TG LT KSDVYSFGVV LELI+GR+ ID+ RP EQNLV
Sbjct: 204 TLHVSSRVMGTYGYCAPEYQRTGYLTNKSDVYSFGVVLLELISGRRVIDTMRPSHEQNLV 263
Query: 302 TWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 361
TWA P+F D ++ +LADP L G YP + L QA+AVA+MC+ E+ RPL+ DV+TALS+
Sbjct: 264 TWALPIFRDPTRYWQLADPLLRGDYPEKSLNQAIAVAAMCLHEEPTVRPLMSDVITALSF 323
Query: 362 LANQTYDPNS 371
L + N+
Sbjct: 324 LGASSNSSNT 333
|
|
| TAIR|locus:2036818 AT1G61860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1058 (377.5 bits), Expect = 5.7e-107, P = 5.7e-107
Identities = 214/362 (59%), Positives = 253/362 (69%)
Query: 5 PCFDSREDEKLNPEKEPDDQKQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELHLP---K 61
PCF + +L P D +G T SR RS G S R+ ++ K
Sbjct: 6 PCFIN--PHQLGPNSPRDSFDEGL-TAYRGHSRKLFALFTFRSHRKG-SCRQKYITEEIK 61
Query: 62 DGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL 121
V + F F+EL AAT NF + IGEGGFGRVYKG+L S QVVAVK+LDRNGL
Sbjct: 62 KYGNVKNCGRIFKFKELIAATDNFSMDCMIGEGGFGRVYKGFLTSLNQVVAVKRLDRNGL 121
Query: 122 QGNREFLVEXXXXXXXXXXXXXXXIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEAL 181
QG REF E IGYC + +QR+LVYEFMP GSLEDHL DLP +L
Sbjct: 122 QGTREFFAEVMVLSLAQHPNLVNLIGYCVEDEQRVLVYEFMPNGSLEDHLFDLPEGSPSL 181
Query: 182 DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241
DW TRM+I GAAKGLEYLHD A+PPVIYRDFK+SNILL+ F+ KLSDFGLA+LGP
Sbjct: 182 DWFTRMRIVHGAAKGLEYLHDYADPPVIYRDFKASNILLQSDFNSKLSDFGLARLGPTEG 241
Query: 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV 301
K HVSTRVMGTYGYCAPEYAMTGQLT KSDVYSFGVV LE+I+GR+AID RP EQNL+
Sbjct: 242 KDHVSTRVMGTYGYCAPEYAMTGQLTAKSDVYSFGVVLLEIISGRRAIDGDRPTEEQNLI 301
Query: 302 TWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 361
+WA PL DRR F+++ DP L+G YP++GL+QALA+A+MC+QE+A TRPL+GDVVTAL +
Sbjct: 302 SWAEPLLKDRRMFAQIVDPNLDGNYPVKGLHQALAIAAMCLQEEAETRPLMGDVVTALEF 361
Query: 362 LA 363
LA
Sbjct: 362 LA 363
|
|
| TAIR|locus:2075517 AT3G02810 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1005 (358.8 bits), Expect = 3.1e-106, Sum P(2) = 3.1e-106
Identities = 202/346 (58%), Positives = 250/346 (72%)
Query: 25 KQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELHLPKDGAGVNIAAQTFTFRELAAATKN 84
K+ T N + P DR R+ E+ +G + I FTFRELA ATKN
Sbjct: 13 KKSSTTNETNDNNEPKPDDRRRAEET----EEIE-QSEGTSLKI----FTFRELATATKN 63
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEXXXXXXXXXXXXXX 144
FR E +GEGGFGRVYKG L+STGQVVAVKQLD++GL GN+EF E
Sbjct: 64 FRQECLLGEGGFGRVYKGTLKSTGQVVAVKQLDKHGLHGNKEFQAEVLSLGQLDHPNLVK 123
Query: 145 XIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
IGYCADGDQRLLVY+++ GSL+DHLH+ D + +DW TRM+IA AA+GL+YLHDKA
Sbjct: 124 LIGYCADGDQRLLVYDYISGGSLQDHLHEPKADSDPMDWTTRMQIAYAAAQGLDYLHDKA 183
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP-VGDKSH-VSTRVMGTYGYCAPEYAM 262
NPPVIYRD K+SNILL++ F PKLSDFGL KLGP GDK +S+RVMGTYGY APEY
Sbjct: 184 NPPVIYRDLKASNILLDDDFSPKLSDFGLHKLGPGTGDKMMALSSRVMGTYGYSAPEYTR 243
Query: 263 TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322
G LT+KSDVYSFGVV LELITGR+A+D+TRP+ EQNLV+WA+P+F D +++ +ADP L
Sbjct: 244 GGNLTLKSDVYSFGVVLLELITGRRALDTTRPNDEQNLVSWAQPIFRDPKRYPDMADPVL 303
Query: 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYD 368
E ++ RGL QA+A+ASMC+QE+A+ RPLI DV+ ALS+L+ T D
Sbjct: 304 ENKFSERGLNQAVAIASMCVQEEASARPLISDVMVALSFLSMPTED 349
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FE20 | PBS1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8399 | 0.9715 | 0.9736 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.994 |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 457 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-57 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-51 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-49 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-38 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-32 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-29 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-28 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-26 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-24 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-20 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-17 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-17 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-17 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 8e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 3e-57
Identities = 71/195 (36%), Positives = 102/195 (52%), Gaps = 11/195 (5%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSNLVNLIGYC 149
+GEGGFG VY + TG+ VA+K + + E L E+ +L L+H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
D + LV E+ GSL+D L + L + ++I +GLEYLH +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHSN---GII 114
Query: 210 YRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE-YAMTGQLT 267
+RD K NILL + KL+DFGL+KL + + ++GT Y APE G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 268 VKSDVYSFGVVFLEL 282
KSD++S GV+ EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 6e-51
Identities = 71/203 (34%), Positives = 103/203 (50%), Gaps = 11/203 (5%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSNLV 143
+ +GEG FG+VY + TG++VA+K + + ++ +RE L E+ +L L H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
L D D+ LV E+ G L D L E R LEYLH K
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE---AR-FYLRQILSALEYLHSK 116
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT 263
+++RD K NILL+E H KL+DFGLA+ + ++T V GT Y APE +
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLLG 170
Query: 264 GQLTVKSDVYSFGVVFLELITGR 286
D++S GV+ EL+TG+
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 7e-51
Identities = 74/200 (37%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 91 IGEGGFGRVYKGWL----ESTGQVVAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNL 145
+GEG FG VYKG L E T VAVK L + EFL E ++ L H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
+G C G+ +V E+MP G L D L E L +++A AKG+EYL K
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 265
++RD + N L+ E K+SDFGL++ D + APE G+
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 266 LTVKSDVYSFGVVFLELITG 285
T KSDV+SFGV+ E+ T
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-50
Identities = 69/200 (34%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 91 IGEGGFGRVYKGWLE----STGQVVAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNL 145
+GEG FG VYKG L+ VAVK L + Q EFL E ++ L H N+V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
+G C + + +V E+M G L +L + L + + A A+G+EYL K
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYLESK-- 121
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD-KSHVSTRVMGTYGYCAPEYAMTG 264
I+RD + N L+ E K+SDFGL++ D ++ + APE G
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEG 178
Query: 265 QLTVKSDVYSFGVVFLELIT 284
+ T KSDV+SFGV+ E+ T
Sbjct: 179 KFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 8e-50
Identities = 78/205 (38%), Positives = 106/205 (51%), Gaps = 12/205 (5%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQL--DRNGLQGNREFLVEVLMLSLLHHSNL 142
+ +G G FG VYK + TG++VAVK L + ++ E+ +L L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 143 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
V LI D D LV E+ G L D+L P L + KIA +GLEYLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP----LSEDEAKKIALQILRGLEYLHS 116
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM 262
+I+RD K NILL+E K++DFGLAK + S ++T V GT Y APE +
Sbjct: 117 NG---IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLL 171
Query: 263 TGQL-TVKSDVYSFGVVFLELITGR 286
G K DV+S GV+ EL+TG+
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 1e-49
Identities = 71/200 (35%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 91 IGEGGFGRVYKGWLE----STGQVVAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNL 145
+GEG FG VYKG L+ VAVK L + Q EFL E ++ L H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
+G C + + ++V E+MP G L D+L + L + + A A+G+EYL K
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRK--NRPKELSLSDLLSFALQIARGMEYLESK-- 122
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD-KSHVSTRVMGTYGYCAPEYAMTG 264
I+RD + N L+ E K+SDFGL++ D ++ + APE G
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEG 179
Query: 265 QLTVKSDVYSFGVVFLELIT 284
+ T KSDV+SFGV+ E+ T
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 3e-45
Identities = 73/203 (35%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 91 IGEGGFGRVYKG-WLESTGQV--VAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLI 146
+GEG FG VYKG G+ VAVK L + + R +FL E ++ L H N+V L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHL-----HDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
G C + + LV E+M G L D+L P+K L + A AKG+EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
K ++RD + N L+ E K+SDFGL++ D T + APE
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 262 MTGQLTVKSDVYSFGVVFLELIT 284
G T KSDV+SFGV+ E+ T
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 3e-39
Identities = 68/208 (32%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVN 144
F IG+GGFG VYK + TG+ VA+K + + + + E+ +L H N+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKIAA---GAAKGLEYL 200
G D+ +V EF GSL+D L E+ +IA KGLEYL
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTES-------QIAYVCKELLKGLEYL 114
Query: 201 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR--VMGTYGYCAP 258
H +I+RD K++NILL KL DFGL+ S R ++GT + AP
Sbjct: 115 HSNG---IIHRDIKAANILLTSDGEVKLIDFGLSA-----QLSDTKARNTMVGTPYWMAP 166
Query: 259 EYAMTGQLTVKSDVYSFGVVFLELITGR 286
E K+D++S G+ +EL G+
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 2e-38
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 90 FIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVL-----MLSLLHHSNLVN 144
+G G FG VY + TG+++AVK ++ L G+ E +E L +LS L H N+V
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVE---LSGDSEEELEALEREIRILSSLQHPNIVR 63
Query: 145 LIGYC--ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEAL--DWNTRMKIAAGAAKGLEYL 200
G + + + E++ GSL L E + + TR + +GL YL
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY-TRQIL-----EGLAYL 117
Query: 201 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEY 260
H +++RD K +NIL++ KL+DFG AK + + V GT + APE
Sbjct: 118 HSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 261 AMTGQLTVKSDVYSFGVVFLELITGR 286
+ +D++S G +E+ TG+
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 13/209 (6%)
Query: 91 IGEGGFGRVYKG-WL---ESTGQVVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVNL 145
+G G FG VYKG W+ E VA+K L + + N+E L E +++ + H ++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
+G C Q L+ + MPLG L D++ + K+ + + AKG+ YL +K
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR- 129
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 265
+++RD + N+L++ H K++DFGLAKL V +K + + + A E +
Sbjct: 130 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187
Query: 266 LTVKSDVYSFGVVFLELIT-GRKAIDSTR 293
T KSDV+S+GV EL+T G K +
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAKPYEGIP 216
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 9e-32
Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 16/203 (7%)
Query: 91 IGEGGFGRVYKGWLE----STGQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNL 145
+GEG FG+V + +TG+ VAVK L+ +G Q +F E+ +L L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 146 IGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
G C R L+ E++P GSL D+L ++ ++ + ++ KG++YL +
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST--RVMGTYGYCAPEYA 261
I+RD + NIL+E K+SDFGLAK+ P + + Y APE
Sbjct: 129 R---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 262 MTGQLTVKSDVYSFGVVFLELIT 284
T + + SDV+SFGV EL T
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 77/205 (37%), Positives = 108/205 (52%), Gaps = 17/205 (8%)
Query: 89 SFIGEGGFGRV----YKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVN 144
+G+G FG V Y ++TG+VVAVK+L + + R+F E+ +L L H N+V
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 145 LIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
G C +R LV E++P GSL D+L +E LD + A+ KG+EYL
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGS 126
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG---TYGYCAPE 259
K ++RD + NIL+E K+ DFGL K+ P DK + R G + Y APE
Sbjct: 127 KR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWY-APE 181
Query: 260 YAMTGQLTVKSDVYSFGVVFLELIT 284
+ +V SDV+SFGVV EL T
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 68/202 (33%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIGY 148
IG G FG VYKG TG VA+KQ+ ++ + + E+ +L L H N+V IG
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 149 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA---AGAAKGLEYLHDKAN 205
D ++ E+ GSL + P E+L +A +GL YLH++
Sbjct: 68 IETSDSLYIILEYAENGSLRQIIKKFGPFPESL-------VAVYVYQVLQGLAYLHEQG- 119
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVSTRVMGTYGYCAPEYAMTG 264
VI+RD K++NIL + KL+DFG+A KL V V+GT + APE
Sbjct: 120 --VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYWMAPEVIEMS 174
Query: 265 QLTVKSDVYSFGVVFLELITGR 286
+ SD++S G +EL+TG
Sbjct: 175 GASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 3e-30
Identities = 74/216 (34%), Positives = 103/216 (47%), Gaps = 21/216 (9%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEV-----LMLSLLH 138
++R +GEG FG VY ++VA+K L L+ + + ++ SL H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVL-AKKLESKSKEVERFLREIQILASLNH 56
Query: 139 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 198
N+V L + D LV E++ GSLED L K L + + I A LE
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKK-IGRKGPLSESEALFILAQILSALE 115
Query: 199 YLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAK-LGPVGDKSHV---STRVMGTY 253
YLH K +I+RD K NILL +G KL DFGLAK L G S + + +GT
Sbjct: 116 YLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 254 GYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGR 286
GY APE + + SD++S G+ EL+TG
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 67/203 (33%), Positives = 108/203 (53%), Gaps = 10/203 (4%)
Query: 83 KNFRPESFIGEGGFGRVYKG-WLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN 141
+ F E +G G FG V++G W VA+K L + L ++F EV L L H +
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVR--VAIKILKSDDLLKQQDFQKEVQALKRLRHKH 63
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
L++L C+ G+ ++ E M GSL L P+ + L + + +A A+G+ YL
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
++ I+RD + NIL+ E K++DFGLA+L + + ++S+ Y + APE A
Sbjct: 122 EQN---SIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAA 176
Query: 262 MTGQLTVKSDVYSFGVVFLELIT 284
G + KSDV+SFG++ E+ T
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 3e-29
Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 31/223 (13%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLV-EVLMLSLLHHSN 141
+ IG+G FG+VY +S G++ +K++D + + + RE + EV +L L+H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHL------HDLPPDKEALDWNTRMKIAAGAAK 195
++ + + +V E+ G L + P+++ LDW ++
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CL 114
Query: 196 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY 255
L+YLH + +++RD K NI L KL DFG++K+ + ++ V+GT Y
Sbjct: 115 ALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYY 169
Query: 256 CAPE------YAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 292
+PE Y KSD++S G V EL T + +
Sbjct: 170 LSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-29
Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 91 IGEGGFGRVYKGWL-----ESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVN 144
+GEG FG+VYKG L + VA+K L N + EF E ++S L H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------------KEALDWNTRMKIAAG 192
L+G C +++E++ G L + L P K +LD + + IA
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 193 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 252
A G+EYL ++ ++RD + N L+ EG K+SDFGL++ D V ++ +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 253 YGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 282
+ PE + G+ T +SD++SFGVV E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 72/201 (35%), Positives = 106/201 (52%), Gaps = 17/201 (8%)
Query: 91 IGEGGFGRVYKG-WLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC 149
+G G FG V+ G W +T VAVK L + G FL E ++ L H LV L C
Sbjct: 14 LGAGQFGEVWMGTWNGTT--KVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
++ + +V E+M GSL D L + + L + +AA A+G+ YL + I
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YI 125
Query: 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---YGYCAPEYAMTGQL 266
+RD + NIL+ E K++DFGLA+L + D + R G + APE A G+
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARL--IED-DEYTAR-EGAKFPIKWTAPEAANYGRF 181
Query: 267 TVKSDVYSFGVVFLELIT-GR 286
T+KSDV+SFG++ E++T GR
Sbjct: 182 TIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 68/200 (34%), Positives = 100/200 (50%), Gaps = 20/200 (10%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
IG+G FG V G GQ VAVK L + + FL E +++ L H NLV L+G
Sbjct: 14 IGKGEFGDVMLGDYR--GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210
G+ +V E+M GSL D+L + + ++ A +G+EYL +K ++
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLEEKN---FVH 125
Query: 211 RDFKSSNILLEEGFHPKLSDFGLAK---LGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLT 267
RD + N+L+ E K+SDFGLAK G K V + APE + +
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPEALREKKFS 177
Query: 268 VKSDVYSFGVVFLELIT-GR 286
KSDV+SFG++ E+ + GR
Sbjct: 178 TKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 70/203 (34%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLIG 147
+G+G FG+V + TG++ A+K L + + +E L E +LS ++H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 148 YCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK-IAAGAAKGLEYLHDKA 204
+ A + LV E+ P G L HL E R + AA LEYLH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE-----RARFYAAEIVLALEYLHSLG 113
Query: 205 NPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT 263
+IYRD K NILL +G H KL+DFGLAK S +T GT Y APE +
Sbjct: 114 ---IIYRDLKPENILLDADG-HIKLTDFGLAKELSSEG-SRTNTFC-GTPEYLAPEVLLG 167
Query: 264 GQLTVKSDVYSFGVVFLELITGR 286
D +S GV+ E++TG+
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 69/203 (33%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 91 IGEGGFGRVYKG-WLESTGQV--VAVKQLDRNGLQGN-REFLVEVLMLSLLHHSNLVNLI 146
+G+G FG V +G W S G+V VAVK L + L +FL E ++ L H NL+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHD--LPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
G ++V E PLGSL D L L + + ++IA G+ YL K
Sbjct: 63 GVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGMRYLESKR 117
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST---RVMGTYGYCAPEYA 261
I+RD + NILL K+ DFGL + P + +V +V + +CAPE
Sbjct: 118 ---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESL 172
Query: 262 MTGQLTVKSDVYSFGVVFLELIT 284
T + SDV+ FGV E+ T
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQ-----VVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSNLVN 144
+GEG FG+V+ G +VAVK L R+ F E +L+ H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTR----------MKIAAGAA 194
G C +GD ++V+E+M G L L PD L ++IA A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 254
G+ YL A+ ++RD + N L+ K+ DFG+++ D V M
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 255 YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ PE M + T +SDV+SFGVV E+ T
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 64/208 (30%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 90 FIGEGGFGRVYKGWLESTGQVVAVKQ--LDRNGLQGN---REFLVEVLMLSLLHHSNLVN 144
+G G FG VY+G G AVK+ L +G G ++ E+ +LS L H N+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
+G + D + E +P GSL L E + +I GLEYLHD+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQI----LLGLEYLHDRN 122
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM-----GTYGYCAPE 259
++RD K +NIL++ KL+DFG+AK V G+ + APE
Sbjct: 123 ---TVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWMAPE 171
Query: 260 YAM-TGQLTVKSDVYSFGVVFLELITGR 286
G + +D++S G LE+ TG+
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 61/226 (26%), Positives = 96/226 (42%), Gaps = 29/226 (12%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLV--EVLMLSLL-H 138
+F+ IGEG F V + T + A+K LD+ L + + V E +L+ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 139 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 198
H ++ L D + V E+ P G L ++ +LD AA LE
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALE 116
Query: 199 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL---------GPVGDKSHVSTR- 248
YLH K +I+RD K NILL++ H K++DFG AK+ + S
Sbjct: 117 YLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 249 --------VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
+GT Y +PE SD+++ G + +++TG+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 70/204 (34%), Positives = 103/204 (50%), Gaps = 27/204 (13%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 149
IGEG G VYK +TG+ VA+K++ + N+E ++ E+L++ H N+V+
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLR--KQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWN-TRMK---IAAGAA---KGLEYLHD 202
GD+ +V E+M GSL D + N RM IA +GLEYLH
Sbjct: 85 LVGDELWVVMEYMDGGSLTD----------IITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
+ VI+RD KS NILL + KL+DFG A+L K + V+GT + APE
Sbjct: 135 Q---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN---SVVGTPYWMAPEVI 188
Query: 262 MTGQLTVKSDVYSFGVVFLELITG 285
K D++S G++ +E+ G
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-26
Identities = 69/202 (34%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 91 IGEGGFGRV----YKGWLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSNLVNL 145
+GEG FG+V Y + TG++VAVK L R Q N + E+ +L L+H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 146 IGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
G C++ + L+ E++PLGSL D+L K L+ + A +G+ YLH +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH-VSTRVMGTYGYCAPEYAM 262
I+RD + N+LL+ K+ DFGLAK P G + + V + A E
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 263 TGQLTVKSDVYSFGVVFLELIT 284
+ + SDV+SFGV EL+T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 17/201 (8%)
Query: 91 IGEGGFGRVYKG-WLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC 149
+G G FG V++G W +T VAVK L + G ++FL E ++ L H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTP--VAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
+ +V E M GSL ++L AL + +AA A G+ YL + I
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQN---YI 125
Query: 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---YGYCAPEYAMTGQL 266
+RD + N+L+ E K++DFGLA++ K + G + APE A+ +
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARV----IKEDIYEAREGAKFPIKWTAPEAALYNRF 181
Query: 267 TVKSDVYSFGVVFLELIT-GR 286
++KSDV+SFG++ E++T GR
Sbjct: 182 SIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 38/211 (18%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLM-LSLLHHSNLVNLIGY- 148
+G G G V K TG+++AVK + N ++L L +LH N ++G+
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 149 --CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDW-NTRM--KIAAGAAKGLEYLHDK 203
+ + E+M GSL+ L KE R+ KIA KGL YLH+K
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKIL------KEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM--------GTYGY 255
+I+RD K SNIL+ KL DFG VS +++ GT Y
Sbjct: 120 HK--IIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSY 165
Query: 256 CAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
APE +VKSD++S G+ +EL TGR
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 7e-25
Identities = 68/202 (33%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 149
IG G VY + VA+K++D Q + + L EV +S +H N+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 150 ADGDQRLLVYEFMPLGSLEDHL-HDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 208
GD+ LV ++ GSL D + P LD + KGLEYLH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRG--GLDEAIIATVLKEVLKGLEYLHSNGQ--- 123
Query: 209 IYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSH-VSTRVMGTYGYCAPEYAMTGQ- 265
I+RD K+ NILL E K++DFG+ A L GD++ V +GT + APE M
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQVH 182
Query: 266 -LTVKSDVYSFGVVFLELITGR 286
K+D++SFG+ +EL TG
Sbjct: 183 GYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 9e-25
Identities = 70/267 (26%), Positives = 116/267 (43%), Gaps = 36/267 (13%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGY 148
IG+G FG V+K ++ +V A+KQ+D + + E + E +L+ L S ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 149 CADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
D + +V E+ G L L P E W + GL +LH K
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAHLHSKK-- 121
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL 266
+++RD KS N+ L+ + K+ D G+AKL + D ++ + ++GT Y +PE
Sbjct: 122 -ILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 267 TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRY 326
KSDV++ GVV E TG+ D+ N + + G +
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDA------NNQGALILKI--------------IRGVF 218
Query: 327 -PIRGLY-QALA-VASMCIQEQAATRP 350
P+ +Y Q LA + C+ + RP
Sbjct: 219 PPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 89 SFIGEGGFGRVYKGWLESTGQVVAVK--QLDRNGLQGNREFLVEVLMLSLLHHSNLVNLI 146
+G+G G VYK + TG++ A+K +D + ++ L E+ L +V
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR-KQLLRELKTLRSCESPYVVKCY 65
Query: 147 G-YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
G + +G+ +V E+M GSL D L + E IA KGL+YLH K +
Sbjct: 66 GAFYKEGEIS-IVLEYMDGGSLADLLKKVGKIPE----PVLAYIARQILKGLDYLHTKRH 120
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVMGTYGYCAPEYAMTG 264
+I+RD K SN+L+ K++DFG++K L D+ + T V GT Y +PE
Sbjct: 121 --IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPERIQGE 175
Query: 265 QLTVKSDVYSFGVVFLELITGR 286
+ +D++S G+ LE G+
Sbjct: 176 SYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 21/201 (10%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G G +G VY+G + VAVK L + ++ EFL E ++ + H NLV L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210
++ EFM G+L D+L + +++ ++ + +A + +EYL K I+
Sbjct: 73 REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127
Query: 211 RDFKSSNILLEEGFHPKLSDFGLAKL-------GPVGDKSHVSTRVMGTYGYCAPEYAMT 263
RD + N L+ E K++DFGL++L G K + + APE
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--------WTAPESLAY 179
Query: 264 GQLTVKSDVYSFGVVFLELIT 284
+ ++KSDV++FGV+ E+ T
Sbjct: 180 NKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 62/201 (30%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRN---GLQGNREFLVEVLMLSLLHHSNLVNLIG 147
IG+G FG+V T ++ A+K +++ R L E +L L+H LVNL
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDKANP 206
D + LV + + G L HL E ++K LEYLH K
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE-----QVKFWICEIVLALEYLHSKG-- 120
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL 266
+I+RD K NILL+E H ++DF +A + T GT GY APE
Sbjct: 121 -IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQGY 176
Query: 267 TVKSDVYSFGVVFLELITGRK 287
+V D +S GV E + G++
Sbjct: 177 SVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLIG 147
I +G +GRV+ +STG + A+K + + + + L E +LS +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 148 YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
Y G + L LV E++P G L L ++ +LD + A LEYLH +
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENV----GSLDEDVARIYIAEIVLALEYLH---SN 112
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS------TRVMGTYGYCAPEY 260
+I+RD K NIL++ H KL+DFGL+K+G V + +++ R++GT Y APE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 261 AMTGQLTVKSDVYSFGVVFLELITG 285
+ + D +S G + E + G
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 6e-24
Identities = 64/196 (32%), Positives = 93/196 (47%), Gaps = 8/196 (4%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSNLVNLIGYC 149
IG+G FG VYKG L+ +V AVK + FL E +L H N+V LIG C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
+V E +P GSL L K L ++++ AA G+EYL K I
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVK 269
+RD + N L+ E K+SDFG+++ G + + APE G+ T +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 270 SDVYSFGVVFLELITG 285
SDV+S+G++ E +
Sbjct: 176 SDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 35/212 (16%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE-----FLVEVLMLSLLHHSNLVNL 145
IGEG +G+VYK + TG++VA+K++ ++ +E + E+ +L L H N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 146 IGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK-------- 195
+ +V+E+M HDL L + +K K
Sbjct: 64 KEIVTSKGKGSIYMVFEYMD--------HDL----TGLLDSPEVKFTESQIKCYMKQLLE 111
Query: 196 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY 255
GL+YLH +++RD K SNIL+ KL+DFGLA+ S T + T Y
Sbjct: 112 GLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWY 167
Query: 256 CAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 286
PE + + + D++S G + EL G+
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 91 IGEGGFGRVYKGWLE--STGQV---VAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVN 144
+G+G FG VY+G + G+ VA+K + + ++ EFL E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA---LDWNTRMKI---AAGAAKGLE 198
L+G + G L+V E M G L+ +L P+ E L T K AA A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 199 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAP 258
YL K ++RD + N ++ E K+ DFG+ + D + + + AP
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 259 EYAMTGQLTVKSDVYSFGVVFLELIT 284
E G T KSDV+SFGVV E+ T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 3e-23
Identities = 71/226 (31%), Positives = 110/226 (48%), Gaps = 23/226 (10%)
Query: 77 ELAAATKNFRPESFIGEGGFGRVYKGWLESTG----QVVAVKQL-DRNGLQGNREFLVEV 131
EL + F E +GE FG++YKG L G Q+VA+K L D N Q EF E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 132 LMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD-------------K 178
+++ LHH N+V L+G +++E++ G L + L P K
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 179 EALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238
+LD + IA A G+EYL ++ +++D + NIL+ E H K+SD GL++
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
D V + + + PE M G+ + SD++SFGVV E+ +
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 4e-23
Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 91 IGEGGFGRVYKGWLESTGQV---VAVKQLDRNGLQGN-REFLVEVLMLSLLHHSNLVNLI 146
+G G FG V KG VAVK L + + +EFL E +++ L H +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
G C G+ +LV E PLG L +L P + + ++ A G+ YL K
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLESKH 115
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG-----YCAPE 259
++RD + N+LL K+SDFG+++ G + +T T G + APE
Sbjct: 116 ---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAPE 168
Query: 260 YAMTGQLTVKSDVYSFGVVFLELIT 284
G+ + KSDV+S+GV E +
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 5e-23
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 91 IGEGGFGRVYKGWL-----ESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNL 145
+GEG FG+V+ E +VAVK L ++F E +L++L H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALD-----------WNTRMKIAAGAA 194
G C +G L+V+E+M G L L PD + L + IA+ A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 254
G+ YL A+ ++RD + N L+ +G K+ DFG+++ D V R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 255 YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ PE + + T +SD++SFGVV E+ T
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 7e-23
Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIG 147
+G+GGFG V +++TG++ A K+LD+ L +G + L E +L + +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 207
D LV M G L+ H++++ + + AA GLE+LH +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR--- 115
Query: 208 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLT 267
++YRD K N+LL++ + ++SD GLA G K GT GY APE
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVYD 172
Query: 268 VKSDVYSFGVVFLELITGR 286
D ++ G E+I GR
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 69/220 (31%), Positives = 112/220 (50%), Gaps = 13/220 (5%)
Query: 82 TKNFRPESFIGEGGFGRVYKG-WL---ESTGQVVAVKQL-DRNGLQGNREFLVEVLMLSL 136
R +G G FG V+KG W+ +S VA+K + DR+G Q +E +L +
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 137 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 196
L H+ +V L+G C G LV + PLGSL DH+ +++LD + AKG
Sbjct: 66 LDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKG 121
Query: 197 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 256
+ YL + +++R+ + NILL+ +++DFG+A L DK + + +
Sbjct: 122 MYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178
Query: 257 APEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPH 295
A E + G+ T +SDV+S+GV E+++ G + RPH
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 1e-22
Identities = 85/279 (30%), Positives = 132/279 (47%), Gaps = 33/279 (11%)
Query: 91 IGEGGFGRVYKG-WLESTGQVV--AVKQLDR-NGLQGNREFLVEVLMLSLLHHSNLVNLI 146
IG+G FG VY G ++S GQ + AVK L+R L+ +FL E +++ H N+++L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 147 GYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
G C + L+V +M G L + + + D + AKG+EYL A+
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYL---AS 116
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS----TRVMGTYGYCAPEYA 261
++RD + N +L+E F K++DFGLA+ + DK + S T + A E
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 262 MTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321
T + T KSDV+SFGV+ EL+T R A P+ + + L RR L P
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT-RGA----PPYPDVDSFDITVYLLQGRR----LLQP- 224
Query: 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360
Y LY+ V C + RP ++V+ +
Sbjct: 225 ---EYCPDPLYE---VMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLI 146
IGEG +G VYK + TG++VA+K++ + L E+ +L L+H N++ L+
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
LV+EFM D + + L + +GL + H
Sbjct: 65 DVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH-SHG- 118
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKSH-VSTRVMGTYGYCAPEYAMT 263
+++RD K N+L+ KL+DFGLA+ PV +H V TR Y APE +
Sbjct: 119 -ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLG 172
Query: 264 -GQLTVKSDVYSFGVVFLELITGR 286
+ D++S G +F EL++ R
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 3e-22
Identities = 71/198 (35%), Positives = 109/198 (55%), Gaps = 12/198 (6%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G G FG V+ G +V AVK L + G FL E ++ L H LV L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKV-AVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210
+ + +V E+M GSL D L D + AL + +AA A G+ Y+ ++ N I+
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYI-ERMN--YIH 125
Query: 211 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR-VMGTYGYCAPEYAMTGQLTVK 269
RD +S+NIL+ +G K++DFGLA+L + D + + + + APE A+ G+ T+K
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 270 SDVYSFGVVFLELIT-GR 286
SDV+SFG++ EL+T GR
Sbjct: 184 SDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 4e-22
Identities = 69/214 (32%), Positives = 106/214 (49%), Gaps = 18/214 (8%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLD---RNGLQGNREFLV---EVLMLSLLHHSNLVN 144
+G+G +G VY G L + GQ++AVKQ++ N L +E+ EV +L L H N+V
Sbjct: 8 LGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
+G C D + + EF+P GS+ L+ P E + +I G A YLH+
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNNC 122
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAK----LGPVGDKSHVSTRVMGTYGYCAPEY 260
V++RD K +N++L KL DFG A+ +G G S++ + GT + APE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 261 AMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRP 294
KSD++S G E+ TG+ + S
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 69/198 (34%), Positives = 107/198 (54%), Gaps = 18/198 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
IGEG FG V +G E TGQ VAVK + + + FL E +++ LHH NLV L+G
Sbjct: 14 IGEGEFGAVLQG--EYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210
+ +V E M G+L + L + + ++ + A+G+EYL K +++
Sbjct: 70 H-NGLYIVMELMSKGNLVNFLRT--RGRALVSVIQLLQFSLDVAEGMEYLESKK---LVH 123
Query: 211 RDFKSSNILLEEGFHPKLSDFGLAKLGPVG-DKSHVSTRVMGTYGYCAPEYAMTGQLTVK 269
RD + NIL+ E K+SDFGLA++G +G D S + + + APE + + K
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSK 177
Query: 270 SDVYSFGVVFLELIT-GR 286
SDV+S+GV+ E+ + GR
Sbjct: 178 SDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 91 IGEGGFGRVYKGW---LESTGQ--VVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNL 145
+GEG FG+V+ L T +VAVK L L ++F E +L+ L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------------KEALDWNTRMKIAAGA 193
G C DGD ++V+E+M G L L PD K L + + IA+
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 194 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 253
A G+ YL A+ ++RD + N L+ K+ DFG+++ D V M
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 254 GYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ PE M + T +SDV+SFGV+ E+ T
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 1e-21
Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G G FG V+ G+ VA+K L + G FL E ++ L H LV L
Sbjct: 14 LGAGQFGEVWMGYYNGH-TKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210
+ ++ E+M GSL D L P+ L N + +AA A+G+ ++ K I+
Sbjct: 72 Q-EPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERKN---YIH 125
Query: 211 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY--GYCAPEYAMTGQLTV 268
RD +++NIL+ E K++DFGLA+L + + + R + + APE G T+
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARL---IEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 269 KSDVYSFGVVFLELIT-GR 286
KSDV+SFG++ E++T GR
Sbjct: 183 KSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-21
Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 91 IGEGGFGRVYKG-WLESTGQV-VAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGY 148
+G G FG V+ G W G++ VA+K + R G +F+ E ++ L H NLV L G
Sbjct: 12 LGSGQFGVVHLGKWR---GKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 149 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 208
C +V E+M G L ++L + K +W M + + +EYL
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRER-KGKLGTEWLLDM--CSDVCEAMEYLESNG---F 121
Query: 209 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---YGYCAPEYAMTGQ 265
I+RD + N L+ E K+SDFGLA+ V D + S+ GT + PE +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSS--QGTKFPVKWAPPEVFDYSR 177
Query: 266 LTVKSDVYSFGVVFLELITGRK 287
+ KSDV+SFGV+ E+ + K
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 88 ESFIGEGGFGRVYKGWLESTGQ---VVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNL 142
E IG G FG V +G L+ G+ VA+K L + G +FL E ++ H N+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 143 VNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAAGAAKGLEYL 200
+ L G +++ E+M GSL+ L +D + + G A G++YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYL 122
Query: 201 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG------ 254
+ ++RD + NIL+ K+SDFGL++ + D T T G
Sbjct: 123 SEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRR--LEDSEATYT----TKGGKIPIR 173
Query: 255 YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ APE + T SDV+SFG+V E+++
Sbjct: 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 2e-21
Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 48/223 (21%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQL----DRNGLQGN--REFLVEVLMLSLLH 138
+ +GEG +G VYK + TG++VA+K++ + G+ R E+ +L L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELK 56
Query: 139 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK--- 195
H N+V L+ + LV+E+ DL K+ LD ++ K
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCD--------MDL---KKYLD-KRPGPLSPNLIKSIM 104
Query: 196 -----GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 250
GL Y H +++RD K NIL+ KL+DFGLA+ + +++ + V+
Sbjct: 105 YQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV 160
Query: 251 GTYGYCAPE-------YAMTGQLTVKSDVYSFGVVFLELITGR 286
T Y APE Y V D++S G +F E+ITG+
Sbjct: 161 -TLWYRAPEILLGSKHY----STAV--DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-21
Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 11/208 (5%)
Query: 91 IGEGGFGRVYKG-WLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC 149
IG G FG V+ G WLE VA+K + R G +F+ E ++ L H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRK--VAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
+ LV+EFM G L D+L + T + + +G+ YL VI
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLR---AQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVK 269
+RD + N L+ E K+SDFG+ + + D+ ST + +PE + + K
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 270 SDVYSFGVVFLELITGRKAIDSTRPHGE 297
SDV+SFGV+ E+ + K R + E
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-21
Identities = 80/294 (27%), Positives = 131/294 (44%), Gaps = 27/294 (9%)
Query: 69 AAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL-DRNGLQGNREF 127
+++ T ++ ++ K E+ I G G YKG G VK++ D N + +
Sbjct: 679 VSKSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS--- 732
Query: 128 LVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRM 187
E+ + L H N+V LIG C L++E++ +L + L +L W R
Sbjct: 733 --EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNL-------SWERRR 783
Query: 188 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 247
KIA G AK L +LH + +P V+ + I+++ P L L L K +S+
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS 842
Query: 248 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL 307
Y APE T +T KSD+Y FG++ +EL+TG+ D+ ++V WAR
Sbjct: 843 ------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA-EFGVHGSIVEWARYC 895
Query: 308 FNDRRKFSKLADPRLEGRYPI--RGLYQALAVASMCIQEQAATRPLIGDVVTAL 359
++D DP + G + + + + +A C RP DV+ L
Sbjct: 896 YSDCH-LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVN 144
F +GEG +G VYK + TGQVVA+K + +E + E+ +L +V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLH----DLPPDKEALDWNTRMKIAAGAAKGLEYL 200
G +V E+ GS+ D + L ++ A I KGLEYL
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA-------ILYQTLKGLEYL 115
Query: 201 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVSTRVMGTYGYCAPE 259
H I+RD K+ NILL E KL+DFG++ +L K + V+GT + APE
Sbjct: 116 HSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT---VIGTPFWMAPE 169
Query: 260 YAMTGQLTVKSDVYSFGVVFLELITGR 286
K+D++S G+ +E+ G+
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 7e-21
Identities = 68/214 (31%), Positives = 95/214 (44%), Gaps = 32/214 (14%)
Query: 90 FIGEGGFGRVYKGWLESTGQVVAVKQ--LDRNGLQGNREFLVEVLMLSLLHHSNLVNLIG 147
IG G FG+VY TG+++AVK+ + N + +E E+ +L LL H NLV
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV---K 63
Query: 148 YCADGDQRLLVYEFMPL---GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
Y R VY FM G+LE+ L LD + +GL YLH
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG--------YC 256
+++RD K +NI L+ KL DFG A K +T MG Y
Sbjct: 120 ---IVHRDIKPANIFLDHNGVIKLGDFGCAV------KLKNNTTTMGEEVQSLAGTPAYM 170
Query: 257 APEYAMTGQLTVK---SDVYSFGVVFLELITGRK 287
APE G+ +D++S G V LE+ TG++
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 8e-21
Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLD-RNGLQGNREFLV-EV-LMLSLLHHS 140
+F+ +G+G +G VYK S Q A+K++D + Q RE V E+ ++ S+ H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHP- 59
Query: 141 NLVNLIGY---CADGDQRLLVYEFMPLGSLEDHLHDLP----PDKEALDWNTRMKIAAGA 193
N+I Y DG++ +V E+ P G L + E W +++
Sbjct: 60 ---NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL---- 112
Query: 194 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 253
+GL+ LH++ +++RD KS+NILL K+ D G++K+ K +++ +GT
Sbjct: 113 LRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTP 165
Query: 254 GYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
Y APE + KSD++S G + E+ T
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 9e-21
Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 91 IGEGGFGRV----YKGWLESTGQVVAVKQLD-RNGLQGNREFLVEVLMLSLLHHSNLVNL 145
+GEG FG+V Y ++TG+ VAVK L +G + E+ +L L+H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 146 IGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
G C + L+ EF+P GSL+++L P +K ++ ++K A KG++YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR--VMGTYGYCAPEYA 261
++RD + N+L+E K+ DFGL K DK + + + + + APE
Sbjct: 129 Q---YVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 262 MTGQLTVKSDVYSFGVVFLELIT 284
+ + + SDV+SFGV EL+T
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL-------DRNGLQGNREFLVEVLMLSL 136
+ +GEG + VYK + TG++VA+K++ ++G+ N L E+ +L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGI--NFTALREIKLLQE 58
Query: 137 LHHSNLVNLIG-YCADGDQRL-LVYEFMPLGSLEDHLHD-----LPPDKEALDWNTRMKI 189
L H N++ L+ + + LV+EFM LE + D P D ++ T
Sbjct: 59 LKHPNIIGLLDVFGH--KSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT---- 111
Query: 190 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS-TR 248
+GLEYLH +++RD K +N+L+ KL+DFGLA +S S R
Sbjct: 112 ----LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLA-------RSFGSPNR 157
Query: 249 VMG----TYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 286
M T Y APE V D++S G +F EL+
Sbjct: 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-20
Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 89 SFIGEGGFGRVYKGWLESTGQVVAVKQ--LDRNGLQG---NREFLV----EVLMLSLLHH 139
+ IG G FG VY G S+G+++AVKQ L R L E+ +L L H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEY 199
N+V +G D D + E++P GS+ L++ +E L N +I KGL Y
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI----LKGLNY 121
Query: 200 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR------VMGTY 253
LH++ +I+RD K +NIL++ K+SDFG++K + S + + G+
Sbjct: 122 LHNRG---IIHRDIKGANILVDNKGGIKISDFGISK--KLEANSLSTKTNGARPSLQGSV 176
Query: 254 GYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
+ APE T K+D++S G + +E++TG+
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 68/197 (34%), Positives = 105/197 (53%), Gaps = 14/197 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 149
IG+G G VY +TGQ VA+KQ++ Q +E ++ E+L++ H N+VN +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
GD+ +V E++ GSL D + + D+ + R + A LE+LH VI
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA-----LEFLHSNQ---VI 137
Query: 210 YRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTV 268
+RD KS NILL KL+DFG A++ P ++S ST V GT + APE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 269 KSDVYSFGVVFLELITG 285
K D++S G++ +E++ G
Sbjct: 195 KVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-20
Identities = 68/203 (33%), Positives = 112/203 (55%), Gaps = 11/203 (5%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 142
++ R + +G+G FG V+ G T +V A+K L + G FL E ++ L H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKV-AIKTL-KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 143 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
V L ++ + +V EFM GSL D L + D + L + +AA A G+ Y+ +
Sbjct: 64 VPLYAVVSE-EPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYI-E 119
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR-VMGTYGYCAPEYA 261
+ N I+RD +++NIL+ + K++DFGLA+L + D + + + + APE A
Sbjct: 120 RMN--YIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 262 MTGQLTVKSDVYSFGVVFLELIT 284
+ G+ T+KSDV+SFG++ EL+T
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 83/291 (28%), Positives = 127/291 (43%), Gaps = 55/291 (18%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV------EVLMLSLLHHSNLVN 144
+GEG +G V K + TGQ+VA+K+ L+ + +V E+ ML L H NLVN
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQLRHENLVN 64
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDH--LHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
LI + LV+EF+ DH L DL LD + K +G+E+ H
Sbjct: 65 LIEVFRRKKRLYLVFEFV------DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH- 117
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVMGTYGYCAPEYA 261
+ +I+RD K NIL+ + KL DFG A+ L G+ V T + T Y APE
Sbjct: 118 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPE-- 170
Query: 262 MTGQLTVKS-------DVYSFGVVFLELITGR------KAIDS----TRPHGEQNLVTWA 304
L V D+++ G + E++TG ID + G NL+
Sbjct: 171 ----LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG--NLIPRH 224
Query: 305 RPLFNDRRKFSKLADPRLEGRYPIRGLY-----QALAVASMCIQEQAATRP 350
+ +F F+ + P ++ P+ + L +A C++ RP
Sbjct: 225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 69/218 (31%), Positives = 96/218 (44%), Gaps = 40/218 (18%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGY-- 148
IGEG +G+VYK + TGQ+VA+K +D E E +L +SN N+ +
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILR--KYSNHPNIATFYG 70
Query: 149 -------CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK------IAAGAAK 195
+ DQ LV E GS+ D + K R+K I +
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIAYILRETLR 124
Query: 196 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTR--VMGT 252
GL YLH+ VI+RD K NILL + KL DFG+ A+L S + R +GT
Sbjct: 125 GLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQL-----DSTLGRRNTFIGT 176
Query: 253 YGYCAPE-----YAMTGQLTVKSDVYSFGVVFLELITG 285
+ APE +SDV+S G+ +EL G
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLV 143
F IG+G FG VYK + T QVVA+K +D + E + E+ LS +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
G G + ++ E+ GS D L D+ + + R + GLEYLH++
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL-----LGLEYLHEE 117
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR---VMGTYGYCAPEY 260
I+RD K++NILL E KL+DFG++ G + ++ +GT + APE
Sbjct: 118 G---KIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEV 169
Query: 261 AMTGQLTVKSDVYSFGVVFLELITG 285
K+D++S G+ +EL G
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 3e-20
Identities = 55/210 (26%), Positives = 104/210 (49%), Gaps = 23/210 (10%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV--EVLMLSLLHHSNLVNLIGY 148
+G G FG V+ ++ ++V +KQ+ + + E +L LL H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 149 CADGDQRLLVYEFMPLGSLEDHLHD----LPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
+ ++V E+ P G+L +++ L + L + ++ +A L ++H K
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------LHHVHTKL 121
Query: 205 NPPVIYRDFKSSNILLEEGFHP---KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
+++RD K+ NILL++ H K+ DFG++K+ + KS T V+GT Y +PE
Sbjct: 122 ---ILHRDLKTQNILLDK--HKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYISPELC 173
Query: 262 MTGQLTVKSDVYSFGVVFLELITGRKAIDS 291
KSD+++ G V EL + ++A ++
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 13/206 (6%)
Query: 91 IGEGGFGRVYKG-WL---ESTGQVVAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNL 145
+G G FG VYKG W+ E+ VA+K L+ G + N EF+ E L+++ + H +LV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
+G C +L V + MP G L D++H+ K+ + + AKG+ YL ++
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR- 129
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 265
+++RD + N+L++ H K++DFGLA+L +K + + + A E +
Sbjct: 130 --LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187
Query: 266 LTVKSDVYSFGVVFLELIT-GRKAID 290
T +SDV+S+GV EL+T G K D
Sbjct: 188 FTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 5e-20
Identities = 64/208 (30%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 91 IGEGGFGRV-----YKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNL 145
+GEG FG+V Y E +VAVK L ++F E +L+ L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK---------EALDWNTRMKIAAGAAKG 196
G C +GD ++V+E+M G L L PD L + + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 197 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 256
+ YL A+ ++RD + N L+ E K+ DFG+++ D V M +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 257 APEYAMTGQLTVKSDVYSFGVVFLELIT 284
PE M + T +SDV+S GVV E+ T
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 9e-20
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 27/225 (12%)
Query: 84 NFRPESFIGEGGFGRVYK----GWLESTGQ-VVAVKQL-DRNGLQGNREFLVEVLMLSLL 137
N IG+G FGRV++ G L +VAVK L + +F E +++
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 65
Query: 138 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------------DKE 179
H N+V L+G CA G L++E+M G L + L P +
Sbjct: 66 DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125
Query: 180 ALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239
L ++ IA A G+ YL ++ ++RD + N L+ E K++DFGL++
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182
Query: 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
D S + PE + T +SDV+++GVV E+ +
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 71/204 (34%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQL--DRNGLQGNREFLVEVLMLSLLHHSNLVNLIGY 148
IGEG +G V+K TGQ+VA+K+ + + L E+ ML L H NLVNLI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 149 CADGDQRLLVYEFMPLGSLEDH--LHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
+ LV+E+ DH L++L + + + KI + + + H K N
Sbjct: 69 FRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH-KHN- 120
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKS-HVSTRVMGTYGYCAPEYAMT 263
I+RD K NIL+ + KL DFG A++ GP D + +V+TR Y APE +
Sbjct: 121 -CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPEL-LV 173
Query: 264 G--QLTVKSDVYSFGVVFLELITG 285
G Q DV++ G VF EL+TG
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQ-LDRNGLQGNREF-LVEVLMLSLLHHSNLVNLIGY 148
+GEG +G V K ++TG++VA+K+ + + ++ L EV +L L H N+VNL
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 149 CADGDQRLLVYEFMP---LGSLEDHLHDLPPDK-EALDWNTRMKIAAGAAKGLEYLHDKA 204
+ LV+E++ L LE LPPD + W + + Y H
Sbjct: 69 FRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--------LQAIAYCHSHN 120
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG 264
+I+RD K NIL+ E KL DFG A+ S ++ V T Y APE
Sbjct: 121 ---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPE----- 171
Query: 265 QLTVKS-------DVYSFGVVFLELITGR 286
L V DV++ G + EL+ G
Sbjct: 172 -LLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 61/202 (30%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHHSNLVNLIG 147
+G GGFGRV ++S + A+K + + + + E +L +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 148 YCADGDQRLLVY---EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
Y D++ +Y E+ G L L D + D T A EYLH++
Sbjct: 59 YRTFKDKKY-IYMLMEYCLGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG 113
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG 264
+IYRD K N+LL+ + KL DFG AK G K+ GT Y APE +
Sbjct: 114 ---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNK 167
Query: 265 QLTVKSDVYSFGVVFLELITGR 286
D +S G++ EL+TGR
Sbjct: 168 GYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 1e-19
Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 90 FIGEGGFGRVYKGWL-----ESTGQV-VAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNL 142
F+G G FG VY+G +G + VAVK L + Q +EFL E ++S +H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 143 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA---LDWNTRMKIAAGAAKGLEY 199
V L+G C + + ++ E M G L +L D ++ L + I AKG Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 200 LHDKANPPVIYRDFKSSNILLEEGFHP-----KLSDFGLAKLGPVGDKSHVSTRVMGTYG 254
L I+RD + N L+ E + K+ DFGLA+ D +
Sbjct: 122 LEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 255 YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ APE + G+ T +SDV+SFGV+ E++T
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 12/206 (5%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 142
++ R E +G+G FG V+ G T +V A+K L + G FL E ++ L H L
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 63
Query: 143 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
V L ++ + +V E+M GSL D L + L + +AA A G+ Y+ +
Sbjct: 64 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYV-E 119
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR-VMGTYGYCAPEYA 261
+ N ++RD +++NIL+ E K++DFGLA+L + D + + + + APE A
Sbjct: 120 RMN--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 262 MTGQLTVKSDVYSFGVVFLELIT-GR 286
+ G+ T+KSDV+SFG++ EL T GR
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 65/223 (29%), Positives = 92/223 (41%), Gaps = 27/223 (12%)
Query: 89 SFIGEGGFGRVYKGWLESTGQVVAVKQ-LDRNGLQGNREFLVEVLMLSLLHHSNLVNLIG 147
S +GEG G V K L++TG + A+K ++ L E+ + +V G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 148 YCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEALDWNTRM------KIAAGAAKGLEY 199
D + E+ GSL+ K+ R+ KIA KGL Y
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIY------KKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 200 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVSTRVMGTYGYCAP 258
LH + +I+RD K SNILL KL DFG++ +L + GT Y AP
Sbjct: 121 LHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYMAP 172
Query: 259 EYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV 301
E ++ SDV+S G+ LE+ R P GE L
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLG 212
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 91 IGEGGFGRVYKGW---LESTGQV--VAVKQLDRNGLQGNREFLV-EVLMLSLL-HHSNLV 143
+G G FG+V + L + V VAVK L RE L+ E+ ++S L +H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA-LDWNTRMKIAAGAAKGLEYLHD 202
NL+G C G L++ E+ G L + L +E+ L + + AKG+ +L
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRR---KRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV---STRVMGTYGYCAPE 259
K I+RD + N+LL G K+ DFGLA+ + D ++V + R+ + APE
Sbjct: 160 KN---CIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVVKGNARL--PVKWMAPE 213
Query: 260 YAMTGQLTVKSDVYSFGVVFLELIT 284
T +SDV+S+G++ E+ +
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 62/196 (31%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G G FG V+ G+ ++ +V AVK L + G + FL E ++ L H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKV-AVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210
+ ++ E+M GSL D L K L + +A A+G+ Y+ K I+
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERKN---YIH 126
Query: 211 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY--GYCAPEYAMTGQLTV 268
RD +++N+L+ E K++DFGLA+ V + + + R + + APE G T+
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 183
Query: 269 KSDVYSFGVVFLELIT 284
KSDV+SFG++ E++T
Sbjct: 184 KSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 8/203 (3%)
Query: 90 FIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLV-EVLMLSLLHHSNLVNLIG 147
IG+G FG V K +S G+++ K++D + + ++ LV EV +L L H N+V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 148 YCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
D + L V E+ G L + +++ ++ +I L H++++
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 206 PP--VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT 263
P V++RD K +NI L+ + KL DFGLAK+ D S T V GT Y +PE
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG-HDSSFAKTYV-GTPYYMSPEQLNH 184
Query: 264 GQLTVKSDVYSFGVVFLELITGR 286
KSD++S G + EL
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 3e-19
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 25/203 (12%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHHSNLVNLIG 147
+G G FGRV + +G+ A+K L + + ++ L E +L + H LVNL G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLH--DLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
D LV E++P G L HL P+ A AA LEYLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA------RFYAAQVVLALEYLHSLD- 121
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM---GTYGYCAPEYAM 262
++YRD K N+LL+ + K++DFG AK V R GT Y APE +
Sbjct: 122 --IVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLCGTPEYLAPEIIL 171
Query: 263 TGQLTVKSDVYSFGVVFLELITG 285
+ D ++ G++ E++ G
Sbjct: 172 SKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 7e-19
Identities = 74/198 (37%), Positives = 96/198 (48%), Gaps = 19/198 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLHHSNLVNLIG 147
IG G FG VY T +VVA+K++ +G Q N ++ + EV L L H N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 207
LV E+ LGS D L K+ L I GA +GL YLH +
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLH---SHE 135
Query: 208 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE--YAM-TG 264
I+RD K+ NILL E KL+DFG A L S ++ V GT + APE AM G
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASL-----VSPANSFV-GTPYWMAPEVILAMDEG 189
Query: 265 QLTVKSDVYSFGVVFLEL 282
Q K DV+S G+ +EL
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 9e-19
Identities = 71/224 (31%), Positives = 99/224 (44%), Gaps = 59/224 (26%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLM----LSLLHHS-NLVNL 145
IG G G+VYK + TG V+AVKQ+ R G N+E +LM + H +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVKC 79
Query: 146 IGY----------------CADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEALDWNTRM 187
GY C D +LL + +P ED L
Sbjct: 80 YGYFITDSDVFICMELMSTCLD---KLLKRIQGPIP----EDILG--------------- 117
Query: 188 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVS 246
K+ K L YL +K VI+RD K SNILL+ + KL DFG++ +L V K+
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAK-- 171
Query: 247 TRVMGTYGYCAPEY----AMTGQLTVKSDVYSFGVVFLELITGR 286
TR G Y APE + +++DV+S G+ +EL TG+
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 29/220 (13%)
Query: 91 IGEGGFGRVYKGW-LESTGQ----VVAVKQLDRNGLQGN-REFLVEVLMLSLLHHSNLVN 144
+GEG FG+V K G+ VAVK L N R+ L E +L ++H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHL--------------------HDLPPDKEALDWN 184
L G C+ LL+ E+ GSL L + PD+ AL
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 185 TRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244
+ A ++G++YL A +++RD + N+L+ EG K+SDFGL++ D
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
++ + A E T +SDV+SFGV+ E++T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 77 ELAAATKNFRPESFIGEGGFGRVYKGWLESTG-----QVVAVKQL-DRNGLQGNREFLVE 130
E+ +T F E +GE FG+VYKG L T Q VA+K L D+ EF E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 131 VLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------------K 178
+M S L H N+V L+G +++ + L + L P K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 179 EALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238
L+ + I A G+E+L ++ V+++D + N+L+ + + K+SD GL +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
D + + + +PE M G+ ++ SD++S+GVV E+ +
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 19/215 (8%)
Query: 85 FRPESFIGEGGFGRVYKG-WLESTGQV---VAVKQL-DRNGLQGNREFLVEVLMLSLLHH 139
F+ +G G FG VYKG W+ +V VA+K+L + + N+E L E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH---DLPPDKEALDWNTRMKIAAGAAKG 196
++ L+G C +L + + MP G L D++ D + L+W ++ AKG
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 197 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 256
+ YL ++ +++RD + N+L++ H K++DFGLAKL +K + + +
Sbjct: 122 MNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 257 APEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAID 290
A E + T +SDV+S+GV EL+T G K D
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL--DRNGLQGNRE---FLVEVLMLSLLH 138
N+R +G+G FGRVY + TG+ +AVKQ+ D + + +E E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 139 HSNLVNLIGYCADGDQRLLVY-EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGL 197
H +V G C D+ L ++ E+MP GS++D L E + TR K +G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV---TR-KYTRQILEGV 117
Query: 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVMGTYGYC 256
EYLH +++RD K +NIL + + KL DFG +K L + V GT +
Sbjct: 118 EYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 257 APEYAMTGQLTVKSDVYSFGVVFLELIT 284
+PE K+DV+S G +E++T
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 88 ESFIGEGGFGRVYKGWLESTGQVV--AVKQLDRNGLQGN-REFLVEVLMLSLL-HHSNLV 143
E IGEG FG+V + ++ G + A+K L + + R+F E+ +L L HH N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHLHD---LPPD---------KEALDWNTRMKIAA 191
NL+G C + + E+ P G+L D L L D L ++ A+
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 192 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 251
A G++YL +K I+RD + N+L+ E K++DFGL++ G++ +V + MG
Sbjct: 127 DVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK-KTMG 178
Query: 252 TYG--YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ A E T KSDV+SFGV+ E+++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIGY 148
IGEG G V+K TG+ VA+K++ L+G + L E+ L H +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 149 CADGDQRLLVYEFMPLGSLEDHLHDLP---PDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
G +LV E+MP L + L D P+ + + RM + KG+ Y+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSY-MRMLL-----KGVAYMHANG- 119
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 265
+++RD K +N+L+ K++DFGLA+L + S +V T Y APE + G
Sbjct: 120 --IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPEL-LYGA 175
Query: 266 LTVKS--DVYSFGVVFLELITGR 286
D+++ G +F EL+ G
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 59/225 (26%), Positives = 90/225 (40%), Gaps = 24/225 (10%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF----LVEVLMLSLLHHSNLVNLI 146
I +G FG VY STG A+K L ++ + + +M+ + L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
D LV E++ G + L E DW + A G+E LH +
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE--DWAK--QYIAEVVLGVEDLHQRG-- 117
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL 266
+I+RD K N+L+++ H KL+DFGL++ G + + +GT Y APE +
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGD 170
Query: 267 TVKSDVYSFGVVFLELITGRKAIDSTRP-HGEQNLVTWARPLFND 310
SD +S G V E + G P H E + L
Sbjct: 171 DKMSDWWSLGCVIFEFLFG------YPPFHAETPDAVFDNILSRR 209
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 21/215 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLI-GYC 149
+G+G FG+VYK + TG A K + + +F+VE+ +LS H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
+ +L+ EF G+L+ + +L + L + + L +LH VI
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VI 125
Query: 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLT-- 267
+RD K+ NILL KL+DFG++ + + +GT + APE
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDN 183
Query: 268 ---VKSDVYSFGVVFLELITGRKAIDSTRPHGEQN 299
K+D++S G+ +EL PH E N
Sbjct: 184 PYDYKADIWSLGITLIELAQMEP------PHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 62/196 (31%), Positives = 96/196 (48%), Gaps = 12/196 (6%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 149
IGEG G V +STG+ VAVK++D Q RE L EV+++ H N+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
GD+ +V EF+ G+L D + ++E + + K L +LH + VI
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLAVLKALSFLHAQG---VI 137
Query: 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVK 269
+RD KS +ILL KLSDFG V + ++GT + APE +
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTE 195
Query: 270 SDVYSFGVVFLELITG 285
D++S G++ +E++ G
Sbjct: 196 VDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-18
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLD--RNGLQGNREFLVEVL-----MLSLLHHSNLV 143
+G G F Y+ TG ++AVKQ+ RN +E +VE L +++ L+H +++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT-SSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 144 NLIG-YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
++G C D L V E+M GS+ L KEA+ N ++ +GL YLH+
Sbjct: 67 RMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLHE 121
Query: 203 KANPPVIYRDFKSSNILLEE-GFHPKLSDFGLA-KLGPVGDKS-HVSTRVMGTYGYCAPE 259
+I+RD K +N+L++ G +++DFG A +L G + +++GT + APE
Sbjct: 122 NQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 260 YAMTGQLTVKSDVYSFGVVFLELITGR 286
Q DV+S G V +E+ T +
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-18
Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 79 AAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH 138
A K + IG+G FG V G + G VAVK + + + FL E +++ L
Sbjct: 2 ALNMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLR 57
Query: 139 HSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGL 197
HSNLV L+G + L +V E+M GSL D+L + L + +K + + +
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAM 115
Query: 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVMGTYGYC 256
EYL +AN ++RD + N+L+ E K+SDFGL K D + + +
Sbjct: 116 EYL--EANN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WT 166
Query: 257 APEYAMTGQLTVKSDVYSFGVVFLELIT-GR 286
APE + + KSDV+SFG++ E+ + GR
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 72/198 (36%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLHHSNLVNLIG 147
IG G FG VY T +VVAVK++ +G Q N ++ + EV L L H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 207
LV E+ LGS D L K+ L I GA +GL YLH
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 208 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT---G 264
+I+RD K+ NILL E KL+DFG A KS + +GT + APE + G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 265 QLTVKSDVYSFGVVFLEL 282
Q K DV+S G+ +EL
Sbjct: 196 QYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-18
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 91 IGEGGFGRVYKG-WLESTGQV---VAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNL 145
+G G FG VYKG W+ V VA+K L N + N+E L E +++ + + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLH---DLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
+G C +L V + MP G L D++ D ++ L+W ++ AKG+ YL +
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM 262
+++RD + N+L++ H K++DFGLA+L + + + + + A E +
Sbjct: 128 VR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 263 TGQLTVKSDVYSFGVVFLELIT-GRKAIDS 291
+ T +SDV+S+GV EL+T G K D
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 6e-18
Identities = 73/282 (25%), Positives = 128/282 (45%), Gaps = 31/282 (10%)
Query: 88 ESFIGEGGFGRVYKGWLESTGQ---VVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLV 143
+ IG G FG V++G L+ G+ VA+K L + R +FL E ++ H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
L G +++ E+M G+L+ +L D + + ++ G A G++YL D
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSDM 126
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL---GPVGDKSHVSTRVMGTYGYCAPEY 260
++RD + NIL+ K+SDFGL+++ P G + ++ + APE
Sbjct: 127 N---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPEA 181
Query: 261 AMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320
+ T SDV+SFG+V E+++ RP+ + + + + + R + + P
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSF-----GERPYWDMSNHEVMKAINDGFRLPAPMDCP 236
Query: 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362
+YQ + C Q+ A RP D+V L L
Sbjct: 237 --------SAVYQLML---QCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 7e-18
Identities = 65/193 (33%), Positives = 95/193 (49%), Gaps = 9/193 (4%)
Query: 90 FIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLIGY 148
+G+G FG V+KG L+ V AVK + Q + +FL E +L H N+V LIG
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPV-AVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 149 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 208
C QR +Y M L D L L K+ L +K A AA G+ YL K
Sbjct: 61 CT---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---C 114
Query: 209 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTV 268
I+RD + N L+ E K+SDFG+++ G S + + + APE G+ +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSS 173
Query: 269 KSDVYSFGVVFLE 281
+SDV+S+G++ E
Sbjct: 174 ESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 7e-18
Identities = 63/193 (32%), Positives = 91/193 (47%), Gaps = 9/193 (4%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIGY 148
IG G FG V+ G L + VAVK R L + +FL E +L H N+V LIG
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 149 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 208
C Q+ +Y M L D L L + L +++ AA G+EYL K
Sbjct: 62 CT---QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 209 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTV 268
I+RD + N L+ E K+SDFG+++ G + + APE G+ +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 269 KSDVYSFGVVFLE 281
+SDV+SFG++ E
Sbjct: 176 ESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 9e-18
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE-----FLVEVLMLSLLHHSNLVNL 145
IGEG +G VYKG + TGQ+VA+K++ L+ E + E+ +L L H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
+ L++EF+ + L+ +L LP + +D +G+ + H +
Sbjct: 65 QDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQY-MDAELVKSYLYQILQGILFCHSRR- 121
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 265
V++RD K N+L++ KL+DFGLA+ G V T + T Y APE +
Sbjct: 122 --VLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEVLLGSP 177
Query: 266 L-TVKSDVYSFGVVFLELITGR 286
+ D++S G +F E+ T +
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 71/205 (34%), Positives = 102/205 (49%), Gaps = 24/205 (11%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSN--LVNL 145
IG GGFG VY TG++ A+K LD+ + QG L E +MLSL+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 146 IGYCADGDQRL-LVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKI-AAGAAKGLEYLH 201
+ Y +L + + M G L HL H + + E M+ AA GLE++H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAE-------MRFYAAEIILGLEHMH 114
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
++ V+YRD K +NILL+E H ++SD GLA K H S +GT+GY APE
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVL 167
Query: 262 MTGQLTVKS-DVYSFGVVFLELITG 285
G S D +S G + +L+ G
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 80/302 (26%), Positives = 134/302 (44%), Gaps = 53/302 (17%)
Query: 91 IGEGGFGRVYKGWLESTGQV----------------VAVKQLDRNGLQGNR-EFLVEVLM 133
+GEG FG V+ + + + VAVK L + + R +FL EV +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 134 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDL-----------PPDKE- 179
LS L N++ L+G C D D ++ E+M G L L H L PP
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 180 -ALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238
A+ +++ + +A A G++YL ++ ++RD + N L+ E K++DFG+++
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE- 297
GD + R + + A E + G+ T SDV++FGV E++ K +P+GE
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE----QPYGEL 245
Query: 298 --QNLVTWARPLFNDRRKFSKLADPRLEGRYPI--RGLYQALAVASMCIQEQAATRPLIG 353
+ ++ A F D+ + L R P +GLY+ + C RP
Sbjct: 246 TDEQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELML---QCWSRDCRERPSFS 296
Query: 354 DV 355
D+
Sbjct: 297 DI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 90 FIGEGGFGRVYKGWLESTG--QVVAVKQLDRNGLQGN-REFLVEVLMLSLL-HHSNLVNL 145
IGEG FG+V K ++ G A+K++ + + R+F E+ +L L HH N++NL
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLHD---LPPD---------KEALDWNTRMKIAAGA 193
+G C L E+ P G+L D L L D L + AA
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 194 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 253
A+G++YL K I+RD + NIL+ E + K++DFGL++ G + +V + MG
Sbjct: 122 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRL 173
Query: 254 G--YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ A E T SDV+S+GV+ E+++
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 68/197 (34%), Positives = 108/197 (54%), Gaps = 14/197 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 149
IG+G G V+ +TGQ VA+KQ++ Q +E ++ E+L++ L + N+VN +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
GD+ +V E++ GSL D + + D+ + R + A LE+LH AN VI
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQA-----LEFLH--AN-QVI 137
Query: 210 YRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTV 268
+RD KS N+LL KL+DFG A++ P ++S ST V GT + APE
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 269 KSDVYSFGVVFLELITG 285
K D++S G++ +E++ G
Sbjct: 195 KVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 70/204 (34%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSN---LVN 144
IG GGFG VY TG++ A+K LD+ + QG L E +MLSL+ + +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
+ D+ + + M G L HL H + +KE + T + + GLE++H+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMHN 115
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM 262
+ V+YRD K +NILL+E H ++SD GLA K H S +GT+GY APE
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVLQ 168
Query: 263 TGQLTVKS-DVYSFGVVFLELITG 285
G S D +S G + +L+ G
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 91 IGEGGFGRVYKGWLESTG-------QVVAVKQLDRNGLQGN-REFLVEVLMLSLL-HHSN 141
+GEG FG+V K E+ G VAVK L + + + + + E+ M+ ++ H N
Sbjct: 20 LGEGAFGQVVKA--EAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTR------------MKI 189
++NL+G C +V E+ G+L D L P E + +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 190 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 249
A A+G+E+L K I+RD + N+L+ E K++DFGLA+ D +T
Sbjct: 138 AYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 250 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ APE T +SDV+SFGV+ E+ T
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 65/204 (31%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 91 IGEGGFGRVYKGWL-----ESTGQVVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVN 144
+G G FG VY+G ++ VAVK L + Q +FL+E L++S +H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE---ALDWNTRMKIAAGAAKGLEYLH 201
LIG + R ++ E M G L+ L + P E +L + A AKG +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 202 DKANPPVIYRDFKSSNILLE---EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAP 258
+ I+RD + N LL G K++DFG+A+ R M + P
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 259 EYAMTGQLTVKSDVYSFGVVFLEL 282
E + G T K+DV+SFGV+ E+
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 77/263 (29%), Positives = 120/263 (45%), Gaps = 32/263 (12%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 149
IG+G FG V+KG T +VVA+K +D + E + E+ +LS + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
+ ++ E++ GS D L P D+ + I KGL+YLH + I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLEPGPLDETQI-----ATILREILKGLDYLHSEKK---I 123
Query: 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVK 269
+RD K++N+LL E KL+DFG+A G + D +GT + APE K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 270 SDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRY--P 327
+D++S G+ +EL G PH E + + + LF K P LEG Y P
Sbjct: 182 ADIWSLGITAIELAKGEP------PHSELHPM---KVLF----LIPKNNPPTLEGNYSKP 228
Query: 328 IRGLYQALAVASMCIQEQAATRP 350
++ +A C+ ++ + RP
Sbjct: 229 LKEFVEA------CLNKEPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 67/205 (32%), Positives = 97/205 (47%), Gaps = 31/205 (15%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQ--LDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIG 147
IG G +G VYK +TG++VA+K L+ + E + E+ ML H N+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLE---PGDDFEIIQQEISMLKECRHPNIVAYFG 67
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKIA---AGAAKGLEYLHDK 203
D+ +V E+ GSL+D P E IA KGL YLH+
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ-------IAYVCRETLKGLAYLHET 120
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTR--VMGTYGYCAPEY 260
I+RD K +NILL E KL+DFG+ A+L + ++ R +GT + APE
Sbjct: 121 G---KIHRDIKGANILLTEDGDVKLADFGVSAQL-----TATIAKRKSFIGTPYWMAPEV 172
Query: 261 A---MTGQLTVKSDVYSFGVVFLEL 282
A G K D+++ G+ +EL
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 19/214 (8%)
Query: 84 NFRPESFIGEGGFGRVYKGWL-----ESTGQVVAVKQL---DRNGLQGNREFLVEVLMLS 135
N + + +G G FG V+ E +V VK L LQ EF E+ M
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQ--SEFRRELDMFR 63
Query: 136 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL-----HDLPPDKEALDWNTRMKIA 190
L H N+V L+G C + + ++ E+ LG L+ L D L ++ +
Sbjct: 64 KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 191 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 250
A G+++L +N ++RD + N L+ K+S L+K + + +
Sbjct: 124 TQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNAL 179
Query: 251 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ APE + KSDV+SFGV+ E+ T
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 66/211 (31%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLM--------LSL 136
FR + +G G FG+V + TG++ A+K L + + E VE LM +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDE--VESLMCEKRIFETANS 58
Query: 137 LHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLH-DLPPDKEALDWNTRMKIAAGAA 194
H LVNL C + + V E+ G L H+H D+ + A + AA
Sbjct: 59 ERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA------VFYAACVV 111
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 254
GL+YLH+ ++YRD K N+LL+ K++DFGL K G +G ST GT
Sbjct: 112 LGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG-MGFGDRTST-FCGTPE 166
Query: 255 YCAPEYAMTGQLTVKSDVYSFGVVFLELITG 285
+ APE T D + GV+ E++ G
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 60/200 (30%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIG 147
+G+GGFG V +++TG++ A K+LD+ L+ G + L+E +L ++ +VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 148 YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
Y + L LV M G L+ H++++ + L+ + +A G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD-- 115
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL 266
++YRD K N+LL++ + +LSD GLA G T+ GT GY APE
Sbjct: 116 -IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPY 171
Query: 267 TVKSDVYSFGVVFLELITGR 286
+ D ++ G E++ GR
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLL-HHSNLVNLI 146
+G+G FG+V+ L+ T Q A+K L ++ + + + +VE +LSL H L +L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
+ V E++ G L H+ D AA GL++LH K
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSKG-- 116
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL 266
++YRD K NILL+ H K++DFG+ K +GD + GT Y APE + +
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLGQKY 173
Query: 267 TVKSDVYSFGVVFLELITGR 286
D +SFGV+ E++ G+
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 73/252 (28%), Positives = 111/252 (44%), Gaps = 64/252 (25%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE-FLV----EVLMLSLLHHSNLVNL 145
IGEG +G+VYK + TG++VA+K++ L +E F + E+ +L L+H N+VNL
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 146 IGYCADGDQRL----------LVYEFMP---LGSLEDHLHDLPPD------KEALDWNTR 186
D L LV+E+M +G LE L D K+ L+
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE---- 127
Query: 187 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 246
GL Y H K ++RD K SNILL KL+DFGLA+L + +
Sbjct: 128 ---------GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 247 TRVMGTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWAR 305
+V+ T Y PE + + + DV+S G + EL T +
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-------------------KK 215
Query: 306 PLFNDRRKFSKL 317
P+F ++ ++L
Sbjct: 216 PIFQANQELAQL 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 25/234 (10%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE----------FLVEVLMLSLLHHS 140
IG+G +GRVY +TG+++AVKQ++ R E+ L L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 141 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 200
N+V +G+ + + E++P GS+ L +E L ++ +GL YL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV----LEGLAYL 124
Query: 201 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEY 260
H K +++RD K+ N+L++ K+SDFG++K + + + G+ + APE
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 261 AMTGQ--LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 312
+ + K D++S G V LE+ GR RP ++ + L N R
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIAAMFKLGNKRS 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 30/217 (13%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSLLH 138
F + IGEG +G VY+ ++G++VA+K++ +R+G+ + L E+ +L L
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--LREITLLLNLR 64
Query: 139 HSNLVNLIGYCADGDQR---LLVYEF--MPLGSLEDHLHDLP-PDKEALDWNTRMK-IAA 191
H N+V L G LV E+ L SL L ++P P E+ ++K +
Sbjct: 65 HPNIVELKEVVV-GKHLDSIFLVMEYCEQDLASL---LDNMPTPFSES-----QVKCLML 115
Query: 192 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 251
+GL+YLH+ +I+RD K SN+LL + K++DFGLA+ G + T +
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVV 170
Query: 252 TYGYCAPE--YAMTGQLTVKSDVYSFGVVFLELITGR 286
T Y APE T T D+++ G + EL+ +
Sbjct: 171 TLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 3e-17
Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 149
IG+G FG V+KG T QVVA+K +D + E + E+ +LS + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
G + ++ E++ GS D L P D+ + T +K KGL+YLH + I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI--ATMLK---EILKGLDYLHSEKK---I 123
Query: 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVK 269
+RD K++N+LL E KL+DFG+A G + D +GT + APE K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 270 SDVYSFGVVFLELITGRKAIDSTRP 294
+D++S G+ +EL G P
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDMHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSN 141
FR +G+GGFG V + +TG++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
+VNL D LV M G L+ H++++ + + AA GLE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLH 119
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
+ +YRD K NILL++ H ++SD GLA P G+ + RV GT GY APE
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVL 173
Query: 262 MTGQLTVKSDVYSFGVVFLELITGR 286
+ T+ D + G + E+I G+
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 65/224 (29%), Positives = 108/224 (48%), Gaps = 46/224 (20%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE-F----LVEVLMLSLLHHSNLVNL 145
I EG +G VY+ + TG++VA+K+L ++ +E F L E+ +L L H N+V +
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLK---MEKEKEGFPITSLREINILLKLQHPNIVTV 69
Query: 146 --IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK--IAAGAAK------ 195
+ ++ D+ +V E++ HDL K ++ MK K
Sbjct: 70 KEVVVGSNLDKIYMVMEYVE--------HDL---KSLME---TMKQPFLQSEVKCLMLQL 115
Query: 196 --GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 253
G+ +LHD +++RD K+SN+LL K+ DFGLA+ G T+++ T
Sbjct: 116 LSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTL 170
Query: 254 GYCAPEYAM-TGQLTVKSDVYSFGVVFLELIT------GRKAID 290
Y APE + + + D++S G +F EL+T G+ ID
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 91 IGEGGFGRVYKGWL---ESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNL 145
+GEG FG V +G L + + VAVK + + + EFL E + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 146 IGYCADGDQR------LLVYEFMPLGSLEDHL-----HDLPPDKEALDWNTRMKIAAGAA 194
IG C + +++ FM G L L LP E L T +K A
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLP---EKLPLQTLLKFMVDIA 123
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD---KSHVSTRVMG 251
G+EYL +N I+RD + N +L E ++DFGL+K GD + ++ +
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180
Query: 252 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ A E T KSDV++FGV E+ T
Sbjct: 181 ---WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 4e-17
Identities = 62/197 (31%), Positives = 101/197 (51%), Gaps = 14/197 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 149
IG+G G VY +TGQ VA++Q++ Q +E ++ E+L++ + N+VN +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
GD+ +V E++ GSL D + + +D + + LE+LH VI
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VI 138
Query: 210 YRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTV 268
+RD KS NILL KL+DFG A++ P K + ++GT + APE
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGP 195
Query: 269 KSDVYSFGVVFLELITG 285
K D++S G++ +E+I G
Sbjct: 196 KVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 4e-17
Identities = 77/263 (29%), Positives = 116/263 (44%), Gaps = 32/263 (12%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFL-VEVLMLSLLHHSNLVNLIGYC 149
IG+G FG VYKG T +VVA+K +D + E + E+ +LS + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
G + ++ E++ GS D L P ++ + I KGL+YLH + I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHSERK---I 123
Query: 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVK 269
+RD K++N+LL E KL+DFG+A G + D +GT + APE K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 270 SDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRY--P 327
+D++S G+ +EL G P R LF K + P LEG+Y P
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHP---------MRVLF----LIPKNSPPTLEGQYSKP 228
Query: 328 IRGLYQALAVASMCIQEQAATRP 350
+ +A C+ + RP
Sbjct: 229 FKEFVEA------CLNKDPRFRP 245
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLM-LSLLHHSN---LVNLI 146
+G G G V K TG V+A K + + ++L L ++H +V+
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVH---IGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 147 G-YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
G + + + + EFM GSL+ P + KIA +GL YL++
Sbjct: 70 GAFLNENNI-CMCMEFMDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 265
+++RD K SNIL+ KL DFG++ G + + ++ +GT Y +PE G+
Sbjct: 125 --IMHRDIKPSNILVNSRGQIKLCDFGVS--GELINS--IADTFVGTSTYMSPERIQGGK 178
Query: 266 LTVKSDVYSFGVVFLELITGR 286
TVKSDV+S G+ +EL G+
Sbjct: 179 YTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-17
Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLL-HHSNLVNLI 146
+G+G FG+V L+ G+ AVK L ++ + + + +VE +L+L + L +L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
+ V EF+ G L H+ D K D AA GL++LH K
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG-- 116
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL 266
+IYRD K N++L+ H K++DFG+ K GD ++ GT Y APE +
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLKY 173
Query: 267 TVKSDVYSFGVVFLELITGR 286
T D +SFGV+ E++ G+
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 4e-17
Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQL-DRNGLQGNREFL--VEVLMLSLLHHSNLVNLIG 147
IG G FG V K + +G ++AVK++ + + L ++V+M S S+ ++
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRS----SDCPYIVK 67
Query: 148 YCA----DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRM--KIAAGAAKGLEYLH 201
+ +GD + E M + SL D + + + KIA K L YL
Sbjct: 68 FYGALFREGDC-WICMELMDI-SL-DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL- 123
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
K +I+RD K SNILL+ + KL DFG++ G + D S TR G Y APE
Sbjct: 124 -KEELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVD-SIAKTRDAGCRPYMAPERI 179
Query: 262 MTGQLT---VKSDVYSFGVVFLELITGR 286
V+SDV+S G+ E+ TG+
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 5e-17
Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 8/199 (4%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIG 147
+G+GGFG V + +TG++ A K+L++ L +G +VE +L+ +H +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 207
LV M G L H++++ + A GLE+LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--- 117
Query: 208 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLT 267
+IYRD K N+LL+ + ++SD GLA + D + GT G+ APE +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAV--ELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175
Query: 268 VKSDVYSFGVVFLELITGR 286
D ++ GV E+I R
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 6e-17
Identities = 60/195 (30%), Positives = 95/195 (48%), Gaps = 10/195 (5%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
IGEG G V + TG+ VAVK++D Q EV+++ HH N+V++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210
GD+ +V EF+ G+L D + ++E + + + L YLH++ VI+
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHNQG---VIH 141
Query: 211 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKS 270
RD KS +ILL KLSDFG V + ++GT + APE +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 271 DVYSFGVVFLELITG 285
D++S G++ +E+I G
Sbjct: 200 DIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 6e-17
Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 14/197 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 149
IG+G G VY +TGQ VA+KQ++ Q +E ++ E+L++ + N+VN +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
GD+ +V E++ GSL D + + +D + + L++LH VI
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VI 137
Query: 210 YRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTV 268
+RD KS NILL KL+DFG A++ P ++S ST V GT + APE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 269 KSDVYSFGVVFLELITG 285
K D++S G++ +E++ G
Sbjct: 195 KVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 8e-17
Identities = 76/286 (26%), Positives = 118/286 (41%), Gaps = 34/286 (11%)
Query: 91 IGEGGFGRVYKG---WLESTGQVVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVNLI 146
IG G FG+V G S +VV VK+L FL EV L+H N++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVV-VKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLH-DLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
G C + LLV EF PLG L+++L + + + ++A A GL +LH +A+
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-QAD 120
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA---- 261
I+ D N L K+ D+GLA D + APE
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 262 ---MTGQLTVKSDVYSFGVVFLELITGRKAIDSTRP---HGEQNLVTWARPLFNDRRKFS 315
+ T KS+++S GV EL T + +P ++ ++ R +
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFT-----AADQPYPDLSDEQVLKQVV-----REQDI 228
Query: 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 361
KL P+L+ +Y R Y+ + + TRP +V L+Y
Sbjct: 229 KLPKPQLDLKYSDR-WYEVMQFCWL----DPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 8e-17
Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 10/195 (5%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
IGEG G V ++S+G++VAVK++D Q EV+++ H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210
GD+ +V EF+ G+L D + ++E + + K L LH + VI+
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLKALSVLHAQG---VIH 139
Query: 211 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKS 270
RD KS +ILL KLSDFG V + ++GT + APE +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 271 DVYSFGVVFLELITG 285
D++S G++ +E++ G
Sbjct: 198 DIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 8e-17
Identities = 68/216 (31%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL--DRNGLQGNRE---FLVEVLMLSLLH 138
N+R +G+G FGRVY + TG+ +AVKQ+ D + ++E E+ +L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 139 HSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 196
H +V G D +R L E MP GS++D L AL N K +G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEG 118
Query: 197 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK------LGPVGDKSHVSTRVM 250
+ YLH +++RD K +NIL + + KL DFG +K L G KS V
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-----VT 170
Query: 251 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
GT + +PE K+D++S G +E++T +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 8e-17
Identities = 63/224 (28%), Positives = 112/224 (50%), Gaps = 18/224 (8%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSN 141
++ P +G+G FG +V K+++ L + R+ L E+++LSLL H N
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLED---HLHDLPPDKEALDWNTRMKIAAGAAKGLE 198
++ + D + L+ E+ G+L D ++E + W ++A +
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA-----VS 115
Query: 199 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAP 258
Y+H KA +++RD K+ NI L + KL DFG++K+ +G + ++ V+GT Y +P
Sbjct: 116 YIH-KAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSP 170
Query: 259 EYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVT 302
E + KSD+++ G V EL+T ++ D+T P NLV
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNLVV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 9e-17
Identities = 76/245 (31%), Positives = 109/245 (44%), Gaps = 23/245 (9%)
Query: 91 IGEGGFGRVYKGWLES---TGQVVAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNLI 146
IG G FG+V G + S QVV VK+L + +Q +FL E L HSNL+ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVV-VKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDL-PPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
G C + LLV EF PLG L+ +L + D T ++A A GL +LH K N
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-KNN 120
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA--MT 263
I+ D N LL K+ D+GL+ D ++ + APE +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 264 GQLTV-----KSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318
G L V +S+V+S GV EL R ++ ++T + R + KL
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELF--ELGSQPYRHLSDEQVLT-----YTVREQQLKLP 231
Query: 319 DPRLE 323
PRL+
Sbjct: 232 KPRLK 236
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 9e-17
Identities = 60/221 (27%), Positives = 106/221 (47%), Gaps = 34/221 (15%)
Query: 91 IGEGGFGRVY----KGWLESTGQ----------VVAVKQLDRNGLQGNR-EFLVEVLMLS 135
+GEG FG V+ +G E G+ +VAVK L + + R +FL E+ ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 136 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLED------------HLHDLPPDKEALDW 183
L + N++ L+G C D ++ E+M G L H +++P ++
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP----SVSI 128
Query: 184 NTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS 243
+ +A A G++YL A+ ++RD + N L+ + K++DFG+++ GD
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 244 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ R + + A E + G+ T SDV++FGV E+ T
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 72/274 (26%), Positives = 120/274 (43%), Gaps = 39/274 (14%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-----EVLMLSLLHH 139
++ IG G +G VY+G TG+VVA+K ++ + + V EV +LS L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLRQ 58
Query: 140 SNLVNLIGYCA---DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 196
S N+ Y G + ++ E+ GS+ + P ++ + R + A
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA----- 113
Query: 197 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 256
L+Y+H VI+RD K++NIL+ + KL DFG+A L + S + +GT +
Sbjct: 114 LKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGTPYWM 168
Query: 257 APEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315
APE G+ K+D++S G+ E+ TG L+ ++P
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP--------- 219
Query: 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATR 349
PRLE + L + +A C+ E+ R
Sbjct: 220 ----PRLEDNGYSKLLREFVA---ACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 64/205 (31%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSN 141
FR +G+GGFG V + +TG++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
+V+L D LV M G L+ H++ + + + + AA GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
+ ++YRD K NILL++ H ++SD GLA P G + RV GT GY APE
Sbjct: 120 QER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVV 173
Query: 262 MTGQLTVKSDVYSFGVVFLELITGR 286
+ T D ++ G + E+I G+
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 29/272 (10%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G G FG V+ G + +V A+K + G +F+ E ++ L H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKV-AIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210
+V EFM G L L+ L + L + + + +G+EYL + I+
Sbjct: 70 QQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIH 123
Query: 211 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR-VMGTYGYCAPEYAMTGQLTVK 269
RD + N L+ K+SDFG+ + V D + S+ + PE + + K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 270 SDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPI 328
SDV+SFGV+ E+ T G+ + + +++ + +L P+L
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS----------RGFRLYRPKLASMT-- 229
Query: 329 RGLYQALAVASMCIQEQAATRPLIGDVVTALS 360
+Y+ V C E+ RP +++ A++
Sbjct: 230 --VYE---VMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 91 IGEGGFGRVYKGW---LESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSNLVNLI 146
IGEG FG VY+G E+ VAVK RE FL E ++ H ++V LI
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
G + + +V E PLG L +L +K +LD + + + + L YL K
Sbjct: 74 GVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR-- 127
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV-STRVMGTYGYCAPEYAMTGQ 265
++RD + N+L+ KL DFGL++ + D+S+ +++ + APE +
Sbjct: 128 -FVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 266 LTVKSDVYSFGVVFLELI 283
T SDV+ FGV E++
Sbjct: 185 FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSN 141
FR +G+GGFG V + +TG++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
+V+L D LV M G L+ H++++ D + AA GLE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
+ ++YRD K NILL++ H ++SD GLA P G+ V RV GT GY APE
Sbjct: 120 RER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVI 173
Query: 262 MTGQLTVKSDVYSFGVVFLELITGR 286
+ T D + G + E+I G+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQ-----VVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVN 144
+G+G FG VY+G + + VA+K ++ R EFL E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE-----ALDWNTRM-KIAAGAAKGLE 198
L+G + G L++ E M G L+ +L L P+ E A +M ++A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 199 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAP 258
YL+ AN ++RD + N ++ E F K+ DFG+ + D + + + +P
Sbjct: 134 YLN--AN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 259 EYAMTGQLTVKSDVYSFGVVFLELIT 284
E G T SDV+SFGVV E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSN 141
FR +G+GGFG V + +TG++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
+V+L D LV M G L+ H++++ D + AA GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLH 119
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
+ ++YRD K NILL++ H ++SD GLA P G+ + RV GT GY APE
Sbjct: 120 RER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVV 173
Query: 262 MTGQLTVKSDVYSFGVVFLELITGR 286
+ T D + G + E+I G+
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 88 ESFIGEGGFGRVYKGWLESTG--QVVAVKQLDRNGLQGN-REFLVEVLMLSLL-HHSNLV 143
+ IGEG FG+V K ++ G A+K++ + + R+F E+ +L L HH N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHLHD---LPPD---------KEALDWNTRMKIAA 191
NL+G C L E+ P G+L D L L D L + AA
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 192 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 251
A+G++YL K I+RD + NIL+ E + K++DFGL++ G + +V + MG
Sbjct: 132 DVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMG 183
Query: 252 TYG--YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ A E T SDV+S+GV+ E+++
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 61/199 (30%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLIG 147
+G+G FG+V L+ +G++ AVK L ++ + + + + E +LSL + + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 148 YCADGDQRLL-VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
C RL V EF+ G L H+ D AA L +LHDK
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG-- 116
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL 266
+IYRD K N+LL+ H KL+DFG+ K G + + ST GT Y APE
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKEG-IFNGKTTST-FCGTPDYIAPEILQEMLY 173
Query: 267 TVKSDVYSFGVVFLELITG 285
D ++ GV+ E++ G
Sbjct: 174 GPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 4e-16
Identities = 68/198 (34%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLHHSNLVNLIG 147
IG G FG VY T +VVA+K++ +G Q N ++ + EV L + H N + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 207
LV E+ LGS D L K+ L I GA +GL YLH
Sbjct: 93 CYLREHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHN--- 145
Query: 208 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT---G 264
+I+RD K+ NILL E KL+DFG A + + + +GT + APE + G
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVILAMDEG 199
Query: 265 QLTVKSDVYSFGVVFLEL 282
Q K DV+S G+ +EL
Sbjct: 200 QYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-16
Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL--DRNGLQGNRE---FLVEVLMLSLLH 138
N+R +G G FG VY + TG+ +AVKQ+ D + + ++E E+ +L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 139 HSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 196
H +V G D +++ L E+MP GS++D L AL N + +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQG 118
Query: 197 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK------LGPVGDKSHVSTRVM 250
+ YLH +++RD K +NIL + + KL DFG +K + G KS V
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-----VT 170
Query: 251 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
GT + +PE K+DV+S +E++T
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 7e-16
Identities = 71/204 (34%), Positives = 97/204 (47%), Gaps = 31/204 (15%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLHHSNLVNLIG 147
IG G FG VY +VVA+K++ +G Q N ++ + EV L L H N + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 148 YCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAA---GAAKGLEYLHD 202
LV E+ LGS D L H P + ++IAA GA +GL YLH
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQE--------VEIAAVTHGALQGLAYLH- 132
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL-GPVGDKSHVSTRVMGTYGYCAPEYA 261
+ +I+RD K+ NILL E KL DFG A + P + +GT + APE
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVI 183
Query: 262 MT---GQLTVKSDVYSFGVVFLEL 282
+ GQ K DV+S G+ +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 8e-16
Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 91 IGEGGFGRVY--KGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGY 148
IGEG FG++Y K +S V+ L + ++ EV++L+ + H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 149 CADGDQRLLVYEFMPLGSLEDHLHD----LPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
+ + +V E+ G L ++ L + + L W ++ + GL+++HD+
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHDRK 121
Query: 205 NPPVIYRDFKSSNILLEE-GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT 263
+++RD KS NI L + G KL DFG+A+ + D ++ +GT Y +PE
Sbjct: 122 ---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQN 176
Query: 264 GQLTVKSDVYSFGVVFLELITGRKAIDSTRPH 295
K+D++S G V EL T + + H
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 23/205 (11%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLM-----LSLL-HHSNLVN 144
+G+G FG+V L+ T ++ AVK L ++ + + + VE M L+L H L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD--VECTMTEKRVLALAGKHPFLTQ 60
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDK 203
L D+ V E++ G L H+ E R + AA GL++LH++
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-----RARFYAAEIVLGLQFLHER 115
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM-GTYGYCAPEYAM 262
+IYRD K N+LL+ H K++DFG+ K G +G V+T GT Y APE +
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTSTFCGTPDYIAPE-IL 168
Query: 263 TGQLTVKS-DVYSFGVVFLELITGR 286
+ Q + D ++ GV+ E++ G+
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 66/207 (31%), Positives = 110/207 (53%), Gaps = 13/207 (6%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNL 142
NF+ +GEG + VYKG +TG++VA+K++ + +G + E+ ++ L H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 143 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
V L ++ +LV+E+M L+ ++ D + ALD NT KG+ + H+
Sbjct: 61 VRLHDVIHTENKLMLVFEYMD-KDLKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LG-PVGDKSHVSTRVMGTYGYCAPEY 260
V++RD K N+L+ + KL+DFGLA+ G PV + S V+ T Y AP+
Sbjct: 119 NR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---NTFSNEVV-TLWYRAPDV 171
Query: 261 AMTGQLTVKS-DVYSFGVVFLELITGR 286
+ + S D++S G + E+ITGR
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 28/217 (12%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQ--LDRNGLQGNREFLVEVLMLSLLHHSN 141
NF+ IGEG +G VYK + TG+VVA+K+ LD + E+ +L L+H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK------ 195
+V L+ ++ LV+EF+ DL K+ +D + I K
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLH--------QDL---KKFMDASPLSGIPLPLIKSYLFQL 109
Query: 196 --GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 253
GL + H V++RD K N+L+ KL+DFGLA+ V +++ V T
Sbjct: 110 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TL 164
Query: 254 GYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAI 289
Y APE + + + D++S G +F E++T R+A+
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G+G +G VY ST +A+K++ + + E+ + S L H N+V +G +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 151 DGDQRLLVYEFMPLGSLEDHLHD----LPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
+ + E +P GSL L L +++ + + T+ + +GL+YLHD
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLHDNQ-- 128
Query: 207 PVIYRDFKSSNILLE--EGFHPKLSDFG----LAKLGPVGDKSHVSTRVMGTYGYCAPEY 260
+++RD K N+L+ G K+SDFG LA + P + GT Y APE
Sbjct: 129 -IVHRDIKGDNVLVNTYSGV-VKISDFGTSKRLAGINP------CTETFTGTLQYMAPEV 180
Query: 261 AMTGQ--LTVKSDVYSFGVVFLELITGR 286
G +D++S G +E+ TG+
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 91 IGEGGFGRVYKGWLES--TGQV---VAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVN 144
+G+G FG VY+G G+ VAVK ++ + L+ EFL E ++ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE------ALDWNTRMKIAAGAAKGLE 198
L+G + G L+V E M G L+ +L L P+ E +++AA A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 199 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAP 258
YL+ K ++RD + N ++ F K+ DFG+ + D + + + AP
Sbjct: 134 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 259 EYAMTGQLTVKSDVYSFGVVFLELIT 284
E G T SD++SFGVV E+ +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL--DRNGLQGNRE---FLVEVLMLSLLH 138
N+R +G+G FGRVY + TG+ +A KQ+ D + ++E E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 139 HSNLVNLIGYCADGDQRLLV--YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 196
H +V G D ++ L E+MP GS++D L AL + K +G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEG 118
Query: 197 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR-VMGTYGY 255
+ YLH +++RD K +NIL + + KL DFG +K S R V GT +
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 256 CAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
+PE K+DV+S G +E++T +
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 88 ESFIGEGGFGRVYKGWLESTGQ--VVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNL 145
E +G G FG V W+ + + VAVK + + G FL E ++ L H LV L
Sbjct: 11 EKKLGAGQFGEV---WMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL 66
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
+ ++ EFM GSL D L K+ L + +A A+G+ ++ +
Sbjct: 67 HAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN- 122
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR-VMGTYGYCAPEYAMTG 264
I+RD +++NIL+ K++DFGLA++ + D + + + APE G
Sbjct: 123 --YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINFG 178
Query: 265 QLTVKSDVYSFGVVFLELIT-GR 286
T+KSDV+SFG++ +E++T GR
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 27/218 (12%)
Query: 91 IGEGGFGRVY-------KGWLESTGQ---------VVAVKQLDRNGLQGNR-EFLVEVLM 133
+GEG FG V+ + + E +VAVK L + R +FL EV +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 134 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH-------DLPPDKEALDWNTR 186
LS L N+ L+G C ++ E+M G L L L + ++L ++T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 187 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 246
+ +A A G+ YL + ++RD + N L+ + + K++DFG+++ D V
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 247 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
R + A E + G+ T KSDV++FGV E++T
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 6e-15
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLM-LSLLHHSNLVNLIGYC 149
+G+G +G VYK TG +A+K++ L+ + +++M L +LH + ++ +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIR---LELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 150 ADGDQRLLVY---EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
VY E+M GSL D L+ E + + +I KGL++L ++ N
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN- 123
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--KSHVSTRVMGTYGYCAPEY---- 260
+I+RD K +N+L+ KL DFG++ G+ S T + G Y APE
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVS-----GNLVASLAKTNI-GCQSYMAPERIKSG 176
Query: 261 AMTGQLT--VKSDVYSFGVVFLELITGR 286
T V+SDV+S G+ LE+ GR
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 6e-15
Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 17/198 (8%)
Query: 91 IGEGGFGRVYKGWLE--STGQVVAVKQL--DRNGLQGNREFLVEVLMLSLLHHSNLVNLI 146
+G G FG V KG + + + VAVK L D N E L E ++ L + +V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
G C + + +LV E LG L L +K + N ++ + G++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQK---NKHVTEKNI-TELVHQVSMGMKYLEETN-- 115
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVMGTY--GYCAPEYAMT 263
++RD + N+LL + K+SDFGL+K LG D+++ + G + + APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALG--ADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 264 GQLTVKSDVYSFGVVFLE 281
+ + KSDV+SFGV+ E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 6e-15
Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 19/195 (9%)
Query: 107 TGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHHSNLVNLIGYCADGDQRLL-VYEFM 162
TG VA+K L + + + F E + + L+H N+V L+ L V+E++
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE 222
P +L + L AL ++ L H++ +++RD K NI++ +
Sbjct: 62 PGRTLREVLAA----DGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQ 114
Query: 223 ---GFHPKLSDFGLAKLGP-VGDKSHV----STRVMGTYGYCAPEYAMTGQLTVKSDVYS 274
H K+ DFG+ L P V D +T V+GT YCAPE +T SD+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 275 FGVVFLELITGRKAI 289
+G++FLE +TG++ +
Sbjct: 175 WGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 20/199 (10%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV---EVLMLSLLHHSNLVNLIG 147
IG G +G VYK +TG++ A+K + L+ +F V E++M+ HSN+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA-LDWNTRMKIAAGAAKGLEYLHDKANP 206
D+ + EF GSL+D H P E+ + + +R + +GL YLH K
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK- 127
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT--- 263
++RD K +NILL + H KL+DFG++ + +GT + APE A
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 264 GQLTVKSDVYSFGVVFLEL 282
G D+++ G+ +EL
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 7e-15
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 88 ESFIGEGGFGRVYKGWLESTG---QVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNL 142
E IG G FG V +G L+ G VA+K L ++G + R+FL E ++ H N+
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 143 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
++L G +++ EFM G+L+ L + + + G A G++YL +
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG---TYGYCAPE 259
++RD + NIL+ K+SDFGL++ T +G + APE
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 260 YAMTGQLTVKSDVYSFGVVFLELIT 284
+ T SDV+S+G+V E+++
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 7e-15
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 27/203 (13%)
Query: 91 IGEGGFGRV-YKGWLESTGQV-VAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGY 148
+G G FG V Y W GQ VA+K + + G EF+ E ++ L H LV L G
Sbjct: 12 LGTGQFGVVKYGKW---RGQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 149 CADGDQRLLVYEFMP----LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
C +V E+M L L +H P + +++ +G+ YL K
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ-------LLEMCKDVCEGMAYLESKQ 120
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---YGYCAPEYA 261
I+RD + N L+++ K+SDFGL++ V D + S+ +G+ + PE
Sbjct: 121 ---FIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVL 173
Query: 262 MTGQLTVKSDVYSFGVVFLELIT 284
+ + + KSDV++FGV+ E+ +
Sbjct: 174 LYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 66/233 (28%), Positives = 104/233 (44%), Gaps = 41/233 (17%)
Query: 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSL 136
+++ +GEG FG VYK TG+VVA+K++ +++G L E+ +L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA--LREIKILKK 63
Query: 137 LHHSNLVNLIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 191
L H N+V LI + +R VY P HDL L N +K+
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-----HDL----SGLLENPSVKLTE 114
Query: 192 GAAK--------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL------- 236
K G+ YLH+ +++RD K++NIL++ K++DFGLA+
Sbjct: 115 SQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171
Query: 237 --GPVGDKSHVSTRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 286
G G + T ++ T Y PE + + T D++ G VF E+ T R
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 71/223 (31%), Positives = 103/223 (46%), Gaps = 30/223 (13%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRN-GLQGNREFLVE--VLMLSLLHHSNLVNLIG 147
+G G +G V K TG ++AVK++ Q + L++ + M S+ V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSV-DCPYTVTFYG 67
Query: 148 YC-ADGDQRLLVYEFMPL--GSLED-----HLHDLPPDKEALDWNTRMKIAAGAAKGLEY 199
+GD V+ M + SL+ + L ++ L KIA K LEY
Sbjct: 68 ALFREGD----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEY 118
Query: 200 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE 259
LH K + VI+RD K SN+L+ KL DFG++ G + D S T G Y APE
Sbjct: 119 LHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVD-SVAKTIDAGCKPYMAPE 173
Query: 260 Y---AMTGQ-LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 298
+ + VKSDV+S G+ +EL TGR DS + +Q
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ 216
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 71/280 (25%), Positives = 115/280 (41%), Gaps = 28/280 (10%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL---DRNGLQGNREFLVEVLMLSLLH 138
NF+ E IG+G F VYK G+VVA+K++ + + ++ L E+ +L L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 139 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 198
H N++ + + ++ +V E G L + K + T K LE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 199 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAP 258
++H K +++RD K +N+ + KL D GL + K+ + ++GT Y +P
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSP 175
Query: 259 EYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318
E KSD++S G + E+ A+ S + NL + L K K
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYS----LCK---KIEKCD 224
Query: 319 DPRLEGRY---PIRGLYQALAVASMCIQEQAATRPLIGDV 355
P L + +R L S CI RP I V
Sbjct: 225 YPPLPADHYSEELRDL------VSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 69/224 (30%), Positives = 100/224 (44%), Gaps = 24/224 (10%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLML-SLLHHSNLV 143
F +G G +G+VYKG TGQ+ A+K +D G + E E+ ML HH N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 66
Query: 144 NLIGYCAD------GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGL 197
G DQ LV EF GS+ D + + + +W I +GL
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 124
Query: 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLG-PVGDKSHVSTRVMGTYGY 255
+LH VI+RD K N+LL E KL DFG+ A+L VG ++ +GT +
Sbjct: 125 SHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN----TFIGTPYW 177
Query: 256 CAPEYAMTGQ-----LTVKSDVYSFGVVFLELITGRKAIDSTRP 294
APE + KSD++S G+ +E+ G + P
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 70/208 (33%), Positives = 99/208 (47%), Gaps = 30/208 (14%)
Query: 91 IGEGGFGRVY---KGWLESTGQVVAVKQL--------DRNGLQGNREFLVEVLMLSLLHH 139
+G+G FG+V+ K GQ+ A+K L DR + R+ L EV +H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------NH 57
Query: 140 SNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGL 197
+V L Y + +L L+ +F+ G L L KE + +K A A L
Sbjct: 58 PFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELALAL 111
Query: 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCA 257
++LH +IYRD K NILL+E H KL+DFGL+K +K S GT Y A
Sbjct: 112 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMA 166
Query: 258 PEYAMTGQLTVKSDVYSFGVVFLELITG 285
PE T +D +SFGV+ E++TG
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 44/213 (20%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSLLHHSNLVN-- 144
+GEG FGR ++ Q A+K++ + ++ +R+ E ++L+ + H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAFK 64
Query: 145 -----------LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 193
++ YC GD + ++ L P+ L W +M +
Sbjct: 65 ESFEADGHLYIVMEYCDGGDL---------MQKIKLQRGKLFPEDTILQWFVQMCL---- 111
Query: 194 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKSHVSTRVMG 251
G++++H+K V++RD KS NI L + KL DFG A+L P ++ T V G
Sbjct: 112 --GVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYACTYV-G 162
Query: 252 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
T Y PE KSD++S G + EL T
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVK----QLDRNGLQGNREFLVEVLMLSLLH-- 138
+ P + IG G +G VYK +G VA+K Q + +GL + + EV +L L
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLST--VREVALLKRLEAF 59
Query: 139 -HSNLVNLIGYCADG--DQRL---LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 192
H N+V L+ CA D+ LV+E + L +L +PP L T +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQ 116
Query: 193 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS-TRVMG 251
+GL++LH +++RD K NIL+ G KL+DFGLA++ ++ T V+
Sbjct: 117 FLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVV 169
Query: 252 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 282
T Y APE + D++S G +F E+
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 91 IGEGGFGRVYKGWLESTGQV--VAVKQLD-----RNGLQGNREFLVEVLMLSLLHHSNLV 143
+GEG FG V +G L + VAVK + R+ ++ +FL E + + H N++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME---DFLSEAVCMKEFDHPNVM 63
Query: 144 NLIGYCADGDQR------LLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAAGAAK 195
LIG C + +++ FM G L L L + L +K A
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 196 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY 255
G+EYL K+ I+RD + N +L E + ++DFGL+K GD +
Sbjct: 124 GMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 256 CAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
A E T KSDV+SFGV E+ T
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 57/218 (26%), Positives = 106/218 (48%), Gaps = 27/218 (12%)
Query: 91 IGEGGFGRVY----KGWLESTGQ------------VVAVKQLDRNGLQGNR-EFLVEVLM 133
+GEG FG V+ +G + + +VAVK L + + R +FL E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 134 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLP-----PDKEALDWNTR 186
+S L N++ L+ C D ++ E+M G L L H+ D + ++T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 187 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 246
+ +A A G++YL ++ ++RD + N L+ + + K++DFG+++ GD +
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 247 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
R + + + E + G+ T SDV++FGV E++T
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 55/198 (27%), Positives = 104/198 (52%), Gaps = 15/198 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIG-YC 149
+G+G FG+VYK + TG + A K ++ + +++VE+ +L+ +H +V L+G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
DG +++ EF P G+++ + +L D+ + ++ I + L+YLH +I
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLEL--DRGLTEPQIQV-ICRQMLEALQYLHSMK---II 132
Query: 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLT-- 267
+RD K+ N+LL KL+DFG++ + S +GT + APE M +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMKDT 190
Query: 268 ---VKSDVYSFGVVFLEL 282
K+D++S G+ +E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 91 IGEGGFGRVY--------KGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLL-HHS 140
+GEG FG+V K + T VAVK L N + L+ E+ ++ L+ H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQT-VTVAVKMLKDNATDKDLADLISEMELMKLIGKHK 78
Query: 141 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH-------DLPPD-----KEALDWNTRMK 188
N++NL+G C ++ E+ G+L + L D D +E L + +
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 189 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 248
A A+G+EYL + I+RD + N+L+ E K++DFGLA+ D ++
Sbjct: 139 CAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 249 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ APE T +SDV+SFG++ E+ T
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSL-LHHSNLVNLI 146
+G+G FG+V L+ T + A+K L ++ + + + +VE +L+L H L +L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61
Query: 147 GYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
+C + V E++ G L H+ D AA GL++LH K
Sbjct: 62 -FCTFQTKEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG 264
+IYRD K N+LL++ H K++DFG+ K G+ ++ GT Y APE + G
Sbjct: 117 ---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPE-ILKG 170
Query: 265 QLTVKS-DVYSFGVVFLELITGR 286
Q +S D +SFGV+ E++ G+
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLHHS 140
+ +P +G G FG V + TGQ VA+K++ + + R + E+ +L L H
Sbjct: 14 DLQP---VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHE 69
Query: 141 NLVNLIG-YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEY 199
N+++L + + + V E + L L P +K+ + + +GL+Y
Sbjct: 70 NIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQY-----FLYQILRGLKY 123
Query: 200 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE 259
+H V++RD K SNIL+ E K+ DFGLA++ +VSTR Y APE
Sbjct: 124 VHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPE 175
Query: 260 YAMTGQ-LTVKSDVYSFGVVFLELITGR 286
+T Q V+ D++S G +F E++ G+
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 38/222 (17%)
Query: 91 IGEGGFGRVYKGWLESTG---------QVVAVKQLDRNGLQGN-REFLVEVLMLSLL-HH 139
+GEG FG+V E+ G VAVK L + + + + + E+ M+ ++ H
Sbjct: 26 LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------------KEALDWNTRM 187
N++NL+G C ++ E+ G+L ++L P +E L + +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 188 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 247
A A+G+EYL A+ I+RD + N+L+ E K++DFGLA+ D H+
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 195
Query: 248 RVMGTYG-----YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
T G + APE T +SDV+SFGV+ E+ T
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHS 140
+F +G+G FG+V + T ++ A+K L ++ + + + +VE +L+L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 141 NLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEY 199
+ + C RL V E++ G L H+ + KE + AA + GL +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP----QAVFYAAEISVGLFF 116
Query: 200 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM-GTYGYCAP 258
LH + +IYRD K N++L+ H K++DFG+ K V V+TR GT Y AP
Sbjct: 117 LHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFCGTPDYIAP 170
Query: 259 EYAMTGQLTVKSDVYSFGVVFLELITGRKAID 290
E D +++GV+ E++ G+ D
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 19/200 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRN---GLQGNREFLVEVLMLSLLHHSNLVNLIG 147
+G G FGRV + TG+ A+K L + ++ + E +L L H +VN++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
D ++ + EF+ G L HL P+ A ++ + +A EYLH K
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA------FEYLHSKD- 138
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 265
+IYRD K N+LL+ H K++DFG AK V D++ + GT Y APE +
Sbjct: 139 --IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT---LCGTPEYLAPEVIQSKG 191
Query: 266 LTVKSDVYSFGVVFLELITG 285
D ++ GV+ E I G
Sbjct: 192 HGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 6e-14
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQ---VVAVKQLDRNGLQGNR-EFLVEVLMLSLLHH 139
+ E IG G FG V G L+ G+ VA+K L + R +FL E ++ H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAAGAAKGL 197
N+++L G ++V E+M GSL+ L HD L + + G A G+
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASGM 119
Query: 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG---TYG 254
+YL D ++RD + NIL+ K+SDFGL+++ + D + G
Sbjct: 120 KYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIR 174
Query: 255 YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ APE + T SDV+S+G+V E+++
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 28/217 (12%)
Query: 91 IGEGGFGRVYKGWLESTG---------QVVAVKQLDRNGLQGNREFLV-EVLMLSLL-HH 139
+GEG FG+V E+ G VAVK L + + + LV E+ M+ ++ H
Sbjct: 23 LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRM 187
N++NL+G C ++ E+ G+L ++L P E + + +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 188 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 247
A+G+EYL A+ I+RD + N+L+ E K++DFGLA+ D +T
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 248 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ APE T +SDV+SFGV+ E+ T
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 91 IGEGGFGRVYKGWLESTG---------QVVAVKQLDRNGLQGNREFLV-EVLMLSLL-HH 139
+GEG FG+V E+ G VAVK L + + LV E+ M+ ++ H
Sbjct: 20 LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------------KEALDWNTRM 187
N++NL+G C ++ E+ G+L ++L P +E L + +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 188 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 247
A A+G+EYL A+ I+RD + N+L+ E K++DFGLA+ D +T
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 248 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ APE T +SDV+SFGV+ E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLIG 147
+G+G FG+V + T ++ A+K L ++ + + + +VE +L+L + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 148 YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
C RL V E++ G L H+ + KE + AA A GL +LH K
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP----HAVFYAAEIAIGLFFLHSKG-- 121
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM-GTYGYCAPEYAMTGQ 265
+IYRD K N++L+ H K++DFG+ K G K +TR GT Y APE
Sbjct: 122 -IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGTPDYIAPEIIAYQP 177
Query: 266 LTVKSDVYSFGVVFLELITGRKAID 290
D ++FGV+ E++ G+ D
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 72/240 (30%), Positives = 107/240 (44%), Gaps = 24/240 (10%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGY- 148
+G G +G+VYKG TGQ+ A+K +D + E +E+ ML HH N+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 149 -----CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
DQ LV EF GS+ D + + + DW I +GL +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH 140
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLG-PVGDKSHVSTRVMGTYGYCAPEYA 261
VI+RD K N+LL E KL DFG+ A+L VG ++ +GT + APE
Sbjct: 141 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN----TFIGTPYWMAPEVI 193
Query: 262 MTGQ-----LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316
+ +SD++S G+ +E+ G + P L+ P +K+SK
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSK 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 65/207 (31%), Positives = 105/207 (50%), Gaps = 27/207 (13%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE-----FLVEVLMLSLLHHSNLVNL 145
IGEG +G VYK + TG++VA+K++ L+ E + E+ +L L+H N+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIR---LETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 146 --IGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
+ + + +L LV+EF+ L L+ ++ P LD +G+ Y H
Sbjct: 64 LDVVHS---ENKLYLVFEFLDL-DLKKYMDSSPLT--GLDPPLIKSYLYQLLQGIAYCHS 117
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LG-PVGDKSHVSTRVMGTYGYCAPEY 260
V++RD K N+L++ KL+DFGLA+ G PV +H V+ T Y APE
Sbjct: 118 HR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEI 170
Query: 261 AMTG-QLTVKSDVYSFGVVFLELITGR 286
+ Q + D++S G +F E++ R
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 9e-14
Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 62/224 (27%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF--------LVEVLML-SLLHHSN 141
+G+G FG VY + TG++VA+K++ ++F L EV L L H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK------ 195
+V L + D+ V+E+M E +L+ L D++ + +
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRK------GKPFSESVIRSIIYQI 108
Query: 196 --GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK----SHVSTRV 249
GL ++H K +RD K N+L+ K++DFGLA+ + + +VSTR
Sbjct: 109 LQGLAHIH-KHG--FFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR- 162
Query: 250 MGTYGYCAPEYAMTGQLTVKSDVYS-------FGVVFLELITGR 286
Y APE + ++S YS G + EL T R
Sbjct: 163 ----WYRAPE------ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 149
IGEG G V + +G+ VAVK +D Q RE L EV+++ H N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
G++ ++ EF+ G+L D + ++E + + + L YLH + VI
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTRLNEEQI-----ATVCESVLQALCYLHSQG---VI 139
Query: 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVK 269
+RD KS +ILL KLSDFG + ++GT + APE +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 270 SDVYSFGVVFLELITGRKAIDSTRP 294
D++S G++ +E++ G S P
Sbjct: 198 VDIWSLGIMVIEMVDGEPPYFSDSP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 18/198 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVK--QLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGY 148
+G G G VYK + T +++AVK LD ++ ++ + E+ +L ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 149 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 208
++ + EFM GSL D +P + L +IA KGL YL + +
Sbjct: 68 FFVENRISICTEFMDGGSL-DVYRKIP--EHVLG-----RIAVAVVKGLTYLW---SLKI 116
Query: 209 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTV 268
++RD K SN+L+ KL DFG++ + ++ +GT Y APE Q +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGEQYGI 172
Query: 269 KSDVYSFGVVFLELITGR 286
SDV+S G+ F+EL GR
Sbjct: 173 HSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 64/194 (32%), Positives = 90/194 (46%), Gaps = 45/194 (23%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE--F----LVEVLMLSLLHHSNLVN 144
IG+G FG V+K + T Q+VA+K++ L N + F L E+ +L LL H N+VN
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 75
Query: 145 LIGYC---ADGDQR-----LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK- 195
LI C A R LV+EF HDL L N +K K
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCE--------HDLA----GLLSNKNVKFTLSEIKK 123
Query: 196 -------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK---LGPVGDKSHV 245
GL Y+H +++RD K++NIL+ + KL+DFGLA+ L +
Sbjct: 124 VMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 246 STRVMGTYGYCAPE 259
+ RV+ T Y PE
Sbjct: 181 TNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 65/234 (27%), Positives = 104/234 (44%), Gaps = 24/234 (10%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIG 147
+G+GG+G+V+ + TG++VA+K++ ++ L R L E +L+ LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
D + L E++P G L++L + A + M A A L Y+H
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIH---- 124
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 265
RD K N L++ H KL+DFGL+K S V+G+ Y APE
Sbjct: 125 -----RDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVLRGKG 174
Query: 266 LTVKSDVYSFGVVFLELITGRKAIDSTRPHGE-QNLVTWA----RPLFNDRRKF 314
D +S G + E + G + P+ +NL W RP+++D R
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFN 228
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 35/210 (16%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQ----LDRNGLQGN--REFLVEVL-MLSLLHHSNLV 143
IGEG +G VYK +TG+ VA+K+ L G+ + RE + +L L H N+V
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE--IALLKQLESFEHPNIV 64
Query: 144 NLIGYCA--DGDQRL---LVYEFMPLGSLEDHLHDLPP---DKEALDWNTRMKIAAGAAK 195
L+ C D+ L LV+E + L +L P E + R + +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLL-----R 118
Query: 196 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS-TRVMGTYG 254
G+++LH +++RD K NIL+ K++DFGLA++ ++ T V+ T
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY----SFEMALTSVVVTLW 171
Query: 255 YCAPEYAMTGQLTVKS--DVYSFGVVFLEL 282
Y APE + Q + + D++S G +F EL
Sbjct: 172 YRAPEVLL--QSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 2e-13
Identities = 61/222 (27%), Positives = 95/222 (42%), Gaps = 39/222 (17%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---------LVEVLMLS 135
+ IG G +G V + TG+ VA+K++ + F L E+ +L
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLR 54
Query: 136 LLHHSNLVNLIGYCADGDQR-----LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK-I 189
L H N++ L+ +V E M E LH + + L + ++
Sbjct: 55 HLRHENIIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLT-DDHIQYF 108
Query: 190 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 249
+GL+YLH AN VI+RD K SNIL+ K+ DFGLA+ D
Sbjct: 109 LYQILRGLKYLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLAR---GVDPDEDEKGF 162
Query: 250 MGTY----GYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 286
+ Y Y APE ++ K+ D++S G +F EL+T +
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL---DRNGLQGNREFLVEVLMLSLLHHS 140
+ +G G FGRV+ + A+K + + L+ + E +L + H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 141 NLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI--AAGAAKG 196
++ L + + DQR L + E++P G L +L + + ++ + A+
Sbjct: 62 FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL------RNSGRFSNSTGLFYASEIVCA 113
Query: 197 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 256
LEYLH K ++YRD K NILL++ H KL+DFG AK + D++ + GT Y
Sbjct: 114 LEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWT---LCGTPEYL 165
Query: 257 APEYAMTGQLTVKSDVYSFGVVFLELITG 285
APE + D ++ G++ E++ G
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 15/197 (7%)
Query: 91 IGEGGFGRVYKGW--LESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLIG 147
+G G FG V KG + VA+K L + R E + E ++ L + +V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 207
C + + +LV E G L L K+ + + +++ + G++YL K
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 208 VIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVMGTY--GYCAPEYAMTG 264
++RD + N+LL + K+SDFGL+K LG D S+ R G + + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALG--ADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 265 QLTVKSDVYSFGVVFLE 281
+ + +SDV+S+G+ E
Sbjct: 174 KFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 35/219 (15%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVA-------VKQLDRNGLQGNREFLVEVLMLSL 136
+F +G G G V K +G ++A +K RN Q RE L +
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN--QIIRE-------LKV 52
Query: 137 LHHSNLVNLIGY----CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA--LDWNTRMKIA 190
LH N ++G+ +DG+ + + E M GSL+ L K+A + N KI+
Sbjct: 53 LHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL------KKAGRIPENILGKIS 105
Query: 191 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 250
+GL YL +K +++RD K SNIL+ KL DFG++ G + D S ++ V
Sbjct: 106 IAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLID-SMANSFV- 159
Query: 251 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 289
GT Y +PE TV+SD++S G+ +E+ GR I
Sbjct: 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 68/233 (29%), Positives = 103/233 (44%), Gaps = 58/233 (24%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL-D--RNGLQGNREFLVEVLMLS-LLH 138
+ + +G+G +G V+K T +VVA+K++ D RN R F E++ L L
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGD 65
Query: 139 HSNLVNLIG-YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA--- 193
H N+V L+ A+ D+ + LV+E+M E LH + I A
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAV--------------IRANILED 106
Query: 194 ----------AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL---GPVG 240
K L+Y+H N VI+RD K SNILL KL+DFGLA+
Sbjct: 107 VHKRYIMYQLLKALKYIH-SGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163
Query: 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGV-------VFLELITGR 286
++ V T + T Y APE + + S Y+ GV + E++ G+
Sbjct: 164 PENPVLTDYVATRWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR--NGLQGNREFLVEVLMLSLLHHSN 141
++P IG G +G V +G+ VA+K++ + + L E+ +L H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 142 LVN----LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGL 197
++ L AD +V + M E LH + + L +GL
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLTEEHIRYFLYQLLRGL 120
Query: 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL---GPVGDK----SHVSTRVM 250
+Y+H AN VI+RD K SN+L+ E ++ DFG+A+ P K +V+TR
Sbjct: 121 KYIH-SAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR-- 175
Query: 251 GTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAI 289
Y APE ++ + T D++S G +F E++ GR+ +
Sbjct: 176 ---WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQ---VVAVKQLDRNGLQGN--REFLVEVLMLSLL 137
K+ + E +G G FG + +G L+ + VA+ L R G R FL E L L
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQF 63
Query: 138 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGL 197
HSN+V L G G+ ++V E+M G+L+ L + L M + G A G+
Sbjct: 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGM 120
Query: 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG--- 254
+YL + +++ + +L+ K+S F + DKS M
Sbjct: 121 KYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVL 173
Query: 255 YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ APE + SDV+SFG+V E+++
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 64/247 (25%), Positives = 102/247 (41%), Gaps = 67/247 (27%)
Query: 88 ESFIGEGGFGRVYKGWLE--STGQVVAVKQLDRNGLQGN-------REFLVEVLMLSLLH 138
E IG G +GRVYK + G+ A+K+ + Q RE + +L L
Sbjct: 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLRELK 60
Query: 139 HSNLVNLIGYC-ADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDW--------NTRMK 188
H N+V+L+ D+ + L++++ HDL W R+
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAE--------HDL--------WQIIKFHRQAKRVS 104
Query: 189 IAAGAAK--------GLEYLHDKANPPVIYRDFKSSNILL----EEGFHPKLSDFGLAKL 236
I K G+ YLH V++RD K +NIL+ E K+ D GLA+L
Sbjct: 105 IPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
Query: 237 --GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGRKAIDSTR 293
P+ + + V+ T Y APE + + K+ D+++ G +F EL+T
Sbjct: 162 FNAPLKPLADLD-PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-------LE 213
Query: 294 P--HGEQ 298
P G +
Sbjct: 214 PIFKGRE 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 8/202 (3%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL---DRNGLQGNREFLVEVLMLSLLHHS 140
NFR E IG G F VY+ G VA+K++ D + + + E+ +L L+H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 141 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 200
N++ + ++ +V E G L + K + T K LE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 201 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEY 260
H + V++RD K +N+ + KL D GL + K+ + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 261 AMTGQLTVKSDVYSFGVVFLEL 282
KSD++S G + E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 65/275 (23%), Positives = 115/275 (41%), Gaps = 22/275 (8%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL---DRNGLQGNREFLVEVLMLSLLHHS 140
NF+ E IG G F VY+ + VA+K++ + + ++ + E+ +L L+H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 141 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 200
N++ + + ++ +V E G L + K + T K +E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 201 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEY 260
H + V++RD K +N+ + KL D GL + K+ + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 261 AMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320
KSD++S G + E+ A+ S + NL + +K + P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLFSLC-------QKIEQCDYP 226
Query: 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDV 355
L + L + + SMCI RP IG V
Sbjct: 227 PLPTEHYSEKLRE---LVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 83 KNFRPESFIGEGGFGRVYKGW-LESTGQVVAVK----QLDRNGLQGNREFLVEVL-MLSL 136
+ + + IGEG +G+V+K L++ G+ VA+K Q G+ + V VL L
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 137 LHHSNLVNLIGYCA----DGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 191
H N+V L C D + +L LV+E + L +L +P + + T +
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMF 117
Query: 192 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 251
+GL++LH V++RD K NIL+ KL+DFGLA++ T V+
Sbjct: 118 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVV 171
Query: 252 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
T Y APE + D++S G +F E+ +
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 61/199 (30%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE---FLVE-VLMLSLLHHSNLVNLI 146
IG+G FG+V ++ G+ AVK L + + +E + E ++L + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
D+ V +++ G L HL ++ + R AA A L YLH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQR---ERSFPEPRARF-YAAEIASALGYLHSLN-- 116
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL 266
+IYRD K NILL+ H L+DFGL K G K+ ++ GT Y APE
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQPY 173
Query: 267 TVKSDVYSFGVVFLELITG 285
D + G V E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 87 PESF------IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHS 140
PE F +G+G FG+VYK + TG + A K +D + +++VE+ +L+ H
Sbjct: 3 PEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHP 62
Query: 141 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 200
N+V L+ + ++ EF G+++ + +L + L + + L YL
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYL 119
Query: 201 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR--VMGTYGYCAP 258
H+ +I+RD K+ NIL KL+DFG++ + + R +GT + AP
Sbjct: 120 HENK---IIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAP 172
Query: 259 EYAMTGQ-----LTVKSDVYSFGVVFLEL 282
E M K+DV+S G+ +E+
Sbjct: 173 EVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 8e-13
Identities = 62/207 (29%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 91 IGEGGFGRVYKGWLES---TGQVVAVKQL--DRNGLQGNREFLVEVLMLSLLHHSNLVNL 145
+G+G FG V + L+S + Q VAVK L D EFL E + H N++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 146 IGYC--ADGDQRL----LVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAAGAAKGL 197
IG + RL ++ FM G L L + + L T ++ A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCA 257
EYL K I+RD + N +L E ++DFGL+K GD + A
Sbjct: 127 EYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 258 PEYAMTGQLTVKSDVYSFGVVFLELIT 284
E T SDV++FGV E++T
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 75/229 (32%), Positives = 105/229 (45%), Gaps = 19/229 (8%)
Query: 78 LAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLML-SL 136
L T + IG+G +G+VYK + G + AVK LD + E E +L SL
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSL 75
Query: 137 LHHSNLVNLIG--YCAD---GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 191
+H N+V G Y AD G Q LV E GS+ + + L + LD I
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 192 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVM 250
GA GL++LH N +I+RD K +NILL KL DFG+ A+L + + S +
Sbjct: 136 GALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS---V 189
Query: 251 GTYGYCAPEYAMTGQ-----LTVKSDVYSFGVVFLELITGRKAIDSTRP 294
GT + APE Q + DV+S G+ +EL G + P
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 9e-13
Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIGY 148
IGEG FG+ + G+ +K+++ + + E EV +LS + H N+V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 149 CADGDQRLLVYEFMPLGSLEDHLHD----LPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
+ +V ++ G L ++ L P+ + LDW ++ +A L+++HD+
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHDRK 121
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG 264
+++RD KS NI L + KL DFG+A++ + ++ +GT Y +PE
Sbjct: 122 ---ILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEICENR 176
Query: 265 QLTVKSDVYSFGVVFLELITGRKAIDS 291
KSD+++ G V E+ T + A ++
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 65/238 (27%), Positives = 94/238 (39%), Gaps = 47/238 (19%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE----FLVEVLMLSLLH 138
+F IG G FG V+ + TGQV A+K L R R E +L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILADAD 59
Query: 139 HSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAAGAA 194
+V L Y + D+ L V E+MP G L + L D+ P++ A + + +A +
Sbjct: 60 SPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS----------- 243
L ++H RD K NIL++ H KL+DFGL K
Sbjct: 118 HKLGFIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 244 -----------HVSTRVM-----GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 285
H RV GT Y APE ++ D +S GV+ E++ G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 58/239 (24%), Positives = 102/239 (42%), Gaps = 48/239 (20%)
Query: 82 TKNFRP-ESFIGEGGFGRVYKGWLESTGQVVAVKQLD----RNGLQGNREF--------- 127
++ + + +GEG +G+V K + TG++VA+K++ N + +R+
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 128 -LVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTR 186
L E+ +++ + H N++ L+ +GD LV + M DL K+ +D R
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA--------SDL---KKVVDRKIR 115
Query: 187 MK------IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK----- 235
+ I GL LH ++RD +NI + K++DFGLA+
Sbjct: 116 LTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYP 172
Query: 236 --LGPVGDKSHVSTRVMGTYG-----YCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 286
+ + R T Y APE M + D++S G +F EL+TG+
Sbjct: 173 PYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 19/217 (8%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF-LVEVLMLSLLHHSNLVNLIGY- 148
IG G + +V L+ T ++ A+K + + + + + V+ SN L+G
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 149 -CADGDQRL-LVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
C + RL V EF+ G L H+ P++ A ++ + +A L +LH++
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNFLHERG 116
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG 264
+IYRD K N+LL+ H KL+D+G+ K G + ST GT Y APE
Sbjct: 117 ---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-IRPGDTTST-FCGTPNYIAPEILRGE 171
Query: 265 QLTVKSDVYSFGVVFLELITGRKAID--STRPHGEQN 299
D ++ GV+ E++ GR D + +QN
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 51/225 (22%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLHHSN 141
++ S +G G +G+V + TG+ VA+K+L R + + R + E+ +L + H N
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHEN 75
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLED--------HLHDLPPDKEALDWNTRMK----- 188
++ L+ F P SLED HL D N +K
Sbjct: 76 VIGLLDV------------FTPASSLEDFQDVYLVTHLMGA-------DLNNIVKCQKLS 116
Query: 189 ------IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242
+ +GL+Y+H A +I+RD K SNI + E K+ DFGLA+
Sbjct: 117 DDHIQFLVYQILRGLKYIH-SAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT 173
Query: 243 SHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGR 286
+V+TR Y APE + D++S G + EL+TG+
Sbjct: 174 GYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV---EVLMLSLLHHSNLVNLIG 147
+G G +G VYK TG++ AVK + L+ +F + E+ M+ H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA---AGAAKGLEYLHDKA 204
++ + E+ GSL+D H P E ++IA +GL YLH K
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSE-------LQIAYVCRETLQGLAYLHSKG 126
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMGTYGYCAPEYAM- 262
++RD K +NILL + KL+DFG+ AK+ K +GT + APE A
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAK---RKSFIGTPYWMAPEVAAV 180
Query: 263 --TGQLTVKSDVYSFGVVFLEL 282
G D+++ G+ +EL
Sbjct: 181 EKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 66/240 (27%), Positives = 97/240 (40%), Gaps = 47/240 (19%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVL----MLSLLH 138
K+F+ +G+G GRV+ L+ TG++ A+K LD+ + R + VL +L+ L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLD 59
Query: 139 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP----PDKEALDWNTRMKIAAGAA 194
H L L LV ++ P G L L P ++ A + AA
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFY------AAEVL 113
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK-----SHVSTRV 249
LEYLH ++YRD K NILL E H LSDF L+K V +R
Sbjct: 114 LALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 250 M----------------------GTYGYCAPEYAMTGQ-LTVKSDVYSFGVVFLELITGR 286
GT Y APE ++G D ++ G++ E++ G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 93 EGGFGRVYKG-WLESTG---QVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLI 146
EG FGR++ G ++ + V VK + + +Q L E +L L H N++ ++
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL-LLQESCLLYGLSHQNILPIL 74
Query: 147 GYCA-DGDQRLLVYEFMPLGSLEDHLHD--LPPDKEALDWNTR--MKIAAGAAKGLEYLH 201
C DG+ ++Y +M G+L+ L L +T+ + +A A G+ YLH
Sbjct: 75 HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGP-----VGDKSHVSTRVMGTYGY 255
+ VI++D + N +++E K++D L++ L P +GD + + M
Sbjct: 135 KRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM----- 186
Query: 256 CAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
A E + + + SDV+SFGV+ EL+T
Sbjct: 187 -ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 22/254 (8%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 142
+F S +G G G V K + +G ++A K + R ++ L +LH N
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIR--ELQVLHECNS 62
Query: 143 VNLIGYC----ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 198
++G+ +DG+ + + E M GSL+ L + E + K++ +GL
Sbjct: 63 PYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLA 117
Query: 199 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAP 258
YL +K +++RD K SNIL+ KL DFG++ G + D ++ +GT Y +P
Sbjct: 118 YLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSP 171
Query: 259 EYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN--DRRKFSK 316
E +V+SD++S G+ +EL GR I P ++ + RP+ + + S
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIFGRPVVDGEEGEPHSI 229
Query: 317 LADPRLEGRYPIRG 330
PR GR P+ G
Sbjct: 230 SPRPRPPGR-PVSG 242
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 7e-12
Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLIGYC 149
+GEG + VYKG + G++VA+K + +G + E +L L H+N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 150 ADGDQRLLVYEFMPLG---SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
+ LV+E++ ++ H L P+ N ++ + +GL Y+H +
Sbjct: 73 HTKETLTLVFEYVHTDLCQYMDKHPGGLHPE------NVKLFLFQ-LLRGLSYIHQRY-- 123
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-TGQ 265
+++RD K N+L+ + KL+DFGLA+ V SH + + T Y P+ + + +
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 266 LTVKSDVYSFGVVFLELITGRKA 288
+ D++ G +F+E+I G A
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 58/200 (29%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSL-LHHSNLVNLI 146
+G+G FG+V L+ T +V A+K L ++ + + + + E +L+L H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
D+ V E++ G L + D AA L +LH
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG-- 116
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL 266
VIYRD K NILL+ H KL+DFG+ K G + +T GT Y APE +
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELEY 173
Query: 267 TVKSDVYSFGVVFLELITGR 286
D ++ GV+ E++ G+
Sbjct: 174 GPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 8e-12
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL---DRNGLQGNREFLVEVLMLSLLHH 139
++ S+IGEG +G V + TG VA+K++ + R L E+ +L H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ-TFCQRT-LREIKILRRFKH 62
Query: 140 SNLVNL------IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 193
N++ + + + D +V E M E L+ L + + + + +
Sbjct: 63 ENIIGILDIIRPPSFESFNDV-YIVQELM-----ETDLYKLIKTQHLSNDHIQYFLYQ-I 115
Query: 194 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 253
+GL+Y+H AN V++RD K SN+LL K+ DFGLA+ + D H T + Y
Sbjct: 116 LRGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLAR---IADPEHDHTGFLTEY 169
Query: 254 ----GYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 286
Y APE + + K+ D++S G + E+++ R
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLIGYC 149
+GEG + VYKG + T +VA+K++ +G + EV +L L H+N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
LV+E++ L+ +L D +++ + +GL Y H + V+
Sbjct: 74 HTEKSLTLVFEYLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VL 126
Query: 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-TGQLTV 268
+RD K N+L+ E KL+DFGLA+ + K++ + V T Y P+ + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYST 184
Query: 269 KSDVYSFGVVFLELITGR 286
+ D++ G +F E+ TGR
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 73/290 (25%), Positives = 126/290 (43%), Gaps = 49/290 (16%)
Query: 91 IGEGGFGRVYKGWLESTGQ-VVAVKQLDRNGL---QGNRE-------FLVEVLML-SLLH 138
+G G FG VYK ++ GQ ++A+K+++ + + RE + EV ++ L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 139 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALD----WNTRMKIAAGAA 194
H N+V + D+ +V + + L +H + L K+ WN +++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA-- 125
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS--TRVMGT 252
L YLH + +++RD +NI+L E ++DFGLAK K S T V+GT
Sbjct: 126 --LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTSVVGT 176
Query: 253 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 312
Y PE K+DV++FG + ++ T + ST N+++ A +
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST------NMLSLATKIVE--- 227
Query: 313 KFSKLADPRLEGRYP--IRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360
+ +P EG Y + + + C+ A RP I V +S
Sbjct: 228 ---AVYEPLPEGMYSEDVTDVITS------CLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 37/224 (16%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN----REFLVEVLMLSLLHHSNLVNLI 146
IG+GG G VY + + VA+K++ R L N + FL E + + L H +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 147 GYCADGDQRLLVYEFMPL--GSLEDHLHDLPPDKEALDWNTRMKIAAGA--------AKG 196
C+DGD VY MP G L KE+L K + GA
Sbjct: 69 SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 197 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA-------------KLGPVGDKS 243
+EY+H K V++RD K NILL + D+G A +
Sbjct: 126 IEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 244 HVST---RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
T +++GT Y APE + + +D+Y+ GV+ +++T
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLIGYC 149
+GEG + V+KG + T +VA+K++ +G + EV +L L H+N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
LV+E++ L+ ++ D + + +GL Y H + V+
Sbjct: 74 HTDKSLTLVFEYLD-KDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRK---VL 126
Query: 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-TGQLTV 268
+RD K N+L+ E KL+DFGLA+ V K++ + V T Y P+ + + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYST 184
Query: 269 KSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV 301
+ D++ G +F E+ +GR + E +L+
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 67/246 (27%), Positives = 114/246 (46%), Gaps = 19/246 (7%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 143
+F S +G G G V+K + +G ++A K + R ++ L +LH N
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIR--ELQVLHECNSP 63
Query: 144 NLIGYC----ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEY 199
++G+ +DG+ + + E M GSL+ L E + K++ KGL Y
Sbjct: 64 YIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTY 118
Query: 200 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE 259
L +K +++RD K SNIL+ KL DFG++ G + D ++ +GT Y +PE
Sbjct: 119 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPE 172
Query: 260 YAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319
+V+SD++S G+ +E+ GR I P ++ + + P+ D +
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFGCPVEGDPAESETSPR 230
Query: 320 PRLEGR 325
PR GR
Sbjct: 231 PRPPGR 236
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 30/206 (14%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLD---RNGLQGNREFLVEV-LMLSLLHHSNLVNLI 146
IGEG F V K TG+ A+K + ++ Q N L E+ + L H N++ LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64
Query: 147 GYCADGDQ-RL-LVYEFMPLGSLEDHLHDLPPD-KEALDWNTRMKIAAGAAKGLEYLHDK 203
D RL LV+E M + +L++L K L K L+++H
Sbjct: 65 EVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK----SHVSTRVMGTYGYCAPE 259
+ +RD K NIL+++ KL+DFG + + K ++STR Y APE
Sbjct: 120 G---IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYISTR-----WYRAPE 168
Query: 260 YAMT-GQLTVKSDVYSFGVVFLELIT 284
+T G K D+++ G VF E+++
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 62/200 (31%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE---FLVEV-LMLSLLHHSNLVNLI 146
IG+G FG+V + G+ AVK L + + +E + E ++L + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDKAN 205
++ V +F+ G L HL +E R + AA A L YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQ-----RERSFPEPRARFYAAEIASALGYLH---S 114
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 265
++YRD K NILL+ H L+DFGL K G +S +T GT Y APE
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 266 LTVKSDVYSFGVVFLELITG 285
D + G V E++ G
Sbjct: 173 YDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 62/201 (30%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 90 FIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLI 146
+G+G FG+V ++TG+ A+K L + + E L E +L H L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDKAN 205
D+ V E+ G L HL +E + R + A L+YLH + N
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDYLHSEKN 116
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 265
V+YRD K N++L++ H K++DFGL K G + D + + T GT Y APE
Sbjct: 117 --VVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDND 172
Query: 266 LTVKSDVYSFGVVFLELITGR 286
D + GVV E++ GR
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFL-----VEVLMLSLLHHSNLVNL 145
IG+G FG+VY+ + T ++ A+K L + + +E +L+ +LL S +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 146 IGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDK 203
+ + D L LV ++M G L HL KE R K A LE+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQ-----KEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT 263
++YRD K NILL+ H L DFGL+K +K+ + GT Y APE +
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVLLD 170
Query: 264 GQ-LTVKSDVYSFGVVFLELITG 285
+ T D +S GV+ E+ G
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 61/201 (30%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 90 FIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLI 146
+G+G FG+V ++TG+ A+K L + + E + E +L H L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDKAN 205
D+ V E+ G L HL +E + R + A LEYLH +
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHSRD- 115
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 265
V+YRD K N++L++ H K++DFGL K G + D + + T GT Y APE
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLEDND 171
Query: 266 LTVKSDVYSFGVVFLELITGR 286
D + GVV E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYC 149
+GEG + VYKG GQ+VA+K + +G + E +L L H+N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 150 ADGDQRLLVYEFMPLG---SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
+ V+E+M + H L P +N R+ + +GL Y+H +
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGGLHP------YNVRLFMFQ-LLRGLAYIHGQH-- 123
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-TGQ 265
+++RD K N+L+ KL+DFGLA+ + +++ S V T Y P+ +
Sbjct: 124 -ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATD 180
Query: 266 LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTW 303
+ D++ G +F+E++ G+ A EQ W
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 32/205 (15%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSLLHHSNLVNLI 146
IGEG +G V+K T ++VA+K++ D G+ + L E+ +L L H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHKNIVRLY 65
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK--------GLE 198
+ LV+E+ DL K+ D + I K GL
Sbjct: 66 DVLHSDKKLTLVFEYCD--------QDL---KKYFD-SCNGDIDPEIVKSFMFQLLKGLA 113
Query: 199 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAP 258
+ H V++RD K N+L+ + KL+DFGLA+ + + + S V+ T Y P
Sbjct: 114 FCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEVV-TLWYRPP 168
Query: 259 EYAMTGQLTVKS-DVYSFGVVFLEL 282
+ +L S D++S G +F EL
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 31/226 (13%)
Query: 91 IGEGGFGRVYKGWL--ESTGQVVAVKQLDRNGL----QGNR---EFLVEVLMLSLLHHSN 141
+G+G F +YKG L +S +V Q L +R F ++S L H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
LV L G C D+ ++V E++ G L+ LH + +L W ++ +A A L YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 202 DKANPPVIYRDFKSSNILL-----EEGFHP--KLSDFGLAKLGPVGDKSHVSTRVMGTYG 254
DK +++ + NIL+ EG+ P KLSD G+ V + R+
Sbjct: 119 DKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI----P 169
Query: 255 YCAPEYAMTGQ--LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 298
+ APE GQ LT+ +D +SFG LE+ + + ST E+
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 6e-11
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF-LVEVLMLSLLHHSNLVNLIGY- 148
IG G + +V L+ T ++ A+K + + + + + V+ SN L+G
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 149 -CADGDQRLL-VYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
C + RL V E++ G L H+ P++ A ++ + +A L YLH++
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNYLHERG 116
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG-PVGDKSHVSTRVMGTYGYCAPEYAMT 263
+IYRD K N+LL+ H KL+D+G+ K G GD ++ GT Y APE
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRG 170
Query: 264 GQLTVKSDVYSFGVVFLELITGRKAID 290
D ++ GV+ E++ GR D
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN-----REFLVEVLMLSLLHHSNLVNL 145
+GEG + VYKG + TGQ+VA+K++ +G RE +L L H+N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIRE----ASLLKDLKHANIVTL 68
Query: 146 IGYCADGDQRLLVYEFM--PLGS-LEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
LV+E++ L ++D L N R+ + +GL Y H
Sbjct: 69 HDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH------NVRLFLFQ-LLRGLAYCHQ 121
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM 262
+ V++RD K N+L+ E KL+DFGLA+ V K++ + V T Y P+ +
Sbjct: 122 RR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLL 176
Query: 263 -TGQLTVKSDVYSFGVVFLELITGR 286
+ + + D++ G +F E+ TGR
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 6e-11
Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 14/201 (6%)
Query: 90 FIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLI 146
+G+G FG+V +++G+ A+K L + + E L E +L H L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDKAN 205
D+ V E++ G L HL +E + R + A L+YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRFYGAEIVSALDYLHSGK- 115
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 265
++YRD K N++L++ H K++DFGL K G + D + + T GT Y APE
Sbjct: 116 --IVYRDLKLENLMLDKDGHIKITDFGLCKEG-ITDAATMKT-FCGTPEYLAPEVLEDND 171
Query: 266 LTVKSDVYSFGVVFLELITGR 286
D + GVV E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQ--LDRNGLQGNREFLVEVLMLSLLHHSNLVNL--I 146
IGEG +G VYK T + +A+K+ L++ + E+ +L + H N+V L +
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 147 GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRM--KIAAGAAKGLEYLHDK 203
+ ++RL LV+E++ L L+ H+ D PD N R+ +G+ Y H
Sbjct: 70 VHS---EKRLYLVFEYLDL-DLKKHM-DSSPD---FAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 204 ANPPVIYRDFKSSNILLEEGFHP-KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM 262
V++RD K N+L++ + KL+DFGLA+ G T + T Y APE +
Sbjct: 122 R---VLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTLWYRAPEILL 176
Query: 263 -TGQLTVKSDVYSFGVVFLELITGR 286
+ + D++S G +F E++ +
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF-LVEVLMLSLLHHSNLVNLIGY- 148
IG G + +V L+ Q+ A+K + + + + + V+ S+ L+G
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 149 -CADGDQRL-LVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
C RL LV E++ G L H+ P++ A + + IA L +LH++
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA------LNFLHERG 116
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAK--LGPVGDKSHVSTRVMGTYGYCAPEYAM 262
+IYRD K N+LL+ H KL+D+G+ K LGP GD ++ GT Y APE
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GD---TTSTFCGTPNYIAPEILR 169
Query: 263 TGQLTVKSDVYSFGVVFLELITGRKAID 290
+ D ++ GV+ E++ GR D
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 54/217 (24%), Positives = 105/217 (48%), Gaps = 36/217 (16%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLD-RNGLQGNREFL-VEVLMLSLLHHSNLVN---- 144
+G+G +G V + G+ +K+L+ RN + R+ E +LS L H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 145 ----------LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAA 194
++G+C GD +Y L++ L P+ + ++W ++ +A
Sbjct: 68 WEGEDGLLYIVMGFCEGGD----LYH-----KLKEQKGKLLPENQVVEWFVQIAMA---- 114
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 254
L+YLH+K +++RD K+ N+ L K+ D G+A++ + ++ +++ ++GT
Sbjct: 115 --LQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPY 167
Query: 255 YCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS 291
Y +PE KSDV++ G E+ T + A ++
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-11
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVK----QLDRNGLQGNREFLVEVLMLSLLHHSN-LVNL 145
IGEG +G+VYK ++TG++VA+K ++D G+ L E+ +L +L S +V L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIYIVRL 66
Query: 146 IGY----CADGDQRL-LVYEFMP--LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 198
+ +G L LV+E++ L D P L T KG+
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP--LPAKTIKSFMYQLLKGVA 124
Query: 199 YLHDKANPPVIYRDFKSSNILLE-EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCA 257
+ H V++RD K N+L++ + K++D GL + + KS+ T + T Y A
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLWYRA 179
Query: 258 PEYAMTG-QLTVKSDVYSFGVVFLELITG 285
PE + + D++S G +F E+
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 7e-11
Identities = 62/199 (31%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLIG 147
IG+G FG+V + T ++ A+K + + + E L E +L+ ++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDKANP 206
++ LV F+ G L HL +E +R + A LE LH K N
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQ-----REGRFDLSRARFYTAELLCALENLH-KFN- 113
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL 266
VIYRD K NILL+ H L DFGL KL + GT Y APE +
Sbjct: 114 -VIYRDLKPENILLDYQGHIALCDFGLCKLNM--KDDDKTNTFCGTPEYLAPELLLGHGY 170
Query: 267 TVKSDVYSFGVVFLELITG 285
T D ++ GV+ E++TG
Sbjct: 171 TKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 67/215 (31%), Positives = 94/215 (43%), Gaps = 17/215 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLML-SLLHHSNLVNLIG-- 147
IG+G +G+V+K + G AVK LD + E E +L +L H N+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 148 YCAD---GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
Y D GDQ LV E GS+ D + E ++ I A GL++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--- 141
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEY-AMT 263
I+RD K +NILL KL DFG++ + +GT + APE A
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAPEVIACE 199
Query: 264 GQL----TVKSDVYSFGVVFLELITGRKAIDSTRP 294
QL + DV+S G+ +EL G + P
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 9e-11
Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 130 EVLMLSLLHHSNLVNLIGYCADGDQRL----LVYEFMPLGSLEDHLHDLPPDKEA-LDWN 184
E+ L + +N++ + G+ D L L+ E+ G L + L DKE L +
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-----DKEKDLSFK 122
Query: 185 TRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244
T++ +A KGL L+ N P Y++ S + L+ E + K+ GL K+ +
Sbjct: 123 TKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN 180
Query: 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
V+ V +Y ++ + T+K D+YS GVV E+ TG+
Sbjct: 181 VNFMVYFSYKMLNDIFS---EYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 25/218 (11%)
Query: 80 AATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH 139
+ K+++ + IG G FG VY+ T + VA+K++ ++ NRE L+ + L+H
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNH 118
Query: 140 SNLVNLIGY----CADGDQRLL----VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 191
N++ L Y C +++ + V EF+P ++ ++ + AL +
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 192 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP-KLSDFGLAK--LGPVGDKSHVSTR 248
+ L Y+H K + +RD K N+L++ H KL DFG AK L S++ +R
Sbjct: 178 QLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234
Query: 249 VMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITG 285
Y APE + T D++S G + E+I G
Sbjct: 235 F-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 84 NFRPESFIGEGGFGRVY---KGWLESTGQVVAVKQLDRNGLQGNREFL----VEVLMLSL 136
NF +G G +G+V+ K G++ A+K L + + + E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 137 LHHSN-LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAA 194
+ LV L Y D +L L+ +++ G L HL+ E+ R+ IA
Sbjct: 61 VRRCPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIAE-IV 115
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK--LGPVGDKSHVSTRVMGT 252
L++LH +IYRD K NILL+ H L+DFGL+K L ++++ GT
Sbjct: 116 LALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGT 169
Query: 253 YGYCAPEYAMTGQLTVKS--DVYSFGVVFLELITG 285
Y APE G D +S GV+ EL+TG
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLIG 147
+G+G FG+V + T ++ A+K L ++ + + + +VE +L+L + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 148 YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
C RL V E++ G L + + KE + AA A GL +LH K
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP----HAVFYAAEIAIGLFFLHSKG-- 121
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM-GTYGYCAPEYAMTGQ 265
+IYRD K N++L+ H K++DFG+ K V+T+ GT Y APE
Sbjct: 122 -IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW---DGVTTKTFCGTPDYIAPEIIAYQP 177
Query: 266 LTVKSDVYSFGVVFLELITGRKAID 290
D ++FGV+ E++ G+ +
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 27/217 (12%)
Query: 91 IGEGGFGRVY---KGWLESTGQVVAVKQLDRNGLQGNRE----FLVEVLMLSLLHHSNLV 143
+G+GG+G+V+ K TG++ A+K L + + N++ E +L + H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDW-NTRMKIAAGAAKGLEYLHD 202
+LI G + L+ E++ G L HL ++E + +T + + LE+LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL-----EREGIFMEDTACFYLSEISLALEHLHQ 118
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM 262
+ +IYRD K NILL+ H KL+DFGL K V+ GT Y APE M
Sbjct: 119 QG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILM 173
Query: 263 TGQLTVKSDVYSFGVVFLELITG---------RKAID 290
D +S G + +++TG +K ID
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID 210
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLIGYC 149
+GEG + V+KG + T +VA+K++ +G + EV +L L H+N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 150 ADGDQRLLVYEFMP--LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 207
LV+E++ L D+ +L + + +GL Y H +
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGNL------MSMHNVKIFMFQLLRGLSYCHKRK--- 123
Query: 208 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-TGQL 266
+++RD K N+L+ E KL+DFGLA+ V K++ + V T Y P+ + + +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEY 181
Query: 267 TVKSDVYSFGVVFLELITGR 286
+ D++ G + E+ TGR
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 61/200 (30%), Positives = 89/200 (44%), Gaps = 14/200 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLIG 147
+G+G FG+V ++TG+ A+K L + + E L E +L H L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDKANP 206
D+ V E+ G L HL +E + R + A L YLH
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALGYLHSCD-- 115
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL 266
V+YRD K N++L++ H K++DFGL K G + D + + T GT Y APE
Sbjct: 116 -VVYRDLKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLEDNDY 172
Query: 267 TVKSDVYSFGVVFLELITGR 286
D + GVV E++ GR
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 73/266 (27%), Positives = 115/266 (43%), Gaps = 32/266 (12%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHH 139
K+F +S +G G FG V ++TG + A+K + ++ L F E +LS+ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKE-ALDWNTRMKIAAGAAKG 196
+ L D D LV E+ P G L L ++ D++ A + + +A +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 197 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG-LAKLGPVGDKSHVSTRVMGTYGY 255
+ Y+H RD K N+L++ H KL+DFG A+L +K S +GT Y
Sbjct: 121 MGYVH---------RDIKPENVLIDRTGHIKLADFGSAARLT--ANKMVNSKLPVGTPDY 169
Query: 256 CAPEYAMT------GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN 309
APE T G V+ D +S GV+ E+I GR P E + N
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS------PFHEGTSAKTYNNIMN 223
Query: 310 DRRKFSKLADPRLEGRYPIRGLYQAL 335
+R DP++ + L Q+L
Sbjct: 224 FQRFLKFPEDPKVSSDF--LDLIQSL 247
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 28/223 (12%)
Query: 76 RELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLM 133
+L ++F IG G FG V +S+ QV A+K L + + + + F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWE--E 93
Query: 134 LSLLHHSN---LVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLP-PDKEALDWNTRM 187
++ H+N +V L + A D + L V E+MP G L + + + P+K A + +
Sbjct: 94 RDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEV 151
Query: 188 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVS 246
+A A + ++H RD K N+LL++ H KL+DFG K+ G
Sbjct: 152 VLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCD 201
Query: 247 TRVMGTYGYCAPEYAMT----GQLTVKSDVYSFGVVFLELITG 285
T V GT Y +PE + G + D +S GV E++ G
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 61/200 (30%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE---FLVEV-LMLSLLHHSNLVNLI 146
IG+G FG+V +S G AVK L + + +E + E ++L L H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDKAN 205
++ V +++ G L HL +E R + AA A + YLH
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQ-----RERCFLEPRARFYAAEVASAIGYLHSLN- 116
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 265
+IYRD K NILL+ H L+DFGL K G + ++ GT Y APE
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCKEGV--EPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 266 LTVKSDVYSFGVVFLELITG 285
D + G V E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 7e-10
Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 42/236 (17%)
Query: 74 TFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR---NGLQGNREFLVE 130
T E+ +N P +G G +G V + TG VAVK+L R + + R + E
Sbjct: 11 TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-E 66
Query: 131 VLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLED-------------HLHDLPPD 177
+ +L + H N++ L+ F P SLE+ L+++
Sbjct: 67 LRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKC 114
Query: 178 KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237
++ D + + I +GL+Y+H + +I+RD K SN+ + E K+ DFGLA+
Sbjct: 115 QKLTDDHVQFLIYQ-ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170
Query: 238 PVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDST 292
+V+TR Y APE + D++S G + EL+TGR T
Sbjct: 171 DDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 21/217 (9%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLH 138
+ P IG G +G V T + VA+K++ N + R L E+ +L L
Sbjct: 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLD 62
Query: 139 HSNLVNLIGYCADGDQR-----LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 193
H N++ + + +VYE M + LH + + L +
Sbjct: 63 HENVIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQL 117
Query: 194 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 253
+GL+Y+H AN V++RD K SN+LL K+ DFGLA+ +K T + T
Sbjct: 118 LRGLKYIH-SAN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTR 172
Query: 254 GYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAI 289
Y APE + + T DV+S G +F EL+ GRK +
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR--NGLQGNREFLVEVLMLSLLHHSNL 142
++ + IG+G +G V TG+ VA+K+++ + L E+ +L LL H ++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 143 VNLIGYCADGDQR-----LLVYEFMPLGSLEDHLH-------DLPPDKEALDWNTRMKIA 190
V + +R +V+E M E LH DL P+ ++
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLR-- 114
Query: 191 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS-TRV 249
L+Y+H AN V +RD K NIL K+ DFGLA++ + + T
Sbjct: 115 -----ALKYIH-TAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 166
Query: 250 MGTYGYCAPEY--AMTGQLTVKSDVYSFGVVFLELITGR 286
+ T Y APE + + T D++S G +F E++TG+
Sbjct: 167 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF----LVEVLMLSLLHHSNLVNLI 146
+GEG +G V K + T ++VA+K+ + + N E L E+ ML L N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 147 GYCADGDQRLLVYEFMP---LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
+ LV+E++ L LE+ + +PP+K R I K + + H
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEK------VRSYIYQ-LIKAIHWCHKN 119
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT 263
+++RD K N+L+ KL DFG A+ G ++ T + T Y +PE +
Sbjct: 120 D---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELLLG 175
Query: 264 GQLTVKSDVYSFGVVFLELITGR 286
D++S G + EL G+
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 7/221 (3%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR--NGLQGNREFLVEVLMLSLLHHSNL 142
P+ IG G FG V+ G+ VA+K++ L + E+ ML H N+
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV 61
Query: 143 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
++ + ++ ++ LH + + L + +GL+YLH
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH- 120
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM 262
A +++RD K N+L+ K+ DFGLA++ + H++ V+ Y Y APE M
Sbjct: 121 SAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILM 177
Query: 263 TGQ-LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVT 302
+ T D++S G +F EL+ R + P + +L+T
Sbjct: 178 GSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 33/209 (15%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV------EVLMLSLLHHSNLVN 144
IG G G VYK TG++ A+K + GN E V E+ +L ++H N+V
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVI-----YGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 145 LIGYCADGDQRLLVYEFMPLGSLED-HLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
+ ++ EFM GSLE H+ D ++ D +A G+ YLH +
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIAD---EQFLAD------VARQILSGIAYLHRR 187
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVMGTYGYCAPEYAM 262
+++RD K SN+L+ + K++DFG+++ L D + S +GT Y +PE
Sbjct: 188 H---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERIN 241
Query: 263 T----GQLT-VKSDVYSFGVVFLELITGR 286
T G D++S GV LE GR
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 91 IGEGGFGRVYKGWLESTGQV-------VAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 143
+G+G F +++KG G V +K LD++ + F M+S L H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
G C GD+ ++V E++ GSL+ +L +K ++ + ++++A A L +L DK
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDK 119
Query: 204 ANPPVIYRDFKSSNILL--EE----GFHP--KLSDFGLAKLGPVGDKSHVSTRVMGTYGY 255
+ + + + N+LL EE G P KLSD G++ V K + R+ +
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI--TVLPKEILLERI----PW 170
Query: 256 CAPEYAMTGQ-LTVKSDVYSFGVVFLELITG 285
PE Q L++ +D +SFG E+ +G
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 42/230 (18%)
Query: 74 TFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR--NGLQGNREFLVEV 131
T E+ +N P +G G +G V + Q VAVK+L R L R E+
Sbjct: 9 TVWEVPERYQNLTP---VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYREL 65
Query: 132 LMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH-DLPPDKEALDWNTRMKIA 190
+L + H N++ L+ F P S+E+ L + D N +K
Sbjct: 66 RLLKHMKHENVIGLLDV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQ 113
Query: 191 AGA-----------AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239
+ +GL+Y+H +I+RD K SN+ + E ++ DFGLA+
Sbjct: 114 KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADD 170
Query: 240 GDKSHVSTRVMGTYGYCAPEYA---MTGQLTVKSDVYSFGVVFLELITGR 286
+V+TR Y APE M TV D++S G + EL+ G+
Sbjct: 171 EMTGYVATR-----WYRAPEIMLNWMHYNQTV--DIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 32/225 (14%)
Query: 74 TFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR---NGLQGNREFLVE 130
T E+ ++ + +G G +G V TG VA+K+L R + L R + E
Sbjct: 9 TIWEVPDRYRDLKQ---VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-E 64
Query: 131 VLMLSLLHHSNLVNLIG-YCADG--DQRLLVYEFMP-----LGSLEDHLHDLPPDKEALD 182
+ +L + H N++ L+ + D D+ Y MP LG L H E L
Sbjct: 65 LRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--------EKLS 116
Query: 183 WNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242
+ + KGL+Y+H +I+RD K N+ + E K+ DFGLA+
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT 173
Query: 243 SHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGR 286
+V TR Y APE + T D++S G + E++TG+
Sbjct: 174 GYVVTR-----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 64/235 (27%), Positives = 101/235 (42%), Gaps = 41/235 (17%)
Query: 66 VNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR---NGLQ 122
V +A TFT K ++ IG G G V + G VAVK+L R N
Sbjct: 10 VQVADSTFT------VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 63
Query: 123 GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALD 182
R + E+++L ++H N+++L+ F P SLE+ D+ E +D
Sbjct: 64 AKRAYR-ELVLLKCVNHKNIISLLNV------------FTPQKSLEE-FQDVYLVMELMD 109
Query: 183 WN-----------TRMK-IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSD 230
N RM + G+++LH +I+RD K SNI+++ K+ D
Sbjct: 110 ANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 166
Query: 231 FGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 285
FGLA+ + + T + T Y APE + D++S G + EL+ G
Sbjct: 167 FGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 19/202 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE---FLVEV-LMLSLLHHSNLVNLI 146
IG+G FG+V ++ + AVK L + + +E + E ++L + H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDKAN 205
D+ V +++ G L HL +E R + AA A L YLH
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQ-----RERCFLEPRARFYAAEIASALGYLHSLN- 116
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAK--LGPVGDKSHVSTRVMGTYGYCAPEYAMT 263
++YRD K NILL+ H L+DFGL K + G ++ GT Y APE
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG----TTSTFCGTPEYLAPEVLHK 170
Query: 264 GQLTVKSDVYSFGVVFLELITG 285
D + G V E++ G
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 84 NFRPESFIGEGGFGRVY---KGWLESTGQVVAVKQLDRNGL----QGNREFLVEVLMLSL 136
NF +G G +G+V+ K +G++ A+K L + + + E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 137 LHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK 195
+ S + + Y D +L L+ +++ G L HL +E +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL----SQRERFKEQEVQIYSGEIVL 116
Query: 196 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY 255
LE+LH +IYRD K NILL+ H L+DFGL+K D+ + GT Y
Sbjct: 117 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGTIEY 172
Query: 256 CAPEYAMTGQLTVKS--DVYSFGVVFLELITG 285
AP+ G D +S GV+ EL+TG
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 35/217 (16%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGL----QGNREFLVEVLMLSLLHHSNLVNLI 146
I G +G VY + T Q A+K++++ L Q + F VE +L+ + +V++
Sbjct: 9 ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVVSM- 66
Query: 147 GYCADGDQRLL--VYEFMPLG---SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
+C+ +R L V E++ G +L ++ LP D RM A LEYLH
Sbjct: 67 -FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM------ARMYFAE-TVLALEYLH 118
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG-------------PVGDKSHVSTR 248
N +++RD K N+L+ H KL+DFGL+K+G + + +
Sbjct: 119 ---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 249 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 285
V GT Y APE + D ++ G++ E + G
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 46/169 (27%), Positives = 69/169 (40%), Gaps = 19/169 (11%)
Query: 141 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLE 198
N+V L Y D LV + G L H+ P++ W M +A L+
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------LD 99
Query: 199 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG-LAKLGPVGDKSHVSTRVMGTYGYCA 257
LH + ++ RD +NILL++ H +L+ F +++ D V YCA
Sbjct: 100 ALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150
Query: 258 PEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP 306
PE + T D +S G + EL+TG K + P G T P
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIP 198
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 28/207 (13%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLHHSNLVNLI- 146
+G G +G V + TG+ VA+K+L R + + R + E+ +L + H N++ L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81
Query: 147 ----GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDK-EALDWNTRMKIAAGAAKGLEYL 200
D Q LV +M + H L DK + L + GL+Y+
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM--------LCGLKYI 133
Query: 201 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEY 260
H +I+RD K N+ + E K+ DFGLA+ +V TR Y APE
Sbjct: 134 HSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEV 185
Query: 261 AMTGQLTVKS-DVYSFGVVFLELITGR 286
+ ++ D++S G + E++TG+
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 30/215 (13%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLHH 139
+N +P IG G G V + TGQ VA+K+L R N R + VLM L++H
Sbjct: 19 QNLKP---IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLM-KLVNH 74
Query: 140 SNLVNLIGYCADGDQRL-------LVYEFMPLGSLEDHLH-DLPPDKEALDWNTRMKIAA 191
N++ L+ + L LV E M +L + DL D E + + +
Sbjct: 75 KNIIGLLN-VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDL--DHERMSYLLYQMLC- 129
Query: 192 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 251
G+++LH + +I+RD K SNI+++ K+ DFGLA+ G ++ V+
Sbjct: 130 ----GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVT 180
Query: 252 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
Y Y APE + D++S G + E+I G
Sbjct: 181 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 19/205 (9%)
Query: 91 IGEGGFGRVYKG--WLESTGQVVAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNLIG 147
IG G FG+V + ++ V VK+L N + EFL + +L H N++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 148 YCADGDQRLLVYEFMPLGSLEDHL---HDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
C + LLV+E+ LG L+ +L + + L ++A A G+ ++H K
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMH-KH 118
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA--- 261
N ++ D N L K+ D+G+ D + APE
Sbjct: 119 N--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 262 ----MTGQLTVKSDVYSFGVVFLEL 282
+T + T S+V++ GV EL
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 72/288 (25%), Positives = 118/288 (40%), Gaps = 57/288 (19%)
Query: 66 VNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR---NGLQ 122
V + TFT + +N +P IG G G V + + VA+K+L R N
Sbjct: 6 VEVGDSTFT---VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 59
Query: 123 GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALD 182
R + E++++ ++H N+++L+ F P SLE+ D+ E +D
Sbjct: 60 AKRAYR-ELVLMKCVNHKNIISLLNV------------FTPQKSLEE-FQDVYLVMELMD 105
Query: 183 WN-----------TRMK-IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSD 230
N RM + G+++LH +I+RD K SNI+++ K+ D
Sbjct: 106 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 162
Query: 231 FGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELI------T 284
FGLA+ S + T + T Y APE + D++S G + E++
Sbjct: 163 FGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219
Query: 285 GRKAIDSTR----------PHGEQNLVTWARPLFNDRRKFSKLADPRL 322
GR ID P + L R +R K++ L P+L
Sbjct: 220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 68/253 (26%), Positives = 111/253 (43%), Gaps = 47/253 (18%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR---------NGLQGNREFLV--EV 131
++F IG G FG V L++ +V A+K L++ + R+ LV +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 132 LMLSLLHHS-----NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTR 186
++ LH++ NL ++ Y GD L+ +F ED L P+ A +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKF------EDRL----PEDMARFYLAE 110
Query: 187 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 246
M IA + L Y+H RD K NIL++ H +L+DFG + L + D + S
Sbjct: 111 MVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQS 160
Query: 247 TRVMGTYGYCAPEY--AM---TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV 301
+ +GT Y +PE AM G+ + D +S GV E++ G P ++LV
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET------PFYAESLV 214
Query: 302 TWARPLFNDRRKF 314
+ N + +F
Sbjct: 215 ETYGKIMNHKERF 227
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 91 IGEGGFGRVY-----KGWLESTGQV---VAVKQLDRN-GLQGNREFLVEVLMLSLLHHSN 141
+G+G FG VY K E +V + V +L+ N +Q N E +LS L H
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQAN----QEAQLLSKLDHPA 63
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
+V + D ++ E+ L+ L +L + L N + G+ Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
+ +++RD K+ NI L+ K+ DFG+++L + ++T GT Y +PE
Sbjct: 124 QRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEAL 177
Query: 262 MTGQLTVKSDVYSFGVVFLEL 282
KSD++S G + E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 76 RELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE---FLVEVL 132
R+L +++ IG G FG V +S+ +V A+K L + + + F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 133 MLSLLHHSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKI 189
+++ + +V L +CA D + L V E+MP G L + + + P+K A + + +
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL 153
Query: 190 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVSTR 248
A A + +H RD K N+LL++ H KL+DFG K+ G T
Sbjct: 154 ALDAIHSMGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTA 203
Query: 249 VMGTYGYCAPEYAMT----GQLTVKSDVYSFGVVFLELITG 285
V GT Y +PE + G + D +S GV E++ G
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 84 NFRPESFIGEGGFGRVY---KGWLESTGQVVAVKQLDRNGL----QGNREFLVEVLMLSL 136
NF +G G +G+V+ K TG++ A+K L + L + E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 137 LHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAA- 194
+ S + + Y + +L L+ +++ G + HL+ E ++ +G
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED-----EVRFYSGEII 115
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 254
LE+LH ++YRD K NILL+ H L+DFGL+K +K + GT
Sbjct: 116 LALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIE 171
Query: 255 YCAPEY--AMTGQLTVKSDVYSFGVVFLELITG 285
Y APE G D +S G++ EL+TG
Sbjct: 172 YMAPEIIRGKGGHGKA-VDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 76 RELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLM 133
R+L +++ IG G FG V +ST +V A+K L + + + + F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 134 LSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKIAA 191
+ +S V + Y D+ L +V E+MP G L + + + P+K A + + +A
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 192 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG----LAKLGPVGDKSHVST 247
A + ++H RD K N+LL++ H KL+DFG + K G V + V
Sbjct: 156 DAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-- 204
Query: 248 RVMGTYGYCAPEYAMT----GQLTVKSDVYSFGVVFLELITG 285
GT Y +PE + G + D +S GV E++ G
Sbjct: 205 ---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 63/236 (26%), Positives = 102/236 (43%), Gaps = 41/236 (17%)
Query: 66 VNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR---NGLQ 122
V I TFT + +N +P IG G G V + + VA+K+L R N
Sbjct: 13 VEIGDSTFT---VLKRYQNLKP---IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH 66
Query: 123 GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALD 182
R + E++++ ++H N++ L+ F P SLE+ D+ E +D
Sbjct: 67 AKRAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSLEE-FQDVYIVMELMD 112
Query: 183 WN-----------TRMK-IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSD 230
N RM + G+++LH +I+RD K SNI+++ K+ D
Sbjct: 113 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 169
Query: 231 FGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
FGLA+ G ++ V+ Y Y APE + D++S G + E+I G
Sbjct: 170 FGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDR---------NGLQGNREFLV--EVLMLSLLHH 139
IG G FG V +++TGQV A+K L++ + R+ LV + ++ LH+
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHY 68
Query: 140 S-----NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAA 194
+ NL ++ Y GD L+ +F ED L P+ A + M +A +
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKF------EDRL----PEDMARFYLAEMVLAIDSV 118
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 254
L Y+H RD K N+LL++ H +L+DFG + L + D + S +GT
Sbjct: 119 HQLGYVH---------RDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPD 168
Query: 255 YCAPEY--AM---TGQLTVKSDVYSFGVVFLELITG 285
Y +PE AM G+ + D +S GV E++ G
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 28/205 (13%)
Query: 91 IGEGGFGRVYKGWLESTG-QVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLI 146
+G G FGRV ++ VA+K+ +++ + ++ E +L+ ++H VNL
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHD---LPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
G D LV EF+ G L P D AA EYL
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF-------YAAQIVLIFEYLQSL 150
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR---VMGTYGYCAPEY 260
++YRD K N+LL++ K++DFG AK+ V TR + GT Y APE
Sbjct: 151 N---IVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTLCGTPEYIAPEI 199
Query: 261 AMTGQLTVKSDVYSFGVVFLELITG 285
+ +D ++ G+ E++ G
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 31/83 (37%), Positives = 44/83 (53%)
Query: 208 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLT 267
+I+RD KS+NILL KL DFG +K+ V GT Y APE +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 268 VKSDVYSFGVVFLELITGRKAID 290
K+D++S GV+ EL+T ++ D
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 36/162 (22%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVK----------------QLDRNGLQGNREFLVEVLML 134
I G FG+VY G ++ ++ AVK Q +R+ L ++ + L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 135 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAA 194
SL +N+ LV E++ G ++ LH D +K + A
Sbjct: 72 SLQSANNV-------------YLVMEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVA 114
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236
L+YLH +I+RD K N+L+ H KL+DFGL+K+
Sbjct: 115 LALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 19/182 (10%)
Query: 104 LESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMP 163
E+ G + +KQ D ++ V ML + S ++ D R Y+
Sbjct: 171 FENKGDYMDMKQAD------TTQY---VPMLEIKEASKYSDIQRSNYD---RPASYKGSN 218
Query: 164 LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG 223
+++ L D E L + A+G+E+L A+ ++RD + N+LL +G
Sbjct: 219 DSEVKNLLSD--DGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQG 273
Query: 224 FHPKLSDFGLAKLGPVGDKSHVST-RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 282
K+ DFGLA+ + D ++VS + APE T SDV+S+G++ E+
Sbjct: 274 KIVKICDFGLAR-DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
Query: 283 IT 284
+
Sbjct: 333 FS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 64/256 (25%), Positives = 98/256 (38%), Gaps = 74/256 (28%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---------QGNREFLVEVLM 133
+F IG G FG V + TG + A+K+L ++ + + R+ L E
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-- 58
Query: 134 LSLLHHSNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKI 189
+ +V L Y + D + L+ E++P G + L D ++E TR I
Sbjct: 59 ----DNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE-----TRFYI 107
Query: 190 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG-DKSHVST- 247
A ++ +H K I+RD K N+LL+ H KLSDFGL G KSH +
Sbjct: 108 AE-TILAIDSIH-KLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCT----GLKKSHRTEF 159
Query: 248 ---------------------------------RVM-----GTYGYCAPEYAMTGQLTVK 269
R + GT Y APE + +
Sbjct: 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE 219
Query: 270 SDVYSFGVVFLELITG 285
D +S GV+ E++ G
Sbjct: 220 CDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 36/98 (36%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 196 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK---LGPVGDKSHVSTRVMGT 252
GL+Y+H AN V++RD K N+L+ K+ DFGLA+ P + + T + T
Sbjct: 117 GLKYIH-SAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172
Query: 253 YGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGRKAI 289
Y APE ++ Q K+ DV+S G + EL+ GRK +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-07
Identities = 32/152 (21%), Positives = 54/152 (35%), Gaps = 17/152 (11%)
Query: 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLV-NLI 146
+ G RVY L + + +K +RE EV +L LL V ++
Sbjct: 4 KLLKGGLTNRVY--LLGTKDEDYVLKINPSREKGADRER--EVAILQLLARKGLPVPKVL 59
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
L+ E++ G D + + + A A+ L LH
Sbjct: 60 ASGESDGWSYLLMEWIE-GETLDEVSEEEKEDIAEQ----------LAELLAKLHQLPLL 108
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238
+ + D NIL+++G + D+ A GP
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 62/199 (31%), Positives = 86/199 (43%), Gaps = 34/199 (17%)
Query: 107 TGQVVAVKQLDRNGLQGNREFLV----EVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162
TG +V V+ D E L EV++ H N++ G ++ FM
Sbjct: 24 TGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81
Query: 163 PLGSLEDHLHDLPPD--KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL 220
GS L P+ EAL N I GA +GL YLH I+R+ K+S+IL+
Sbjct: 82 AYGSANSLLKTYFPEGMSEALIGN----ILFGALRGLNYLHQNG---YIHRNIKASHILI 134
Query: 221 EEGFHPKLSDFGLAKLGPV---GDKSHV-------STRVMGTYGYCAPEYA---MTGQLT 267
LS GL+ L + G K+ V ST V+ + +PE + G
Sbjct: 135 SGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYG-YN 188
Query: 268 VKSDVYSFGVVFLELITGR 286
VKSD+YS G+ EL TGR
Sbjct: 189 VKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 41/175 (23%), Positives = 74/175 (42%), Gaps = 12/175 (6%)
Query: 128 LVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD-LPPDKEALDWNTR 186
L+E ++L ++H +++ + G +V L L+ L L +
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV-----LPHYSSDLYTYLTKRSRPLPIDQA 159
Query: 187 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 246
+ I +GL YLH + +I+RD K+ NI + + + D G A+ PV + +
Sbjct: 160 LIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG 215
Query: 247 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV 301
+ GT APE + K+D++S G+V E++ I P + V
Sbjct: 216 --LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYV 268
|
Length = 357 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 62/260 (23%), Positives = 100/260 (38%), Gaps = 70/260 (26%)
Query: 91 IGEGGFGRVYKGWL-----ESTGQVVAVKQLDRNGLQGN--REFLVEV-LMLSLLHHSNL 142
+G G FG+V + ++ + VAVK L + G + + + E+ +++ + HH N+
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKML-KEGATASEYKALMTELKILIHIGHHLNV 73
Query: 143 VNLIGYCADGDQRLLV-YEFMPLGSLEDHL----HDLPPDKEALDWNTRMKIAAGAAKGL 197
VNL+G C L+V E+ G+L ++L P + MK G + L
Sbjct: 74 VNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133
Query: 198 --------------------------EYLHDKANPPV----------------------- 208
E + P+
Sbjct: 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK 193
Query: 209 -IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV---STRVMGTYGYCAPEYAMTG 264
I+RD + NILL E K+ DFGLA+ D +V R+ + APE
Sbjct: 194 CIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL--PLKWMAPESIFDK 250
Query: 265 QLTVKSDVYSFGVVFLELIT 284
T +SDV+SFGV+ E+ +
Sbjct: 251 VYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 39/119 (32%), Positives = 60/119 (50%), Gaps = 16/119 (13%)
Query: 176 PDKEALD-WNTRMKI------AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKL 228
P +E D W + + + + A+G+E+L A+ I+RD + NILL E K+
Sbjct: 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKI 215
Query: 229 SDFGLAKLGPVGDKSHV---STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
DFGLA+ D +V S R+ + APE T +SDV+SFGV+ E+ +
Sbjct: 216 CDFGLAR-DIYKDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 37/112 (33%), Positives = 56/112 (50%), Gaps = 11/112 (9%)
Query: 177 DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236
D+ ALD + + AKG+ +L K I+RD + NILL G K+ DFGLA+
Sbjct: 207 DELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR- 262
Query: 237 GPVGDKSHVSTRVMGT----YGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
D ++V V G + APE T +SDV+S+G++ E+ +
Sbjct: 263 DIRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 65/252 (25%), Positives = 106/252 (42%), Gaps = 47/252 (18%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR---------NGLQGNREFLV--EVL 132
+F IG G FG V ++ T ++ A+K L++ + R LV +
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61
Query: 133 MLSLLHHS-----NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRM 187
++ LH++ L ++ Y GD L+ +F ED L P+ A + M
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF------EDRL----PEDMARFYIAEM 111
Query: 188 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 247
+A + L Y+H RD K N+LL+ H +L+DFG + L D + S+
Sbjct: 112 VLAIHSIHQLHYVH---------RDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSS 161
Query: 248 RVMGTYGYCAPEY--AM---TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVT 302
+GT Y +PE AM G+ + D +S GV E++ G P ++LV
Sbjct: 162 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET------PFYAESLVE 215
Query: 303 WARPLFNDRRKF 314
+ N +F
Sbjct: 216 TYGKIMNHEERF 227
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 33/109 (30%), Positives = 56/109 (51%), Gaps = 5/109 (4%)
Query: 177 DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236
+ AL + + + A G+E+L A+ ++RD + N+L+ EG K+ DFGLA+
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR- 287
Query: 237 GPVGDKSHVST-RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ D +++S + APE T SDV+SFG++ E+ T
Sbjct: 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 31/228 (13%)
Query: 77 ELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSL 136
+L + + RP +G G G V+ + VAVK++ Q + L E+ ++
Sbjct: 2 DLGSRYMDLRP---LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRR 58
Query: 137 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAA-- 194
L H N+V + L +GSL L+ + +E ++ + + G
Sbjct: 59 LDHDNIVKVYEVLGPSGSDLT----EDVGSLT-ELNSVYIVQEYMETDLANVLEQGPLSE 113
Query: 195 -----------KGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAK-LGPVGD 241
+GL+Y+H AN V++RD K +N+ + E K+ DFGLA+ + P
Sbjct: 114 EHARLFMYQLLRGLKYIH-SAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDP--H 168
Query: 242 KSHVSTRVMG--TYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGR 286
SH G T Y +P ++ T D+++ G +F E++TG+
Sbjct: 169 YSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 64/254 (25%), Positives = 115/254 (45%), Gaps = 42/254 (16%)
Query: 91 IGEGGFGRVYKGWLESTG--QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIG- 147
+G G +G VYK + + A+KQ++ G+ + E+ +L L H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKV 66
Query: 148 YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK--------GLE 198
+ + D+++ L++++ + D H + + + M++ K G+
Sbjct: 67 FLSHSDRKVWLLFDY----AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 199 YLHDKANPPVIYRDFKSSNILL----EEGFHPKLSDFGLAKL-----GPVGDKSHVSTRV 249
YLH AN V++RD K +NIL+ E K++D G A+L P+ D V
Sbjct: 123 YLH--ANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-- 177
Query: 250 MGTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLF 308
T+ Y APE + + K+ D+++ G +F EL+T H Q + + P
Sbjct: 178 --TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-----HCRQEDIKTSNPFH 230
Query: 309 NDR--RKFSKLADP 320
+D+ R FS + P
Sbjct: 231 HDQLDRIFSVMGFP 244
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 63/254 (24%), Positives = 117/254 (46%), Gaps = 42/254 (16%)
Query: 91 IGEGGFGRVYKGWLE--STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIG- 147
+G G +G VYK + + A+KQ++ G+ + E+ +L L H N+++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 66
Query: 148 YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK--------GLE 198
+ + D+++ L++++ + D H + + + +++ G K G+
Sbjct: 67 FLSHADRKVWLLFDY----AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 199 YLHDKANPPVIYRDFKSSNILL----EEGFHPKLSDFGLAKL-----GPVGDKSHVSTRV 249
YLH AN V++RD K +NIL+ E K++D G A+L P+ D V
Sbjct: 123 YLH--ANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-- 177
Query: 250 MGTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLF 308
T+ Y APE + + K+ D+++ G +F EL+T H Q + + P
Sbjct: 178 --TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-----HCRQEDIKTSNPYH 230
Query: 309 NDR--RKFSKLADP 320
+D+ R F+ + P
Sbjct: 231 HDQLDRIFNVMGFP 244
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 5e-06
Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 30/223 (13%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR--EFLVEVLMLSLLHHSNLVNLIG- 147
IG G FG V+ + T + K + GL+ + ++EV ++ L H N+V I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 148 YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
+ +Q+L ++ EF G L ++ ++ + + I L Y H+ +
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 207 P----VIYRDFKSSNILLEEGFH-----------------PKLSDFGLAKLGPVGDKSHV 245
P V++RD K NI L G K+ DFGL+K + +H
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH- 199
Query: 246 STRVMGTYGYCAPEYAM--TGQLTVKSDVYSFGVVFLELITGR 286
+GT Y +PE + T KSD+++ G + EL +G+
Sbjct: 200 --SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 69/270 (25%), Positives = 105/270 (38%), Gaps = 84/270 (31%)
Query: 91 IGEGGFGRVYKGWL-----ESTGQVVAVKQLDRNGLQGNREFLVEVL--MLSLLHHSNLV 143
+G G FG+V + +T + VAVK L L+ L ++ + HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 144 NLIG--------------YCADGDQRLLVY------EFMPLGSL-------EDHLHDLPP 176
NL+G +C G+ L Y EF+P + + D+
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGN--LSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISE 132
Query: 177 D-KEALDWNTRMKIAAGA--------------------------------------AKGL 197
D K LD T + +A + AKG+
Sbjct: 133 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGM 192
Query: 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV---STRVMGTYG 254
E+L A+ I+RD + NILL E K+ DFGLA+ D +V R+
Sbjct: 193 EFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL--PLK 246
Query: 255 YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ APE T++SDV+SFGV+ E+ +
Sbjct: 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 60/256 (23%), Positives = 90/256 (35%), Gaps = 59/256 (23%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---------QGNREFLVEVLML 134
+F IG G FG V + TG + A+K L + + + R+ LVE
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA--- 58
Query: 135 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAAG 192
+ +V + D L+ EF+P G + L D ++ + +A
Sbjct: 59 ---DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAID 115
Query: 193 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA---------------KLG 237
A L ++H RD K N+LL+ H KLSDFGL
Sbjct: 116 AIHQLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 238 PVGD------------------KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVF 279
P D + ++ +GT Y APE M D +S GV+
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 280 LELITGRKAIDSTRPH 295
E++ G S P
Sbjct: 227 YEMLIGYPPFCSETPQ 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 48/208 (23%), Positives = 79/208 (37%), Gaps = 30/208 (14%)
Query: 94 GGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV---EVLMLSLLHHSNLVNLIGYCA 150
+ K + T +VAVK+++ + + + E++ L H N++ +
Sbjct: 13 LMIVHLAKH--KPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPD--KEALDWNTRMKIAAGAAKGLEYLHDKANPPV 208
+ +V M GS ED L P+ E I L+Y+H K
Sbjct: 70 VDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF----ILKDVLNALDYIHSKG---F 122
Query: 209 IYRDFKSSNILLEEGFHPKLSDFGLA--------KLGPVGDKSHVSTRVMGTYGYCAPEY 260
I+R K+S+ILL LS + + V D S + + + +PE
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL---PWLSPEV 179
Query: 261 ---AMTGQLTVKSDVYSFGVVFLELITG 285
+ G KSD+YS G+ EL G
Sbjct: 180 LQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 35/113 (30%), Positives = 61/113 (53%), Gaps = 11/113 (9%)
Query: 176 PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235
D LD + ++ ++ A+G+++L K I+RD + N+LL +G K+ DFGLA+
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 236 LGPVGDKSHVSTRVMGT----YGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ D ++V V G + APE TV+SDV+S+G++ E+ +
Sbjct: 261 -DIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 28/77 (36%), Positives = 42/77 (54%)
Query: 208 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLT 267
+++RD KS+NI L KL DFG +K V++ GT Y APE + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 268 VKSDVYSFGVVFLELIT 284
K+D++S GV+ EL+T
Sbjct: 250 KKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 48/163 (29%), Positives = 72/163 (44%), Gaps = 28/163 (17%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---------QGNREFLVEVLML 134
+F IG+G FG V + TG++ A+K L ++ + + R+ L E
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE---- 57
Query: 135 SLLHHSN---LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 191
S+ +V+L D L+ EF+P G L L E + TR +A
Sbjct: 58 -----SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---TRFYMAE 109
Query: 192 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234
+E +H I+RD K NIL++ G H KLSDFGL+
Sbjct: 110 -CVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 64/268 (23%), Positives = 93/268 (34%), Gaps = 56/268 (20%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---------QGNREFLVEVLM 133
++F IG G FG V + TG V A+K L + + + R+ LVE
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 134 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 193
L + V + D L+ EF+P G + L K+ L A
Sbjct: 61 LWV------VKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAET 110
Query: 194 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA------------------- 234
++ +H I+RD K N+LL+ H KLSDFGL
Sbjct: 111 VLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167
Query: 235 ----KLGPVGDKSHVST----------RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 280
+ K T +GT Y APE M D +S GV+
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 281 ELITGRKAIDSTRPHGE-QNLVTWARPL 307
E++ G S P + ++ W L
Sbjct: 228 EMLIGYPPFCSETPQETYKKVMNWKETL 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 55/244 (22%), Positives = 97/244 (39%), Gaps = 48/244 (19%)
Query: 77 ELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSL 136
++ +T+ F+ S +GEG FG+V + W + AVK + RN + R+ +E+ +
Sbjct: 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVK-IVRNVPKYTRDAKIEIQFMEK 181
Query: 137 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD--------LPPDKEAL-DW---- 183
+ AD R PL ++ + + +P L DW
Sbjct: 182 VRQ----------ADPADRF------PLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKH 225
Query: 184 ---NTR--MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG-----------FHPK 227
+ R +I L+Y H + + +++ D K NIL+E P
Sbjct: 226 GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPD 283
Query: 228 LSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 287
+ LG D+ H T ++ T Y +PE + +D++S G + EL TG+
Sbjct: 284 PCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343
Query: 288 AIDS 291
D+
Sbjct: 344 LYDT 347
|
Length = 467 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 50/195 (25%), Positives = 75/195 (38%), Gaps = 23/195 (11%)
Query: 94 GGFGRVY--KGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD 151
G G V+ + + V VK + G E+ +L + H ++NLI
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGR-----EIDILKTISHRAIINLIHAYRW 157
Query: 152 GDQRLLVYEFMPLGSLEDHLHDL---PPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 208
+V MP + DL L + I + L YLH + +
Sbjct: 158 KSTVCMV---MP-----KYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---I 206
Query: 209 IYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLT 267
I+RD K+ NI L+E + L DFG A KL D GT +PE
Sbjct: 207 IHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS-GTLETNSPELLALDPYC 265
Query: 268 VKSDVYSFGVVFLEL 282
K+D++S G+V E+
Sbjct: 266 AKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 7/88 (7%)
Query: 91 IGEGGFGRV-----YKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLL-HHSNLV 143
+G G FG+V Y + VAVK L + RE L+ E+ +LS L +H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIV 102
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHL 171
NL+G C G L++ E+ G L + L
Sbjct: 103 NLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 31/89 (34%), Positives = 43/89 (48%), Gaps = 7/89 (7%)
Query: 91 IGEGGFGRVYK----GWLESTGQV-VAVKQLDRNGLQGNREFLVEVL--MLSLLHHSNLV 143
+G G FGRV + G S + VAVK L ++ L+ L M L H N+V
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHLH 172
NL+G C G ++ E+ G L D+LH
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 7/88 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQ-----VVAVKQLDRNGLQGNREFLV-EVLMLSLL-HHSNLV 143
+G G FG+V + G+ VAVK L + RE L+ E+ +LS L H N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHL 171
NL+G C G L++ E+ G L + L
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 20/180 (11%)
Query: 111 VAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDH 170
V +K LD + + F M+ + H ++V L G C + ++V EF+ G L+
Sbjct: 35 VILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLF 94
Query: 171 LHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL-------EEG 223
+H + L + K+A A L YL DK +++ + + NILL E G
Sbjct: 95 MHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECG 148
Query: 224 FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLEL 282
KLSD G+ V + R+ + APE + L++ +D +SFG E+
Sbjct: 149 PFIKLSDPGIPI--TVLSRQECVERI----PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 30/106 (28%), Positives = 47/106 (44%), Gaps = 10/106 (9%)
Query: 187 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPK---LSDFGLAKLGPVGDKS 243
+ I + ++YLH+ +I+RD K+ NI + HP L DFG A PV +
Sbjct: 185 LAIERSVLRAIQYLHENR---IIHRDIKAENIFIN---HPGDVCLGDFGAACF-PVDINA 237
Query: 244 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 289
+ GT APE D++S G+V E+ T ++
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 8e-04
Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 20/158 (12%)
Query: 133 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 192
++S + H +L + G C G + ++V EF+ G L+ L +K + ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQ 125
Query: 193 AAKGLEYLHDKANPPVIYRDFKSSNIL-----LEEGFHP--KLSDFGLAKLGPVGDKSHV 245
A L YL DK +++ + + NIL L EG P KLSD G++ + + V
Sbjct: 126 LASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERV 181
Query: 246 STRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLEL 282
R+ + APE G L+ +D +SFG LE+
Sbjct: 182 E-RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 47/186 (25%), Positives = 77/186 (41%), Gaps = 42/186 (22%)
Query: 118 RNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE---FMPLGSLEDHLHDL 174
+ G + + E+L L L+H N++ + + +L E +M + L+
Sbjct: 201 KAGSRAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSF 252
Query: 175 PPDKEALDWNTR------MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKL 228
D EA DW R I +EY+HDK +I+RD K NI L L
Sbjct: 253 MYD-EAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVL 308
Query: 229 SDFGLA----------KLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 278
DFG A G VG + S ++ GYC ++T D++S G++
Sbjct: 309 GDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYC--------EIT---DIWSCGLI 357
Query: 279 FLELIT 284
L++++
Sbjct: 358 LLDMLS 363
|
Length = 501 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 457 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.43 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.36 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.29 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.21 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.2 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.15 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.14 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.01 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.97 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.79 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.74 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.69 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.61 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.55 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.54 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.48 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.45 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.4 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.37 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.36 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.32 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.28 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.22 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.21 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.18 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.14 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.99 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.92 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.91 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.91 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.88 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.8 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.73 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.66 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.63 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.45 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.42 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.21 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.19 | |
| PLN02236 | 344 | choline kinase | 97.17 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.16 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.04 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.87 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.86 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.78 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.68 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.66 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.54 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.53 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.51 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.45 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.28 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.11 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.91 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.78 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.68 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.61 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.41 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.13 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-58 Score=457.46 Aligned_cols=291 Identities=58% Similarity=0.981 Sum_probs=259.1
Q ss_pred ccccccHHHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEE
Q 012761 69 AAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGY 148 (457)
Q Consensus 69 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 148 (457)
....|++.++..+|++|...+.||+|+||.||+|...+ +..||||++.........+|..|+.++.+++|||||+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 56789999999999999999999999999999999976 48999998876543315669999999999999999999999
Q ss_pred EecCC-eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceE
Q 012761 149 CADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPK 227 (457)
Q Consensus 149 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~k 227 (457)
|.+.+ +.+||||||++|+|.++|+..... +|+|..+++||.++|+||+|||....++||||||||+|||||+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99998 599999999999999999973322 899999999999999999999999888999999999999999999999
Q ss_pred EeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhh
Q 012761 228 LSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL 307 (457)
Q Consensus 228 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 307 (457)
|+|||+|+..+.. .....+...||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+...+....+++.|+.+.
T Consensus 218 lsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred ccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999999765442 222222227999999999999999999999999999999999999999987777778899999998
Q ss_pred hhcccccccccCCccC-CCCCh-HhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 308 FNDRRKFSKLADPRLE-GRYPI-RGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 308 ~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
+.+. .+.+++||.+. +.++. .++.++..++.+|++.+|.+||+|.+|+++|+.+..
T Consensus 297 ~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 297 LEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 8877 78899999988 67775 688899999999999999999999999999966653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-50 Score=382.13 Aligned_cols=250 Identities=27% Similarity=0.398 Sum_probs=208.6
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCC-eeeEEEec
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGD-QRLLVYEF 161 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lV~E~ 161 (457)
+.+..+.||+|..|+||+++|+.|++.+|+|++..+.. ...+++.+|+++++..+||+||.+||.|.+.. ...|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 45667789999999999999999999999999965432 23467899999999999999999999999988 59999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|++|+|++++.. .+++++...-+|+.+|++||.|||+ .+ ||||||||+||||+..|.|||||||.+.....
T Consensus 160 MDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn- 231 (364)
T KOG0581|consen 160 MDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVN- 231 (364)
T ss_pred cCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhh-
Confidence 999999999976 3679999999999999999999996 67 99999999999999999999999999975321
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC-
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD- 319 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d- 319 (457)
.....++||..|||||.+.+..|+.++||||||+.|+||++|+.||....+ ....|+.-+ ..+++
T Consensus 232 ---S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~----~~~~~~~Ll-------~~Iv~~ 297 (364)
T KOG0581|consen 232 ---SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP----PYLDIFELL-------CAIVDE 297 (364)
T ss_pred ---hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC----CCCCHHHHH-------HHHhcC
Confidence 255668999999999999999999999999999999999999999965411 112222111 11222
Q ss_pred --CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 320 --PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 320 --~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
|.+... ....++..++..||++||.+||++.++++.
T Consensus 298 ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 298 PPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 222221 135578899999999999999999999763
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-50 Score=401.78 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=213.4
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
..|...++||+|||+.||.+++..+|..||+|++.+.. ....+.+.+|++|.+.|+|||||+++++|++.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 46999999999999999999999999999999998743 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
|+|+.++|..+++. ..++++.++..++.||+.||.|||+.+ |||||||..||||+++.+|||+|||||.....
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999975 678999999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
.. ....++||||.|+|||++....++..+||||+|||||.||+|++||+...- .+-...+......
T Consensus 171 ~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v------kety~~Ik~~~Y~------ 236 (592)
T KOG0575|consen 171 DG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV------KETYNKIKLNEYS------ 236 (592)
T ss_pred cc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH------HHHHHHHHhcCcc------
Confidence 32 334568999999999999999999999999999999999999999976431 1111111111111
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.|......+.+||..+|+.+|.+||++.+|+..
T Consensus 237 ------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 237 ------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 122334578899999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=383.70 Aligned_cols=254 Identities=25% Similarity=0.379 Sum_probs=207.3
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC-------hHHHHHHHHHHHhcCCCCceeeEEEEecCC
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG-------NREFLVEVLMLSLLHHSNLVNLIGYCADGD 153 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 153 (457)
..+.|.+.+.||+|+||.|-+|..+.||+.||||++++..... ...+.+|+++|++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3456888999999999999999999999999999998643222 123578999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC---CceEEee
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG---FHPKLSD 230 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~---~~~kL~D 230 (457)
..|+||||+.||.|.+.+-. .+.+.+..-..++.|++.||.|||++| |+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999976 567888888999999999999999999 9999999999999655 7899999
Q ss_pred ccccccCCCCCCccccccccccccccchhhhhcCC---CCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhh
Q 012761 231 FGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ---LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL 307 (457)
Q Consensus 231 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 307 (457)
||+|++.. ......++|||+.|.|||++.+.. +..++|+||||||||-+|+|.+||....... .+ ...+
T Consensus 323 FGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl---~eQI 394 (475)
T KOG0615|consen 323 FGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SL---KEQI 394 (475)
T ss_pred cchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cH---HHHH
Confidence 99999743 344567789999999999998764 3348899999999999999999997654321 01 1111
Q ss_pred hhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 308 FNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 308 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...... +-|... .+...+.++||.+||..||++||++.|++.
T Consensus 395 ~~G~y~----f~p~~w----~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 395 LKGRYA----FGPLQW----DRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hcCccc----ccChhh----hhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111111 111111 134568899999999999999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=386.12 Aligned_cols=260 Identities=33% Similarity=0.504 Sum_probs=211.3
Q ss_pred CCccceeeecCcEEEEEEEECCCCeE-EEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEecCC-eeeEEEe
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQV-VAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGD-QRLLVYE 160 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~-vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lV~E 160 (457)
+.+.+.||.|+||+||+|.++. .. ||||++....... .+.|.+|+.+|.+|+|||||.++|+|.+.. .++||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 3444559999999999999974 55 9999998654332 458999999999999999999999999988 7999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC-ceEEeeccccccCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF-HPKLSDFGLAKLGPV 239 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~~~~ 239 (457)
|+++|+|.++|+.. ....+++..++.|+.+|++||+|||+.++ ||||||||+||||+.++ ++||||||+++....
T Consensus 121 y~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred eCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999863 46789999999999999999999999874 89999999999999998 999999999985322
Q ss_pred CCCccccccccccccccchhhhh--cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAM--TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
.. ...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||....+. .+... ..
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---~~~~~---v~--------- 259 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---QVASA---VV--------- 259 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---HHHHH---HH---------
Confidence 11 2333468999999999999 568999999999999999999999999876541 11111 10
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcCCC
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYD 368 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~ 368 (457)
....+...+......+..|+..||..||..||++.+++..|+.+......
T Consensus 260 -~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 260 -VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred -hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 01111111112334678899999999999999999999999999875543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=376.18 Aligned_cols=243 Identities=27% Similarity=0.379 Sum_probs=207.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|++.++||+|+||+||+++.++|++.||+|++++..... .+....|..+|..++||+||+++..|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 568999999999999999999999999999999998754433 35577899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
+||+.||.|..+|+. ...+++..+..++..|+.||.|||+++ ||||||||+|||||++|+++|+|||+++..-
T Consensus 104 ld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999986 578999999999999999999999999 9999999999999999999999999998532
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.....+.+++||+.|||||++.+..|+..+|+|||||++|||++|.+||...+ ...+...+..... ..
T Consensus 177 --~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k~----~~ 244 (357)
T KOG0598|consen 177 --KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGKL----PL 244 (357)
T ss_pred --cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCcC----CC
Confidence 22234455899999999999999999999999999999999999999997654 2333333333220 00
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCC
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRP 350 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 350 (457)
.+.-....+.+++..+|+.+|++|.
T Consensus 245 -------~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 245 -------PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -------CCccCCHHHHHHHHHHhccCHHHhc
Confidence 1111234688999999999999996
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=373.67 Aligned_cols=203 Identities=31% Similarity=0.496 Sum_probs=184.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
..+|.+.+.||.|+||+||+|+++.++..||||.+.+... ...+.+..|+.+|+.++|||||.+++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 4678889999999999999999999999999999987643 22355788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC------CceEEeeccc
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG------FHPKLSDFGL 233 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~------~~~kL~DFGl 233 (457)
|||.||+|.++|+. .+.+++.++..++.||+.||++||+++ ||||||||.||||+.+ -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999987 568999999999999999999999999 9999999999999754 4689999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRP 294 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~ 294 (457)
|+... ......+.+|++.|||||++...+|+.|+|+||+|+|||+|++|+.||+...+
T Consensus 162 AR~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 162 ARFLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhhCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 99754 33455678999999999999999999999999999999999999999986554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-50 Score=367.65 Aligned_cols=258 Identities=24% Similarity=0.351 Sum_probs=212.7
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEE-EEecCCe-eeEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIG-YCADGDQ-RLLV 158 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~-~~lV 158 (457)
.+|.++++||+|+||.||++.+..+|..||.|.+...... .......|+.+|++|+|||||++++ .|.+++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4688999999999999999999999999999999854333 2356889999999999999999998 4555555 8999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN-PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~-~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||.+|+|...++..+.....+++.++|+++.|++.||..+|..-+ ..|+||||||.||+|+.+|.|||+|||+++..
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999999887788899999999999999999999998321 23999999999999999999999999999974
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
..........+|||.||+||.+...+|+.||||||+||++|||+.-++||.+.. +.+.-..+.. .
T Consensus 179 --~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~L~~KI~q-------g 243 (375)
T KOG0591|consen 179 --SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLSLCKKIEQ-------G 243 (375)
T ss_pred --cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHHHHHHHHc-------C
Confidence 334455667899999999999999999999999999999999999999998752 2222111111 1
Q ss_pred cCCccCCCCC-hHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 318 ADPRLEGRYP-IRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 318 ~d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
--|. .| .-...++..||..|+..||+.||+.-.++..+
T Consensus 244 d~~~----~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 244 DYPP----LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred CCCC----CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 1111 12 23466888999999999999999975555544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=352.60 Aligned_cols=265 Identities=26% Similarity=0.356 Sum_probs=213.9
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
+.|+.+..+|+|+||+||++++++||+.||||++..... ...+-.++|+++|++|.|+|+|.++.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 457778889999999999999999999999999975432 223557899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
||+..-|.+ |.. ....++...+.+++.|++.|+.|||+++ +|||||||+||||+.+|.+||||||+|+....
T Consensus 82 ~~dhTvL~e-Le~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDHTVLHE-LER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecchHHHHH-HHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 998644444 443 2456889999999999999999999999 99999999999999999999999999996442
Q ss_pred CCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccch--------hhhhhhhhcc
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV--------TWARPLFNDR 311 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~--------~~~~~~~~~~ 311 (457)
.....+..+.|.+|+|||.+.+ .+|+..+|||++||++.||++|.+-|.+..+.+...++ ..-..+|...
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 3445677889999999999987 58999999999999999999999999887665543222 2223334433
Q ss_pred cccccccCCccC------CCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 312 RKFSKLADPRLE------GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 312 ~~~~~~~d~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.-+.-+.-|... ..++ ....-+++++..||+.||.+|++.++++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 333333333322 2232 23447789999999999999999999873
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=368.61 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=212.2
Q ss_pred HHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhc-CCCCceeeEEEEecCCe
Q 012761 79 AAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLL-HHSNLVNLIGYCADGDQ 154 (457)
Q Consensus 79 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 154 (457)
....++|.+.+.||+|+|++||+|+.+.+++.||||++.+..+.. .+.+..|-..|.+| .||.|++|+..|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 445679999999999999999999999999999999998654322 23467788999999 79999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
+|+|+||+++|+|.++|+. .+.|++.....++.+|+.||+|||+.| ||||||||+|||||.+|+++|+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999999987 478999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCc---------ccc--ccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhh
Q 012761 235 KLGPVGDKS---------HVS--TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTW 303 (457)
Q Consensus 235 ~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~ 303 (457)
+..+..... ..+ ..++||..|.+||++..+..++.+|||+||||||+|+.|.+||...+.. .+
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---li--- 295 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---LI--- 295 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---HH---
Confidence 875432221 111 4589999999999999999999999999999999999999999765431 11
Q ss_pred hhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 304 ARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 304 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.+.++.-... +...++ ..+.+|+...|..||.+|+++.+|.+.
T Consensus 296 FqkI~~l~y~--------fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 FQKIQALDYE--------FPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHHhccc--------CCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 1111111111 112222 467899999999999999999888654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=343.92 Aligned_cols=238 Identities=27% Similarity=0.371 Sum_probs=205.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
..+|...+.||.|+||.|.+++++.+|..+|+|++++...- ..+...+|..+|+.+.||+++++++.|.+...+++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 45899999999999999999999999999999999875432 234577899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||++||.|..+|+. .+++++..+..++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+...
T Consensus 123 meyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999986 578999999999999999999999999 9999999999999999999999999998632
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
..+.+.||||.|+|||++...+|+.++|+|+|||++|||+.|.+||...++. ..-..++...-.++..+
T Consensus 196 -----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~------~iY~KI~~~~v~fP~~f 264 (355)
T KOG0616|consen 196 -----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI------QIYEKILEGKVKFPSYF 264 (355)
T ss_pred -----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH------HHHHHHHhCcccCCccc
Confidence 2256789999999999999999999999999999999999999999876651 12222333332232222
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCC
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATR 349 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 349 (457)
...+.+|+...|+.|-.+|
T Consensus 265 ------------s~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 265 ------------SSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ------------CHHHHHHHHHHHhhhhHhh
Confidence 3467789999999999988
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=357.32 Aligned_cols=263 Identities=26% Similarity=0.370 Sum_probs=212.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcCh-HHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN-REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~-~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.++|.+..+||.|..++||+|+...++..||||++..+..... +.+.+|+..++.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 5689999999999999999999999999999999997655544 788999999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC-CC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG-PV 239 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~-~~ 239 (457)
||.+|++.+++... ....+++..+..|++++++||.|||.+| .||||||+.||||+.+|.|||+|||.+... ..
T Consensus 105 fMa~GS~ldIik~~--~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTY--YPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHH--ccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999864 3455999999999999999999999999 999999999999999999999999986532 22
Q ss_pred CCCcccc-ccccccccccchhhhhcC--CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 240 GDKSHVS-TRVMGTYGYCAPEYAMTG--QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 240 ~~~~~~~-~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
+...... ..++||++|||||+++.. .|+.|+|||||||+..||.+|..||....+.... . ..+-.+. +.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l---~tLqn~p---p~ 251 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--L---LTLQNDP---PT 251 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--H---HHhcCCC---CC
Confidence 3222222 567899999999997643 7999999999999999999999999877653211 0 1111110 00
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+.-..+...-.......+..++..||+.||++|||+.++++
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00000000001112336778999999999999999999985
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=366.08 Aligned_cols=248 Identities=24% Similarity=0.313 Sum_probs=208.1
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
..++|.+++.||+|+||.||+|+-+.||..+|+|++++..... ...+..|..+|....+|+||+|+..|++.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999999999999999998764433 3557789999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||++||++..+|.. ...|++..+..++.+++.||+.||+.| +|||||||+|+|||..|++||+||||+.-.
T Consensus 219 iMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999986 688999999999999999999999999 999999999999999999999999998421
Q ss_pred CC----------------------CCCc------c-----------------ccccccccccccchhhhhcCCCCccchH
Q 012761 238 PV----------------------GDKS------H-----------------VSTRVMGTYGYCAPEYAMTGQLTVKSDV 272 (457)
Q Consensus 238 ~~----------------------~~~~------~-----------------~~~~~~gt~~y~aPE~~~~~~~~~ksDv 272 (457)
.. .+.. . .....+|||.|||||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 00 0000 0 0123579999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCC-cccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCC
Q 012761 273 YSFGVVFLELITGRKAIDSTRPHG-EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL 351 (457)
Q Consensus 273 wSlGvil~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 351 (457)
||||||+||||.|.+||....+.. ..+++.|...+.... -. ....++.+||.+||. ||.+|.-
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-----~~----------~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-----EV----------DLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-----cC----------cccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999999998877643 245555553321111 11 112578899999999 9999997
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=363.84 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=215.4
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccC----CC-cChHHHHHHHHHHHhcC-CCCceeeEEEEecCCe
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN----GL-QGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQ 154 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~----~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 154 (457)
....|.+.+.||+|+||+|++|.+..++..||+|++.+. .. ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 467899999999999999999999999999999988764 11 22345668999999999 9999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC-CceEEeeccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG-FHPKLSDFGL 233 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~-~~~kL~DFGl 233 (457)
.++||||+.||+|.+++.. ..++.+..+.+++.|++.|++|||+.+ |+||||||+|||++.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999986 577889999999999999999999999 9999999999999999 9999999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhcCC-CC-ccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ-LT-VKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 311 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 311 (457)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... .......+....
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~ki~~~~ 239 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYRKIRKGE 239 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHHHHhcCC
Confidence 98753 2233456689999999999999877 85 78999999999999999999998632 222222233322
Q ss_pred cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 312 RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 312 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
..++..++ ..++..|+.+||..+|.+|+++.+++ .-..+..
T Consensus 240 ~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 240 FKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred ccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 22222221 35788999999999999999999999 6666654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=365.58 Aligned_cols=250 Identities=27% Similarity=0.395 Sum_probs=215.0
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccC
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMP 163 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~ 163 (457)
.|.....||+|..|.||.|+...+++.||||++........+-+.+|+.+|+.++|+|||++++.|...+.+|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 47777889999999999999999999999999998877777889999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCc
Q 012761 164 LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS 243 (457)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 243 (457)
||+|.+.+.. ..+++.++..|+.+++.||+|||.++ |+|||||.+|||++.+|.+||+|||++..... ..
T Consensus 354 ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~--~~ 423 (550)
T KOG0578|consen 354 GGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISE--EQ 423 (550)
T ss_pred CCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccc--cc
Confidence 9999999975 45999999999999999999999999 99999999999999999999999999975433 23
Q ss_pred cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccC
Q 012761 244 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLE 323 (457)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 323 (457)
.....++|||.|||||++....|++|.||||||++++||+-|.+||-..++-....+ +.... -|.+
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL-------Ia~ng------~P~l- 489 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATNG------TPKL- 489 (550)
T ss_pred CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH-------HhhcC------CCCc-
Confidence 356678999999999999999999999999999999999999999976554221111 11111 1122
Q ss_pred CCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 324 GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 324 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
..+......+.+++.+||+.|+.+||++.|+++.
T Consensus 490 -k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 -KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1223345678899999999999999999999863
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=352.79 Aligned_cols=257 Identities=28% Similarity=0.401 Sum_probs=205.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCC--eeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD--QRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lV~ 159 (457)
..+|...+.||+|+||.||++.+.++|..+|||.+........+.+.+|+.+|++|+|||||+++|.....+ .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345777888999999999999999999999999998653333566899999999999999999999855554 689999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC-CCceEEeeccccccCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE-GFHPKLSDFGLAKLGP 238 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~-~~~~kL~DFGla~~~~ 238 (457)
||+++|+|.+++... ...|++..+..++.||++||.|||+++ ||||||||+||||+. ++.+||+|||++....
T Consensus 96 Ey~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 999999999999873 227999999999999999999999999 999999999999999 7999999999997543
Q ss_pred C-CCCccccccccccccccchhhhhcCC-CCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 239 V-GDKSHVSTRVMGTYGYCAPEYAMTGQ-LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 239 ~-~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
. ...........||+.|||||++..+. ...++|||||||++.||+||++||.... ....+...+....
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~~~ig~~~----- 239 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEALLLIGRED----- 239 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHHHHHhccC-----
Confidence 2 12222334578999999999999643 3459999999999999999999997631 1111111111111
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
.-| .+|.....++.+++..|++.+|++|||+.+++...
T Consensus 240 -~~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 240 -SLP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred -CCC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 112 22333445788999999999999999999998765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=358.86 Aligned_cols=264 Identities=26% Similarity=0.387 Sum_probs=205.1
Q ss_pred hcCCCccceeeecCcEEEEEEEEC-----CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCceeeEEEEecC-C
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLE-----STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADG-D 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~ 153 (457)
.++|.+.+.||+|+||.||+|.+. .++..||||++..... .....+..|+.++..+ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 468999999999999999999752 3456899999875422 2235688999999999 899999999988764 4
Q ss_pred eeeEEEeccCCCCHHHhhhcCCC---------------------------------------------------------
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPP--------------------------------------------------------- 176 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 176 (457)
.+++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 58899999999999999874211
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccccccccccc
Q 012761 177 -DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY 255 (457)
Q Consensus 177 -~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y 255 (457)
...++++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 1245888999999999999999999999 999999999999999999999999999753222211122233467789
Q ss_pred cchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHH
Q 012761 256 CAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQA 334 (457)
Q Consensus 256 ~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 334 (457)
+|||++.+..++.++|||||||+||||++ |..||....... ... ..+.... .... +......+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~~~-~~~~~~~------~~~~----~~~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----EFC-QRLKDGT------RMRA----PENATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----HHH-HHHhcCC------CCCC----CCCCCHHH
Confidence 99999998899999999999999999997 999997543211 011 1111110 0111 11223468
Q ss_pred HHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 335 LAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 335 ~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
.+|+.+||+.+|.+||++.+|++.|+.+..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=363.19 Aligned_cols=247 Identities=30% Similarity=0.409 Sum_probs=215.2
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..... .+.+.+|+++++.|+|||||.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999999999999999998765433 3568899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+.| +|..+|.. .+.++++.+..|+.+++.||.|||+.+ |+|||+||.|||++.+|.+||||||+|+.. .
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m--~ 151 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAM--S 151 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhc--c
Confidence 9976 99999986 678999999999999999999999999 999999999999999999999999999963 3
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
....+.+.+.|||.|||||++.+++|+..+|+||||||+|||++|++||.... +...+..+..+...
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d~v~------- 218 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKDPVK------- 218 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcCCCC-------
Confidence 45567778899999999999999999999999999999999999999996532 33333333333221
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+|......+..++...|+.||.+|.+..+++.
T Consensus 219 -----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 -----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -----CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 23345567889999999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=361.79 Aligned_cols=256 Identities=31% Similarity=0.467 Sum_probs=208.3
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.+++.||+|.||.||.|.++. ...||+|.+.... ...+.|.+|+.+|++|+|+|||+++++|..++.++||||||+.
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 4566779999999999999975 4589999997653 3457899999999999999999999999998899999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
|+|.++|.. .....+...+.+.++.|||+||+||++++ +|||||.+.||||+++..+||+|||||+.. .++...
T Consensus 286 GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~~Y~ 359 (468)
T KOG0197|consen 286 GSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLI-GDDEYT 359 (468)
T ss_pred CcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccccc-CCCcee
Confidence 999999986 45677899999999999999999999999 999999999999999999999999999942 222222
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLE 323 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 323 (457)
......-...|.|||.+..+.++.|||||||||+||||+| |+.|+......+ ++. .+..+. .+.-|.
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---v~~----~le~Gy---Rlp~P~-- 427 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---VLE----LLERGY---RLPRPE-- 427 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---HHH----HHhccC---cCCCCC--
Confidence 2222233567999999999999999999999999999998 777776544211 111 111111 222222
Q ss_pred CCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 324 GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 324 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.....+.+|+..||+.+|++|||++.+...|+.+...
T Consensus 428 -----~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 428 -----GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred -----CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 2334677899999999999999999999999887643
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=368.36 Aligned_cols=245 Identities=27% Similarity=0.444 Sum_probs=209.0
Q ss_pred HHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcCh---HHHHHHHHHHHhcC-CCCceeeEEEEecCCee
Q 012761 80 AATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLH-HSNLVNLIGYCADGDQR 155 (457)
Q Consensus 80 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~---~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~ 155 (457)
...++|.+.++||+|+||+|+++..+.+++.||||++++...-.. +..+.|.+++.... ||.++.++.+|++.+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 346799999999999999999999999999999999998765444 45677888888876 99999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
|+||||+.||++..+.+. ..+++..+..++..|+.||.|||+++ |||||||.+|||||.+|++||+|||+++
T Consensus 445 ~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 999999999996666553 67999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 236 LGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
-.. .....+.+++|||.|||||++.+..|+.++|+|||||+|||||.|..||.+.+.. ..+.
T Consensus 517 e~m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe----------------e~Fd 578 (694)
T KOG0694|consen 517 EGM--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE----------------EVFD 578 (694)
T ss_pred ccC--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHH
Confidence 532 1233566799999999999999999999999999999999999999999865431 1111
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCCh
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 352 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 352 (457)
.++.. .-.||.....+.+.|+.++|..+|++|.-+
T Consensus 579 sI~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 579 SIVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHhcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12111 113455556789999999999999999987
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=355.64 Aligned_cols=249 Identities=29% Similarity=0.410 Sum_probs=214.2
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC-hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
..|....+||+|.||.||+|.+..+++.||+|++....... .+++.+|+.+|..+.++||.++|+.|..+..+|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45677788999999999999999999999999999765544 46788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
|.||++.++|.. ...+++..+..|+.+++.||.|||.++ .+|||||+.||||..+|.+||+|||++......
T Consensus 93 ~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~- 164 (467)
T KOG0201|consen 93 CGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT- 164 (467)
T ss_pred hcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech-
Confidence 999999999975 344578888899999999999999999 999999999999999999999999998754332
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
.....+++||+.|||||++....|+.|+||||||++++||++|.+|+....|.....+ ++.-.-|.
T Consensus 165 -~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------------Ipk~~PP~ 230 (467)
T KOG0201|consen 165 -VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------------IPKSAPPR 230 (467)
T ss_pred -hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------------ccCCCCCc
Confidence 2333668999999999999988999999999999999999999999988777432211 22334456
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+.+.+. ..+.+++..||..+|+.||++.++++
T Consensus 231 L~~~~S----~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 231 LDGDFS----PPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccccC----HHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 666444 34788999999999999999999885
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=327.83 Aligned_cols=269 Identities=28% Similarity=0.404 Sum_probs=215.2
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.+|...++||+|.||.||+|++..||+.||||.+......+ .....+|+..|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46788889999999999999999999999999998654332 3568899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
||+ .+|+..+++ ....|+..++..++.++++||+|||.+. |+||||||.|+|++.+|.+||+|||+|+.....
T Consensus 82 fm~-tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 996 699999987 5678999999999999999999999999 999999999999999999999999999975443
Q ss_pred CCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhh------------
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL------------ 307 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~------------ 307 (457)
+ ...+..+-|.+|+|||.+.+. .|+...|+||.|||+.||+.|.+-|.+..+-+. +....+.+
T Consensus 155 ~--~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ--L~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 155 N--RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ--LSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred C--cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH--HHHHHHHcCCCCcccCcccc
Confidence 3 334444789999999999875 799999999999999999999988876554222 11111110
Q ss_pred -hhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 308 -FNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 308 -~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
+.+-.++.....+.+..-++ .....+++|+..++..||.+|+++.+++++ .++.+
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~-~yf~~ 286 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKH-PYFKS 286 (318)
T ss_pred ccccHHHHhcCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcc-hhhhc
Confidence 01111111122222222222 345567999999999999999999999875 34443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=352.31 Aligned_cols=269 Identities=24% Similarity=0.306 Sum_probs=207.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecC--CeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 157 (457)
.+.|+.+..||+|.||.||+|++..+|+.||+|++..+... ...-..+|+.+|++|.||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 34678888999999999999999999999999999876422 234567899999999999999999998876 68999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
|+|||+. +|.-++.. ..-.|++.++.-++.||+.||+|||..+ |+|||||.+|||||.+|.+||+|||||++.
T Consensus 196 VFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 9999974 78877765 3457899999999999999999999999 999999999999999999999999999975
Q ss_pred CCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhh-hhhhhcccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWA-RPLFNDRRKFS 315 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~-~~~~~~~~~~~ 315 (457)
..... ...+..+-|.+|+|||++.+. .|+.+.|+||.||||.||++|++.|.+.........+--. ..--.+.+...
T Consensus 269 ~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 44433 335666789999999999976 7999999999999999999999999876543221111000 00000001000
Q ss_pred cccCCc---cCCCCCh--H-----hHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 316 KLADPR---LEGRYPI--R-----GLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 316 ~~~d~~---l~~~~~~--~-----~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.+.... ....|.. . -....++|+..+|..||.+|.|+.+++..
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111100 0111110 1 12356789999999999999999999863
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=352.71 Aligned_cols=267 Identities=24% Similarity=0.328 Sum_probs=213.3
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHH--HHHHHHHHHhcC-CCCceeeEEEEecCC-eee
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE--FLVEVLMLSLLH-HSNLVNLIGYCADGD-QRL 156 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~--~~~E~~~l~~l~-hpniv~l~~~~~~~~-~~~ 156 (457)
..++|.+.+.||.|+||.||+|+...++..||||.+++.-. ..++ -++|+..|++|+ ||||++|.+++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 45789999999999999999999999999999999976432 2333 467999999999 999999999999988 999
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+|||||+ .+|.++++. ....+++..+..|+.||++||+|+|.+| +.||||||+|||+..+..+||+|||+|+.
T Consensus 87 fVfE~Md-~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhhh-hhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 9999996 799999987 3788999999999999999999999999 99999999999999999999999999984
Q ss_pred CCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccc----------hhhhh
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNL----------VTWAR 305 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l----------~~~~~ 305 (457)
. ......+..+.|.+|+|||++.. +-|+.+.|+|++|||++|+.+-++.|.+....+.... ..|..
T Consensus 160 v---~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 160 V---RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred c---ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 3 23345677889999999999875 5789999999999999999999999987654432111 11111
Q ss_pred h-hhh--cccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 306 P-LFN--DRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 306 ~-~~~--~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
. .+. -...++.+.-..+..-.+ ....++++++.+||+.||.+|||+.++++.-
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 0 000 001111111111211222 2566889999999999999999999998754
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=345.24 Aligned_cols=258 Identities=27% Similarity=0.349 Sum_probs=207.7
Q ss_pred HHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--------------ChHHHHHHHHHHHhcCCCCcee
Q 012761 79 AAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--------------GNREFLVEVLMLSLLHHSNLVN 144 (457)
Q Consensus 79 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--------------~~~~~~~E~~~l~~l~hpniv~ 144 (457)
....++|++.+.||+|.||.|-+|++..+++.||||++.+.... ..+...+|+.+|++|+|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 44568999999999999999999999999999999999753211 1246889999999999999999
Q ss_pred eEEEEecC--CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC
Q 012761 145 LIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE 222 (457)
Q Consensus 145 l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~ 222 (457)
|+.+..+. +.+|||+|||..|.+...-.+ ...|++.++++++.+++.||+|||.++ ||||||||+|+||++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d----~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPD----KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCC----cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence 99999774 679999999998887654332 233999999999999999999999999 999999999999999
Q ss_pred CCceEEeeccccccCCCCCC---ccccccccccccccchhhhhcCC----CCccchHHHHHHHHHHHHhCCCCCCCCCCC
Q 012761 223 GFHPKLSDFGLAKLGPVGDK---SHVSTRVMGTYGYCAPEYAMTGQ----LTVKSDVYSFGVVFLELITGRKAIDSTRPH 295 (457)
Q Consensus 223 ~~~~kL~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDvwSlGvil~elltG~~p~~~~~~~ 295 (457)
+|+|||+|||.+...+.+.. .......+|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||.....
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~- 324 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE- 324 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-
Confidence 99999999999976533321 11233478999999999988742 35789999999999999999999965432
Q ss_pred CcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 296 GEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 296 ~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
... +..+++..|.-...++....+.+||.++|++||+.|.++.+|....
T Consensus 325 -----~~l----------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 325 -----LEL----------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -----HHH----------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 111 2233333333222223456788999999999999999999997655
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=340.64 Aligned_cols=252 Identities=27% Similarity=0.403 Sum_probs=202.5
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.|+..+.||+|+||.||+|.+..+++.||||.+...... ....+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 477889999999999999999999999999998754322 22457789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999999888642 2346899999999999999999999999 999999999999999999999999999753222
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...... +...
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~~~~----------~~~~ 220 (285)
T cd05631 156 E---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEVDRR----------VKED 220 (285)
T ss_pred C---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HHHHHH----------hhcc
Confidence 1 123457899999999999999999999999999999999999999765432110 000000 0000
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCC-----hHHHHH
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVT 357 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ev~~ 357 (457)
...++......+.+|+.+||+.+|.+||+ +.++++
T Consensus 221 --~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 --QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01112223346789999999999999997 666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=335.36 Aligned_cols=254 Identities=26% Similarity=0.325 Sum_probs=209.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChH---HHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR---EFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~---~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.+.|++++.||.|.-|+||++++..++..+|+|++.+......+ ....|.+||+.++||.++.||+.|+.++..|||
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 45788899999999999999999999999999999987555443 456799999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
||||+||+|..+++.+ ....+++..+..++..|+-||+|||-.| ||+|||||+||||.++|++.|+||.|+..++
T Consensus 156 meyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 9999999999999874 5678999999999999999999999999 9999999999999999999999999975421
Q ss_pred C---------------------------------CCCc---------------------cccccccccccccchhhhhcC
Q 012761 239 V---------------------------------GDKS---------------------HVSTRVMGTYGYCAPEYAMTG 264 (457)
Q Consensus 239 ~---------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~~~ 264 (457)
. .... ..+..++||..|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 1 0000 011235799999999999999
Q ss_pred CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchh
Q 012761 265 QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQE 344 (457)
Q Consensus 265 ~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~ 344 (457)
..+.++|+|+|||+|||||.|.-||.+..... .+..++-..+.-.-.+.....+.+||++.|.+
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~----------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE----------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchh----------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhcc
Confidence 99999999999999999999999998754321 12222222222111123456889999999999
Q ss_pred hcCCCCC----hHHHH
Q 012761 345 QAATRPL----IGDVV 356 (457)
Q Consensus 345 dP~~RPt----~~ev~ 356 (457)
||++|.. +.||-
T Consensus 375 dP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIK 390 (459)
T ss_pred ChhhhhccccchHHhh
Confidence 9999998 55554
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=351.15 Aligned_cols=263 Identities=29% Similarity=0.427 Sum_probs=211.9
Q ss_pred HHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 79 AAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 79 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
....+.+.+...||+|.||+||+|++.. .||||++....... .+.|.+|+..+++-+|.||+-+.|+|-.... .
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 3344566778889999999999999974 59999998765443 3679999999999999999999999988877 9
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
||..+|.|-+|..+||. ....|+..+.+.||.||++||.|||.++ |||||||..||||.+++.|||+||||+..
T Consensus 464 IiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred eeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence 99999999999999997 3578999999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCccccccccccccccchhhhhc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccc
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMT---GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRK 313 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 313 (457)
..............|...|||||++.. .+|++.+||||||||+|||+||..||..... .+.|....+.++.
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--dqIifmVGrG~l~---- 611 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--DQIIFMVGRGYLM---- 611 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--hheEEEecccccC----
Confidence 444433333444568889999999974 3799999999999999999999999973322 1222211111111
Q ss_pred cccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 314 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 314 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
.|.... .......+.+|+..||.+++++||.+.+|+..|+.+..
T Consensus 612 ----pd~s~~---~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 612 ----PDLSKI---RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ----ccchhh---hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 111111 11234578889999999999999999999999988876
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=340.56 Aligned_cols=265 Identities=26% Similarity=0.401 Sum_probs=204.3
Q ss_pred cCCCccceeeecCcEEEEEEEECC----------------CCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceee
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLES----------------TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNL 145 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l 145 (457)
++|++.+.||+|+||.||+|.+.. ++..||+|++...... ....+.+|+.++..++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999998643 3457999998764322 23568899999999999999999
Q ss_pred EEEEecCCeeeEEEeccCCCCHHHhhhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 012761 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPP---------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210 (457)
Q Consensus 146 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiH 210 (457)
++++.+.+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 9999999999999999999999999864211 1235788999999999999999999999 999
Q ss_pred ccCCccCeEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh--CCCC
Q 012761 211 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT--GRKA 288 (457)
Q Consensus 211 rDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt--G~~p 288 (457)
|||||+|||++.++.+||+|||++................++..|+|||++..+.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999975433322222333456788999999998899999999999999999987 4566
Q ss_pred CCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 289 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 289 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
|..... ..+...+...+........... +......+.+|+.+||+.+|++||++.+|+..|+
T Consensus 242 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTD---EQVIENAGEFFRDQGRQVYLFR-------PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCH---HHHHHHHHHHhhhccccccccC-------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 654332 1222222222211110000011 1122346889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=347.56 Aligned_cols=253 Identities=25% Similarity=0.382 Sum_probs=206.2
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|.+.+.||+|+||.||+|++..+++.||||++..... .....+..|+.++..++||||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 478999999999999999999999999999999975422 23356788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999975 456899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCc-ccchhhhhhhhhccccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE-QNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~ 318 (457)
......||+.|+|||++.+..++.++|||||||++|||++|..||........ ..+..|... +.
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------~~ 218 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET----------LQ 218 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc----------cc
Confidence 23345799999999999988999999999999999999999999976543211 111111100 00
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.+... .........+.+++.+||+.+|.+||++.+++..
T Consensus 219 ~~~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPVYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 11110 0001224567899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=355.56 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=209.3
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC-C--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG-L--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~-~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.-|++.+-||.|+.|.|-+|++..||+.+|||++.+.. . .....+.+|+.||+.+.|||++.+|+++.+..++|||+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45788899999999999999999999999999997642 1 11245789999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|.|.++|-. +++|++.++.+++.||+.|+.|||..+ |+||||||+|+|||..+++||+|||+|.+-..
T Consensus 92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999976 688999999999999999999999999 99999999999999999999999999976322
Q ss_pred CCCccccccccccccccchhhhhcCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.....+.||.+-|.+||++.+.+| +.++||||+|||||.||||+.||+..+ +-........... ++
T Consensus 165 ---gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ir~LLlKV~~G~f---~M- 231 (786)
T KOG0588|consen 165 ---GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------IRVLLLKVQRGVF---EM- 231 (786)
T ss_pred ---CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------HHHHHHHHHcCcc---cC-
Confidence 234455799999999999999998 579999999999999999999998432 2221111111111 11
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
|.....++.+|+.+||..||.+|.|++||++.-
T Consensus 232 --------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 232 --------PSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred --------CCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 112234688999999999999999999998764
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=347.23 Aligned_cols=246 Identities=27% Similarity=0.368 Sum_probs=202.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++..... .....+..|+.++..++||||+++++++.+.+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 3579999999999999999999999999999999975322 2335688999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 97 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999999975 456889999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||....+. .....+.....
T Consensus 170 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~------ 232 (329)
T PTZ00263 170 DR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEKILAGRL------ 232 (329)
T ss_pred CC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHHHhcCCc------
Confidence 21 22357999999999999989999999999999999999999999654321 11111111110
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCC-----hHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVT 357 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ev~~ 357 (457)
.+ +......+.+|+..||+.||.+||+ +.+++.
T Consensus 233 --~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 --KF----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred --CC----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 01 1112235779999999999999997 466553
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=337.03 Aligned_cols=246 Identities=21% Similarity=0.352 Sum_probs=198.8
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCceeeEEEEec----CCeeeEEEec
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCAD----GDQRLLVYEF 161 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lV~E~ 161 (457)
..||+|++|.||+|.+ +|+.||||.+....... .+.+.+|+.+|.+++||||+++++++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999998 48899999997654333 3567799999999999999999999876 3568999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
+++|+|.+++.. ...+++...+.++.+++.||.|||+. + ++||||||+|||+++++.+||+|||++......
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999999975 35689999999999999999999985 6 889999999999999999999999998753221
Q ss_pred CCccccccccccccccchhhhhc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMT--GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .+. ........
T Consensus 177 -----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~---~~i~~~~~------ 239 (283)
T PHA02988 177 -----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIY---DLIINKNN------ 239 (283)
T ss_pred -----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHHhcCC------
Confidence 123468899999999976 68999999999999999999999999764321 111 11111111
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
.+. .+......+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 240 ~~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 240 SLK----LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCC----CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 011 111223468899999999999999999999999988753
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=341.70 Aligned_cols=245 Identities=24% Similarity=0.301 Sum_probs=201.9
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 478899999999999999999999999999999975322 23356788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999975 456899999999999999999999999 99999999999999999999999999875321
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+.....
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~------- 215 (291)
T cd05612 154 -----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKILAGKL------- 215 (291)
T ss_pred -----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCc-------
Confidence 122357899999999999888999999999999999999999999754321 11111111110
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCC-----hHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVT 357 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ev~~ 357 (457)
. ++......+.+++.+||+.||.+||+ +.+++.
T Consensus 216 -~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 216 -E----FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred -C----CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 1 11112346789999999999999995 666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=347.08 Aligned_cols=242 Identities=25% Similarity=0.340 Sum_probs=197.8
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 165 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~g 165 (457)
+.||+|+||.||++++..+|+.||||++..... .....+..|+.++..++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975422 12245778999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccc
Q 012761 166 SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV 245 (457)
Q Consensus 166 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 245 (457)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GAT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCc
Confidence 99999875 457899999999999999999999999 999999999999999999999999998742111 122
Q ss_pred cccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCC
Q 012761 246 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGR 325 (457)
Q Consensus 246 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 325 (457)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+... +..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~---~~~~~--------~~~---- 213 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE---LILME--------EIR---- 213 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHH---HHHcC--------CCC----
Confidence 33457999999999999889999999999999999999999999653321 1111 11111 111
Q ss_pred CChHhHHHHHHHHHHcchhhcCCCC-----ChHHHHH
Q 012761 326 YPIRGLYQALAVASMCIQEQAATRP-----LIGDVVT 357 (457)
Q Consensus 326 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~ 357 (457)
++......+.+++.+||+.||++|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1122334688999999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=351.57 Aligned_cols=261 Identities=26% Similarity=0.400 Sum_probs=203.9
Q ss_pred hcCCCccceeeecCcEEEEEEEE-----CCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCceeeEEEEecCCe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWL-----ESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 154 (457)
.++|++.+.||+|+||.||+|++ ..++..||||++..... ...+.+.+|+.++..+ +||||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 35789999999999999999974 34567899999975432 2335688899999999 89999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCC----------------------------------------------------------
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPP---------------------------------------------------------- 176 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 176 (457)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864211
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCc
Q 012761 177 -------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS 243 (457)
Q Consensus 177 -------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 243 (457)
....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1235889999999999999999999999 999999999999999999999999999753322211
Q ss_pred cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCcc
Q 012761 244 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
.......++..|+|||++.+..++.++|||||||++|||++ |..||...... ..+..+. ..... ...+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~----~~~~~---~~~~-- 339 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMI----KEGYR---MLSP-- 339 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHH----HhCcc---CCCC--
Confidence 11222345677999999999999999999999999999998 88888654321 1111111 11100 0001
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHh
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 361 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 361 (457)
.....++.+|+..||+.+|++||++.+|++.|++
T Consensus 340 -----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 340 -----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1112468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=352.34 Aligned_cols=263 Identities=25% Similarity=0.393 Sum_probs=204.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCC-----CeEEEEEEeccCCCc-ChHHHHHHHHHHHhc-CCCCceeeEEEEecCCe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLEST-----GQVVAVKQLDRNGLQ-GNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 154 (457)
.++|.+.+.||+|+||.||+|++..+ +..||||++...... ....+..|+.+++.+ +|+||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 45799999999999999999986443 357999999754322 234678899999999 89999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCC-----------------------------------------------------------
Q 012761 155 RLLVYEFMPLGSLEDHLHDLP----------------------------------------------------------- 175 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 175 (457)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885421
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcccccc
Q 012761 176 -------PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 248 (457)
Q Consensus 176 -------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 248 (457)
....++++..+++++.||+.||.|||+.+ |+||||||+|||+++++.++|+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 01235888999999999999999999999 99999999999999999999999999875322221112222
Q ss_pred ccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCC
Q 012761 249 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYP 327 (457)
Q Consensus 249 ~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 327 (457)
..++..|+|||++.+..++.++|||||||++|||++ |+.||....... .+. ...... ..+.. +
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~----~~~~~~------~~~~~----~ 337 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFY----KMVKRG------YQMSR----P 337 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHH----HHHHcc------cCccC----C
Confidence 345678999999998899999999999999999997 999997543211 011 011110 00101 1
Q ss_pred hHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 328 IRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 328 ~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
......+.+++.+||+.+|.+||++.+|++.|+++.
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 111246889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=344.41 Aligned_cols=200 Identities=27% Similarity=0.366 Sum_probs=177.3
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.++|++.+.||+|+||.||++++..++..||+|++..... .....+.+|+.++..++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4689999999999999999999999999999999976422 223568899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999999975 34689999999999999999999985 5 99999999999999999999999999874322
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 292 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~ 292 (457)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred c----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 223356899999999999889999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=342.30 Aligned_cols=242 Identities=26% Similarity=0.306 Sum_probs=196.1
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCH
Q 012761 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 167 (457)
Q Consensus 91 lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 167 (457)
||+|+||.||+|++..++..||+|++.... ......+..|+.++..++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999999999999999997532 22235678899999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccc
Q 012761 168 EDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 247 (457)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 247 (457)
.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+++..... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccc
Confidence 999975 456899999999999999999999999 999999999999999999999999998753221 22234
Q ss_pred cccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCC
Q 012761 248 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYP 327 (457)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 327 (457)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............. ++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~~~~~------------~~ 213 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQEPLR------------FP 213 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCCC------------CC
Confidence 46799999999999998999999999999999999999999965321 1222222211111 11
Q ss_pred hHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 328 IRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 328 ~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
......+.+++.+||+.+|.+||++..+.+.|
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 12234678999999999999998754443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=339.84 Aligned_cols=249 Identities=21% Similarity=0.379 Sum_probs=212.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChH---HHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR---EFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~---~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
..+|.+.+.||+|.||+|-+|+....|+.||||.|+++...+.. .+.+|++||+.|+||||+.+|.+|.+.+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45788899999999999999999889999999999987766654 467899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||..+|.|.+++.. ...|++.++..++.||+.|+.|||.++ |+|||||.+|||||+++++||+|||++....
T Consensus 132 MEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999976 678999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCccccccccccccccchhhhhcCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
. ....+++||++-|.+||++.+.+| ++.+|.|||||+||.|+.|..||++.+. .+++. ++-.. ..
T Consensus 205 ~---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvr---QIs~G-----aY 270 (668)
T KOG0611|consen 205 D---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVR---QISRG-----AY 270 (668)
T ss_pred c---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHH---Hhhcc-----cc
Confidence 2 345667899999999999999888 5789999999999999999999987642 22222 11110 11
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
..|. ....+.-||++||..+|++|-|+.+|....
T Consensus 271 rEP~--------~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 271 REPE--------TPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred cCCC--------CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1111 122456799999999999999999998654
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=336.27 Aligned_cols=267 Identities=22% Similarity=0.283 Sum_probs=203.7
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
++|.+.+.||+|+||.||+|+++.+++.||||++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 478999999999999999999999999999999975422 223567889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|++++.+..+... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9998777655432 356899999999999999999999999 999999999999999999999999999754322
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc-cchhhhhhh-------hhccc
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-NLVTWARPL-------FNDRR 312 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~-~l~~~~~~~-------~~~~~ 312 (457)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||......... .+.....++ +....
T Consensus 154 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 S-NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred c-cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 2 11223456899999999999888999999999999999999999999764321110 000000000 00000
Q ss_pred ccccccCCccCC------CCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 313 KFSKLADPRLEG------RYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 313 ~~~~~~d~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+.....+.... .+.......+.+|+.+||+.||++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 011111111110 011112346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=336.18 Aligned_cols=266 Identities=22% Similarity=0.323 Sum_probs=202.5
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
++|.+.+.||.|+||.||+|++..++..||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 579999999999999999999999999999999975432 2335678899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
++ ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 97 589988865 2345789999999999999999999999 9999999999999999999999999987532221
Q ss_pred Cccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccch-hhh-------hhhhhccc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV-TWA-------RPLFNDRR 312 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~-~~~-------~~~~~~~~ 312 (457)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|++||............ ... ++.+....
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred --ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 12233568999999999875 46899999999999999999999999764432111000 000 00000001
Q ss_pred ccccccCCccCCCC----ChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 313 KFSKLADPRLEGRY----PIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 313 ~~~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+.....+...... .......+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11111111110000 0112346789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=334.17 Aligned_cols=259 Identities=31% Similarity=0.485 Sum_probs=208.0
Q ss_pred cCCCccceeeecCcEEEEEEEECCCC-----eEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTG-----QVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
++|++.+.||+|+||.||+|.+...+ ..||+|.+...... ....+.+|+.++..++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 47889999999999999999876554 68999998754322 2356889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC
Q 012761 157 LVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF 224 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~ 224 (457)
++|||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ |+|+||||+|||+++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999975321 1156889999999999999999999999 99999999999999999
Q ss_pred ceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhh
Q 012761 225 HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTW 303 (457)
Q Consensus 225 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~ 303 (457)
.++|+|||++......+.........+++.|+|||++.+..++.++|||||||++|||++ |..||...... .+...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999875433322223334457888999999988899999999999999999998 99999764431 11111
Q ss_pred hhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHh
Q 012761 304 ARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 361 (457)
Q Consensus 304 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 361 (457)
+. ... ....+......+.+|+.+||+.+|.+||++.+|++.|..
T Consensus 239 i~----~~~----------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 IR----SRQ----------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HH----cCC----------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 000 001122234578899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=360.02 Aligned_cols=254 Identities=20% Similarity=0.238 Sum_probs=206.6
Q ss_pred CCCccceeeecCcEEEEEEEECCC-CeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 84 NFRPESFIGEGGFGRVYKGWLEST-GQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
.|.+.+.||+|+||.||+|....+ +..||+|.+..........+..|+.+++.++||||+++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 488999999999999999998877 7889999876554444456788999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++|+|.++|........++++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988654334567899999999999999999999999 99999999999999999999999999986433222
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCcc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... .++
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~~------~~~-- 290 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYGK------YDP-- 290 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC------CCC--
Confidence 2233456799999999999988999999999999999999999999965322 11111111100 011
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
++......+.+++..||+.+|++||++.+++.
T Consensus 291 ---~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 ---FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11122346889999999999999999999864
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=325.70 Aligned_cols=268 Identities=24% Similarity=0.327 Sum_probs=210.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-C-hHHHHHHHHHHHhcCCCCceeeEEEEecC--CeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-G-NREFLVEVLMLSLLHHSNLVNLIGYCADG--DQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 157 (457)
.++|..++.|++|+||.||+|+++.|+..||+|+++..... + --.-++|+.+|.+++|||||.+-.+.... +..||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 45788899999999999999999999999999999864311 1 12467899999999999999999987654 57999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
|||||+ -+|..++... .+++...++..++.|+++||+|||... |+|||||++|+|++..|.+||+|||+|+..
T Consensus 155 VMe~~E-hDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVE-HDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHH-hhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 999996 5899999874 367889999999999999999999999 999999999999999999999999999863
Q ss_pred CCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccch-hh-------hhhhh
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV-TW-------ARPLF 308 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~-~~-------~~~~~ 308 (457)
+......+..+-|.+|+|||.+.+. .|+.+.|+||+|||+.||+++++-|.+....+..+.+ .. +++-+
T Consensus 228 --gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 228 --GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred --cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 3444556778889999999999875 6999999999999999999999999876543321111 00 01100
Q ss_pred hc-----ccccccccCCccCCCCChH-hHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 309 ND-----RRKFSKLADPRLEGRYPIR-GLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 309 ~~-----~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.. ...+.......+++.+... ....-++|+..+|..||.+|.|+.+.++.
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00 0111112222233444332 34567889999999999999999998763
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=334.96 Aligned_cols=265 Identities=22% Similarity=0.327 Sum_probs=200.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.++|.+.+.||+|+||.||+|++..++..||||++...... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46899999999999999999999989999999999754322 23457789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+. ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 688887764 2356889999999999999999999999 999999999999999999999999998743221
Q ss_pred CCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc--cccc--
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR--RKFS-- 315 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~~-- 315 (457)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ............. ..+.
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 157 --SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred --CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccch
Confidence 122234568999999999875 458899999999999999999999997643211 0000000000000 0000
Q ss_pred ---cccCCc---------cCCCCC-hHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 316 ---KLADPR---------LEGRYP-IRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 316 ---~~~d~~---------l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...++. +...+. ......+.+++..||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 000000 001245778999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=338.65 Aligned_cols=261 Identities=27% Similarity=0.467 Sum_probs=206.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCe----EEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQ----VVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
..+|++.+.||+|+||.||+|++..++. .||||++..... .....+..|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 3579999999999999999999866555 489999875422 2346788999999999999999999999764 577
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence 99999999999999975 2346889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
..............++..|+|||++.+..++.++|||||||++|||++ |..||....... +. ..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~-- 229 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKGER-- 229 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHhCCCC--
Confidence 433322222222334678999999999999999999999999999998 999987543211 11 11111110
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
... +......+..++..||+.+|.+||++.+++..|..+....
T Consensus 230 -~~~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 230 -LPQ-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred -CCC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 011 1112346788999999999999999999999998886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=340.72 Aligned_cols=243 Identities=24% Similarity=0.334 Sum_probs=198.2
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 165 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~g 165 (457)
+.||+|+||.||++++..++..||||++..... .....+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975422 22356788999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccc
Q 012761 166 SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV 245 (457)
Q Consensus 166 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 245 (457)
+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AAT 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccc
Confidence 99998865 456899999999999999999999999 999999999999999999999999998742211 112
Q ss_pred cccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCC
Q 012761 246 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGR 325 (457)
Q Consensus 246 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 325 (457)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+... +..+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~~--------~~~~--- 214 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILME--------DIKF--- 214 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhccC--------CccC---
Confidence 23457999999999999889999999999999999999999999654321 111111111 1111
Q ss_pred CChHhHHHHHHHHHHcchhhcCCCC-----ChHHHHHH
Q 012761 326 YPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 358 (457)
Q Consensus 326 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~~ 358 (457)
+......+.+++.+||+.+|++|| ++.++++.
T Consensus 215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 -PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 112234678999999999999997 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=360.76 Aligned_cols=263 Identities=24% Similarity=0.277 Sum_probs=214.3
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCceeeEEE-Eec------C
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGY-CAD------G 152 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~-~~~------~ 152 (457)
...++++.+.|.+|||+.||+|.+...|..||+|++-.......+.+.+|+.+|++|. |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 3567889999999999999999999877999999998776666678899999999998 9999999993 321 1
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecc
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 232 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFG 232 (457)
-+++|+||||.||.|-++|.... ...|++.++++|+.++++|+.+||... +||||||||-+||||..+++.||||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 35789999999999999998633 344999999999999999999999985 779999999999999999999999999
Q ss_pred ccccCCCCCCcc--c-----cccccccccccchhhhh---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchh
Q 012761 233 LAKLGPVGDKSH--V-----STRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVT 302 (457)
Q Consensus 233 la~~~~~~~~~~--~-----~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~ 302 (457)
.|.-.-..-... . .-...-|+.|+|||++. +...+.|+|||+|||+||-|+....||+.....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------- 264 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------- 264 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------
Confidence 986321111010 0 01124589999999986 557899999999999999999999999765321
Q ss_pred hhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 303 WARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 303 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
.+++....-...+.....+.+||..||+.+|.+||++-+|+..+.+++...
T Consensus 265 -------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 -------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 233333222222356788999999999999999999999999999998755
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=329.42 Aligned_cols=257 Identities=24% Similarity=0.373 Sum_probs=204.0
Q ss_pred hcCCCccceeeecCcEEEEEEEEC---CCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLE---STGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
.++|++.+.||+|+||.||+|.++ ..+..||+|.+...... ....+..|+.++..++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 357889999999999999999875 34678999999765322 23568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.++|+|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999999975 2357899999999999999999999999 999999999999999999999999987642
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.... ........++..|+|||++.+..++.++|||||||++|||++ |..||...... .+... +.+..
T Consensus 158 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~----~~~~~---- 225 (266)
T cd05064 158 KSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKA----VEDGF---- 225 (266)
T ss_pred cccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHH----HHCCC----
Confidence 2111 111112345678999999999999999999999999999875 99999754321 11111 11110
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
.... +......+.+++..||+.+|.+||++.+|++.|..+
T Consensus 226 --~~~~----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 --RLPA----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCC----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0011 111234678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=341.92 Aligned_cols=242 Identities=26% Similarity=0.337 Sum_probs=196.7
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 165 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~g 165 (457)
+.||+|+||.||++++..+|..||+|++..... .....+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975422 22345678999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccc
Q 012761 166 SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV 245 (457)
Q Consensus 166 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 245 (457)
+|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~ 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GAT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCc
Confidence 99998865 457899999999999999999999999 999999999999999999999999998742111 112
Q ss_pred cccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCC
Q 012761 246 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGR 325 (457)
Q Consensus 246 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 325 (457)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... + ........ ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~---~~~~~~~~--------~~---- 213 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L---FELILMEE--------IR---- 213 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHHHhcCC--------CC----
Confidence 234579999999999998899999999999999999999999996543211 1 11111110 01
Q ss_pred CChHhHHHHHHHHHHcchhhcCCCC-----ChHHHHH
Q 012761 326 YPIRGLYQALAVASMCIQEQAATRP-----LIGDVVT 357 (457)
Q Consensus 326 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~ 357 (457)
++......+.+++..||+.+|.+|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1112234678999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=332.40 Aligned_cols=264 Identities=27% Similarity=0.402 Sum_probs=210.0
Q ss_pred hcCCCccceeeecCcEEEEEEEEC-----CCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLE-----STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
.++|.+.+.||+|+||.||++.+. .++..+|+|.+..........+..|+.++..++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357889999999999999999852 345679999987654444567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceE
Q 012761 157 LVYEFMPLGSLEDHLHDLPP---------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPK 227 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~k 227 (457)
+||||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 99999999999999975321 2235899999999999999999999999 99999999999999999999
Q ss_pred EeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhh
Q 012761 228 LSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARP 306 (457)
Q Consensus 228 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~ 306 (457)
|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||....... +.. .
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~---~ 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE---C 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---H
Confidence 999999875332222122223446778999999998889999999999999999998 899986543211 111 1
Q ss_pred hhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 307 LFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 307 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
+.. .. .+.+... ....+.+|+.+||+.+|.+||++.+|+..|+.+...
T Consensus 235 i~~-~~------~~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQ-GR------VLQRPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHc-CC------cCCCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 111 00 0011111 224688999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=316.16 Aligned_cols=267 Identities=25% Similarity=0.328 Sum_probs=216.8
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecC-----Cee
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADG-----DQR 155 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 155 (457)
..++|++.+.||+|||+.||+++...++..||+|++.....++.+..++|++..++++|||+++++++...+ ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 457899999999999999999999999999999999877777778899999999999999999999886543 348
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
||+++|...|+|.+.+......+..+++.+.+.|+.+|++||++||+.. +|+.||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999887777788999999999999999999999986 579999999999999999999999999987
Q ss_pred cCCCCCCccc-------cccccccccccchhhhhc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhh
Q 012761 236 LGPVGDKSHV-------STRVMGTYGYCAPEYAMT---GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWAR 305 (457)
Q Consensus 236 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~ 305 (457)
..+....... -..-..|..|+|||.+.- ...+.++|||||||+||+|+.|.-||+..-..+. ++.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-Sla---- 252 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-SLA---- 252 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-eEE----
Confidence 5433221111 011246889999999863 4678999999999999999999999975332111 110
Q ss_pred hhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 306 PLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
-.+.++.+.-.-.......+.+++..||+.||.+||++.+++..++.+
T Consensus 253 ---------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 ---------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ---------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 112222221111112456788999999999999999999999998766
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=317.49 Aligned_cols=250 Identities=26% Similarity=0.346 Sum_probs=211.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|.||.||+|+.+.++-.||+|++.+... ....++.+|+++-+.|+||||+++|++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 4689999999999999999999999999999999976533 2346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
+||.+.|+|...|... ....+++.....++.|+|.||.|+|..+ ||||||||+|+|++..+.+||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999852 3456888889999999999999999999 9999999999999999999999999987533
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
......+|||..|.+||...+..++..+|+|++||+.||++.|.+||....... -.+.+.. .++.
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e------tYkrI~k-----~~~~ 240 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE------TYKRIRK-----VDLK 240 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH------HHHHHHH-----cccc
Confidence 334567899999999999999999999999999999999999999997654211 0011101 1222
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
+| ......+.++|..|+..+|.+|....|++..
T Consensus 241 ~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 241 FP-------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred CC-------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 22 2234578899999999999999999999763
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=346.80 Aligned_cols=253 Identities=24% Similarity=0.318 Sum_probs=200.7
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|++.+.||+|+||.||+|++..+++.||||++..... .....+..|+.++..++||||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 479999999999999999999999999999999975321 22345778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999975 356899999999999999999999999 99999999999999999999999999864321
Q ss_pred CCCc------------------------------------cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHH
Q 012761 240 GDKS------------------------------------HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELI 283 (457)
Q Consensus 240 ~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ell 283 (457)
.... ......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 0111246999999999999989999999999999999999
Q ss_pred hCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCC---hHHHHH
Q 012761 284 TGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL---IGDVVT 357 (457)
Q Consensus 284 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ev~~ 357 (457)
+|..||....+.. ....+..... .+..+.. ......+.+++.+|+. +|.+|++ +.+++.
T Consensus 234 ~G~~Pf~~~~~~~------~~~~i~~~~~---~~~~~~~-----~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQE------TYRKIINWKE---TLQFPDE-----VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHHH------HHHHHHcCCC---ccCCCCC-----CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999997644311 0111111000 0000100 0113457788888996 8999998 887765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=330.44 Aligned_cols=259 Identities=26% Similarity=0.422 Sum_probs=206.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECC-----CCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLES-----TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 155 (457)
..+|.+.+.||+|+||.||+|.+.. ++..||||.+...... ....+.+|+.++..+.||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568888999999999999998753 3578999998765433 346789999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc
Q 012761 156 LLVYEFMPLGSLEDHLHDLP----------PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH 225 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~ 225 (457)
++||||+++++|.+++.... .....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997532 22356889999999999999999999999 999999999999999999
Q ss_pred eEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhh
Q 012761 226 PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWA 304 (457)
Q Consensus 226 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~ 304 (457)
++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||...... .+....
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH
Confidence 99999999874322221112223446788999999999999999999999999999998 99998654321 111111
Q ss_pred hhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 305 RPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 305 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
. . . . . +. .+......+.+++.+||+.+|.+||++.||++.|+
T Consensus 238 ~---~-~-~----~-~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T---Q-G-R----L-LQ----RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H---c-C-C----c-CC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 0 0 0 0 00 11122346889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=341.26 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=201.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCC-eEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTG-QVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
.++|.+.+.||+|+||.||+|.+..++ ..||+|++..... .....+..|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 457999999999999999999876654 6899999865321 223567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999975 456899999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..||....+. .....+.....
T Consensus 182 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i~~~~~----- 245 (340)
T PTZ00426 182 DT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKILEGII----- 245 (340)
T ss_pred CC-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHHhcCCC-----
Confidence 21 123457999999999999888999999999999999999999999754321 00111111100
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCC-----ChHHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 358 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~~ 358 (457)
.++......+.+++..||+.+|++|+ ++.++++.
T Consensus 246 -------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01111224578899999999999996 77777653
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=339.72 Aligned_cols=249 Identities=26% Similarity=0.357 Sum_probs=194.8
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.+|...+.||+|+||.||+|++..+++.||||++...... ....+.+|+.+++.++|+||+++++++.+.+.+++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 4677788999999999999999989999999998654322 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~- 221 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT- 221 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc-
Confidence 9999986532 3456788899999999999999999 999999999999999999999999998753221
Q ss_pred Cccccccccccccccchhhhhc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMT-----GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
........||..|+|||++.. ...+.++|||||||++|||++|+.||...... .|.........
T Consensus 222 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~------~~~~~~~~~~~---- 290 (353)
T PLN00034 222 -MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------DWASLMCAICM---- 290 (353)
T ss_pred -cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc------cHHHHHHHHhc----
Confidence 112234579999999998743 23456899999999999999999999743221 11111100000
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
...+.. +......+.+|+.+||+.+|++||++.||++.
T Consensus 291 ~~~~~~----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 SQPPEA----PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred cCCCCC----CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000111 11223468899999999999999999999873
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=325.10 Aligned_cols=262 Identities=23% Similarity=0.328 Sum_probs=210.8
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|.+.+.||+|+||.||+|++..++..||||.+..... .....+..|+.+++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 579999999999999999999998999999998864322 22245788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988654444566899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
.. .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ...+...+. ....
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~~-------~~~~ 225 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKIE-------QCDY 225 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHHh-------cCCC
Confidence 11 1122346888999999998888999999999999999999999998643221 111111110 0111
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
+.+ ........+.+++.+||+.+|.+||++.+|++.|..+.
T Consensus 226 ~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 PPL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111 01122356889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=338.83 Aligned_cols=266 Identities=23% Similarity=0.365 Sum_probs=198.1
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecC-----Ceee
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG-----DQRL 156 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~ 156 (457)
+|.+.+.||+|+||.||+|++..++..||||++.... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4888999999999999999999999999999987432 22335688999999999999999999988543 2479
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 789988865 456899999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCC-ccccccccccccccchhhhhc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccch-h--------hh
Q 012761 237 GPVGDK-SHVSTRVMGTYGYCAPEYAMT--GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV-T--------WA 304 (457)
Q Consensus 237 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~-~--------~~ 304 (457)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||..........+. . +.
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 322211 112234579999999999875 67899999999999999999999999654321110000 0 00
Q ss_pred hhhhhcc--cccccccC---CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 305 RPLFNDR--RKFSKLAD---PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 305 ~~~~~~~--~~~~~~~d---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
..+.... ..+..+.. ..+...++ .....+.+++.+||+.+|++||++.|++..
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000 00000000 00000000 112357899999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=328.43 Aligned_cols=272 Identities=22% Similarity=0.306 Sum_probs=212.8
Q ss_pred HHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEec--cCCCcChHHHHHHHHHHHhcCCCCceeeEEEEec----
Q 012761 78 LAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLD--RNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD---- 151 (457)
Q Consensus 78 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~--~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---- 151 (457)
.......|...+.||+|.||.|+.+.++.+|..||||.+. .......+...+|+.+|+.++|+||+.+.+.+..
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 3445667777899999999999999999999999999997 3344445678899999999999999999999865
Q ss_pred -CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEee
Q 012761 152 -GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSD 230 (457)
Q Consensus 152 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~D 230 (457)
-+..|+|+|+| ..+|...++. +..|+...+..++.||++||.|+|+.+ |+||||||+|+|++.+..+||||
T Consensus 97 ~f~DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecc
Confidence 35689999999 5789999876 455999999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhh
Q 012761 231 FGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN 309 (457)
Q Consensus 231 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 309 (457)
||+|+...........+..+.|.+|.|||++.. ..|+.+.||||.|||+.||++|++-|.+.+......++........
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 999997543333344567788999999999875 4799999999999999999999999987765443333221111100
Q ss_pred c--------ccc------cccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 310 D--------RRK------FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 310 ~--------~~~------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
+ ... +.......+...++ .....+++|+.+||..||.+|+|++|++..
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 000 00000000111111 334578899999999999999999999763
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=345.53 Aligned_cols=254 Identities=26% Similarity=0.301 Sum_probs=205.0
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|.+.+.||+|+||.||+|++..+++.||||++..... .....+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 478999999999999999999999999999999975422 23456888999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999976 367899999999999999999999999 99999999999999999999999999875332
Q ss_pred CC---------------------------CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 012761 240 GD---------------------------KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 292 (457)
Q Consensus 240 ~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~ 292 (457)
.. .........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 001223456999999999999999999999999999999999999999765
Q ss_pred CCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCC-hHHHHHH
Q 012761 293 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-IGDVVTA 358 (457)
Q Consensus 293 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~ev~~~ 358 (457)
.... ....+..... .+.-|... .....+.+++.+||+ +|.+||+ +.+++..
T Consensus 234 ~~~~------~~~~i~~~~~---~~~~p~~~-----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQE------TYNKIINWKE---SLRFPPDP-----PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHH------HHHHHhccCC---cccCCCCC-----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 4211 1111111000 00011100 023467889999997 9999999 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=331.77 Aligned_cols=262 Identities=27% Similarity=0.436 Sum_probs=210.0
Q ss_pred cCCCccceeeecCcEEEEEEEECC-----CCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLES-----TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
.+|.+.+.||+|+||.||+|++.. ++..+++|.+..........+.+|+.+++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 468888999999999999998542 456799999876554445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc
Q 012761 158 VYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH 225 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~ 225 (457)
||||+++++|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999975321 2345899999999999999999999999 999999999999999999
Q ss_pred eEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhh
Q 012761 226 PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWA 304 (457)
Q Consensus 226 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~ 304 (457)
++|+|||++................++..|+|||++.+..++.++|||||||++|||+| |..||....... +...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIEC- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-
Confidence 99999999875333222222233456788999999998899999999999999999999 999986543211 1111
Q ss_pred hhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 305 RPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 305 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
+.... . +.. +......+.+++.+||+.+|++||++.+|+++|+.+..
T Consensus 238 ---~~~~~-~-----~~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ---ITQGR-V-----LER----PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ---HhCCC-C-----CCC----CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 01000 0 001 11123468899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=343.12 Aligned_cols=204 Identities=27% Similarity=0.360 Sum_probs=177.9
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|++.+.||+|+||.||+|++..+++.||||++..... .....+..|+.++..++||||+++++++.+...++|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 478999999999999999999999999999999975322 22345778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999975 457899999999999999999999999 99999999999999999999999999874321
Q ss_pred CCCc---------------------------------cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCC
Q 012761 240 GDKS---------------------------------HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286 (457)
Q Consensus 240 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~ 286 (457)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0112357999999999999989999999999999999999999
Q ss_pred CCCCCCC
Q 012761 287 KAIDSTR 293 (457)
Q Consensus 287 ~p~~~~~ 293 (457)
.||....
T Consensus 234 ~Pf~~~~ 240 (363)
T cd05628 234 PPFCSET 240 (363)
T ss_pred CCCCCCC
Confidence 9997644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=357.78 Aligned_cols=259 Identities=23% Similarity=0.282 Sum_probs=208.4
Q ss_pred HHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCC----
Q 012761 80 AATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGD---- 153 (457)
Q Consensus 80 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---- 153 (457)
...++|.+.+.||+|+||.||+|++..+++.||||++...... ....+..|+.++..++|+||++++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457999999999999999999999999999999999765332 2345778999999999999999988775432
Q ss_pred ----eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEe
Q 012761 154 ----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLS 229 (457)
Q Consensus 154 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~ 229 (457)
.+++||||+++|+|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 368999999999999999765445567999999999999999999999999 9999999999999999999999
Q ss_pred eccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhh
Q 012761 230 DFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN 309 (457)
Q Consensus 230 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 309 (457)
|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .........
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~~~ 259 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKTLA 259 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc
Confidence 99999754332222233456799999999999998999999999999999999999999965321 111111111
Q ss_pred cccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 310 DRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 310 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
. ..++ .+......+.+++..||+.+|.+||++.+++..
T Consensus 260 ~------~~~~-----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 G------RYDP-----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred C------CCCC-----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 0111 111223468899999999999999999999763
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=337.45 Aligned_cols=244 Identities=24% Similarity=0.347 Sum_probs=195.1
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.||+|+||.||+|++..++..||||++..... .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 469999999999999999999999999976422 2234577899999888 699999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~ 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CC
Confidence 999998865 457999999999999999999999999 999999999999999999999999998642111 12
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCC--cccchhhhhhhhhcccccccccCCcc
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHG--EQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||+...... ......+....+.... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-------~~- 223 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-------IR- 223 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-------CC-
Confidence 2334679999999999999899999999999999999999999997533221 1122222222111110 01
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCCCh
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRPLI 352 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 352 (457)
.+......+.+++.+||+.+|.+||++
T Consensus 224 ---~p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 224 ---IPRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred ---CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 111223467899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=345.30 Aligned_cols=253 Identities=24% Similarity=0.306 Sum_probs=198.8
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.|...+.||+|+||.||+|++..++..||||++...... ....+..|+.++..++||||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 688899999999999999999999999999999754322 23467889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999975 356899999999999999999999999 999999999999999999999999997532100
Q ss_pred CC---------------------------------------------ccccccccccccccchhhhhcCCCCccchHHHH
Q 012761 241 DK---------------------------------------------SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSF 275 (457)
Q Consensus 241 ~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSl 275 (457)
.. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 001123579999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCc-ccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHH--cchhhcCCCCCh
Q 012761 276 GVVFLELITGRKAIDSTRPHGE-QNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASM--CIQEQAATRPLI 352 (457)
Q Consensus 276 Gvil~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~ 352 (457)
||++|||++|..||....+... ..+..|.. . +.-+. .. ....++.+++.+ |+..+|..||++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~-------~---~~~~~-~~----~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWEN-------T---LHIPP-QV----KLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHcccc-------c---cCCCC-CC----CCCHHHHHHHHHHccCcccccCCCCH
Confidence 9999999999999976443211 00111100 0 00000 00 122356677776 556667779999
Q ss_pred HHHHHH
Q 012761 353 GDVVTA 358 (457)
Q Consensus 353 ~ev~~~ 358 (457)
.+++..
T Consensus 300 ~~~l~h 305 (381)
T cd05626 300 DDIKAH 305 (381)
T ss_pred HHHhcC
Confidence 999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=324.93 Aligned_cols=256 Identities=26% Similarity=0.400 Sum_probs=206.6
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
.+|.+.+.||+|+||.||+|.+..++..||+|++.... .....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45888899999999999999999889999999987543 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999998652 2356899999999999999999999999 99999999999999999999999999875332211
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
.......++..|+|||++.+..++.++|||||||++|||++ |..||...... .....+ ... ..+.
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~~-~~~------~~~~ 225 (263)
T cd05052 160 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELL-EKG------YRME 225 (263)
T ss_pred -eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH-HCC------CCCC
Confidence 11112234567999999988899999999999999999998 89998653221 111111 100 0111
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
. +......+.+++.+||+.+|++||++.+++++|+.+
T Consensus 226 ~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 R----PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred C----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1 112235688899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=337.69 Aligned_cols=240 Identities=27% Similarity=0.406 Sum_probs=192.4
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHH---HhcCCCCceeeEEEEecCCeeeEE
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLML---SLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l---~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+..|+.++ ..++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 6788999999999999999999999999999975421 1224455666554 566799999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++++|..++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988864 46999999999999999999999999 9999999999999999999999999986422
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.....
T Consensus 153 ~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~~~~~------ 218 (324)
T cd05589 153 GF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIVNDEV------ 218 (324)
T ss_pred CC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC------
Confidence 11 12223467999999999999889999999999999999999999999754321 11111111110
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCCh
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 352 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 352 (457)
. ++......+.+++.+||+.+|.+||++
T Consensus 219 --~----~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 219 --R----YPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred --C----CCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 1 111223457889999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=338.20 Aligned_cols=200 Identities=27% Similarity=0.369 Sum_probs=176.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.++|++.+.||+|+||.||++.+..++..+|+|++..... .....+..|+.+++.++||||++++++|.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4689999999999999999999999999999999876422 223568899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
|+++++|.+++.. ...+++..+..++.+++.||.|||+. + |+|+||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999975 35688999999999999999999974 6 99999999999999999999999999864321
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 292 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~ 292 (457)
. ......||..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred h----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 1 122346899999999999888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=328.57 Aligned_cols=260 Identities=24% Similarity=0.421 Sum_probs=203.7
Q ss_pred HhcCCCccceeeecCcEEEEEEEECC-----CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCe
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLES-----TGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ 154 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 154 (457)
+.++|++.+.||+|+||.||+|.+.. ++..||||.+..... ....++..|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 46789999999999999999998642 356899999864322 233568899999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEE
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPD------KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKL 228 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL 228 (457)
.++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||||+|||+++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999998753211 235688899999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhh
Q 012761 229 SDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPL 307 (457)
Q Consensus 229 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 307 (457)
+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||...... .....+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~~--- 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRFV--- 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---
Confidence 99999875332222112222345778999999998899999999999999999999 68888654321 111111
Q ss_pred hhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 308 FNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 308 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
.. . ... .+ +......+.+++.+||+.+|++||++.|+++.|+
T Consensus 235 ~~-~----~~~--~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 ME-G----GLL--DK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred Hc-C----CcC--CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00 0 000 01 1112346889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=327.57 Aligned_cols=259 Identities=28% Similarity=0.461 Sum_probs=204.2
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCe----EEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQ----VVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
.+|++.+.||+|+||.||+|.+..++. .|++|.+..... ....++..|+.++..+.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 478889999999999999999877665 477787754322 123567778889999999999999998754 56788
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
++||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999975 2356899999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.............++..|+|||++.++.++.++|||||||++|||++ |..||....+.. +..+ +.... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~----~~~~~---~ 229 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDL----LEKGE---R 229 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCCC---c
Confidence 33332222334557788999999998899999999999999999998 999997654321 1111 11111 1
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
...+.. ....+..++..|+..+|.+||++.|+++.|..+...
T Consensus 230 ~~~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 230 LAQPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CCCCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 111111 123567899999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=335.31 Aligned_cols=242 Identities=26% Similarity=0.390 Sum_probs=196.2
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCC-CceeeEEEEecCCeeeEEE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHS-NLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~lV~ 159 (457)
+|.+.+.||+|+||.||+|++..+++.||||++..... ...+.+..|+.++..+.|+ +|+.+++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58889999999999999999999999999999975421 2335677899999998764 6888999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999999875 356889999999999999999999999 99999999999999999999999999864221
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ..+....
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~---~~i~~~~-------- 217 (324)
T cd05587 154 GG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELF---QSIMEHN-------- 217 (324)
T ss_pred CC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHHHcCC--------
Confidence 11 1223457999999999999989999999999999999999999999754321 111 1111100
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCCh
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 352 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 352 (457)
. .++......+.+++.+||+.+|.+|++.
T Consensus 218 ~----~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 V----SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred C----CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0 1111223467899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=338.55 Aligned_cols=243 Identities=26% Similarity=0.333 Sum_probs=196.7
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 165 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~g 165 (457)
+.||+|+||.||++++..++..||+|++..... .....+..|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975322 22345678999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 166 SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 166 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
+|..++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~ 151 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GA 151 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cc
Confidence 99998865 4578999999999999999999997 67 999999999999999999999999998742211 11
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 324 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 324 (457)
......||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+.... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~~~~~i~~~~--------~~--- 214 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEE--------IR--- 214 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------HHHHHHhcCC--------CC---
Confidence 223457999999999999889999999999999999999999999654321 1111111100 01
Q ss_pred CCChHhHHHHHHHHHHcchhhcCCCC-----ChHHHHHH
Q 012761 325 RYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 358 (457)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~~ 358 (457)
++......+.+++.+||+.||++|+ ++.++++.
T Consensus 215 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 -FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1112234678899999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=322.60 Aligned_cols=249 Identities=26% Similarity=0.374 Sum_probs=197.1
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCH
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 167 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 167 (457)
+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 359999999999999988899999998864322 2235688999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccc
Q 012761 168 EDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 247 (457)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 247 (457)
.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++.............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999965 2346899999999999999999999999 9999999999999999999999999987432211111111
Q ss_pred cccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCC
Q 012761 248 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRY 326 (457)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 326 (457)
....+..|+|||.+.++.++.++|||||||++|||++ |..||....... .. ..+... .....
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~~----~~~~~~----------~~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---TR----EAIEQG----------VRLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---HH----HHHHcC----------CCCCC
Confidence 1123457999999998899999999999999999998 888886433210 00 000000 00011
Q ss_pred ChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 327 PIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 327 ~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
+......+.+++.+||+.+|++||++.+|.++|.
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1122346889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=326.24 Aligned_cols=257 Identities=28% Similarity=0.452 Sum_probs=210.5
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
...+|.+.+.||.|+||.||+|.+.. +..+++|.+..........+..|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34678999999999999999999987 88999999987665556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||+++++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999999999763 2456899999999999999999999999 999999999999999999999999998753221
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
........++..|+|||++....++.++||||||+++|+|++ |+.||...... .+..... ..
T Consensus 158 --~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~----~~-------- 220 (261)
T cd05148 158 --VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQIT----AG-------- 220 (261)
T ss_pred --cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHH----hC--------
Confidence 111223346778999999988899999999999999999998 89999654321 1111111 00
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
.....+......+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 221 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 221 --YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred --CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 00011122335678999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=338.62 Aligned_cols=264 Identities=25% Similarity=0.391 Sum_probs=204.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECC-----CCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCceeeEEEEecC-C
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLES-----TGQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADG-D 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~ 153 (457)
.++|++.+.||.|+||.||+|.+.. +++.||+|++..... .....+..|+.++..+ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 3579999999999999999997543 357899999875322 2234577899999999 799999999988654 5
Q ss_pred eeeEEEeccCCCCHHHhhhcCCC---------------------------------------------------------
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPP--------------------------------------------------------- 176 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 176 (457)
.++++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 68899999999999999864211
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcccccccccccccc
Q 012761 177 DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 256 (457)
Q Consensus 177 ~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~ 256 (457)
....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.++|+|||++................++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 0236899999999999999999999999 9999999999999999999999999997543222111222344577899
Q ss_pred chhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHH
Q 012761 257 APEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQAL 335 (457)
Q Consensus 257 aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 335 (457)
|||++.+..++.++|||||||++|||++ |..||....... .+. ..+..... + ..+......+.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~----~~~~~~~~------~----~~~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFC----RRLKEGTR------M----RAPEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHH----HHHhccCC------C----CCCccCCHHHH
Confidence 9999999999999999999999999998 999996543211 011 11111100 0 01112235688
Q ss_pred HHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 336 AVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 336 ~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
+++.+||+.+|++||++.+|++.|+.+..
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=335.35 Aligned_cols=239 Identities=28% Similarity=0.403 Sum_probs=193.5
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.||+|+||.||+|+++.++..||||++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997532 12234567788888776 699999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~ 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GK 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CC
Confidence 999999875 356899999999999999999999999 999999999999999999999999998742211 12
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 324 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 324 (457)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~-----~------ 214 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILNDEV-----V------ 214 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcCCC-----C------
Confidence 233457999999999999889999999999999999999999999754321 11111111110 1
Q ss_pred CCChHhHHHHHHHHHHcchhhcCCCCChHH
Q 012761 325 RYPIRGLYQALAVASMCIQEQAATRPLIGD 354 (457)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 354 (457)
++......+.+++..||+.||.+||++.+
T Consensus 215 -~~~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 215 -YPTWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred -CCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 11112346789999999999999999843
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=328.34 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=197.2
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCH
Q 012761 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 167 (457)
Q Consensus 91 lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 167 (457)
||+|+||+||++.+..+++.||+|.+...... ....+..|+.+++.++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999998754322 224567899999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccc
Q 012761 168 EDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 247 (457)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 247 (457)
..++.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 9888654344567999999999999999999999999 9999999999999999999999999987533222 1223
Q ss_pred cccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCC
Q 012761 248 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYP 327 (457)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 327 (457)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........ ....+ .++
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~----------~~~~~--~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRI----------LNDSV--TYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhh----------cccCC--CCc
Confidence 45789999999999999999999999999999999999999975432110 00111111 11100 112
Q ss_pred hHhHHHHHHHHHHcchhhcCCCC-----ChHHHHH
Q 012761 328 IRGLYQALAVASMCIQEQAATRP-----LIGDVVT 357 (457)
Q Consensus 328 ~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~ 357 (457)
......+.+++..||+.+|++|| ++.+++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 22345678999999999999999 5555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=323.83 Aligned_cols=258 Identities=25% Similarity=0.405 Sum_probs=206.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCC---CeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLEST---GQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
.++|++.+.||+|+||.||+|.+..+ ...||||.+...... ....+..|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 35789999999999999999998643 458999998754322 23568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+|||+++++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 99999999999999752 347899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.............+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .+.... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~----~~~~---- 225 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAV----EDGY---- 225 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHH----HcCC----
Confidence 32222222222345678999999998899999999999999999998 99998543221 111111 1000
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
..+. +......+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 226 -~~~~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 -RLPP-----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -CCCC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0010 112234678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=344.65 Aligned_cols=263 Identities=23% Similarity=0.341 Sum_probs=206.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCC-----CeEEEEEEeccCCCc-ChHHHHHHHHHHHhcC-CCCceeeEEEEecCCe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLEST-----GQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 154 (457)
.++|.+.++||+|+||.||+|.+... +..||||++...... ..+.+.+|+.++..+. ||||++++++|.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 56889999999999999999986432 357999999754322 2356889999999996 9999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCC----------------------------------------------------------
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPP---------------------------------------------------------- 176 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 176 (457)
.+|||||+++|+|.++|+....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998864210
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC
Q 012761 177 ----------------------------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE 222 (457)
Q Consensus 177 ----------------------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~ 222 (457)
....+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 1135888999999999999999999999 999999999999999
Q ss_pred CCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccch
Q 012761 223 GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLV 301 (457)
Q Consensus 223 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~ 301 (457)
++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||....... .+.
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TFY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HHH
Confidence 99999999999875332222222223456788999999998899999999999999999997 999986532211 000
Q ss_pred hhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 302 TWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 302 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
....... .+. .+......+.+++..||+.+|++||++.+|+++|+.+.
T Consensus 351 ----~~~~~~~------~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 ----NKIKSGY------RMA----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ----HHHhcCC------CCC----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 0111110 001 11122346889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=345.74 Aligned_cols=254 Identities=26% Similarity=0.309 Sum_probs=198.6
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|.+.+.||+|+||.||++.+..+++.||||++..... .....+..|+.++..++||||+++++++.+.+..||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 478999999999999999999999999999999865321 12345788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999975 356889999999999999999999999 99999999999999999999999999853111
Q ss_pred CCCc---------------------------------------------cccccccccccccchhhhhcCCCCccchHHH
Q 012761 240 GDKS---------------------------------------------HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYS 274 (457)
Q Consensus 240 ~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS 274 (457)
.... ......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0001246999999999999889999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCC---CC
Q 012761 275 FGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATR---PL 351 (457)
Q Consensus 275 lGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt 351 (457)
|||++|||++|..||....+... ...+..... .+.-|.. ......+.+++.+||+ +|.+| ++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~------~~~i~~~~~---~~~~p~~-----~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHET------YRKIINWRE---TLYFPDD-----IHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHH------HHHHHccCC---ccCCCCC-----CCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 99999999999999975433110 011111000 0000100 0123467889999997 66665 58
Q ss_pred hHHHHHH
Q 012761 352 IGDVVTA 358 (457)
Q Consensus 352 ~~ev~~~ 358 (457)
+.+++..
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 8888764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=336.26 Aligned_cols=242 Identities=25% Similarity=0.361 Sum_probs=196.4
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEEE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 159 (457)
+|.+.+.||+|+||.||+|++..++..||||++...... ....+..|..++..+ +|++|+.+++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588899999999999999999999999999999754221 223466677777776 5899999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999999865 356899999999999999999999999 99999999999999999999999999874221
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ..+.....
T Consensus 154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~---~~i~~~~~------- 218 (323)
T cd05616 154 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELF---QSIMEHNV------- 218 (323)
T ss_pred C--CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHH---HHHHhCCC-------
Confidence 1 11233467999999999999999999999999999999999999999754321 111 11111110
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCCh
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 352 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 352 (457)
.++......+.+++.+||+.+|.+|++.
T Consensus 219 -----~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -----AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -----CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1122234567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=342.46 Aligned_cols=261 Identities=18% Similarity=0.177 Sum_probs=199.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
..+|.+.+.||+|+||.||+|++..+++.||||... ...+.+|+.+++.|+||||++++++|......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 367999999999999999999999999999999754 23467899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+. ++|..++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 165 ~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~- 235 (391)
T PHA03212 165 YK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI- 235 (391)
T ss_pred CC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc-
Confidence 95 788888865 356899999999999999999999999 999999999999999999999999998642211
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc-----cchhhhhhhhhcc-----
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-----NLVTWARPLFNDR----- 311 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~-----~l~~~~~~~~~~~----- 311 (457)
.........||+.|+|||++.+..++.++|||||||++|||++|..||......... .+.......-...
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 112233467999999999999889999999999999999999999887543221110 0000000000000
Q ss_pred ---ccccc---------ccCCccCCCCC--hHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 312 ---RKFSK---------LADPRLEGRYP--IRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 312 ---~~~~~---------~~d~~l~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..+.. ...+.....+. ......+.+|+.+||+.||.+|||+.|++.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 00000000000 012346788999999999999999999985
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=335.73 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=194.1
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.||+|+||.||+|++..+++.||+|++..... .....+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999986422 2234567788888776 799999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~ 151 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CC
Confidence 999988865 457999999999999999999999999 999999999999999999999999998742111 11
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCC--cccchhhhhhhhhcccccccccCCcc
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHG--EQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+....+....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---------- 221 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---------- 221 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------
Confidence 2234679999999999999999999999999999999999999996432221 1112222222111110
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCCCh
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRPLI 352 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 352 (457)
..++......+.+++.+||+.||++||++
T Consensus 222 -~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 222 -IRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 01222234567899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=359.91 Aligned_cols=264 Identities=28% Similarity=0.456 Sum_probs=215.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECC-----CCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLES-----TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 155 (457)
..+....+.||+|.||+||+|+... ..+.||||.++..... ...+|++|++++..|+|||||+|+|+|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 3456677789999999999998643 3468999999876544 567899999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCC------C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPP------D----KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH 225 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~ 225 (457)
++|+|||..|+|.++|....+ . ..+|+..+.+.||.|||.||+||-++. +|||||-..|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 999999999999999975422 1 334899999999999999999999999 999999999999999999
Q ss_pred eEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhh
Q 012761 226 PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWA 304 (457)
Q Consensus 226 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~ 304 (457)
|||+|||+++-....+.........-..+|||||.++.++||.+||||||||+|||+++ |+.|+.+....+ .+.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---VIe-- 716 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---VIE-- 716 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH---HHH--
Confidence 99999999985444444443333344678999999999999999999999999999997 888987754321 111
Q ss_pred hhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 305 RPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 305 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.++++. + -..|.....++..|+..||+.+|++||+++||-.+|......
T Consensus 717 --~i~~g~---------l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 717 --CIRAGQ---------L-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred --HHHcCC---------c-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 122221 1 112333445788999999999999999999999999887653
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=342.88 Aligned_cols=253 Identities=24% Similarity=0.340 Sum_probs=215.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEecCCe-eeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQ-RLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~lV 158 (457)
.++|..++.||+|.||.+++++++..+..|++|.+....... .+...+|+.+++++.|||||.+.+.|..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367899999999999999999999999999999998654433 3467899999999999999999999999888 9999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|+|++||+|.+.+.... ..-+++..+.+++.|++.|+.|||++. |+|||||+.|||++.++.|+|.|||+|+...
T Consensus 83 m~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999999999998743 467899999999999999999999988 9999999999999999999999999999744
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
... .....++||+.||.||.+.+.+|+.|+|||||||++|||++-+++|...+.. .|+ ..+.+ ..+
T Consensus 158 ~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li---~ki~~------~~~ 223 (426)
T KOG0589|consen 158 PED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELI---LKINR------GLY 223 (426)
T ss_pred Cch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHH---HHHhh------ccC
Confidence 332 3455678999999999999999999999999999999999999999765432 111 11111 122
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.| .+.....++..++..||+.+|..||++.+++.+
T Consensus 224 ~P-----lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SP-----LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CC-----CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 22 233456688899999999999999999999876
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=335.17 Aligned_cols=242 Identities=26% Similarity=0.375 Sum_probs=194.9
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.||+|+||.||+|++..+++.||||++..... .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999999999999999999975422 2234567788888765 799999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~ 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GV 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC--Cc
Confidence 999998865 356899999999999999999999999 999999999999999999999999998743221 12
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 324 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 324 (457)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~~~~-----~~~----- 215 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESILHDD-----VLY----- 215 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHHcCC-----CCC-----
Confidence 233457999999999999889999999999999999999999999754321 1111111111 111
Q ss_pred CCChHhHHHHHHHHHHcchhhcCCCC-------ChHHHHH
Q 012761 325 RYPIRGLYQALAVASMCIQEQAATRP-------LIGDVVT 357 (457)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~dP~~RP-------t~~ev~~ 357 (457)
+......+.+++..||+.+|++|| ++.++++
T Consensus 216 --p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 216 --PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 111224678999999999999999 6666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=319.78 Aligned_cols=261 Identities=24% Similarity=0.350 Sum_probs=211.8
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|.+.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.+++.++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999999889999999986422 222456889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++++|..++.........+++..++.++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998764444567899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
.. .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||..... ++......+.. ....
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~------~~~~ 226 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEK------CDYP 226 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhhc------CCCC
Confidence 21 122334688899999999888899999999999999999999999864321 11111111110 0011
Q ss_pred CccCCCCCh-HhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 320 PRLEGRYPI-RGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 320 ~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
+ .+. .....+.+++.+||..+|++||++.+|+++|..+.
T Consensus 227 ~-----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 227 P-----LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred C-----CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1 111 22346789999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=327.95 Aligned_cols=266 Identities=22% Similarity=0.314 Sum_probs=195.2
Q ss_pred cCCCccceeeecCcEEEEEEEECC-CCeEEEEEEeccCCCc--ChHHHHHHHHHHHhc---CCCCceeeEEEEe-----c
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLES-TGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLL---HHSNLVNLIGYCA-----D 151 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l---~hpniv~l~~~~~-----~ 151 (457)
++|.+.+.||+|+||.||+|++.. ++..||||++...... ....+.+|+.+++.+ .||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 378999999999999999999854 4688999998754322 223566677776665 6999999999985 2
Q ss_pred CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeec
Q 012761 152 GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDF 231 (457)
Q Consensus 152 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DF 231 (457)
....++||||+. ++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 6899998752 2345899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCc-ccchhhhhhhhhc
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE-QNLVTWARPLFND 310 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~ 310 (457)
|++...... .......||+.|+|||++.+..++.++|||||||++|||++|++||......+. ..+..........
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 999753322 223345689999999999888999999999999999999999999976543211 0011100000000
Q ss_pred cc----cc-ccccCCccCC---CCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 311 RR----KF-SKLADPRLEG---RYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 311 ~~----~~-~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.. .+ .....+.... .........+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 00 0000000000 000112245678999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=345.85 Aligned_cols=253 Identities=23% Similarity=0.289 Sum_probs=198.8
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|++.+.||+|+||.||+|++..+++.||||++..... .....+..|+.++..++||||+++++.+.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 378999999999999999999999999999999975321 22356788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999975 356889999999999999999999999 99999999999999999999999999742110
Q ss_pred CC-----------------------------------------CccccccccccccccchhhhhcCCCCccchHHHHHHH
Q 012761 240 GD-----------------------------------------KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 278 (457)
Q Consensus 240 ~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvi 278 (457)
.. ........+||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0001123579999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcc-cchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCC---ChHH
Q 012761 279 FLELITGRKAIDSTRPHGEQ-NLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP---LIGD 354 (457)
Q Consensus 279 l~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~e 354 (457)
+|||++|+.||....+.... .+..|.. ....+. .. .....+.+++.+|+ .+|.+|+ ++.+
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~~----------~~~~~~-~~----~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWET----------TLHIPS-QA----KLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccCc----------cccCCC-CC----CCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 99999999999765432110 0111100 000010 01 12235667777766 4999999 7888
Q ss_pred HHHH
Q 012761 355 VVTA 358 (457)
Q Consensus 355 v~~~ 358 (457)
++..
T Consensus 298 ll~h 301 (376)
T cd05598 298 IKAH 301 (376)
T ss_pred HhCC
Confidence 8754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=349.12 Aligned_cols=267 Identities=21% Similarity=0.324 Sum_probs=196.6
Q ss_pred HHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC------CCceeeEEEEe
Q 012761 77 ELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH------SNLVNLIGYCA 150 (457)
Q Consensus 77 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h------pniv~l~~~~~ 150 (457)
++...+++|.+.+.||+|+||.||+|++..+++.||||+++... .....+..|+.++..+.| ++|++++++|.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445788999999999999999999999999999999996432 223445667777776654 45889999887
Q ss_pred cC-CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCccCeEEcCCC----
Q 012761 151 DG-DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFKSSNILLEEGF---- 224 (457)
Q Consensus 151 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLkp~NILl~~~~---- 224 (457)
.. ..+++|||++ +++|.+++.. ...+++..+..|+.||+.||.|||+ .+ ||||||||+||||+.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 64 5789999988 7889988865 3579999999999999999999998 48 99999999999998665
Q ss_pred ------------ceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 012761 225 ------------HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 292 (457)
Q Consensus 225 ------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~ 292 (457)
.+||+|||++... .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||+..
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4999999987532 12234568999999999999999999999999999999999999999765
Q ss_pred CCCCcccchh---------hhh--------hhhhcccccccccCCc----cCCCCCh---HhHHHHHHHHHHcchhhcCC
Q 012761 293 RPHGEQNLVT---------WAR--------PLFNDRRKFSKLADPR----LEGRYPI---RGLYQALAVASMCIQEQAAT 348 (457)
Q Consensus 293 ~~~~~~~l~~---------~~~--------~~~~~~~~~~~~~d~~----l~~~~~~---~~~~~l~~li~~cl~~dP~~ 348 (457)
.......+.. |.. .++.....+....++. +....+. -....+.+|+..||+.||++
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 4322111110 110 0000000000000100 0000000 01245779999999999999
Q ss_pred CCChHHHHH
Q 012761 349 RPLIGDVVT 357 (457)
Q Consensus 349 RPt~~ev~~ 357 (457)
|||+.|+++
T Consensus 429 R~ta~e~L~ 437 (467)
T PTZ00284 429 RLNARQMTT 437 (467)
T ss_pred CCCHHHHhc
Confidence 999999986
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=342.47 Aligned_cols=255 Identities=22% Similarity=0.274 Sum_probs=203.2
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
..++|.+.+.||+|+||.||++++..++..||+|++..... .....+..|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 45689999999999999999999999999999999975321 223457789999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999865 35788899999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCccccccccccccccchhhhhcC----CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTG----QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRK 313 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 313 (457)
.... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+.....
T Consensus 193 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~- 264 (370)
T cd05596 193 DANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKN- 264 (370)
T ss_pred cCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCC-
Confidence 2211 1122345799999999998753 4789999999999999999999999764321 11111111110
Q ss_pred cccccCCccCCCCChHhHHHHHHHHHHcchhhcCC--CCChHHHHHH
Q 012761 314 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAAT--RPLIGDVVTA 358 (457)
Q Consensus 314 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ev~~~ 358 (457)
.+..|. .......+.+++..||+.+|.+ ||++.+++..
T Consensus 265 --~~~~~~-----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 --SLTFPD-----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --cCCCCC-----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 011110 0112357889999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=332.48 Aligned_cols=241 Identities=27% Similarity=0.418 Sum_probs=192.2
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHh-cCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSL-LHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.||+|+||.||+|++..++..||||++..... .....+..|..++.. ++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999975321 223345566666664 4799999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 999999875 356899999999999999999999999 9999999999999999999999999997532222 2
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 324 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 324 (457)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~--------~~~--- 214 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELFDSILND--------RPH--- 214 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcC--------CCC---
Confidence 233467999999999999889999999999999999999999999754321 111111111 011
Q ss_pred CCChHhHHHHHHHHHHcchhhcCCCCChHHHH
Q 012761 325 RYPIRGLYQALAVASMCIQEQAATRPLIGDVV 356 (457)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~ 356 (457)
++......+.+++..||+.+|.+||++.+.+
T Consensus 215 -~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 215 -FPRWISKEAKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred -CCCCCCHHHHHHHHHHccCCHHHcCCChHHH
Confidence 1111234577899999999999999986433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=325.35 Aligned_cols=251 Identities=33% Similarity=0.513 Sum_probs=193.6
Q ss_pred ccceeeecCcEEEEEEEEC----CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 87 PESFIGEGGFGRVYKGWLE----STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 87 ~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+.+.||.|.||.||+|.+. ..+..|+||.+..... ...+.+.+|+..+..++||||+++++++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4567999999999999998 3467899999965322 2357899999999999999999999999988889999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++|+|.++|... ....+++.+++.|+.||+.||.|||+.+ |+|+||+++|||++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 9999999999873 2467899999999999999999999998 9999999999999999999999999997642222
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
.........+...|+|||++....++.++||||||+++|||++ |+.||..... ..+...+ .+... +
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~~~~-~~~~~------~ 224 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEIIEKL-KQGQR------L 224 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHHHHH-HTTEE------T
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccc-ccccc------c
Confidence 2222233456788999999999889999999999999999999 6788755421 1111111 11111 0
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
.. +......+..++..||..+|.+||++.++++.|
T Consensus 225 ~~----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PI----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TS----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ee----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 01 111234577999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=326.81 Aligned_cols=261 Identities=27% Similarity=0.406 Sum_probs=205.2
Q ss_pred CCCccceeeecCcEEEEEEEECC-----CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLES-----TGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
+|.+.+.||+|+||.||+|.... ....+++|.+..... .....+..|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47888999999999999998753 235789998875432 223568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccC
Q 012761 158 VYEFMPLGSLEDHLHDLP--------------------PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 217 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~N 217 (457)
||||+.+++|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986421 11245889999999999999999999999 9999999999
Q ss_pred eEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 012761 218 ILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHG 296 (457)
Q Consensus 218 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~ 296 (457)
||+++++.++|+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||....+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999875322221111222345678999999988889999999999999999998 99998654321
Q ss_pred cccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 297 EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 297 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
.+..+. .... ... .+......+.+++..||+.+|.+||++.++++.|+.+..
T Consensus 237 --~~~~~~----~~~~------~~~----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 --RLFNLL----KTGY------RME----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred --HHHHHH----hCCC------CCC----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111111 1100 011 111223468899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=344.99 Aligned_cols=203 Identities=25% Similarity=0.306 Sum_probs=175.6
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.|...+.||+|+||.||+|++..+++.||||++..... .....+..|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58899999999999999999999999999999975322 123467889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999975 356889999999999999999999999 999999999999999999999999997521100
Q ss_pred C---------------------------------------------CccccccccccccccchhhhhcCCCCccchHHHH
Q 012761 241 D---------------------------------------------KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSF 275 (457)
Q Consensus 241 ~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSl 275 (457)
. ........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0001123579999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 012761 276 GVVFLELITGRKAIDSTR 293 (457)
Q Consensus 276 Gvil~elltG~~p~~~~~ 293 (457)
||+||||++|+.||....
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (382)
T cd05625 235 GVILYEMLVGQPPFLAQT 252 (382)
T ss_pred hHHHHHHHhCCCCCCCCC
Confidence 999999999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=322.56 Aligned_cols=262 Identities=23% Similarity=0.340 Sum_probs=210.9
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|.+.+.||.|+||.||++.+..++..||||.+...... ....+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4788899999999999999999888999999988653222 2346888999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++++|.+++.........+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998754444567899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
.. .......|+..|+|||++.+..++.++||||||+++|+|++|..||...... ...+.... .....
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-------~~~~~ 225 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI-------EQCDY 225 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhh-------hcCCC
Confidence 21 1222346889999999998888999999999999999999999998643221 11111110 01111
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
+.+.. ......+.+++.+||+.+|.+|||+.+|.+.++++.
T Consensus 226 ~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 PPLPS---DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCc---ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11111 112346889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=333.57 Aligned_cols=242 Identities=26% Similarity=0.382 Sum_probs=194.9
Q ss_pred ceeeecCcEEEEEEEEC---CCCeEEEEEEeccCCC----cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 89 SFIGEGGFGRVYKGWLE---STGQVVAVKQLDRNGL----QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+.||+|+||.||+++.. .+++.||||++..... .....+..|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999863 4688999999975321 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 153 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE- 153 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC-
Confidence 999999999975 456888899999999999999999999 999999999999999999999999998642211
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.....
T Consensus 154 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~~~~~--------- 217 (323)
T cd05584 154 -GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKILKGKL--------- 217 (323)
T ss_pred -CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCC---------
Confidence 12233457999999999999888999999999999999999999999754321 11111111110
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCC-----ChHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVT 357 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~ 357 (457)
..+......+.+++..||+.+|++|| ++.+++.
T Consensus 218 ---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 ---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ---CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11112234678999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=321.02 Aligned_cols=256 Identities=26% Similarity=0.394 Sum_probs=205.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||.||+|.+.. +..||||.+.... .....+..|+.+++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 4678999999999999999999764 5789999987643 2356788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999997632 356899999999999999999999999 9999999999999999999999999997643211
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
.........+..|+|||++.+..++.++||||||+++|||++ |+.||...... .+... ..... ..
T Consensus 158 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~------~~ 223 (261)
T cd05068 158 -YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQQ----VDQGY------RM 223 (261)
T ss_pred -ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HHcCC------CC
Confidence 111111223457999999988899999999999999999999 99998654321 11110 00000 00
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
..+......+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 ----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 01112235688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=326.46 Aligned_cols=259 Identities=29% Similarity=0.445 Sum_probs=204.0
Q ss_pred cCCCccceeeecCcEEEEEEEEC----CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLE----STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
++|++.+.||+|+||.||+|.+. .++..|++|.+..... .....+.+|+.+++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 56888899999999999999853 3457899999875322 223568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC
Q 012761 158 VYEFMPLGSLEDHLHDLPP-------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF 224 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~ 224 (457)
||||+++++|.+++..... ....+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999863211 1245889999999999999999999999 99999999999999999
Q ss_pred ceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhh
Q 012761 225 HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTW 303 (457)
Q Consensus 225 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~ 303 (457)
.+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||....+. .+...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999975433222222333456778999999988889999999999999999998 99998654321 11111
Q ss_pred hhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHh
Q 012761 304 ARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 361 (457)
Q Consensus 304 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 361 (457)
+ ..... ...... ....+.+++.+||+.+|.+||++.+|++.|..
T Consensus 239 ~----~~~~~------~~~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 V----RKRQL------LPCSED----CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H----HcCCc------CCCCCC----CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 11100 011111 22467889999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=339.58 Aligned_cols=253 Identities=26% Similarity=0.307 Sum_probs=202.1
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|.+.+.||+|+||.||++++..+++.||||++..... .....+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 478999999999999999999999999999999975422 22345788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999762 357899999999999999999999999 99999999999999999999999999975332
Q ss_pred CCCccccccccccccccchhhhh------cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAM------TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRK 313 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 313 (457)
... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...... .....+......
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~ 227 (330)
T cd05601 155 NKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRF 227 (330)
T ss_pred CCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCc
Confidence 221 1223357899999999987 456789999999999999999999999654321 111111111000
Q ss_pred cccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 314 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 314 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+ .. +. .......+.+|+..||+ +|.+||++.+++.
T Consensus 228 ~-~~--~~-----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 L-KF--PE-----DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred c-CC--CC-----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 00 00 01123457789999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=321.00 Aligned_cols=256 Identities=24% Similarity=0.336 Sum_probs=204.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||.||+|++..++..||+|++..........+.+|+.++..++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45799999999999999999999888999999999765444455678899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999999875 356899999999999999999999998 9999999999999999999999999987532211
Q ss_pred Cccccccccccccccchhhhh---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.......|++.|+|||.+. ...++.++|||||||++|||++|+.||....+.... ..+... ...
T Consensus 161 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~~~~~---------~~~ 227 (267)
T cd06646 161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLMSKS---------NFQ 227 (267)
T ss_pred --cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--eeeecC---------CCC
Confidence 1122346889999999884 345788999999999999999999998654332111 000000 011
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
.+.+.. .......+.+++.+||+.+|++||++.++++.|
T Consensus 228 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 PPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 111111 111235688999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=341.84 Aligned_cols=258 Identities=21% Similarity=0.269 Sum_probs=201.3
Q ss_pred HHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCe
Q 012761 78 LAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ 154 (457)
Q Consensus 78 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 154 (457)
+....++|++.+.||+|+||.||++++..+++.||+|++.+... .....+..|+.+++.++||||+++++++.+.+.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 33345789999999999999999999999999999999864221 223457789999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
.++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 9999999999999999964 35888999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccchhhhhcC----CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhc
Q 012761 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAMTG----QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND 310 (457)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 310 (457)
....... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+...
T Consensus 190 ~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~ 262 (370)
T cd05621 190 MKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDH 262 (370)
T ss_pred eecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhC
Confidence 7532211 1122345799999999998754 3789999999999999999999999754321 111111111
Q ss_pred ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCC--CCChHHHHHH
Q 012761 311 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAAT--RPLIGDVVTA 358 (457)
Q Consensus 311 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ev~~~ 358 (457)
...+ .-| . .......+.+++..||+.++.+ ||++.++++.
T Consensus 263 ~~~~---~~p---~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 KNSL---NFP---E--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred Cccc---CCC---C--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1000 000 0 0112345678888899855543 8899988774
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=328.77 Aligned_cols=263 Identities=27% Similarity=0.402 Sum_probs=207.2
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCC-----CeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCceeeEEEEecCC
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLEST-----GQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGD 153 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 153 (457)
..++|.+.+.||+|+||.||++.+... ...+|+|.+..... .....+..|+.++..+ +||||+++++++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 346788999999999999999987643 37899999875422 2234578899999999 7999999999999999
Q ss_pred eeeEEEeccCCCCHHHhhhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLP------------PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE 221 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~ 221 (457)
..+++|||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 9999999999999999986421 23457899999999999999999999999 99999999999999
Q ss_pred CCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccc
Q 012761 222 EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNL 300 (457)
Q Consensus 222 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l 300 (457)
.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... +
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~ 243 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---L 243 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---H
Confidence 999999999999975433222122222335678999999988899999999999999999997 888886543211 1
Q ss_pred hhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 301 VTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
. ....... ....+......+.+|+.+||+.+|.+||++.++++.|+.+.
T Consensus 244 ~----~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 F----KLLKEGY----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H----HHHHcCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1 0111100 00111223456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=323.87 Aligned_cols=260 Identities=26% Similarity=0.426 Sum_probs=205.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCe----EEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQ----VVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
.++|.+.+.||+|+||.||+|++..++. .||+|++...... ....+..|+.++..++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 4678899999999999999999876665 4899998754322 235688899999999999999999998754 578
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+++||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999999975 2356899999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
..............+++.|+|||.+.+..++.++|||||||++|||++ |..||+.... ..+..++.. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~----~~--- 228 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLLEK----GE--- 228 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHC----CC---
Confidence 433222111222334678999999988899999999999999999998 8999865432 112221111 00
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.+.. +......+.+++..||+.+|++||++.+++..|..+...
T Consensus 229 ---~~~~----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 229 ---RLPQ----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ---cCCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 0000 111234678999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=319.43 Aligned_cols=253 Identities=27% Similarity=0.359 Sum_probs=203.7
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-----ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-----GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
++|.+.+.||+|++|.||++.+..++..||||.+...... ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999989999999998754221 12467889999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999875 346889999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCc-cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 238 PVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 238 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
...... .......|+..|+|||++.+..++.++|||||||++|||++|+.||........ . .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~---~~~~~------- 221 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---I---FKIAT------- 221 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---H---HHHhc-------
Confidence 221111 111234678899999999988899999999999999999999999965422100 0 00000
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
......++......+.+++..||..+|.+||++.+++..
T Consensus 222 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 ---QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 000011122233467899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=324.69 Aligned_cols=259 Identities=26% Similarity=0.392 Sum_probs=203.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECC-----CCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLES-----TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 155 (457)
+++|.+.+.||+|+||.||+|.+.. ++..|++|.+...... ....+..|+.+++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 5679999999999999999999976 6789999988754322 234688999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC---ceEEe
Q 012761 156 LLVYEFMPLGSLEDHLHDLPP---DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF---HPKLS 229 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~---~~kL~ 229 (457)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999975321 1236899999999999999999999999 99999999999998654 59999
Q ss_pred eccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhh
Q 012761 230 DFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLF 308 (457)
Q Consensus 230 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 308 (457)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||...... .+.. ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~---~~~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVME---FVT 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---HHH
Confidence 9999875322111111112234567999999998899999999999999999997 99998754321 1111 110
Q ss_pred hcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 309 NDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 309 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
. .. ....+......+.+++.+||+.+|++||++.+|++.|.
T Consensus 236 ~-~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 G-GG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred c-CC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0 00 00111122346889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=319.54 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=201.5
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
++|.+.+.||+|+||.||++.++. +..+|+|.+.... .....+..|+.+++.++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 468889999999999999998865 5689999886543 23567889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++|+|.++++.. ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999998752 246899999999999999999999999 99999999999999999999999999875322111
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+...+. . .. ....+.
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~---~-~~---~~~~~~ 224 (256)
T cd05114 156 -TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMIS---R-GF---RLYRPK 224 (256)
T ss_pred -eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH---C-CC---CCCCCC
Confidence 11122335668999999988889999999999999999999 8999865432 11111111 1 00 111111
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
. ....+.+++.+||+.+|.+||++.++++.|
T Consensus 225 ~-------~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 L-------ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred C-------CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1 224688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=348.75 Aligned_cols=264 Identities=24% Similarity=0.323 Sum_probs=198.3
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecC--------C
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADG--------D 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--------~ 153 (457)
.++|.+.+.||+|+||.||+|.+..++..||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999999999999999986432 2345799999999999999999887432 2
Q ss_pred eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC-ceEEeecc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF-HPKLSDFG 232 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~-~~kL~DFG 232 (457)
.+++||||++ ++|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 4678999997 5787777644344567999999999999999999999999 99999999999998654 79999999
Q ss_pred ccccCCCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhh--
Q 012761 233 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN-- 309 (457)
Q Consensus 233 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~-- 309 (457)
+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+..... .+......+-.
T Consensus 217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~~~~~p~ 291 (440)
T PTZ00036 217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQVLGTPT 291 (440)
T ss_pred cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCC
Confidence 997543222 22335789999999998764 68999999999999999999999997654321 11111110000
Q ss_pred ------cccc-----cccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 310 ------DRRK-----FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 310 ------~~~~-----~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.... +..+....+...++.....++.+|+.+||+.+|.+||++.|++..
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000 001111111111222234578899999999999999999999853
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=321.55 Aligned_cols=258 Identities=27% Similarity=0.396 Sum_probs=202.1
Q ss_pred CCccceeeecCcEEEEEEEECCC---CeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCCe-----
Q 012761 85 FRPESFIGEGGFGRVYKGWLEST---GQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ----- 154 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 154 (457)
|.+.+.||+|+||.||+|.+..+ +..||||++...... ....+..|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999987653 478999998754322 23568899999999999999999999876554
Q ss_pred -eeEEEeccCCCCHHHhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeec
Q 012761 155 -RLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDF 231 (457)
Q Consensus 155 -~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DF 231 (457)
.++||||+++++|..++.... .....+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999999986432 22357899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhc
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFND 310 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 310 (457)
|+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... .+..+.. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~~---~- 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYLR---H- 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---c-
Confidence 99875433222111222335678999999988889999999999999999999 88888654321 1111110 0
Q ss_pred ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 311 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 311 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
.. .+. .+......+.+++.+||+.+|.+||++.+|++.|..+
T Consensus 231 ~~------~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN------RLK----QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC------CCC----CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 011 1112345788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=332.81 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=198.1
Q ss_pred CCCccceeeecCcEEEEEEEEC---CCCeEEEEEEeccCCC----cChHHHHHHHHHHHhcC-CCCceeeEEEEecCCee
Q 012761 84 NFRPESFIGEGGFGRVYKGWLE---STGQVVAVKQLDRNGL----QGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQR 155 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~----~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~ 155 (457)
+|++.+.||+|+||.||+++.. .++..||+|++..... ...+.+..|+.++..+. ||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5888999999999999998864 4688999999875321 22345778999999994 99999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999875 456899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 236 LGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
...... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ......+..
T Consensus 154 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~----- 225 (332)
T cd05614 154 EFLSEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILK----- 225 (332)
T ss_pred cccccC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhc-----
Confidence 532222 1122345799999999998865 4789999999999999999999999754322111 111111111
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCC-----ChHHHHH
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVT 357 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~ 357 (457)
.++.+.. .....+.+++.+||+.||++|| ++.++++
T Consensus 226 ---~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 ---CDPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---CCCCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1122211 1234578899999999999999 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=328.20 Aligned_cols=268 Identities=24% Similarity=0.348 Sum_probs=205.2
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCC-----eeeEE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD-----QRLLV 158 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~lV 158 (457)
.|...+++|.|+||.||+|+...+++.||||.+..+. +.-..|+++|+.+.|||||++..+|.... .+.||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4677789999999999999999999999999986543 23346899999999999999999886432 34689
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC-CceEEeeccccccC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG-FHPKLSDFGLAKLG 237 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~-~~~kL~DFGla~~~ 237 (457)
||||+ .+|.+.++.....+..++.-.+.-+..||++||.|||+.+ |+||||||.|||+|.+ |.+||||||.|+..
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99997 6999998865555677888899999999999999999999 9999999999999865 99999999999975
Q ss_pred CCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc-----
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR----- 311 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----- 311 (457)
..+... .....|..|+|||.+.+. .|+.+.||||.|||+.||+.|++-|.+.+..+. |+..+.-+=...
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVLGTPTREDIK 251 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHhCCCCHHHHh
Confidence 554433 234568889999999875 799999999999999999999999987654332 222221111000
Q ss_pred ---cccccccCCccCCC-----CChHhHHHHHHHHHHcchhhcCCCCChHHHHH--HHHhhhh
Q 012761 312 ---RKFSKLADPRLEGR-----YPIRGLYQALAVASMCIQEQAATRPLIGDVVT--ALSYLAN 364 (457)
Q Consensus 312 ---~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~--~L~~l~~ 364 (457)
....+.-.|.+... +......++++|+.++|+.+|.+|.++.|++. .++.+..
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 00011111222111 22234457889999999999999999999984 3444443
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=326.78 Aligned_cols=252 Identities=27% Similarity=0.385 Sum_probs=201.7
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
+|++.+.||+|+||.||++.+..++..||||++...... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999999888999999999754322 22456789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999888642 2356899999999999999999999999 999999999999999999999999998753222
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
. ......|++.|+|||++.+..++.++|||||||++|||++|..||....... ....+...+...
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~--------- 220 (285)
T cd05605 156 E---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKED--------- 220 (285)
T ss_pred C---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhc---------
Confidence 1 1223478999999999998899999999999999999999999997643211 001110000000
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCC-----ChHHHHH
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVT 357 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~ 357 (457)
...++......+.+|+..||+.||.+|| ++.+++.
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 221 --QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred --ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0111222334678899999999999999 6777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=332.68 Aligned_cols=242 Identities=26% Similarity=0.416 Sum_probs=195.5
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.||+|+||.||+|++..++..||||++..... .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999975421 2234567788888877 699999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--V 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--C
Confidence 999998875 357999999999999999999999999 9999999999999999999999999986422111 1
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 324 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 324 (457)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+.... ..
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~~~~~i~~~~--------~~--- 214 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------ELFQSILEDE--------VR--- 214 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------HHHHHHHcCC--------CC---
Confidence 223457899999999999999999999999999999999999999754321 1111111110 01
Q ss_pred CCChHhHHHHHHHHHHcchhhcCCCCCh-----HHHHH
Q 012761 325 RYPIRGLYQALAVASMCIQEQAATRPLI-----GDVVT 357 (457)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~ev~~ 357 (457)
++......+.+|+.+||+.+|.+||++ .+++.
T Consensus 215 -~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 -YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 111223467899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=332.20 Aligned_cols=245 Identities=24% Similarity=0.332 Sum_probs=196.1
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.||+|+||.||+|++..+++.||||++...... ....+..|+.++..+ +||||+.+++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999864322 224577888988888 599999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~ 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GD 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CC
Confidence 999998865 356999999999999999999999999 999999999999999999999999998742111 12
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 324 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 324 (457)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.........+...+........ .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~~-- 220 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK---------PI-- 220 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC---------CC--
Confidence 2334679999999999999999999999999999999999999997544332222222222211111 00
Q ss_pred CCChHhHHHHHHHHHHcchhhcCCCCChH
Q 012761 325 RYPIRGLYQALAVASMCIQEQAATRPLIG 353 (457)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 353 (457)
.++......+.+++.+||+.||.+||++.
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 11112234578999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=324.24 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=206.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCC-----CeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLEST-----GQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 155 (457)
.++|.+.+.||+|+||.||+|.+... +..||+|.+..... .....+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 45788999999999999999988643 37899999875432 2235688899999999999999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEe
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPD------KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLS 229 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~ 229 (457)
++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999999753321 235789999999999999999999999 9999999999999999999999
Q ss_pred eccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhh
Q 012761 230 DFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLF 308 (457)
Q Consensus 230 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 308 (457)
|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+..+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~---- 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLKFV---- 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHHHH----
Confidence 9999875333222222333456788999999988889999999999999999998 89998654321 111111
Q ss_pred hcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 309 NDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 309 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
.... .+.+ +......+.+++.+||+.+|++|||+.+++..|+
T Consensus 235 ~~~~------~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGG------HLDL----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCC------CCCC----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1110 0011 1112356889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=320.55 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=205.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|++.+.||+|+||.||+|.... +..||+|.+..... ..+.+..|+.+++.++|+||+++++++.+.+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 4578999999999999999998754 67899999865432 356788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 9999999999752 2456888999999999999999999998 9999999999999999999999999997532211
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
........++..|+|||++....++.++|||||||++|+|++ |..||...... .+...... . ...
T Consensus 158 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~----~------~~~ 223 (261)
T cd05072 158 -YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSALQR----G------YRM 223 (261)
T ss_pred -eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHHHc----C------CCC
Confidence 111222345678999999988889999999999999999998 99998653321 11111110 0 011
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
..... ....+.+++.+||+.+|++||++.++++.|+.+
T Consensus 224 ~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 PRMEN----CPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11111 224678899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=333.01 Aligned_cols=238 Identities=28% Similarity=0.360 Sum_probs=191.0
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHH-HHHhcCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVL-MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.||+|+||.||+|++..+++.||||++..... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999975322 12233445544 56789999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..... ...
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~ 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSK 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCC
Confidence 999999875 457899999999999999999999999 99999999999999999999999999874211 122
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 324 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 324 (457)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+.... ..+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~--------~~~~~ 217 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILNKP--------LRLKP 217 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHcCC--------CCCCC
Confidence 23346799999999999998999999999999999999999999975432 11111111111 01111
Q ss_pred CCChHhHHHHHHHHHHcchhhcCCCCChH
Q 012761 325 RYPIRGLYQALAVASMCIQEQAATRPLIG 353 (457)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 353 (457)
.....+.+++.+||+.+|.+||++.
T Consensus 218 ----~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 ----NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ----CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1234678999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=331.51 Aligned_cols=241 Identities=28% Similarity=0.424 Sum_probs=193.4
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHh-cCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSL-LHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.||+|+||.||+|++..++..||||++..... .....+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999975421 223456667777775 4899999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--A 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--C
Confidence 999999975 356899999999999999999999999 9999999999999999999999999987422221 1
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 324 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 324 (457)
......||+.|+|||++.+..++.++|||||||++|||++|..||...... .+... +.. ..+.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~---i~~--------~~~~~-- 215 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQS---IRM--------DNPCY-- 215 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHH---HHh--------CCCCC--
Confidence 223457999999999999889999999999999999999999999754321 11111 100 01111
Q ss_pred CCChHhHHHHHHHHHHcchhhcCCCCChH-HHH
Q 012761 325 RYPIRGLYQALAVASMCIQEQAATRPLIG-DVV 356 (457)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ev~ 356 (457)
+......+.+++.+||+.+|.+||++. ++.
T Consensus 216 --~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 216 --PRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred --CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 111234678899999999999999997 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=330.05 Aligned_cols=241 Identities=27% Similarity=0.424 Sum_probs=193.1
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHh-cCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSL-LHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.||+|+||.||+|+++.++..||||++..... .....+..|..++.. ++||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999975421 223456667777765 4899999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--N 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--C
Confidence 999999865 356899999999999999999999999 9999999999999999999999999986422211 2
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 324 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 324 (457)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ..+.. ..+.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~---~~~~~--------~~~~~-- 215 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELF---ESIRV--------DTPHY-- 215 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHHHh--------CCCCC--
Confidence 233467999999999999989999999999999999999999999654321 111 11100 01111
Q ss_pred CCChHhHHHHHHHHHHcchhhcCCCCChH-HHH
Q 012761 325 RYPIRGLYQALAVASMCIQEQAATRPLIG-DVV 356 (457)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ev~ 356 (457)
+......+.+++..||+.||++||++. +++
T Consensus 216 --~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 --PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111234678899999999999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=323.73 Aligned_cols=266 Identities=26% Similarity=0.389 Sum_probs=206.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCC----------------eEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCcee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTG----------------QVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVN 144 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~----------------~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~ 144 (457)
..+|++.+.||+|+||.||+|.+..++ ..||+|.+...... ....+..|+.++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 457899999999999999999876533 56899998765322 3456888999999999999999
Q ss_pred eEEEEecCCeeeEEEeccCCCCHHHhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccC
Q 012761 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP-------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 217 (457)
Q Consensus 145 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~N 217 (457)
+++++...+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999976321 1236899999999999999999999999 9999999999
Q ss_pred eEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh--CCCCCCCCCCC
Q 012761 218 ILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT--GRKAIDSTRPH 295 (457)
Q Consensus 218 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt--G~~p~~~~~~~ 295 (457)
||++.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999875333322223334456788999999988889999999999999999998 6677754332
Q ss_pred CcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 296 GEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 296 ~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
..+...+...+......... ..+.....++.+++.+||+.+|.+||++.+|++.|.
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYL-------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhccccccccccC-------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11222221111111100000 011122357899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=325.70 Aligned_cols=258 Identities=26% Similarity=0.373 Sum_probs=202.9
Q ss_pred cCCCccceeeecCcEEEEEEEECCC-----CeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLEST-----GQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
.+|++.+.||+|+||.||+|.+..+ +..||||++...... ....+..|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 3577888999999999999987543 578999999754322 2356788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC
Q 012761 157 LVYEFMPLGSLEDHLHDLP------------PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF 224 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~ 224 (457)
+++||+++++|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985321 11346889999999999999999999999 99999999999999999
Q ss_pred ceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhh
Q 012761 225 HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTW 303 (457)
Q Consensus 225 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~ 303 (457)
.+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||..... . .+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~---~~ 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---Q---DV 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---H---HH
Confidence 999999999875433222222233456788999999988899999999999999999998 8888865322 1 11
Q ss_pred hhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 304 ARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 304 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
...+.... . ..++......+.+|+..||+.+|.+||++.+|+..|+
T Consensus 236 ~~~i~~~~----------~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 236 IEMIRNRQ----------V-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHHHcCC----------c-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 11111110 0 0111223345789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=320.38 Aligned_cols=269 Identities=24% Similarity=0.331 Sum_probs=207.3
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCC-ceeeEEEEecCC-----
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSN-LVNLIGYCADGD----- 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~----- 153 (457)
...|...+.||+|.||+||+|+.+.+|+.||+|.+...... ......+|+.+|+.|+|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34566677799999999999999999999999999865432 2345789999999999999 999999998877
Q ss_pred -eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecc
Q 012761 154 -QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 232 (457)
Q Consensus 154 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFG 232 (457)
.+++||||++ -+|..++.........++...+..++.||+.||+|||+++ |+||||||.||||++.|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 7899999995 6999999875543356788899999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhh-c
Q 012761 233 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN-D 310 (457)
Q Consensus 233 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~-~ 310 (457)
+|+..... ....+..++|.+|+|||++.+. .|+...||||+|||++||++++.-|.+....+ .+.....-+-. .
T Consensus 166 lAra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~--ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 166 LARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID--QLFRIFRLLGTPN 241 (323)
T ss_pred hHHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH--HHHHHHHHcCCCC
Confidence 99854332 2335566789999999999987 79999999999999999999999887654321 11111110000 0
Q ss_pred cccccccc---CC--ccCCCCCh--------HhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 311 RRKFSKLA---DP--RLEGRYPI--------RGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 311 ~~~~~~~~---d~--~l~~~~~~--------~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
...++.+. +- ........ .......+++..||+.+|.+|.+++.+++.
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 01111111 10 00011100 011367899999999999999999999875
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=331.35 Aligned_cols=243 Identities=25% Similarity=0.378 Sum_probs=196.1
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcC-CCCceeeEEEEecCCeeeEEE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~ 159 (457)
+|...+.||+|+||.||+|+++.++..||||++..... .....+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47788999999999999999999999999999975321 22345777888888876 578888999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999865 456999999999999999999999999 99999999999999999999999999874221
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+ ...+.....
T Consensus 154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~---~~~i~~~~~------- 218 (323)
T cd05615 154 D--GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---EL---FQSIMEHNV------- 218 (323)
T ss_pred C--CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HH---HHHHHhCCC-------
Confidence 1 11223456999999999999889999999999999999999999999764321 11 111111110
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIG 353 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 353 (457)
.++......+.+++.+||+.+|.+|++..
T Consensus 219 -----~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 -----SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -----CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 11112234678899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=324.29 Aligned_cols=251 Identities=26% Similarity=0.371 Sum_probs=206.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
..+|.+.+.||.|+||.||+|++..++..|++|.+..........+..|+.+++.+.||||+++++++......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35799999999999999999999888999999999876655567788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.. ..+++.+++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999999864 45889999999999999999999999 9999999999999999999999999987532221
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+.. .+..+ .... .+.
T Consensus 171 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~----~~~~-------~~~ 235 (296)
T cd06654 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLI----ATNG-------TPE 235 (296)
T ss_pred --cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHH----hcCC-------CCC
Confidence 11233468899999999988889999999999999999999999996543211 01100 0000 000
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+ ..+......+.+++.+||..+|++||++.+++.
T Consensus 236 ~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 236 L--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred C--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 1 011122345788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=326.32 Aligned_cols=260 Identities=25% Similarity=0.379 Sum_probs=204.8
Q ss_pred hcCCCccceeeecCcEEEEEEEE-----CCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCceeeEEEEecCCe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWL-----ESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 154 (457)
.++|.+.+.||+|+||.||++.+ ..++..||||.+..... ...+.+..|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 35799999999999999999975 23456899999875432 2235688999999999 79999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
.++||||+++++|.++++.. ....+++.+++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999752 1234899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccc
Q 012761 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRK 313 (457)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 313 (457)
................++..|+|||++....++.++|||||||++|||++ |..||....... .+.. ......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~----~~~~~~- 261 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYK----LIKEGY- 261 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHH----HHHcCC-
Confidence 75332221111222345778999999998899999999999999999998 999986543211 0111 111000
Q ss_pred cccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 314 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 314 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
.+. .+......+.+++.+||+.+|++||++.+|++.|..+
T Consensus 262 -----~~~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 -----RMA----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----cCC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000 1111234688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=333.92 Aligned_cols=239 Identities=27% Similarity=0.340 Sum_probs=193.2
Q ss_pred ceeeecCcEEEEEEEE---CCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccC
Q 012761 89 SFIGEGGFGRVYKGWL---ESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMP 163 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~---~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~ 163 (457)
+.||+|+||.||+++. ..+|..||+|++...... ....+..|+.++..++||||+++++++.+.+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999876 356899999999754321 23456789999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCc
Q 012761 164 LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS 243 (457)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 243 (457)
+|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... .
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~ 152 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--E 152 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC--C
Confidence 9999999865 456899999999999999999999999 999999999999999999999999998753221 1
Q ss_pred cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccC
Q 012761 244 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLE 323 (457)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 323 (457)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+......
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~i~~~~~~---------- 216 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTMILKAKLG---------- 216 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHHHHcCCCC----------
Confidence 2233467999999999999888999999999999999999999999754321 111111111110
Q ss_pred CCCChHhHHHHHHHHHHcchhhcCCCCChHH
Q 012761 324 GRYPIRGLYQALAVASMCIQEQAATRPLIGD 354 (457)
Q Consensus 324 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 354 (457)
++......+.+++.+||+.+|.+||++.+
T Consensus 217 --~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 --MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11112345778999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=339.13 Aligned_cols=248 Identities=25% Similarity=0.301 Sum_probs=195.7
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|++.+.||+|+||.||++.+..+++.||||++.... ......+..|+.++..++||||+++++++.+.+.++|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999999999999999997432 222356778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999975 456899999999999999999999999 99999999999999999999999999864321
Q ss_pred CCC---------------------------------ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCC
Q 012761 240 GDK---------------------------------SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286 (457)
Q Consensus 240 ~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~ 286 (457)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 100 00112357999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCCh
Q 012761 287 KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 352 (457)
Q Consensus 287 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 352 (457)
.||....+... ...+...... ..+.+. . .....+.+++.+|+. +|.+|++.
T Consensus 234 ~Pf~~~~~~~~------~~~i~~~~~~--~~~p~~----~--~~s~~~~~li~~l~~-~p~~R~~~ 284 (360)
T cd05627 234 PPFCSETPQET------YRKVMNWKET--LVFPPE----V--PISEKAKDLILRFCT-DSENRIGS 284 (360)
T ss_pred CCCCCCCHHHH------HHHHHcCCCc--eecCCC----C--CCCHHHHHHHHHhcc-ChhhcCCC
Confidence 99976543211 1111110000 001110 0 122456778877764 99999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=331.91 Aligned_cols=241 Identities=25% Similarity=0.320 Sum_probs=191.6
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHH-HHHHhcCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEV-LMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~-~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.||+|+||.||+|++..++..||+|++..... .....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999975321 1223344444 456788999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..... ...
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~ 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNG 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc--CCC
Confidence 999999975 456788899999999999999999999 99999999999999999999999999874211 122
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 324 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 324 (457)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+..... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~----~~~----- 216 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNKPL----QLK----- 216 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHHhCCc----CCC-----
Confidence 234467999999999999989999999999999999999999999754321 11111111110 011
Q ss_pred CCChHhHHHHHHHHHHcchhhcCCCCChHHHH
Q 012761 325 RYPIRGLYQALAVASMCIQEQAATRPLIGDVV 356 (457)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~ 356 (457)
......+.+++..||+.+|.+||++.+.+
T Consensus 217 ---~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 217 ---PNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred ---CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 11234678999999999999999987544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=327.71 Aligned_cols=264 Identities=25% Similarity=0.366 Sum_probs=206.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECC-------CCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCceeeEEEEecC
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLES-------TGQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADG 152 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 152 (457)
.++|.+.+.||+|+||.||++++.. +...||+|.+..... .....+..|+.++..+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3579999999999999999998643 235799999975422 2235678899999999 799999999999999
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL 220 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl 220 (457)
+..++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999975322 1245899999999999999999999999 9999999999999
Q ss_pred cCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 012761 221 EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQN 299 (457)
Q Consensus 221 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~ 299 (457)
+.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----- 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence 9999999999999875432221111222234568999999988889999999999999999998 8888864321
Q ss_pred chhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 300 LVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 300 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
...... +.... .. ..+......+.+++.+||+.+|.+||++.+|++.|..+...
T Consensus 249 -~~~~~~-~~~~~----~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 249 -EELFKL-LKEGH----RM------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred -HHHHHH-HHcCC----CC------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 111111 11000 00 11112235778899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=323.24 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=196.2
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCH
Q 012761 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 167 (457)
Q Consensus 91 lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 167 (457)
||+|+||.||+++...+|+.||+|.+...... ....+..|+.+++.++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999753222 233456799999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccc
Q 012761 168 EDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 247 (457)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 247 (457)
.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++...... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~ 152 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTIT 152 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceee
Confidence 9888642 2345889999999999999999999999 999999999999999999999999998753322 1223
Q ss_pred cccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCC
Q 012761 248 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYP 327 (457)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 327 (457)
...|++.|+|||++.+..++.++|||||||++|||++|+.||....... ............. +.. ...
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~------~~~-~~~--- 220 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLEDE------VKF-EHQ--- 220 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhccc------ccc-ccc---
Confidence 3568999999999998889999999999999999999999996543211 1111111111100 000 001
Q ss_pred hHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 328 IRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 328 ~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
....++.+|+..||+.+|.+||+++|+++.+
T Consensus 221 -~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 221 -NFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred -cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 1234678999999999999999998876433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=319.24 Aligned_cols=258 Identities=27% Similarity=0.452 Sum_probs=204.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCe---EEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQ---VVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
.++|...+.||+|+||.||+|++..++. .+|+|.+..... .....+..|+.++..++||||+++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4578888999999999999999876554 799999875432 224568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++++|.+++.. ....+++.+++.++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999975 2356899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCccc-cccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 238 PVGDKSHV-STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 238 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
........ ......++.|+|||++....++.++|||||||++|||++ |+.||...... .+...+ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i-~~~~--- 227 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAI-NDGF--- 227 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHH-hcCC---
Confidence 32221111 111223457999999998889999999999999999997 99999654321 111111 1110
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
..+. +......+.+++.+||+.+|.+||++.+|++.|+++
T Consensus 228 --~~~~-----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 --RLPA-----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --CCCC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011 111234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=315.59 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=204.9
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+|.+.+.||+|+||.||+|.+..++..|++|.+..... .....+..|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 47888999999999999999999999999999875432 2345688899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~- 154 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN- 154 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc-
Confidence 9999999999763 2457899999999999999999999998 999999999999999999999999998753322
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
........|++.|+|||++.+..++.++|||||||++|+|++|+.||...... .+. ..... ... +.
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~---~~~~~------~~~-~~ 220 (256)
T cd08529 155 -TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALI---LKIIR------GVF-PP 220 (256)
T ss_pred -cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHc------CCC-CC
Confidence 12223356889999999999888999999999999999999999999654311 111 11111 011 11
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
+.. .....+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VSQ----MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred Ccc----ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111 123468899999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=319.29 Aligned_cols=258 Identities=26% Similarity=0.364 Sum_probs=198.9
Q ss_pred CCccceeeecCcEEEEEEEECCCCe--EEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecC------Ce
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQ--VVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG------DQ 154 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~ 154 (457)
|.+.+.||+|+||.||+|.+..++. .||+|.+.... ......+..|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567889999999999999877665 68999887542 22235688899999999999999999987532 24
Q ss_pred eeEEEeccCCCCHHHhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 232 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFG 232 (457)
.+++|||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999874321 22356899999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcc
Q 012761 233 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDR 311 (457)
Q Consensus 233 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 311 (457)
++................+++.|+|||++.+..++.++|||||||++|||++ |..||...... .+. ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~----~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIY----DYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHHcC
Confidence 9986433221111122345678999999998899999999999999999999 78888653221 111 111111
Q ss_pred cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 312 RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 312 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
... . .+......+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 231 ~~~------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL------K----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC------C----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 100 0 1112234578999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=328.56 Aligned_cols=238 Identities=26% Similarity=0.348 Sum_probs=190.5
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHH-HHHHhcCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEV-LMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~-~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
++||+|+||.||+|++..++..||+|++..... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999975322 1223344554 467889999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..... ...
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~ 151 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEE 151 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCC
Confidence 999988865 456888999999999999999999999 99999999999999999999999999874211 112
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 324 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 324 (457)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+.... +
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~----------~-- 213 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNILHKP----------L-- 213 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHhcCC----------C--
Confidence 23346799999999999988999999999999999999999999965431 11111111110 0
Q ss_pred CCChHhHHHHHHHHHHcchhhcCCCCChH
Q 012761 325 RYPIRGLYQALAVASMCIQEQAATRPLIG 353 (457)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 353 (457)
.++......+.+++.+||+.+|.+||+..
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11222345688999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=322.24 Aligned_cols=274 Identities=28% Similarity=0.382 Sum_probs=202.6
Q ss_pred hcCCCccceeeecCcEEEEEEEE----CCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEec--CCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWL----ESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~ 155 (457)
.++|++.+.||+|+||.||++.. ..++..||||.+........+.+..|+.+++.++||||+++++++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 35788999999999999999974 34688999999876554445678899999999999999999998754 3468
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 999999999999999975 2346899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCccc-cccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 236 LGPVGDKSHV-STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 236 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
.......... .....++..|+|||++.+..++.++|||||||++|||++|..++......-...+.......... ..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 235 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV-YHL 235 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccch-HHH
Confidence 6433322111 11122345699999998888999999999999999999998765432110000000000000000 000
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
...+.....-..+......+.+|+.+||+.+|++|||+.+|+..|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000000000001112234688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=321.10 Aligned_cols=269 Identities=28% Similarity=0.409 Sum_probs=203.4
Q ss_pred CCccceeeecCcEEEEEEEE----CCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecC--CeeeE
Q 012761 85 FRPESFIGEGGFGRVYKGWL----ESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQRLL 157 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 157 (457)
|...+.||+|+||+||++.. ..++..||+|.+..... .....+.+|+.+++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988653 34678999999976432 2346788999999999999999999988653 46889
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999965 35999999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCcc-ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 238 PVGDKSH-VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 238 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
....... ......++..|+|||++....++.++|||||||++|||++|..||...... ...+..+....... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~-~~~~~ 235 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTV-VRLIE 235 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccch-hhhhh
Confidence 3322111 112234566799999998888999999999999999999999998653321 11111111100000 00111
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
+.+.......+......+.+++..||+.+|++||++.+|++.|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111111112223457889999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=324.84 Aligned_cols=265 Identities=23% Similarity=0.378 Sum_probs=202.4
Q ss_pred cCCCccceeeecCcEEEEEEEECCC--------------CeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLEST--------------GQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIG 147 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~--------------~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~ 147 (457)
++|++.+.||+|+||.||++++..+ ...||||.+...... ....+.+|+.++..++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5799999999999999999987543 235899998754222 2356889999999999999999999
Q ss_pred EEecCCeeeEEEeccCCCCHHHhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeE
Q 012761 148 YCADGDQRLLVYEFMPLGSLEDHLHDLPP--------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNIL 219 (457)
Q Consensus 148 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NIL 219 (457)
++...+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999864211 1124789999999999999999999999 999999999999
Q ss_pred EcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh--CCCCCCCCCCCCc
Q 012761 220 LEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT--GRKAIDSTRPHGE 297 (457)
Q Consensus 220 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt--G~~p~~~~~~~~~ 297 (457)
++.++.+||+|||++................++..|+|||++..+.++.++|||||||++|+|++ |..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence 99999999999999875433222222223345778999999998899999999999999999998 5567654332
Q ss_pred ccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 298 QNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 298 ~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
..+.......+........... +......+.+|+.+||+.+|++||++.+|++.|.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQ-------TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHHhhhhccccccCCC-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111111111100000001 1112247899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=341.15 Aligned_cols=261 Identities=28% Similarity=0.412 Sum_probs=208.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCe---E-EEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQ---V-VAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~---~-vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 154 (457)
.++..+.+.||+|.||.||+|.++..+. . ||||...... .....+|++|+++++.++|||||++||++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3455666899999999999999876422 3 8999987532 2344689999999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
++||||+|.||+|.++|+.. ...++..+++.++.+.|.||+|||+++ +|||||-.+|+|++.++.+||+|||++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred cEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999999873 346999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccc
Q 012761 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRK 313 (457)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 313 (457)
+.......... ..--...|+|||.+..+.|+.++|||||||++||+++ |..||.+.... .+..++ ..+..
T Consensus 310 ~~~~~~~~~~~--~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~kI---~~~~~- 380 (474)
T KOG0194|consen 310 RAGSQYVMKKF--LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAKI---VKNGY- 380 (474)
T ss_pred cCCcceeeccc--cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHHH---HhcCc-
Confidence 86431111110 1123568999999999999999999999999999999 88888765432 111111 11111
Q ss_pred cccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 314 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 314 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
.-..+......+..++.+|+..+|++||+|.++.+.|+.+....
T Consensus 381 ---------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 381 ---------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred ---------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 11112233456777888999999999999999999999998754
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=325.19 Aligned_cols=261 Identities=27% Similarity=0.412 Sum_probs=203.9
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCe--EEEEEEeccCC-CcChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQ--VVAVKQLDRNG-LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~i~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV 158 (457)
++|.+.+.||+|+||.||+|....++. .+++|.+.... ....+.+..|+.++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999999877664 46888876422 22335688899999999 799999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCce
Q 012761 159 YEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP 226 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~ 226 (457)
|||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999975321 1235899999999999999999999999 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhh
Q 012761 227 KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWAR 305 (457)
Q Consensus 227 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~ 305 (457)
||+|||++...... ........+..|+|||++....++.++|||||||++|||++ |..||...... .+. .
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~---~ 229 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELY---E 229 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH---H
Confidence 99999998632111 01111123457999999988889999999999999999997 99999654321 111 1
Q ss_pred hhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 306 PLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
.+.. ...+.. +......+.+|+.+||+.+|.+||++.++++.|..+....
T Consensus 230 ~~~~-------~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 230 KLPQ-------GYRMEK----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHhc-------CCCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1100 001111 1112346789999999999999999999999998887643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=325.84 Aligned_cols=264 Identities=25% Similarity=0.378 Sum_probs=207.9
Q ss_pred hcCCCccceeeecCcEEEEEEEEC-------CCCeEEEEEEeccCC-CcChHHHHHHHHHHHhc-CCCCceeeEEEEecC
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLE-------STGQVVAVKQLDRNG-LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADG 152 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 152 (457)
..+|.+.+.||+|+||.||+|++. ..+..||+|.+.... ......+..|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467889999999999999999752 234579999987542 22346788999999999 799999999999999
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL 220 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl 220 (457)
...++||||+++++|.+++..... ....+++.+++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999975321 1246889999999999999999999999 9999999999999
Q ss_pred cCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 012761 221 EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQN 299 (457)
Q Consensus 221 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~ 299 (457)
+.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----- 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence 9999999999999975433222222223345678999999988889999999999999999998 7888754321
Q ss_pred chhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 300 LVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 300 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
..+...+ ..... . ..+......+.+++.+||+.+|.+||++.+|++.|.++...
T Consensus 246 -~~~~~~~-~~~~~---~-------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 -EELFKLL-KEGHR---M-------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -HHHHHHH-HcCCc---C-------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111111 11100 0 01112235688899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=334.06 Aligned_cols=241 Identities=25% Similarity=0.328 Sum_probs=192.1
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHH-HHHhcCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVL-MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.||+|+||.||+|++..+|+.||||++..... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999975321 12234455554 56779999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~ 151 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SD 151 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CC
Confidence 999988865 457899999999999999999999999 999999999999999999999999998742211 12
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 324 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 324 (457)
......||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+.... ..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~~~----~~~~----- 216 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILHKP----LVLR----- 216 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHcCC----ccCC-----
Confidence 233467999999999999999999999999999999999999999754321 1111111110 0111
Q ss_pred CCChHhHHHHHHHHHHcchhhcCCCCChHHHH
Q 012761 325 RYPIRGLYQALAVASMCIQEQAATRPLIGDVV 356 (457)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~ 356 (457)
......+.+++..||+.+|.+||++.+.+
T Consensus 217 ---~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 217 ---PGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred ---CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 12234677899999999999999986443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=321.64 Aligned_cols=264 Identities=24% Similarity=0.377 Sum_probs=208.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECC----CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEec-CCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLES----TGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCAD-GDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~ 155 (457)
.++|.+.+.||+|+||.||+|.+.. ++..|++|++..... .....+..|+.+++.++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 5689999999999999999999876 358899998874422 223567889999999999999999998766 5678
Q ss_pred eEEEeccCCCCHHHhhhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeec
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPD----KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDF 231 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DF 231 (457)
+++++|+++++|.+++...... ...+++.+++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998764322 256899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhc
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFND 310 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 310 (457)
|+++.....+.........++..|+|||++.+..++.++|||||||++|||++ |+.||....+. .+..+.. .
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~----~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYLK----D 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHHH----c
Confidence 99975433322222233456778999999988889999999999999999999 99999764331 1222111 1
Q ss_pred ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 311 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 311 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
... . .... .....+.+++.+||+.+|++||++.+|+..|..+..+
T Consensus 235 ~~~---~---~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 235 GYR---L---AQPI----NCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCC---C---CCCC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 100 0 0011 1124678999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=322.17 Aligned_cols=258 Identities=27% Similarity=0.440 Sum_probs=203.9
Q ss_pred cCCCccceeeecCcEEEEEEEEC-----CCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLE-----STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
++|...+.||+|+||.||++... .++..+++|.+..........+..|+.+++.++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46788899999999999999743 3467899999876544445678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCce
Q 012761 158 VYEFMPLGSLEDHLHDLPP-----------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP 226 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~ 226 (457)
||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999975321 1135899999999999999999999999 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhh
Q 012761 227 KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWAR 305 (457)
Q Consensus 227 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~ 305 (457)
+|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |.+||....... .. .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~---~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AI---E 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HH---H
Confidence 9999999875332221112223345778999999998899999999999999999998 899986543211 11 0
Q ss_pred hhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 306 PLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
.. .... ....... ....+.+|+.+||+.+|.+||++.+|+..|+
T Consensus 236 ~~-~~~~------~~~~~~~----~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 CI-TQGR------ELERPRT----CPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HH-HcCc------cCCCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00 0000 0001111 2245789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=337.21 Aligned_cols=262 Identities=22% Similarity=0.284 Sum_probs=203.7
Q ss_pred HHHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEec
Q 012761 75 FRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCAD 151 (457)
Q Consensus 75 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 151 (457)
+.++....++|.+.+.||+|+||.||+++++.+++.||+|++..... .....+..|+.++..++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 34455556899999999999999999999999999999999864221 123457789999999999999999999999
Q ss_pred CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeec
Q 012761 152 GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDF 231 (457)
Q Consensus 152 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DF 231 (457)
....++||||+++|+|.+++.. ..++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999865 35888899999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhcC----CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhh
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG----QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL 307 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 307 (457)
|++....... .......+||+.|+|||++... .++.++|||||||++|||++|..||..... ......+
T Consensus 187 G~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i 259 (371)
T cd05622 187 GTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKI 259 (371)
T ss_pred CceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHH
Confidence 9997532211 1122346799999999998754 378999999999999999999999975432 1111111
Q ss_pred hhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCC--CCChHHHHHHH
Q 012761 308 FNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAAT--RPLIGDVVTAL 359 (457)
Q Consensus 308 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ev~~~L 359 (457)
......+ ...+ .......+.+++..||+..+.+ ||++.++++..
T Consensus 260 ~~~~~~~-~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 260 MNHKNSL-TFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HcCCCcc-cCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1111100 0000 1122346778999999844433 77888887654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=319.39 Aligned_cols=254 Identities=28% Similarity=0.412 Sum_probs=201.2
Q ss_pred HHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCceeeEEEEecC------
Q 012761 80 AATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADG------ 152 (457)
Q Consensus 80 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~------ 152 (457)
.+++.|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35677899999999999999999999999999999997543 3446788899999998 699999999998753
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecc
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 232 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFG 232 (457)
...++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence 4689999999999999998752 2356899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccchhhhh-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhh
Q 012761 233 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL 307 (457)
Q Consensus 233 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 307 (457)
++...... ........|++.|+|||++. ...++.++|||||||++|||++|..||....+... ...
T Consensus 157 ~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-----~~~-- 227 (272)
T cd06637 157 VSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFL-- 227 (272)
T ss_pred Cceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-----HHH--
Confidence 98753221 11223457899999999986 33688899999999999999999999965432111 000
Q ss_pred hhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 308 FNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 308 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.. . ...+.+. .......+.+|+.+||+.+|.+||++.+++.
T Consensus 228 ~~-~-----~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 IP-R-----NPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred Hh-c-----CCCCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 0 0011110 0112246789999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=337.15 Aligned_cols=263 Identities=26% Similarity=0.374 Sum_probs=205.1
Q ss_pred hcCCCccceeeecCcEEEEEEEEC-----CCCeEEEEEEeccCCCcC-hHHHHHHHHHHHhcC-CCCceeeEEEEecCCe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLE-----STGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLH-HSNLVNLIGYCADGDQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~-~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 154 (457)
.++|.+.+.||+|+||.||+|++. .++..||||++....... ...+..|+.+|..+. ||||+++++++.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346888899999999999999864 345689999997543222 346889999999997 9999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCC----------------------------------------------------------
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPP---------------------------------------------------------- 176 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 176 (457)
.++||||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999964321
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE
Q 012761 177 ------------------------------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL 220 (457)
Q Consensus 177 ------------------------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl 220 (457)
....+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 1234778889999999999999999998 9999999999999
Q ss_pred cCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 012761 221 EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQN 299 (457)
Q Consensus 221 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~ 299 (457)
++++.++|+|||+++...............+++.|+|||++....++.++|||||||++|||++ |..||.......
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~--- 349 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--- 349 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH---
Confidence 9999999999999975322221111223457788999999998889999999999999999998 888886543211
Q ss_pred chhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 300 LVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 300 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
.....+.... .+ ..+......+.+|+..||+.+|.+||++.+|+..|+.+.
T Consensus 350 ---~~~~~~~~~~------~~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 ---QFYNAIKRGY------RM----AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---HHHHHHHcCC------CC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0001011000 00 111122357889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=332.21 Aligned_cols=251 Identities=25% Similarity=0.290 Sum_probs=210.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcC-CCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l 157 (457)
...|.+.+.||.|.||.||+++.+.||..+|+|++.+..... ...+.+|+.+|+.+. |||||.++++|.+.+.+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 467888899999999999999999999999999998765543 357899999999999 9999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC----CCceEEeeccc
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE----GFHPKLSDFGL 233 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~----~~~~kL~DFGl 233 (457)
|||++.||.|.+.+... .+++..+..++.|++.++.|||+.+ |+||||||+|+|+.. ++.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999763 3999999999999999999999999 999999999999953 35799999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccc
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRK 313 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 313 (457)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.......... .+.....
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~~- 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGDF- 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCCC-
Confidence 987443 334566899999999999998999999999999999999999999998765322111 1111111
Q ss_pred cccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 314 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 314 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.....+-+.....+.+++..|+..||.+|+++.++++
T Consensus 256 -------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 -------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1111111123557889999999999999999999988
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=316.09 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=200.5
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
.+|++.+.||+|+||.||++.++. +..+|+|++..... ....+..|+.+++.++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 358888999999999999998864 67899999875432 3457888999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~- 154 (256)
T cd05059 82 ANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ- 154 (256)
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc-
Confidence 999999999752 346899999999999999999999999 9999999999999999999999999987532111
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
........++..|+|||++.+..++.++|||||||++|+|++ |..||....... +.. .. . ......
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~---~~-~------~~~~~~ 221 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVE---SV-S------AGYRLY 221 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHH---HH-H------cCCcCC
Confidence 111111224457999999998899999999999999999999 899987543211 111 00 0 001111
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
. +......+.+++.+||+.+|++||++.+|++.|
T Consensus 222 ~----~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 R----PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred C----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1 111234688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=321.53 Aligned_cols=251 Identities=26% Similarity=0.370 Sum_probs=206.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||.|+||.||++++..++..||+|.+........+.+..|+.+++.++||||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36899999999999999999999888999999999876555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999864 45889999999999999999999999 9999999999999999999999999987532222
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
.......+++.|+|||.+.+..++.++|||||||++|+|++|..||....+.... .... ... .+.
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--~~~~----~~~-------~~~ 234 (297)
T cd06656 170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YLIA----TNG-------TPE 234 (297)
T ss_pred --cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe--eeec----cCC-------CCC
Confidence 1223356889999999999888999999999999999999999999764432110 0000 000 000
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+ ..+......+.+++.+||+.+|.+||++.+|++
T Consensus 235 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 L--QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 011112345778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=317.16 Aligned_cols=253 Identities=28% Similarity=0.449 Sum_probs=202.8
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChH--HHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR--EFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~--~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
|++.+.||+|+||+||++++..+++.||+|++......... ....|+.++..++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 67789999999999999999999999999999876443322 2355999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++++|.+++.. ...+++..++.++.||+.||.+||+.+ |+|+||||+|||++.++.++|+|||++... ...
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SEN 151 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TST
T ss_pred ccccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--ccc
Confidence 99999999973 467899999999999999999999999 999999999999999999999999998753 122
Q ss_pred ccccccccccccccchhhhh-cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 243 SHVSTRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
........++..|+|||++. +..++.++||||||+++|+|++|..||....... ............. ...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~---~~~~~~~~~~~~~-----~~~- 222 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD---QLEIIEKILKRPL-----PSS- 222 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH---HHHHHHHHHHTHH-----HHH-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchh---hhhhhhhcccccc-----ccc-
Confidence 23344567899999999998 7789999999999999999999999997651111 1111111110000 000
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.. ........+.+++..||+.+|++||++.++++
T Consensus 223 ~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 223 SQ--QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TT--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cc--ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00011267899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=318.67 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=199.9
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
++|.+.++||+|+||.||+|++..+++.||+|++..... .....+.+|+.++..++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 368888999999999999999999999999999875422 2235688999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999996542 3678889999999999999999999 999999999999999999999999998743211
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCccc-chhhhhhhhhcccccccccCC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN-LVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~d~ 320 (457)
......||..|+|||++.+..++.++|||||||++|+|++|+.||.......... ...+....... ..+
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~ 218 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-------DPP 218 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-------CCC
Confidence 2233578999999999998889999999999999999999999997543221110 01111110000 011
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.+. .......+.+++.+||+.+|.+||++.+++..
T Consensus 219 ~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 219 VLP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 110 11123467899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=325.18 Aligned_cols=261 Identities=27% Similarity=0.429 Sum_probs=203.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCe--EEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQ--VVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 157 (457)
.++|.+.+.||+|+||.||+|.+..++. .+++|.+..... .....+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 4688999999999999999999877765 457777654321 2335688899999999 89999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc
Q 012761 158 VYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH 225 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~ 225 (457)
||||+++++|.+++..... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 9999999999999975321 1236899999999999999999999999 999999999999999999
Q ss_pred eEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhh
Q 012761 226 PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWA 304 (457)
Q Consensus 226 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~ 304 (457)
++|+|||++...... .......++..|+|||++....++.++|||||||++|||+| |..||...... .+..
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~-- 234 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE-- 234 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHH--
Confidence 999999998632111 11111234567999999988889999999999999999998 99998654321 1111
Q ss_pred hhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 305 RPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 305 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.. ... .... .+......+.+|+.+||+.+|++||++.++++.|..+...
T Consensus 235 -~~-~~~------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 235 -KL-PQG------YRLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred -HH-hcC------CcCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 10 000 0000 1111234678999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=324.50 Aligned_cols=266 Identities=22% Similarity=0.350 Sum_probs=201.1
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
++|.+.+.||+|+||.||+|++..++..||+|.+...... ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5799999999999999999999989999999999754322 234677899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
++ ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LD-KDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 97 488888765 2345889999999999999999999999 9999999999999999999999999987532221
Q ss_pred Cccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhh--------hhhhhccc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWA--------RPLFNDRR 312 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~ 312 (457)
.......+|+.|+|||++.+ ..++.++|||||||++|+|+||+.||......+........ ++.+....
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 12223467899999999865 46899999999999999999999999765432211111000 00000000
Q ss_pred ccccccCCccCC----CCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 313 KFSKLADPRLEG----RYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 313 ~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+.....+.... .........+.+++.+||+.||.+|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000 000112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=315.23 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=203.7
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
+|.+.+.||.|+||.||++.+..++..||+|.+.... ....+.+..|+.+++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788899999999999999999999999999986532 223456788999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||+++++.++|+|||++......
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 153 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-- 153 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc--
Confidence 999999988642 2346889999999999999999999999 999999999999999999999999998753221
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCcc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
........|++.|+|||++.+..++.++||||||+++|+|++|..||..... ........... ..+ +
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~~~------~~~-~ 220 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVCQGS------YKP-L 220 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHhcCC------CCC-C
Confidence 1222345688999999999888899999999999999999999999975332 11111111100 000 1
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
+......+.+++.+||+.+|.+||++.+++..
T Consensus 221 ----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 ----PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11123457889999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=316.32 Aligned_cols=251 Identities=25% Similarity=0.385 Sum_probs=201.1
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
++|.+.+.||+|+||.||++.+.. +..||||.+..... ....+.+|+.++..++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 468888999999999999998764 45699999875432 3567899999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
.+++|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~- 154 (256)
T cd05113 82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE- 154 (256)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc-
Confidence 999999999752 236899999999999999999999999 9999999999999999999999999987532221
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
........++..|+|||++.+..++.++|||||||++|+|++ |..||...... .+.. .+..... .+
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~---~~~~~~~------~~- 221 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVE---KVSQGLR------LY- 221 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH---HHhcCCC------CC-
Confidence 111122345678999999988889999999999999999998 99998654321 1111 1111000 00
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
.+......+.+++.+||+.+|.+||++.+|+..|
T Consensus 222 ----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 222 ----RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 0111235788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=338.97 Aligned_cols=264 Identities=20% Similarity=0.208 Sum_probs=199.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++|+|+||+++++++......+||||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4479999999999999999999999999999996432 3456899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+. ++|.+++.. ....+++.+++.|+.||+.||.|||+.+ |+||||||+||||+.++.++|+|||+++......
T Consensus 242 ~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 788888864 2347999999999999999999999999 9999999999999999999999999997543322
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCc-----ccchhhhhhhhhccccccc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE-----QNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~-----~~l~~~~~~~~~~~~~~~~ 316 (457)
.........||+.|+|||++.+..++.++|||||||+||||++|..++........ ..+...+.........+..
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 22223346799999999999998999999999999999999999876543221110 1111111110000000000
Q ss_pred cc----------------CCccC-CCCC--hHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 317 LA----------------DPRLE-GRYP--IRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 317 ~~----------------d~~l~-~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.. .+... ..+. ......+.+|+..||+.||.+|||+.||++.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 00000 0000 0112357789999999999999999999863
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=321.88 Aligned_cols=265 Identities=25% Similarity=0.417 Sum_probs=203.1
Q ss_pred cCCCccceeeecCcEEEEEEEECC----------------CCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceee
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLES----------------TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNL 145 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l 145 (457)
++|++.+.||+|+||.||++.+.. ++..||+|++...... ....+..|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 579999999999999999986432 3457999998754322 23578899999999999999999
Q ss_pred EEEEecCCeeeEEEeccCCCCHHHhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCe
Q 012761 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD-------KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNI 218 (457)
Q Consensus 146 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NI 218 (457)
++++...+..++||||+++++|.+++...... ...+++.+++.++.|++.||.|||+.+ |+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 99999999999999999999999998763221 235788899999999999999999999 99999999999
Q ss_pred EEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh--CCCCCCCCCCCC
Q 012761 219 LLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT--GRKAIDSTRPHG 296 (457)
Q Consensus 219 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt--G~~p~~~~~~~~ 296 (457)
|++.++.++|+|||++................+++.|++||+...+.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999875322221112222345678999999888899999999999999999998 677876543211
Q ss_pred cccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 297 EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 297 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
+.......+..... ....+. +......+.+|+.+||+.+|.+||++.+|++.|.
T Consensus 242 ---~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 ---VIENTGEFFRDQGR--QVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ---HHHHHHHHHhhccc--cccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11111111111100 011111 1112356789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=322.47 Aligned_cols=265 Identities=21% Similarity=0.286 Sum_probs=203.7
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
++|.+.+.||+|+||.||++.+..++..||+|.+...... ....+..|+.++..++||||++++++|.+.+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4689999999999999999999999999999998754222 234578899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
+++++|.+++.. ...+++..+..++.||+.||.|||+ .+ ++|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999975 3568999999999999999999997 47 999999999999999999999999998643211
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccc-------
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRK------- 313 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------- 313 (457)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||..........+.............
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 ----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 123457889999999998888999999999999999999999998654322111111000000000000
Q ss_pred -------------cccccCCccCCCCCh-HhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 314 -------------FSKLADPRLEGRYPI-RGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 314 -------------~~~~~d~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
...+.... ....+. .....+.+++.+||+.+|++||++.+|+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000000 000000 1234588999999999999999999998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=331.59 Aligned_cols=265 Identities=23% Similarity=0.300 Sum_probs=199.9
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecC------
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADG------ 152 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------ 152 (457)
..++|.+.+.||+|+||.||++.+..+++.||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 45789999999999999999999998999999999975422 2235677899999999999999999988653
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecc
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 232 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFG 232 (457)
...++||||++ ++|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 35799999996 467776643 4888999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCccc-------------
Q 012761 233 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN------------- 299 (457)
Q Consensus 233 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~------------- 299 (457)
+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 165 ~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 165 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred ccccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9975321 122234578999999999998899999999999999999999999997543211000
Q ss_pred ---chhhhhhhhhcccccccccCCcc--------CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 300 ---LVTWARPLFNDRRKFSKLADPRL--------EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 300 ---l~~~~~~~~~~~~~~~~~~d~~l--------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
+......+.........+..+.. ....+......+.+|+.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00001111111111101110100 000111123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=310.60 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=207.1
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc----Ch----HHHHHHHHHHHhcC-CCCceeeEEEEec
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ----GN----REFLVEVLMLSLLH-HSNLVNLIGYCAD 151 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~----~~----~~~~~E~~~l~~l~-hpniv~l~~~~~~ 151 (457)
..+.|...+.||.|..++|-++.++.+|..+|+|++...... .. +.-..|+.||+++. ||+|+++.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 356788889999999999999999999999999999742211 11 23457999999985 9999999999999
Q ss_pred CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeec
Q 012761 152 GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDF 231 (457)
Q Consensus 152 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DF 231 (457)
+..+++|+|.|+.|.|.|+|.. .-.+++....+|+.|++.|++|||..+ ||||||||+|||++++.+++|+||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 9999999999999999999976 678999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhc------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhh
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT------GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWAR 305 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~ 305 (457)
|+++..+.+. .....||||+|+|||.+.- ..|+...|+|++|||+|.|+.|.+||..... .-..+
T Consensus 168 GFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------mlMLR 238 (411)
T KOG0599|consen 168 GFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------MLMLR 238 (411)
T ss_pred ceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH------HHHHH
Confidence 9999766554 3456899999999998853 3688999999999999999999999964321 01111
Q ss_pred hhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 306 PLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
-+...... .-.|... +....+.+||.+||+.||.+|.|++|++..
T Consensus 239 ~ImeGkyq---F~speWa-----dis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 239 MIMEGKYQ---FRSPEWA-----DISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHhcccc---cCCcchh-----hccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 11111111 1111111 234567899999999999999999999853
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=314.40 Aligned_cols=247 Identities=26% Similarity=0.400 Sum_probs=194.6
Q ss_pred eeeecCcEEEEEEEE--CCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCC
Q 012761 90 FIGEGGFGRVYKGWL--ESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 165 (457)
Q Consensus 90 ~lG~G~~g~Vy~~~~--~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~g 165 (457)
.||+|+||.||+|.+ ..++..||+|++..... ...+.+..|+.+++.+.||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 45678999999875432 22357889999999999999999999885 45678999999999
Q ss_pred CHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc-
Q 012761 166 SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH- 244 (457)
Q Consensus 166 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~- 244 (457)
+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||.|||++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999965 346899999999999999999999999 9999999999999999999999999987533222111
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLE 323 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 323 (457)
......++..|+|||.+....++.++|||||||++|||++ |..||...... .+.... ..... +.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~i----~~~~~------~~-- 218 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQMI----ESGER------ME-- 218 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HCCCC------CC--
Confidence 1122234578999999988889999999999999999998 99999754321 111111 11100 11
Q ss_pred CCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHh
Q 012761 324 GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 361 (457)
Q Consensus 324 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 361 (457)
.+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 219 --~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 --CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred --CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111223467899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=335.06 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=200.3
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecCC-----eee
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD-----QRL 156 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~ 156 (457)
+|.+.+.||+|+||.||++.+..++..||||++.... ......+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5788999999999999999998899999999986432 223356889999999999999999999998776 789
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 678887754 457999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccch-hh-----------
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV-TW----------- 303 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~-~~----------- 303 (457)
..... ........+|+.|+|||++.+. .++.++|||||||++|||++|+.||....+....... ..
T Consensus 153 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 43222 1222334678999999998864 5799999999999999999999999765432111100 00
Q ss_pred ----hhhhhhcccccccccCCccCC--CCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 304 ----ARPLFNDRRKFSKLADPRLEG--RYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 304 ----~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
....+.... ...+.+.. .........+.+|+.+||+.||++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGP----HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCC----CCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 00000000 0111124567899999999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=312.17 Aligned_cols=252 Identities=21% Similarity=0.273 Sum_probs=206.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
+++|.+-..||+|.|+.||++.+..+|+.+|+|++.... ..+.+++.+|+.|.+.|+||||+++++.+.+....|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 467888889999999999999999999999999997543 335678999999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc---CCCceEEeecccccc
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE---EGFHPKLSDFGLAKL 236 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~ 236 (457)
|+|.|++|..-+-. ...+++..+--.+.||+++|.|+|.++ |||||+||+|+||. ..--+||+|||+|..
T Consensus 90 e~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999998776654 356788888999999999999999999 99999999999994 344699999999986
Q ss_pred CCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.. ........+|||.|||||++...+|+..+|||+.|||||-||.|.+||.+...+ .+.+ .+.... .
T Consensus 163 l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye---~I~~g~----y 229 (355)
T KOG0033|consen 163 VN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYE---QIKAGA----Y 229 (355)
T ss_pred eC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHH---HHhccc----c
Confidence 44 233445678999999999999999999999999999999999999999874322 1111 111111 1
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
-+++.-.. .....+.+|+.+||..||.+|.|+.|.+.
T Consensus 230 d~~~~~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 230 DYPSPEWD----TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CCCCcccC----cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 12221111 22346789999999999999999999874
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=320.63 Aligned_cols=266 Identities=26% Similarity=0.347 Sum_probs=207.9
Q ss_pred ccHHHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCceeeEEEEe-
Q 012761 73 FTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCA- 150 (457)
Q Consensus 73 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~- 150 (457)
+.+..+..+.++|.+.+.||+|+||.||++++..++..||+|++.... .....+..|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445566678899999999999999999999999999999999886432 2245678899999999 6999999999884
Q ss_pred ----cCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCce
Q 012761 151 ----DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP 226 (457)
Q Consensus 151 ----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~ 226 (457)
..+..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345789999999999999988653334567899999999999999999999999 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccccccccchhhhhc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccch
Q 012761 227 KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-----GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV 301 (457)
Q Consensus 227 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~ 301 (457)
+|+|||++....... .......|++.|+|||++.. ..++.++|||||||++|||++|+.||....+.. .+.
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~ 239 (286)
T cd06638 164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALF 239 (286)
T ss_pred EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHh
Confidence 999999987532221 12223468999999998753 457899999999999999999999996543211 111
Q ss_pred hhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 302 TWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 302 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
... . .....+.++. .....+.+++.+||+.+|.+||++.||++.+
T Consensus 240 ~~~----~--~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 KIP----R--NPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hcc----c--cCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000 0 0000111111 1123588899999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=313.20 Aligned_cols=251 Identities=33% Similarity=0.466 Sum_probs=204.2
Q ss_pred ceeeecCcEEEEEEEECCC---CeEEEEEEeccCCCcC-hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLEST---GQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~---~~~vavK~i~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.||+|+||.||+|.+... +..|++|.+....... ...+..|+.++..++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999865 8899999998654333 56788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 165 GSLEDHLHDLPPD-----KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 165 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
++|.+++...... ...+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999863221 467999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
...........+++.|+|||.+....++.++|||||||++|+|++ |..||...... .+.. .... .. ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~---~~~~-~~---~~- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLE---YLRK-GY---RL- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHH---HHHc-CC---CC-
Confidence 332222334567889999999988889999999999999999999 69999765321 1111 1110 00 00
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
..+......+.+++.+||+.+|.+||++.+++..|
T Consensus 227 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 227 ------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred ------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11112235788999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=317.68 Aligned_cols=257 Identities=25% Similarity=0.419 Sum_probs=203.0
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCe---EEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQ---VVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.+|++.+.||+|+||.||+|.+..++. .||||.+.... ......|..|+.+++.++||||+++++++.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457889999999999999999876654 69999987542 22345788999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++++|.+++... ...+++.+++.++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999998752 346899999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCCcccccc-cc--ccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 239 VGDKSHVSTR-VM--GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 239 ~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
.......... .. .+..|+|||++.+..++.++|||||||++|||++ |..||...... .+..++.. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~----~~-- 228 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQ----DY-- 228 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHc----CC--
Confidence 2221111111 11 2457999999998899999999999999999886 99998654321 12222111 00
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
.... +......+.+++..||+.+|.+||++.+|+..|+.+
T Consensus 229 ----~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 ----RLPP----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----cCCC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 111224578899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=320.07 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=201.2
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.|+..+.||+|+||.||++.+..+++.||||.+....... ...+..|+.+++.++|+||+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3778889999999999999999999999999987543322 2356789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999999998642 2346899999999999999999999999 999999999999999999999999998753222
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||........ ... ....... . ..
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~~-~~~~~~~------~-~~ 222 (285)
T cd05630 156 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REE-VERLVKE------V-QE 222 (285)
T ss_pred c---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HHH-HHhhhhh------h-hh
Confidence 1 12234789999999999988999999999999999999999999975432110 000 0000000 0 00
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCC-----hHHHHH
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVT 357 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ev~~ 357 (457)
.++......+.+|+..||+.+|.+||+ +.|+++
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 ----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 111112345789999999999999999 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=317.14 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=203.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||.||+|++..++..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 35788889999999999999999989999999999765444445678899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.. ...+++.+++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~-- 158 (267)
T cd06645 88 CGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITA-- 158 (267)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccC--
Confidence 999999999875 456899999999999999999999999 99999999999999999999999999864321
Q ss_pred Cccccccccccccccchhhhh---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.........|++.|+|||++. ...++.++|||||||++|+|++|..||....+... +.... .. ...
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~~~----~~-----~~~ 227 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMT----KS-----NFQ 227 (267)
T ss_pred cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHhhh----cc-----CCC
Confidence 112223457899999999974 45688999999999999999999999865432111 00000 00 001
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+.+... ......+.+++.+||+.+|++||++.+|+.
T Consensus 228 ~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 228 PPKLKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCccccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 1111110 011235778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=320.11 Aligned_cols=260 Identities=25% Similarity=0.419 Sum_probs=204.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECC-----CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLES-----TGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 155 (457)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... .....+..|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 4679999999999999999998743 578999999875432 2235688899999999999999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccC
Q 012761 156 LLVYEFMPLGSLEDHLHDLPP------------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 217 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~N 217 (457)
++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999974221 1235789999999999999999999999 9999999999
Q ss_pred eEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 012761 218 ILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHG 296 (457)
Q Consensus 218 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~ 296 (457)
||++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999874322221111222334667999999988899999999999999999997 88888543221
Q ss_pred cccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHh
Q 012761 297 EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 361 (457)
Q Consensus 297 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 361 (457)
.+...+ .... .. . .+......+.+++.+||+.+|.+||++.||++.|++
T Consensus 240 -----~~~~~~-~~~~----~~--~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -----EVIYYV-RDGN----VL--S----CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHHHHH-hcCC----CC--C----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111111 1110 00 0 111123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=319.79 Aligned_cols=263 Identities=25% Similarity=0.379 Sum_probs=204.5
Q ss_pred HhcCCCccceeeecCcEEEEEEEECC-----CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCe
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLES-----TGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ 154 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 154 (457)
..++|.+.+.||+|+||.||+|.++. .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999997652 345899998865432 223457889999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEE
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPP------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKL 228 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL 228 (457)
.++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999975321 1244577889999999999999999999 999999999999999999999
Q ss_pred eeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhh
Q 012761 229 SDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPL 307 (457)
Q Consensus 229 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 307 (457)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||...... .+.. ..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~---~~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLK---FV 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---HH
Confidence 99999875332222122222345678999999998899999999999999999998 78888653321 1111 11
Q ss_pred hhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 308 FNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 308 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
.. ... +.. +......+.+++.+||+.+|++||++.++++.|....
T Consensus 235 ~~-~~~------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 MD-GGY------LDQ----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred Hc-CCC------CCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 10 000 001 1112346889999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=330.44 Aligned_cols=194 Identities=23% Similarity=0.332 Sum_probs=168.8
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
...+|.+.+.||+|+||.||+|++..++..||+|+.... ....|+.+++.++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 456899999999999999999999998999999975433 23568999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+. ++|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 138 ~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred ccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 995 688888864 3457899999999999999999999999 999999999999999999999999998742211
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 290 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~ 290 (457)
.......||+.|+|||++.+..++.++|||||||++|||+++..++.
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 12234578999999999999899999999999999999999766553
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=331.00 Aligned_cols=265 Identities=23% Similarity=0.295 Sum_probs=198.6
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecCC-----
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD----- 153 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 153 (457)
..++|.+.+.||+|+||.||++++..++..||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999999999999999997542 223456788999999999999999999986543
Q ss_pred -eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecc
Q 012761 154 -QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 232 (457)
Q Consensus 154 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFG 232 (457)
..++||||+. ++|...+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 4799999996 466666642 4788899999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc------------cc
Q 012761 233 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ------------NL 300 (457)
Q Consensus 233 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~------------~l 300 (457)
++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .+
T Consensus 169 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 169 LARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred Ccccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 9874221 12223457899999999999989999999999999999999999999764321100 00
Q ss_pred h----hhhhhhhhcccccc-----cccCCccC---CCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 301 V----TWARPLFNDRRKFS-----KLADPRLE---GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 301 ~----~~~~~~~~~~~~~~-----~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
. .....+........ ++...-+. ..........+.+|+.+||+.||++|||+.|++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 00000000000000 00000000 00000113467899999999999999999999763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=314.26 Aligned_cols=255 Identities=28% Similarity=0.405 Sum_probs=202.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
..+|.+.+.||+|+||.||+|.+..+ ..||+|++..... ....+..|+.+++.++||||+++++++. .+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 35699999999999999999998765 5699999975432 3467889999999999999999999875 4568999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+|+||||+|||+++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 9999999999752 2346789999999999999999999999 9999999999999999999999999997543222
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
. .......++..|+|||++.+..++.++|||||||++|+|++ |..||....... +. ... ... ...
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~---~~~-~~~------~~~ 222 (262)
T cd05071 157 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VL---DQV-ERG------YRM 222 (262)
T ss_pred c-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HH---HHH-hcC------CCC
Confidence 1 11122346678999999988899999999999999999999 888886543211 10 000 000 000
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
. .+......+.+|+.+|++.+|++||++.++++.|+..
T Consensus 223 ~----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 P----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred C----CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0 1112334678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=317.70 Aligned_cols=265 Identities=24% Similarity=0.313 Sum_probs=194.9
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhc---CCCCceeeEEEEec-----CC
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLL---HHSNLVNLIGYCAD-----GD 153 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l---~hpniv~l~~~~~~-----~~ 153 (457)
+|.+.+.||+|+||.||+|++..+++.||+|.+...... ....+..|+.++..+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 488899999999999999999999999999998754222 223456677766655 69999999998864 34
Q ss_pred eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 233 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGl 233 (457)
..++||||++ ++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 5799999997 5888888652 2345899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCc-ccchhhhhhhhhcc-
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE-QNLVTWARPLFNDR- 311 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~- 311 (457)
+...... .......||..|+|||++.+..++.++|||||||++|+|++|++||........ ..+..+........
T Consensus 155 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 8753221 122345689999999999988999999999999999999999999965432111 00111000000000
Q ss_pred ---ccc-ccccCCccC---CCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 312 ---RKF-SKLADPRLE---GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 312 ---~~~-~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
... .....+... ..........+.+++.+||+.||++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 000000000 0001112346789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.25 Aligned_cols=253 Identities=29% Similarity=0.433 Sum_probs=201.5
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
++|++.+.||+|+||.||+|.+.. +..||+|.+..... ....+.+|+.+++.++|+||+++++++. ....++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred HHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 578899999999999999998764 67799999876443 3467899999999999999999999885 45688999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++++|.+++... ....+++.+++.++.+++.||.|||+.+ |+|+||||+|||+++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 83 SKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 999999999752 2346899999999999999999999999 99999999999999999999999999975332211
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||...... .+.... ... ..+
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~----~~~------~~~- 222 (260)
T cd05070 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQV----ERG------YRM- 222 (260)
T ss_pred -ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----HcC------CCC-
Confidence 11122345678999999988889999999999999999999 88998654321 111111 000 001
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHh
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 361 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 361 (457)
..+......+.+|+.+||+.+|.+||++.++++.|+.
T Consensus 223 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 ---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111223568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=311.45 Aligned_cols=250 Identities=27% Similarity=0.358 Sum_probs=205.3
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
++|.+.+.||.|+||.||+|.+..++..|++|.+..... ...+.+|+.+++.++||||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678999999999999999999998889999999976532 578999999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~- 153 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM- 153 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc-
Confidence 99999999865 2467899999999999999999999999 9999999999999999999999999987533222
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCcc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
.......|+..|+|||++.+..++.++|||||||++|+|++|+.||....+.... ... . ....+.+
T Consensus 154 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~~~-------~----~~~~~~~ 219 (256)
T cd06612 154 -AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--FMI-------P----NKPPPTL 219 (256)
T ss_pred -cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--hhh-------c----cCCCCCC
Confidence 1223345788999999998889999999999999999999999999754332110 000 0 0000111
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
. .+......+.+++.+||+.+|.+||++.+|+.
T Consensus 220 ~--~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 S--DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred C--chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0 11112346888999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=312.24 Aligned_cols=254 Identities=26% Similarity=0.347 Sum_probs=207.1
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
++|.+.+.||.|+||.||+|.+..++..+++|++..........+..|+.+++.++||||+++++++.+.+.++++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57899999999999999999998889999999998765555678899999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-- 154 (262)
T cd06613 83 GGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-- 154 (262)
T ss_pred CCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh--
Confidence 99999999875 2357899999999999999999999999 999999999999999999999999998753221
Q ss_pred ccccccccccccccchhhhhcC---CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTG---QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
........++..|+|||.+.+. .++.++|||||||++|+|++|..||....+... ..... .. ....
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~~~----~~-----~~~~ 223 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFLIS----KS-----NFPP 223 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH----hc-----cCCC
Confidence 1122335688899999998776 789999999999999999999999975442111 10000 00 0011
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+.+ .........+.+++.+||+.+|.+||++.+|+.
T Consensus 224 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111 112233457889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=328.59 Aligned_cols=264 Identities=26% Similarity=0.398 Sum_probs=202.1
Q ss_pred hcCCCccceeeecCcEEEEEEEE-----CCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhc-CCCCceeeEEEEecC-C
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWL-----ESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLL-HHSNLVNLIGYCADG-D 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~ 153 (457)
.++|++.+.||+|+||.||+|.+ ..+++.||||++...... ....+..|+.++..+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35799999999999999999984 345789999999754322 235678899999999 689999999988654 4
Q ss_pred eeeEEEeccCCCCHHHhhhcCCC---------------------------------------------------------
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPP--------------------------------------------------------- 176 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 176 (457)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999864210
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcccccccc
Q 012761 177 ------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 250 (457)
Q Consensus 177 ------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 250 (457)
....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0134788999999999999999999999 9999999999999999999999999987532222111122234
Q ss_pred ccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChH
Q 012761 251 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIR 329 (457)
Q Consensus 251 gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 329 (457)
+++.|+|||++.+..++.++|||||||++|+|++ |..||....... .+ ...+..... ...+ . .
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~----~~~~~~~~~---~~~~---~----~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF----CRRLKEGTR---MRAP---D----Y 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HH----HHHHhccCC---CCCC---C----C
Confidence 5678999999988899999999999999999997 898886532210 01 011111100 0001 0 1
Q ss_pred hHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 330 GLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 330 ~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
....+.+++..||+.+|.+||++.+|++.|+.+..
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12357899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=317.15 Aligned_cols=259 Identities=30% Similarity=0.465 Sum_probs=206.3
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCe----EEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQ----VVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
.+|.+.+.||+|+||.||+|.+..++. .||+|.+...... ....+.+|+.++..++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 578888999999999999999876654 6899988765432 33578899999999999999999999987 78899
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+|+||||+|||+++++.++|+|||++...
T Consensus 86 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 9999999999999975 2345899999999999999999999998 999999999999999999999999999764
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.............++..|+|||.+....++.++|||||||++|||++ |+.||+..... .+.. .+. ... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~---~~~-~~~---~ 229 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPD---LLE-KGE---R 229 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHH---HHh-CCC---C
Confidence 33222111122234567999999988899999999999999999998 99999765321 1111 111 110 0
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
...+ ......+.+++.+||..+|.+||++.++++.|..+...
T Consensus 230 ~~~~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 230 LPQP-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 1111 11224678899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=314.73 Aligned_cols=257 Identities=24% Similarity=0.325 Sum_probs=204.0
Q ss_pred HHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 78 LAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 78 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
+..+++++.....||+|+||.||+|++..++..|++|.+........+.+.+|+.+++.++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 34456777777889999999999999988899999999887655556678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC-CCceEEeecccc
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEAL--DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE-GFHPKLSDFGLA 234 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~-~~~~kL~DFGla 234 (457)
|+||+++++|.+++... ...+ ++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++
T Consensus 83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 83 FMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 99999999999999752 2334 78889999999999999999999 999999999999976 679999999998
Q ss_pred ccCCCCCCccccccccccccccchhhhhcC--CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccc
Q 012761 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAMTG--QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 312 (457)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 312 (457)
....... .......|++.|+|||++... .++.++|||||||++|+|++|+.||....... ...+......
T Consensus 157 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~--- 228 (268)
T cd06624 157 KRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK--- 228 (268)
T ss_pred eecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc---
Confidence 7532211 122234578999999998764 37899999999999999999999986532211 1111111000
Q ss_pred ccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 313 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 313 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..+. ++......+.+++.+||+.+|.+||++.+++.
T Consensus 229 -----~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 -----IHPE----IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -----cCCC----CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0111 12223346789999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=318.02 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=198.0
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.|+..+.||+|+||.||++.+..+++.||+|.+....... ...+..|+.+++.++|+||+.+++++...+..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677889999999999999999999999999997543222 2346789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999999988652 2346999999999999999999999999 999999999999999999999999998653222
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
. ......|+..|+|||++.+..++.++|||||||++|+|++|..||........ ...+........ .
T Consensus 156 ~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~~~~~~--------~ 222 (285)
T cd05632 156 E---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRRVLETE--------E 222 (285)
T ss_pred C---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhhhccc--------c
Confidence 1 12335689999999999988999999999999999999999999975432110 011111000000 0
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChH
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIG 353 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 353 (457)
.++......+.+|+..||+.+|++||++.
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 223 ----VYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred ----ccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 11112234578899999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=322.72 Aligned_cols=264 Identities=25% Similarity=0.395 Sum_probs=205.6
Q ss_pred cCCCccceeeecCcEEEEEEEECC-------CCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCceeeEEEEecCC
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLES-------TGQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGD 153 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 153 (457)
.+|.+.+.||+|+||.||+|++.. ....||+|.+..... .....+..|+.++..+ +||||+++++++.+..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 578899999999999999997632 345799999875422 2235678899999999 5999999999999999
Q ss_pred eeeEEEeccCCCCHHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE 221 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~ 221 (457)
..++||||+++|+|.+++..... ....+++.+++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 99999999999999999975321 2346899999999999999999999999 99999999999999
Q ss_pred CCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccc
Q 012761 222 EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNL 300 (457)
Q Consensus 222 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l 300 (457)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||....... +
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---L 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 999999999999975332221111122234567999999998899999999999999999999 888886543211 1
Q ss_pred hhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 301 VTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
... ...... . ..+......+.+++.+||+.+|++||++.++++.|..+....
T Consensus 246 ~~~----~~~~~~----~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 246 FKL----LREGHR----M------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHH----HHcCCC----C------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 111 111100 0 011122346779999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=331.94 Aligned_cols=243 Identities=27% Similarity=0.413 Sum_probs=200.3
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCH
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 167 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 167 (457)
++-||.|..|.||+|+++ ++.||||+++. .-..++..|++|.||||+.+.|+|....-+|||||||..|-|
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 455999999999999987 68999998752 223578999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccc
Q 012761 168 EDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 247 (457)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 247 (457)
...|+. ..+++......|..+||.||.|||.+. |||||||.-||||..+..|||+|||-++... +. ...-
T Consensus 200 ~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~--~~-STkM 269 (904)
T KOG4721|consen 200 YEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELS--DK-STKM 269 (904)
T ss_pred HHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhh--hh-hhhh
Confidence 999986 677888899999999999999999999 9999999999999999999999999987422 21 2223
Q ss_pred cccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCC
Q 012761 248 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYP 327 (457)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 327 (457)
.++||..|||||++.+.+.+.|+|||||||||||||||..||...... .+.|... .. .|.-..|
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVG----sN--------sL~LpvP 333 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVG----SN--------SLHLPVP 333 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEecc----CC--------cccccCc
Confidence 478999999999999999999999999999999999999999654321 2222211 01 1111222
Q ss_pred hHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 328 IRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 328 ~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
......+.-|+.+||+..|..||++++++..|+-....
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 23345677899999999999999999999999755543
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=326.85 Aligned_cols=256 Identities=23% Similarity=0.256 Sum_probs=196.8
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|++.+.||+|+||.||++++..+++.||||++.+.. ......+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999999999999999997521 122345788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999965 2356899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCccccccccccccccchhhhhc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMT-----GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
.. ........||+.|+|||++.. ..++.++|||||||++|+|++|+.||..... ......+......+
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~ 227 (331)
T cd05597 155 DG-TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHF 227 (331)
T ss_pred CC-CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcc
Confidence 21 112223469999999999873 4578899999999999999999999965432 11111111111000
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhc--CCCCChHHHHHH
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQA--ATRPLIGDVVTA 358 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP--~~RPt~~ev~~~ 358 (457)
.+ +.... .....+.+++.+||..++ ..||++.+++..
T Consensus 228 -~~--~~~~~----~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 -QF--PPDVT----DVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -cC--CCccC----CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 00001 123356777777765433 347888888765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=318.37 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=200.2
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
|++.+.||.|+||.||++.+..++..+++|.+..........+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 57778899999999999999999999999999765444456788899999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
++|..++.. ...++++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~ 158 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQ 158 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc--cc
Confidence 999998764 2457899999999999999999999999 999999999999999999999999998653211 11
Q ss_pred ccccccccccccchhhhh-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 245 VSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
......+++.|+|||++. +..++.++|||||||++|+|++|++||....+.. .+.. ..... ...+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~----~~~~~--~~~~~~ 230 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLK----IAKSE--PPTLAQ 230 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHH----HhhcC--CCCCCC
Confidence 223356899999999984 3457889999999999999999999986543210 0111 00000 001111
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+......+.+++.+||+.+|.+||++.++++
T Consensus 231 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 231 -------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112346889999999999999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=312.49 Aligned_cols=249 Identities=28% Similarity=0.465 Sum_probs=197.6
Q ss_pred ceeeecCcEEEEEEEECCCC---eEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLESTG---QVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~---~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.||+|+||.||+|+...++ ..||+|.+...... ....+..|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999876544 78999999865432 3457889999999999999999999876 4568999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++..........
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999976 236899999999999999999999999 9999999999999999999999999987543322211
Q ss_pred c-cccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCcc
Q 012761 245 V-STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 245 ~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
. .....++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ..+..++.. .. ...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~----~~---~~~---- 218 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLES----GE---RLP---- 218 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHc----CC---cCC----
Confidence 1 111223567999999998899999999999999999998 9999975432 112222211 10 000
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
.+......+.+++.+||+.+|.+||++.+|++.|..+
T Consensus 219 ---~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 ---RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1111234678999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=315.87 Aligned_cols=264 Identities=25% Similarity=0.352 Sum_probs=199.6
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+|++.+.||+|+||.||+|++..++..||||.+...... ....+..|+.+++.++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 578889999999999999999989999999998754222 235688899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+. ++|.+++.... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 154 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP- 154 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC-
Confidence 97 68988886532 2356899999999999999999999999 999999999999999999999999998753222
Q ss_pred CccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhh----------hhc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL----------FND 310 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~----------~~~ 310 (457)
........+++.|+|||++.+. .++.++|||||||++|+|+||+.||........ +....... ...
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 155 -VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred -cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchh
Confidence 1222334578899999988754 578999999999999999999999975432110 00000000 000
Q ss_pred ----ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 311 ----RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 311 ----~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...+.......+.. .......++.+++.+||+.||.+|||+.+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000000 00012346779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=332.66 Aligned_cols=245 Identities=31% Similarity=0.421 Sum_probs=204.8
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcCh---HHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
-|.-++.||.|+||.||.|++..+.+.||||.+...+.+.. .++..|+..|..|.|||++.+.|+|......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 36667789999999999999999999999999987766554 468899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|| -|+-.|+|.- .+++|.+..+..|..+.+.||.|||+.+ .||||||..||||.+.|.|||+|||.|....
T Consensus 107 YC-lGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-- 177 (948)
T KOG0577|consen 107 YC-LGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA-- 177 (948)
T ss_pred HH-hccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC--
Confidence 99 4788888765 3578999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCccccccccccccccchhhhh---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
....++|||.|||||++. .+.|+-++|||||||+..||.-.++|+...+.... ...+ ...
T Consensus 178 ----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA---LYHI----AQN------ 240 (948)
T KOG0577|consen 178 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHI----AQN------ 240 (948)
T ss_pred ----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH---HHHH----Hhc------
Confidence 234578999999999986 56899999999999999999999999876553211 1111 100
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
--|.|. .......+..++..||+.-|.+|||.++++.
T Consensus 241 esPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 241 ESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 112222 2244667888999999999999999988764
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.80 Aligned_cols=251 Identities=30% Similarity=0.471 Sum_probs=204.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||.|+||.||+|... ++.||||.+..... ....+..|+.+++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 457899999999999999999875 78999999986643 456789999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999752 2236899999999999999999999999 9999999999999999999999999997542211
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
....++..|+|||++....++.++||||||+++|+|++ |..||..... ..+.... .... ..
T Consensus 157 -----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~----~~~~------~~ 218 (256)
T cd05039 157 -----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHV----EKGY------RM 218 (256)
T ss_pred -----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----hcCC------CC
Confidence 12234567999999988889999999999999999997 9999864422 1111111 1000 00
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
..+......+.+++.+||+.+|++||++.+++++|..+
T Consensus 219 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 ----EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ----CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 01112235688999999999999999999999999653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=317.60 Aligned_cols=264 Identities=29% Similarity=0.437 Sum_probs=205.1
Q ss_pred cCCCccceeeecCcEEEEEEEECC----CCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEec--CCee
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLES----TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQR 155 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~ 155 (457)
+.|.+.+.||+|+||.||+|.+.. ++..||||++...... ....+..|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 467788999999999999998653 4789999999865443 35678999999999999999999999877 5678
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999762 336999999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCc-cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc--------cchhhhhh
Q 012761 236 LGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ--------NLVTWARP 306 (457)
Q Consensus 236 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~--------~l~~~~~~ 306 (457)
........ .......++..|+|||.+.+..++.++||||||+++|||++|..|+......... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 64322111 1111223456799999998889999999999999999999999998653221100 00000001
Q ss_pred hhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 307 LFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 307 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
.+.. ......+......+.+|+.+||+.+|.+||++.||+++|+.+
T Consensus 238 ~~~~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKE----------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHc----------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1110 000011111235688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=320.22 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=205.7
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
.+|.+.+.||.|+||.||+|.+..+++.|+||.+..........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46999999999999999999998899999999998765555677889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++++|..++.. ..+++.+++.++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~- 169 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ- 169 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc-
Confidence 99999999864 45899999999999999999999999 9999999999999999999999999987533222
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCcc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+... ........ ...+..
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~~~~~~--~~~~~~--- 237 (296)
T cd06655 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNG--TPELQN--- 237 (296)
T ss_pred -ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcC--CcccCC---
Confidence 122335688999999999888899999999999999999999999976443111 00000000 000001
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+......+.+++.+||+.+|.+||++.+++.
T Consensus 238 ----~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 238 ----PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ----cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1112235778999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=310.61 Aligned_cols=248 Identities=29% Similarity=0.397 Sum_probs=198.3
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCH
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 167 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 167 (457)
+.||.|+||.||++.+.. ++.||+|.+...... ....+..|+.+++.+.||||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 369999999999999987 899999998765443 345788999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccc
Q 012761 168 EDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 247 (457)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 247 (457)
.+++... ...+++..++.++.+++.+|.|||+++ ++||||||+|||++.++.++|+|||++.............
T Consensus 80 ~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9999652 346889999999999999999999999 9999999999999999999999999987532211111111
Q ss_pred cccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCC
Q 012761 248 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRY 326 (457)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 326 (457)
...++..|+|||.+.++.++.++|||||||++|+|++ |..||....... ..... ... .....
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~~----~~~----------~~~~~ 216 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRERI----ESG----------YRMPA 216 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHHH----hcC----------CCCCC
Confidence 2234567999999988899999999999999999999 888886543211 11111 000 00011
Q ss_pred ChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 327 PIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 327 ~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
+......+.+++.+||+.+|.+||++.||++.|.
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1122347889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=325.62 Aligned_cols=248 Identities=24% Similarity=0.345 Sum_probs=213.2
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.-|.+++.||+|.|.+|-+|++.-||..||||++++..... ...+.+|++.|+.++|||||+||.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45888889999999999999999999999999998765443 3568899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE-cCCCceEEeeccccccCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl-~~~~~~kL~DFGla~~~~~ 239 (457)
+-++|+|.++|-. ....|.+..+.+++.||+.|+.|+|+.. ||||||||+||.+ ..-|-|||+|||++..+..
T Consensus 98 LGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999976 4567999999999999999999999999 9999999999887 5678999999999976544
Q ss_pred CCCccccccccccccccchhhhhcCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLT-VKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
+. ..+..||...|.|||++.+..|+ ++.||||||||||-|++|++||...++.+ .+-.++
T Consensus 172 G~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----------------TLTmIm 232 (864)
T KOG4717|consen 172 GK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----------------TLTMIM 232 (864)
T ss_pred cc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh----------------hhhhhh
Confidence 43 34567999999999999999986 68999999999999999999998765432 222344
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
|-.. ..|.....++.+||..||..||++|-+.+||+.
T Consensus 233 DCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 233 DCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 4322 234556778999999999999999999988864
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.59 Aligned_cols=264 Identities=20% Similarity=0.213 Sum_probs=200.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECC--CCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLES--TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
..+|.+.+.||+|+||.||++.... ++..||||.+... ..+.+|+.+++.++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 4579999999999999999997643 4678999988643 33567999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
|++. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.++|+|||++.....
T Consensus 166 e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9995 688888843 467999999999999999999999999 99999999999999999999999999975433
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc-cchhhhhhhhhccccccc--
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-NLVTWARPLFNDRRKFSK-- 316 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~-- 316 (457)
...........||+.|+|||++....++.++|||||||++|||++|+.||......... .+......+-.....+..
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 33222334567999999999999889999999999999999999999999765433211 111100000000000000
Q ss_pred ---------ccCCccCCCCCh-------HhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 317 ---------LADPRLEGRYPI-------RGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 317 ---------~~d~~l~~~~~~-------~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.........+.. .....+.+++.+||+.+|++||++.|++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000100 112357789999999999999999999875
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=311.99 Aligned_cols=250 Identities=27% Similarity=0.455 Sum_probs=201.4
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcCh---------HHHHHHHHHHHhcCCCCceeeEEEEecCCe
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN---------REFLVEVLMLSLLHHSNLVNLIGYCADGDQ 154 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~---------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 154 (457)
+|.+...||.|+||.||+|.+..++..||+|.+........ +.+..|+.+++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 47788899999999999999988899999999875432221 357789999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+|||+++++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999975 356889999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCC----ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhc
Q 012761 235 KLGPVGDK----SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND 310 (457)
Q Consensus 235 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 310 (457)
+....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||...... .. +..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~-------~~~- 223 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QA-------IFK- 223 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HH-------HHH-
Confidence 75432111 11112345888999999998888999999999999999999999999754221 00 000
Q ss_pred ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 311 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 311 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
......+.+. ......+.+++.+||+.+|.+||++.+|++
T Consensus 224 ---~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 ---IGENASPEIP----SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---HhccCCCcCC----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0011111221 122356788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=317.86 Aligned_cols=264 Identities=26% Similarity=0.400 Sum_probs=202.5
Q ss_pred cCCCccceeeecCcEEEEEEEE----CCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCceeeEEEEecC--Cee
Q 012761 83 KNFRPESFIGEGGFGRVYKGWL----ESTGQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQR 155 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 155 (457)
+.|.+.+.||+|+||.||+++. ..++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4678899999999999999984 3567899999987542 22335788999999999999999999998775 568
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 9999999999999998652 346899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCc-cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCC--------Ccccchhhhhh
Q 012761 236 LGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPH--------GEQNLVTWARP 306 (457)
Q Consensus 236 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~--------~~~~l~~~~~~ 306 (457)
........ .......++..|+|||++.+..++.++|||||||++|||+++..|+...... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 54322211 1122345677899999998888999999999999999999988765321100 00000000001
Q ss_pred hhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 307 LFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 307 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
....... . ..+......+.+|+.+||+.+|.+||++.++++.|+.+
T Consensus 238 ~~~~~~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKR------L----PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCcc------C----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111100 0 01112345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=312.03 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=203.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||.||+|.... +..||+|.+..... ....+..|+.+++.++|+||+++++++. .+..++||||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 4678999999999999999998754 78899999876543 3567899999999999999999999874 4578999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 82 MENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999998652 2356899999999999999999999999 9999999999999999999999999987533211
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
........++..|+|||++....++.++||||||+++|||++ |+.||....... +.... ... ...
T Consensus 157 -~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~------~~~ 222 (260)
T cd05067 157 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQNL----ERG------YRM 222 (260)
T ss_pred -cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH----HcC------CCC
Confidence 111222345678999999988889999999999999999999 999997543211 11110 000 001
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHh
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 361 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 361 (457)
.... .....+.+++.+||+.+|++||++.+++..|+.
T Consensus 223 ~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPD----NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1111 123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=318.55 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=202.2
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
+.|++.+.||.|+||.||+|++..++..|++|.+..........+..|+.+++.+.||||+++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56899999999999999999999999999999998665444567888999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++++|..++.. ....+++..++.++.|++.+|.|||+.+ |+||||||+||+++.++.++|+|||++..... .
T Consensus 92 ~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--~ 163 (292)
T cd06644 92 PGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--T 163 (292)
T ss_pred CCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccc--c
Confidence 99999888764 2346899999999999999999999999 99999999999999999999999998864211 1
Q ss_pred ccccccccccccccchhhhh-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 243 SHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
........+++.|+|||++. ...++.++|||||||++|+|++|..||....+. .....+.. .
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~-------~ 230 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAK-------S 230 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHhc-------C
Confidence 11223346888999999985 345788999999999999999999998654321 11111110 0
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..+.+. .+......+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 231 EPPTLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCccCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 011110 11122346788999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=314.70 Aligned_cols=249 Identities=29% Similarity=0.375 Sum_probs=204.4
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
++|.+.+.||.|+||.||+|++..++..||+|.+.... ......+..|+.+++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999999999999999987543 22345688899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999975 27899999999999999999999999 9999999999999999999999999987643221
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
.......|++.|+|||++.+..++.++|||||||++|+|+||..||....+... ...+. ....+.
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~~~~-------~~~~~~ 217 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LFLIP-------KNNPPS 217 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HHHhh-------hcCCCC
Confidence 223345688899999999988899999999999999999999999975442110 00000 001111
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+... .....+.+++.+||..+|++||++++++.
T Consensus 218 ~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1111 02235788999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.61 Aligned_cols=260 Identities=29% Similarity=0.464 Sum_probs=204.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCe----EEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQ----VVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
..+|+..+.||+|+||.||+|.+..++. .||+|.+...... ....+..|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 3578888999999999999999877665 5788888654322 224678899999999999999999998764 467
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+++||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 85 ~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 89999999999999875 2346899999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
..............++..|+|||++.+..++.++|||||||++|||++ |..||..... ..+..++ .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~~~-- 229 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDLL----EKGER-- 229 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HCCCC--
Confidence 433222212223345778999999988899999999999999999997 8999865422 1111111 11110
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
...+ ......+..++..||..+|++||++.++++.|..+...
T Consensus 230 -~~~~-------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 230 -LPQP-------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -CCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0001 11234678899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=313.67 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=203.3
Q ss_pred cCCCccceeeecCcEEEEEEEECCCC---eEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTG---QVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.+|++.+.||+|+||.||+|.+..++ ..+|+|.+...... ....+..|+.++..++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57889999999999999999886443 47999998754322 235688899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++++|.+++... ...+++.+++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999752 346899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCccc-cccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 239 VGDKSHV-STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 239 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
....... .....++..|+|||++.+..++.++|||||||++|||++ |..||....... +..... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~----~~~---- 226 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIE----EGY---- 226 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHh----CCC----
Confidence 2221111 111223567999999998899999999999999999886 999986543211 111111 100
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
.... +......+.+++.+|++.+|.+||++.++++.|+.+
T Consensus 227 --~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 --RLPA----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --cCCC----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0001 111234678999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=318.16 Aligned_cols=263 Identities=22% Similarity=0.344 Sum_probs=200.8
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
++|.+.+.||.|+||.||+|++..++..||+|.+...... ....+..|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 5799999999999999999999989999999998754322 234677899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
++ ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 689888865 2446889999999999999999999999 9999999999999999999999999987532221
Q ss_pred CccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhh-----------h
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLF-----------N 309 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~-----------~ 309 (457)
.......+++.|+|||++.+. .++.++|||||||++|+|++|++||....... ....+...+ .
T Consensus 159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhh
Confidence 122234578899999998754 57889999999999999999999997543211 111000000 0
Q ss_pred cccccccccCCccCCCC----ChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 310 DRRKFSKLADPRLEGRY----PIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 310 ~~~~~~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
....+.....+...... .......+.+|+.+||+.||.+|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000001110000 0112336788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=311.50 Aligned_cols=248 Identities=24% Similarity=0.385 Sum_probs=194.5
Q ss_pred eeecCcEEEEEEEEC--CCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCH
Q 012761 91 IGEGGFGRVYKGWLE--STGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 167 (457)
Q Consensus 91 lG~G~~g~Vy~~~~~--~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 167 (457)
||+|+||.||+|.+. .++..||+|++...... ..+.+.+|+.+++.++||||+++++++. ....++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999775 44567999998754322 2356889999999999999999999885 4578999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccc-c
Q 012761 168 EDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV-S 246 (457)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~ 246 (457)
.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++........... .
T Consensus 82 ~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 82 NKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999874 2457899999999999999999999999 99999999999999999999999999875332221111 1
Q ss_pred ccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCC
Q 012761 247 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGR 325 (457)
Q Consensus 247 ~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 325 (457)
....+++.|+|||++.+..++.++|||||||++|||++ |..||....... +...+ ..... + .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~~------~----~ 218 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VMSFI----EQGKR------L----D 218 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----HCCCC------C----C
Confidence 11223578999999988889999999999999999996 999997543311 11111 11100 0 1
Q ss_pred CChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 326 YPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 326 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
.+.....++.+++.+||+.+|++||++.+|.+.|..+
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1122345788999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=326.86 Aligned_cols=256 Identities=21% Similarity=0.230 Sum_probs=198.0
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|.+.+.||+|+||.||++++..+++.||+|++..... .....+..|+.++..++|+||+.+++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999875221 12345778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999975 2356899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCccccccccccccccchhhhhc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMT-----GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
.. ........||+.|+|||++.+ +.++.++|||||||++|||++|+.||...... .....+......+
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~ 227 (331)
T cd05624 155 DG-TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERF 227 (331)
T ss_pred CC-ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCcc
Confidence 21 112223579999999999875 46889999999999999999999999754321 1111111111000
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCC--CCChHHHHHH
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAAT--RPLIGDVVTA 358 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ev~~~ 358 (457)
. +.+.+ ......+.+++.+||...+++ |+++.+++..
T Consensus 228 -~-~p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 -Q-FPSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -c-CCCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 00001 112346788899988865544 4577777653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=316.37 Aligned_cols=248 Identities=25% Similarity=0.357 Sum_probs=212.6
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
|.++..||+|+||.||+|.++.+|+.+|||.+..+ .+.+++..|+.++.+...|++|++||.|.....+|+|||||-.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 66778899999999999999999999999998765 3568899999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
|++.+.++. .+++|++.++..|+...++||+|||... -||||||..||||+.+|.+||+|||.|-. ..+...
T Consensus 113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQ--LTDTMA 184 (502)
T KOG0574|consen 113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQ--LTDTMA 184 (502)
T ss_pred CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccch--hhhhHH
Confidence 999999986 4689999999999999999999999988 89999999999999999999999999864 333334
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 324 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 324 (457)
....+.||+.|||||++..-.|+.++||||||++..||.-|++||..-.|.... +. .--+|...-
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---------FM------IPT~PPPTF 249 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---------FM------IPTKPPPTF 249 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee---------Ee------ccCCCCCCC
Confidence 455688999999999999999999999999999999999999999876653211 11 111222222
Q ss_pred CCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 325 RYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.-|.....++-+++..||-..|++|-|+-.+++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 334455778899999999999999999888765
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=310.65 Aligned_cols=250 Identities=29% Similarity=0.411 Sum_probs=199.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEe-cCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA-DGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lV~E 160 (457)
.++|.+.+.||+|+||.||++... +..||+|.+.... ..+.+..|+.+++.++|+|++++++++. ..+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 357899999999999999999775 6789999986542 3467889999999999999999999764 4567899999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 81 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999998752 2345889999999999999999999999 999999999999999999999999998743221
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
. ....++..|+|||++.+..++.++|||||||++|+|++ |+.||..... ..+..... . . ..
T Consensus 156 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~---~-~------~~ 217 (256)
T cd05082 156 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVE---K-G------YK 217 (256)
T ss_pred C-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHh---c-C------CC
Confidence 1 22334567999999988889999999999999999997 9998864321 11111111 0 0 00
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
+.+ +......+.+++.+||+.+|++||++.++++.|+.+
T Consensus 218 ~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 MDA----PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 111 112234678899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=325.93 Aligned_cols=256 Identities=22% Similarity=0.225 Sum_probs=197.6
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|.+.+.||+|+||.||+++++.++..||+|++.+.. ......+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999999999999999986421 112345778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999975 2356899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCccccccccccccccchhhhh-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
.. .......+||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+......
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~- 226 (332)
T cd05623 155 DG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKER- 226 (332)
T ss_pred CC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCcc-
Confidence 11 12223357999999999986 34688999999999999999999999975432 1111111111100
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcC--CCCChHHHHHH
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAA--TRPLIGDVVTA 358 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~--~RPt~~ev~~~ 358 (457)
..-|.. .......+.+++.+|+..++. .|+++.++++.
T Consensus 227 --~~~p~~----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 --FQFPAQ----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --ccCCCc----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000100 011234577788887765444 47888888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=328.32 Aligned_cols=265 Identities=23% Similarity=0.299 Sum_probs=199.4
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecC------
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG------ 152 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------ 152 (457)
..++|.+.+.||+|+||.||++.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999999999999999997532 22335678899999999999999999987543
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecc
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 232 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFG 232 (457)
...++||||++ ++|..++.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 35799999996 577777743 4788999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCccc-ch--------h-
Q 012761 233 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN-LV--------T- 302 (457)
Q Consensus 233 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~-l~--------~- 302 (457)
+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... +. .
T Consensus 172 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9975321 112234578999999999999899999999999999999999999997543211000 00 0
Q ss_pred ------hhhhhhhccccccc-----ccCCcc---CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 303 ------WARPLFNDRRKFSK-----LADPRL---EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 303 ------~~~~~~~~~~~~~~-----~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.......+...+.. +....+ ...........+.+++.+||+.||.+|||+.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000011000000 000000 000011123467899999999999999999998763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=310.38 Aligned_cols=250 Identities=21% Similarity=0.322 Sum_probs=202.0
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEec-CCeeeEEEe
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCAD-GDQRLLVYE 160 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lV~E 160 (457)
+|++.+.||+|++|.||++.+..+++.||+|.+..... ...+.+..|+.+++.++|+|++++++.+.. ...+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 48899999999999999999998899999999975432 233568889999999999999999998764 446789999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++++|.+++... ....+++.+++.++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999999752 2356899999999999999999999999 999999999999999999999999998754221
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
........|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ..+...+.... . +
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~~~~------~-~ 220 (257)
T cd08223 156 --CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRIIEGK------L-P 220 (257)
T ss_pred --CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhcC------C-C
Confidence 1223345688999999999988999999999999999999999999864321 11111111100 0 1
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+ +......+.+++.+|++.+|.+||++.++++
T Consensus 221 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 PM----PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CC----ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11 1123346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=314.49 Aligned_cols=252 Identities=29% Similarity=0.442 Sum_probs=198.0
Q ss_pred ceeeecCcEEEEEEEECCCC------eEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 89 SFIGEGGFGRVYKGWLESTG------QVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~------~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+.||+|+||.||+|++.... ..||||.+..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 35999999999999986543 6899998865432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC-----ceEEeeccc
Q 012761 162 MPLGSLEDHLHDLPP---DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF-----HPKLSDFGL 233 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~-----~~kL~DFGl 233 (457)
+++++|.+++..... ....+++.+++.++.||+.||.|||+.+ ++|+||||+|||++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975321 2345889999999999999999999998 99999999999999877 899999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccc
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRR 312 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 312 (457)
+................++..|+|||++.++.++.++|||||||++|||++ |..||...... .+.... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~----~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHV----TAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHH----hcCC
Confidence 875332222222223345778999999999899999999999999999998 99998643321 111111 0000
Q ss_pred ccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 313 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 313 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
. . ..+......+.+++.+||+.+|.+||++.+|++.|.
T Consensus 231 ~---~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 R---L-------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred c---c-------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 0 111122356789999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=313.07 Aligned_cols=252 Identities=28% Similarity=0.436 Sum_probs=195.9
Q ss_pred ceeeecCcEEEEEEEECCCCe--EEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQ--VVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~--~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.||+|+||.||+|++..++. .+++|.+..... .....+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 358999999999999987765 468888864322 2335688899999999 799999999999999999999999999
Q ss_pred CCHHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecc
Q 012761 165 GSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 232 (457)
Q Consensus 165 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFG 232 (457)
++|.+++..... ....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999975321 1235889999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcc
Q 012761 233 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDR 311 (457)
Q Consensus 233 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 311 (457)
++...... ........+..|+|||++....++.++|||||||++|||++ |..||...... .+. ..+.. .
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~---~~~~~-~ 227 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELY---EKLPQ-G 227 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHH---HHHhC-C
Confidence 98532111 01111223567999999988889999999999999999997 99999653221 111 11100 0
Q ss_pred cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 312 RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 312 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
..... +......+.+++.+|++.+|.+||++.+++..|..+.
T Consensus 228 ------~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 ------YRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ------CCCCC----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00001 1112346789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=350.73 Aligned_cols=264 Identities=21% Similarity=0.291 Sum_probs=206.7
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|.+.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999999999999999999754322 2356889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecc
Q 012761 160 EFMPLGSLEDHLHDLP-------PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 232 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~-------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFG 232 (457)
||++|++|.+++.... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 11235677888999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCC----------------ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCC
Q 012761 233 LAKLGPVGDK----------------SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHG 296 (457)
Q Consensus 233 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~ 296 (457)
++........ .......+||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9975411110 001123569999999999999999999999999999999999999996533211
Q ss_pred cccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCC-ChHHHHHHHHhhhh
Q 012761 297 EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-LIGDVVTALSYLAN 364 (457)
Q Consensus 297 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~ev~~~L~~l~~ 364 (457)
+. +. . .+.++.-... .......+.+++.+||+.+|++|| ++.++++.|+....
T Consensus 239 ---i~-~~-~---------~i~~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ---IS-YR-D---------VILSPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ---hh-hh-h---------hccChhhccc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 00 0 0111100000 001123577899999999999996 57778888877654
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=317.53 Aligned_cols=264 Identities=27% Similarity=0.343 Sum_probs=207.2
Q ss_pred ccHHHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCceeeEEEEec
Q 012761 73 FTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCAD 151 (457)
Q Consensus 73 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 151 (457)
++..++..++++|.+.+.||+|+||.||++....+++.+|+|++.... .....+..|+.++..+ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 445566667899999999999999999999999999999999986542 2245677899999998 79999999999875
Q ss_pred C-----CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCce
Q 012761 152 G-----DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP 226 (457)
Q Consensus 152 ~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~ 226 (457)
. ...++||||+++++|.++++........+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 3589999999999999998754334567899999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccccccccchhhhhcC-----CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccch
Q 012761 227 KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-----QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV 301 (457)
Q Consensus 227 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~ 301 (457)
+|+|||++........ ......|+..|+|||++... .++.++|||||||++|||++|+.||....+. ..+.
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLF 243 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHH
Confidence 9999999875332211 12234688999999998643 3689999999999999999999999654321 1111
Q ss_pred hhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 302 TWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 302 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+. .. ....+.+ +......+.+++.+||+.+|++||++.++++
T Consensus 244 ~~~----~~--~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 KIP----RN--PPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHh----cC--CCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 110 00 0001111 1122346889999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=312.56 Aligned_cols=266 Identities=28% Similarity=0.349 Sum_probs=202.8
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+..|+.+++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468889999999999999999998899999999865422 233567899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++++|..++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999888887654 346899999999999999999999999 999999999999999999999999999754322
Q ss_pred CCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc-cchhhhhhh-------hhcc
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-NLVTWARPL-------FNDR 311 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~-~l~~~~~~~-------~~~~ 311 (457)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++|..||......+.. .+....... +...
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 21 2223457889999999876 45789999999999999999999999765432110 000000000 0000
Q ss_pred cccccccCCccCCCCCh-----HhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 312 RKFSKLADPRLEGRYPI-----RGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 312 ~~~~~~~d~~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.-...+..+......+. .....+.+++.+||+.+|++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00001111111111111 12346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=316.91 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=204.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||.|+||.||++.+..++..||+|++..........+..|+.+++.++||||+++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 45789999999999999999999888999999999765444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~- 156 (280)
T cd06611 84 CDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST- 156 (280)
T ss_pred cCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc-
Confidence 999999999875 2356999999999999999999999999 999999999999999999999999988653221
Q ss_pred Cccccccccccccccchhhhh-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
........|++.|+|||++. ...++.++|||||||++|+|++|+.||....... ........
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~------ 223 (280)
T cd06611 157 -LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLKILKS------ 223 (280)
T ss_pred -ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHHHhcC------
Confidence 11223356899999999985 3357789999999999999999999997543211 01111100
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
..+.+. .+......+.+++..||+.+|.+||++.+|++.
T Consensus 224 -~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 224 -EPPTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -CCCCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001110 011123467889999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=311.12 Aligned_cols=250 Identities=29% Similarity=0.436 Sum_probs=199.3
Q ss_pred ceeeecCcEEEEEEEECC-CC--eEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLES-TG--QVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~-~~--~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.||+|++|.||+|.+.. ++ ..||||.+..... ...+.+..|+.+++.++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999999865 33 3699999987655 445678899999999999999999999988 889999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976321 56899999999999999999999999 9999999999999999999999999997643322111
Q ss_pred -ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCcc
Q 012761 245 -VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 245 -~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
......++..|+|||++....++.++|||||||++|+|++ |..||....... +.. ....... ....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~~~~~~~---~~~~--- 222 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILK---KIDKEGE---RLER--- 222 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHhcCC---cCCC---
Confidence 1122456788999999988899999999999999999998 999986543211 111 1111000 0001
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
+......+.+++.+||+.+|++||++.+|++.|.
T Consensus 223 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 ----PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1112346889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=312.49 Aligned_cols=249 Identities=26% Similarity=0.344 Sum_probs=204.0
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
..|...+.||.|+||.||+|.+..++..||||++..... .....+..|+.+++.+.||||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 357778889999999999999988899999999875432 2345688899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999999864 45889999999999999999999998 9999999999999999999999999987533222
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
.......++..|+|||++.+..++.++|||||||++|||++|..||....+..... .. . ....+.
T Consensus 156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~~-~------~~~~~~ 220 (277)
T cd06640 156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF------LI-P------KNNPPT 220 (277)
T ss_pred --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh------hh-h------cCCCCC
Confidence 12233467889999999988889999999999999999999999997544321100 00 0 000111
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.+......+.+++..||+.+|.+||++.+++..
T Consensus 221 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 221 ----LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ----CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 122334568899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=323.33 Aligned_cols=262 Identities=26% Similarity=0.379 Sum_probs=205.2
Q ss_pred cCCCccceeeecCcEEEEEEEECC-------CCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCceeeEEEEecCC
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLES-------TGQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGD 153 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 153 (457)
.+|.+.+.||+|+||.||+|++.. .+..||+|.+..... .....+..|+.++..+ +||||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468999999999999999998642 224789998875422 2235788999999999 7999999999999999
Q ss_pred eeeEEEeccCCCCHHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE 221 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~ 221 (457)
..+++|||+++|+|.+++..... ....+++.+++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 99999999999999999875321 2346889999999999999999999999 99999999999999
Q ss_pred CCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccc
Q 012761 222 EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNL 300 (457)
Q Consensus 222 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l 300 (457)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------ 242 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------ 242 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH------
Confidence 999999999999875332221111222334567999999998899999999999999999998 8888865432
Q ss_pred hhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 301 VTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
..+...+ ..... ...+......+.+++.+||+.+|.+||++.+++..|..+..
T Consensus 243 ~~~~~~~-~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 EELFKLL-KEGHR----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHH-HcCCC----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1111111 11000 00111223468899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=334.93 Aligned_cols=200 Identities=26% Similarity=0.387 Sum_probs=173.2
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-C-----CCceeeEEEEecCCeeeE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-H-----SNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~l~~~~~~~~~~~l 157 (457)
+|.++++||+|+||.|.+|.+..|++.||||+++.. ..-..+...|+.+|..|+ | -|||+++++|...+++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 578899999999999999999999999999999754 234466778999999997 4 399999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC--CceEEeeccccc
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG--FHPKLSDFGLAK 235 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~--~~~kL~DFGla~ 235 (457)
|+|.+ .-+|.++|+.. ....|+...+..|+.||+.||.+||+.+ |||+||||+||||.+. ..|||+|||.++
T Consensus 266 VfELL-~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhh-hhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 99998 57999999874 3456899999999999999999999999 9999999999999643 479999999998
Q ss_pred cCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCC
Q 012761 236 LGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPH 295 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~ 295 (457)
.....-. ..+-+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+.+..
T Consensus 340 ~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 340 FESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred ccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 6332221 345577899999999999999999999999999999999888765543
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=316.23 Aligned_cols=248 Identities=28% Similarity=0.384 Sum_probs=202.1
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
.|...+.||+|+||.||+|.+..++..||+|.+..... .....+..|+.+++.++||||+++++++...+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 46667789999999999999988899999999875432 22356889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 99999998864 46899999999999999999999998 9999999999999999999999999987532211
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCcc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||....+... ..+ .. ....+.+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~----~~------~~~~~~~ 221 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFL----IP------KNSPPTL 221 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hhh----hh------cCCCCCC
Confidence 122234678899999999988899999999999999999999999865432211 000 00 0111112
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.+ .....+.+++.+||+.+|.+||++.+|+..
T Consensus 222 ~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EG----QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred Cc----ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 22 223468899999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=312.53 Aligned_cols=256 Identities=30% Similarity=0.373 Sum_probs=193.9
Q ss_pred ceeeecCcEEEEEEEECC--CCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCC
Q 012761 89 SFIGEGGFGRVYKGWLES--TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 165 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~g 165 (457)
+.||+|+||.||+|.... ++..+|+|.+...... ....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 359999999999998643 4568999998765322 2346888999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 166 SLEDHLHDLPP-DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 166 sL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
+|.+++..... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975322 2335677888899999999999999999 9999999999999999999999999987532222212
Q ss_pred ccccccccccccchhhhhcC-------CCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 245 VSTRVMGTYGYCAPEYAMTG-------QLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~-------~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
......++..|+|||++... .++.++|||||||++|||++ |..||....... ...+. .. .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~---~~--~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT---VR--EQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH---hh--cccCC
Confidence 22335678889999998642 35789999999999999996 999996543221 11110 00 01112
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
+.++.+... ....+.+++..|+ .+|++||++.+|+..|.
T Consensus 230 ~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 223332221 2234677888998 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=309.45 Aligned_cols=255 Identities=28% Similarity=0.435 Sum_probs=204.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||.||+|.+.. +..||||.+..... ....+..|+.+++.++||||+++++++......++||||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 4689999999999999999999864 57899999876433 456789999999999999999999999998999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++... ....+++..++.++.+++.||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 83 ~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999762 2346899999999999999999999999 9999999999999999999999999987543211
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
........++..|+|||.+.+..++.++|||||||++|+|++ |+.||...... ...... ... + ..
T Consensus 158 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~---~~~---~----~~ 223 (261)
T cd05034 158 -YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQV---ERG---Y----RM 223 (261)
T ss_pred -hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---HcC---C----CC
Confidence 111112234567999999998889999999999999999998 99998654321 111111 000 0 00
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHh
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 361 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 361 (457)
.. +......+.+++.+||+.+|.+||++.++++.|+.
T Consensus 224 ~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PR----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00 11113468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=353.23 Aligned_cols=258 Identities=21% Similarity=0.323 Sum_probs=202.2
Q ss_pred HHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEec--CCee
Q 012761 80 AATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQR 155 (457)
Q Consensus 80 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~ 155 (457)
...++|.+.+.||.|+||.||+|++..++..||+|++...... ....+..|+.++..|+|||||+++++|.+ ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3457899999999999999999999999999999998754332 23568899999999999999999998855 4568
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeeeccCCccCeEEcC---------
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN----PPVIYRDFKSSNILLEE--------- 222 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~----~~iiHrDLkp~NILl~~--------- 222 (457)
||||||+++|+|.++|.........+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999997643344679999999999999999999998542 23999999999999964
Q ss_pred --------CCceEEeeccccccCCCCCCccccccccccccccchhhhhc--CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 012761 223 --------GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT--GQLTVKSDVYSFGVVFLELITGRKAIDST 292 (457)
Q Consensus 223 --------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvil~elltG~~p~~~~ 292 (457)
.+.+||+|||++...... .......||+.|+|||++.+ ..++.++||||||||||||++|..||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 345899999999753221 12234579999999999864 45889999999999999999999999643
Q ss_pred CCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 293 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 293 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.. ....... +... ....+. .....+.+||..||+.+|.+||++.+++.
T Consensus 247 ~~-----~~qli~~-lk~~------p~lpi~-----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NN-----FSQLISE-LKRG------PDLPIK-----GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred Cc-----HHHHHHH-HhcC------CCCCcC-----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 22 1111111 1110 011111 12346889999999999999999999984
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=307.05 Aligned_cols=247 Identities=28% Similarity=0.408 Sum_probs=195.6
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCH
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 167 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 167 (457)
++||.|+||.||+|.+. ++..||+|.+...... ....+.+|+.++..++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36999999999999875 5789999998754322 234688899999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccc
Q 012761 168 EDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 247 (457)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 247 (457)
.+++.. ....+++..++.++.+++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++....... .....
T Consensus 80 ~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~ 152 (250)
T cd05085 80 LSFLRK---KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSG 152 (250)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc-cccCC
Confidence 999865 2345889999999999999999999999 9999999999999999999999999986422111 11111
Q ss_pred cccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCC
Q 012761 248 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRY 326 (457)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 326 (457)
...+++.|+|||++....++.++||||||+++|+|++ |..||...... ..... .... ... ..
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~----~~~~------~~~----~~ 215 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQ----VEKG------YRM----SC 215 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHH----HHcC------CCC----CC
Confidence 2234567999999998899999999999999999998 99998654321 11110 1000 000 11
Q ss_pred ChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 327 PIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 327 ~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
+......+.+++.+||+.+|++||++.++++.|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1122357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=309.03 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=203.6
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEec--CCeeeEEE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQRLLVY 159 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lV~ 159 (457)
+|.+.+.||.|+||.||++.+..++..||+|.+...... ....+..|+.+++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999999999999999998754332 23467889999999999999999998764 45679999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH-----DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH-----~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
||+++++|.+++.........+++..++.++.||+.||.||| +.+ |+|+||+|+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999764444567999999999999999999999 777 999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
....... .......|++.|+|||++....++.++||||||+++|+|++|..||..... ..+...+ .
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~----~----- 223 (265)
T cd08217 158 KILGHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASKI----K----- 223 (265)
T ss_pred ccccCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHHH----h-----
Confidence 8643322 112334689999999999988899999999999999999999999975431 1111111 0
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
....+.+ +......+.+++.+||+.+|.+||++.+|++
T Consensus 224 -~~~~~~~----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 224 -EGKFRRI----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred -cCCCCCC----ccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0011111 2223457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=308.55 Aligned_cols=253 Identities=28% Similarity=0.420 Sum_probs=200.3
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
++|.+...||+|+||.||+|.+..+ ..+|+|.+.... .....+..|+.+++.+.|||++++++++. .+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 4688889999999999999988664 469999886543 23467889999999999999999999875 45688999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
.+++|.+++... ....+++..++.++.|++.||.|||+.+ |+|+||||+|||+++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999999752 2345899999999999999999999999 99999999999999999999999999975322211
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||....+. ....+.. .. ..+.
T Consensus 158 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~~------~~~~ 223 (260)
T cd05069 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQVE----RG------YRMP 223 (260)
T ss_pred -cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----cC------CCCC
Confidence 11122345678999999988889999999999999999999 89998654321 1111110 00 0000
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHh
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 361 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 361 (457)
.+......+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 224 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 ----CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111223568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=326.03 Aligned_cols=263 Identities=21% Similarity=0.307 Sum_probs=198.5
Q ss_pred HHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecC----
Q 012761 79 AAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADG---- 152 (457)
Q Consensus 79 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---- 152 (457)
....++|.+.+.||.|+||.||+|.+..++..||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 3456889999999999999999999999999999999875422 2235577899999999999999999987543
Q ss_pred --CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEee
Q 012761 153 --DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSD 230 (457)
Q Consensus 153 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~D 230 (457)
...+++++++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcC
Confidence 3568999988 7899888753 46899999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhh--
Q 012761 231 FGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL-- 307 (457)
Q Consensus 231 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~-- 307 (457)
||++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+..+....
T Consensus 162 fg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~ 234 (343)
T cd07878 162 FGLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVVGT 234 (343)
T ss_pred CccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCC
Confidence 999975322 1234568999999999876 468999999999999999999999996543211 010000000
Q ss_pred -----h---hcc--c----ccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 308 -----F---NDR--R----KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 308 -----~---~~~--~----~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
+ ... . .+.......+...+ ......+.+|+.+||+.||.+|||+.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000 0 00000000000000 0112246789999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=309.53 Aligned_cols=251 Identities=27% Similarity=0.373 Sum_probs=195.9
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-----ChHHHHHHHHHHHhcCCCCceeeEEEEec--CCee
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-----GNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQR 155 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~ 155 (457)
.+|...+.||+|+||.||+|.+..++..|++|.+...... ....+.+|+.+++.++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4789999999999999999999999999999998653221 12457889999999999999999999875 3678
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++++||+++++|.+++.. ...+++...+.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999975 345889999999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCC-CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 236 LGPVGD-KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 236 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
...... .........++..|+|||++.+..++.++|||||||++|||++|+.||...... . .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~-~~~~~~~----- 223 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----A-AIFKIAT----- 223 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----H-HHHHHhc-----
Confidence 432211 111122345889999999999888999999999999999999999999653221 0 0000000
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
....+.+ +......+..++ .||..+|++||+++||+.
T Consensus 224 -~~~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 224 -QPTNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCCCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0011211 111223445555 688889999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=311.87 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=202.6
Q ss_pred CCCccceeeecCcEEEEEEEECC-CCeEEEEEEeccCCC----------cChHHHHHHHHHHHh-cCCCCceeeEEEEec
Q 012761 84 NFRPESFIGEGGFGRVYKGWLES-TGQVVAVKQLDRNGL----------QGNREFLVEVLMLSL-LHHSNLVNLIGYCAD 151 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~i~~~~~----------~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~ 151 (457)
+|.+.+.||+|+||.||+|.+.. ++..+|+|.+..... .....+..|+.++.. ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999987 678999998864221 112346678887765 789999999999999
Q ss_pred CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCccCeEEcCCCceEEee
Q 012761 152 GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFKSSNILLEEGFHPKLSD 230 (457)
Q Consensus 152 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLkp~NILl~~~~~~kL~D 230 (457)
.+..++||||+++++|.+++.........+++..++.++.|++.||.|||+ .+ ++|+||+|+|||++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999886543445679999999999999999999996 66 99999999999999999999999
Q ss_pred ccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhc
Q 012761 231 FGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND 310 (457)
Q Consensus 231 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 310 (457)
||++....... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||..... .........
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~~~~- 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATKIVE- 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHHHhh-
Confidence 99997533222 23345688999999999988899999999999999999999999864321 111111111
Q ss_pred ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 311 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 311 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
....+..... ....+.+++.+||+.+|++||++.||..+|.
T Consensus 228 -----~~~~~~~~~~----~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 -----AVYEPLPEGM----YSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -----ccCCcCCccc----CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0111111111 2346788999999999999999999999884
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=315.39 Aligned_cols=239 Identities=24% Similarity=0.389 Sum_probs=188.0
Q ss_pred eeeecCcEEEEEEEECCC------------------------CeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceee
Q 012761 90 FIGEGGFGRVYKGWLEST------------------------GQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNL 145 (457)
Q Consensus 90 ~lG~G~~g~Vy~~~~~~~------------------------~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l 145 (457)
+||+|+||.||+|.+..+ ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999985321 24689999876543344578889999999999999999
Q ss_pred EEEEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC-
Q 012761 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF- 224 (457)
Q Consensus 146 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~- 224 (457)
++++.+....++||||+++|+|..++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999864 2456899999999999999999999998 99999999999997543
Q ss_pred ------ceEEeeccccccCCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHH-hCCCCCCCCCCCC
Q 012761 225 ------HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELI-TGRKAIDSTRPHG 296 (457)
Q Consensus 225 ------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~ell-tG~~p~~~~~~~~ 296 (457)
.++|+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|..||....+..
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 4899999987542111 12356788999998875 56899999999999999994 7999987544321
Q ss_pred cccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 297 EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 297 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
. ..+ +.... .+.. .....+.+++.+||+.+|++||++.+|++.|
T Consensus 230 ~---~~~----~~~~~--------~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 K---ERF----YEKKH--------RLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred H---HHH----HHhcc--------CCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1 111 11000 0001 1123578999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=314.06 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=203.9
Q ss_pred cHHHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCceeeEEEEec-
Q 012761 74 TFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCAD- 151 (457)
Q Consensus 74 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~- 151 (457)
++.++....+.|++.+.||.|+||.||+|++..+++.||+|++.... .....+..|+.++..+ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44555566789999999999999999999999999999999986543 2345678899999988 69999999999853
Q ss_pred -----CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCce
Q 012761 152 -----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP 226 (457)
Q Consensus 152 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~ 226 (457)
.+..+++|||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||+|+||++++++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 46789999999999999998752 2345888899999999999999999999 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccccccccchhhhh-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccch
Q 012761 227 KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV 301 (457)
Q Consensus 227 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~ 301 (457)
+|+|||++....... .......|++.|+|||.+. ...++.++|||||||++|||++|..||....+......
T Consensus 161 ~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~- 237 (282)
T cd06636 161 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL- 237 (282)
T ss_pred EEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-
Confidence 999999986432111 1123356899999999876 34688899999999999999999999965432111000
Q ss_pred hhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 302 TWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 302 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
. .....+.+. .......+.+++.+||+.+|.+||++.|+++
T Consensus 238 ------~------~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 ------I------PRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ------H------hhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 000011111 0112346889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=315.32 Aligned_cols=267 Identities=26% Similarity=0.364 Sum_probs=203.6
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
++|++.+.||+|+||.||+|.+..+++.||||.+..... .....+..|+.+++.++|+||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368899999999999999999999999999999875422 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|++++.+..++.. ...+++..++.++.||+.||.|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9998777665543 355899999999999999999999999 999999999999999999999999998764332
Q ss_pred CCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCccc-chhhhhhh-------hhcc
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN-LVTWARPL-------FNDR 311 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~-l~~~~~~~-------~~~~ 311 (457)
.. .......++..|+|||++... .++.++||||||+++|+|++|++||......+... +......+ +...
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 21 123345688999999999887 78999999999999999999999997543211100 00000000 0000
Q ss_pred ccc-----ccccCCc-cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 312 RKF-----SKLADPR-LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 312 ~~~-----~~~~d~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..+ ....++. +...++......+.+++.+||..+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 0000000 000111122467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=317.92 Aligned_cols=253 Identities=26% Similarity=0.323 Sum_probs=201.6
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|.+.+.||+|+||.||+|.+..++..||||.+...... ....+..|+.++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4688999999999999999999988999999999865433 2356888999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999998752 2457899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCc---------------------------cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 012761 240 GDKS---------------------------HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 292 (457)
Q Consensus 240 ~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~ 292 (457)
.... .......||..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 0111346889999999999888999999999999999999999999754
Q ss_pred CCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHH
Q 012761 293 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVV 356 (457)
Q Consensus 293 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~ 356 (457)
.... .+. .+.+....-.........+.+++.+||+.+|++||+....+
T Consensus 236 ~~~~--~~~--------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~ 283 (316)
T cd05574 236 NRDE--TFS--------------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGA 283 (316)
T ss_pred chHH--HHH--------------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhH
Confidence 3210 000 01110000000001345788999999999999999944333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=307.85 Aligned_cols=252 Identities=23% Similarity=0.376 Sum_probs=205.8
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+|+..+.||.|+||.||.++...++..+++|.+.... ......+.+|+.+++.++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999999999999999987543 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997532 356899999999999999999999999 9999999999999999999999999987543222
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||..... ......+... .+ .+.
T Consensus 156 --~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~--~~----~~~ 221 (256)
T cd08221 156 --SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIVQG--NY----TPV 221 (256)
T ss_pred --ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcC--CC----CCC
Confidence 122345689999999999888889999999999999999999999965332 1111111110 00 000
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
+......+.+++..||+.+|.+||++.++++.+
T Consensus 222 -----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 -----VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -----ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 112234688999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=311.52 Aligned_cols=256 Identities=29% Similarity=0.398 Sum_probs=203.0
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCceeeEEEEecCC------
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGD------ 153 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~------ 153 (457)
.+++|.+.+.||.|+||.||+|.+..+++.|++|++..... ....+..|+.+++.+ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 46899999999999999999999988899999999876543 346788999999999 6999999999996644
Q ss_pred eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 233 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGl 233 (457)
..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 589999999999999998754333567899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhh
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-----GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLF 308 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~ 308 (457)
+...... ........|+..|+|||++.. ..++.++|||||||++|+|++|..||...... ..+.. +.
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~ 231 (275)
T cd06608 160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFK----IP 231 (275)
T ss_pred ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHH----hh
Confidence 8653221 122233568899999998753 34778999999999999999999999643221 11111 00
Q ss_pred hcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 309 NDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 309 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
. ...+.+. .+......+.+++.+||..||++|||+.++++
T Consensus 232 ~-------~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 R-------NPPPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred c-------cCCCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 0011111 11123346889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=308.67 Aligned_cols=251 Identities=25% Similarity=0.326 Sum_probs=198.1
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-----cChHHHHHHHHHHHhcCCCCceeeEEEEecC--Cee
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-----QGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQR 155 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 155 (457)
.+|.+.+.||+|+||.||++.+..++..||||.+..... .....+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 578999999999999999999999999999999864321 1124678899999999999999999998764 467
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999875 345888999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCC-ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 236 LGPVGDK-SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 236 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~-~~~~~----- 223 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AAI-FKIAT----- 223 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HHH-HHHhc-----
Confidence 5322111 11122346889999999998888999999999999999999999999643211 100 00000
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
. ......+......+.+++.+|+. +|++||++.+|+.
T Consensus 224 ----~-~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 224 ----Q-PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ----C-CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0 00111233334567789999985 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=309.59 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=200.0
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--C--------hHHHHHHHHHHHhcCCCCceeeEEEEecCC
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--G--------NREFLVEVLMLSLLHHSNLVNLIGYCADGD 153 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~--------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 153 (457)
+|.+.+.||.|+||.||+|....+++.||||.+...... . .+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 577889999999999999999888999999988642111 1 135778999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 233 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGl 233 (457)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999976 257899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhcCC--CCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ--LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 311 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 311 (457)
+................|+..|+|||++.... ++.++||||||+++|+|++|..||..... .... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~-~~~~~~~ 228 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAAM-FKLGNKR 228 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHHH-HHhhccc
Confidence 87533221111223356889999999987654 88999999999999999999999864321 1111 0000000
Q ss_pred cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 312 RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 312 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
....+...... .....+.+++..||+.+|.+||++.+|+.
T Consensus 229 --~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 --SAPPIPPDVSM----NLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred --cCCcCCccccc----cCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00111111111 12357888999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.31 Aligned_cols=264 Identities=30% Similarity=0.447 Sum_probs=208.1
Q ss_pred cCCCccceeeecCcEEEEEEEECCCC-----eEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTG-----QVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
.+....+.||+|.||.||.|...... ..||||.+.+.. .+...+|++|..+|+.++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 34566778999999999999876532 349999988653 344578999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPP---DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 233 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGl 233 (457)
|++|||.+|+|..+|+..+. ....|+....+.++.+||+|+.||++++ +|||||..+|+||+....|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999987422 2557899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccc
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRR 312 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 312 (457)
|+-....+.......-.-...|||||.+..+.++.|+|||||||+|||++| |..||...+..+ +.. ...+..
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---v~~---~~~~gg- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---VLL---DVLEGG- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---HHH---HHHhCC-
Confidence 983222222111111122357999999999999999999999999999998 778886554321 111 011111
Q ss_pred ccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 313 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 313 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
.+. .|......+.+|+..||+.+|++||++..+++.+..+....
T Consensus 922 ---RL~-------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 922 ---RLD-------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred ---ccC-------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 111 12223445679999999999999999999999998877643
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=310.62 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=203.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECCC---CeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLEST---GQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
.++|.+.+.||+|+||.||+|.+... ...|+||.+.... ....+.+.+|+.+++.+.||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 35688899999999999999987543 3579999887554 2334578899999999999999999999875 55789
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++++|.+++.. ....+++..++.++.+++.||.|||+.+ ++|+||||+|||++.++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 9999999999999975 2346899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.... ........++..|+|||.+....++.++|||||||++|||++ |..||....... ...+. ....
T Consensus 158 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~----~~~~---- 225 (270)
T cd05056 158 EDES-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIGRI----ENGE---- 225 (270)
T ss_pred cccc-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHH----HcCC----
Confidence 3221 111222234567999999988889999999999999999986 999996543211 11111 0000
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
...... .....+.+++.+|+..+|.+||++.+++..|+.+...
T Consensus 226 --~~~~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 --RLPMPP----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --cCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 001111 2234688899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=313.70 Aligned_cols=261 Identities=24% Similarity=0.350 Sum_probs=208.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.++|++.+.||+|+||.||++.+..++..||+|++..... .....+..|+++++.++||||+++++++...+.+++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 3578889999999999999999998999999999875432 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
|+++++|.+++.. ...+++..+..++.+++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999999865 3568999999999999999999997 56 99999999999999999999999999864211
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCc-----ccchhhhhhhhhccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE-----QNLVTWARPLFNDRRKF 314 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~-----~~l~~~~~~~~~~~~~~ 314 (457)
. ......|+..|+|||++.+..++.++|||||||++|+|++|..||........ ..+..+........
T Consensus 157 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 229 (284)
T cd06620 157 S----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP--- 229 (284)
T ss_pred h----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc---
Confidence 1 12235689999999999888999999999999999999999999976543211 11122222221111
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
.+.+.. ......+.+++.+||+.+|.+||++.||++..-.+.
T Consensus 230 ----~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 230 ----PPRLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred ----CCCCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 011110 012346889999999999999999999998754443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=317.96 Aligned_cols=201 Identities=22% Similarity=0.266 Sum_probs=167.4
Q ss_pred ccceeeec--CcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 87 PESFIGEG--GFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 87 ~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
+.++||+| +|++||++.+..+|+.||||++...... ....+..|+.+++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45779999 7899999999999999999999764322 2245677999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC-CC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV-GD 241 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~-~~ 241 (457)
++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+||+.+..... +.
T Consensus 82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999998642 2345899999999999999999999999 99999999999999999999999986542111 10
Q ss_pred Cc----cccccccccccccchhhhhc--CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 012761 242 KS----HVSTRVMGTYGYCAPEYAMT--GQLTVKSDVYSFGVVFLELITGRKAIDST 292 (457)
Q Consensus 242 ~~----~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvil~elltG~~p~~~~ 292 (457)
.. .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 00 01112356778999999976 46899999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=307.19 Aligned_cols=255 Identities=24% Similarity=0.326 Sum_probs=192.3
Q ss_pred eeeecCcEEEEEEEECCC--CeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCC
Q 012761 90 FIGEGGFGRVYKGWLEST--GQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGS 166 (457)
Q Consensus 90 ~lG~G~~g~Vy~~~~~~~--~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gs 166 (457)
.||+|+||.||++..... ...+++|.+..... ...+.+.+|+.+++.++||||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975432 24567777765432 234678999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcccc
Q 012761 167 LEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 246 (457)
Q Consensus 167 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 246 (457)
|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999764333455777888999999999999999999 999999999999999999999999998642222111222
Q ss_pred ccccccccccchhhhhc-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 247 TRVMGTYGYCAPEYAMT-------GQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 247 ~~~~gt~~y~aPE~~~~-------~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
....++..|+|||++.. ..++.++|||||||++|||++ |..||..... ........... ...+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~--~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKDQ--QVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhhc--ccccC
Confidence 34567889999998753 245789999999999999997 4667754332 11111111111 12334
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
++.+...+. ..+.+++..|+ .+|.+||++.+|++.|.
T Consensus 231 ~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 444433332 35667888899 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=312.80 Aligned_cols=263 Identities=22% Similarity=0.282 Sum_probs=197.7
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+|.+.+.||+|+||.||+|++..+|..||+|.+..... .....+..|+.+++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 47888999999999999999999999999999875322 1235677899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+. ++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 578887764 2356899999999999999999999999 9999999999999999999999999987532221
Q ss_pred CccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhc--cc---ccc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND--RR---KFS 315 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~---~~~ 315 (457)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..|+....... ..+ ......+.. .. ...
T Consensus 154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQL-KRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHH-HHHHHHhCCCChHHhHHhh
Confidence 112234578899999998765 47899999999999999999999864322211 000 000000000 00 000
Q ss_pred cccC----CccCC-----CCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 316 KLAD----PRLEG-----RYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 316 ~~~d----~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+.+ +.... .........+.+++.+||+.+|.+|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 00000 001122456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=316.51 Aligned_cols=200 Identities=25% Similarity=0.351 Sum_probs=162.9
Q ss_pred cceeeecCcEEEEEEEECC--CCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEec--CCeeeEEEeccC
Q 012761 88 ESFIGEGGFGRVYKGWLES--TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQRLLVYEFMP 163 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~--~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lV~E~~~ 163 (457)
.+.||+|+||.||+|+++. ++..||+|.+.... ....+.+|+.+++.++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 3579999999999999753 56899999987543 23567889999999999999999999854 456889999985
Q ss_pred CCCHHHhhhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE----cCCCceEEeecccc
Q 012761 164 LGSLEDHLHDLP-----PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL----EEGFHPKLSDFGLA 234 (457)
Q Consensus 164 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl----~~~~~~kL~DFGla 234 (457)
++|.+++.... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58888775321 12236899999999999999999999999 9999999999999 45678999999999
Q ss_pred ccCCCCCC-ccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 012761 235 KLGPVGDK-SHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTR 293 (457)
Q Consensus 235 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~ 293 (457)
........ ........||+.|+|||++.+. .++.++|||||||++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 75332211 1122345789999999998764 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=308.33 Aligned_cols=255 Identities=27% Similarity=0.369 Sum_probs=189.4
Q ss_pred eeeecCcEEEEEEEECC--CCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCC
Q 012761 90 FIGEGGFGRVYKGWLES--TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGS 166 (457)
Q Consensus 90 ~lG~G~~g~Vy~~~~~~--~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gs 166 (457)
.||+|+||.||+|.... ....+++|.+...... ....+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 59999999999997543 3457889987644322 23467889999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccc
Q 012761 167 LEDHLHDLPPD-KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV 245 (457)
Q Consensus 167 L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 245 (457)
|.+++...... ...+++...+.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999764321 234567888999999999999999999 99999999999999999999999999864322221111
Q ss_pred cccccccccccchhhhhc-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 246 STRVMGTYGYCAPEYAMT-------GQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 246 ~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
.....+++.|+|||++.. ..++.++|||||||++|||++ |..||....... .. ....... ...+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~---~~~~~~~--~~~~ 230 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VL---KQVVREQ--DIKL 230 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HH---HHHhhcc--CccC
Confidence 223345778999998753 356889999999999999999 778886443211 10 0001100 1122
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
..+.+...+ ...+..++..|+ .+|++||++.+|++.|.
T Consensus 231 ~~~~~~~~~----~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDLKY----SDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccccC----CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 223222222 234566778888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=326.38 Aligned_cols=236 Identities=24% Similarity=0.303 Sum_probs=184.9
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhc---CCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLL---HHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 91 lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
||+|+||.||+|++..++..||||++....... ...+..|..++..+ .||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999997532221 22344566666554 699999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~ 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence 999999875 456899999999999999999999999 9999999999999999999999999987422211 2
Q ss_pred ccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccC
Q 012761 245 VSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLE 323 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 323 (457)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... .....+..... .+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~i~~~~~---~~~~---- 218 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRNIAFGKV---RFPK---- 218 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHHHHcCCC---CCCC----
Confidence 23346799999999998764 5899999999999999999999999654321 11111111000 0000
Q ss_pred CCCChHhHHHHHHHHHHcchhhcCCCCCh
Q 012761 324 GRYPIRGLYQALAVASMCIQEQAATRPLI 352 (457)
Q Consensus 324 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 352 (457)
. .....+.+++.+||+.+|.+||++
T Consensus 219 ~----~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 219 N----VLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred c----cCCHHHHHHHHHHcCCCHHHCCCC
Confidence 0 112457789999999999999953
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=314.84 Aligned_cols=239 Identities=25% Similarity=0.431 Sum_probs=189.9
Q ss_pred eeeecCcEEEEEEEECCCCe-------EEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 90 FIGEGGFGRVYKGWLESTGQ-------VVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 90 ~lG~G~~g~Vy~~~~~~~~~-------~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
.||.|+||.||+|.+...+. .|++|.+........+.+..|+.+++.++||||+++++++......++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 59999999999998865443 48888886554444567888999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc--------eEEeecccc
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH--------PKLSDFGLA 234 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~--------~kL~DFGla 234 (457)
++|+|..++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. ++|+|||++
T Consensus 82 ~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 82 KFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999752 346899999999999999999999999 999999999999987654 699999987
Q ss_pred ccCCCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCC-CCCCCCCCCCcccchhhhhhhhhccc
Q 012761 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGR-KAIDSTRPHGEQNLVTWARPLFNDRR 312 (457)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~ 312 (457)
..... .....++..|+|||++.+. .++.++|||||||++|||++|. .||....+... . ......
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~----~~~~~~- 221 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---L----QFYEDR- 221 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---H----HHHHcc-
Confidence 64221 1234678899999999864 5799999999999999999995 55543322110 0 011111
Q ss_pred ccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 313 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 313 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
..++.....++.+++.+||+.+|++||++.++++.|
T Consensus 222 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 -----------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -----------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 011212234688999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=307.72 Aligned_cols=238 Identities=26% Similarity=0.448 Sum_probs=191.0
Q ss_pred ceeeecCcEEEEEEEECCCC----------eEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 89 SFIGEGGFGRVYKGWLESTG----------QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~----------~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
+.||+|+||.||+|.+..++ ..|++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36999999999999998766 35888887654332 5778899999999999999999999988 778999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC-------ceEEeec
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF-------HPKLSDF 231 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~-------~~kL~DF 231 (457)
|||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .++|+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999999762 236899999999999999999999999 99999999999999887 7999999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhcC--CCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhh
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG--QLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLF 308 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 308 (457)
|++..... .....++..|+|||++... .++.++|||||||++|+|++ |..||........ ..+.
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~~~---- 219 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ERFY---- 219 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HHHH----
Confidence 99875322 1223467789999998876 78999999999999999999 5777755432111 1000
Q ss_pred hcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 309 NDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 309 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
.... .. +......+.+++.+||+.+|.+||++.+|++.|
T Consensus 220 ~~~~---~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 220 QDQH---RL---------PMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred hcCC---CC---------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0000 00 111125788999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=311.92 Aligned_cols=242 Identities=26% Similarity=0.346 Sum_probs=204.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHH---HHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~---~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|..+++||+|.||+|.+++.+.+++.||||++++.......+. +.|-++|...+||.+..+...|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 5789999999999999999999999999999999998766555443 5688899999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||..||.|.-+|.. ...+++.....+-..|+.||.|||+.+ ||+||||.+|+|||.+|++||+|||+++-.
T Consensus 247 MeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~- 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE- 318 (516)
T ss_pred EEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc-
Confidence 999999999998875 567888889999999999999999999 999999999999999999999999999842
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.........+||||.|+|||++....|+.+.|+|.+||++|||++|+.||...+... |...+ +...-
T Consensus 319 -I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFeLI---l~ed~------ 385 (516)
T KOG0690|consen 319 -IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFELI---LMEDL------ 385 (516)
T ss_pred -ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---HHHHH---Hhhhc------
Confidence 222334567899999999999999999999999999999999999999997654321 11111 11111
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCC
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRP 350 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 350 (457)
.+|.....++..|+...|..||.+|.
T Consensus 386 ------kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 ------KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ------cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 12333345678899999999999996
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=313.99 Aligned_cols=266 Identities=26% Similarity=0.355 Sum_probs=201.8
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
++|.+.+.||+|+||.||+|.+..+++.||+|++...... ..+.+..|+.+++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4688899999999999999999988999999998654322 23567889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++++|..+... ...+++..++.++.||+.||.|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999988887754 345899999999999999999999999 999999999999999999999999998753322
Q ss_pred CCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCc-ccchhhhhhhhh-------cc
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE-QNLVTWARPLFN-------DR 311 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~-~~l~~~~~~~~~-------~~ 311 (457)
. .......++..|+|||++.+ ..++.++|||||||++|||++|++||........ ..+..+...+.. ..
T Consensus 154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 2 22334567899999999875 3578899999999999999999999865432110 001111110000 00
Q ss_pred cccccccCCccCCCC-----ChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 312 RKFSKLADPRLEGRY-----PIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 312 ~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.....+..+...... .......+.+++.+||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000111110000 1122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=310.28 Aligned_cols=258 Identities=24% Similarity=0.368 Sum_probs=202.6
Q ss_pred cCCCccceeeecCcEEEEEEEECC-----CCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLES-----TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
.+|.+.+.||.|+||.||+|+.+. +...|++|.+...... ....+..|+.+++.++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578899999999999999999754 3468999988754332 2457899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeec
Q 012761 157 LVYEFMPLGSLEDHLHDLPPD-----KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDF 231 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DF 231 (457)
+||||+++++|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999763311 126899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhc
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFND 310 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 310 (457)
|++....... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .+.... ...
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~~---~~~ 234 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNRL---QAG 234 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHHH---HcC
Confidence 9986432111 112223356778999999988889999999999999999999 78888543221 111111 000
Q ss_pred ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 311 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 311 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
.+ ..+ .+......+.+++.+||+.+|.+||++.+++..|.
T Consensus 235 --~~---~~~-----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 --KL---ELP-----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --Cc---CCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 000 01112246889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=305.40 Aligned_cols=251 Identities=27% Similarity=0.444 Sum_probs=201.4
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
.+|++.+.||.|+||.||++.+.. +..+|+|.+..... ....+..|+.+++.++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 468888999999999999998864 67899998875433 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
.+++|.+++.. ....+++..++.++.+++.+|+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 154 (256)
T cd05112 82 EHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ- 154 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc-
Confidence 99999999875 2346889999999999999999999999 9999999999999999999999999987532211
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
........++..|+|||++.++.++.++|||||||++|||++ |..||..... ......+... .....+.
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~----~~~~~~~ 224 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVETINAG----FRLYKPR 224 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHhCC----CCCCCCC
Confidence 111122335678999999988889999999999999999998 9999865331 1111111100 0111111
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
+ ....+.+|+.+||+.+|++||++.+|++.|
T Consensus 225 ~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 L-------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred C-------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1 234688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=316.34 Aligned_cols=249 Identities=25% Similarity=0.345 Sum_probs=200.8
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
|.....||.|+||.||++.+..++..||||.+........+.+.+|+.+++.++||||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 34446699999999999999888999999998765444456788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++...... ..
T Consensus 104 ~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~ 173 (292)
T cd06658 104 GALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VP 173 (292)
T ss_pred CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccc--cc
Confidence 999998854 45889999999999999999999999 999999999999999999999999998643221 11
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 324 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 324 (457)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....+.. ... . + .....+.+..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~---~-~------~~~~~~~~~~ 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMR---R-I------RDNLPPRVKD 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H-H------HhcCCCcccc
Confidence 2233568999999999988889999999999999999999999996543211 000 0 0 0111111111
Q ss_pred CCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 325 RYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.. .....+.+++..||+.+|.+||++.++++.
T Consensus 241 ~~--~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SH--KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cc--ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11 123357789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=305.12 Aligned_cols=248 Identities=26% Similarity=0.407 Sum_probs=200.7
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-----cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-----QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
+|+..+.||+|+||.||+|....++..|++|.+..... ...+.+..|+.+++.++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47778899999999999999988899999999865431 1235688999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999975 346889999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCccccccccccccccchhhhhcCC-CCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQ-LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
... ......|+..|++||.+.... ++.++|+|||||++|+|++|+.||...... ..+..+. . ....
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~----~-~~~~--- 220 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFKIG----R-SKEL--- 220 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHHHHHH----h-cccC---
Confidence 222 223456889999999988766 899999999999999999999999654311 0010000 0 0000
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+. .+......+.+++.+||+.+|.+||++.+++.
T Consensus 221 --~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 --PP----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --CC----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11 11122346788999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=306.41 Aligned_cols=254 Identities=24% Similarity=0.388 Sum_probs=202.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
..+|.+.+.||+|+||.||++.+.. +..+|+|.+.... .....+.+|+.+++.++|+||+++++++.+ ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 4678999999999999999998754 5679999887542 234678899999999999999999999887 778999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999999752 2456888999999999999999999998 9999999999999999999999999987533221
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
. .......++..|+|||++....++.++|||||||++|+|++ |+.||...... .+..+. .... ..
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~~~------~~ 222 (260)
T cd05073 157 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL----ERGY------RM 222 (260)
T ss_pred c-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----hCCC------CC
Confidence 1 11122345677999999988889999999999999999999 89998654321 111111 1000 00
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHh
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 361 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 361 (457)
.. +......+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PR----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CC----cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01 11223468899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=313.62 Aligned_cols=256 Identities=23% Similarity=0.341 Sum_probs=203.6
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|.+.+.||+|+||.||++.+..+++.|++|.+..... .....+..|+.+++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 478899999999999999999999999999999876532 22346778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999975 356899999999999999999999999 99999999999999999999999999864211
Q ss_pred CCCc-------------cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhh
Q 012761 240 GDKS-------------HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP 306 (457)
Q Consensus 240 ~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~ 306 (457)
.... .......|+..|+|||++....++.++|||||||++|||++|..||...... .+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQ 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH
Confidence 1000 0112245788999999998888999999999999999999999999653321 11111
Q ss_pred hhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 307 LFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 307 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
.... ....+..... ....+.+++.+||+.+|++||+..++.+.|+
T Consensus 228 ~~~~-----~~~~~~~~~~----~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 228 VISD-----DIEWPEGDEA----LPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHhc-----ccCCCCcccc----CCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 1110 1111111111 2245789999999999999999877766664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=304.60 Aligned_cols=252 Identities=31% Similarity=0.466 Sum_probs=200.7
Q ss_pred CCccceeeecCcEEEEEEEECCCC----eEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTG----QVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
|.+.+.||.|+||.||++++...+ ..||+|.+...... ....+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 456788999999999999998766 89999999765433 4567889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999997521 122899999999999999999999999 99999999999999999999999999976433
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
..... .....+++.|+|||.+....++.++||||||+++|+|++ |..||..... ..+.... .... ..
T Consensus 156 ~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~---~~~~----~~- 223 (258)
T smart00219 156 DDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYL---KKGY----RL- 223 (258)
T ss_pred ccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---hcCC----CC-
Confidence 32111 112236789999999988889999999999999999998 7888865321 1111111 1100 00
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
.. +......+.+++.+||..+|++||++.++++.|
T Consensus 224 --~~----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 --PK----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CC----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01 111234688899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=308.70 Aligned_cols=260 Identities=26% Similarity=0.324 Sum_probs=204.1
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecC--CeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lV~ 159 (457)
++|...+.||.|++|.||++.+..+++.||+|.+..... .....+.+|+++++.++||||++++++|.+. ..+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 468889999999999999999998999999999875433 2345688999999999999999999998654 4689999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++++|.+++.........+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987654334567899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCC--Ccccchhhhhhhhhcccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPH--GEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..||...... ....+..+.... ....+
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 228 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-----PNPEL 228 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-----Cchhh
Confidence 11 12345788999999999889999999999999999999999999765321 111122221110 00011
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+. ... .......+.+++.+||+.+|.+||++.||++
T Consensus 229 ~~~-~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 229 KDE-PGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ccC-CCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 110 000 0112356889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=304.56 Aligned_cols=258 Identities=28% Similarity=0.383 Sum_probs=206.4
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
++|++.+.||.|+||.||+|....++..+++|++..... .....+..|+.+++.++|+||+++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 478999999999999999999988899999999975432 2446788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++..... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999975221 246899999999999999999999999 9999999999999999999999999987543332
Q ss_pred Cc--cccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 242 KS--HVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 242 ~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.. .......|+..|+|||++... .++.++|||||||++|+|++|+.||....... .+...... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~-----------~ 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQN-----------D 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhcC-----------C
Confidence 22 122345689999999998877 78999999999999999999999997554321 11111100 0
Q ss_pred CCccCCCCC-hHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 319 DPRLEGRYP-IRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 319 d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+.+..... ......+.+++..||+.+|++||++.+|+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111111000 122356789999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=310.31 Aligned_cols=265 Identities=23% Similarity=0.351 Sum_probs=199.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.++|.+.+.||.|+||.||+|..+.+++.||||.+...... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 36799999999999999999999988999999998754322 23456789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+. ++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 84 ~~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 997 5999988752 346899999999999999999999999 999999999999999999999999998643221
Q ss_pred CCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhh----------
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN---------- 309 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~---------- 309 (457)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||........ .+. .....+.
T Consensus 157 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 157 S--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED-QLH-KIFRVLGTPTEETWPGV 232 (291)
T ss_pred C--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHH-HHHHhcCCCChhhhhhh
Confidence 1 11122346888999999875 4588999999999999999999999965431110 000 0000000
Q ss_pred -ccc-----ccccccCCccCCCCC-hHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 310 -DRR-----KFSKLADPRLEGRYP-IRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 310 -~~~-----~~~~~~d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
... .........+....+ ......+.+++..||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 000000000000000 011256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=305.73 Aligned_cols=250 Identities=21% Similarity=0.320 Sum_probs=203.2
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+|++.+.||+|+||.||+++...+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 48889999999999999999998999999999875322 2335788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++... ....+++.+++.++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~- 154 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST- 154 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcc-
Confidence 9999999998752 2345789999999999999999999999 999999999999999999999999998753221
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
........|++.|+|||++.+..++.++|||||||++|+|++|..||..... ........... . +.
T Consensus 155 -~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~~------~-~~ 220 (256)
T cd08218 155 -VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIRGS------Y-PP 220 (256)
T ss_pred -hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhcCC------C-CC
Confidence 1122234688899999999888899999999999999999999999864321 11111111110 0 01
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+......+.+++.+||+.+|.+||++.+|++
T Consensus 221 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 ----VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ----CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11122346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=308.88 Aligned_cols=240 Identities=23% Similarity=0.376 Sum_probs=188.3
Q ss_pred ceeeecCcEEEEEEEECCC------------CeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 89 SFIGEGGFGRVYKGWLEST------------GQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~------------~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
+.||+|+||.||+|+.... ...|++|.+..........+..|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3589999999999986422 2368999887654444457888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc-------eEEe
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH-------PKLS 229 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~-------~kL~ 229 (457)
+||||+++++|..++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. ++|+
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999988864 2356899999999999999999999999 999999999999986654 8999
Q ss_pred eccccccCCCCCCccccccccccccccchhhhh-cCCCCccchHHHHHHHHHHHH-hCCCCCCCCCCCCcccchhhhhhh
Q 012761 230 DFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELI-TGRKAIDSTRPHGEQNLVTWARPL 307 (457)
Q Consensus 230 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvil~ell-tG~~p~~~~~~~~~~~l~~~~~~~ 307 (457)
|||++..... .....++..|+|||++. +..++.++|||||||++|||+ +|..||......... .+
T Consensus 155 d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~ 221 (262)
T cd05077 155 DPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RF 221 (262)
T ss_pred CCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HH
Confidence 9999864321 12235788899999887 457899999999999999998 588887543221100 00
Q ss_pred hhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 308 FNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 308 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
.... . .... .....+.+|+.+||+.+|.+||++.+|+..|
T Consensus 222 ~~~~--~-~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 222 YEGQ--C-MLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HhcC--c-cCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0000 0 0111 1234678999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=306.16 Aligned_cols=252 Identities=27% Similarity=0.402 Sum_probs=191.6
Q ss_pred ceeeecCcEEEEEEEECC---CCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCceeeEEEEe-cCCeeeEEEeccC
Q 012761 89 SFIGEGGFGRVYKGWLES---TGQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCA-DGDQRLLVYEFMP 163 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~---~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lV~E~~~ 163 (457)
+.||+|+||.||+|.+.. ....||+|.+.... ......+..|+.+++.++||||+++++++. .+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998643 34689999986432 223457888999999999999999999875 4556889999999
Q ss_pred CCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCc
Q 012761 164 LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS 243 (457)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 243 (457)
+++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999752 344677888999999999999999998 999999999999999999999999998743221110
Q ss_pred c--ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhC-CCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 244 H--VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG-RKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 244 ~--~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
. ......++..|+|||++.+..++.++|||||||++|||++| .+||..... ..+.... ... . .+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~---~~~-~------~~ 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYL---LQG-R------RL 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH---hcC-C------CC
Confidence 0 11223457789999999888999999999999999999995 555643221 1111111 110 0 00
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
...... ...+.+++..||+.+|++||++.+|+..|+.+.
T Consensus 222 ~~~~~~----~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 LQPEYC----PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCcC----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 011111 236789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=305.98 Aligned_cols=251 Identities=27% Similarity=0.400 Sum_probs=199.4
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc------ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ------GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
+|.+.+.||.|+||.||+|... ++..+|||.+...... ....+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 4788899999999999999874 6889999998754221 12457889999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 80 FMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999975 346889999999999999999999999 999999999999999999999999998753
Q ss_pred CCC----CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccc
Q 012761 238 PVG----DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRK 313 (457)
Q Consensus 238 ~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 313 (457)
... ..........|+..|+|||++.+..++.++|||||||++|+|++|..||........ ... ... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~~----~~~-~-- 223 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--MFY----IGA-H-- 223 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--HHH----hhh-c--
Confidence 211 111122335689999999999988899999999999999999999999965432110 000 000 0
Q ss_pred cccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 314 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 314 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
....+.+.. .....+.+++.+||+.+|.+||++.+++.
T Consensus 224 --~~~~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 224 --RGLMPRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --cCCCCCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 001111211 22346789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=306.63 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=202.0
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc------ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ------GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
+|+..+.||+|+||.||++....++..||+|++...... ....+..|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999999899999999998753211 13568889999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC-ceEEeecccccc
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF-HPKLSDFGLAKL 236 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~ 236 (457)
||||+++++|.+++.. ..++++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++ .++|+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999975 356899999999999999999999999 99999999999998776 599999999875
Q ss_pred CCCCCC--ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 237 GPVGDK--SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 237 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
...... ........|+..|+|||++.+..++.++|||||||++|+|++|..||........ .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~----- 225 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIAS----- 225 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhc-----
Confidence 432211 1112234688999999999888899999999999999999999999964332111 111100000
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.... ...+......+.+++.+||+.+|.+||++.++++
T Consensus 226 -~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 -ATTA----PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -cCCC----CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0001 1122223456888999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=309.85 Aligned_cols=253 Identities=27% Similarity=0.346 Sum_probs=196.1
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHH-HHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLM-LSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
++|.+.+.||+|+||.||++.+..+|..||||++..... .....+..|+.+ ++.++||||+++++++......++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 478999999999999999999999999999999876432 122345556654 666789999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
|++ ++|.+++.........+++..++.++.||+.||.|||++ + ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 788888765444456799999999999999999999987 7 99999999999999999999999999875321
Q ss_pred CCCccccccccccccccchhhhhc----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMT----GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
. ...+...|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||...... ...+.. ...
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~----~~~------ 222 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQ----VVE------ 222 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHH----HHh------
Confidence 1 12233468889999998864 45788999999999999999999998642210 011110 000
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...+.+.. ......+.+++..||+.+|.+||++.+++.
T Consensus 223 -~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 223 -EPSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -cCCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111100 012346889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=304.47 Aligned_cols=254 Identities=25% Similarity=0.344 Sum_probs=208.0
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
++|.+.+.||.|++|.||+|.+..++..|+||++..... .....+..|+.++..++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 468889999999999999999999999999999986543 3356789999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
+++++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999975 3678999999999999999999999 98 999999999999999999999999998754322
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
. .......++..|+|||.+.+..++.++||||||+++|+|++|..||..........+..+.. . ...+
T Consensus 154 ~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~-------~~~~ 221 (264)
T cd06623 154 L--DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---D-------GPPP 221 (264)
T ss_pred C--CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---c-------CCCC
Confidence 2 11223467889999999998889999999999999999999999997654311111111111 0 0111
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.+... .....+.+++..||..+|++||++.++++.
T Consensus 222 ~~~~~---~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 SLPAE---EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCcc---cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111 023578899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=314.73 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=201.0
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
|.....||.|+||.||++.+..++..||+|.+..........+.+|+.++..++||||+++++++...+..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 34445799999999999999888999999999765545556788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
++|..++.. ..+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++....... .
T Consensus 103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~ 172 (297)
T cd06659 103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P 172 (297)
T ss_pred CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--c
Confidence 999998754 46899999999999999999999999 9999999999999999999999999986432221 1
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 324 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 324 (457)
......|++.|+|||++.+..++.++|||||||++|||++|+.||....+.. ..... ... ..+.+..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~~----~~~------~~~~~~~ 239 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKRL----RDS------PPPKLKN 239 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----hcc------CCCCccc
Confidence 2233568999999999998889999999999999999999999997543211 11000 000 0000000
Q ss_pred CCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 325 RYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.......+.+++.+||+.+|.+||++.+|+..
T Consensus 240 --~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 --AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred --cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 01122457889999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=310.19 Aligned_cols=263 Identities=24% Similarity=0.292 Sum_probs=200.4
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-----ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-----GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
+|.+.+.||.|+||.||+|.+..++..||||.+...... ....+..|+.+++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477888999999999999999988999999999765432 234567899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+ +++|.+++... ...+++..++.++.||++||.|||+.+ |+|+||+|+|||++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 89999999752 236999999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhh-------hhc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL-------FND 310 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~-------~~~ 310 (457)
... .......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||....+... +......+ ...
T Consensus 154 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 154 SPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHHHHcCCCchhhhhh
Confidence 322 12223356788999998865 4678999999999999999999888765432110 00000000 000
Q ss_pred ccccccccCCccCCCC-----ChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 311 RRKFSKLADPRLEGRY-----PIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 311 ~~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
................ .......+.+++.+||+.+|++||++.||+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000000000000001 1122457889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=330.04 Aligned_cols=245 Identities=25% Similarity=0.371 Sum_probs=204.6
Q ss_pred eeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCHHH
Q 012761 90 FIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLED 169 (457)
Q Consensus 90 ~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~ 169 (457)
+||+|.||+||-|++..|...+|||-+........+-+..|+.+.+.|+|.|||+++|.+..+..+-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999999999999999999987655556678899999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc-CCCceEEeeccccccCCCCCCcccc
Q 012761 170 HLHDLPPDKEAL--DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE-EGFHPKLSDFGLAKLGPVGDKSHVS 246 (457)
Q Consensus 170 ~l~~~~~~~~~l--~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~ 246 (457)
+|.. .=+++ .+.+.-.+.+||++||.|||++. |||||||-+||||+ -.|.+||+|||-++.... .+..+
T Consensus 662 LLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~T 733 (1226)
T KOG4279|consen 662 LLRS---KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCT 733 (1226)
T ss_pred HHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCccc
Confidence 9986 33456 77888899999999999999999 99999999999995 679999999999986432 33445
Q ss_pred ccccccccccchhhhhcC--CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCC
Q 012761 247 TRVMGTYGYCAPEYAMTG--QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 324 (457)
Q Consensus 247 ~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 324 (457)
.++.||..|||||++..+ .|+.++|||||||++.||.||++||........ . ++.-+ + --+.|
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---A-----MFkVG--m-yKvHP---- 798 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---A-----MFKVG--M-YKVHP---- 798 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---h-----hhhhc--c-eecCC----
Confidence 567899999999999876 589999999999999999999999976543211 0 00000 0 11122
Q ss_pred CCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 325 RYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..|.+...++..+|.+|+.++|.+||++.++++
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 234456778899999999999999999999975
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=310.66 Aligned_cols=251 Identities=26% Similarity=0.375 Sum_probs=205.2
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
++|.+.+.||.|+||.||++....++..|++|.+........+.+..|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 68999999999999999999988889999999987654445567889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~- 169 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 169 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc-
Confidence 99999999864 35789999999999999999999999 9999999999999999999999999886433222
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCcc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
.......|++.|+|||++....++.++|||||||++|+|++|+.||......... .... ... .+.+
T Consensus 170 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--~~~~----~~~-------~~~~ 235 (293)
T cd06647 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YLIA----TNG-------TPEL 235 (293)
T ss_pred -cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--eehh----cCC-------CCCC
Confidence 1223346889999999998888999999999999999999999999765432110 0000 000 0000
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
..+......+.+++..||+.+|.+||++.+++..
T Consensus 236 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 --QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111123457789999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=309.47 Aligned_cols=244 Identities=27% Similarity=0.371 Sum_probs=200.4
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|.+.+.||+|+||.||++.+..+++.||+|++..... .....+..|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 478899999999999999999998999999999875422 22356888999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999976 357899999999999999999999999 99999999999999999999999999875332
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ......... .
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~--------~ 214 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------QIYEKILEG--------K 214 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcC--------C
Confidence 2 23456899999999998888899999999999999999999999654310 000011110 0
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCC-----ChHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVV 356 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~ 356 (457)
..+ +......+.+++.+||+.+|.+|| +++|++
T Consensus 215 ~~~----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 215 VRF----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ccC----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 111 111234678899999999999999 555554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=357.55 Aligned_cols=263 Identities=29% Similarity=0.496 Sum_probs=215.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
...|...++||+|+||.||+|++..++..||||.+..... ....|+.++++++|||||+++++|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 4567888899999999999999988899999999864322 123468889999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++|+|.++++. ++|..+..|+.||+.||+|||....++|+||||||+||+++.++.+++. ||.+....
T Consensus 765 ~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~--- 833 (968)
T PLN00113 765 IEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC--- 833 (968)
T ss_pred CCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc---
Confidence 999999999953 8999999999999999999996544449999999999999999888876 66554211
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
......||+.|+|||++.+..++.++|||||||++|||+||+.||+.... ....+..|++....+. ....++|+.
T Consensus 834 ---~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 908 (968)
T PLN00113 834 ---TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDC-HLDMWIDPS 908 (968)
T ss_pred ---cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCcc-chhheeCcc
Confidence 11223678999999999998999999999999999999999999964332 3345677776554332 344566776
Q ss_pred cCCC--CChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 322 LEGR--YPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 322 l~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
+... .+.....++.+++.+||+.+|++||+|.||+++|+.+..
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 6543 344567788999999999999999999999999988865
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=306.94 Aligned_cols=258 Identities=26% Similarity=0.382 Sum_probs=199.5
Q ss_pred CCccceeeecCcEEEEEEEECC---CCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCC------
Q 012761 85 FRPESFIGEGGFGRVYKGWLES---TGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGD------ 153 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 153 (457)
|.+.+.||+|+||.||+|.+.. ++..||||++..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6678899999999999998643 578999999975432 22356888999999999999999999886542
Q ss_pred eeeEEEeccCCCCHHHhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeec
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDF 231 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DF 231 (457)
..++++||+.+|+|.+++.... .....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875321 12235889999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhc
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFND 310 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 310 (457)
|++................+++.|++||.+....++.++|||||||++|+|++ |.+||..... ..+..+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~---- 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLIK---- 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHHc----
Confidence 99875433222222223345678999999998889999999999999999999 8888864432 111111110
Q ss_pred ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 311 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 311 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
.. .. . .+......+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 231 ~~---~~---~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GN---RL---K----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC---cC---C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 00 0 0112234788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=303.16 Aligned_cols=249 Identities=22% Similarity=0.357 Sum_probs=201.8
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+|.+.+.||+|+||.||++....++..+|||.+..... .....+..|+.+++.++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 58889999999999999999999999999999976432 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC-CceEEeeccccccCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG-FHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~~~ 240 (457)
+++++|.+++... ....+++..++.++.+++.+|.|||+++ |+|+||+|+||+++.+ +.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999752 2345899999999999999999999999 9999999999999754 46899999998754322
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..+....... ...
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~~~--~~~---- 220 (256)
T cd08220 156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMSGT--FAP---- 220 (256)
T ss_pred c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHhcC--CCC----
Confidence 1 122356889999999998888999999999999999999999998654321 1111111100 000
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+ +......+.+++.+||+.+|.+||++.+++.
T Consensus 221 -~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 -I----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -C----CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 1112346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=309.64 Aligned_cols=263 Identities=23% Similarity=0.313 Sum_probs=202.4
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+|.+.+.||.|+||.||+|.+..++..||||++..... .....+..|+.+++.++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 47888999999999999999988899999999976542 2235788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+ +++|.+++... ...+++.+++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998752 366999999999999999999999999 9999999999999999999999999987543322
Q ss_pred CccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhh-----------h
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLF-----------N 309 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~-----------~ 309 (457)
. .......|+..|+|||++.+. .++.++|||||||++|||++|.+||....... ...+....+ .
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhcc
Confidence 1 122335689999999998654 46899999999999999999988876533211 111111000 0
Q ss_pred cccccccccCCccC----CCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 310 DRRKFSKLADPRLE----GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 310 ~~~~~~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+-.....+..+... ..........+.+++.+||+.+|.+||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000000 0000112367889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=308.43 Aligned_cols=267 Identities=23% Similarity=0.335 Sum_probs=199.0
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC-hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++++|.+.+.||+|+||.||+|....++..||+|++....... ...+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999999889999999997553322 346788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+. ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 83 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9995 677777654 2345788899999999999999999999 99999999999999999999999999875322
Q ss_pred CCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchh-hhh---h------hh
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVT-WAR---P------LF 308 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~-~~~---~------~~ 308 (457)
.. .......+++.|+|||++.+. .++.++|||||||++|+|++|..||........ .+.. |.. + ..
T Consensus 156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 156 PS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhhhh
Confidence 11 112234578899999998754 578899999999999999999999975443111 1100 000 0 00
Q ss_pred hccccc-ccccC---C-ccCCCC-ChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 309 NDRRKF-SKLAD---P-RLEGRY-PIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 309 ~~~~~~-~~~~d---~-~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...... ..... + .+.... .......+.+++.+|++.+|++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000 00000 0 000000 0011346778999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=311.71 Aligned_cols=198 Identities=25% Similarity=0.352 Sum_probs=161.4
Q ss_pred ceeeecCcEEEEEEEECC--CCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEec--CCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLES--TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lV~E~~~~ 164 (457)
+.||+|+||.||+|++.. ++..||+|.+.... ....+.+|+.+++.++||||+++++++.. ....++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 579999999999999754 56789999987543 23567889999999999999999999854 567899999986
Q ss_pred CCHHHhhhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE----cCCCceEEeeccccc
Q 012761 165 GSLEDHLHDLP-----PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL----EEGFHPKLSDFGLAK 235 (457)
Q Consensus 165 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl----~~~~~~kL~DFGla~ 235 (457)
++|.+++.... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 57777764321 12345899999999999999999999999 9999999999999 567899999999997
Q ss_pred cCCCCCC-ccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 012761 236 LGPVGDK-SHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDST 292 (457)
Q Consensus 236 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~ 292 (457)
....... ........||+.|+|||++.+. .++.++|||||||++|||+||++||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 5332211 1122345689999999998764 5899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=305.28 Aligned_cols=248 Identities=26% Similarity=0.388 Sum_probs=200.9
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcC---CCCceeeEEEEecCCeeeEEE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLH---HSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lV~ 159 (457)
.|...+.||.|+||.||+|.+..++..||+|.+..... .....+..|+.+++.+. |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 57788899999999999999998999999999875432 23456888999999986 999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999999864 36899999999999999999999999 99999999999999999999999999876433
Q ss_pred CCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.. .......|+..|+|||.+.++ .++.++|||||||++|+|++|..||........ .... ....
T Consensus 154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~----------~~~~ 218 (277)
T cd06917 154 NS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MMLI----------PKSK 218 (277)
T ss_pred Cc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hhcc----------ccCC
Confidence 22 222334688999999998754 568999999999999999999999975432111 0000 0011
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+.+... .....+.+++..||+.+|.+||++.+++.
T Consensus 219 ~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1112111 12346889999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=305.94 Aligned_cols=248 Identities=27% Similarity=0.364 Sum_probs=201.6
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
-|+..+.||.|+||.||+|.+..++..||||++..... .....+.+|+.++..++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 47778899999999999999988899999999875432 22356888999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++++|.+++.. ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence 99999999864 46899999999999999999999999 9999999999999999999999999986532221
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCcc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
.......++..|+|||.+.+..++.++|||||||++|+|++|..||...... .+...... ...+.+
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~-------~~~~~~ 221 (277)
T cd06641 156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLIPK-------NNPPTL 221 (277)
T ss_pred -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHHhc-------CCCCCC
Confidence 1222346888999999998888899999999999999999999998653321 11111000 001112
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
... ....+.+++.+||+.+|.+||++.+++..
T Consensus 222 ~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGN----YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred Ccc----cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 122 23457889999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=304.39 Aligned_cols=246 Identities=29% Similarity=0.449 Sum_probs=197.3
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
++|.+.+.||+|+||.||++.. ++..||+|.+.... ....+..|+.+++.++||||+++++++... ..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 5688999999999999999864 57889999986542 346788999999999999999999998664 579999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 81 SKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999752 2346899999999999999999999999 999999999999999999999999998753221
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
......+..|+|||++.+..++.++|||||||++|+|++ |+.||...... .+... +.... ..+
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~-~~~~~----~~~-- 217 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVKEC-VEKGY----RME-- 217 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHHHH-HhCCC----CCC--
Confidence 112234567999999988899999999999999999998 99998654321 11111 11110 001
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
. +......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 218 ~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 218 P----PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred C----CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 1 1122346789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=302.64 Aligned_cols=253 Identities=26% Similarity=0.385 Sum_probs=202.3
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+|.+.+.||+|+||.||+|.+..++..|++|.+...... ....+..|+.+++.++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 478889999999999999999888999999999865443 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.. ...+++..++.++.+++.||.|||+.+ |+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999975 345889999999999999999999999 9999999999999999999999999987643322
Q ss_pred Cccc--cccccccccccchhhhhcCC---CCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 242 KSHV--STRVMGTYGYCAPEYAMTGQ---LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 242 ~~~~--~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.... .....++..|+|||++.... ++.++||||||+++|+|++|+.||...... .... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~---~~~~~------- 221 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIM---FHVGA------- 221 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHH---HHHhc-------
Confidence 2111 11346788999999998765 889999999999999999999999654311 0000 00000
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...+.+... ......+.+++..||+.+|.+||++.+++.
T Consensus 222 ~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 GHKPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 001111110 011345778999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=310.31 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=199.9
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
++|.+.+.||+|+||.||++++..++..||+|.+..... .....+.+|+.++..++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 368889999999999999999998999999999875421 2235688999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
+++++|..++... .....+++..+..++.+++.||.|||+ .+ |+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 9999999988752 123478999999999999999999997 47 999999999999999999999999998643211
Q ss_pred CCccccccccccccccchhhhhcC------CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTG------QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
......+++.|+|||++.+. .++.++|||||||++|+|++|+.||....... ..........
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~----- 224 (286)
T cd06622 157 ----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAIVD----- 224 (286)
T ss_pred ----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHHhh-----
Confidence 22234578899999998543 35889999999999999999999996532211 1111100000
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...+. .+......+.+++.+||+.+|.+||++.+++.
T Consensus 225 --~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 225 --GDPPT----LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred --cCCCC----CCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 00111 12223456788999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=306.16 Aligned_cols=254 Identities=26% Similarity=0.374 Sum_probs=204.6
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
++|+..+.||.|+||.||++.++.+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 467888899999999999999998999999999876533 2335688999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
+++++|.+++... ...+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999999762 2678999999999999999999999 88 999999999999999999999999998643211
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
. .....++..|+|||++.+..++.++||||||+++|+|++|..||...... .............. ..+
T Consensus 155 ~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~-------~~~ 222 (265)
T cd06605 155 L----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNE-------PPP 222 (265)
T ss_pred H----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcC-------CCC
Confidence 1 11256889999999999889999999999999999999999999654321 11122222211111 011
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+... .....+.+++..||..+|.+||++.+++.
T Consensus 223 ~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 RLPSG---KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCChh---hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11110 02346889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=331.37 Aligned_cols=251 Identities=21% Similarity=0.329 Sum_probs=208.1
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccC
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMP 163 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~ 163 (457)
.|.++..||.|.||+||+|..+.++...|.|+|....-...+.|+.|+.||..+.||+||+|++.|+..+.+||+.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 46677789999999999999999999999999987766667889999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCc
Q 012761 164 LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS 243 (457)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 243 (457)
||-+...+-. -...|++.++..++.|++.||.|||+++ |||||||..|||++-+|.++|+|||.+... ....
T Consensus 113 GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn--~~t~ 184 (1187)
T KOG0579|consen 113 GGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN--KSTR 184 (1187)
T ss_pred CchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc--hhHH
Confidence 9999888765 3568999999999999999999999999 999999999999999999999999987531 1122
Q ss_pred cccccccccccccchhhhh-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 244 HVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.....++|||+|||||+++ ..+|++++|||||||+|.||..+.+|....++.. ....+... .-+.++
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR------VllKiaKS--ePPTLl 256 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKS--EPPTLL 256 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH------HHHHHhhc--CCCccc
Confidence 2344589999999999976 3589999999999999999999999876655421 11111110 011222
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
. |......+.+++..||..||..||++.++++
T Consensus 257 q-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 Q-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred C-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 2 3345567889999999999999999999874
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=310.25 Aligned_cols=270 Identities=22% Similarity=0.292 Sum_probs=200.0
Q ss_pred CCCccceeeecCcEEEEEEEECC--CCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecC--Ceee
Q 012761 84 NFRPESFIGEGGFGRVYKGWLES--TGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQRL 156 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~--~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 156 (457)
.|.+.+.||+|+||.||+|.+.. ++..||||.+.... ......+..|+.++..++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999999988 78999999998632 23346678899999999999999999999988 8899
Q ss_pred EEEeccCCCCHHHhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC----CCceEEeec
Q 012761 157 LVYEFMPLGSLEDHLHDLPPD-KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE----GFHPKLSDF 231 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~----~~~~kL~DF 231 (457)
+||||++ ++|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 4677766543222 247899999999999999999999999 999999999999999 999999999
Q ss_pred cccccCCCCCC-ccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc-------cchh
Q 012761 232 GLAKLGPVGDK-SHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-------NLVT 302 (457)
Q Consensus 232 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~-------~l~~ 302 (457)
|++........ ........+++.|+|||++.+. .++.++|||||||++|+|++|++||......... .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99875432221 1122334678999999988764 5789999999999999999999999765432200 0000
Q ss_pred hhhhh----------hhcccccccccCCccCCCCC---------h--HhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 303 WARPL----------FNDRRKFSKLADPRLEGRYP---------I--RGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 303 ~~~~~----------~~~~~~~~~~~d~~l~~~~~---------~--~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
....+ +.....+....+......++ . .....+.+++.+||+.+|++||++.|++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00000000000000000111 0 22346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=308.02 Aligned_cols=263 Identities=25% Similarity=0.318 Sum_probs=198.7
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+|+..+.||.|+||.||+|++..++..||||.+..... .....+..|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 58889999999999999999998999999999875432 2235688999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+. ++|..++... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 6898888652 2456899999999999999999999999 9999999999999999999999999987532221
Q ss_pred CccccccccccccccchhhhhcCC-CCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhh-----------
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQ-LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN----------- 309 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~----------- 309 (457)
.......+++.|+|||++.+.. ++.++|||||||++|+|+||+.||...... ..+.......-.
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 155 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred --cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhH
Confidence 1223345788999999887644 688999999999999999999999653321 111111000000
Q ss_pred ---cccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 310 ---DRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 310 ---~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
....+.......+.. ........+.+++.+||+.||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000000 00011235678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=308.41 Aligned_cols=267 Identities=24% Similarity=0.343 Sum_probs=201.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEecC--CeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADG--DQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 157 (457)
.++|.+.+.||.|+||.||+|.+..++..|++|.+....... ...+.+|+.++..++||||+++++++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357899999999999999999999889999999997543222 23567899999999999999999998877 88999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+. ++|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.++|+|||++...
T Consensus 84 v~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 84 VMEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred EehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 999997 5999888752 236899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc-cchhhh-------hhhh
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-NLVTWA-------RPLF 308 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~-~l~~~~-------~~~~ 308 (457)
.... .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||......... .+.... ++.+
T Consensus 157 ~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 157 GSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred cCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence 3221 122334578899999998754 4689999999999999999999999754332110 000000 0000
Q ss_pred hc-----ccccccccCCccCCCCChH-hHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 309 ND-----RRKFSKLADPRLEGRYPIR-GLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 309 ~~-----~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.. ...+.......+...++.. ....+.+++.+||+.+|++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 0001111111122222222 2456788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=296.97 Aligned_cols=250 Identities=28% Similarity=0.409 Sum_probs=205.2
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccC
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMP 163 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~ 163 (457)
+|.+.+.||.|++|.||++.+..++..|++|++..........+.+|+.+++.++|+||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 47888999999999999999988899999999987654455788999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCc
Q 012761 164 LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS 243 (457)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 243 (457)
+++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999998762 257899999999999999999999998 99999999999999999999999999875433221
Q ss_pred cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccC
Q 012761 244 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLE 323 (457)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 323 (457)
.....++..|+|||++....++.++||||||+++|+|++|+.||........ ...... .....+..+
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~--~~~~~~~~~--- 220 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA------LFKIAT--NGPPGLRNP--- 220 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHHh--cCCCCcCcc---
Confidence 2345688999999999888899999999999999999999999975432110 000000 001111111
Q ss_pred CCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 324 GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 324 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
......+.+++.+||+.+|++||++.++++
T Consensus 221 ----~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 ----EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ----cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 001346889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=306.42 Aligned_cols=249 Identities=25% Similarity=0.337 Sum_probs=201.9
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccC
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMP 163 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~ 163 (457)
.|...+.||+|++|.||++.+..++..|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 35556789999999999999988899999999876544445668899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCc
Q 012761 164 LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS 243 (457)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 243 (457)
+++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++...... .
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~ 169 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--V 169 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccC--C
Confidence 9999999865 45889999999999999999999999 999999999999999999999999988643222 1
Q ss_pred cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccC
Q 012761 244 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLE 323 (457)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 323 (457)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+. .....+... ..+.+.
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~~~-------~~~~~~ 236 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIRDN-------LPPKLK 236 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHhc-------CCCCCc
Confidence 1223356899999999998888999999999999999999999999654321 111111110 011111
Q ss_pred CCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 324 GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 324 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
. +......+.+++.+||+.+|++||++.++++
T Consensus 237 ~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 N--LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred c--cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1 1112346889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=297.05 Aligned_cols=252 Identities=25% Similarity=0.347 Sum_probs=205.6
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecC--CeeeEEE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQRLLVY 159 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lV~ 159 (457)
+|...+.||+|++|.||+|.+..++..|++|++..... .....+..|+.+++.++||||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47788999999999999999998899999999976543 3356788999999999999999999999988 8999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999976 237999999999999999999999998 99999999999999999999999999876443
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
...........++..|+|||.+....++.++||||||+++|+|++|..||..... ....... +..
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~----------~~~ 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYK----------IGS 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHh----------ccc
Confidence 3221113345688999999999888899999999999999999999999976541 1111110 000
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.......+......+.+++.+|++.+|.+||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 00111112222457889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=304.38 Aligned_cols=267 Identities=24% Similarity=0.346 Sum_probs=200.3
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
+|++.+.||.|++|.||+|++..++..||||.+...... ....+..|+.+++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 588899999999999999999999999999999765332 2356778999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
+ ++|.+++.... ....+++..++.++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~-- 153 (284)
T cd07836 81 D-KDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIP-- 153 (284)
T ss_pred C-ccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--
Confidence 7 48888886532 2346899999999999999999999999 999999999999999999999999998743221
Q ss_pred ccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCc-ccchhhhhhhhhcc----ccccc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE-QNLVTWARPLFNDR----RKFSK 316 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~----~~~~~ 316 (457)
........+++.|++||++.+. .++.++|||||||++|+|++|+.||........ ..+........... .....
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1112234578899999998654 578999999999999999999999976543211 00000000000000 00000
Q ss_pred ccCC--cc----CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 317 LADP--RL----EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 317 ~~d~--~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.... .. ...+.......+.+++..||+.+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 00 00011112346789999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=313.58 Aligned_cols=265 Identities=27% Similarity=0.397 Sum_probs=216.5
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC-hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
....+.+.||+|.||.|.++.... +..||||.++...... ..+|..|+.+|.+|+||||+.++++|..++.+++|+||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 456778889999999999999865 6899999998764433 47899999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
|++|+|.++|..... ..+.-.....|+.||+.||+||.+.+ +|||||.+.|+|++.++++||+|||+++....++
T Consensus 617 mEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999976321 22455567789999999999999999 9999999999999999999999999999766677
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh--CCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT--GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
..+...+.+-...|||||.+..++++.++|||+||+++||+++ ...||..... ...++-+..++.....-..+.-
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCcceeccC
Confidence 6666666777889999999999999999999999999999854 6788865433 2334434444433322111222
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
| .-....+.+++..||..+-++||+++++...|.+.+
T Consensus 769 P-------~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 769 P-------PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred C-------CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 2 223456779999999999999999999999987654
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=303.97 Aligned_cols=248 Identities=28% Similarity=0.336 Sum_probs=202.8
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
+|.+.+.||.|+||.||+|.+..++..||+|++..... ...+.+..|+.+++.++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58889999999999999999998999999999975432 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+.+++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999975 257899999999999999999999999 999999999999999999999999998754322
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
. ......|+..|+|||++.+..++.++|+||||+++|+|++|..||....... ..+....... .
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~-------~-- 217 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET-------A-- 217 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc-------c--
Confidence 1 2233568889999999988889999999999999999999999997654321 1111111110 0
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCCh--HHHH
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLI--GDVV 356 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~ev~ 356 (457)
....+......+.+++.+||+.+|.+||++ .|++
T Consensus 218 --~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 --DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 011111223578899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=298.33 Aligned_cols=252 Identities=24% Similarity=0.377 Sum_probs=207.3
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+|.+.+.||.|+||.||++.+..++..|++|++..... .....+..|+++++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 57888999999999999999998899999999976543 3446788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.........+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999864333578999999999999999999999998 9999999999999999999999999987533222
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
.......|++.|+|||.+....++.++||||||+++|+|++|..||...... ......... ... .
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~------~~~-~ 222 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKILKG------QYP-P 222 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHhcC------CCC-C
Confidence 2233356889999999998888999999999999999999999998654321 111111110 011 1
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+ +......+.+++.+||..+|++||++.++++
T Consensus 223 ~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 I----PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1 1122346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=300.56 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=202.0
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+|.+.+.||.|+||.||++..+.++..||+|.+..... ...+.+.+|+.+++.++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47888999999999999999999999999999875422 2345678899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC-ceEEeeccccccCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF-HPKLSDFGLAKLGPVG 240 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~~~~~ 240 (457)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++ .++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999999752 2345899999999999999999999999 99999999999998875 4699999998753221
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
........|++.|+|||++.+..++.++|||||||++|+|++|..||..... ..+....... .+.+
T Consensus 156 --~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~------~~~~ 221 (257)
T cd08225 156 --MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQG------YFAP 221 (257)
T ss_pred --cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhcc------cCCC
Confidence 1122234688999999999888899999999999999999999999864322 1222211111 0111
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+ .......+.+++.+||+.+|++||++.+|+.
T Consensus 222 -~----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 -I----SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -C----CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1 1122346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=306.09 Aligned_cols=267 Identities=21% Similarity=0.275 Sum_probs=197.6
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcC-CCCceeeEEEEecCCe-----
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQ----- 154 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~----- 154 (457)
++|++.+.||+|+||.||+|.+..+++.||||.+..... .....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468899999999999999999999999999999875432 22356888999999995 6999999999887665
Q ss_pred eeEEEeccCCCCHHHhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC-CCceEEeecc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPD-KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE-GFHPKLSDFG 232 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~-~~~~kL~DFG 232 (457)
.++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||+|+|||++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 888888653322 456899999999999999999999999 999999999999998 8999999999
Q ss_pred ccccCCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhh-c
Q 012761 233 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN-D 310 (457)
Q Consensus 233 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~-~ 310 (457)
++...... ........+++.|+|||++.+ ..++.++|||||||++|+|++|..||........ +.......-. .
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIFKLLGTPT 232 (295)
T ss_pred cceecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHhCCCC
Confidence 98753221 111223356888999998865 4579999999999999999999999975432110 0000000000 0
Q ss_pred ccccccccC-------CccC----CCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 311 RRKFSKLAD-------PRLE----GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 311 ~~~~~~~~d-------~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...+..... +... ..........+.+++.+||+.+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000000 0000 0000112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=300.83 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=205.3
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+|++.+.||.|+||.||++++..++..+++|.+..... .....+..|+.+++.++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 47888999999999999999998999999999875432 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998764434567899999999999999999999999 999999999999999999999999999764332
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...... .+.. ... ...+ +
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~---~~~--~~~~-----~- 219 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRY---KVQ--RGKY-----P- 219 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHh--cCCC-----C-
Confidence 222345788999999999888999999999999999999999999654321 1110 000 0000 1
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..+.....++.+++..||+.+|.+||++.++++
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 ---PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ---CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111233456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=304.40 Aligned_cols=255 Identities=27% Similarity=0.373 Sum_probs=206.3
Q ss_pred HHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 80 AATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 80 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
..++.|...+.||.|+||.||+|.+..++..|++|++..... ....+..|+.+++.++|+||+++++++...+..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 346678888999999999999999998899999999976543 4567889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 999999999999862 247999999999999999999999998 99999999999999999999999998864322
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
.. .......++..|++||++.+..++.++|||||||++|+|++|+.||....+.. ... ..... ......+
T Consensus 169 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~~~----~~~~~--~~~~~~~ 238 (286)
T cd06614 169 EK--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--ALF----LITTK--GIPPLKN 238 (286)
T ss_pred ch--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHHhc--CCCCCcc
Confidence 21 12233457889999999988889999999999999999999999986543211 000 00000 0000111
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
+......+.+++.+||+.+|.+||++.+++..
T Consensus 239 -------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 239 -------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -------hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00122467889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=300.57 Aligned_cols=237 Identities=26% Similarity=0.338 Sum_probs=193.5
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCH
Q 012761 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 167 (457)
Q Consensus 91 lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 167 (457)
||.|+||.||++++..++..||+|++...... ....+..|+.+++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999999988999999999764322 235688999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccc
Q 012761 168 EDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 247 (457)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 247 (457)
.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 999975 345899999999999999999999999 9999999999999999999999999987543322 122
Q ss_pred cccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCC
Q 012761 248 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYP 327 (457)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 327 (457)
...|++.|++||.+....++.++|+||||+++|+|++|..||...... ......... +......++
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~----------~~~~~~~~~ 216 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDIL----------KGNGKLEFP 216 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHh----------ccCCCCCCC
Confidence 346889999999998888999999999999999999999999765421 111111111 101111122
Q ss_pred hHhHHHHHHHHHHcchhhcCCCCC
Q 012761 328 IRGLYQALAVASMCIQEQAATRPL 351 (457)
Q Consensus 328 ~~~~~~l~~li~~cl~~dP~~RPt 351 (457)
......+.+++.+||+.+|.+||+
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLG 240 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcC
Confidence 222457889999999999999999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=306.28 Aligned_cols=256 Identities=24% Similarity=0.317 Sum_probs=196.3
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcC-CCCceeeEEEEecCCeeeEEEec
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+|...+.||+|+||.||++.+..++..||+|.+...... ....+..|+.++.++. ||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 566677899999999999999999999999998754322 3356788999999996 99999999999999999999999
Q ss_pred cCCCCHHHhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 162 MPLGSLEDHLHDL-PPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 162 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
+. ++|.++.... ......+++..+..++.+++.||+|||+. + |+||||||+|||++.++.++|+|||++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 85 4655543211 11236799999999999999999999975 7 99999999999999999999999999864322
Q ss_pred CCCccccccccccccccchhhhhcC---CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTG---QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
. .......|++.|+|||++.+. .++.++|||||||++|+|++|+.||..... ..........
T Consensus 161 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~------- 225 (288)
T cd06616 161 S---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK------- 225 (288)
T ss_pred C---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-------
Confidence 1 112234688999999998865 689999999999999999999999965431 1111111000
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
...+.+....+......+.+|+.+||+.+|.+||++.+|+..
T Consensus 226 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 226 GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122111112234578899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=332.41 Aligned_cols=276 Identities=25% Similarity=0.427 Sum_probs=224.0
Q ss_pred ccccccccHHHHHHHhcCC---------CccceeeecCcEEEEEEEECCCC---eEEEEEEeccCCCc-ChHHHHHHHHH
Q 012761 67 NIAAQTFTFRELAAATKNF---------RPESFIGEGGFGRVYKGWLESTG---QVVAVKQLDRNGLQ-GNREFLVEVLM 133 (457)
Q Consensus 67 ~~~~~~~~~~~~~~~~~~f---------~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~i~~~~~~-~~~~~~~E~~~ 133 (457)
..-...++|++-..+.+.| .++++||.|.||.||+|+++..| ..||||.++..... ...+|+.|+.|
T Consensus 604 k~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsI 683 (996)
T KOG0196|consen 604 KTYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASI 683 (996)
T ss_pred eeecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhh
Confidence 3445667777665555544 57889999999999999998766 47999999865433 34689999999
Q ss_pred HHhcCCCCceeeEEEEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC
Q 012761 134 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 213 (457)
Q Consensus 134 l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDL 213 (457)
|.+++||||++|.|+........||.|||++|+|+.+|+. ....+++.+..-++.+|+.||.||-+.+ +|||||
T Consensus 684 MGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDL 757 (996)
T KOG0196|consen 684 MGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDL 757 (996)
T ss_pred cccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhh
Confidence 9999999999999999999999999999999999999986 3456899999999999999999999999 999999
Q ss_pred CccCeEEcCCCceEEeeccccccCCCCCCccccccccc--cccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 012761 214 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG--TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAID 290 (457)
Q Consensus 214 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~ 290 (457)
...||||+.+...|++|||++++...+. ....+...| ..+|.|||.+...+++.+||||||||+|||.++ |.+||.
T Consensus 758 AARNILVNsnLvCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW 836 (996)
T KOG0196|consen 758 AARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 836 (996)
T ss_pred hhhheeeccceEEEeccccceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc
Confidence 9999999999999999999999753333 223333333 468999999999999999999999999999775 999986
Q ss_pred CCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 291 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 291 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
.....+ .+. -++++ .+-..|.+....|.+|++.|||+|-.+||.+.+|+..|+++...+
T Consensus 837 dmSNQd---VIk----aIe~g----------yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 837 DMSNQD---VIK----AIEQG----------YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ccchHH---HHH----HHHhc----------cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 544211 111 11111 111223445567889999999999999999999999999988654
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=306.33 Aligned_cols=248 Identities=31% Similarity=0.401 Sum_probs=197.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.+.|...+.||+|+||.||+|.+..+++.||+|.+....... ...+..|+.+++.++||||++++++|.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888999999999999999998889999999986543222 24678899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+. |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||+|+||++++++.++|+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99996 677777653 2346899999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCccccccccccccccchhhhh---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
.. ....+++.|+|||++. ...++.++||||||+++|||++|..||........ .......
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~~----- 229 (307)
T cd06607 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN----- 229 (307)
T ss_pred CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhcC-----
Confidence 21 2346788999999874 35688999999999999999999999865432110 0000000
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
..+.+. +......+.+++.+||+.+|.+||++.+|+..
T Consensus 230 --~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 --DSPTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCCCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 001110 11123468899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=319.84 Aligned_cols=247 Identities=25% Similarity=0.344 Sum_probs=212.3
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcCh--HHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~--~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
....|.+.+.||+|.|+.|.+|++..++..||||++++...... ..+.+|+++|..|+|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 35689999999999999999999999999999999987654332 5588999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+.+|.+.++|.. .....+..+..++.|+++|++|||+++ |+|||||++||||+.+.++||+|||++....
T Consensus 134 ~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 999999999999986 455666889999999999999999999 9999999999999999999999999998644
Q ss_pred CCCCccccccccccccccchhhhhcCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
........+|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||++..- .++
T Consensus 207 ---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--------------------k~L 263 (596)
T KOG0586|consen 207 ---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--------------------KEL 263 (596)
T ss_pred ---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--------------------ccc
Confidence 3345566899999999999998877 6799999999999999999999986432 233
Q ss_pred cCCccCCCCChH--hHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 318 ADPRLEGRYPIR--GLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 318 ~d~~l~~~~~~~--~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
-++.+.+.+-.. -..++-+++..+|-.+|.+|+++.++.+
T Consensus 264 r~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 264 RPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred cchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 334444443222 2456788999999999999999998864
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=302.27 Aligned_cols=266 Identities=21% Similarity=0.289 Sum_probs=197.3
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
++|.+.+.||+|++|.||+|.+..+++.||+|.+..... .....+..|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 578999999999999999999998899999999875432 223568889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC-CCceEEeeccccccCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE-GFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~-~~~~kL~DFGla~~~~~ 239 (457)
|++ ++|.+++... ....+++..+..++.||+.||+|||+.+ |+|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 5788877542 2334678889999999999999999999 999999999999985 56799999999975322
Q ss_pred CCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc-cchhhhh-h---hhhcccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-NLVTWAR-P---LFNDRRK 313 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~-~l~~~~~-~---~~~~~~~ 313 (457)
. ........+++.|+|||++.+. .++.++|||||||++|+|+||..||......+.. .+..+.. + .+.....
T Consensus 156 ~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 P--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred C--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 1 1122334678899999998764 5789999999999999999999999754321110 0000000 0 0000000
Q ss_pred cccc-------cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 314 FSKL-------ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 314 ~~~~-------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+... ....+. .........+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 000000 001112346788999999999999999999986
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=302.55 Aligned_cols=262 Identities=26% Similarity=0.342 Sum_probs=198.7
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
|++.+.||.|++|.||+|.++.+|..||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67788999999999999999989999999998754322 2356888999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
+ ++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~- 153 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV- 153 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-
Confidence 5 68999987532 246899999999999999999999998 9999999999999999999999999987532221
Q ss_pred ccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhc-----------
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND----------- 310 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----------- 310 (457)
.......+++.|+|||++.+. .++.++|||||||++|+|++|+.||....... .+..........
T Consensus 154 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 154 -RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred -cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhc
Confidence 112233568899999988654 57899999999999999999999996543211 111110000000
Q ss_pred ---ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 311 ---RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 311 ---~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...+.....+.+. .........+.+++.+||+.+|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000000 001112346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=300.75 Aligned_cols=246 Identities=27% Similarity=0.392 Sum_probs=197.7
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCH
Q 012761 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 167 (457)
Q Consensus 91 lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 167 (457)
||.|+||.||++++..+++.|++|++..... .....+..|+.+++.++||||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999998899999999976543 2345688899999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC-----
Q 012761 168 EDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK----- 242 (457)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~----- 242 (457)
.+++.. ...+++..++.++.||+.||.|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999976 237899999999999999999999999 99999999999999999999999999875433211
Q ss_pred -ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 243 -SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 243 -~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
........++..|+|||.+....++.++||||||+++|+|++|..||...... ............ .+.
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~~~-----~~~ 222 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILNGKIE-----WPE 222 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCCcC-----CCc
Confidence 11223356788999999998888999999999999999999999999654321 111111110000 000
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
. . .....+.+++.+||+.+|.+||++..+.+.|
T Consensus 223 ~---~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 223 D---V--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred c---c--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0 0 0135678999999999999999997666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=305.96 Aligned_cols=269 Identities=26% Similarity=0.354 Sum_probs=197.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCC------
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGD------ 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 153 (457)
.++|.+.+.||+|+||.||+|++..+++.||||.+...... ....+..|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 46799999999999999999999999999999998653221 2235678999999999999999999987654
Q ss_pred --eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeec
Q 012761 154 --QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDF 231 (457)
Q Consensus 154 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DF 231 (457)
..++||||+. ++|.+++.. ....+++.+++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 3599999996 588888764 2346899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCc--cccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhh--
Q 012761 232 GLAKLGPVGDKS--HVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP-- 306 (457)
Q Consensus 232 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~-- 306 (457)
|++......... .......++..|+|||++.+. .++.++||||||+++|||++|+.||.................
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 998754322211 112234578899999988764 478899999999999999999999976443211111111000
Q ss_pred ---hhhcccc---cccccCCc-----cCCCC-ChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 307 ---LFNDRRK---FSKLADPR-----LEGRY-PIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 307 ---~~~~~~~---~~~~~d~~-----l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+..... +..+..+. +.... +......+.+|+.+||+.+|.+||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000000 00000000 00000 0001235678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=301.30 Aligned_cols=243 Identities=27% Similarity=0.356 Sum_probs=188.6
Q ss_pred eeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHh---cCCCCceeeEEEEecCCeeeEEEeccC
Q 012761 90 FIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSL---LHHSNLVNLIGYCADGDQRLLVYEFMP 163 (457)
Q Consensus 90 ~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~---l~hpniv~l~~~~~~~~~~~lV~E~~~ 163 (457)
+||+|+||.||++.+..++..||+|.+....... ...+..|..+++. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999899999999987543221 1233444444433 479999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCc
Q 012761 164 LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS 243 (457)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 243 (457)
+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+|||+++++.++|+|||++......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--- 150 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc---
Confidence 9999999875 356999999999999999999999999 999999999999999999999999998642211
Q ss_pred cccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCcc
Q 012761 244 HVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||..........+... .. .....+
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~--------~~~~~~ 218 (279)
T cd05633 151 -KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TL--------TVNVEL 218 (279)
T ss_pred -CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---hh--------cCCcCC
Confidence 1223468999999999864 4689999999999999999999999976543221111100 00 011111
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCC-----ChHHHHHH
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 358 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~~ 358 (457)
+......+.+++..||+.+|.+|| ++.++++.
T Consensus 219 ----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 ----PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ----ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 222335688999999999999999 58877654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=312.39 Aligned_cols=265 Identities=21% Similarity=0.312 Sum_probs=198.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCceeeEEEEecC-----Cee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG-----DQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 155 (457)
+++|.+.+.||+|+||.||+|++..+++.||||.+.... ......+..|+.+++.++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 578999999999999999999999999999999986432 22335678899999999999999999987654 357
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++|+||+. ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 99999996 588887754 46899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCC-ccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc--
Q 012761 236 LGPVGDK-SHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR-- 311 (457)
Q Consensus 236 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-- 311 (457)
....... ........||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ........+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCH
Confidence 5322211 112233568999999998764 468999999999999999999999996543210 011111000000
Q ss_pred cccccccCCc---------cCCCC-----ChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 312 RKFSKLADPR---------LEGRY-----PIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 312 ~~~~~~~d~~---------l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
..+..+.+.. ..... .......+.+++.+||+.+|++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 00000 01123468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=297.69 Aligned_cols=251 Identities=25% Similarity=0.322 Sum_probs=198.7
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC-----CcChHHHHHHHHHHHhcCCCCceeeEEEEecC--Cee
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG-----LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQR 155 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 155 (457)
.+|.+.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999999999999999875321 12234678899999999999999999998764 468
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++|+||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999875 345889999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCC-ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 236 LGPVGDK-SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 236 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ..+. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~----~~------- 221 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AAIF----KI------- 221 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HHHH----HH-------
Confidence 5322111 11122356889999999998888999999999999999999999999653221 0000 00
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.........+......+.+++.+||+ +|..||+..+++.
T Consensus 222 ---~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 ---ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00001111233334578899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=306.49 Aligned_cols=251 Identities=30% Similarity=0.416 Sum_probs=199.5
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.|...+.||+|+||.||++++..++..||+|.+....... ...+..|+.+++.++|||++++++++.+.+..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4778889999999999999998889999999987543222 2467889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+. |+|.+++.. ...++++.++..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 106 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred CCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 997 578777754 2456899999999999999999999999 99999999999999999999999998864322
Q ss_pred CCccccccccccccccchhhhh---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
.....|++.|+|||++. .+.++.++|||||||++|+|++|..||....... .+..+. ...
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~----~~~------ 240 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIA----QNE------ 240 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHH----hcc------
Confidence 12346888999999974 4568899999999999999999999986532110 001110 000
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
.+... .......+.+++.+||+.+|.+||++.+|+..+-.+.
T Consensus 241 -~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 241 -SPTLQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -CCCCC---CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 00000 1112346789999999999999999999998765544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=300.93 Aligned_cols=259 Identities=23% Similarity=0.273 Sum_probs=194.8
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcC-CCCceeeEEEEecC--CeeeEEEe
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLH-HSNLVNLIGYCADG--DQRLLVYE 160 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~--~~~~lV~E 160 (457)
|++.+.||+|+||.||+|.+..++..||+|++..... ........|+.++..+. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 6778899999999999999998999999999875422 12234457888888885 99999999999987 88999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+. ++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||+|+||+++. +.++|+|||++......
T Consensus 81 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 588888765 2357899999999999999999999999 999999999999999 99999999998753222
Q ss_pred CCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccc-------
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR------- 312 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------- 312 (457)
. ......++..|+|||++.. ..++.++|||||||++|||++|..||....+.+ ...+.........
T Consensus 153 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 153 P---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred C---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhh
Confidence 1 1223457889999998754 457899999999999999999999997644321 1111111100000
Q ss_pred ---ccccccCCccCCC----CChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 313 ---KFSKLADPRLEGR----YPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 313 ---~~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.......+..... ........+.+++.+||+.+|++||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000001110000 00123467899999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=293.37 Aligned_cols=253 Identities=22% Similarity=0.260 Sum_probs=200.4
Q ss_pred HhcCCCcc-ceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCceeeEEEEec----CCe
Q 012761 81 ATKNFRPE-SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCAD----GDQ 154 (457)
Q Consensus 81 ~~~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~----~~~ 154 (457)
.+++|.+. ++||-|-.|.|-.+.++.|++.+|+|++. +....++|+++.-.. .|||||.++++|.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 46777765 57999999999999999999999999885 335566788776555 49999999999865 356
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC---CCceEEeec
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE---GFHPKLSDF 231 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~---~~~~kL~DF 231 (457)
+++|||+|+||.|...+++ .....+++.++..|+.||..|+.|||+.+ |.||||||+|+|... |-.+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 7899999999999999987 34567999999999999999999999999 999999999999954 557999999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccch-hhhhhhhhc
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV-TWARPLFND 310 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~-~~~~~~~~~ 310 (457)
|+|+.... .....+.+-|+.|.|||++...+|+..+|+||+||++|-||+|.+||...... -+. .....+...
T Consensus 209 GFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~g 282 (400)
T KOG0604|consen 209 GFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTG 282 (400)
T ss_pred ccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhcc
Confidence 99985321 22344567899999999999999999999999999999999999999865431 111 111111111
Q ss_pred ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 311 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 311 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.. +..+++.. .....+.++|+.+|..+|.+|.|+.+++.
T Consensus 283 qy---~FP~pEWs-----~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 283 QY---EFPEPEWS-----CVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred Cc---cCCChhHh-----HHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 11 12222211 23557788999999999999999999865
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=310.25 Aligned_cols=264 Identities=24% Similarity=0.321 Sum_probs=199.4
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecC------
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG------ 152 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------ 152 (457)
..++|.+.+.||+|+||.||+|.+..++..||||.+.... ......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999999999999999986532 22235677899999999999999999998643
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecc
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 232 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFG 232 (457)
...++||||+. ++|.+.+.. .++...+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999996 588888754 2888999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCc-ccch--------hh
Q 012761 233 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE-QNLV--------TW 303 (457)
Q Consensus 233 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~-~~l~--------~~ 303 (457)
++...... .......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+.... ..+. .+
T Consensus 164 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 164 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cceeCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99753221 112334678999999999999999999999999999999999999965432110 0000 00
Q ss_pred -------hhhhhhccc-----ccccccCCc----cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 304 -------ARPLFNDRR-----KFSKLADPR----LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 304 -------~~~~~~~~~-----~~~~~~d~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
......... .+..+.... .....+......+.+++.+||+.||++||++.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000000 000111100 000001123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=314.75 Aligned_cols=253 Identities=23% Similarity=0.282 Sum_probs=203.3
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcC-CCCceeeEEEEecCCeeeE
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l 157 (457)
..+.|.+++.||+||.+.||++...+ ...||+|.+.... .+...-|.+|+.+|.+|+ |.+||.|++|-..++.+|+
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 35679999999999999999998765 4667777665432 223456999999999996 9999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||- ..+|..+|... ...++.-.++.+..|++.++.++|+++ |||.||||.|+|+-. |.+||+|||+|...
T Consensus 438 vmE~G-d~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred Eeecc-cccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 99976 47999999862 233332388999999999999999999 999999999999964 69999999999987
Q ss_pred CCCCCccccccccccccccchhhhhcC-----------CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhh
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTG-----------QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP 306 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~ 306 (457)
..+.........+||+.||+||.+... +.+.++||||||||||+|+.|+.||.... + .
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n--~---- 578 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----N--Q---- 578 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----H--H----
Confidence 776666667778999999999998643 25678999999999999999999995321 1 1
Q ss_pred hhhcccccccccCCccCCCCChH-hHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 307 LFNDRRKFSKLADPRLEGRYPIR-GLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 307 ~~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
-.++..+.||.-.-.|+.- ....+++++..||+.||++||++.|+++
T Consensus 579 ----~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 579 ----IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ----HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1234566666544444322 2334899999999999999999999976
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=301.17 Aligned_cols=262 Identities=23% Similarity=0.309 Sum_probs=199.0
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecC--CeeeEEEe
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQRLLVYE 160 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lV~E 160 (457)
|.+.+.||.|+||.||+|.+..++..||+|++.... ......+..|+.+++.++|||++++++++.+. ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667889999999999999999889999999998653 22335688899999999999999999999888 88999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|++ ++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||+|+|||+++++.++|+|||++......
T Consensus 81 ~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 997 4888888652 257899999999999999999999999 999999999999999999999999998754332
Q ss_pred CCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhc--ccccccc
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND--RRKFSKL 317 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~ 317 (457)
.. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .......... ...+..+
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGV 229 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhcccc
Confidence 21 11233456888999998764 4678999999999999999999999975443211 1100000000 0000000
Q ss_pred cC--------------CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 318 AD--------------PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 318 ~d--------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+ ..+...+.......+.+++.+||+.+|.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 00000000011457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=311.22 Aligned_cols=250 Identities=28% Similarity=0.386 Sum_probs=206.3
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.+.|+.-++||+||||.||-++.+.||+.||.|.+.+..+ .+....++|..||.+++.+.||.+-..|.+.+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 4679999999999999999999999999999999876433 2334578899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
+..|.||+|.-+|... ....+++..++.++.+|+.||++||+.+ ||+|||||+|||||+.|+++|+|+|||.-.+
T Consensus 264 LtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999874 3467999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.+.. ....+||.+|||||++.++.|+...|+|||||+||||+.|+-||-........ .+.-+....
T Consensus 339 ~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~--eEvdrr~~~--------- 404 (591)
T KOG0986|consen 339 EGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR--EEVDRRTLE--------- 404 (591)
T ss_pred CCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH--HHHHHHHhc---------
Confidence 4432 22348999999999999999999999999999999999999999653321100 000011111
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIG 353 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 353 (457)
| ...|+..-..++..|....|+.||.+|.-.+
T Consensus 405 ~---~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 405 D---PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred c---hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1 1233444456788899999999999997654
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=305.96 Aligned_cols=267 Identities=23% Similarity=0.321 Sum_probs=198.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEecC--CeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADG--DQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 157 (457)
.++|.+.+.||.|+||.||+|.+..++..||+|.+....... ...+..|+.+++.++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 568999999999999999999999999999999987543221 23466899999999999999999998765 56899
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+. ++|.+++... ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++...
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 5888888652 356899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc-cchhhhh-------hhh
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-NLVTWAR-------PLF 308 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~-~l~~~~~-------~~~ 308 (457)
.... .......+++.|+|||++.+ ..++.++|||||||++|||++|++||....+.... .+..+.. +.+
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 3221 12222345788999999875 46799999999999999999999999754432110 0000000 000
Q ss_pred hcccccccc-cCCccCCCCC---hHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 309 NDRRKFSKL-ADPRLEGRYP---IRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 309 ~~~~~~~~~-~d~~l~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
......... .......... ......+.+++.+||+.||++||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 0000000000 011346778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=296.35 Aligned_cols=250 Identities=22% Similarity=0.276 Sum_probs=195.0
Q ss_pred HHHHHHhcCCCcccee--eecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCceeeEEEEecC
Q 012761 76 RELAAATKNFRPESFI--GEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADG 152 (457)
Q Consensus 76 ~~~~~~~~~f~~~~~l--G~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 152 (457)
.+.....++|.+.+.+ |.|+||.||++..+.++..+|+|.+........ |+.....+ +||||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 3445556788888777 999999999999999999999999875432211 22222222 699999999999999
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC-ceEEeec
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF-HPKLSDF 231 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~-~~kL~DF 231 (457)
+..++||||+++++|.+++.. ...+++..++.++.||++||.|||+.+ ++||||||+||+++.++ .++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecC
Confidence 999999999999999999975 347999999999999999999999999 99999999999999888 9999999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 311 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 311 (457)
|++..... .....|+..|+|||++.+..++.++|||||||++|+|++|..||...... ...+..+.... ..
T Consensus 155 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~~- 225 (267)
T PHA03390 155 GLCKIIGT------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ-QK- 225 (267)
T ss_pred ccceecCC------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh-cc-
Confidence 99875321 12245789999999999889999999999999999999999999744321 11112222111 00
Q ss_pred cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCC-hHHHHH
Q 012761 312 RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-IGDVVT 357 (457)
Q Consensus 312 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~ev~~ 357 (457)
.. . ........+.+++..||+.+|.+||+ +.++++
T Consensus 226 ----~~---~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 ----KL---P----FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----cC---C----cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 0 01123346889999999999999996 588763
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=293.46 Aligned_cols=248 Identities=29% Similarity=0.426 Sum_probs=203.7
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+|.+.+.||+|++|.||++++..++..|++|.+..... .....+..|+.+++.++|||++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 47888999999999999999998899999999987644 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999875 357899999999999999999999999 9999999999999999999999999997643322
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
. ......++..|+|||.+.+..++.++||||||+++|+|++|..||...... ..... ... . ..+.
T Consensus 154 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~--~-----~~~~ 218 (254)
T cd06627 154 K--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AALFR-IVQ--D-----DHPP 218 (254)
T ss_pred c--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHH-Hhc--c-----CCCC
Confidence 2 123356889999999998878899999999999999999999998654311 10000 000 0 0011
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+ +......+.+++.+||..+|++||++.+++.
T Consensus 219 ~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 L----PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 1122346789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=298.87 Aligned_cols=242 Identities=27% Similarity=0.377 Sum_probs=191.6
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCH
Q 012761 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 167 (457)
Q Consensus 91 lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 167 (457)
||+|+||.||++.+..++..||+|.+..... .....+..|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999999998999999999875422 2234567899999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccc
Q 012761 168 EDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 247 (457)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 247 (457)
.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++...... ....
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~ 152 (277)
T cd05577 81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIK 152 (277)
T ss_pred HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccc
Confidence 9999752 2246899999999999999999999999 999999999999999999999999998753221 1222
Q ss_pred cccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCC
Q 012761 248 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYP 327 (457)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 327 (457)
...++..|+|||++.+..++.++|||||||++|+|++|+.||......... .......... .. .++
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~--------~~----~~~ 218 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK--EELKRRTLEM--------AV----EYP 218 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH--HHHHhccccc--------cc----cCC
Confidence 345788999999998888999999999999999999999999654321110 0000000000 00 111
Q ss_pred hHhHHHHHHHHHHcchhhcCCCCChHH
Q 012761 328 IRGLYQALAVASMCIQEQAATRPLIGD 354 (457)
Q Consensus 328 ~~~~~~l~~li~~cl~~dP~~RPt~~e 354 (457)
......+.+++.+||+.+|.+||+.++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCc
Confidence 122346789999999999999995444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=295.10 Aligned_cols=244 Identities=23% Similarity=0.297 Sum_probs=190.5
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcCh---HHHHHHHHH-HHhcCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN---REFLVEVLM-LSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~---~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.||.|+||.||+|.+..+++.||||.+........ ..+..|..+ ...+.|+||+++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 569999999999999998899999999875432221 233444444 4455899999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+|||++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999975 356899999999999999999999999 99999999999999999999999999875322
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 324 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 324 (457)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ............. .+...
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~----~~~~~- 217 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDNILSRRINW----PEEVK- 217 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcccCC----CCccc-
Confidence 22346888999999998888899999999999999999999999654321 1111111100000 00111
Q ss_pred CCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 325 RYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
......+.+++.+||+.+|++||++.++.+.|
T Consensus 218 ---~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 218 ---EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ---ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 11234688999999999999999887665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=302.14 Aligned_cols=245 Identities=25% Similarity=0.332 Sum_probs=197.9
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCH
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 167 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 167 (457)
...||+|+||.||++....++..||||.+..........+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35699999999999999989999999998765444456788999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccc
Q 012761 168 EDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 247 (457)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 247 (457)
.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 105 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~ 174 (292)
T cd06657 105 TDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRK 174 (292)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--cccc
Confidence 998754 35889999999999999999999999 9999999999999999999999999886432221 1223
Q ss_pred cccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCC
Q 012761 248 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYP 327 (457)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 327 (457)
...|++.|+|||++.+..++.++|||||||++|+|++|..||....... ....... ...+.+...
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~~~~~----------~~~~~~~~~-- 239 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIRD----------NLPPKLKNL-- 239 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh----------hCCcccCCc--
Confidence 3568899999999988889999999999999999999999986533211 1111100 011111100
Q ss_pred hHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 328 IRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 328 ~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
......+.+++.+||+.+|.+||++.+++.
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 012235778999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=300.56 Aligned_cols=259 Identities=16% Similarity=0.200 Sum_probs=187.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCC---CeEEEEEEeccCCCcChH-----------HHHHHHHHHHhcCCCCceeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLEST---GQVVAVKQLDRNGLQGNR-----------EFLVEVLMLSLLHHSNLVNLIG 147 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~i~~~~~~~~~-----------~~~~E~~~l~~l~hpniv~l~~ 147 (457)
.+.|.+.+.||+|+||.||+|.+..+ +..+|+|+.......... ....+...+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999998877 667788865433211111 1223334556678999999999
Q ss_pred EEecCC----eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC
Q 012761 148 YCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG 223 (457)
Q Consensus 148 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~ 223 (457)
++.... ..+++++++. .++.+.+.. ....++..+..|+.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 765543 3467888774 467666654 233577889999999999999999999 9999999999999999
Q ss_pred CceEEeeccccccCCCCCCc-----cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 012761 224 FHPKLSDFGLAKLGPVGDKS-----HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 298 (457)
Q Consensus 224 ~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~ 298 (457)
+.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~-- 240 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG-- 240 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--
Confidence 99999999999754221111 11123469999999999999899999999999999999999999997653221
Q ss_pred cchhhhh-hhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 299 NLVTWAR-PLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 299 ~l~~~~~-~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
.+..... .++. .+....+. .......+.+++..|++.+|++||++.++++.|
T Consensus 241 ~~~~~~~~~~~~------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 NLIHAAKCDFIK------RLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHhHHHHHH------Hhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1111110 0000 01111100 001134688999999999999999999999876
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=309.73 Aligned_cols=266 Identities=21% Similarity=0.298 Sum_probs=200.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEec----CCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCAD----GDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~ 155 (457)
.++|.+.+.||.|+||.||+|....++..||+|++.... ......+..|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999999999999999987542 2234567789999999999999999998753 3568
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 689988865 355899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCC--ccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc-
Q 012761 236 LGPVGDK--SHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR- 311 (457)
Q Consensus 236 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~- 311 (457)
....... ........|+..|+|||++.. ..++.++|||||||++|||++|+.||......... ..+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~---~~~~~~~g~~~ 232 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL---KLILSVLGSPS 232 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH---HHHHHHhCCCh
Confidence 5322221 112234578899999999865 46899999999999999999999999764332110 0000000000
Q ss_pred ---------cccccccCC-ccCCCC-----ChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 312 ---------RKFSKLADP-RLEGRY-----PIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 312 ---------~~~~~~~d~-~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
..+....+. ...... .......+.+++.+||+.+|.+||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000000 000000 01224578899999999999999999998774
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=307.53 Aligned_cols=270 Identities=22% Similarity=0.312 Sum_probs=201.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecC-----Ce
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG-----DQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 154 (457)
.++|.+.+.||+|+||.||+|++..++..||||.+.... ......+..|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999999999999999987532 22234677899999999999999999988654 34
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
.++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 789888865 356999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCccc-chhhhhh------
Q 012761 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN-LVTWARP------ 306 (457)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~-l~~~~~~------ 306 (457)
....... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.......... +......
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 7543221 22233467889999998875 468999999999999999999999996543211000 0000000
Q ss_pred -hhhcc------cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH--HHhh
Q 012761 307 -LFNDR------RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA--LSYL 362 (457)
Q Consensus 307 -~~~~~------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~--L~~l 362 (457)
.+... .......++.+... .......+.+++.+||+.+|++||++.++++. |..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARL-FPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHH-cccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000 00000011111100 11234567899999999999999999999876 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=308.44 Aligned_cols=268 Identities=25% Similarity=0.346 Sum_probs=199.5
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccC--CCcChHHHHHHHHHHHhc-CCCCceeeEEEEecC--Cee
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN--GLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADG--DQR 155 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~--~~~ 155 (457)
..++|.+.+.||.|+||.||+|.+..++..||||.+... .......+..|+.++..+ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 457899999999999999999999888999999988642 122335577899999999 999999999998654 468
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++||||++ ++|..++.. ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 599988865 27889999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCc---cccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCccc-chhhhhh----
Q 012761 236 LGPVGDKS---HVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN-LVTWARP---- 306 (457)
Q Consensus 236 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~-l~~~~~~---- 306 (457)
........ .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... +......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 54332211 12234568999999998765 467899999999999999999999996543211100 0000000
Q ss_pred ---hhh--ccc-ccccccCC---ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 307 ---LFN--DRR-KFSKLADP---RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 307 ---~~~--~~~-~~~~~~d~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.+. ... .+..+... .+....+ .....+.+++..||+.+|.+||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLP-KASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhcc-CCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000 000 00000000 0000000 123568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=298.14 Aligned_cols=263 Identities=25% Similarity=0.324 Sum_probs=200.6
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
|.+.+.||.|++|.||++.+..+++.+++|.+...... ....+..|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778899999999999999888999999998765332 3456888999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++ +|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 74 88888765 2357899999999999999999999999 9999999999999999999999999987543322
Q ss_pred ccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCccc-chhh-------hhhhhh----
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN-LVTW-------ARPLFN---- 309 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~-l~~~-------~~~~~~---- 309 (457)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+... +... ....+.
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 122234578899999998876 78999999999999999999999996544211100 0000 000000
Q ss_pred -cccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 310 -DRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 310 -~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
....+....+..+ ..........+.+++..||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000000000 0011123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=297.20 Aligned_cols=242 Identities=26% Similarity=0.341 Sum_probs=189.4
Q ss_pred eeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHH---HHHhcCCCCceeeEEEEecCCeeeEEEeccC
Q 012761 90 FIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVL---MLSLLHHSNLVNLIGYCADGDQRLLVYEFMP 163 (457)
Q Consensus 90 ~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~---~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~ 163 (457)
+||+|+||.||+|++..+++.||+|.+....... ...+..|.. +++...||||+.+++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999889999999987643221 122334433 3444579999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCc
Q 012761 164 LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS 243 (457)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 243 (457)
+++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--- 150 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc---
Confidence 9999998864 457999999999999999999999999 999999999999999999999999998643211
Q ss_pred cccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCcc
Q 012761 244 HVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
......|+..|+|||++.++ .++.++|||||||++|+|++|+.||............ ... ....+.+
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~~--------~~~~~~~ 218 (278)
T cd05606 151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMT--------LTMAVEL 218 (278)
T ss_pred -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HHh--------hccCCCC
Confidence 12234689999999998754 6899999999999999999999999765332211100 000 0011111
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCC-----ChHHHHH
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVT 357 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~ 357 (457)
.. .....+.+++.+||..+|.+|| ++.++++
T Consensus 219 ~~----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 PD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CC----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11 1235788999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=305.44 Aligned_cols=263 Identities=23% Similarity=0.297 Sum_probs=193.3
Q ss_pred ceeeec--CcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEG--GFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G--~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
..||.| +||+||++++..+++.||||++...... ..+.+..|+.+++.++||||++++++|...+..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999999999999999998754322 235678899999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC-CCc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG-DKS 243 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~-~~~ 243 (457)
++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++++||+.+...... ...
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999987632 345899999999999999999999999 999999999999999999999999865321111 000
Q ss_pred cc----cccccccccccchhhhhcC--CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhh---------hh
Q 012761 244 HV----STRVMGTYGYCAPEYAMTG--QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP---------LF 308 (457)
Q Consensus 244 ~~----~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~---------~~ 308 (457)
.. .....++..|+|||++.+. .++.++|||||||++|+|++|..||....... .+...... ..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCcccccc
Confidence 00 0112346679999998763 57899999999999999999999996543211 00000000 00
Q ss_pred -------hcc----------cc-----cccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 309 -------NDR----------RK-----FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 309 -------~~~----------~~-----~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
... .. ...+.+..+...........+.+|+.+||+.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 00 000111111111122345678999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=302.58 Aligned_cols=268 Identities=25% Similarity=0.326 Sum_probs=196.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCC------
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGD------ 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 153 (457)
.++|.+.+.||.|+||.||+|.+..++..||||++...... ....+.+|+.+++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999999999999999998654322 2245678999999999999999999875433
Q ss_pred --eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeec
Q 012761 154 --QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDF 231 (457)
Q Consensus 154 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DF 231 (457)
..++||||+. ++|...+.. ....+++..+..++.||++||.|||+.+ |+|+||||+|||+++++.++|+||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 4699999996 467777654 2457999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCc---------cccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccc-
Q 012761 232 GLAKLGPVGDKS---------HVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNL- 300 (457)
Q Consensus 232 Gla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l- 300 (457)
|++......... ...+...+++.|+|||++.+. .++.++|||||||++|||++|++||...........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 998753222111 112234678889999988654 588999999999999999999999975443211000
Q ss_pred hhhhhhh----hhcccccccccC--------CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 301 VTWARPL----FNDRRKFSKLAD--------PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 301 ~~~~~~~----~~~~~~~~~~~d--------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
....... ......+....+ +.+...+ ......+.+++.+||+.+|.+||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000 000000000000 0010000 011246789999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=324.32 Aligned_cols=273 Identities=19% Similarity=0.212 Sum_probs=188.3
Q ss_pred HHhcCCCccceeeecCcEEEEEEEECCCC-eEEEEEEec--------------c---CCCcChHHHHHHHHHHHhcCCCC
Q 012761 80 AATKNFRPESFIGEGGFGRVYKGWLESTG-QVVAVKQLD--------------R---NGLQGNREFLVEVLMLSLLHHSN 141 (457)
Q Consensus 80 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~i~--------------~---~~~~~~~~~~~E~~~l~~l~hpn 141 (457)
...++|++.+.||+|+||.||++.++... ..+++|.+. + ........+.+|+.+|..++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999998765422 222222111 0 11112345788999999999999
Q ss_pred ceeeEEEEecCCeeeEEEeccCCCCHHHhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE
Q 012761 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL 220 (457)
Q Consensus 142 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl 220 (457)
|+++++++.+.+..|+|++++. ++|.+++.... ..........+..|+.||+.||.|||+.+ ||||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999985 57777765421 11223345677889999999999999999 9999999999999
Q ss_pred cCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCC-CCCCCCCCccc
Q 012761 221 EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA-IDSTRPHGEQN 299 (457)
Q Consensus 221 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p-~~~~~~~~~~~ 299 (457)
+.++.+||+|||++....... ........||+.|+|||++.+..++.++|||||||+||||++|..+ +..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 999999999999997543221 1222346799999999999998999999999999999999998864 43322221111
Q ss_pred chhhhhhhhhcccccc-------cccCC-cc---CCCCC-----hHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 300 LVTWARPLFNDRRKFS-------KLADP-RL---EGRYP-----IRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 300 l~~~~~~~~~~~~~~~-------~~~d~-~l---~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+......+......+. ..++. .+ ....+ ......+.+++.+||+.||.+||++.|++.
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 2111111000000000 00000 00 00000 001134667899999999999999999986
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=299.41 Aligned_cols=266 Identities=26% Similarity=0.341 Sum_probs=198.9
Q ss_pred HHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCC----
Q 012761 80 AATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGD---- 153 (457)
Q Consensus 80 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---- 153 (457)
...++|++.+.||+|+||.||+|.+..+++.||||++..... .....+..|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 356789999999999999999999998899999999975432 22345778999999999999999999987655
Q ss_pred ------eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceE
Q 012761 154 ------QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPK 227 (457)
Q Consensus 154 ------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~k 227 (457)
..++|+||+++ +|..++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999975 77777764 2346899999999999999999999999 99999999999999999999
Q ss_pred EeeccccccCCCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhh
Q 012761 228 LSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP 306 (457)
Q Consensus 228 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~ 306 (457)
|+|||++........ .......++..|+|||++.+. .++.++|||||||++|+|++|++||........ +.. +..
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~--~~~-~~~ 232 (302)
T cd07864 157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ--LEL-ISR 232 (302)
T ss_pred eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHH
Confidence 999999875433221 122233467889999988653 578999999999999999999999975432110 100 000
Q ss_pred hhhc--ccccccc--------cCC------ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 307 LFND--RRKFSKL--------ADP------RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 307 ~~~~--~~~~~~~--------~d~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.... ...++.+ .++ .+...+. .....+.+++.+||+.+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0000000 000 0000000 11346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=294.71 Aligned_cols=261 Identities=25% Similarity=0.342 Sum_probs=195.5
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhc---CCCCceeeEEEEecCCe-----
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLL---HHSNLVNLIGYCADGDQ----- 154 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~----- 154 (457)
|++.+.||.|+||.||+|+++.++..||+|.+...... ....+..|+.++..+ .||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67788999999999999999888999999999753222 123466677776665 59999999999988776
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
.+++|||+. ++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999997 58988886532 236899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhh---c-
Q 012761 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN---D- 310 (457)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~- 310 (457)
....... ......++..|+|||++.+..++.++|||||||++|+|++|.+||....... .+..+...... .
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 155 RIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEE 229 (287)
T ss_pred eeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHh
Confidence 7543221 1123357889999999998899999999999999999999999987543211 11111110000 0
Q ss_pred --------ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 311 --------RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 311 --------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...+........ ..........+.+++.+||+.+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000000 0011122456788999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=318.79 Aligned_cols=244 Identities=25% Similarity=0.400 Sum_probs=196.0
Q ss_pred CccceeeecCcEEEEEEEECCCCeEEEEEEeccCC----CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCe--eeEEE
Q 012761 86 RPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG----LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ--RLLVY 159 (457)
Q Consensus 86 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~lV~ 159 (457)
+...+||+|.|-+||+|.+..+|..||--.++... ....+.|..|+.+|+.|+||||+++|.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34456999999999999999999988865554321 1223678999999999999999999999988665 67899
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc-CCCceEEeeccccccCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE-EGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~-~~~~~kL~DFGla~~~~ 238 (457)
|++..|+|..|+.. .+.++...+..|+.||++||.|||++. |||||||||.+||||+ ..|.|||+|+|||....
T Consensus 123 EL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999987 456788899999999999999999985 7899999999999997 46899999999998632
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhh--ccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN--DRRKFSK 316 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~~ 316 (457)
. .....++|||.|||||+.. ..|+..+||||||.+++||+|+..||....... ..-+.... .+..+..
T Consensus 198 ~----s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A-----QIYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 198 K----SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA-----QIYKKVTSGIKPAALSK 267 (632)
T ss_pred c----cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH-----HHHHHHHcCCCHHHhhc
Confidence 2 2234478999999999887 689999999999999999999999997654321 11111100 1122333
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+-|| ++.+||..||.. .++||++.|++.
T Consensus 268 V~dP------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 VKDP------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred cCCH------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 3343 567899999999 999999999986
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=336.74 Aligned_cols=257 Identities=26% Similarity=0.295 Sum_probs=208.4
Q ss_pred HHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecC
Q 012761 76 RELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG 152 (457)
Q Consensus 76 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 152 (457)
.++....++|.++++||+|+||.|.+++++.|++.||+|++.+.. .....-|..|..+|..-+.+-|+.++..|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 455556789999999999999999999999999999999998632 22345688899999988999999999999999
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecc
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 232 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFG 232 (457)
+++|+|||||+||+|..+|.. ..++++..+..++..|+.||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999976 237999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccchhhhh----c-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhh
Q 012761 233 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAM----T-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL 307 (457)
Q Consensus 233 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 307 (457)
.+-... .+....+...+|||.|++||++. + +.|+..+|+||+||++|||+.|.-||+... ++.--..+
T Consensus 221 sClkm~-~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KI 293 (1317)
T KOG0612|consen 221 SCLKMD-ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKI 293 (1317)
T ss_pred hHHhcC-CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHH
Confidence 886532 23334455578999999999986 2 579999999999999999999999997543 33322222
Q ss_pred hhcccccccccCCccCCCCC--hHhHHHHHHHHHHcchhhcCCCCC---hHHHHH
Q 012761 308 FNDRRKFSKLADPRLEGRYP--IRGLYQALAVASMCIQEQAATRPL---IGDVVT 357 (457)
Q Consensus 308 ~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~li~~cl~~dP~~RPt---~~ev~~ 357 (457)
+.-.. .-.|| .....++.+||...+. +|+.|.. +.++-.
T Consensus 294 m~hk~----------~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 294 MNHKE----------SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred hchhh----------hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 22211 11222 1234567788877665 4777887 777654
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=297.86 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=202.4
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcC-CCCceeeEEEEecCCeeeEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV 158 (457)
++|.+.+.||.|+||.||++....++..||+|++..... .....+..|+.++..++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 478999999999999999999998999999999876322 22356788999999999 99999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999976 347999999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCCc------------------cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccc
Q 012761 239 VGDKS------------------HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNL 300 (457)
Q Consensus 239 ~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l 300 (457)
..... .......++..|+|||++....++.++||||||+++++|++|..||...... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~ 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LT 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HH
Confidence 22210 1122346788999999998888999999999999999999999999754310 00
Q ss_pred hhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCCh----HHHHH
Q 012761 301 VTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI----GDVVT 357 (457)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~ev~~ 357 (457)
....... ...++......+.+++..||+.+|.+||++ .+++.
T Consensus 231 ---~~~~~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 ---FQKILKL------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---HHHHHhc------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0111100 011111223468899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=300.03 Aligned_cols=244 Identities=30% Similarity=0.422 Sum_probs=194.7
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
|...+.||+|+||.||+|++..++..|++|++....... ...+..|+.+++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666778999999999999999899999999987543222 24578899999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+. ++|.+++.. ...++++.+++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 678777754 2456899999999999999999999999 99999999999999999999999998864211
Q ss_pred Cccccccccccccccchhhhh---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.....|+..|+|||++. ...++.++|||||||++|+|++|..||........ ....... ......
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~--~~~~~~ 241 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN--DSPTLQ 241 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhc--CCCCCC
Confidence 12356889999999984 45688999999999999999999999866432111 1111000 000111
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...+ ...+.+++.+||+.+|.+||++.+++.
T Consensus 242 ----~~~~----~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 242 ----SNEW----TDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred ----cccc----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 235788999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=314.88 Aligned_cols=272 Identities=23% Similarity=0.319 Sum_probs=204.3
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecC------CeeeE
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADG------DQRLL 157 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~~l 157 (457)
+...+.||+|+||.||+++++.+|..||||.+..... ...+....|+++|++|+|+|||++++.-.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4455679999999999999999999999999986432 3346678899999999999999999885543 35689
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc--CCC--ceEEeeccc
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE--EGF--HPKLSDFGL 233 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~--~~~--~~kL~DFGl 233 (457)
|||||.||+|...|.. +.+...|++.+.+.++.++..||.|||+++ |+||||||.||++- .+| ..||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999976 445567999999999999999999999999 99999999999993 334 479999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccc
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 312 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 312 (457)
|+-.+. ....+.++||..|++||++.. +.|+..+|.|||||++|+.+||..||-.........-+.|..-. ....
T Consensus 171 Arel~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t-kkp~ 246 (732)
T KOG4250|consen 171 ARELDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT-KKPS 246 (732)
T ss_pred cccCCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc-cCCC
Confidence 985332 235677899999999999984 88999999999999999999999999755443211112221111 1111
Q ss_pred ccccccCCccC------------CCCChHhHHHHHHHHHHcchhhcCCCC--ChHHHHHHHHhhhh
Q 012761 313 KFSKLADPRLE------------GRYPIRGLYQALAVASMCIQEQAATRP--LIGDVVTALSYLAN 364 (457)
Q Consensus 313 ~~~~~~d~~l~------------~~~~~~~~~~l~~li~~cl~~dP~~RP--t~~ev~~~L~~l~~ 364 (457)
.......+... ..........+-..+..+|..+|++|. ...+.-..+..|..
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 11111111111 111223344666778888999999999 65555555555544
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=342.56 Aligned_cols=253 Identities=26% Similarity=0.353 Sum_probs=201.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
+-++.-..+||.|.||.||.|.+.++|...|+|-+.... ......+.+|+.+|..|+|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 445667788999999999999999999999999987432 233356788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
|||.+|+|.+++.. ..-+++.....+..|++.|+.|||++| ||||||||.||||+.+|.+|++|||.|.....
T Consensus 1314 EyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999975 344666677788999999999999999 99999999999999999999999999975322
Q ss_pred CC--CccccccccccccccchhhhhcC---CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 240 GD--KSHVSTRVMGTYGYCAPEYAMTG---QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 240 ~~--~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
.. ....-..++||+.|||||++.+. ....++||||||||++||+||+.||...+. .|+-=+- +
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~-----V 1454 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYH-----V 1454 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhH-----H
Confidence 21 11122357899999999999864 356789999999999999999999976542 1211000 0
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...-.| .+|.....+-.+++..||+.||++|+++.++++
T Consensus 1455 ~~gh~P----q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1455 AAGHKP----QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred hccCCC----CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 011112 223334456678999999999999988886654
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=299.79 Aligned_cols=248 Identities=30% Similarity=0.387 Sum_probs=196.3
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
+.|...+.||+|+||.||+|++..++..||+|.+...... ....+..|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 4477778899999999999999988999999998643222 2246778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 688877754 2356899999999999999999999998 99999999999999999999999999875321
Q ss_pred CCCccccccccccccccchhhhh---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.....|++.|+|||++. ...++.++|||||||++|+|++|..||........ +..+. .
T Consensus 168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~----~------- 228 (308)
T cd06634 168 ------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIA----Q------- 228 (308)
T ss_pred ------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--HHHHh----h-------
Confidence 12346788999999975 34678899999999999999999999865322110 00000 0
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
...+... .......+.+++.+||+.+|.+||++.+|+...
T Consensus 229 ~~~~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 229 NESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred cCCCCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0001110 112234678999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=304.58 Aligned_cols=267 Identities=23% Similarity=0.301 Sum_probs=202.1
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecCC-----eee
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD-----QRL 156 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~ 156 (457)
+|.+.+.||.|+||.||+|++..++..||||.+.... ....+.+..|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999998889999999987643 233467889999999999999999999988775 789
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 588888865 347999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCC-ccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCccc-chhhhhhhhhc---
Q 012761 237 GPVGDK-SHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN-LVTWARPLFND--- 310 (457)
Q Consensus 237 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~--- 310 (457)
...... ........++..|+|||++.+. .++.++||||||+++|+|++|..||.......... +.........+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 433321 0122334678899999999887 78999999999999999999999997654311000 00000000000
Q ss_pred ---ccccccccC---Ccc---CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 311 ---RRKFSKLAD---PRL---EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 311 ---~~~~~~~~d---~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.......+. ... ...........+.+++.+||+.+|.+||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000 000 000011123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=296.21 Aligned_cols=264 Identities=22% Similarity=0.307 Sum_probs=197.8
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcC-CCCceeeEEEEecCCeeeEEEecc
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
|.+.+.||.|+||.||+|+...++..|+||.+...... ......+|+..+..+. ||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 67788999999999999999888999999998754322 2234567899999999 999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
+|+|.+++.... ...+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-- 152 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-- 152 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCC--
Confidence 789999887521 347899999999999999999999999 999999999999999999999999998753221
Q ss_pred ccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc-cchhhhhh----hhhccccccc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-NLVTWARP----LFNDRRKFSK 316 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~-~l~~~~~~----~~~~~~~~~~ 316 (457)
.......++..|+|||++.. ..++.++||||||+++|+|++|++||......... ....+... .+.+...+..
T Consensus 153 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 153 -PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred -CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 12233467889999998754 45789999999999999999999999655432110 00000000 0000000000
Q ss_pred ccCCccC-------CCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 317 LADPRLE-------GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 317 ~~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.++..+. ..........+.+++.+||+.+|.+||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000 0001112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=304.32 Aligned_cols=261 Identities=21% Similarity=0.344 Sum_probs=194.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCC------
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGD------ 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 153 (457)
.++|.+.+.||+|+||.||+|++..++..||||++...... ....+..|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999999888999999998754221 2345788999999999999999999986543
Q ss_pred eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 233 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGl 233 (457)
.+++|+||+. .+|..++. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4689999996 47776652 35889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhh----h--
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWAR----P-- 306 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~----~-- 306 (457)
+..... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||................ +
T Consensus 164 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 164 ARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 875321 1223467889999999876 468999999999999999999999997643211000000000 0
Q ss_pred --hhhcc--c----ccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 307 --LFNDR--R----KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 307 --~~~~~--~----~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
...+. . .........+...++ .....+.+++.+||+.+|.+||++.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFP-KASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhc-CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0 000000000000000 123467899999999999999999999854
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=295.03 Aligned_cols=256 Identities=23% Similarity=0.296 Sum_probs=199.4
Q ss_pred CCCccceeeecCcEEEEEEEEC---CCCeEEEEEEeccCCC----cChHHHHHHHHHHHhc-CCCCceeeEEEEecCCee
Q 012761 84 NFRPESFIGEGGFGRVYKGWLE---STGQVVAVKQLDRNGL----QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 155 (457)
+|.+.+.||+|+||.||+++.. .++..||||++..... .....+..|+.++..+ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999999864 3578899999874321 2235678899999999 599999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++||||+++++|.+++.. ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999864 356899999999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCCccccccccccccccchhhhhcCC--CCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccc
Q 012761 236 LGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ--LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRK 313 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 313 (457)
...... ........|+..|+|||.+.+.. .+.++||||||+++|+|++|..||....... ............
T Consensus 154 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~--- 227 (288)
T cd05583 154 EFLAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS--- 227 (288)
T ss_pred cccccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc---
Confidence 532221 11122346889999999987654 7889999999999999999999986432111 111111111111
Q ss_pred cccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHh
Q 012761 314 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 361 (457)
Q Consensus 314 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~ 361 (457)
.+..... ....+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 228 -----~~~~~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 -----KPPFPKT----MSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -----CCCCCcc----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1111111 22457789999999999999999988887743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=293.98 Aligned_cols=245 Identities=25% Similarity=0.353 Sum_probs=192.2
Q ss_pred CCCccceeeecCcEEEEEEEEC---CCCeEEEEEEeccCCC----cChHHHHHHHHHHHhc-CCCCceeeEEEEecCCee
Q 012761 84 NFRPESFIGEGGFGRVYKGWLE---STGQVVAVKQLDRNGL----QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 155 (457)
+|++.+.||.|+||.||+++.. .+|..||+|++..... ...+.+..|+.++..+ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788899999999999999874 3688999999875322 2235678899999999 599999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||+|+|||++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999975 356889999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCccccccccccccccchhhhhcC--CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccc
Q 012761 236 LGPVGDKSHVSTRVMGTYGYCAPEYAMTG--QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRK 313 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 313 (457)
...... ........|+..|+|||.+... .++.++||||||+++|+|++|..||...... .....+........
T Consensus 154 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~-- 228 (290)
T cd05613 154 EFHEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE-- 228 (290)
T ss_pred eccccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccC--
Confidence 532221 1122335688999999998753 4788999999999999999999999643221 11111121111111
Q ss_pred cccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCC
Q 012761 314 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP 350 (457)
Q Consensus 314 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 350 (457)
+. ++......+.+++.+||+.+|.+||
T Consensus 229 ------~~----~~~~~~~~~~~ll~~~l~~~p~~R~ 255 (290)
T cd05613 229 ------PP----YPQEMSALAKDIIQRLLMKDPKKRL 255 (290)
T ss_pred ------CC----CCccCCHHHHHHHHHHhcCCHHHhc
Confidence 11 1112234677899999999999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=297.26 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=194.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcC-CCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~ 159 (457)
.++|.+.+.||+|+||.||+|.+..+++.||||.+...... ....+..|+.++..+. ||||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 46789999999999999999999988999999999764322 2345666777666665 999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
||+. ++|.+++.. ....+++..+..++.||+.||.|||+ .+ |+||||+|+||++++++.++|+|||++....
T Consensus 94 e~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9985 577777654 23478999999999999999999997 47 9999999999999999999999999986532
Q ss_pred CCCCccccccccccccccchhhhhcCC----CCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQ----LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
... ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||...... .......+....
T Consensus 167 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~-- 236 (296)
T cd06618 167 DSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEEP-- 236 (296)
T ss_pred CCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCCC--
Confidence 211 122335788999999987543 789999999999999999999999643211 011111111100
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
..+... . .....+.+++.+||+.+|.+||++.+++..
T Consensus 237 ~~~~~~---~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PSLPPN---E----GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCC---C----CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 0 123468899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=307.97 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=205.6
Q ss_pred CCccceeeecCcEEEEEEEECCC----CeEEEEEEeccC-CCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 85 FRPESFIGEGGFGRVYKGWLEST----GQVVAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~i~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
..+.++||.|.||.||+|....- ...||||..+.+ .....+.|+.|..+++.++||||++++|+|.+ ...||||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence 34456799999999999986432 357999998874 34456789999999999999999999999976 4689999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
|+++.|.|..+|+. .+..|+......++.||..||.|||+.. +|||||-..||||.....|||+|||+++....
T Consensus 470 EL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 470 ELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred ecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 99999999999987 5678999999999999999999999999 99999999999999999999999999997544
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
......+ ...-..-|||||.+.-..++.++|||.|||++||++. |..||.+....+.... ++.+. .+.
T Consensus 544 ~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-------iEnGe---RlP 612 (974)
T KOG4257|consen 544 DAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-------IENGE---RLP 612 (974)
T ss_pred cchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-------ecCCC---CCC
Confidence 4333222 3334567999999999999999999999999999865 9999987554322111 11111 111
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
.|+.....+..|+.+||..+|.+||.+.++...|..+..
T Consensus 613 -------~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 613 -------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -------CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 122233356689999999999999999999999987765
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=301.65 Aligned_cols=266 Identities=22% Similarity=0.299 Sum_probs=200.7
Q ss_pred HHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEec-CCe
Q 012761 78 LAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCAD-GDQ 154 (457)
Q Consensus 78 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~ 154 (457)
+..++++|.+.+.||.|+||.||+|.+..++..||||++..... .....+..|+.++..++||||++++++|.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 34568899999999999999999999999999999999865322 234567889999999999999999999865 567
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
.++|+||+ +++|..++.. .++++..+..++.|++.||.|||+.+ |+|+||+|+|||+++++.++|+|||++
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence 89999998 5789888864 45788889999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCc-ccchh--------hh
Q 012761 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE-QNLVT--------WA 304 (457)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~-~~l~~--------~~ 304 (457)
..... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||........ ..+.. |.
T Consensus 156 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 156 RIQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred cccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 74221 1123457888999998765 5689999999999999999999999965432110 00000 11
Q ss_pred hhhhhcccccccccCCccCCCCCh-----HhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 305 RPLFNDRRKFSKLADPRLEGRYPI-----RGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 305 ~~~~~~~~~~~~~~d~~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
...... .....+..-......+. .....+.+++.+||+.+|++||++.+++..
T Consensus 231 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 231 NTICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred Hhccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 100000 00000000011111111 123578899999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=303.10 Aligned_cols=271 Identities=22% Similarity=0.295 Sum_probs=202.7
Q ss_pred ccHHHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEe
Q 012761 73 FTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCA 150 (457)
Q Consensus 73 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 150 (457)
....++...+++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++..++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 3456677788999999999999999999999988999999999975422 22356778999999999999999999886
Q ss_pred cC------CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC
Q 012761 151 DG------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF 224 (457)
Q Consensus 151 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~ 224 (457)
.. ...+++++++ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC 157 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCC
Confidence 43 3467888877 7899888864 45899999999999999999999999 99999999999999999
Q ss_pred ceEEeeccccccCCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc-cchh
Q 012761 225 HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-NLVT 302 (457)
Q Consensus 225 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~-~l~~ 302 (457)
.++|+|||++..... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+..
T Consensus 158 ~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (345)
T cd07877 158 ELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232 (345)
T ss_pred CEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999875321 1233467899999999876 46889999999999999999999999654321100 0000
Q ss_pred hh-------hhhhhcc--c----ccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 303 WA-------RPLFNDR--R----KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 303 ~~-------~~~~~~~--~----~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.. ...+... . .+.......... ........+.+++..||+.+|.+||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 0000000 0 000000000000 000123467899999999999999999998765
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=302.88 Aligned_cols=243 Identities=26% Similarity=0.386 Sum_probs=202.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChH---HHHHHHHHHHhcC-CCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR---EFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~---~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l 157 (457)
..+|..+.+||+|+||+|.+|..+.+.+.||||+++++...... --+.|.++|.... -|.++.++.+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 34788899999999999999999999999999999886543332 3456778887664 6789999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+.||+|--+++.. +.+.+..+..+|..|+-||-+||+++ ||+||||.+|||||.+|++||+|||+++-.
T Consensus 428 VMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999999874 44556678899999999999999999 999999999999999999999999999853
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
-.+. ..+.+++|||.|+|||++...+|+.++|+|||||+||||+.|++||++.+.. ..+..+
T Consensus 501 i~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~----------------elF~aI 562 (683)
T KOG0696|consen 501 IFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----------------ELFQAI 562 (683)
T ss_pred ccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHHH
Confidence 2222 2345689999999999999999999999999999999999999999876532 112223
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCC
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL 351 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 351 (457)
.+... .||.....+++.+....|..+|.+|.-
T Consensus 563 ~ehnv--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 563 MEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 33222 345555678899999999999999964
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=292.72 Aligned_cols=251 Identities=22% Similarity=0.294 Sum_probs=198.0
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-----cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-----QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
+|.+.+.||+|+||.||++++..++..+++|+++.... .....+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999999987777777777654221 1223566789999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999998754445567999999999999999999999999 999999999999975 569999999987532
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ......... ..
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~-------~~ 221 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIVE-------GP 221 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHc-------CC
Confidence 221 122234578899999999888889999999999999999999999864321 111111111 01
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+.+ +......+.+++.+||+.+|++||++.++++
T Consensus 222 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 TPSL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1111 1223357889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=296.77 Aligned_cols=257 Identities=21% Similarity=0.242 Sum_probs=189.7
Q ss_pred CcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCHHHhhh
Q 012761 95 GFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH 172 (457)
Q Consensus 95 ~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~ 172 (457)
++|.||+++...++..||||++.... ......+..|+.+++.++||||+++++++.+.+..+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 44566666677789999999997642 2334678899999999999999999999999999999999999999999997
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC-----ccccc
Q 012761 173 DLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK-----SHVST 247 (457)
Q Consensus 173 ~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~-----~~~~~ 247 (457)
.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||.+........ .....
T Consensus 92 ~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 92 TH--FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred Hh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 52 2345889999999999999999999999 99999999999999999999999998864322111 11112
Q ss_pred cccccccccchhhhhc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhh----hhhh------cccccc
Q 012761 248 RVMGTYGYCAPEYAMT--GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWAR----PLFN------DRRKFS 315 (457)
Q Consensus 248 ~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~----~~~~------~~~~~~ 315 (457)
...++..|+|||++.. ..++.++|||||||++|||++|..||....... .+..... ..+. ......
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcC
Confidence 3457788999999875 358899999999999999999999997543211 1111000 0000 000000
Q ss_pred ----cccCCccCC----CCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 316 ----KLADPRLEG----RYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 316 ----~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
...++.... .........+.+++..||+.+|++||++.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 011111100 1111224567889999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=292.85 Aligned_cols=263 Identities=27% Similarity=0.363 Sum_probs=199.5
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
|+..+.||+|+||.||+|+...+++.||+|++.... ......+..|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999999999999999998653 223356788999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
+ ++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~- 152 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL- 152 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc-
Confidence 7 5899999762 246899999999999999999999999 9999999999999999999999999987533222
Q ss_pred ccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCc-ccchhhhh-------hhhhc---
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE-QNLVTWAR-------PLFND--- 310 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~-~~l~~~~~-------~~~~~--- 310 (457)
.......++..|+|||++.+. .++.++|||||||++|||++|.+||........ ..+..... ....+
T Consensus 153 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 153 -RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred -cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 122234567889999998776 789999999999999999999999965432110 00000000 00000
Q ss_pred -ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 311 -RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 311 -~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...+...........++ .....+.+++..||+.+|++||++.+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000000000 11346899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=301.73 Aligned_cols=265 Identities=23% Similarity=0.323 Sum_probs=198.8
Q ss_pred HHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCC--
Q 012761 78 LAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGD-- 153 (457)
Q Consensus 78 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-- 153 (457)
+....++|.+.+.||+|+||.||++.+..++..||||++...... ....+..|+.+++.++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 344578899999999999999999999999999999998653221 2346788999999999999999999987653
Q ss_pred ----eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEe
Q 012761 154 ----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLS 229 (457)
Q Consensus 154 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~ 229 (457)
..++||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 458999999 7899888864 46899999999999999999999999 9999999999999999999999
Q ss_pred eccccccCCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCc-ccch------
Q 012761 230 DFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE-QNLV------ 301 (457)
Q Consensus 230 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~-~~l~------ 301 (457)
|||++..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||........ ..+.
T Consensus 161 dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07880 161 DFGLARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235 (343)
T ss_pred eccccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999875321 1223467889999999876 3588999999999999999999999975432100 0000
Q ss_pred --hhhhhhhhcc-----cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 302 --TWARPLFNDR-----RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 302 --~~~~~~~~~~-----~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+...+.... ..+.......+. .........+.+++.+||+.+|++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 000000000000 000112335789999999999999999999884
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=300.43 Aligned_cols=265 Identities=20% Similarity=0.236 Sum_probs=193.4
Q ss_pred CCCccceeeecCcEEEEEEEECCC--CeEEEEEEeccCC--CcChHHHHHHHHHHHhc-CCCCceeeEEEEec----CCe
Q 012761 84 NFRPESFIGEGGFGRVYKGWLEST--GQVVAVKQLDRNG--LQGNREFLVEVLMLSLL-HHSNLVNLIGYCAD----GDQ 154 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~--~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~----~~~ 154 (457)
+|.+.+.||+|+||.||++.+..+ +..||||.+.... ......+..|+.++..+ .||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 478889999999999999999887 8899999987432 12235678899999999 59999999987543 245
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
.+++++|+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788899885 689988864 457899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCC--ccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc-cch--------h
Q 012761 235 KLGPVGDK--SHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-NLV--------T 302 (457)
Q Consensus 235 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~-~l~--------~ 302 (457)
........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||......... .+. .
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 75332211 111233568999999998765 46899999999999999999999999754321100 000 0
Q ss_pred hhhhhhhccc-----ccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 303 WARPLFNDRR-----KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 303 ~~~~~~~~~~-----~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+...+..... .+.......+.. ........+.+++.+||+.+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 000000000000 00112346889999999999999999999863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=303.88 Aligned_cols=267 Identities=21% Similarity=0.303 Sum_probs=197.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecC---------
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADG--------- 152 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--------- 152 (457)
..+|.+.+.||.|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36899999999999999999999999999999999776555567788999999999999999999876543
Q ss_pred -----CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc-CCCce
Q 012761 153 -----DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE-EGFHP 226 (457)
Q Consensus 153 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~-~~~~~ 226 (457)
...++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++ +++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35789999997 588888754 46899999999999999999999999 99999999999997 56678
Q ss_pred EEeeccccccCCCCCC-ccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhh
Q 012761 227 KLSDFGLAKLGPVGDK-SHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWA 304 (457)
Q Consensus 227 kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~ 304 (457)
+|+|||++........ ........++..|+|||++.. ..++.++|||||||++|+|++|+.||....+..........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999875321111 111123457889999998764 46788999999999999999999999765432111000000
Q ss_pred hhhhh--ccccc----cc-ccCCccCCCCC-----hHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 305 RPLFN--DRRKF----SK-LADPRLEGRYP-----IRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 305 ~~~~~--~~~~~----~~-~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+... +...+ .. +.........+ .....++.+++..||+.+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000 00000 00 00000000000 112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=301.34 Aligned_cols=263 Identities=22% Similarity=0.300 Sum_probs=197.3
Q ss_pred cCCC-ccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--------------hHHHHHHHHHHHhcCCCCceeeEE
Q 012761 83 KNFR-PESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--------------NREFLVEVLMLSLLHHSNLVNLIG 147 (457)
Q Consensus 83 ~~f~-~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--------------~~~~~~E~~~l~~l~hpniv~l~~ 147 (457)
++|. +.+.||.|+||.||+|.+..+++.||||.+....... ...+..|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 4577999999999999999889999999986543222 124778999999999999999999
Q ss_pred EEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceE
Q 012761 148 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPK 227 (457)
Q Consensus 148 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~k 227 (457)
++...+..++||||+. ++|.+++.. ...+++.....++.||+.||.|||+.+ |+|+||+|+|||++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 9999999999999996 689998864 456899999999999999999999999 99999999999999999999
Q ss_pred EeeccccccCCCCC------------CccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 012761 228 LSDFGLAKLGPVGD------------KSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRP 294 (457)
Q Consensus 228 L~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~ 294 (457)
|+|||++....... .........+++.|+|||++.+. .++.++|||||||++|+|++|..||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999987533100 01111223468889999998764 468999999999999999999999976543
Q ss_pred CCcccchhhhhhhhhccc--cccc------------ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 295 HGEQNLVTWARPLFNDRR--KFSK------------LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 295 ~~~~~l~~~~~~~~~~~~--~~~~------------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.. ....+........ .+.. ...+.+... .......+.+++..||+.+|++||++.+++.
T Consensus 240 ~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 ID---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HH---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 21 1111111000000 0000 000000000 0112356789999999999999999999986
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=283.64 Aligned_cols=254 Identities=28% Similarity=0.412 Sum_probs=197.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcC-CCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~ 159 (457)
.++...+..||.|+-|.|++++.+.+|...|||.+.+... +..+.++..+.++...+ +|.||+.+|||..+...++.|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 3455666779999999999999999999999999987643 23355666777666554 899999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
|.|. .-++.+|.. -..++++..+-++...+++||.||.++.. |||||+||+|||+|+.|++||||||++-+.
T Consensus 171 elMs-~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrl-- 242 (391)
T KOG0983|consen 171 ELMS-TCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRL-- 242 (391)
T ss_pred HHHH-HHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeeccccccee--
Confidence 9984 445555554 35679999999999999999999998653 999999999999999999999999998642
Q ss_pred CCCccccccccccccccchhhhhc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMT---GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
......++..|.+.|||||.+.- ..|+.++|||||||.|+||.||+.||.+..-. ..-+. .++.+
T Consensus 243 -vdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~lt----kvln~------ 310 (391)
T KOG0983|consen 243 -VDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEVLT----KVLNE------ 310 (391)
T ss_pred -ecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHHHH----HHHhc------
Confidence 22334456689999999999873 47999999999999999999999999875421 11111 11111
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
. -|.|.+.- .-...+.+++..||+.|+.+||...++++.
T Consensus 311 e-PP~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 311 E-PPLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred C-CCCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1 13332211 123467889999999999999999998763
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=311.75 Aligned_cols=254 Identities=28% Similarity=0.393 Sum_probs=206.4
Q ss_pred CCCccceeeecCcEEEEEEEECCCC---eEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTG---QVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
+..+.++||+|.||+|++|.|+..+ ..||||.+...... .-..|++|+.+|.+|+|||+++|||+..+ ....+||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3445677999999999999987532 47999999876554 45789999999999999999999999988 6778999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
|++++|+|.+.|+. ..+..|.......++.|||.||.||..++ +|||||-..||||-....||||||||.+....
T Consensus 190 ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999999987 45667888899999999999999999999 99999999999999999999999999997655
Q ss_pred CCCccccc-cccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 240 GDKSHVST-RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 240 ~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
.+...... ...-.+.|+|||.+....++.++|||+|||+||||+| |..||-+.++.... +.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL-----------------~~ 327 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL-----------------KN 327 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH-----------------Hh
Confidence 54433322 2234578999999999999999999999999999998 67888776642211 11
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
+|..=+-.-+......+.+++..||..+|.+||++..|.+.+-
T Consensus 328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 2211001112335667889999999999999999999985553
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=313.99 Aligned_cols=260 Identities=28% Similarity=0.391 Sum_probs=218.6
Q ss_pred HHHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCceeeEEEEec--
Q 012761 75 FRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCAD-- 151 (457)
Q Consensus 75 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~-- 151 (457)
+..+..-+..|++...||.|.+|.||+++.+.+++.+|+|++.... ...+++..|..+|+.+. |||++.++++|..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3444455778999999999999999999999999999999998764 34577888999998885 9999999999853
Q ss_pred ---CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEE
Q 012761 152 ---GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKL 228 (457)
Q Consensus 152 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL 228 (457)
++++|||||||.+|+..|+++... ...+.|..+..|+..++.||.+||... +||||||-.|||++.++.|||
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 578999999999999999998765 678999999999999999999999998 999999999999999999999
Q ss_pred eeccccccCCCCCCccccccccccccccchhhhhc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhh
Q 012761 229 SDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-----GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTW 303 (457)
Q Consensus 229 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~ 303 (457)
+|||++... ........+.+||+.|||||++.. ..|+..+|+|||||+..||.-|.+|+-...|...
T Consensus 165 vDFGvSaQl--dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra------ 236 (953)
T KOG0587|consen 165 VDFGVSAQL--DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA------ 236 (953)
T ss_pred eeeeeeeee--ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh------
Confidence 999998642 222233445789999999999863 3578899999999999999999999977665321
Q ss_pred hhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 304 ARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 304 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+....+|.+.-.-+.....++.++|..||..|..+||++.++++
T Consensus 237 ---------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 ---------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ---------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 122333455444446667889999999999999999999999874
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.79 Aligned_cols=147 Identities=29% Similarity=0.417 Sum_probs=133.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|+||.||+|++..++..||||++....... ...+..|+.++..++||||+++++++...+..|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468999999999999999999999899999999997543222 25678899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
|||+.+++|.+++.. ...+++..++.|+.||+.||.|||..+ ||||||||+||||+.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999975 346889999999999999999999998 9999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=306.38 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=206.1
Q ss_pred CccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCC
Q 012761 86 RPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 165 (457)
Q Consensus 86 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~g 165 (457)
.....||.|.||.||.|.|+...-.||||.++.+. -..++|+.|+.+|+.+.|||+|+|+|+|..+..+|||.|||.+|
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG 348 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG 348 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence 34467999999999999999988999999997664 35689999999999999999999999999999999999999999
Q ss_pred CHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccc
Q 012761 166 SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV 245 (457)
Q Consensus 166 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 245 (457)
+|.+||... .+..++....+.++.||..||+||..++ +|||||-..|+||.++..||++||||+++...+..+.
T Consensus 349 NLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA- 422 (1157)
T KOG4278|consen 349 NLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA- 422 (1157)
T ss_pred cHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceec-
Confidence 999999863 4566777888999999999999999999 9999999999999999999999999999754332211
Q ss_pred cccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCC
Q 012761 246 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 324 (457)
Q Consensus 246 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 324 (457)
....--..-|.|||-+....++.|+|||+|||+|||+.| |.-||.+.+- ..+..+++.+.. +
T Consensus 423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-------SqVY~LLEkgyR--------M-- 485 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYGLLEKGYR--------M-- 485 (1157)
T ss_pred ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-------HHHHHHHhcccc--------c--
Confidence 111122467999999999999999999999999999987 6667754321 122222332211 1
Q ss_pred CCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 325 RYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 325 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
.-|......+.+|++.||+..|.+||+++|+-+.|+.+-
T Consensus 486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 112233456889999999999999999999999886543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=303.81 Aligned_cols=264 Identities=21% Similarity=0.301 Sum_probs=198.4
Q ss_pred HHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCe---
Q 012761 80 AATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ--- 154 (457)
Q Consensus 80 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--- 154 (457)
...++|.+.+.||+|+||.||+|++..++..||||++.... ......+..|+.+++.+.||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999999999999999987532 2223557789999999999999999998766554
Q ss_pred ---eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeec
Q 012761 155 ---RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDF 231 (457)
Q Consensus 155 ---~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DF 231 (457)
.++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccc
Confidence 89999998 6799998864 46899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCc-ccchhhhh---h
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE-QNLVTWAR---P 306 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~-~~l~~~~~---~ 306 (457)
|++...... .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||........ ..+..... +
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 163 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred ccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 998753221 2334678899999998653 678999999999999999999999965432110 00000000 0
Q ss_pred hhhccc---ccccccCC---ccCCCC---ChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 307 LFNDRR---KFSKLADP---RLEGRY---PIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 307 ~~~~~~---~~~~~~d~---~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+.... .....+.. .....+ .......+.+++.+||+.+|.+|||+.+|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000 00000000 000000 0012457889999999999999999999865
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=282.79 Aligned_cols=237 Identities=30% Similarity=0.386 Sum_probs=193.7
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCH
Q 012761 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 167 (457)
Q Consensus 91 lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 167 (457)
||.|+||.||++.+..+++.||+|++...... ....+..|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999888999999998765432 234688899999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccc
Q 012761 168 EDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 247 (457)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 247 (457)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 999975 346899999999999999999999998 9999999999999999999999999987532221 1233
Q ss_pred cccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCC
Q 012761 248 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYP 327 (457)
Q Consensus 248 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 327 (457)
...++..|++||.+.+..++.++|+||||+++|+|++|..||..... ........... .. ++
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~--------~~----~~ 213 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILKDP--------LR----FP 213 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcCC--------CC----CC
Confidence 45688899999999888889999999999999999999999965432 11111111100 01 11
Q ss_pred hHhHHHHHHHHHHcchhhcCCCCChHH
Q 012761 328 IRGLYQALAVASMCIQEQAATRPLIGD 354 (457)
Q Consensus 328 ~~~~~~l~~li~~cl~~dP~~RPt~~e 354 (457)
......+.+++.+||..+|++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111346789999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=295.06 Aligned_cols=271 Identities=30% Similarity=0.461 Sum_probs=206.2
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHh--cCCCCceeeEEEEecCC----eee
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSL--LHHSNLVNLIGYCADGD----QRL 156 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~~----~~~ 156 (457)
....+.++||+|.||.||+|.+. ++.||||++... ....|..|..|.+. +.|+||+.++++-.... .++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 44566778999999999999986 589999999753 45678888888776 57999999999876555 899
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeeeccCCccCeEEcCCCceEEee
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA------NPPVIYRDFKSSNILLEEGFHPKLSD 230 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~------~~~iiHrDLkp~NILl~~~~~~kL~D 230 (457)
||++|.+.|+|.++|.. ..++|....+|+..+++||+|||+.. +|+|+|||||+.||||..|++..|+|
T Consensus 285 LVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 99999999999999985 67999999999999999999999753 47899999999999999999999999
Q ss_pred ccccccCCCCCCccccccccccccccchhhhhcC-CCC-----ccchHHHHHHHHHHHHhCCCCCCCCCCCCcccch-h-
Q 012761 231 FGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLT-----VKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV-T- 302 (457)
Q Consensus 231 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~-~- 302 (457)
||+|.....+.........+||.+|||||++.+. .+. .+.||||+|.|||||++.-..++. .+.....+. +
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEA 438 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhH
Confidence 9999887766665556668999999999999764 222 368999999999999998765542 111111000 0
Q ss_pred hh--hhhhhc--ccccccccCCccCCCC-ChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 303 WA--RPLFND--RRKFSKLADPRLEGRY-PIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 303 ~~--~~~~~~--~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
-+ .+-+.+ ...+++-..|.+...+ ....+..+.+.+..||..||+.|.|+.=|.+++..+.-
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 00 000000 0001111222222211 11346678889999999999999999999999988764
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=282.81 Aligned_cols=257 Identities=24% Similarity=0.346 Sum_probs=201.6
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCceeeEEEEecCCeeeEEEeccCCCCH
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSL 167 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~E~~~~gsL 167 (457)
.+||+|.|+.|--++...+|..||||+|.+........+.+|++++...+ |+||+.|+++|+++...|||||-|.||.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 45999999999999999999999999999886667788999999999986 99999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC---ceEEeeccccccCCCCC-C-
Q 012761 168 EDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF---HPKLSDFGLAKLGPVGD-K- 242 (457)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~---~~kL~DFGla~~~~~~~-~- 242 (457)
..+|+. ...+++.++.++.++|+.||.|||.+| |.||||||+|||..... .||||||.+..-..... .
T Consensus 164 LshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 164 LSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999986 567899999999999999999999999 99999999999996544 58999998864211111 1
Q ss_pred ---ccccccccccccccchhhhh-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 243 ---SHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 243 ---~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
+....+.+|+..|||||++. ...|+.++|.||||||||-||.|.+||.+.-..+ ..|-+...-..+.
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d----CGWdrGe~Cr~CQ- 311 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD----CGWDRGEVCRVCQ- 311 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc----CCccCCCccHHHH-
Confidence 11223467999999999875 2368999999999999999999999998765432 2232211000000
Q ss_pred ccccCCccCCC--CChHh----HHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 315 SKLADPRLEGR--YPIRG----LYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 315 ~~~~d~~l~~~--~~~~~----~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..++...-.|. ||.++ ..+..+++...|..++.+|.++..++.
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 01111111222 33332 456778999999999999999988876
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=284.46 Aligned_cols=209 Identities=25% Similarity=0.334 Sum_probs=173.3
Q ss_pred HHhcCCCccceeeecCcEEEEEEEECCCCe----EEEEEEeccC--CCcChHHHHHHHHHHHhcCCCCceeeEEEEec-C
Q 012761 80 AATKNFRPESFIGEGGFGRVYKGWLESTGQ----VVAVKQLDRN--GLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD-G 152 (457)
Q Consensus 80 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~i~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 152 (457)
+-...|+....||+|.||.||+|...+++. .+|||.|+.. .........+|+.+++.|+||||+.+..+|.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 345679999999999999999996655432 7899999754 22233567899999999999999999999877 7
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC----CceE
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPP-DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG----FHPK 227 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~----~~~k 227 (457)
..+++++||.+ -+|.+.++.... ....++...+..|+.||+.|+.|||++- |+||||||.||||..+ |.||
T Consensus 101 ~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence 78999999997 478887764322 2357999999999999999999999998 9999999999999766 9999
Q ss_pred EeeccccccCCCCCCcc-ccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 012761 228 LSDFGLAKLGPVGDKSH-VSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDST 292 (457)
Q Consensus 228 L~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~ 292 (457)
|+|||+++.....-... ....++-|.+|+|||.+.+. .||.+.|||+.|||+.||+|-.+-|.+.
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999998754332222 33456779999999999876 6999999999999999999999888653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=281.04 Aligned_cols=223 Identities=23% Similarity=0.240 Sum_probs=179.1
Q ss_pred cCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCHHHhhhc
Q 012761 94 GGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD 173 (457)
Q Consensus 94 G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 173 (457)
|.||.||++++..+++.||+|.+.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999999999999999997642 233455555566799999999999999999999999999999999875
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccccccccc
Q 012761 174 LPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 253 (457)
Q Consensus 174 ~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~ 253 (457)
...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..... ......++.
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~ 146 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVEN 146 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCc
Confidence 345899999999999999999999999 99999999999999999999999998754221 112234577
Q ss_pred cccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHH
Q 012761 254 GYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQ 333 (457)
Q Consensus 254 ~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 333 (457)
.|+|||.+....++.++|||||||++|||++|..|+....... . ...... .+......
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~------~~~~~~----~~~~~~~~ 204 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------N------THTTLN----IPEWVSEE 204 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------c------cccccC----CcccCCHH
Confidence 8999999988889999999999999999999998875422100 0 000000 11112346
Q ss_pred HHHHHHHcchhhcCCCCChHHH
Q 012761 334 ALAVASMCIQEQAATRPLIGDV 355 (457)
Q Consensus 334 l~~li~~cl~~dP~~RPt~~ev 355 (457)
+.+++.+||+.||++||++.+.
T Consensus 205 ~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHHHHccCCHHHhcCCCcc
Confidence 7889999999999999997544
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=297.59 Aligned_cols=243 Identities=26% Similarity=0.331 Sum_probs=198.6
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCC
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG 165 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~g 165 (457)
.++||+|.||+||-|+++.+|+.||||+|++-... ....+.+|+.||..++||.||.+...|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 46799999999999999999999999999875443 3466889999999999999999999999999999999999655
Q ss_pred CHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC---CceEEeeccccccCCCCCC
Q 012761 166 SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG---FHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 166 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~---~~~kL~DFGla~~~~~~~~ 242 (457)
-|+-.|.. ...+|++.....++.||+.||.|||.++ |+|+||||+||||.+. -.+||||||+|++.+.
T Consensus 649 MLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--- 719 (888)
T KOG4236|consen 649 MLEMILSS---EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--- 719 (888)
T ss_pred HHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch---
Confidence 55555544 5778999999999999999999999999 9999999999999643 3699999999997432
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc-CCc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA-DPR 321 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~-d~~ 321 (457)
......++||+.|+|||++.++.|+..-|+||.|||+|--|+|..||+...+ +-+.++ -...+ .|.
T Consensus 720 ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQIQ--------NAaFMyPp~ 786 (888)
T KOG4236|consen 720 KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQIQ--------NAAFMYPPN 786 (888)
T ss_pred hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHHhh--------ccccccCCC
Confidence 3345568999999999999999999999999999999999999999975432 111110 01112 222
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVV 356 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~ 356 (457)
... +....+++||...||..-++|-+....+
T Consensus 787 PW~----eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 787 PWS----EISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred chh----hcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 222 1234678999999999999999887654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=305.26 Aligned_cols=241 Identities=24% Similarity=0.277 Sum_probs=195.2
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEEE
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.+..|.+...+|.|+|+.|-.+.+..+++..++|++.+.. .+..+|+.++... +||||+++++.+.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3567888888999999999999999999999999998652 2233466555444 6999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE-cCCCceEEeeccccccCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl-~~~~~~kL~DFGla~~~~ 238 (457)
|++.|+-|.+.+.. .+.....+..|+.+|+.|+.|||++| ||||||||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999988888765 22333677889999999999999999 9999999999999 699999999999998543
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.. ....+-|..|.|||++....|+.++||||||++||+||+|+.||...... ..+.
T Consensus 468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~----------------- 523 (612)
T KOG0603|consen 468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIH----------------- 523 (612)
T ss_pred hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHH-----------------
Confidence 32 22335688999999999999999999999999999999999999765432 1111
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.....+.+.......+.+|+.+||+.+|.+||+|.++..
T Consensus 524 ~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 524 TRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 111112222234567889999999999999999999865
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=320.80 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=190.5
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCceeeEEEEe---------
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCA--------- 150 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--------- 150 (457)
-..+|+...+||+||||.||+++++-+|..||||+|.... ......+.+|+..|.+|+|||||+++..+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3568999999999999999999999999999999998764 122356888999999999999999873211
Q ss_pred ---------------------------------------------------------------------cC---------
Q 012761 151 ---------------------------------------------------------------------DG--------- 152 (457)
Q Consensus 151 ---------------------------------------------------------------------~~--------- 152 (457)
+.
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 00
Q ss_pred --------------------------------CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 012761 153 --------------------------------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 200 (457)
Q Consensus 153 --------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yL 200 (457)
-.+||-||||+..+|.+++....... .....++++.+|+.||.|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHH
Confidence 12477899999888888887532211 4578899999999999999
Q ss_pred HhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC----------------CCCCccccccccccccccchhhhhcC
Q 012761 201 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP----------------VGDKSHVSTRVMGTYGYCAPEYAMTG 264 (457)
Q Consensus 201 H~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~ 264 (457)
|+++ ||||||||.||||+++..|||+|||+|+... .+......+..+||..|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999997511 01111134567899999999999865
Q ss_pred ---CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccC--CCCChHhHHHHHHHHH
Q 012761 265 ---QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLE--GRYPIRGLYQALAVAS 339 (457)
Q Consensus 265 ---~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~li~ 339 (457)
.|+.|+|+|||||||+||+. ||...- +...+ +..+-++.+. ..+.......-..+|.
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~i-------------L~~LR~g~iP~~~~f~~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASI-------------LTNLRKGSIPEPADFFDPEHPEEASLIR 852 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHH-------------HHhcccCCCCCCcccccccchHHHHHHH
Confidence 49999999999999999986 453211 10000 1111122221 1222334445678999
Q ss_pred HcchhhcCCCCChHHHHH
Q 012761 340 MCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 340 ~cl~~dP~~RPt~~ev~~ 357 (457)
++++.||.+|||+.|++.
T Consensus 853 ~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHhcCCCccCCCHHHHhh
Confidence 999999999999999874
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=278.08 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=204.1
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeee
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 156 (457)
..++|.++++||+|+|.+|.++++++|.+.||+|++++.-.. +..-...|..+..+- +||.+|-++.+|..+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 357899999999999999999999999999999999865333 333455666666654 6999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+|.||++||+|.-+++. +..|+++.+..+...|..||.|||+.| ||+||||.+|||+|..|++||+|+|+++-
T Consensus 328 fvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999888875 678999999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCC-Ccccchhhhhhhhhcccccc
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPH-GEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~~ 315 (457)
.- .....+.+++|||.|.|||++.+..|....|+|+|||+++||+.|+.||+..... ..++..++.-+++-+
T Consensus 401 ~l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile----- 473 (593)
T KOG0695|consen 401 GL--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE----- 473 (593)
T ss_pred CC--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh-----
Confidence 32 2223455689999999999999999999999999999999999999999864322 223333333222211
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCC
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL 351 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt 351 (457)
..+ +.|.....++..++...|+.||.+|..
T Consensus 474 ----kqi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 474 ----KQI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ----hcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 111 123233456677889999999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=297.37 Aligned_cols=250 Identities=26% Similarity=0.345 Sum_probs=208.0
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.++..+..||-|+||.|=++..+.....+|+|++++.... ..+.+..|..+|...+.|.||++|-.|.+..++|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 4566677799999999999988765556899998865433 3355778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
|-|-||.|...|.+ ++.++..+...++..+++|++|||+++ ||+|||||+|.||+.+|-+||.|||+|+....
T Consensus 500 EaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999987 677888999999999999999999999 99999999999999999999999999987544
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
+. .+.++||||.|.|||++.+...+.++|.|||||++||||+|.+||.+.++....+++--. +..+
T Consensus 573 g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG---------id~i-- 638 (732)
T KOG0614|consen 573 GR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG---------IDKI-- 638 (732)
T ss_pred CC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh---------hhhh--
Confidence 33 456789999999999999999999999999999999999999999988775433332110 0011
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCC-----hHHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVTA 358 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ev~~~ 358 (457)
.+|........+++...+..+|.+|.- +.+|.+.
T Consensus 639 -----~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 639 -----EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred -----hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 123233456788999999999999986 5555443
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=281.67 Aligned_cols=255 Identities=25% Similarity=0.332 Sum_probs=194.9
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHh-cCCCCceeeEEEEecCCeeeEEEecc
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSL-LHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
.+-+..||.|.||+|++-.++.+|+..|||+|+.... .....++.|.....+ -++||||++||.+..+...|+.||+|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 3344569999999999999999999999999987655 233567777776544 46999999999999999999999999
Q ss_pred CCCCHHHhhhc-CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 163 PLGSLEDHLHD-LPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 163 ~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+ .+|..+... ....+..+++.-.-.|....+.||.||-.... |||||+||+||||+..|.+||||||++-.. .
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqL---v 219 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQL---V 219 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhH---H
Confidence 5 566654321 11235678999999999999999999998654 999999999999999999999999998531 1
Q ss_pred Cccccccccccccccchhhhhc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMT--GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
.+...+.-.|...|||||.+.. ..|+.+||||||||+|||+.||+.|+..... +.+.+..... -|
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~--------gd 286 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVI--------GD 286 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHc--------CC
Confidence 2233445578889999999874 3599999999999999999999999976543 2222211111 11
Q ss_pred C-ccCCCC-ChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 320 P-RLEGRY-PIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 320 ~-~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
| .|.... .......+..++..||.+|-..||...++.++
T Consensus 287 pp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 287 PPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1 111111 12245678899999999999999999998764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=281.30 Aligned_cols=271 Identities=25% Similarity=0.354 Sum_probs=206.8
Q ss_pred HHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHh--cCCCCceeeEEEEecC--
Q 012761 77 ELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSL--LHHSNLVNLIGYCADG-- 152 (457)
Q Consensus 77 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~-- 152 (457)
.-....++..+.+.||+|.||.||+|.++ |..||||+|... +.+.+.+|.++..- |+|+||+.+++.=..+
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 33455678889999999999999999997 789999999753 45667788877764 6999999999874333
Q ss_pred --CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeeeccCCccCeEEcCCCc
Q 012761 153 --DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-----KANPPVIYRDFKSSNILLEEGFH 225 (457)
Q Consensus 153 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-----~~~~~iiHrDLkp~NILl~~~~~ 225 (457)
.++|||.+|.+.|||.|+|.. .+++-...++++..+|.||++||. +|.|.|.|||||+.||||..++.
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence 368999999999999999975 679999999999999999999994 57788999999999999999999
Q ss_pred eEEeeccccccCCCCCC--ccccccccccccccchhhhhcCC------CCccchHHHHHHHHHHHHhC----------CC
Q 012761 226 PKLSDFGLAKLGPVGDK--SHVSTRVMGTYGYCAPEYAMTGQ------LTVKSDVYSFGVVFLELITG----------RK 287 (457)
Q Consensus 226 ~kL~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~ksDvwSlGvil~elltG----------~~ 287 (457)
..|+|+|||........ .......+||.+|||||++...- .-..+||||||.|+||++-. +.
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 99999999976443321 12233468999999999987531 12358999999999999753 24
Q ss_pred CCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCC-ChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 288 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRY-PIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 288 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
||...-+.+.. ..+...... -.-+.|.+...+ ..+.+..+.+|+..||..+|.-|.|+--+-+.|.++..
T Consensus 435 Pyyd~Vp~DPs-~eeMrkVVC------v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 435 PYYDVVPSDPS-FEEMRKVVC------VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CcccCCCCCCC-HHHHhccee------ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 66544332211 111100000 011122222222 34578899999999999999999999999999998874
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=294.58 Aligned_cols=214 Identities=26% Similarity=0.345 Sum_probs=180.6
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcCh---HHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
-|..++.||-|.||.|.++...+|...||+|.+++...... ..+..|..||..-..+-||+||..|.+++.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 46778889999999999999999999999999986533222 345678999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC---
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG--- 237 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~--- 237 (457)
|++||++-.+|.. .+-+++..+..++..+..|+++.|..| +|||||||+|||||.+|++||+||||+.=.
T Consensus 710 YIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999876 467888899999999999999999999 999999999999999999999999998521
Q ss_pred ------CCCCCc-------------------------------cccccccccccccchhhhhcCCCCccchHHHHHHHHH
Q 012761 238 ------PVGDKS-------------------------------HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 280 (457)
Q Consensus 238 ------~~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ 280 (457)
..++.. .....++||+.|+|||++....|+..+|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 111100 0012357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCcc-cchhhh
Q 012761 281 ELITGRKAIDSTRPHGEQ-NLVTWA 304 (457)
Q Consensus 281 elltG~~p~~~~~~~~~~-~l~~~~ 304 (457)
||+.|+.||....+.+.+ .+..|-
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~ 887 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWR 887 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehh
Confidence 999999999877665443 334443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=288.36 Aligned_cols=254 Identities=26% Similarity=0.389 Sum_probs=198.0
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcCh-------HHHHHHHHHHHhcCCCCceeeEEEEe-cCCee
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN-------REFLVEVLMLSLLHHSNLVNLIGYCA-DGDQR 155 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~ 155 (457)
+|-++.+||+|||+.||+|.+....+.||||+-..+..... +...+|..|.+.|.||.||++|++|. +.+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 47778899999999999999988889999998765432221 23578999999999999999999985 56788
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc---CCCceEEeecc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE---EGFHPKLSDFG 232 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~---~~~~~kL~DFG 232 (457)
|-|+|||+|-+|.-+|.. ...+++.++..|+.||+.||.||.+.. +||||-||||.||||- .-|.+||+|||
T Consensus 544 CTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred eeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 999999999999999976 567899999999999999999999874 7799999999999994 46889999999
Q ss_pred ccccCCCCCCcc-----ccccccccccccchhhhhcC----CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhh
Q 012761 233 LAKLGPVGDKSH-----VSTRVMGTYGYCAPEYAMTG----QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTW 303 (457)
Q Consensus 233 la~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~ 303 (457)
++++...+...+ .+....||++|++||++.-+ +.+.|+||||+|||+|..+.|+.||..... .+++...
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdILqe 696 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDILQE 696 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHHhh
Confidence 999754433222 23446799999999998744 568899999999999999999999964322 1222221
Q ss_pred hhhhhhcccccccccCCccCCCCCh--HhHHHHHHHHHHcchhhcCCCCChHHHH
Q 012761 304 ARPLFNDRRKFSKLADPRLEGRYPI--RGLYQALAVASMCIQEQAATRPLIGDVV 356 (457)
Q Consensus 304 ~~~~~~~~~~~~~~~d~~l~~~~~~--~~~~~l~~li~~cl~~dP~~RPt~~ev~ 356 (457)
. .++.. ..-.||. ....++.++|++||+.--++|.+..++.
T Consensus 697 N-----------TIlkA-tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 N-----------TILKA-TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred h-----------chhcc-eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1 01110 0011221 2345778999999999999998766553
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=283.49 Aligned_cols=265 Identities=20% Similarity=0.270 Sum_probs=203.6
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC--C----CceeeEEEEecCCe
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH--S----NLVNLIGYCADGDQ 154 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h--p----niv~l~~~~~~~~~ 154 (457)
.+++|.+...+|+|.||.|..+.+..++..||||+++... .-.+..+-|+.+|.++.+ | -+|.+.++|.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3789999999999999999999999999999999987542 234556779999999942 2 36778888999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC------------
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE------------ 222 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~------------ 222 (457)
.|||+|.+ |-|+.++|.. ....+++..++..++.|++++++|||+.+ ++|.||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred eEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 99999988 6799999976 34667899999999999999999999999 999999999999931
Q ss_pred --------CCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 012761 223 --------GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRP 294 (457)
Q Consensus 223 --------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~ 294 (457)
+..++|+|||.|....... ..++.|.-|.|||++.+-.++.++||||+||||+||.||...|.....
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 3458999999998632222 346678899999999999999999999999999999999999977653
Q ss_pred CCcccchhh--------------hhhhhhcc----------cccccccCCc-c---CCCCChHhHHHHHHHHHHcchhhc
Q 012761 295 HGEQNLVTW--------------ARPLFNDR----------RKFSKLADPR-L---EGRYPIRGLYQALAVASMCIQEQA 346 (457)
Q Consensus 295 ~~~~~l~~~--------------~~~~~~~~----------~~~~~~~d~~-l---~~~~~~~~~~~l~~li~~cl~~dP 346 (457)
.+..-+.+. +..++... .+...+.++. + .-...+.+..++++|+..||..||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 221111111 11111111 0001111111 0 001123456789999999999999
Q ss_pred CCCCChHHHHH
Q 012761 347 ATRPLIGDVVT 357 (457)
Q Consensus 347 ~~RPt~~ev~~ 357 (457)
.+|+|+.|++.
T Consensus 395 ~~RiTl~EAL~ 405 (415)
T KOG0671|consen 395 ARRITLREALS 405 (415)
T ss_pred cccccHHHHhc
Confidence 99999999975
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=300.67 Aligned_cols=258 Identities=30% Similarity=0.460 Sum_probs=211.5
Q ss_pred CCccceeeecCcEEEEEEEECCCC----eEEEEEEeccC-CCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTG----QVVAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~i~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.+..++||.|.||+||+|.+--.| .+||||++... ......+++.|+.+|..|.|||+++|+++|.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 345678999999999999885444 47999998754 3345678999999999999999999999998765 88999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
+||++|+|.++++. .+..+.....+.|..||++||.|||++. ++||||-..||||.....+||.|||+++....
T Consensus 777 q~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999987 5677888999999999999999999999 99999999999999999999999999998666
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
+..........-.+-|||-|.+....|+.++|||||||++|||+| |..|+++....+..+ +++.+. .+.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d-------lle~ge---RLs 920 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD-------LLEKGE---RLS 920 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH-------HHhccc---cCC
Confidence 554443333333567999999999999999999999999999988 888988765432222 222221 122
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
- |+-...++.-++..||..|+..||+++++...+.+.+..+
T Consensus 921 q-------PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 921 Q-------PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred C-------CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 2 2234556888999999999999999999999998877633
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=266.68 Aligned_cols=239 Identities=29% Similarity=0.392 Sum_probs=193.9
Q ss_pred CcEEEEEEEECCCCeEEEEEEeccCCCcC-hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCHHHhhhc
Q 012761 95 GFGRVYKGWLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD 173 (457)
Q Consensus 95 ~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 173 (457)
+||.||+|.+..++..+|+|++....... ...+..|+..++.++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999889999999998765444 67899999999999999999999999999999999999999999999875
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccccccccc
Q 012761 174 LPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 253 (457)
Q Consensus 174 ~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~ 253 (457)
. ..+++..++.++.+++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......++.
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 2 23899999999999999999999998 9999999999999999999999999987643322 233456788
Q ss_pred cccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHH
Q 012761 254 GYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQ 333 (457)
Q Consensus 254 ~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 333 (457)
.|++||.+....++.++||||||+++|+|++|..||..... ...+..+.. .... ....... .....
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~---~~~~------~~~~~~~---~~~~~ 216 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIG---KPKP------PFPPPEW---KISPE 216 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHh---ccCC------CCccccc---cCCHH
Confidence 99999999888899999999999999999999999865321 111111111 0000 0000000 02246
Q ss_pred HHHHHHHcchhhcCCCCChHHHHH
Q 012761 334 ALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 334 l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=300.12 Aligned_cols=263 Identities=21% Similarity=0.241 Sum_probs=172.1
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCC----CeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEE------Ee
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLEST----GQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGY------CA 150 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~----~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~------~~ 150 (457)
..++|.+.+.||+|+||.||+|++..+ +..||||++..... .+.+..+ .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999999988 89999998864321 1111111 1122222223222211 24
Q ss_pred cCCeeeEEEeccCCCCHHHhhhcCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 012761 151 DGDQRLLVYEFMPLGSLEDHLHDLPPD----------------KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFK 214 (457)
Q Consensus 151 ~~~~~~lV~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLk 214 (457)
.....+|||||+.+++|.+++...... ........+..|+.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 567899999999999999998752110 011123456689999999999999999 9999999
Q ss_pred ccCeEEcC-CCceEEeeccccccCCCCCCccccccccccccccchhhhhcC----------------------CCCccch
Q 012761 215 SSNILLEE-GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG----------------------QLTVKSD 271 (457)
Q Consensus 215 p~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ksD 271 (457)
|+||||+. ++.+||+|||+++...... ........+|+.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 6899999999997532221 2233456789999999976432 2345679
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCC-------CCcccchhhhhhhhhcccccccccCCccCCCCC--hHhHHHHHHHHHHcc
Q 012761 272 VYSFGVVFLELITGRKAIDSTRP-------HGEQNLVTWARPLFNDRRKFSKLADPRLEGRYP--IRGLYQALAVASMCI 342 (457)
Q Consensus 272 vwSlGvil~elltG~~p~~~~~~-------~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~li~~cl 342 (457)
||||||+||||+++..+++.... .....+..|...... ...+.+...+. ........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP-------RASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc-------ccchhhhhhhhhccccchHHHHHHHHHc
Confidence 99999999999998766432100 000111112111000 00000000000 001123458999999
Q ss_pred hhhcCCCCChHHHHHH
Q 012761 343 QEQAATRPLIGDVVTA 358 (457)
Q Consensus 343 ~~dP~~RPt~~ev~~~ 358 (457)
+.||++|||+.++++.
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999874
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=245.64 Aligned_cols=263 Identities=24% Similarity=0.320 Sum_probs=195.7
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+|.-.+.||+|.||+||+|+...+++.||+|.++.+... ......+|+-+|+.|.|.|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 456667899999999999999999999999999865322 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
|. .+|..+... -.+.++...+..++.|+++||.|+|+++ +.||||||.|.|++.+|.+||+|||+++.....-
T Consensus 83 cd-qdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hh-HHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 95 678887765 3567899999999999999999999999 9999999999999999999999999998643322
Q ss_pred CccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhh--hh-cc-cccc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPL--FN-DR-RKFS 315 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~--~~-~~-~~~~ 315 (457)
.-...-+-|.+|.+|.++.+. -|+...|+||-|||+.||.. |++.|.+.+-.+. +....+.+ .. +. ..+.
T Consensus 156 --rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq--lkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred --EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH--HHHHHHHhCCCccccCCccc
Confidence 222334568999999999876 48999999999999999986 5555654332211 21111111 11 11 1112
Q ss_pred cccCCccCCCCChH-hHH--------HHHHHHHHcchhhcCCCCChHHHHH
Q 012761 316 KLADPRLEGRYPIR-GLY--------QALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 316 ~~~d~~l~~~~~~~-~~~--------~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+.|-..-..|+.. ... .=.+++...|.-+|..|.++++.++
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 23332222222221 111 1235666677778999998887764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=251.43 Aligned_cols=206 Identities=27% Similarity=0.335 Sum_probs=169.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG-LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.++......||+|+||.|-+.++..+|...|+|.+...- .+.....+.|+.+..+. .+|.+|.++|.+..+...|+.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 344555667999999999999999999999999997532 22335567777776554 5999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
|.|+ .+|..+....-.....+++...-+|+..|++||.|||++-. |||||+||+|||++.+|++|+||||++-...
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~- 200 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLV- 200 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeeh-
Confidence 9995 68877766544557889999999999999999999999754 9999999999999999999999999986421
Q ss_pred CCCccccccccccccccchhhhhc----CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMT----GQLTVKSDVYSFGVVFLELITGRKAIDSTR 293 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDvwSlGvil~elltG~~p~~~~~ 293 (457)
.+...+-..|...|||||.+.. ..|+.++||||||+.+.||.+++.||+...
T Consensus 201 --dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 201 --DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred --hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 1112222468888999999864 379999999999999999999999997643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=293.82 Aligned_cols=262 Identities=27% Similarity=0.445 Sum_probs=202.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECC-------CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcC-CCCceeeEEEEecC
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLES-------TGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLH-HSNLVNLIGYCADG 152 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~ 152 (457)
.++..+.+.||+|.||.|++|.... ....||||.+..... ...+.+..|+.+|+.+. |+||+.++|+|...
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 3444566689999999999997542 146799999875433 34567899999999985 99999999999999
Q ss_pred CeeeEEEeccCCCCHHHhhhcCC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLP---P-------DK--EALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL 220 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl 220 (457)
...++|+||+..|+|..+|...+ . .. ..|+....+.++.||+.|++||++.. +|||||-..|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 99999999999999999998644 0 01 24899999999999999999999998 9999999999999
Q ss_pred cCCCceEEeeccccccCCCCCCccccccccc--cccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 012761 221 EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG--TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGE 297 (457)
Q Consensus 221 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~ 297 (457)
..+..+||+|||+|+.....+.... ....| ...|||||.+....|+.++|||||||+||||+| |..|+.+... .
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~ 528 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--T 528 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--H
Confidence 9999999999999985333222211 11222 345999999999999999999999999999998 6777754221 1
Q ss_pred ccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 298 QNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 298 ~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
..+.. .+.++.. +.- |.....++..++..||+.+|++||++.++++.|+...
T Consensus 529 ~~l~~----~l~~G~r---~~~-------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 529 EELLE----FLKEGNR---MEQ-------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHHHH----HHhcCCC---CCC-------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 11221 2222211 111 2223456778999999999999999999999998853
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=283.70 Aligned_cols=262 Identities=21% Similarity=0.284 Sum_probs=181.3
Q ss_pred HhcCCCccceeeecCcEEEEEEEEC----------------CCCeEEEEEEeccCCCcChH--------------HHHHH
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLE----------------STGQVVAVKQLDRNGLQGNR--------------EFLVE 130 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~----------------~~~~~vavK~i~~~~~~~~~--------------~~~~E 130 (457)
..++|.+.++||+|+||.||+|.+. ..++.||||.+........+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999752 23467999998754322222 23457
Q ss_pred HHHHHhcCCCCc-----eeeEEEEec--------CCeeeEEEeccCCCCHHHhhhcCCC--------------------C
Q 012761 131 VLMLSLLHHSNL-----VNLIGYCAD--------GDQRLLVYEFMPLGSLEDHLHDLPP--------------------D 177 (457)
Q Consensus 131 ~~~l~~l~hpni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~ 177 (457)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.++|+.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876554 667777643 3568999999999999999874211 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccccccccccccc
Q 012761 178 KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCA 257 (457)
Q Consensus 178 ~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 257 (457)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++........ .......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 224577889999999999999999999 99999999999999999999999999864322211 11112235789999
Q ss_pred hhhhhcCC--------------------C--CccchHHHHHHHHHHHHhCCC-CCCCCCCCCc------ccchhhhhhhh
Q 012761 258 PEYAMTGQ--------------------L--TVKSDVYSFGVVFLELITGRK-AIDSTRPHGE------QNLVTWARPLF 308 (457)
Q Consensus 258 PE~~~~~~--------------------~--~~ksDvwSlGvil~elltG~~-p~~~~~~~~~------~~l~~~~~~~~ 308 (457)
||.+.... | ..+.||||+|||+|+|++|.. ||........ ..+..|.. ..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~~ 457 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-YK 457 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-hc
Confidence 99876432 1 124799999999999999975 6643221110 11111211 00
Q ss_pred hcccccccccCCccCCCCChHhHHHHHHHHHHcchhhc---CCCCChHHHHH
Q 012761 309 NDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQA---ATRPLIGDVVT 357 (457)
Q Consensus 309 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~ev~~ 357 (457)
... .+-. ..........+|+..+|..+| .+|+|+.|++.
T Consensus 458 ~~~------~~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 GQK------YDFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ccC------CCcc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 000 0000 011223467889999999766 68999999975
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=265.24 Aligned_cols=267 Identities=24% Similarity=0.373 Sum_probs=198.6
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccC-CCcC-hHHHHHHHHHHHhcCCCCceeeEEEEec--------C
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN-GLQG-NREFLVEVLMLSLLHHSNLVNLIGYCAD--------G 152 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~-~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~--------~ 152 (457)
..|.-..+||+|.||.||+|+.+++++.||+|++-.. ...+ .....+|+.+|..|.|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3455567799999999999999999999999986532 1112 2457889999999999999999987743 2
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecc
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 232 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFG 232 (457)
..+|+||.+|+ -+|.-+|.+ ....++..++.+++.+++.||.|+|... |+|||+|+.|+||+.+|.+||+|||
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence 34799999996 578888865 3467899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCC--ccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhh
Q 012761 233 LAKLGPVGDK--SHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN 309 (457)
Q Consensus 233 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 309 (457)
+++.....+. ....+..+-|.+|++||.+.+. .|+++.|||.-|||+.||+||.+-+.+...... ...+..+..
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq---l~~Is~LcG 246 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ---LHLISQLCG 246 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH---HHHHHHHhc
Confidence 9975433322 1224455679999999999875 799999999999999999999988865433221 111111111
Q ss_pred c--ccccccccC----------CccCCCCC--hHhH------HHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 310 D--RRKFSKLAD----------PRLEGRYP--IRGL------YQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 310 ~--~~~~~~~~d----------~~l~~~~~--~~~~------~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
. ...++.+.+ |...+.+. ...+ ...++|+..++..||.+|+++.+++..-
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 0 011111111 11111111 0112 2678899999999999999999988654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=248.62 Aligned_cols=255 Identities=21% Similarity=0.348 Sum_probs=193.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCceeeEEE-EecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGY-CADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~-~~~~~~~~lV~ 159 (457)
.+.|.+.+.||+|.||.+.++.|+.+...+++|.+.... ...++|.+|.-.--.|. |.||+.-|++ |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 467999999999999999999999999999999998763 35678888887655554 8999998876 67778889999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE-c-CCCceEEeeccccccC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL-E-EGFHPKLSDFGLAKLG 237 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl-~-~~~~~kL~DFGla~~~ 237 (457)
||++.|+|..-+.. ..+.+....+++.|+++||.|+|+++ +||||||.+|||| + +..++||||||+.+..
T Consensus 102 E~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999988864 45888899999999999999999999 9999999999999 3 3447999999998642
Q ss_pred CCCCCccccccccccccccchhhhhcC-----CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTG-----QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 312 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 312 (457)
+.. ....-.+..|.+||+.... ...+.+|||.||||+|..|||.+||.... ........|....-+...
T Consensus 174 --g~t---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 174 --GTT---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWLKRKNP 247 (378)
T ss_pred --Cce---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHhcccCc
Confidence 111 1122345679999987632 34678999999999999999999997432 233344444433322222
Q ss_pred ccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 313 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 313 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
.++..+. .+ ...++++..+-|..++++|=-+.++.++..
T Consensus 248 ~~P~~F~-----~f----s~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 248 ALPKKFN-----PF----SEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred cCchhhc-----cc----CHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 2222222 22 235778888899999999955556555543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=237.99 Aligned_cols=211 Identities=35% Similarity=0.536 Sum_probs=184.6
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCHHH
Q 012761 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLED 169 (457)
Q Consensus 91 lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~ 169 (457)
||+|.+|.||++....+++.+++|++...... ....+.+|+..++.+.|++|+++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999999865432 24678999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC-CCceEEeeccccccCCCCCCcccccc
Q 012761 170 HLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE-GFHPKLSDFGLAKLGPVGDKSHVSTR 248 (457)
Q Consensus 170 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~ 248 (457)
++... ...+++..++.++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 99752 146899999999999999999999998 999999999999999 89999999999875433221 1233
Q ss_pred ccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCC
Q 012761 249 VMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYP 327 (457)
Q Consensus 249 ~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 327 (457)
..+...|++||.+... .++.++|+|+||+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4578889999998877 788999999999999999
Q ss_pred hHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 328 IRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 328 ~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
..+.+++..|++.+|.+||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 357889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-33 Score=257.17 Aligned_cols=267 Identities=24% Similarity=0.354 Sum_probs=199.8
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccC--CCcChHHHHHHHHHHHhcCCCCceeeEEEEecC-----Ceee
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN--GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADG-----DQRL 156 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~ 156 (457)
+....+.||-|.||+||.+.+..+|+.||+|++... .....+.+.+|+.+|..++|.|++..++...-. .++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 456788999999999999999999999999998642 233346788999999999999999998876543 2467
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
++.|+|. .+|...+-. ...|+...+.-++.||++||.|||+.+ |.||||||.|.|++.|..+||||||+++.
T Consensus 134 V~TELmQ-SDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHH-hhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 8888884 567666654 678999999999999999999999999 99999999999999999999999999997
Q ss_pred CCCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhh--hhhh----
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWAR--PLFN---- 309 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~--~~~~---- 309 (457)
...++..+. +.-+-|..|.|||++++. .|+.+.||||.|||+.||+..+..|....+.....++.-.. +-.+
T Consensus 206 ee~d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 555554443 334568899999999976 69999999999999999999998887766544322221100 0000
Q ss_pred --cccccccc----cCCccCCCC----ChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 310 --DRRKFSKL----ADPRLEGRY----PIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 310 --~~~~~~~~----~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
++.+.+.+ -.|.+.--| +.....+.+.+...++.++|.+|.+..+.+..+
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 00000001 111111111 112344567788889999999999988876654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=278.59 Aligned_cols=254 Identities=24% Similarity=0.308 Sum_probs=209.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
..+|.+.+.||.|.||.||+++++.++...|+|+++........-+.+|+.+++..+|||||.+++.|...+.+|++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46899999999999999999999999999999999987766677788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
|.+|+|.+..+. ..+|++.++..+.+..++||+|||+++ -+|||||-.|||+++.|.+||+|||.+.. ...
T Consensus 94 cgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaq--ita 164 (829)
T KOG0576|consen 94 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQ--ITA 164 (829)
T ss_pred cCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhh--hhh
Confidence 999999998775 678999999999999999999999999 79999999999999999999999998753 223
Q ss_pred Cccccccccccccccchhhhh---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.-.....+.||+.|||||+.. .+.|..++|||++|+...||---++|.....+... +. +.. ...+
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~--l~-----LmT-----kS~~ 232 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA--LF-----LMT-----KSGF 232 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH--HH-----Hhh-----ccCC
Confidence 333455688999999999875 56899999999999999999888887655443211 11 111 1222
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+|.-.. ........+-.++..||..+|++||++..+++
T Consensus 233 qpp~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 233 QPPTLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCccc-CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 322111 11233456778999999999999999987653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=269.12 Aligned_cols=198 Identities=23% Similarity=0.344 Sum_probs=172.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcCh--------HHHHHHHHHHHhcC---CCCceeeEEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN--------REFLVEVLMLSLLH---HSNLVNLIGYCA 150 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~--------~~~~~E~~~l~~l~---hpniv~l~~~~~ 150 (457)
..+|...+.||+|.||.|++|.++.+...|+||.|.+...-.. -.+-.|+.||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3568999999999999999999999999999999976532211 12456999999997 999999999999
Q ss_pred cCCeeeEEEecc-CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEe
Q 012761 151 DGDQRLLVYEFM-PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLS 229 (457)
Q Consensus 151 ~~~~~~lV~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~ 229 (457)
+++.+||+||-- ++.+|.+++.. +..+++..+..|+.||+.|+++||+++ |||||||-+||.|+.+|.+||+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEe
Confidence 999999999964 56689999975 677999999999999999999999999 9999999999999999999999
Q ss_pred eccccccCCCCCCccccccccccccccchhhhhcCCC-CccchHHHHHHHHHHHHhCCCCCC
Q 012761 230 DFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAID 290 (457)
Q Consensus 230 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~ 290 (457)
|||.+... .......++||..|.|||++.+.+| +..-|||+|||+||.++....||.
T Consensus 713 dfgsaa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99998642 2233456789999999999998887 567899999999999999999885
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=254.80 Aligned_cols=134 Identities=22% Similarity=0.364 Sum_probs=115.3
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-----C---CCceeeEEEEec--
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-----H---SNLVNLIGYCAD-- 151 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-----h---pniv~l~~~~~~-- 151 (457)
..+|.+.++||.|.|++||+|.+..+.+.||+|+.+... .-.+..+.|+.+|++++ | .+||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 367999999999999999999999999999999986532 23466788999999884 2 379999999965
Q ss_pred --CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc
Q 012761 152 --GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE 221 (457)
Q Consensus 152 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~ 221 (457)
+.++|+|+|++ |.+|..+|.. ...+.++...+..|+.||+.||.|||.... |||.||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeee
Confidence 56899999998 7899999876 345678999999999999999999998764 99999999999993
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=278.09 Aligned_cols=254 Identities=28% Similarity=0.391 Sum_probs=191.4
Q ss_pred CCccceeeecCcEE-EEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCceeeEEEEecCCeeeEEEecc
Q 012761 85 FRPESFIGEGGFGR-VYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 85 f~~~~~lG~G~~g~-Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
|...+++|.|+.|+ ||+|... |+.||||++-.. ...-..+|+..|+.-+ |||||++++.-.+....||+.|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 44556689998886 8999986 789999998543 2244678999998885 999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC---C--CceEEeeccccccC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE---G--FHPKLSDFGLAKLG 237 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~---~--~~~kL~DFGla~~~ 237 (457)
. .+|.+++...............+.++.|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++..
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 4 7999999762111111122456789999999999999999 999999999999965 2 57999999999976
Q ss_pred CCCCCccc-cccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhC-CCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 238 PVGDKSHV-STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG-RKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 238 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
+.+..... .....||-+|+|||++....-+.++||||||||+|+.++| .+||...-. ...|++ .....+.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~-R~~NIl-------~~~~~L~ 733 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE-RQANIL-------TGNYTLV 733 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH-hhhhhh-------cCcccee
Confidence 55543222 2346799999999999988888899999999999999987 899964321 111222 1111111
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHH---------HHHHhhhh
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVV---------TALSYLAN 364 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~---------~~L~~l~~ 364 (457)
.+. +.... ++.+||.+|+..+|..||++.+|+ ++|..+.+
T Consensus 734 ~L~--------~~~d~-eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~d 782 (903)
T KOG1027|consen 734 HLE--------PLPDC-EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRD 782 (903)
T ss_pred eec--------cCchH-HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHh
Confidence 111 00111 688999999999999999999998 45666654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=238.00 Aligned_cols=199 Identities=34% Similarity=0.452 Sum_probs=174.1
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccC
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMP 163 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~ 163 (457)
|.+.+.||.|++|.||++.+..++..+++|.+...... ....+..|+..+..++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 56778899999999999999988899999999876544 46778899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 164 LGSLEDHLHDLPPDKEA-LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 164 ~gsL~~~l~~~~~~~~~-l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
+++|.+++... .. +++..+..++.+++.+|.+||+.+ ++|+||+|.||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 99999999762 22 889999999999999999999998 99999999999999999999999999876433321
Q ss_pred ccccccccccccccchhhh-hcCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 012761 243 SHVSTRVMGTYGYCAPEYA-MTGQLTVKSDVYSFGVVFLELITGRKAIDS 291 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~-~~~~~~~ksDvwSlGvil~elltG~~p~~~ 291 (457)
.......++..|++||.+ ....++.++|||+||+++++|++|+.||+.
T Consensus 154 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 -ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122335678889999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=237.20 Aligned_cols=260 Identities=18% Similarity=0.282 Sum_probs=200.7
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCceeeEEEEecCC--eeeE
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGD--QRLL 157 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~--~~~l 157 (457)
..++|++.+.+|+|.|+.||.|....+.+.++||+++.. ..+.+.+|+.+|..|. ||||+++++...+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 357899999999999999999998888999999999754 3577899999999998 999999999998764 4679
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC-CCceEEeecccccc
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE-GFHPKLSDFGLAKL 236 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~-~~~~kL~DFGla~~ 236 (457)
|+||+.+.++..+.. .|+...+..++.+++.||.|||+.| |+|||+||.|+++|. ...++|+|+|+|.+
T Consensus 113 iFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence 999999988877664 4778889999999999999999999 999999999999985 56799999999987
Q ss_pred CCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhc-----
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND----- 310 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----- 310 (457)
...+....+ .+.+..|.-||.+.. ..|+..-|+|||||+|..|+..+.||..-.. ....|+..+.-+-.+
T Consensus 183 YHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 183 YHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred cCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHH
Confidence 655443322 345677899999875 4689999999999999999999999865332 222333333221111
Q ss_pred ccccccccCCccCC--------C---CC-h--H--hHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 311 RRKFSKLADPRLEG--------R---YP-I--R--GLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 311 ~~~~~~~~d~~l~~--------~---~~-~--~--~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
-.+..-.+||.... . +. . + ...++++++...|..|-.+|||++|+..
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 01111223332211 1 10 0 1 1357889999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=262.81 Aligned_cols=269 Identities=21% Similarity=0.258 Sum_probs=203.5
Q ss_pred HHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC------CCceeeEEEEecC
Q 012761 79 AAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH------SNLVNLIGYCADG 152 (457)
Q Consensus 79 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h------pniv~l~~~~~~~ 152 (457)
......|.+....|+|-|++|.+|.+...|+.||||+|..+.. -.+.=+.|+++|.+|+. -|++.|+-.|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 3456788888999999999999999999899999999987643 23455779999999963 4899999999999
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC-CceEEeec
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG-FHPKLSDF 231 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~-~~~kL~DF 231 (457)
+++|||||-+ ..+|.+.|..+.. .-.|....+..++.|++-||..|-..+ |+|.||||+||||++. ..+|||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccC
Confidence 9999999988 4799999987543 445788899999999999999999999 9999999999999865 56899999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccch----------
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV---------- 301 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~---------- 301 (457)
|.|......+ . +...-+..|.|||++.+-+|+...|+||.||+||||.||+..|.+.....-..+.
T Consensus 582 GSA~~~~ene---i-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 582 GSASFASENE---I-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred cccccccccc---c-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence 9987533222 1 1222356799999999999999999999999999999999998765432211110
Q ss_pred -----hhhhhhhhcccc----------------cccccCC------ccCC--CCCh---HhHHHHHHHHHHcchhhcCCC
Q 012761 302 -----TWARPLFNDRRK----------------FSKLADP------RLEG--RYPI---RGLYQALAVASMCIQEQAATR 349 (457)
Q Consensus 302 -----~~~~~~~~~~~~----------------~~~~~d~------~l~~--~~~~---~~~~~l~~li~~cl~~dP~~R 349 (457)
.+....|..... +-..+.| .|.+ .++. ..+.++.+|+..||..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 011111111000 0011111 1111 2333 346688899999999999999
Q ss_pred CChHHHHH
Q 012761 350 PLIGDVVT 357 (457)
Q Consensus 350 Pt~~ev~~ 357 (457)
.+..+++.
T Consensus 738 it~nqAL~ 745 (752)
T KOG0670|consen 738 ITVNQALK 745 (752)
T ss_pred CCHHHHhc
Confidence 99998875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=245.24 Aligned_cols=271 Identities=24% Similarity=0.363 Sum_probs=211.1
Q ss_pred HHHHHHHhcCCCccceeeecCcEEEEEEEECCCC-----eEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEE
Q 012761 75 FRELAAATKNFRPESFIGEGGFGRVYKGWLESTG-----QVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGY 148 (457)
Q Consensus 75 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~ 148 (457)
..++.....+++...++-+|.||.||.|.+.+.+ +.|-+|.++.... -....++.|..++..++|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3455666677889999999999999999876533 3456666653321 223567889999999999999999999
Q ss_pred Eec-CCeeeEEEeccCCCCHHHhhhc----CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC
Q 012761 149 CAD-GDQRLLVYEFMPLGSLEDHLHD----LPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG 223 (457)
Q Consensus 149 ~~~-~~~~~lV~E~~~~gsL~~~l~~----~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~ 223 (457)
+.+ .+..+++|.++.-|+|..+|.. .+...+.++-.+...++.|++.|++|||+++ |||.||-..|.++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 755 5677899999999999999982 2334567888899999999999999999999 9999999999999999
Q ss_pred CceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchh
Q 012761 224 FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVT 302 (457)
Q Consensus 224 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~ 302 (457)
..+||+|=.+++-.-..+.......-.....||+||.+.+..|+.++|||||||+||||+| |+.|+-.-+|.+-
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm----- 507 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM----- 507 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-----
Confidence 9999999999885545554444333345667999999999999999999999999999998 7888765554221
Q ss_pred hhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 303 WARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 303 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
..++.++.. +.. |.....++..++.-||...|++||+..+++.-|.++..+
T Consensus 508 --~~ylkdGyR---laQ-------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 508 --EHYLKDGYR---LAQ-------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred --HHHHhccce---ecC-------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 112222221 111 223456788999999999999999999999999887654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=237.47 Aligned_cols=262 Identities=25% Similarity=0.299 Sum_probs=197.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccC--CCcChHHHHHHHHHHHhcCCCCceeeEEEEecC------C
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN--GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADG------D 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 153 (457)
..+|.-.+.+|.|.- .|.-+.+.-+++.||+|.+... .....+...+|...+..+.|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456777888999988 7778888888999999998654 223346678899999999999999999998643 3
Q ss_pred eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 233 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGl 233 (457)
..|+|||+|. .+|...++. .++-.+...|+.|++.|+.|||+.+ |+||||||+||++..+..+||+|||+
T Consensus 95 e~y~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence 5799999995 789888863 4777888999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCc----------------
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE---------------- 297 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~---------------- 297 (457)
|+.. +.....+..+.|..|.|||++.+-.|...+||||+||++.||++|+.-|.+...-+.
T Consensus 165 ar~e---~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 165 ARTE---DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred hccc---CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 9852 222455667889999999999988899999999999999999999988864322110
Q ss_pred ccchhhhhhhhhcc-----ccccccc-CCccCC--CCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 298 QNLVTWARPLFNDR-----RKFSKLA-DPRLEG--RYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 298 ~~l~~~~~~~~~~~-----~~~~~~~-d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..+..-++.+.... ..+.+++ |..... ..+......+.+++..||..+|++|.++.+++.
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 01111111111111 1111111 111110 011223556778999999999999999999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=243.09 Aligned_cols=204 Identities=27% Similarity=0.374 Sum_probs=171.8
Q ss_pred HHHHhcCCCccceeeecCcEEEEEEEECC---CCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCceeeEEEEecCC
Q 012761 78 LAAATKNFRPESFIGEGGFGRVYKGWLES---TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGD 153 (457)
Q Consensus 78 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~ 153 (457)
+....+.|..+++||+|.|++||++.+.. ....||+|.+.... .-..+..|+++|..+. +.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 44456789999999999999999998876 67899999997643 3456889999999986 999999999999999
Q ss_pred eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc-CCCceEEeecc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE-EGFHPKLSDFG 232 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~-~~~~~kL~DFG 232 (457)
+..+|+||++.....+++.. ++..++..++..++.||.++|.+| ||||||||+|+|.+ ..+.-.|+|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 99999999999999998865 678899999999999999999999 99999999999996 56788999999
Q ss_pred ccccC-----------------CC--CCCc-----------------------cccccccccccccchhhhhcC-CCCcc
Q 012761 233 LAKLG-----------------PV--GDKS-----------------------HVSTRVMGTYGYCAPEYAMTG-QLTVK 269 (457)
Q Consensus 233 la~~~-----------------~~--~~~~-----------------------~~~~~~~gt~~y~aPE~~~~~-~~~~k 269 (457)
+|... .. +... .......||++|.|||++... ..+.+
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 99610 00 0000 001124699999999999865 57899
Q ss_pred chHHHHHHHHHHHHhCCCCCCCCC
Q 012761 270 SDVYSFGVVFLELITGRKAIDSTR 293 (457)
Q Consensus 270 sDvwSlGvil~elltG~~p~~~~~ 293 (457)
+||||.|||++.+++++.||....
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred cceeeccceeehhhccccccccCc
Confidence 999999999999999999996543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=271.20 Aligned_cols=196 Identities=16% Similarity=0.214 Sum_probs=138.7
Q ss_pred hcCC-CCceeeEEEE-------ecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 012761 136 LLHH-SNLVNLIGYC-------ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 207 (457)
Q Consensus 136 ~l~h-pniv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ 207 (457)
.++| .||+.++++| ......+++|||+ +++|.++|.. ....+++.+++.|+.||++||.|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4455 5778888877 2334567788987 5799999974 2456999999999999999999999999
Q ss_pred eeeccCCccCeEEcCCC-------------------ceEEeeccccccCCCCCC--------------cccccccccccc
Q 012761 208 VIYRDFKSSNILLEEGF-------------------HPKLSDFGLAKLGPVGDK--------------SHVSTRVMGTYG 254 (457)
Q Consensus 208 iiHrDLkp~NILl~~~~-------------------~~kL~DFGla~~~~~~~~--------------~~~~~~~~gt~~ 254 (457)
|+||||||+||||+..+ .+||+|||+++....... .......+||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 99999999999996544 455666666543110000 000112468999
Q ss_pred ccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHH
Q 012761 255 YCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQA 334 (457)
Q Consensus 255 y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 334 (457)
|||||++.+..|+.++|||||||+||||++|.+|+..... ....+.. ....+... .....+
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--------~~~~~~~------~~~~~~~~-----~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--------TMSSLRH------RVLPPQIL-----LNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--------HHHHHHH------hhcChhhh-----hcCHHH
Confidence 9999999999999999999999999999999887643210 0000000 01111111 112345
Q ss_pred HHHHHHcchhhcCCCCChHHHHH
Q 012761 335 LAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 335 ~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..++.+||+.+|.+||++.||++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 67888999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=207.68 Aligned_cols=168 Identities=22% Similarity=0.197 Sum_probs=126.9
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
|+|.+++.. ....+++.+++.|+.||+.||.|||+.+ ||+|||++.++.+++ ||++......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 689999975 2456999999999999999999999876 999999999999999 9998753221
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 324 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 324 (457)
...||+.|+|||++.+..++.++|||||||++|||+||+.||...... ......+..... .. ++ ..
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-----~~~~~~~~~~~~---~~-~~--~~ 128 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-----SAILEILLNGMP---AD-DP--RD 128 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-----cHHHHHHHHHhc---cC-Cc--cc
Confidence 125899999999999999999999999999999999999999654321 111111111100 00 00 00
Q ss_pred CCChHh-H--HHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 325 RYPIRG-L--YQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 325 ~~~~~~-~--~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
...... . ..+.+++.+||+.+|.+||++.++++.+..+..
T Consensus 129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 011111 2 258899999999999999999999999876653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-25 Score=218.16 Aligned_cols=263 Identities=22% Similarity=0.234 Sum_probs=197.2
Q ss_pred CCCccceeeecCcEEEEEEEECCCC-eEEEEEEeccCCCcChHHHHHHHHHHHhcCC----CCceeeEEEE-ecCCeeeE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTG-QVVAVKQLDRNGLQGNREFLVEVLMLSLLHH----SNLVNLIGYC-ADGDQRLL 157 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h----pniv~l~~~~-~~~~~~~l 157 (457)
+|.+.+.||+|+||.||++.+..++ ..+|+|............+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 8999999999999999999987764 6789998776433333367778888888862 6899999999 57788999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC-----CceEEeecc
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG-----FHPKLSDFG 232 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~-----~~~kL~DFG 232 (457)
||+.+ |.+|.++....+ ...++..+++.|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 899999886643 578999999999999999999999999 9999999999999754 469999999
Q ss_pred ccc--cCCCCCCc---cc---cccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhh
Q 012761 233 LAK--LGPVGDKS---HV---STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWA 304 (457)
Q Consensus 233 la~--~~~~~~~~---~~---~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~ 304 (457)
+++ ........ .. .....||..|+++.+..+...+.+.|+||++.++.||+.|..||......... .
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~--~--- 247 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK--S--- 247 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH--H---
Confidence 998 32111111 11 12355999999999999999999999999999999999999999654432221 0
Q ss_pred hhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 305 RPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 305 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.+..... ...... .....+. .+..+...+-..+...+|....+...|..+...
T Consensus 248 -~~~~~~~--~~~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 248 -KFEKDPR--KLLTDR--FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred -HHHHHhh--hhcccc--ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 0000000 011111 1112223 344444445557999999999999998777654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=223.06 Aligned_cols=168 Identities=17% Similarity=0.114 Sum_probs=130.2
Q ss_pred HHhcCCCccceeeecCcEEEEEEEECC-CCeEEEEEEeccCCC-----cChHHHHHHHHHHHhcCCCCceeeEEEEecCC
Q 012761 80 AATKNFRPESFIGEGGFGRVYKGWLES-TGQVVAVKQLDRNGL-----QGNREFLVEVLMLSLLHHSNLVNLIGYCADGD 153 (457)
Q Consensus 80 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~i~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 153 (457)
...++|.+.+.||+|+||+||+|++.. +++.||||++..... .....+.+|+.+|..++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 346789999999999999999999876 678889998763311 123458899999999999999863322 24
Q ss_pred eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC-CccCeEEcCCCceEEeecc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF-KSSNILLEEGFHPKLSDFG 232 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDL-kp~NILl~~~~~~kL~DFG 232 (457)
..+|||||++|++|.. +.. .. ...++.+++++|.|||+.+ |+|||| ||+|||++.++.++|+|||
T Consensus 92 ~~~LVmE~~~G~~L~~-~~~----~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-ARP----HG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHH-hCc----cc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 5799999999999963 211 11 1467889999999999999 999999 9999999999999999999
Q ss_pred ccccCCCCCCccc------cccccccccccchhhhhcC
Q 012761 233 LAKLGPVGDKSHV------STRVMGTYGYCAPEYAMTG 264 (457)
Q Consensus 233 la~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 264 (457)
+|+.......... .+...+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9986433221111 1356788999999998643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-23 Score=203.81 Aligned_cols=261 Identities=30% Similarity=0.405 Sum_probs=198.2
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCC-CceeeEEEEecCCeeeEEEe
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHS-NLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~lV~E 160 (457)
|.+.+.||.|+||.||++.+. ..+++|.+....... ...+..|+.++..+.|+ +|+++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 677888999999999999987 789999998654332 56788999999999988 79999999987777899999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC-ceEEeeccccccCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF-HPKLSDFGLAKLGPV 239 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~~~~ 239 (457)
++.++++.+++...... ..++......++.|++.++.|+|..+ ++||||||+||+++..+ .++++|||++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 99999999777652111 36889999999999999999999999 99999999999999988 799999999875333
Q ss_pred CCCcc----ccccccccccccchhhhhc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCC-Ccccchhhhhhhhhcc
Q 012761 240 GDKSH----VSTRVMGTYGYCAPEYAMT---GQLTVKSDVYSFGVVFLELITGRKAIDSTRPH-GEQNLVTWARPLFNDR 311 (457)
Q Consensus 240 ~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvil~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~ 311 (457)
..... ......||..|+|||.+.. ..++...|+||+|++++++++|..||...... ........+... .
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~---~ 231 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL---P 231 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc---C
Confidence 32221 2356789999999999987 57889999999999999999999997554321 000111111100 0
Q ss_pred cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 312 RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 312 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.. .................+.+++..|+..+|..|.++.+....
T Consensus 232 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 000011110001223567889999999999999999887765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=196.22 Aligned_cols=206 Identities=24% Similarity=0.320 Sum_probs=174.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC-CCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH-SNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lV~E 160 (457)
...|.+++.||.|+||.+|+|....+|..||||+-... .....+..|..+...|++ ..|..+..|..+.++-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 56799999999999999999999999999999987644 234567889999999985 788888889999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC---CCceEEeeccccccC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE---GFHPKLSDFGLAKLG 237 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~---~~~~kL~DFGla~~~ 237 (457)
++ |.+|++++.. -...++..+++.++.|++.-++|+|.++ +|||||||+|+|+.- ...+.|+|||+|+..
T Consensus 92 LL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 88 8999999875 2467888999999999999999999999 999999999999953 346899999999863
Q ss_pred CCCC-Ccc----ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCC
Q 012761 238 PVGD-KSH----VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHG 296 (457)
Q Consensus 238 ~~~~-~~~----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~ 296 (457)
-... ..+ ......||..|.+-....+...+...|+-|+|.+|..+.-|..||.+..+..
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 2221 111 1234679999999887777778899999999999999999999998876643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=198.94 Aligned_cols=204 Identities=25% Similarity=0.353 Sum_probs=173.6
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCceeeEEEEecCCeeeEEEec
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
-+|++.+.||+|+||+.+.|...-++++||||.-... ....++..|.+..+.|. .++|...+.|...+.+-.||+|+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 3799999999999999999999889999999976543 23467788888888886 79999999998888899999998
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC-----CceEEeecccccc
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG-----FHPKLSDFGLAKL 236 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~-----~~~kL~DFGla~~ 236 (457)
+ |.+|+|++.- -...++..+++.||.|++.-++|+|++. +|+|||||+|+||... ..+.|+|||+|+.
T Consensus 106 L-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 106 L-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred h-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 8 8899998864 2467999999999999999999999999 9999999999999643 3589999999986
Q ss_pred CCCCC-Cccc----cccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCC
Q 012761 237 GPVGD-KSHV----STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPH 295 (457)
Q Consensus 237 ~~~~~-~~~~----~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~ 295 (457)
.-... ..+. .....||..||+=....+...+.+.|+-|||-+++++|-|..||.+....
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 43222 1222 23467999999998888889999999999999999999999999887654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-24 Score=198.55 Aligned_cols=246 Identities=20% Similarity=0.332 Sum_probs=190.9
Q ss_pred ccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 87 PESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 87 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+..+|.+...|..|+|++.. ..+++|++.... ....+.|..|.-.|+.+.||||+++++.|.....+.++..||+.
T Consensus 194 l~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34458889999999999974 567778776432 23347899999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEe--eccccccCCCCCC
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLS--DFGLAKLGPVGDK 242 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~--DFGla~~~~~~~~ 242 (457)
|+|...|+.. ..-.++..++.+++.++++|+.|||+..+ -|.---|.+..|++|++.+.+|+ |--++.
T Consensus 272 gslynvlhe~--t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsf------- 341 (448)
T KOG0195|consen 272 GSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSF------- 341 (448)
T ss_pred hHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeee-------
Confidence 9999999973 34567788999999999999999999763 24444699999999999887765 322211
Q ss_pred ccccccccccccccchhhhhcCCC---CccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQL---TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~---~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
......-.|.||+||.+...+- -.++|+|||+|+||||.|...||....+.+-.- .+.-
T Consensus 342 --qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm----------------kial 403 (448)
T KOG0195|consen 342 --QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM----------------KIAL 403 (448)
T ss_pred --eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh----------------hhhh
Confidence 1111234688999999987643 357999999999999999999998776643210 1111
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
.-++-.+|+.....+.+|+.-|+..||.+||.+..|+-.|++.
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 2233345555666788899999999999999999999998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=230.05 Aligned_cols=253 Identities=21% Similarity=0.270 Sum_probs=189.1
Q ss_pred CccceeeecCcEEEEEEEECCCCeEEEEEEeccC--CCcChH----HHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 86 RPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN--GLQGNR----EFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 86 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~--~~~~~~----~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
....++|.|.+|.|+.+........++.|.+... ...... .+..|+.+-..|.|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567799999998888877665665666654321 111111 2455777778899999988877777766666669
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
|||++ +|..++.. ...+....+-.++.|++.|+.|||+.| |.|||||++|+++..+|.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 99999875 346888899999999999999999999 99999999999999999999999999986555
Q ss_pred CCCc--cccccccccccccchhhhhcCCCCc-cchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 240 GDKS--HVSTRVMGTYGYCAPEYAMTGQLTV-KSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 240 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.... ......+|+..|+|||++.+..|.+ ..||||.||+++.|++|+.||-.....+... ......... .
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~-~ 545 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQR-N 545 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhhcccccc-c
Confidence 5444 6667789999999999999999976 6899999999999999999996544332211 000000000 0
Q ss_pred ccCCccCCCCCh--HhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 317 LADPRLEGRYPI--RGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 317 ~~d~~l~~~~~~--~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+ ..+.... ........++.++|+.+|.+|-|+.+|++
T Consensus 546 ~----~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 I----FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred c----ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 0011110 11234567999999999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-23 Score=190.71 Aligned_cols=172 Identities=11% Similarity=0.101 Sum_probs=133.8
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHH---------HHHHHHHHHhcCCCCceeeEEEEec
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE---------FLVEVLMLSLLHHSNLVNLIGYCAD 151 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~---------~~~E~~~l~~l~hpniv~l~~~~~~ 151 (457)
..++|+..++||.|+||.||++.. ++..+|||++.......... +.+|+..+.++.|++|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 358899999999999999999655 36689999997543322222 5789999999999999999988664
Q ss_pred C--------CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC
Q 012761 152 G--------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG 223 (457)
Q Consensus 152 ~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~ 223 (457)
. ...+|||||++|.+|.++.. ++. ..+.+++.+|..||+.+ ++||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence 3 35789999999999988742 222 34669999999999999 9999999999999988
Q ss_pred CceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh
Q 012761 224 FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284 (457)
Q Consensus 224 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt 284 (457)
+ ++|+|||......... .. ..++....|..++|+|+||+++..+..
T Consensus 172 g-i~liDfg~~~~~~e~~---a~-----------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRK---AK-----------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred C-EEEEECCCcccccchh---hH-----------HHHHHHhHhcccccccceeEeehHHHH
Confidence 8 9999999876431111 00 113445567789999999999886643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-23 Score=222.40 Aligned_cols=247 Identities=23% Similarity=0.235 Sum_probs=182.2
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC-CcChHHHH---HHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG-LQGNREFL---VEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~-~~~~~~~~---~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
+|...+.||.+.|=+|.+|++.+ |. |+||++-+.. ...-+.|. .|++ ...++|||.+++.-+-......|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 78888999999999999999875 55 8999986543 22334443 3444 55678999999998877788889999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC--
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG-- 237 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~-- 237 (457)
+|+. -+|.|.|.. +.-|...+...|+.|++.||.-+|..+ |+|||||.+||||+.-.-+.|+||..-+..
T Consensus 101 qyvk-hnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHh-hhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 9984 589888865 456788889999999999999999999 999999999999999989999999876532
Q ss_pred CCCCCccc---cccccccccccchhhhhcC----------C-CCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchh
Q 012761 238 PVGDKSHV---STRVMGTYGYCAPEYAMTG----------Q-LTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVT 302 (457)
Q Consensus 238 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~-~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~ 302 (457)
+.++.... ..+...-.+|+|||.+... . .+++.||||+||+++||++ |+++|+... |..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~a 246 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLA 246 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHh
Confidence 22322211 1112223469999988641 2 6789999999999999988 577775321 222
Q ss_pred hhhh-hhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 303 WARP-LFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 303 ~~~~-~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
+-.. ....+..+..+-|+ .+..++..|++.||.+|.++++.++.-
T Consensus 247 Yr~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred HhccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhh
Confidence 1111 01111122233333 356799999999999999999999884
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=184.35 Aligned_cols=138 Identities=16% Similarity=0.087 Sum_probs=108.3
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--C-------hH-----------------HHHHHHHHHHhcCCCC
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--G-------NR-----------------EFLVEVLMLSLLHHSN 141 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~-------~~-----------------~~~~E~~~l~~l~hpn 141 (457)
...||+|+||.||+|.+. +|+.||||+++..... . .. ....|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999987 7999999999754211 1 01 1234999999998887
Q ss_pred ceeeEEEEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeccCCccCeEE
Q 012761 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL-HDKANPPVIYRDFKSSNILL 220 (457)
Q Consensus 142 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~~~~iiHrDLkp~NILl 220 (457)
+.....+... ..+|||||++++++...+.. ...++...+..++.|++.+|.|| |+.+ |+||||||+|||+
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 7544433222 23899999998777654322 24688999999999999999999 6888 9999999999999
Q ss_pred cCCCceEEeecccccc
Q 012761 221 EEGFHPKLSDFGLAKL 236 (457)
Q Consensus 221 ~~~~~~kL~DFGla~~ 236 (457)
+ ++.++|+|||+|..
T Consensus 152 ~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 152 H-DGKLYIIDVSQSVE 166 (190)
T ss_pred E-CCcEEEEEcccccc
Confidence 8 47899999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-21 Score=177.18 Aligned_cols=138 Identities=19% Similarity=0.125 Sum_probs=110.5
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--------------------------hHHHHHHHHHHHhcCCCC
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--------------------------NREFLVEVLMLSLLHHSN 141 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--------------------------~~~~~~E~~~l~~l~hpn 141 (457)
...||+|+||.||+|.+. +|+.||||+++...... ...+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999987 79999999998642110 011356889999999998
Q ss_pred ceeeEEEEecCCeeeEEEeccCCCCHHHh-hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCccCeE
Q 012761 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDH-LHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFKSSNIL 219 (457)
Q Consensus 142 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLkp~NIL 219 (457)
+.....+... ..+|||||++|+++... +. ...++......++.|++.+|.+||+ .+ |+||||||+|||
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIl 150 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNIL 150 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEE
Confidence 8655544433 24899999998855433 33 2457788999999999999999999 88 999999999999
Q ss_pred EcCCCceEEeeccccccC
Q 012761 220 LEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 220 l~~~~~~kL~DFGla~~~ 237 (457)
++ ++.++|+|||++...
T Consensus 151 l~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 151 YH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred EE-CCCEEEEEcccceec
Confidence 99 789999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=184.59 Aligned_cols=236 Identities=20% Similarity=0.299 Sum_probs=149.7
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCC----------CCceeeEEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHH----------SNLVNLIGYC 149 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~h----------pniv~l~~~~ 149 (457)
..+.....||.|+++.||.+.+..|++.+|||++...... ..+.+.+|......+.+ -.++-.++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 3455667899999999999999999999999998754321 12445555554444322 1222222222
Q ss_pred e---------cC---C-----eeeEEEeccCCCCHHHhhh---cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 012761 150 A---------DG---D-----QRLLVYEFMPLGSLEDHLH---DLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209 (457)
Q Consensus 150 ~---------~~---~-----~~~lV~E~~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ii 209 (457)
. .. . ..+++|+-+ -++|.+++. ........+....++.+..|+++.+++||..| |+
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 1 11 1 236778877 468877754 21112234556667778899999999999999 99
Q ss_pred eccCCccCeEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcC--------CCCccchHHHHHHHHHH
Q 012761 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG--------QLTVKSDVYSFGVVFLE 281 (457)
Q Consensus 210 HrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~ksDvwSlGvil~e 281 (457)
|+||+|+|+|++.+|.++|+||+..... +.. ... ...+..|.+||..... .++.+.|.|+||++||.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~--g~~--~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRA--GTR--YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEET--TEE--EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeec--Cce--eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 9999999999999999999999877642 211 111 2345779999977542 57889999999999999
Q ss_pred HHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCC
Q 012761 282 LITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATR 349 (457)
Q Consensus 282 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 349 (457)
|.+|..||+...+.... .| .+ .... .....+..||..+|+.+|.+|
T Consensus 243 lWC~~lPf~~~~~~~~~---~~---------~f---------~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADP---EW---------DF---------SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTS---GG---------GG---------TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccc---cc---------cc---------hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999865432111 11 11 1111 233467789999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-20 Score=172.94 Aligned_cols=187 Identities=18% Similarity=0.128 Sum_probs=141.2
Q ss_pred CccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcCh----HHHHHHHHHHHhcC-CCCceeeEEEEecCCeeeEEEe
Q 012761 86 RPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN----REFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 86 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~----~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~E 160 (457)
.+...|++|+||+||++.. .+..++.+.+........ ..+.+|+.+|.+|. |+++++++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567799999999997755 478888888876544222 24788999999996 5889999886 45699999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC-CccCeEEcCCCceEEeeccccccCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF-KSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDL-kp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
|+.|.+|...+.. ....++.|++.+|.+||+.| |+|||| ||+|||++.++.++|+|||++.....
T Consensus 79 yI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999998754321 11357889999999999999 999999 79999999999999999999985332
Q ss_pred CCCc----c-------ccccccccccccchhhhhcC-CCC-ccchHHHHHHHHHHHHhCCCCCCCC
Q 012761 240 GDKS----H-------VSTRVMGTYGYCAPEYAMTG-QLT-VKSDVYSFGVVFLELITGRKAIDST 292 (457)
Q Consensus 240 ~~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~ksDvwSlGvil~elltG~~p~~~~ 292 (457)
.... . .......++.|++|+...-- ..+ ...++++.|+-+|.++|++.++...
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 2210 0 01112367888999764322 233 6789999999999999999887543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=209.37 Aligned_cols=199 Identities=21% Similarity=0.246 Sum_probs=160.1
Q ss_pred HHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC---CCCceeeEEEEecCCee
Q 012761 79 AAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH---HSNLVNLIGYCADGDQR 155 (457)
Q Consensus 79 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~ 155 (457)
......|.+.+.||+|+||.||+|...+ |+.||||+-....... |..=.+++.+|. -+.|..+...+.-.+.-
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 3345678889999999999999999987 9999999876543322 222233333443 34566666667777888
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc-------CCCceEE
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE-------EGFHPKL 228 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~-------~~~~~kL 228 (457)
+||+||.+.|+|.+++.. .+.++|.-++.++.|+++.++.||..+ |||+||||+|+||. +..-++|
T Consensus 770 ~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 999999999999999973 677899999999999999999999999 99999999999993 2345899
Q ss_pred eeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCC
Q 012761 229 SDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 288 (457)
Q Consensus 229 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p 288 (457)
+|||.+.-...-.........++|-.+-.+|+..+.+|++..|.|.|+-+++.||.|++.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999998532222222345557789999999999999999999999999999999999763
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.8e-21 Score=182.78 Aligned_cols=198 Identities=22% Similarity=0.221 Sum_probs=140.7
Q ss_pred CCCCceeeEEEEec---------------------------CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHH
Q 012761 138 HHSNLVNLIGYCAD---------------------------GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 190 (457)
Q Consensus 138 ~hpniv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 190 (457)
.|||||.++++|.+ ...+|+||..++ .+|..++-. ...+......|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 59999999987743 234689998875 689999865 345666778899
Q ss_pred HHHHHHHHHHHhCCCCCeeeccCCccCeEE--cCCC--ceEEeeccccccCCCC----CCccccccccccccccchhhhh
Q 012761 191 AGAAKGLEYLHDKANPPVIYRDFKSSNILL--EEGF--HPKLSDFGLAKLGPVG----DKSHVSTRVMGTYGYCAPEYAM 262 (457)
Q Consensus 191 ~qi~~~L~yLH~~~~~~iiHrDLkp~NILl--~~~~--~~kL~DFGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~ 262 (457)
.|+++|+.|||.++ |.|||||++|||| |+++ .+.|+|||++-..... ..........|....||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 9999999999999 4444 4788999998532210 1111122346888899999886
Q ss_pred cCC------CCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHH
Q 012761 263 TGQ------LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALA 336 (457)
Q Consensus 263 ~~~------~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 336 (457)
.-+ --.|+|.|+.|.+.||+++...||...... .|. ...+.+---|.+....| ..+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem---~L~---------~r~Yqe~qLPalp~~vp----p~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM---LLD---------TRTYQESQLPALPSRVP----PVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh---eec---------hhhhhhhhCCCCcccCC----hHHHH
Confidence 421 125899999999999999999999873221 111 11111222233333333 24678
Q ss_pred HHHHcchhhcCCCCChHHHHHHHH
Q 012761 337 VASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 337 li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
++...|+.||++|++..-....|.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 899999999999999877666653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=172.64 Aligned_cols=136 Identities=20% Similarity=0.240 Sum_probs=108.4
Q ss_pred CccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-----CCCCceeeEEEEecCC---e-ee
Q 012761 86 RPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-----HHSNLVNLIGYCADGD---Q-RL 156 (457)
Q Consensus 86 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~---~-~~ 156 (457)
.-.++||+|+||.||. +..++.. +||++........+.+.+|+.+++.+ .||||+++++++.++. . +.
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 4457899999999995 6666555 69998765444567899999999999 5799999999998874 3 33
Q ss_pred EEEec--cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeeeccCCccCeEEcC----CCceEEe
Q 012761 157 LVYEF--MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGL-EYLHDKANPPVIYRDFKSSNILLEE----GFHPKLS 229 (457)
Q Consensus 157 lV~E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L-~yLH~~~~~~iiHrDLkp~NILl~~----~~~~kL~ 229 (457)
+|+|| +++++|.+++.. ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 557999999965 235554 35678888777 9999999 999999999999963 3479999
Q ss_pred ecccc
Q 012761 230 DFGLA 234 (457)
Q Consensus 230 DFGla 234 (457)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-22 Score=203.14 Aligned_cols=226 Identities=27% Similarity=0.339 Sum_probs=176.9
Q ss_pred eeeecCcEEEEEEEE---CCCCeEEEEEEeccCCCcCh--HHHHHHHHHHHhcC-CCCceeeEEEEecCCeeeEEEeccC
Q 012761 90 FIGEGGFGRVYKGWL---ESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYEFMP 163 (457)
Q Consensus 90 ~lG~G~~g~Vy~~~~---~~~~~~vavK~i~~~~~~~~--~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~E~~~ 163 (457)
.+|.|.||.|++++- .+.+..+|+|++.+...... .....|..++...+ ||.+|+++..++.+..++++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999997542 34578899999875432221 23455778888887 9999999999999999999999999
Q ss_pred CCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCc
Q 012761 164 LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS 243 (457)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 243 (457)
||.|...+.. ...+++.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 9999988865 456777788888999999999999999 99999999999999999999999999985322211
Q ss_pred cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccC
Q 012761 244 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLE 323 (457)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 323 (457)
.+||..|||||++. ....++|.||||++++||+||..||.. ..... +....
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~----------Il~~~-- 203 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKR----------ILKAE-- 203 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHH----------Hhhhc--
Confidence 18999999999988 568899999999999999999999965 01111 11111
Q ss_pred CCCChHhHHHHHHHHHHcchhhcCCCCCh
Q 012761 324 GRYPIRGLYQALAVASMCIQEQAATRPLI 352 (457)
Q Consensus 324 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 352 (457)
-..|......+..++..++..+|.+|.-.
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 11233334456678888888889988865
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-21 Score=206.00 Aligned_cols=216 Identities=24% Similarity=0.364 Sum_probs=154.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
-.+|..+++|..|.||.||+++|+.+.+.+|+| ++++...- .+ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lil----Rn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLIL----RN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhh----hc---cccccCCccee------------------
Confidence 468999999999999999999999999999995 44332210 00 22222233332
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
|+-..+++. .++++... +.+++|||+.+ |+|||+||+|.||+.-|++|++|||+++.+....
T Consensus 136 ---gDc~tllk~----~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLKN----IGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhccc----CCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 455555543 23444322 77899999999 9999999999999999999999999987532211
Q ss_pred Cc-------------cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhh
Q 012761 242 KS-------------HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLF 308 (457)
Q Consensus 242 ~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~ 308 (457)
.. .....++||+.|+|||++....|+..+|+|++|+|+||.+-|..||++..+.. .+..++
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------lfg~vi 271 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVI 271 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------HHhhhh
Confidence 11 11234689999999999999999999999999999999999999998876532 222233
Q ss_pred hcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHH
Q 012761 309 NDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVV 356 (457)
Q Consensus 309 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~ 356 (457)
.+...+.+- |..+ ..++.+++.++|+.+|..|.-....+
T Consensus 272 sd~i~wpE~-dea~--------p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 272 SDDIEWPEE-DEAL--------PPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred hhhcccccc-CcCC--------CHHHHHHHHHHHHhChHhhcccchhh
Confidence 333333333 2222 23678899999999999997544443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.2e-20 Score=188.94 Aligned_cols=217 Identities=27% Similarity=0.405 Sum_probs=163.4
Q ss_pred HHhcCCCCceeeEEEEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-eecc
Q 012761 134 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV-IYRD 212 (457)
Q Consensus 134 l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i-iHrD 212 (457)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++.....++.+|+.||.|||... | .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 3568899999999999999999999999999999999986 4567999999999999999999999865 4 9999
Q ss_pred CCccCeEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcC-------CCCccchHHHHHHHHHHHHhC
Q 012761 213 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-------QLTVKSDVYSFGVVFLELITG 285 (457)
Q Consensus 213 Lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~ksDvwSlGvil~elltG 285 (457)
|++.|+++|..+.+||+|||+..+..............-..-|.|||.+... ..+.++||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998764321111111111234569999998763 146789999999999999999
Q ss_pred CCCCCCCCCCCc-ccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 286 RKAIDSTRPHGE-QNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 286 ~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
..||+....... ..++.++.. . ....+-|.+.... +....+..++..||..+|.+||++..|-..++.+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~---~---~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK---G---GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHh---c---CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999976433221 122222211 0 1122223222111 222368899999999999999999999988866643
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=8e-19 Score=166.46 Aligned_cols=144 Identities=17% Similarity=0.130 Sum_probs=112.3
Q ss_pred hcCCCccceeeecCcEEEEEEE-ECCCCeEEEEEEeccCCCcC------------------------hHHHHHHHHHHHh
Q 012761 82 TKNFRPESFIGEGGFGRVYKGW-LESTGQVVAVKQLDRNGLQG------------------------NREFLVEVLMLSL 136 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~~vavK~i~~~~~~~------------------------~~~~~~E~~~l~~ 136 (457)
...|.+.+.||+|+||.||+|. +..+|+.||||++....... ...+..|+.++..
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458899999999999999998 66789999999987542110 0124679999999
Q ss_pred cCCCC--ceeeEEEEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 012761 137 LHHSN--LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFK 214 (457)
Q Consensus 137 l~hpn--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLk 214 (457)
+.+.+ +.+++++ ...+|||||+++.+|...+.. ...+.......++.||+.+|.+||+.+. |+|||||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dik 176 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLS 176 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCC
Confidence 97633 3444443 235899999999888765432 2345566778999999999999999874 9999999
Q ss_pred ccCeEEcCCCceEEeecccccc
Q 012761 215 SSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 215 p~NILl~~~~~~kL~DFGla~~ 236 (457)
|+||+++ ++.++|+|||++..
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhc
Confidence 9999999 88999999999864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-18 Score=161.30 Aligned_cols=134 Identities=21% Similarity=0.293 Sum_probs=113.7
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--------hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--------NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
+.||+|++|.||+|.+ .+..|+||+........ ...+.+|+.++..+.|++|.....++.+.+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 46789999876432211 1346789999999999999888888878888999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
|++|++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998641 12 78899999999999999999 99999999999999 78999999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=4e-18 Score=157.23 Aligned_cols=130 Identities=22% Similarity=0.302 Sum_probs=107.5
Q ss_pred eeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--------hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 90 FIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--------NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 90 ~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+||+|+||.||+|.+ ++..|++|......... ...+..|+.++..+.|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 46789999865432211 14467899999999998876666666677778999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
++|++|.+++... . ..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 79 ~~g~~l~~~~~~~----~-------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEG----N-------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhc----H-------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999987541 1 178999999999999999 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=8e-18 Score=155.44 Aligned_cols=143 Identities=16% Similarity=0.070 Sum_probs=112.0
Q ss_pred HHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc----------------------ChHHHHHHHHH
Q 012761 76 RELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ----------------------GNREFLVEVLM 133 (457)
Q Consensus 76 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~----------------------~~~~~~~E~~~ 133 (457)
.++......|.+.+.||.|+||.||++.+. +|+.||||++...... ....+..|..+
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 86 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA 86 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence 345555556888999999999999999875 6899999987653210 01125678888
Q ss_pred HHhcCCCC--ceeeEEEEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 012761 134 LSLLHHSN--LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 211 (457)
Q Consensus 134 l~~l~hpn--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHr 211 (457)
+..+.|++ ++.+++ ....++||||++|++|..+... .....++.+++.++.++|+.+ |+|+
T Consensus 87 l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~ 149 (198)
T cd05144 87 LKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHG 149 (198)
T ss_pred HHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcC
Confidence 98888774 444443 2345899999999998765431 235678999999999999999 9999
Q ss_pred cCCccCeEEcCCCceEEeecccccc
Q 012761 212 DFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 212 DLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
||||+||++++++.++|+|||++..
T Consensus 150 Dl~p~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 150 DLSEFNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred CCCcccEEEcCCCcEEEEECCcccc
Confidence 9999999999999999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.7e-19 Score=178.31 Aligned_cols=176 Identities=24% Similarity=0.347 Sum_probs=130.3
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecc
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 232 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFG 232 (457)
.++||.|++|.-.+|.+||... ......++...+.++.|++.|++| ++ .+|+|+||.||++..+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 3578999999999999999743 234567888999999999999999 67 8999999999999999999999999
Q ss_pred ccccCCCCC----CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhh
Q 012761 233 LAKLGPVGD----KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPL 307 (457)
Q Consensus 233 la~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 307 (457)
+........ .....+...||..||+||.+.+..|+.|+|||+||+||+||++ =.-+++... .
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~-------------t 468 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA-------------T 468 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-------------h
Confidence 987533322 1123345679999999999999999999999999999999998 222221110 0
Q ss_pred hhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHH
Q 012761 308 FNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDV 355 (457)
Q Consensus 308 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 355 (457)
+.+- -...++|.....+| +-..|+.+++...|.+||++.++
T Consensus 469 ~~d~--r~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 469 LTDI--RDGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hhhh--hcCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHH
Confidence 0000 01222333333333 33578899999999999954443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.1e-18 Score=177.99 Aligned_cols=145 Identities=21% Similarity=0.295 Sum_probs=116.2
Q ss_pred cHHHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--------ChHHHHHHHHHHHhcCCCCceee
Q 012761 74 TFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--------GNREFLVEVLMLSLLHHSNLVNL 145 (457)
Q Consensus 74 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--------~~~~~~~E~~~l~~l~hpniv~l 145 (457)
++.........|...+.||+|+||.||++.+... .+++|+....... ....+..|+.++..++|++++..
T Consensus 324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p 401 (535)
T PRK09605 324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP 401 (535)
T ss_pred eeccccccccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence 3444444456677889999999999999987643 3444433211111 12457889999999999999988
Q ss_pred EEEEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc
Q 012761 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH 225 (457)
Q Consensus 146 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~ 225 (457)
+.++.+....++||||+++++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ .++.
T Consensus 402 ~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~ 465 (535)
T PRK09605 402 VIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDR 465 (535)
T ss_pred EEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCc
Confidence 888887788899999999999999885 34679999999999999999 9999999999999 6789
Q ss_pred eEEeecccccc
Q 012761 226 PKLSDFGLAKL 236 (457)
Q Consensus 226 ~kL~DFGla~~ 236 (457)
++|+|||+++.
T Consensus 466 ~~liDFGla~~ 476 (535)
T PRK09605 466 LYLIDFGLGKY 476 (535)
T ss_pred EEEEeCccccc
Confidence 99999999975
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=138.63 Aligned_cols=135 Identities=19% Similarity=0.172 Sum_probs=113.8
Q ss_pred ccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC--CCceeeEEEEecCCeeeEEEeccCC
Q 012761 87 PESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH--SNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 87 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.+.||.|.++.||++.... ..++||.+..... ...+..|+..+..++| .++++++.++...+..+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 45679999999999999854 6899999865432 4678899999999986 5899999988888889999999988
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+.+..+ +......++.+++.+|.+||.....+++|+||+|.|||++..+.++|+|||++..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 776543 4456778899999999999986434499999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.4e-16 Score=143.82 Aligned_cols=134 Identities=21% Similarity=0.179 Sum_probs=97.3
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHH----------------------HHHHHHHHHhcCCCC--
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NRE----------------------FLVEVLMLSLLHHSN-- 141 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~----------------------~~~E~~~l~~l~hpn-- 141 (457)
.+.||+|+||.||+|.+. +++.||||++....... ... ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999986 68999999987532211 111 134556666665433
Q ss_pred ceeeEEEEecCCeeeEEEeccCCCCHHH-hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCccCeE
Q 012761 142 LVNLIGYCADGDQRLLVYEFMPLGSLED-HLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFKSSNIL 219 (457)
Q Consensus 142 iv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLkp~NIL 219 (457)
+.+++++ ...++||||++++.+.. .+... ... .....++.+++.++.++|. .+ |+|+||||+||+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nil 147 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNIL 147 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEE
Confidence 4444443 24689999999855432 12110 001 5678899999999999999 88 999999999999
Q ss_pred EcCCCceEEeecccccc
Q 012761 220 LEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 220 l~~~~~~kL~DFGla~~ 236 (457)
++ ++.++|+|||.+..
T Consensus 148 i~-~~~~~liDfg~a~~ 163 (187)
T cd05119 148 VD-DGKVYIIDVPQAVE 163 (187)
T ss_pred EE-CCcEEEEECccccc
Confidence 99 89999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.6e-16 Score=146.34 Aligned_cols=134 Identities=21% Similarity=0.205 Sum_probs=104.3
Q ss_pred ceee-ecCcEEEEEEEECCCCeEEEEEEeccCCC-------------cChHHHHHHHHHHHhcCCCCc--eeeEEEEecC
Q 012761 89 SFIG-EGGFGRVYKGWLESTGQVVAVKQLDRNGL-------------QGNREFLVEVLMLSLLHHSNL--VNLIGYCADG 152 (457)
Q Consensus 89 ~~lG-~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-------------~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~ 152 (457)
..|| .||.|+||.+... +..++||.+..... .....+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4587 8889999998775 67899998864221 122457789999999998875 6677764432
Q ss_pred Ce----eeEEEeccCC-CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceE
Q 012761 153 DQ----RLLVYEFMPL-GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPK 227 (457)
Q Consensus 153 ~~----~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~k 227 (457)
.. .++|||+++| .+|.+++.. ..++.. .+.+|+.+|.+||+.| |+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence 22 2599999997 689988864 234443 3678999999999999 99999999999999989999
Q ss_pred Eeecccccc
Q 012761 228 LSDFGLAKL 236 (457)
Q Consensus 228 L~DFGla~~ 236 (457)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.4e-17 Score=176.96 Aligned_cols=255 Identities=24% Similarity=0.278 Sum_probs=188.6
Q ss_pred cCCCccceeeecCcEEEEEEEEC-CCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcC-CCCceeeEEEEecCCeeeEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLE-STGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV 158 (457)
..|.+.+.||+|.|+.|-..... .+...+|+|.+..... ........|..+-..+. |.|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 35667777999999999887663 3345677777765431 11123344777777777 99999999999999999999
Q ss_pred EeccCCCCHHHhh-hcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeeccCCccCeEEcCCC-ceEEeeccccc
Q 012761 159 YEFMPLGSLEDHL-HDLPPDKEALDWNTRMKIAAGAAKGLEYLH-DKANPPVIYRDFKSSNILLEEGF-HPKLSDFGLAK 235 (457)
Q Consensus 159 ~E~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~ 235 (457)
++|..++++.+.+ +. .....+....-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ .++++|||+|.
T Consensus 100 ~~~s~g~~~f~~i~~~---~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP---DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccC---CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999999888 43 2224555677889999999999999 888 99999999999999999 99999999998
Q ss_pred cCCC-CCCccccccccc-cccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccc
Q 012761 236 LGPV-GDKSHVSTRVMG-TYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 312 (457)
Q Consensus 236 ~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 312 (457)
.... ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|++...... .....|... ..
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~----~~ 248 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSN----KG 248 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeeccc----cc
Confidence 7555 333444445678 9999999998874 45788999999999999999999987654332 111222211 00
Q ss_pred ccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHH
Q 012761 313 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVV 356 (457)
Q Consensus 313 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~ 356 (457)
.+ .....+ .......+++..++..+|..|.+.+++.
T Consensus 249 ~~----~~~~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 249 RF----TQLPWN----SISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cc----ccCccc----cCChhhhhcccccccCCchhcccccccc
Confidence 00 011111 1223567788889999999999988874
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.5e-15 Score=140.87 Aligned_cols=205 Identities=23% Similarity=0.309 Sum_probs=144.1
Q ss_pred HHHHHHhcCCCCceeeEEEEecCC-----eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 012761 130 EVLMLSLLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204 (457)
Q Consensus 130 E~~~l~~l~hpniv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 204 (457)
-...|-.+-|.|||+++.|+.+.. ...++.|||.-|+|..+|+........+......+|+.||+.||.|||+..
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 334455667999999999986643 468899999999999999987667788888899999999999999999975
Q ss_pred CCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC--CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHH
Q 012761 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 282 (457)
Q Consensus 205 ~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~el 282 (457)
|||+|+++..+-|++..+|-+|+.----....+... .........+-++|.+||.-.....+.++|||+||.+.+||
T Consensus 197 -PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 -PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred -CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 779999999999999999988875311110000000 00011123467889999987777788899999999999999
Q ss_pred HhCCCCCCCCCCC--CcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 283 ITGRKAIDSTRPH--GEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 283 ltG~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..|..-....... .+.++. .....+-++. -..++..|++.+|..||+|++++-
T Consensus 276 ailEiq~tnseS~~~~ee~ia----------~~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIA----------NVIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCCCcceeehhhhhh----------hheeeccCcc------------ccCcCcccccCCCCCCcchhhhhc
Confidence 8886532111110 001111 0111111111 124677799999999999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.5e-14 Score=145.18 Aligned_cols=256 Identities=24% Similarity=0.243 Sum_probs=184.6
Q ss_pred cCCCccceeee--cCcEEEEEEEE--CCCCeEEEEEEecc--CCCcChHHHHHHHHHHHhcC-CCCceeeEEEEecCCee
Q 012761 83 KNFRPESFIGE--GGFGRVYKGWL--ESTGQVVAVKQLDR--NGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQR 155 (457)
Q Consensus 83 ~~f~~~~~lG~--G~~g~Vy~~~~--~~~~~~vavK~i~~--~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~ 155 (457)
..|-+.+.+|. |.+|.||.+.. ..++..+|+|.-+. ........-.+|+.....++ |+|.++.+..+...+.+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 35667788999 99999999998 77889999998443 22233333445666666665 99999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeeeccCCccCeEEcCC-CceEEee
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK----GLEYLHDKANPPVIYRDFKSSNILLEEG-FHPKLSD 230 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~----~L~yLH~~~~~~iiHrDLkp~NILl~~~-~~~kL~D 230 (457)
++-+|++ +.+|..+.+. ....++....+.++.+... ||.++|..+ ++|-|+||.||++..+ ...+++|
T Consensus 194 fiqtE~~-~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeeccc-cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 9999988 5788888775 2334677788888888888 999999999 9999999999999988 8899999
Q ss_pred ccccccCCCCCCcc---ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhh
Q 012761 231 FGLAKLGPVGDKSH---VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL 307 (457)
Q Consensus 231 FGla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 307 (457)
||+.......+... ...+..|...|++||.+. +-++.++|+|+||.++++..++-......- ...|..
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~------~~~W~~-- 337 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGK------NSSWSQ-- 337 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCC------CCCccc--
Confidence 99987544433222 223346778899999764 578999999999999999999876543210 011110
Q ss_pred hhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 308 FNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 308 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
++... +...+.......+..++.++++.+|..|++.+.+.. |..|..
T Consensus 338 ------~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~-l~~i~s 384 (524)
T KOG0601|consen 338 ------LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA-LNVIHS 384 (524)
T ss_pred ------ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc-cccccc
Confidence 00111 111222222334555889999999999998876653 544443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.3e-13 Score=139.11 Aligned_cols=139 Identities=21% Similarity=0.155 Sum_probs=97.9
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcCh----------------------------------------HHH
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN----------------------------------------REF 127 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~----------------------------------------~~~ 127 (457)
.+.||.|++|.||+|++. +|+.||||+.+....... -.|
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 367999999999999986 589999999865321000 013
Q ss_pred HHHHHHHHhcC----CCCceeeEEEE-ecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 012761 128 LVEVLMLSLLH----HSNLVNLIGYC-ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK-GLEYLH 201 (457)
Q Consensus 128 ~~E~~~l~~l~----hpniv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~-~L~yLH 201 (457)
..|+..+.++. |.+-+.+-.++ ......+|||||++|++|.++.... ...+ ....++..++. .+..+|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCC---CHHHHHHHHHHHHHHHHH
Confidence 44555555552 32223332333 2245579999999999998876531 1112 23456666666 478899
Q ss_pred hCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 202 ~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
..| ++|+|++|.||+++.++.++|+|||++..
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 998 99999999999999999999999999865
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.7e-12 Score=131.75 Aligned_cols=170 Identities=19% Similarity=0.185 Sum_probs=130.3
Q ss_pred EEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCHHHhhhcCCCCCCC
Q 012761 101 KGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA 180 (457)
Q Consensus 101 ~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~ 180 (457)
.|..+.++.+|.|..++...........+-+..|+.|+||||+++++.+......|||+|.+. -|..++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------
Confidence 455667788999998876544333456778889999999999999999999999999999884 57777765
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccccccccccccchhh
Q 012761 181 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEY 260 (457)
Q Consensus 181 l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 260 (457)
+........+.||+.||.|||+.++ ++|++|.-+.|+|+..|..||++|.++........ ......---.|..|+.
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEE 176 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhh
Confidence 3356777889999999999986554 99999999999999999999999998864332221 1111111234677775
Q ss_pred hhcCCCCccchHHHHHHHHHHHHhC
Q 012761 261 AMTGQLTVKSDVYSFGVVFLELITG 285 (457)
Q Consensus 261 ~~~~~~~~ksDvwSlGvil~elltG 285 (457)
+... +-..|.|.|||+++|++.|
T Consensus 177 ~~~s--~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPS--EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCcc--ccchhhhhHHHHHHHHhCc
Confidence 4322 2457999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.43 E-value=8.4e-13 Score=118.18 Aligned_cols=131 Identities=18% Similarity=0.071 Sum_probs=97.4
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCcee-eEEEEecCCeeeEEEeccCCCC
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVN-LIGYCADGDQRLLVYEFMPLGS 166 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~-l~~~~~~~~~~~lV~E~~~~gs 166 (457)
.+.|+.|.++.||++... +..|++|+...... ....+..|+.++..+.+.++++ ++.+. ....++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 356889999999999865 67899998765431 2234678999999887655544 44433 334589999999987
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 167 LEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA--NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 167 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+.... . ....++.+++++|..||..+ ...++|+|++|.||+++ ++.++|+|||.+..
T Consensus 78 l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 76430 0 11346788999999999987 22359999999999999 66899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.2e-12 Score=136.95 Aligned_cols=144 Identities=18% Similarity=0.152 Sum_probs=96.2
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC----------------------------------hH---
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG----------------------------------NR--- 125 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~----------------------------------~~--- 125 (457)
..|.. +.||+|++|.||+|+++.+|+.||||+++..-... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 78999999999999998889999999997541100 00
Q ss_pred ---HHHHHHHHHHhcC----CCCceeeEEEEec-CCeeeEEEeccCCCCHHHhh--hcCCCCCCCCCHHHHHHHHHHHHH
Q 012761 126 ---EFLVEVLMLSLLH----HSNLVNLIGYCAD-GDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAAGAAK 195 (457)
Q Consensus 126 ---~~~~E~~~l~~l~----hpniv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~qi~~ 195 (457)
++..|+..+.++. +.+.+.+-.++.+ ....+|||||++|+.+.++- .........+....+..++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 1344554444442 4444444444433 55678999999999998742 221111112333333333333
Q ss_pred HHHHHHhCCCCCeeeccCCccCeEEcCCC----ceEEeeccccccC
Q 012761 196 GLEYLHDKANPPVIYRDFKSSNILLEEGF----HPKLSDFGLAKLG 237 (457)
Q Consensus 196 ~L~yLH~~~~~~iiHrDLkp~NILl~~~~----~~kL~DFGla~~~ 237 (457)
++..| ++|+|+||.||+++.++ .++++|||++...
T Consensus 276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 34567 99999999999999887 9999999998754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=1e-11 Score=113.63 Aligned_cols=135 Identities=14% Similarity=0.082 Sum_probs=98.1
Q ss_pred ceeeecCcEEEEEEEECC------CCeEEEEEEeccCCC---------------c------C-hHHH----HHHHHHHHh
Q 012761 89 SFIGEGGFGRVYKGWLES------TGQVVAVKQLDRNGL---------------Q------G-NREF----LVEVLMLSL 136 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~------~~~~vavK~i~~~~~---------------~------~-~~~~----~~E~~~l~~ 136 (457)
..||.|..+.||.|.... .+..+|||+.+.... . . ...+ ..|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 469999999999998653 257999999753210 0 0 1122 378999988
Q ss_pred cCC--CCceeeEEEEecCCeeeEEEeccCCCCHH-HhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeecc
Q 012761 137 LHH--SNLVNLIGYCADGDQRLLVYEFMPLGSLE-DHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL-HDKANPPVIYRD 212 (457)
Q Consensus 137 l~h--pniv~l~~~~~~~~~~~lV~E~~~~gsL~-~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~~~~iiHrD 212 (457)
+.. -++..++++ ...+|||||+.+..+. ..+.+ ..++..+...+..+++.+|..| |+.+ |||+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 864 456666654 4568999999764332 22322 2344556778889999999999 8888 99999
Q ss_pred CCccCeEEcCCCceEEeecccccc
Q 012761 213 FKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 213 Lkp~NILl~~~~~~kL~DFGla~~ 236 (457)
|++.|||+. ++.+.|+|||.+..
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCcee
Confidence 999999997 46899999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=7.4e-13 Score=142.18 Aligned_cols=250 Identities=20% Similarity=0.219 Sum_probs=172.1
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
..+.|.+.+.+-+|.++.++.+.-..+|...++|+....... ..+....+-.++-..+||.++.....+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 356777778899999999999887777766666665432111 11222222222222334555554444445567899
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
|++|+.+++|...|+.. .+++.......+..+..+++|||... ++|+|++|.|+|...+++.+++|||.....
T Consensus 882 ~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 99999999999999873 24555555667778889999999987 899999999999999999999999843221
Q ss_pred CCC----CC----c---------------------cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCC
Q 012761 238 PVG----DK----S---------------------HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 288 (457)
Q Consensus 238 ~~~----~~----~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p 288 (457)
... .. . .......||+.|.+||.+.+......+|+|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 00 0 112235689999999999999999999999999999999999999
Q ss_pred CCCCCCCC-cccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChH
Q 012761 289 IDSTRPHG-EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIG 353 (457)
Q Consensus 289 ~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 353 (457)
|+...+.. ..++.... +..| .-+....+.+.+++...+..+|.+|-.+.
T Consensus 1035 ~na~tpq~~f~ni~~~~------------~~~p----~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNRD------------IPWP----EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhhhccccCC------------CCCC----CCccccChhhhhhhhhhhccCchhccCcc
Confidence 98766531 11111100 0011 01122345667788889999999998876
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.3e-11 Score=110.52 Aligned_cols=142 Identities=20% Similarity=0.252 Sum_probs=110.1
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCC--CCceeeEEEEecCC---eeeEEEecc
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHH--SNLVNLIGYCADGD---QRLLVYEFM 162 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~---~~~lV~E~~ 162 (457)
+.|+.|.++.||++...+ |..+++|+...... .....+..|+.++..+.+ .++.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998754 67899999765432 134568899999999976 44577777766543 568999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA-------------------------------------- 204 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-------------------------------------- 204 (457)
+|.++.+.+.. ..++......++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99888776531 34677788888889999999888531
Q ss_pred ---------------CCCeeeccCCccCeEEcC--CCceEEeecccccc
Q 012761 205 ---------------NPPVIYRDFKSSNILLEE--GFHPKLSDFGLAKL 236 (457)
Q Consensus 205 ---------------~~~iiHrDLkp~NILl~~--~~~~kL~DFGla~~ 236 (457)
...++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999988 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.4e-12 Score=129.30 Aligned_cols=249 Identities=23% Similarity=0.222 Sum_probs=175.1
Q ss_pred hcCCCccceeeecCcEEEEEEEEC-CCCeEEEEEEeccCCCcChHH--HHHHHHHHHhcC-CCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLE-STGQVVAVKQLDRNGLQGNRE--FLVEVLMLSLLH-HSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~i~~~~~~~~~~--~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l 157 (457)
..+|..+..||.|.|+.|+....+ .++..|++|.+.........+ -..|+.+...+. |.+++.++..+..-.+.|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 457888899999999999987755 567899999886654333322 245666666654 8888888877777778889
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC-CceEEeecccccc
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG-FHPKLSDFGLAKL 236 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~-~~~kL~DFGla~~ 236 (457)
-.|||.++++...+.. ...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||+...
T Consensus 344 p~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred chhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 9999999987766532 345777888999999999999999999 9999999999999875 7889999998864
Q ss_pred CCCCCCcccccccccccccc--chhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 237 GPVGDKSHVSTRVMGTYGYC--APEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
..... ....++-+++ +++......+..+.|++|||.-+.+.+++..--... ..|.. +
T Consensus 417 ~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~--------~~~~~--------i 475 (524)
T KOG0601|consen 417 LAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG--------VQSLT--------I 475 (524)
T ss_pred cceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccc--------cccee--------e
Confidence 21111 1112233344 455455667889999999999999999986532111 11110 0
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
..-.-+.+.+ ...++..+...++..++..||.+.++........
T Consensus 476 ~~~~~p~~~~-----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 476 RSGDTPNLPG-----LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ecccccCCCc-----hHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 0011111111 1145556777789999999999988877665443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.9e-10 Score=112.91 Aligned_cols=171 Identities=18% Similarity=0.207 Sum_probs=132.7
Q ss_pred cEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEe----cCCeeeEEEeccCCC-CHHHh
Q 012761 96 FGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA----DGDQRLLVYEFMPLG-SLEDH 170 (457)
Q Consensus 96 ~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~----~~~~~~lV~E~~~~g-sL~~~ 170 (457)
-.+.|++....+|..|++|+++.+..........-+++++++.|+|||++..+|. .+..++|||+|.++. +|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3568999999999999999996554444445566788999999999999998876 345789999999864 67766
Q ss_pred hhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 171 LHDLP-----------PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 171 l~~~~-----------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
..... .....+++...|.++.|+..||.++|+.| +.-+-|.+.+||++.+.+++|+..|+..+...
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54322 12345788999999999999999999999 88899999999999999999988887654222
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 288 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p 288 (457)
+. + |-+. --.+-|.=.||.+++-|.||..-
T Consensus 446 d~---------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DP---------T-------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC---------C-------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 11 0 1111 12467999999999999999653
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.4e-10 Score=101.64 Aligned_cols=131 Identities=24% Similarity=0.303 Sum_probs=101.2
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--------hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--------NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.+|++|.-+.+|.+.+. |..+++|.=....... ...-.+|+.++.++.--.|...+=+..+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35889999999998764 4556777532221111 1234679999999887677766667778888899999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
|++|..|.+.+... ...++..|=.-+.-||..+ |+|+||.++||++.... +.++||||+.+
T Consensus 80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999898751 2557777777888999999 99999999999998764 99999999875
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=8.9e-10 Score=97.68 Aligned_cols=143 Identities=21% Similarity=0.242 Sum_probs=106.5
Q ss_pred ccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--------cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 87 PESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--------QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 87 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
...+|-+|..+.|+++.+. |+.++||.=..... -......+|+++|.++.--.|.-..=++.+.+.-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5677999999999999875 78877875322111 1123467799999988766776666677788888899
Q ss_pred EeccCC-CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC---ceEEeecccc
Q 012761 159 YEFMPL-GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF---HPKLSDFGLA 234 (457)
Q Consensus 159 ~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~---~~kL~DFGla 234 (457)
|||++| .++.+++.... .......-...++..|-+.|.-||..+ |||+||..+||+|..++ .+.|+|||++
T Consensus 89 ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence 999986 37888876532 122222333678888889999999999 99999999999996544 4689999998
Q ss_pred cc
Q 012761 235 KL 236 (457)
Q Consensus 235 ~~ 236 (457)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 65
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4e-09 Score=104.05 Aligned_cols=266 Identities=16% Similarity=0.175 Sum_probs=161.9
Q ss_pred ccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCceeeEEE----Ee---cCCeeeEE
Q 012761 87 PESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGY----CA---DGDQRLLV 158 (457)
Q Consensus 87 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~----~~---~~~~~~lV 158 (457)
..+.||+|+.+.+|-.-.- .-.+.|++.........+ .+..|... .||-+-.-+.+ .. .+...-++
T Consensus 15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchh---hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3456999999999964221 234568777654322222 23333333 35533221111 11 12235678
Q ss_pred EeccCCCC-HHHhhhc--CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 159 YEFMPLGS-LEDHLHD--LPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 159 ~E~~~~gs-L~~~l~~--~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
|+.+++.. +..++.- ....-....|...++++..++.+...||..| .+-+|++++|+||.+++.|.|.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 88887653 2222221 1223345789999999999999999999999 8999999999999999999999865443
Q ss_pred cCCCCCCccccccccccccccchhhhh-----cCCCCccchHHHHHHHHHHHHhC-CCCCCCCCCCCc--ccch-hhhhh
Q 012761 236 LGPVGDKSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITG-RKAIDSTRPHGE--QNLV-TWARP 306 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG-~~p~~~~~~~~~--~~l~-~~~~~ 306 (457)
+. .........+|...|.+||.-. +-.-+..+|.|.|||+|++|+.| ++||.+...... .-+. ..+..
T Consensus 166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 32 2222344567899999999754 23456789999999999999887 999976432110 0011 11112
Q ss_pred hhhcccccccccCCccCCCCChHh-HHHHHHHHHHcchhh--cCCCCChHHHHHHHHhhhhc
Q 012761 307 LFNDRRKFSKLADPRLEGRYPIRG-LYQALAVASMCIQEQ--AATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 307 ~~~~~~~~~~~~d~~l~~~~~~~~-~~~l~~li~~cl~~d--P~~RPt~~ev~~~L~~l~~~ 365 (457)
.+....+-..-..|.. +.+|... ...+..+..+|+... +.-||+++-++..|..+...
T Consensus 243 ~f~ya~~~~~g~~p~P-~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 243 RFAYASDQRRGLKPPP-RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred eeeechhccCCCCCCC-CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 2221111111111111 1222221 224556777777653 56899999999999888764
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=7.6e-09 Score=99.73 Aligned_cols=141 Identities=17% Similarity=0.110 Sum_probs=100.7
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-----------ChHHHHHHHHHHHhcCCCCc--eeeEEEEec----
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-----------GNREFLVEVLMLSLLHHSNL--VNLIGYCAD---- 151 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-----------~~~~~~~E~~~l~~l~hpni--v~l~~~~~~---- 151 (457)
+.+-.-....|+++.. .|+.|.||........ ....+.+|...+..|..-+| +.++++...
T Consensus 28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 3444444455667655 3788999977433211 11147789988888864444 344555543
Q ss_pred -CCeeeEEEeccCCC-CHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC-------
Q 012761 152 -GDQRLLVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE------- 222 (457)
Q Consensus 152 -~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~------- 222 (457)
....+||+|++++. +|.+++.... ..+.+......++.+++..+.-||+.| |+|+||++.|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCC
Confidence 23468999999876 7999885321 234556677899999999999999999 999999999999975
Q ss_pred CCceEEeecccccc
Q 012761 223 GFHPKLSDFGLAKL 236 (457)
Q Consensus 223 ~~~~kL~DFGla~~ 236 (457)
++.+.|+||+.+..
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46899999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.7e-09 Score=94.63 Aligned_cols=124 Identities=21% Similarity=0.204 Sum_probs=80.4
Q ss_pred EEEEEEECCCCeEEEEEEeccCCCc---------------------Ch-----HHHHHHHHHHHhcCCC--CceeeEEEE
Q 012761 98 RVYKGWLESTGQVVAVKQLDRNGLQ---------------------GN-----REFLVEVLMLSLLHHS--NLVNLIGYC 149 (457)
Q Consensus 98 ~Vy~~~~~~~~~~vavK~i~~~~~~---------------------~~-----~~~~~E~~~l~~l~hp--niv~l~~~~ 149 (457)
.||.|...+ |..+|||+.+..... .. ....+|...|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 489998754 789999997542100 00 1246799999999865 456666553
Q ss_pred ecCCeeeEEEeccC--CCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeeeccCCccCeEEcCCCce
Q 012761 150 ADGDQRLLVYEFMP--LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEY-LHDKANPPVIYRDFKSSNILLEEGFHP 226 (457)
Q Consensus 150 ~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~y-LH~~~~~~iiHrDLkp~NILl~~~~~~ 226 (457)
..+|||||++ |..+..+... .++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 3479999998 5555544332 11123456778888885555 57888 9999999999999987 99
Q ss_pred EEeecccccc
Q 012761 227 KLSDFGLAKL 236 (457)
Q Consensus 227 kL~DFGla~~ 236 (457)
.|+|||.+..
T Consensus 146 ~iIDf~qav~ 155 (188)
T PF01163_consen 146 YIIDFGQAVD 155 (188)
T ss_dssp EE--GTTEEE
T ss_pred EEEecCccee
Confidence 9999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.7e-08 Score=92.83 Aligned_cols=134 Identities=20% Similarity=0.128 Sum_probs=97.4
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc----------------------ChHHHHHHHHHHHhcCCC--
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ----------------------GNREFLVEVLMLSLLHHS-- 140 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~----------------------~~~~~~~E~~~l~~l~hp-- 140 (457)
..+...||.|.-+.||.|... .|..+|||.=+..... ......+|.+.|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 556688999999999999986 4899999964321000 012356799999988754
Q ss_pred CceeeEEEEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE
Q 012761 141 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL 220 (457)
Q Consensus 141 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl 220 (457)
.+.+.+++ +.-.+||||++|-.|...- ++....-.|+..|+.-+.-+-..| |||+|+++-|||+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 67777654 4557999999986554332 123344556666666666666778 9999999999999
Q ss_pred cCCCceEEeeccccc
Q 012761 221 EEGFHPKLSDFGLAK 235 (457)
Q Consensus 221 ~~~~~~kL~DFGla~ 235 (457)
+++|.+.++||--+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999996543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.4e-07 Score=87.73 Aligned_cols=106 Identities=24% Similarity=0.267 Sum_probs=83.3
Q ss_pred hHHHHHHHHHHHhcCCC--CceeeEEEEecCC----eeeEEEeccCCC-CHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 012761 124 NREFLVEVLMLSLLHHS--NLVNLIGYCADGD----QRLLVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 196 (457)
Q Consensus 124 ~~~~~~E~~~l~~l~hp--niv~l~~~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~ 196 (457)
.....+|...+..|..- .+++++++..... ..+||+|++++. +|.+++... ..++......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHH
Confidence 34577888888777543 3455666655432 358999999874 799998752 125666788999999999
Q ss_pred HHHHHhCCCCCeeeccCCccCeEEcCCC---ceEEeecccccc
Q 012761 197 LEYLHDKANPPVIYRDFKSSNILLEEGF---HPKLSDFGLAKL 236 (457)
Q Consensus 197 L~yLH~~~~~~iiHrDLkp~NILl~~~~---~~kL~DFGla~~ 236 (457)
+.-||+.| |+|+|+++.|||++.+. .+.|+||+-++.
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999 99999999999998876 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.8e-07 Score=83.99 Aligned_cols=138 Identities=15% Similarity=0.106 Sum_probs=102.3
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeccC---C---CcChHHHHHHHHHHHhcCCC--CceeeEEEEe-c----CCeeeE
Q 012761 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRN---G---LQGNREFLVEVLMLSLLHHS--NLVNLIGYCA-D----GDQRLL 157 (457)
Q Consensus 91 lG~G~~g~Vy~~~~~~~~~~vavK~i~~~---~---~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~-~----~~~~~l 157 (457)
-|+||.+.|+..... |..+-||.-... . ......|.+|+..|..|..- .+.++. ++. . ...-+|
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 567888899987765 446888876411 1 23567899999999998643 244444 332 1 224579
Q ss_pred EEeccCC-CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc--eEEeecccc
Q 012761 158 VYEFMPL-GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH--PKLSDFGLA 234 (457)
Q Consensus 158 V~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~--~kL~DFGla 234 (457)
|+|-+.+ -+|.+++... ...+.+......++.+++..|.-||+.+ +.|+|+.+.|||++.++. +.++||.-+
T Consensus 103 VTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 103 VTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 9997753 4899888652 2235677788899999999999999999 999999999999986666 999999766
Q ss_pred cc
Q 012761 235 KL 236 (457)
Q Consensus 235 ~~ 236 (457)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 53
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.6e-08 Score=105.55 Aligned_cols=150 Identities=19% Similarity=0.262 Sum_probs=96.7
Q ss_pred HHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccc-------cccccccccccchhhhhc
Q 012761 191 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV-------STRVMGTYGYCAPEYAMT 263 (457)
Q Consensus 191 ~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~ 263 (457)
.+++.||.|+|.... +||++|.|++|.++.++..||+.|+++........... ..-..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 344589999998653 99999999999999999999999998764322111100 001122457999999999
Q ss_pred CCCCccchHHHHHHHHHHHHhC-CCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcc
Q 012761 264 GQLTVKSDVYSFGVVFLELITG-RKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCI 342 (457)
Q Consensus 264 ~~~~~ksDvwSlGvil~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl 342 (457)
...+.++|+|||||++|.+..| +.-+...... ..+..... ..+... ..+......++.+-+..++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-----~~~~~~~~--------~~~~~~-~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-----LSYSFSRN--------LLNAGA-FGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc-----chhhhhhc--------cccccc-ccccccCcHHHHHHHHHHh
Confidence 8889999999999999999944 4434332211 11111100 011110 0111122335667777888
Q ss_pred hhhcCCCCChHHHH
Q 012761 343 QEQAATRPLIGDVV 356 (457)
Q Consensus 343 ~~dP~~RPt~~ev~ 356 (457)
..++..||++.++.
T Consensus 250 ~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLL 263 (700)
T ss_pred cCCcccCcchhhhh
Confidence 99999999776654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.8e-07 Score=96.26 Aligned_cols=137 Identities=19% Similarity=0.176 Sum_probs=90.9
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcCh------------------------------H----------HHH
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN------------------------------R----------EFL 128 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~------------------------------~----------~~~ 128 (457)
..|+.++-|.||+|++++ |+.||||+.+.+-.... + ++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 569999999999999976 99999999865311100 0 134
Q ss_pred HHHHHHHhcC-----CCCceeeEEEE-ecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH-HHHHH
Q 012761 129 VEVLMLSLLH-----HSNLVNLIGYC-ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG-LEYLH 201 (457)
Q Consensus 129 ~E~~~l~~l~-----hpniv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~-L~yLH 201 (457)
.|...+.++. .|+| .+=.+| .-.....|+|||++|..+.+...-. ...++.. .++..++++ +..+-
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k---~ia~~~~~~f~~q~~ 282 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRK---ELAELLVRAFLRQLL 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHH---HHHHHHHHHHHHHHH
Confidence 4555555442 2333 333333 3356778999999999888874321 1334422 233333322 33344
Q ss_pred hCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 202 ~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
..| ++|.|.+|.||+++.+|.+.+.|||+...
T Consensus 283 ~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 283 RDG---FFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred hcC---ccccCCCccceEEecCCcEEEEcCcceec
Confidence 457 99999999999999999999999999864
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.8e-06 Score=81.43 Aligned_cols=140 Identities=16% Similarity=0.174 Sum_probs=86.9
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC--ceeeEEEEecCCeeeEEEeccCCCC
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN--LVNLIGYCADGDQRLLVYEFMPLGS 166 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~lV~E~~~~gs 166 (457)
..||.|..+.||+. . +..+++|...... ......+|.+++..+..-. +.+.+++..+.+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~-~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---K-TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---c-CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 46899999999984 1 4467889876532 3456788999998886433 4677888878888899999999863
Q ss_pred -HHHh---------------------hhcCCCCCCCCCHHHHHHHHH----------HHHH-HHHHHHhC-CCCCeeecc
Q 012761 167 -LEDH---------------------LHDLPPDKEALDWNTRMKIAA----------GAAK-GLEYLHDK-ANPPVIYRD 212 (457)
Q Consensus 167 -L~~~---------------------l~~~~~~~~~l~~~~~~~i~~----------qi~~-~L~yLH~~-~~~~iiHrD 212 (457)
+... ||........++.. ...+.. .+.. ...+|... ..+.++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 2111 22211111111100 000000 0111 12222211 123478999
Q ss_pred CCccCeEEcCCCceEEeecccccc
Q 012761 213 FKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 213 Lkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+.|.||++++++ +.|+||+.+..
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.4e-08 Score=104.90 Aligned_cols=191 Identities=18% Similarity=0.097 Sum_probs=141.4
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC-ceeeEEEEecCCeeeEEE
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN-LVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lV~ 159 (457)
-++.+...+.+++|.++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-+..++..++++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 3444555566899999999998776654443 6655432 45667899999999999 677777777788899999
Q ss_pred eccCCC-CHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 160 EFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 160 E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
+++.++ +...... .....+...+...+...-+++++|||+.. -+|+| ||+..+ +..++.||+......
T Consensus 314 ~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 314 RICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred hhhcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccC
Confidence 999877 2222221 12344555566677778889999999875 58998 777766 688999999876433
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS 291 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~ 291 (457)
... ......+|+.++|||+.....+..+.|+|++|+-..+|.-|.+|-..
T Consensus 383 ~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 383 RTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 222 33446799999999999999999999999999988888888777543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.9e-06 Score=78.50 Aligned_cols=136 Identities=13% Similarity=0.094 Sum_probs=90.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHH---------HHHHHHHHHhcC---CCCceeeEEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE---------FLVEVLMLSLLH---HSNLVNLIGYC 149 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~---------~~~E~~~l~~l~---hpniv~l~~~~ 149 (457)
.++|...+++-......|.+... +|..+++|..........+. ..+.+..+..+. --.+..++.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 56788888888877766766554 47889999876543222221 223333333332 22333333332
Q ss_pred e-----cCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC
Q 012761 150 A-----DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF 224 (457)
Q Consensus 150 ~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~ 224 (457)
. -....+|||||++|..|.++.. ++. .++..++.+|.-||+.| +.|+|++|.|+++.+++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence 2 2345678999999988876542 222 25566778899999999 99999999999998654
Q ss_pred ceEEeeccccc
Q 012761 225 HPKLSDFGLAK 235 (457)
Q Consensus 225 ~~kL~DFGla~ 235 (457)
+++.||+..+
T Consensus 173 -i~iID~~~k~ 182 (229)
T PF06176_consen 173 -IRIIDTQGKR 182 (229)
T ss_pred -EEEEECcccc
Confidence 9999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.40 E-value=4e-06 Score=78.50 Aligned_cols=153 Identities=20% Similarity=0.165 Sum_probs=103.1
Q ss_pred cccccHHHHHHHhcCCCccceee---ecCcEEEEEEEECCCCeEEEEEEeccCCCcCh-------------------HH-
Q 012761 70 AQTFTFRELAAATKNFRPESFIG---EGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN-------------------RE- 126 (457)
Q Consensus 70 ~~~~~~~~~~~~~~~f~~~~~lG---~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~-------------------~~- 126 (457)
....++..+....+...+....| .|.-+.||+|... ++..||||++........ +.
T Consensus 32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~l 110 (268)
T COG1718 32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKL 110 (268)
T ss_pred hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHH
Confidence 34456666666777776666554 5666689998763 478999999865322111 11
Q ss_pred ----HHHHHHHHHhcC--CCCceeeEEEEecCCeeeEEEeccCCCC-HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 012761 127 ----FLVEVLMLSLLH--HSNLVNLIGYCADGDQRLLVYEFMPLGS-LEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEY 199 (457)
Q Consensus 127 ----~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~y 199 (457)
...|...|.++. +-.+.+.+.+.. -.|||||+.... -.-.|.+ -++.......+..++++.+.-
T Consensus 111 v~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~ 181 (268)
T COG1718 111 VFAWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRR 181 (268)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHH
Confidence 245777777774 445566666543 369999995431 1112222 223333677788888888888
Q ss_pred HHh-CCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 200 LHD-KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 200 LH~-~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
|-. .+ +||+||+.-|||+. ++.+.|+|||-|..
T Consensus 182 l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 182 LYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred HHHhcC---cccccchhhheEEE-CCeEEEEECccccc
Confidence 887 66 99999999999999 88999999997753
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.37 E-value=6.2e-06 Score=78.45 Aligned_cols=141 Identities=21% Similarity=0.184 Sum_probs=85.2
Q ss_pred eeecCc-EEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCceeeEEEEecCCeeeEEEeccCCCCHH
Q 012761 91 IGEGGF-GRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLE 168 (457)
Q Consensus 91 lG~G~~-g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~E~~~~gsL~ 168 (457)
|-.|.+ ..||+.... +..+.||+..... ...+..|+.++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 444444 678998653 4678888876442 345677888888885 444567777777666789999999987776
Q ss_pred Hhh-------------------hcCCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----C
Q 012761 169 DHL-------------------HDLPPDKEALDWN--TRMKIAA--------------------GAAKGLEYLHD----K 203 (457)
Q Consensus 169 ~~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------qi~~~L~yLH~----~ 203 (457)
... |.......++... ..+.... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 2211111111100 0000000 01111222211 1
Q ss_pred CCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 204 ~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
..+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 124489999999999999987788999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.2e-06 Score=79.08 Aligned_cols=145 Identities=19% Similarity=0.209 Sum_probs=84.4
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCC--CceeeEEEEec---CCeeeEEEecc
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHS--NLVNLIGYCAD---GDQRLLVYEFM 162 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~~---~~~~~lV~E~~ 162 (457)
++.|+.|..+.||++.... ..+++|..... .....+..|..+++.|... .+..++.+... ....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 3579999999999998865 48999987654 3346677888888888633 35566664433 23468999999
Q ss_pred CCCCHHH----------------h---hhcCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 012761 163 PLGSLED----------------H---LHDLPPDKEALDWNT---------RMKI------------AAGAAK-GLEYLH 201 (457)
Q Consensus 163 ~~gsL~~----------------~---l~~~~~~~~~l~~~~---------~~~i------------~~qi~~-~L~yLH 201 (457)
+|..+.. . |+........+.+.. .... +..+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9887776 1 112111111111111 0000 111222 333444
Q ss_pred hC----CCCCeeeccCCccCeEEc-CCCceEEeecccccc
Q 012761 202 DK----ANPPVIYRDFKSSNILLE-EGFHPKLSDFGLAKL 236 (457)
Q Consensus 202 ~~----~~~~iiHrDLkp~NILl~-~~~~~kL~DFGla~~ 236 (457)
+. ....++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 21 234499999999999999 667778999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.7e-05 Score=72.87 Aligned_cols=133 Identities=21% Similarity=0.279 Sum_probs=95.1
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccCC----------------CcChHHHHHHHHHHHhcC------CCCceee
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG----------------LQGNREFLVEVLMLSLLH------HSNLVNL 145 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~----------------~~~~~~~~~E~~~l~~l~------hpniv~l 145 (457)
..+||.|+.-.||.- .. ....+||+..... ....++..+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 456999999999973 32 4567899987654 122355666776665555 7899999
Q ss_pred EEEEecCCeeeEEEeccCC------CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeE
Q 012761 146 IGYCADGDQRLLVYEFMPL------GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNIL 219 (457)
Q Consensus 146 ~~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NIL 219 (457)
+|+..++...-+|+|.+.. .+|.+++.. ..++. .+...+-+-..||-+.+ |+.+||+|.||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~----~~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE----ELRQALDEFKRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH----HHHHHHHHHHHHHHHcC---CeecCCCcccEE
Confidence 9999999999999998743 268888854 34554 33334445567788888 999999999999
Q ss_pred EcCC--C--ceEEee-ccccc
Q 012761 220 LEEG--F--HPKLSD-FGLAK 235 (457)
Q Consensus 220 l~~~--~--~~kL~D-FGla~ 235 (457)
+... + .+.|+| ||...
T Consensus 151 ~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred EEecCCCceEEEEEeCCCCcc
Confidence 9432 2 578887 55443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.28 E-value=3.6e-06 Score=76.88 Aligned_cols=104 Identities=27% Similarity=0.290 Sum_probs=81.1
Q ss_pred HHHHHHHHhcCC-CCceeeEEEEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 012761 128 LVEVLMLSLLHH-SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206 (457)
Q Consensus 128 ~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~ 206 (457)
..|..++..+++ +++++++|+|- .++|.||...+++....... ..-..-+|..+.+||.++++.+++|+.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358888999986 69999999993 36789999877654220000 0112368999999999999999999985444
Q ss_pred CeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 207 ~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
.+.-.|++++|+-++++|++|++|.+.+..
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 489999999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.1e-05 Score=71.56 Aligned_cols=129 Identities=20% Similarity=0.177 Sum_probs=91.5
Q ss_pred CccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCcee-eEEEEecCCeeeEEEeccCC
Q 012761 86 RPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVN-LIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 86 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~-l~~~~~~~~~~~lV~E~~~~ 164 (457)
...+.|++|++|.||++.+. |..+|+|+-..+. ....+..|+++|..+.-.++.+ ++.|-.+ ++.|||+.|
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G 96 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG 96 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence 45667999999999999986 5689999876653 3577899999999988766654 4433222 355999998
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC-ccCeEEcCCCceEEeecccccc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFK-SSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLk-p~NILl~~~~~~kL~DFGla~~ 236 (457)
-.|.++-.. .+ .+-+..+++.---|-..| |-|+.|. |..++|..++.+.|+||..|..
T Consensus 97 ~~L~~~~~~-------~~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIG-------GD----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhc-------cc----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 888876643 12 233444555544555667 9999985 5555555555999999998863
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.2e-05 Score=87.85 Aligned_cols=150 Identities=17% Similarity=0.273 Sum_probs=93.4
Q ss_pred cceeeecCcEEEEEEEECCCC--eEEEEEEeccCCC-cChHHHHHHHHHHHhcC-CCCc--eeeEEEEecC---CeeeEE
Q 012761 88 ESFIGEGGFGRVYKGWLESTG--QVVAVKQLDRNGL-QGNREFLVEVLMLSLLH-HSNL--VNLIGYCADG---DQRLLV 158 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~--~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~-hpni--v~l~~~~~~~---~~~~lV 158 (457)
.+.|+.|.+..+|+......+ ..+++|+...... .....+.+|+.+++.|. |.++ .+++.+|.+. ...|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 466889999999998765432 4678887654322 23356889999999996 6665 7778887664 457899
Q ss_pred EeccCCCCHHH-----------------------hhhcCCCC-------CCCCCH--HHHHHHH---------------H
Q 012761 159 YEFMPLGSLED-----------------------HLHDLPPD-------KEALDW--NTRMKIA---------------A 191 (457)
Q Consensus 159 ~E~~~~gsL~~-----------------------~l~~~~~~-------~~~l~~--~~~~~i~---------------~ 191 (457)
|||++|..+.+ .||..... ..+..+ .++..+. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764321 12221110 011111 1111111 1
Q ss_pred HHHHHHHHHHhCCC--------CCeeeccCCccCeEEcC-CCc-eEEeeccccccC
Q 012761 192 GAAKGLEYLHDKAN--------PPVIYRDFKSSNILLEE-GFH-PKLSDFGLAKLG 237 (457)
Q Consensus 192 qi~~~L~yLH~~~~--------~~iiHrDLkp~NILl~~-~~~-~kL~DFGla~~~ 237 (457)
.+...+.+|..+-+ +.+||+|+++.|||++. ++. +-|.||.++..+
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 13334567754322 24999999999999974 333 568999988764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.6e-05 Score=75.34 Aligned_cols=141 Identities=18% Similarity=0.219 Sum_probs=77.4
Q ss_pred ceeeecCcE-EEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCC---CceeeEEEEecCC---eeeEEEec
Q 012761 89 SFIGEGGFG-RVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHS---NLVNLIGYCADGD---QRLLVYEF 161 (457)
Q Consensus 89 ~~lG~G~~g-~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~~---~~~lV~E~ 161 (457)
..|+.|+.. .||+. +..+++|+.... .....+..|..++..|... .+..+++.....+ ..+++|++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 457777766 48875 235778875542 2345788899999888632 3344444433322 34889999
Q ss_pred cCCCCHHHh------------------hhcCCCCCCCC-------------CHHHHH--HH---H----HHHHHH-HHHH
Q 012761 162 MPLGSLEDH------------------LHDLPPDKEAL-------------DWNTRM--KI---A----AGAAKG-LEYL 200 (457)
Q Consensus 162 ~~~gsL~~~------------------l~~~~~~~~~l-------------~~~~~~--~i---~----~qi~~~-L~yL 200 (457)
++|.++.+. ||.......+. .|.... .+ . .+.+.. ++.+
T Consensus 76 i~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 155 (235)
T cd05155 76 LEGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAA 155 (235)
T ss_pred ecCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHH
Confidence 998766322 22221111000 011110 00 0 011111 1111
Q ss_pred Hh---CCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 201 HD---KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 201 H~---~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
.. ...+.++|+|+.+.|||++++...-|+||+.+..
T Consensus 156 ~~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 156 LRAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred hcccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 1233489999999999998776567999998764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.2e-05 Score=83.81 Aligned_cols=139 Identities=21% Similarity=0.162 Sum_probs=88.2
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC-------------------------------------hHHHHHHH
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG-------------------------------------NREFLVEV 131 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-------------------------------------~~~~~~E~ 131 (457)
+.||.-+.|.||+|+.+. |+.||||+-+..-... .-+|.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 569999999999999987 9999999875421100 00134444
Q ss_pred HHHHh----cCCCCc---eeeEEEEec-CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 012761 132 LMLSL----LHHSNL---VNLIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203 (457)
Q Consensus 132 ~~l~~----l~hpni---v~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 203 (457)
+-..+ +.|-++ |.+=.+|.+ .....|+||||+|..+.+.-.- ....++...+..-+.++.. +-|-..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~--~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYL--EQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHH--HHHHhc
Confidence 43333 345451 112222322 3467899999999877765332 1234555544444444322 222234
Q ss_pred CCCCeeeccCCccCeEEcC----CCceEEeecccccc
Q 012761 204 ANPPVIYRDFKSSNILLEE----GFHPKLSDFGLAKL 236 (457)
Q Consensus 204 ~~~~iiHrDLkp~NILl~~----~~~~kL~DFGla~~ 236 (457)
| ++|+|-+|.||++.. ++.+.|.|||+...
T Consensus 321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred C---CccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 6 999999999999983 67899999999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00011 Score=69.44 Aligned_cols=143 Identities=22% Similarity=0.210 Sum_probs=80.9
Q ss_pred ceeeecCcEEEEEEEECC-CCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCc-eeeEEEEecCCeeeEEEeccCCCC
Q 012761 89 SFIGEGGFGRVYKGWLES-TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL-VNLIGYCADGDQRLLVYEFMPLGS 166 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~-~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~E~~~~gs 166 (457)
+.|..|-...+|++.... .+..|++|+...... ..-....|+.++..+...++ ++++..+. -.+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457778888999987543 246788997754322 11233468888888864444 44444332 247999999876
Q ss_pred HHHh-----------------hhcCCCCC-------CCC-CHHHHHHHHH----------------------HHHHHHHH
Q 012761 167 LEDH-----------------LHDLPPDK-------EAL-DWNTRMKIAA----------------------GAAKGLEY 199 (457)
Q Consensus 167 L~~~-----------------l~~~~~~~-------~~l-~~~~~~~i~~----------------------qi~~~L~y 199 (457)
+... +|...... ... .+..+..+.. .+...+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5311 12211111 111 1222112211 11111112
Q ss_pred H----HhC-CCCCeeeccCCccCeEEcC-CCceEEeecccccc
Q 012761 200 L----HDK-ANPPVIYRDFKSSNILLEE-GFHPKLSDFGLAKL 236 (457)
Q Consensus 200 L----H~~-~~~~iiHrDLkp~NILl~~-~~~~kL~DFGla~~ 236 (457)
| -.. ....++|+|+.+.|||++. ++.+.|+||..|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 2 111 1234999999999999997 57899999987753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00021 Score=70.22 Aligned_cols=77 Identities=14% Similarity=0.100 Sum_probs=56.2
Q ss_pred ccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC---CCceeeEEEEecC---CeeeEEEe
Q 012761 87 PESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH---SNLVNLIGYCADG---DQRLLVYE 160 (457)
Q Consensus 87 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h---pniv~l~~~~~~~---~~~~lV~E 160 (457)
-.+.||.|..+.||.....+ + .+.+|..+. ......+..|...|+.|.- ..+.++++++.+. +..+||||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQ-G-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred eeeecCCccceeEEEEEcCC-C-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 34569999999999986543 3 466777432 1134578899999998863 3678888887653 56899999
Q ss_pred ccCCCCH
Q 012761 161 FMPLGSL 167 (457)
Q Consensus 161 ~~~~gsL 167 (457)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00016 Score=69.30 Aligned_cols=139 Identities=15% Similarity=0.048 Sum_probs=79.5
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCc-eeeEEEEecCCeeeEEEeccCCCCHHH
Q 012761 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL-VNLIGYCADGDQRLLVYEFMPLGSLED 169 (457)
Q Consensus 91 lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~E~~~~gsL~~ 169 (457)
+..|-...+|+.. .++..+++|+.......-.-....|..+++.+..-.+ .+++.... -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 4567777899886 3467888987654322211235678888888864434 33444332 368999999866532
Q ss_pred -----------------hhhcCCCCCCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCCeeeccCCccC
Q 012761 170 -----------------HLHDLPPDKEALDWNTR-MKIAAG---------AAKGLEYLHDK-----ANPPVIYRDFKSSN 217 (457)
Q Consensus 170 -----------------~l~~~~~~~~~l~~~~~-~~i~~q---------i~~~L~yLH~~-----~~~~iiHrDLkp~N 217 (457)
.||.......+++.... ..+..+ +...+..+-.. ..+.++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 12332222222332211 111111 11112222221 12348999999999
Q ss_pred eEEcCCCceEEeecccccc
Q 012761 218 ILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 218 ILl~~~~~~kL~DFGla~~ 236 (457)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.91 E-value=9.2e-05 Score=82.05 Aligned_cols=196 Identities=20% Similarity=0.178 Sum_probs=136.8
Q ss_pred HHHHHHHHHhcCCCCceeeEEEEecCCee----eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 012761 127 FLVEVLMLSLLHHSNLVNLIGYCADGDQR----LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202 (457)
Q Consensus 127 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 202 (457)
...|...+.++.|+|++.++.|....... .+..+++..-++...+.. -..++..+.+.+..++..||.|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 34577788888999999999987654332 234577888888888865 5678889999999999999999999
Q ss_pred CCCCCeeeccCCcc---CeEEcCCCceEEe--eccccccCCCCCCccccccccccccccchhhhhcCCCCc--cchHHHH
Q 012761 203 KANPPVIYRDFKSS---NILLEEGFHPKLS--DFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTV--KSDVYSF 275 (457)
Q Consensus 203 ~~~~~iiHrDLkp~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--ksDvwSl 275 (457)
.. ..|.-|..+ +..++..+.+.++ ||+.+...+...... ...-+..|.+||......+.. ..|+|++
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHH
Confidence 86 677766665 5555666777777 998887543332221 122345578888776655444 4799999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHH
Q 012761 276 GVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDV 355 (457)
Q Consensus 276 Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 355 (457)
|..+..+..|..+-.... ....+++... . ..+.+....|+..++++|+++.++
T Consensus 379 gll~~~~~~~~~i~~~~~-------------------~~~~~l~~~~----~----~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA-------------------VPVSLLDVLS----T----SELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHhhhhhcCccccccc-------------------chhhhhcccc----c----hhhhhhhhhhcchhhhhccchhhh
Confidence 999999998865432111 0111111111 0 145677888999999999999999
Q ss_pred HHHH
Q 012761 356 VTAL 359 (457)
Q Consensus 356 ~~~L 359 (457)
+...
T Consensus 432 l~~~ 435 (1351)
T KOG1035|consen 432 LTHP 435 (1351)
T ss_pred hhch
Confidence 8754
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00018 Score=65.84 Aligned_cols=125 Identities=26% Similarity=0.375 Sum_probs=89.3
Q ss_pred cCCCccceeeecCc-EEEEEEEECCCCeEEEEEEecc---CC-------Cc-----------ChHHHHHHHHHHHhcC--
Q 012761 83 KNFRPESFIGEGGF-GRVYKGWLESTGQVVAVKQLDR---NG-------LQ-----------GNREFLVEVLMLSLLH-- 138 (457)
Q Consensus 83 ~~f~~~~~lG~G~~-g~Vy~~~~~~~~~~vavK~i~~---~~-------~~-----------~~~~~~~E~~~l~~l~-- 138 (457)
.+++.++.||.|.- |.||+++.. |..||||++.. .. .. ...-|..|.+...+|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78889999999999 999999986 78999999321 10 00 0123677888777775
Q ss_pred -CCCc--eeeEEEEecC------------------CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 012761 139 -HSNL--VNLIGYCADG------------------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGL 197 (457)
Q Consensus 139 -hpni--v~l~~~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L 197 (457)
+.++ |+.+||..=. ....||.||++... .+ ...-+.+|.+-|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~----~~~~~~~~~~dl 177 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PL----QIRDIPQMLRDL 177 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------cc----chhHHHHHHHHH
Confidence 4566 8999987321 12356777765422 12 233456777788
Q ss_pred HHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 198 ~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
..+|..+ |+-+|+++.|.. .-+|+|||.+
T Consensus 178 ~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 9999999 999999999985 4589999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00023 Score=69.64 Aligned_cols=144 Identities=17% Similarity=0.112 Sum_probs=84.8
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC--ceeeEEE------EecCCeeeEEE
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN--LVNLIGY------CADGDQRLLVY 159 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~------~~~~~~~~lV~ 159 (457)
.+.|..|....+|+.... +..+++|+... .....+..|+.++..|.+-+ +.+++.. ....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 455777877889988653 34788998764 23455667888887775332 4444432 12345568999
Q ss_pred eccCCCCHHH--------------hhhcCC----CC---CCCCCHHHHH----------HHHHHHHHHHHHHHhC----C
Q 012761 160 EFMPLGSLED--------------HLHDLP----PD---KEALDWNTRM----------KIAAGAAKGLEYLHDK----A 204 (457)
Q Consensus 160 E~~~~gsL~~--------------~l~~~~----~~---~~~l~~~~~~----------~i~~qi~~~L~yLH~~----~ 204 (457)
+|++|..+.. .||... .. .....|.... .....+..++.++... .
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999866432 111111 00 0111222111 0111233445555431 1
Q ss_pred CCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 205 ~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+..++|+|+.|.|||+++++.+.|.||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 23499999999999999887778999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00075 Score=68.71 Aligned_cols=76 Identities=20% Similarity=0.147 Sum_probs=52.8
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccC------C-CcChHHHHHHHHHHHhcC---CCCceeeEEEEecCCeeeEE
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRN------G-LQGNREFLVEVLMLSLLH---HSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~------~-~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lV 158 (457)
+.||.|.+..||++.....++.|+||.-... . ....+.+..|.+.|..+. -.++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4699999999999998654468999985311 1 113355677888887763 2356666665 44667899
Q ss_pred EeccCCCC
Q 012761 159 YEFMPLGS 166 (457)
Q Consensus 159 ~E~~~~gs 166 (457)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0011 Score=65.38 Aligned_cols=157 Identities=16% Similarity=0.141 Sum_probs=87.8
Q ss_pred HHHHHHhcCCCc-----cceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCC--CceeeEEE
Q 012761 76 RELAAATKNFRP-----ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHS--NLVNLIGY 148 (457)
Q Consensus 76 ~~~~~~~~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~ 148 (457)
.++......|.+ .+.|+.|....+|+.... +..+++|+..... ....+..|+.++..|... .+.+++..
T Consensus 10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t 85 (307)
T TIGR00938 10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKS 85 (307)
T ss_pred HHHHHHHHhcCCCCceeccccCCccccceEEEEeC--CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccC
Confidence 444444445544 455777777889988653 3367889875421 234555677777776432 23444432
Q ss_pred ------EecCCeeeEEEeccCCCCHHH--------------hhhcCCC----CCC----CCCHHHHH------------H
Q 012761 149 ------CADGDQRLLVYEFMPLGSLED--------------HLHDLPP----DKE----ALDWNTRM------------K 188 (457)
Q Consensus 149 ------~~~~~~~~lV~E~~~~gsL~~--------------~l~~~~~----~~~----~l~~~~~~------------~ 188 (457)
....+..+++++|++|..+.. .+|.... ... .-.|.... .
T Consensus 86 ~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~ 165 (307)
T TIGR00938 86 RDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH 165 (307)
T ss_pred CCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH
Confidence 122456789999998854320 1221110 000 01111110 0
Q ss_pred HHHHHHHHHHHHHh----CCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 189 IAAGAAKGLEYLHD----KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 189 i~~qi~~~L~yLH~----~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
....+...++++.. ..+..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 166 ~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 166 MGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 11123345555543 1234599999999999999887778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0012 Score=65.42 Aligned_cols=159 Identities=16% Similarity=0.118 Sum_probs=84.1
Q ss_pred ccHHHHHHHhcCCCc-----cceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCC--Cceee
Q 012761 73 FTFRELAAATKNFRP-----ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHS--NLVNL 145 (457)
Q Consensus 73 ~~~~~~~~~~~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hp--niv~l 145 (457)
.+..++......|.+ .+.|+.|....+|+..... | .+++|++.. .....+..|+.++..|... .+.++
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~-g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~ 81 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQ-G-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAP 81 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCC-C-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcc
Confidence 344455554455644 3446677777899987543 3 688998762 1233444455555555321 13333
Q ss_pred EE------EEecCCeeeEEEeccCCCCHH-----------Hh---hhcCCC----C---CCCCCH-HHHHH---------
Q 012761 146 IG------YCADGDQRLLVYEFMPLGSLE-----------DH---LHDLPP----D---KEALDW-NTRMK--------- 188 (457)
Q Consensus 146 ~~------~~~~~~~~~lV~E~~~~gsL~-----------~~---l~~~~~----~---~~~l~~-~~~~~--------- 188 (457)
+. +....+..+++++|++|..+. .. +|.... . ...+.| .....
T Consensus 82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (319)
T PRK05231 82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE 161 (319)
T ss_pred eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence 32 122345678999999886431 11 121110 0 011112 11111
Q ss_pred ---HHHH-HHHHHHHHHhC----CCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 189 ---IAAG-AAKGLEYLHDK----ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 189 ---i~~q-i~~~L~yLH~~----~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
.+.+ +...+..+... -+..+||+|+.|.|||++.+...-|+||+.+..
T Consensus 162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1111 11122333211 233499999999999998765568999998764
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.002 Score=63.21 Aligned_cols=142 Identities=25% Similarity=0.258 Sum_probs=82.6
Q ss_pred ceeeecCcEEEEEEEECC------CCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCc-eeeEEEEecCCeeeEEEec
Q 012761 89 SFIGEGGFGRVYKGWLES------TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL-VNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~------~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~E~ 161 (457)
+.|..|-...+|+..... ++..|++|+..... ........|..++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 345666667899887643 25789999976542 222445678888888764333 345555432 368999
Q ss_pred cCCCCHHHh-----------------hhcCCCCC--C---CCC--HHHHHH--------------------------HHH
Q 012761 162 MPLGSLEDH-----------------LHDLPPDK--E---ALD--WNTRMK--------------------------IAA 191 (457)
Q Consensus 162 ~~~gsL~~~-----------------l~~~~~~~--~---~l~--~~~~~~--------------------------i~~ 191 (457)
++|..+... ||...... . ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988765421 22211110 0 111 111111 111
Q ss_pred HHHHHHHHHHh------CCCCCeeeccCCccCeEEcCC----CceEEeeccccc
Q 012761 192 GAAKGLEYLHD------KANPPVIYRDFKSSNILLEEG----FHPKLSDFGLAK 235 (457)
Q Consensus 192 qi~~~L~yLH~------~~~~~iiHrDLkp~NILl~~~----~~~kL~DFGla~ 235 (457)
.+...+.+|-. ..+..++|+|+.+.|||++++ +.+.|+||..|.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22223344432 123458999999999999874 889999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.42 E-value=4e-05 Score=86.61 Aligned_cols=160 Identities=12% Similarity=0.000 Sum_probs=118.6
Q ss_pred HHHHHHHHhcCCCCceeeEEEEec--CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q 012761 128 LVEVLMLSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA- 204 (457)
Q Consensus 128 ~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~- 204 (457)
..|...++...|+++.....-... ....+.+++|+.+|.+.+.|.........++...+.....+.+.+..-+|...
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 334445556678888776554433 34568899999999999998875555555665555555555466666666543
Q ss_pred -CCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHH
Q 012761 205 -NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELI 283 (457)
Q Consensus 205 -~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ell 283 (457)
....+|++||+-|.+|..+.++++.++|+.+.... .........+++.|+.|+....-.++.++|+|..|+.+|++.
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 24479999999999999999999999999983211 122233456788899999988888999999999999999999
Q ss_pred hCCCCC
Q 012761 284 TGRKAI 289 (457)
Q Consensus 284 tG~~p~ 289 (457)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887765
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.00026 Score=68.78 Aligned_cols=145 Identities=17% Similarity=0.121 Sum_probs=95.8
Q ss_pred ccHHHHHHHhcC---CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-----cCh-----------------HHH
Q 012761 73 FTFRELAAATKN---FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-----QGN-----------------REF 127 (457)
Q Consensus 73 ~~~~~~~~~~~~---f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-----~~~-----------------~~~ 127 (457)
+.|.-|....++ +.+.+.||-|.-+.||.+-+.. |.+.++|+-+.... ... -..
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa 157 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA 157 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence 334444444433 5677889999999999998764 88999996432111 000 123
Q ss_pred HHHHHHHHhcCC--CCceeeEEEEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 012761 128 LVEVLMLSLLHH--SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205 (457)
Q Consensus 128 ~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~ 205 (457)
.+|...|+.|.. --+.+.+++ +..++|||++.|-.|...-+- .+. ..+...+..-+--|-.+|
T Consensus 158 ~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~d~---~~ly~~lm~~Iv~la~~G- 222 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------EDP---PTLYDDLMGLIVRLANHG- 222 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec-------CCh---HHHHHHHHHHHHHHHHcC-
Confidence 567777777753 234445543 456799999988777654322 122 233344444456677778
Q ss_pred CCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 206 ~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
+||+|+.-=||+|++++.++++||--+.
T Consensus 223 --lIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 223 --LIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred --ceecccchheeEEecCCCEEEeechHhh
Confidence 9999999999999999999999996543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0036 Score=60.82 Aligned_cols=31 Identities=26% Similarity=0.408 Sum_probs=25.8
Q ss_pred CCeeeccCCccCeEEcCCCc-eEEeecccccc
Q 012761 206 PPVIYRDFKSSNILLEEGFH-PKLSDFGLAKL 236 (457)
Q Consensus 206 ~~iiHrDLkp~NILl~~~~~-~kL~DFGla~~ 236 (457)
+.++|+|++|.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999987555 46999998865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.005 Score=61.84 Aligned_cols=142 Identities=18% Similarity=0.186 Sum_probs=81.7
Q ss_pred eeeecCcEEEEEEEECC----CCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCc-eeeEEEEecCCeeeEEEeccCC
Q 012761 90 FIGEGGFGRVYKGWLES----TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL-VNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 90 ~lG~G~~g~Vy~~~~~~----~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~E~~~~ 164 (457)
.|..|-.-.+|++.... ++..|++|+...... ..-....|..++..+..-++ .++++++..+ .|.+|+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 45557777899987532 246899998765432 22223668888888865444 3455655332 57999987
Q ss_pred CCHHHh-----------------hhcCCCC--CCCCCHHHHHHHHHHH-----------------HHHHHHHH----h-C
Q 012761 165 GSLEDH-----------------LHDLPPD--KEALDWNTRMKIAAGA-----------------AKGLEYLH----D-K 203 (457)
Q Consensus 165 gsL~~~-----------------l~~~~~~--~~~l~~~~~~~i~~qi-----------------~~~L~yLH----~-~ 203 (457)
.+|... +|..... .....+....+++.++ ...+..|. . .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 665421 2222111 1122233333333221 11122222 1 1
Q ss_pred CCCCeeeccCCccCeEEcC-CCceEEeecccccc
Q 012761 204 ANPPVIYRDFKSSNILLEE-GFHPKLSDFGLAKL 236 (457)
Q Consensus 204 ~~~~iiHrDLkp~NILl~~-~~~~kL~DFGla~~ 236 (457)
....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1234899999999999976 57899999988753
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0069 Score=60.61 Aligned_cols=74 Identities=19% Similarity=0.107 Sum_probs=47.0
Q ss_pred eeeecCcEEEEEEEECCCCeEEEEEEecc------CC-CcChHHHHHHHHHHHhcC--CCCceeeEEEEecCCeeeEEEe
Q 012761 90 FIGEGGFGRVYKGWLESTGQVVAVKQLDR------NG-LQGNREFLVEVLMLSLLH--HSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 90 ~lG~G~~g~Vy~~~~~~~~~~vavK~i~~------~~-~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~lV~E 160 (457)
.||.|....||++.....+..|+||.-.. .. .-.......|...|+... .|..++-+- +.+.+...+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy-~~D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF-HFDTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE-EEccccceehHh
Confidence 48999999999999864446899997431 11 122344556777776654 354444322 335566679999
Q ss_pred ccCC
Q 012761 161 FMPL 164 (457)
Q Consensus 161 ~~~~ 164 (457)
+++.
T Consensus 81 dL~~ 84 (370)
T TIGR01767 81 DLSH 84 (370)
T ss_pred hCcc
Confidence 9854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0059 Score=59.59 Aligned_cols=74 Identities=22% Similarity=0.273 Sum_probs=48.5
Q ss_pred ccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC---CCCceeeEEEEecCCeeeEEEeccC
Q 012761 87 PESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH---HSNLVNLIGYCADGDQRLLVYEFMP 163 (457)
Q Consensus 87 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lV~E~~~ 163 (457)
-.+.|+.|....+|+.. .++..+-||+-.. .....|..|..-|+.|. --.+++++++....+..+|||||++
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 34568989999999876 4578899998762 23457888999998884 3457788888877777899999998
Q ss_pred CC
Q 012761 164 LG 165 (457)
Q Consensus 164 ~g 165 (457)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.014 Score=57.50 Aligned_cols=140 Identities=18% Similarity=0.258 Sum_probs=81.2
Q ss_pred ccceeeecCcEEEEEEEECCCCeEEEEEEecc--CCCcChHHHHHHHHHHHhcCC--CCceeeEEEEecCC--eeeEEEe
Q 012761 87 PESFIGEGGFGRVYKGWLESTGQVVAVKQLDR--NGLQGNREFLVEVLMLSLLHH--SNLVNLIGYCADGD--QRLLVYE 160 (457)
Q Consensus 87 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~--~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~--~~~lV~E 160 (457)
+.+.+..|..-.+|..... ++.++|+ ... ..........+|..+++.+.- .-+...+++|.++. ..+.||+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 3334433333345554433 7888888 332 222233455667888877653 23344566666665 6699999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHH-HHHHHH-------------------------------------------
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIA-AGAAKG------------------------------------------- 196 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~-~qi~~~------------------------------------------- 196 (457)
|+.|..+.+.+... ... ..++ ..+++.
T Consensus 106 ~veGe~~~~~~~~~-----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~ 176 (321)
T COG3173 106 WVEGEVVWSALPPE-----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR 176 (321)
T ss_pred EecceeccCcCCcc-----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence 99884333222110 000 0111 133333
Q ss_pred -------HHHHHhCC-----CCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 197 -------LEYLHDKA-----NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 197 -------L~yLH~~~-----~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
..||+... .+.++|+|+.+.||+++..+.+=|.||+++.++.
T Consensus 177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 44444332 2359999999999999988889999999998643
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.018 Score=56.57 Aligned_cols=29 Identities=24% Similarity=0.330 Sum_probs=25.2
Q ss_pred CCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 206 ~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
..++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 34899999999999987 678999998765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.025 Score=57.66 Aligned_cols=73 Identities=14% Similarity=0.110 Sum_probs=48.4
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccC----CC---cChHHHHHHHHHHHhcC---CCCceeeEEEEecCCeeeE
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN----GL---QGNREFLVEVLMLSLLH---HSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~----~~---~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~l 157 (457)
.+.||.|....||+.... +..|+||.-... +. ........|...|..+. ..++.+++.++. +..++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 456899999999998763 456889986521 10 12233344566666554 246777888776 45678
Q ss_pred EEeccCC
Q 012761 158 VYEFMPL 164 (457)
Q Consensus 158 V~E~~~~ 164 (457)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 9999976
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.013 Score=58.33 Aligned_cols=139 Identities=19% Similarity=0.172 Sum_probs=92.4
Q ss_pred CccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--C------------------h-H-----HHHHHHHHHHhcCC
Q 012761 86 RPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--G------------------N-R-----EFLVEVLMLSLLHH 139 (457)
Q Consensus 86 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~------------------~-~-----~~~~E~~~l~~l~h 139 (457)
.+..+|..|.-+.||.|... +|..+|||+++..-+. + . + -...|++-|.+|+.
T Consensus 147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 34456888999999998765 4788999998642110 0 0 1 13568888888875
Q ss_pred CCceeeEEEEecCCeeeEEEeccCCCC-HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCe
Q 012761 140 SNLVNLIGYCADGDQRLLVYEFMPLGS-LEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNI 218 (457)
Q Consensus 140 pniv~l~~~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NI 218 (457)
..|...--... ..-.|||+|+.... -.-.|. .-.|+...+..+-.+++.-|.-|.+.+. +||.||.=-|+
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~ 296 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNL 296 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhh
Confidence 54432211111 12368999984221 112232 2456666778888888888888887654 99999999999
Q ss_pred EEcCCCceEEeeccccc
Q 012761 219 LLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 219 Ll~~~~~~kL~DFGla~ 235 (457)
|+-+ |.+.|+|.+-+.
T Consensus 297 Lyhd-G~lyiIDVSQSV 312 (520)
T KOG2270|consen 297 LYHD-GKLYIIDVSQSV 312 (520)
T ss_pred eEEC-CEEEEEEccccc
Confidence 9964 689999987653
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.026 Score=56.34 Aligned_cols=142 Identities=20% Similarity=0.218 Sum_probs=79.1
Q ss_pred eeeecCcEEEEEEEECCC---CeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCc-eeeEEEEecCCeeeEEEeccCCC
Q 012761 90 FIGEGGFGRVYKGWLEST---GQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL-VNLIGYCADGDQRLLVYEFMPLG 165 (457)
Q Consensus 90 ~lG~G~~g~Vy~~~~~~~---~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~E~~~~g 165 (457)
.|..|=...+|+...... +..|++|+...... ..-...+|..+++.+..-++ .++++++..+ +|.+|+++-
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence 344466667888865432 23788998765422 12233568888888875555 3556555322 589999776
Q ss_pred CHHH-----------------hhhcCCCC--CCCCCHHHHHHHHHHH----------------------HHHHHHHH---
Q 012761 166 SLED-----------------HLHDLPPD--KEALDWNTRMKIAAGA----------------------AKGLEYLH--- 201 (457)
Q Consensus 166 sL~~-----------------~l~~~~~~--~~~l~~~~~~~i~~qi----------------------~~~L~yLH--- 201 (457)
+|.. .+|..... ..+-.|....++..++ ..-+..+.
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 5521 12222111 1111233332222221 11122221
Q ss_pred -hCC-CCCeeeccCCccCeEEcC-CCceEEeecccccc
Q 012761 202 -DKA-NPPVIYRDFKSSNILLEE-GFHPKLSDFGLAKL 236 (457)
Q Consensus 202 -~~~-~~~iiHrDLkp~NILl~~-~~~~kL~DFGla~~ 236 (457)
..+ +..++|.||.+.|||+++ ++.++|+||..|..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111 223789999999999974 57899999988753
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.0094 Score=55.29 Aligned_cols=30 Identities=30% Similarity=0.350 Sum_probs=21.2
Q ss_pred CeeeccCCccCeEE-cCCCceEEeecccccc
Q 012761 207 PVIYRDFKSSNILL-EEGFHPKLSDFGLAKL 236 (457)
Q Consensus 207 ~iiHrDLkp~NILl-~~~~~~kL~DFGla~~ 236 (457)
.++|+||.+.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 38899999999999 8899999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.02 Score=57.99 Aligned_cols=75 Identities=24% Similarity=0.234 Sum_probs=49.0
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEecc-----CC-CcChHHHHHHHHHHHhcC--CCCcee-eEEEEecCCeeeEE
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDR-----NG-LQGNREFLVEVLMLSLLH--HSNLVN-LIGYCADGDQRLLV 158 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~-----~~-~~~~~~~~~E~~~l~~l~--hpniv~-l~~~~~~~~~~~lV 158 (457)
.+.||.|.-.-||++.+...+..|+||.-.. .. .-..+....|...|+.+. .|..|+ ++. .+.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 4568999999999998854356799997431 11 122345666777777664 454444 443 355667789
Q ss_pred EeccCC
Q 012761 159 YEFMPL 164 (457)
Q Consensus 159 ~E~~~~ 164 (457)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.036 Score=54.64 Aligned_cols=30 Identities=17% Similarity=0.187 Sum_probs=27.5
Q ss_pred CeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 207 ~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
.++|+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.038 Score=55.01 Aligned_cols=140 Identities=21% Similarity=0.323 Sum_probs=82.4
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC---CCcee---eEE----EEecCCeeeEEEe
Q 012761 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH---SNLVN---LIG----YCADGDQRLLVYE 160 (457)
Q Consensus 91 lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h---pniv~---l~~----~~~~~~~~~lV~E 160 (457)
|.+ .-..+|+....+ |. +++|+.... ....++..|+..+..|.- +-.++ +-| ........+-|++
T Consensus 34 l~s-~eN~~f~~~~~~-g~-~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 34 LNS-EENSNFRVQTED-GR-YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccc-ccCceEEEEecC-CC-eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 444 456789887754 44 489988765 445667777777777742 21122 111 1122236778899
Q ss_pred ccCCCCHHH-h--------------hh----cCC----CCCCCCCHHH-------------HHHHHHHHHHHHHHHHhCC
Q 012761 161 FMPLGSLED-H--------------LH----DLP----PDKEALDWNT-------------RMKIAAGAAKGLEYLHDKA 204 (457)
Q Consensus 161 ~~~~gsL~~-~--------------l~----~~~----~~~~~l~~~~-------------~~~i~~qi~~~L~yLH~~~ 204 (457)
|++|..+.. . || ..+ .....+.|.. ......++...+..+.+.-
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999877762 1 11 111 1112333431 1113344555555555432
Q ss_pred ----CCC---eeeccCCccCeEEcCCCc-eEEeeccccc
Q 012761 205 ----NPP---VIYRDFKSSNILLEEGFH-PKLSDFGLAK 235 (457)
Q Consensus 205 ----~~~---iiHrDLkp~NILl~~~~~-~kL~DFGla~ 235 (457)
+.. +||+|+.|.|||++.+.. +-+.||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 122 899999999999998875 8899999875
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.18 Score=50.18 Aligned_cols=72 Identities=18% Similarity=0.109 Sum_probs=43.3
Q ss_pred ecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCC--CceeeE---E--EEecCCeeeEEEeccCCC
Q 012761 93 EGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHS--NLVNLI---G--YCADGDQRLLVYEFMPLG 165 (457)
Q Consensus 93 ~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~---~--~~~~~~~~~lV~E~~~~g 165 (457)
.+....||+.... ++..+++|+.+... .....+..|+..+..|... .++... | +...++..+.|+++++|.
T Consensus 35 ~s~eN~vy~v~~~-~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~ 112 (325)
T PRK11768 35 NSYENRVYQFGDE-DGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR 112 (325)
T ss_pred ccccceEEEEecC-CCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence 3455679988764 36679999876432 3455677788777766421 122211 1 122345678899999876
Q ss_pred C
Q 012761 166 S 166 (457)
Q Consensus 166 s 166 (457)
.
T Consensus 113 ~ 113 (325)
T PRK11768 113 A 113 (325)
T ss_pred C
Confidence 4
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.032 Score=51.79 Aligned_cols=138 Identities=17% Similarity=0.117 Sum_probs=83.2
Q ss_pred EEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHH
Q 012761 110 VVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 188 (457)
Q Consensus 110 ~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~ 188 (457)
+..+|++..-... ...-|..+..++.+++ .|+++..- +...+-++.|+|-... -. ..-.
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-------------i~---~~N~ 146 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-------------IN---FSNF 146 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------------cc---hhHH
Confidence 3445555544333 3455677888888775 46777622 3445678899883211 01 1112
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCc
Q 012761 189 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTV 268 (457)
Q Consensus 189 i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 268 (457)
|..+ +..|.-.|+.. ...+|+|..|+||+-|..|.+||.|=+..-. .+-.|.--|+ ...++
T Consensus 147 i~ag-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~Y---~~lT~ 207 (308)
T PF07387_consen 147 ITAG-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIEY---ESLTQ 207 (308)
T ss_pred HHHh-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeeec---cccCh
Confidence 2222 46788889543 2389999999999999999999999764321 0111222111 24567
Q ss_pred cchHHHHHHHHHHHHhCC
Q 012761 269 KSDVYSFGVVFLELITGR 286 (457)
Q Consensus 269 ksDvwSlGvil~elltG~ 286 (457)
++.+-+|=.-++++....
T Consensus 208 ~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 208 EAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred HHHHHHHHHHHHHHHHHH
Confidence 777777766666666544
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.05 Score=54.12 Aligned_cols=73 Identities=21% Similarity=0.179 Sum_probs=56.5
Q ss_pred CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeec
Q 012761 152 GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDF 231 (457)
Q Consensus 152 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DF 231 (457)
..+.|++|++- |+.|.- + ....+.+...|+.+.+..+.-|...- +.-|||+...||||+ +|+|.|+||
T Consensus 298 ~~y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred ceEEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEe
Confidence 34556777764 444432 2 23467889999999888888777654 489999999999999 999999999
Q ss_pred ccccc
Q 012761 232 GLAKL 236 (457)
Q Consensus 232 Gla~~ 236 (457)
-+++.
T Consensus 366 klsRl 370 (488)
T COG5072 366 KLSRL 370 (488)
T ss_pred eeeec
Confidence 99985
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.16 Score=58.35 Aligned_cols=31 Identities=35% Similarity=0.353 Sum_probs=26.1
Q ss_pred CCeeeccCCccCeEEcCCC--ceE-Eeecccccc
Q 012761 206 PPVIYRDFKSSNILLEEGF--HPK-LSDFGLAKL 236 (457)
Q Consensus 206 ~~iiHrDLkp~NILl~~~~--~~k-L~DFGla~~ 236 (457)
..+||+|+++.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3499999999999998775 555 999998865
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.14 Score=53.22 Aligned_cols=75 Identities=11% Similarity=0.049 Sum_probs=45.4
Q ss_pred cceeeecCcEEEEEEEECCC--------CeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCce-eeEEEEecCCeeeEE
Q 012761 88 ESFIGEGGFGRVYKGWLEST--------GQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV-NLIGYCADGDQRLLV 158 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~--------~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~lV 158 (457)
.+.|..|-.-.+|++..... ++.|++++.......- -....|..++..+..-+|- ++++.+. -+.|
T Consensus 110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l-IdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL-YNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce-eCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 44566676777888875421 4678898876532211 1334577777777654453 4555543 2467
Q ss_pred EeccCCCCH
Q 012761 159 YEFMPLGSL 167 (457)
Q Consensus 159 ~E~~~~gsL 167 (457)
.||++|-+|
T Consensus 185 ~efi~g~~l 193 (442)
T PTZ00296 185 EEWLYGDPL 193 (442)
T ss_pred EEeeCCccC
Confidence 899987644
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.18 Score=49.10 Aligned_cols=30 Identities=33% Similarity=0.361 Sum_probs=25.1
Q ss_pred CeeeccCCccCeEEcCC--C---ceEEeecccccc
Q 012761 207 PVIYRDFKSSNILLEEG--F---HPKLSDFGLAKL 236 (457)
Q Consensus 207 ~iiHrDLkp~NILl~~~--~---~~kL~DFGla~~ 236 (457)
.++|||++..|||+..+ | .+++.||-+++.
T Consensus 216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred EEEcCccCHHhEeEccccccccccceeeccccccC
Confidence 49999999999999644 3 689999988764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.19 Score=51.19 Aligned_cols=76 Identities=17% Similarity=0.177 Sum_probs=44.9
Q ss_pred cceeeecCcEEEEEEEECCCC-e-----EEEEEEeccCCCcChHHHHHHHHHHHhcCCCCc-eeeEEEEecCCeeeEEEe
Q 012761 88 ESFIGEGGFGRVYKGWLESTG-Q-----VVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL-VNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~-~-----~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~E 160 (457)
.+.|..|-...+|++...... . .|.++.... .....-.-.+|+.+++.|...++ .++++.+.. ++|+|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 344656778889998754321 2 244443321 11111223568889999876555 445555543 58999
Q ss_pred ccCCCCHH
Q 012761 161 FMPLGSLE 168 (457)
Q Consensus 161 ~~~~gsL~ 168 (457)
|++|-+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99987654
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.021 Score=58.98 Aligned_cols=48 Identities=27% Similarity=0.375 Sum_probs=39.2
Q ss_pred HHHHHHHHHHHhcCCCCceeeEEEEecC-CeeeEEEeccCCCCHHHhhhc
Q 012761 125 REFLVEVLMLSLLHHSNLVNLIGYCADG-DQRLLVYEFMPLGSLEDHLHD 173 (457)
Q Consensus 125 ~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~ 173 (457)
..+.-...+++.+.|+|+..++++.... ....+|+|++ +.+|++.+..
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 4567788899999999999999987654 4467889998 6799998865
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 457 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-53 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-52 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-46 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-45 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-42 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-42 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-42 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-39 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 8e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 539 bits (1392), Expect = 0.0
Identities = 114/313 (36%), Positives = 167/313 (53%), Gaps = 20/313 (6%)
Query: 61 KDGAGVNIAAQTFTFRELAAATKNFRPE------SFIGEGGFGRVYKGWLESTGQVVAVK 114
K + +F+F EL T NF + +GEGGFG VYKG++ VAVK
Sbjct: 3 KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVK 60
Query: 115 QL----DRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDH 170
+L D + ++F E+ +++ H NLV L+G+ +DGD LVY +MP GSL D
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 171 LHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSD 230
L L W+ R KIA GAA G+ +LH+ I+RD KS+NILL+E F K+SD
Sbjct: 121 LSC-LDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISD 176
Query: 231 FGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 290
FGLA+ ++ +++R++GT Y APE + G++T KSD+YSFGVV LE+ITG A+D
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 291 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP 350
R Q L+ + ++ + D ++ + +VAS C+ E+ RP
Sbjct: 236 EHRE--PQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 351 LIGDVVTALSYLA 363
I V L +
Sbjct: 293 DIKKVQQLLQEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 539 bits (1390), Expect = 0.0
Identities = 118/315 (37%), Positives = 171/315 (54%), Gaps = 5/315 (1%)
Query: 47 SRSNGVSKRELHLPKDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLES 106
S+ + + V + +L AT NF + IG G FG+VYKG L
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 107 TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGS 166
G VA+K+ QG EF E+ LS H +LV+LIG+C + ++ +L+Y++M G+
Sbjct: 63 -GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 167 LEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP 226
L+ HL+ ++ W R++I GAA+GL YLH +I+RD KS NILL+E F P
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVP 178
Query: 227 KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
K++DFG++K G D++H+ST V GT GY PEY + G+LT KSDVYSFGVV E++ R
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 287 KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQA 346
AI + P NL WA + + ++ DP L + L + A C+ +
Sbjct: 239 SAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSS 297
Query: 347 ATRPLIGDVVTALSY 361
RP +GDV+ L Y
Sbjct: 298 EDRPSMGDVLWKLEY 312
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 514 bits (1326), Expect = 0.0
Identities = 124/293 (42%), Positives = 176/293 (60%), Gaps = 6/293 (2%)
Query: 70 AQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN-REFL 128
+ F+ REL A+ NF ++ +G GGFG+VYKG L G +VAVK+L QG +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGELQFQ 75
Query: 129 VEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 188
EV M+S+ H NL+ L G+C +RLLVY +M GS+ L + P + LDW R +
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 189 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 248
IA G+A+GL YLHD +P +I+RD K++NILL+E F + DFGLAKL D +HV+T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTA 194
Query: 249 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ--NLVTWARP 306
V GT G+ APEY TG+ + K+DV+ +GV+ LELITG++A D R + L+ W +
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 307 LFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359
L +++ L D L+G Y + Q + VA +C Q RP + +VV L
Sbjct: 255 LLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 3e-91
Identities = 78/315 (24%), Positives = 110/315 (34%), Gaps = 29/315 (9%)
Query: 73 FTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVL 132
L + + G FG V+K L + VAVK Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQS-WQNEYEVY 70
Query: 133 MLSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 188
L + H N++ IG G L+ F GSL D L + WN
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCH 125
Query: 189 IAAGAAKGLEYLH-------DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241
IA A+GL YLH D P + +RD KS N+LL+ ++DFGLA G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 242 KSHVSTRVMGTYGYCAPEYAMTG-----QLTVKSDVYSFGVVFLELITGRKAIDSTRPHG 296
+ + +GT Y APE ++ D+Y+ G+V EL + A D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 297 EQNL--VTWARPLFNDRRKF--SKLADPRLEGRYPIRGLYQALA-VASMCIQEQAATRPL 351
P D ++ K P L + L C A R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 352 IGDVVTALSYLANQT 366
G V ++ + T
Sbjct: 306 AGCVGERITQMQRLT 320
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 6e-68
Identities = 71/328 (21%), Positives = 119/328 (36%), Gaps = 44/328 (13%)
Query: 73 FTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFL--VE 130
E + N + IG G +G VYKG L+ + VAVK + F+
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSF---ANRQNFINEKN 57
Query: 131 VLMLSLLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNT 185
+ + L+ H N+ I + LLV E+ P GSL +L DW +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVS 112
Query: 186 RMKIAAGAAKGLEYLH------DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK---- 235
++A +GL YLH D P + +RD S N+L++ +SDFGL+
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 236 --LGPVGDKSHVSTRVMGTYGYCAPEYAM-------TGQLTVKSDVYSFGVVFLELITGR 286
L G++ + + +GT Y APE + D+Y+ G+++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 287 KAIDSTRPHGEQNL----VTWARPLFNDRRKF--SKLADPRLEGRYPIRGLYQALAVASM 340
+ E + P F D + + P+ + L ++
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 341 --CIQEQAATRPLIGDVVTALSYLANQT 366
C + A R ++ L
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIW 320
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 4e-65
Identities = 67/212 (31%), Positives = 110/212 (51%), Gaps = 27/212 (12%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN-------REFLVEVLMLSLLHHSNLV 143
IG+GGFG V+KG L VVA+K L +G +EF EV ++S L+H N+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
L G + +V EF+P G L L D + W+ ++++ A G+EY+ ++
Sbjct: 87 KLYGLMH--NPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 204 ANPPVIYRDFKSSNILLEEG-----FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAP 258
NPP+++RD +S NI L+ K++DFGL++ H + ++G + + AP
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 259 EYAMTGQL---TVKSDVYSFGVVFLELITGRK 287
E + + T K+D YSF ++ ++TG
Sbjct: 196 E-TIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 4e-65
Identities = 74/199 (37%), Positives = 104/199 (52%), Gaps = 10/199 (5%)
Query: 91 IGEGGFGRVYKG-WLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIG 147
IG G FG V++ W G VAVK L EFL EV ++ L H N+V +G
Sbjct: 45 IGAGSFGTVHRAEW---HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 207
+V E++ GSL LH +E LD R+ +A AKG+ YLH++ NPP
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPP 159
Query: 208 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLT 267
+++R+ KS N+L+++ + K+ DFGL++L S S GT + APE
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSN 217
Query: 268 VKSDVYSFGVVFLELITGR 286
KSDVYSFGV+ EL T +
Sbjct: 218 EKSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 4e-62
Identities = 64/198 (32%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G G FG V K + VA+KQ++ + + F+VE+ LS ++H N+V L G C
Sbjct: 16 VGRGAFGVVCKAKW--RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210
+ LV E+ GSL + LH P M ++G+ YLH +I+
Sbjct: 72 N--PVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 211 RDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVK 269
RD K N+LL G K+ DFG A D T G+ + APE + K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 270 SDVYSFGVVFLELITGRK 287
DV+S+G++ E+IT RK
Sbjct: 184 CDVFSWGIILWEVITRRK 201
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 3e-61
Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 23/205 (11%)
Query: 91 IGEGGFGRVYKG-WLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIG 147
+ E G ++KG W G + VK L R+F E L + H N++ ++G
Sbjct: 18 LNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 148 YCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
C + +MP GSL + LH+ +D + +K A A+G+ +LH
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLHTL-E 131
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 265
P + S +++++E ++S + S S M + APE A+ +
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRMYAPAWVAPE-ALQKK 183
Query: 266 ----LTVKSDVYSFGVVFLELITGR 286
+D++SF V+ EL+T
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-60
Identities = 69/209 (33%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 91 IGEGGFGRVYKG-WLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSLLHHSNLVNL 145
IG GGFG+VY+ W+ G VAVK D + Q E + ++L H N++ L
Sbjct: 15 IGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
G C LV EF G L L + + + + A A+G+ YLHD+A
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 206 PPVIYRDFKSSNILLEEGFHP--------KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCA 257
P+I+RD KSSNIL+ + K++DFGLA+ ++ + G Y + A
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAA-GAYAWMA 182
Query: 258 PEYAMTGQLTVKSDVYSFGVVFLELITGR 286
PE + SDV+S+GV+ EL+TG
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-58
Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G+G FG+ K TG+V+ +K+L R + R FL EV ++ L H N++ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210
+ + E++ G+L + W+ R+ A A G+ YLH +I+
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIH 131
Query: 211 RDFKSSNILLEEGFHPKLSDFGLAKL------------GPVGDKSHVSTRVMGTYGYCAP 258
RD S N L+ E + ++DFGLA+L V+G + AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 259 EYAMTGQLTVKSDVYSFGVVFLELITGRKA 288
E K DV+SFG+V E+I A
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 3e-57
Identities = 69/201 (34%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIGY 148
IG G FG VYKG VAVK L+ + F EV +L H N++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 149 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 208
Q +V ++ SL HLH + + + IA A+G++YLH K +
Sbjct: 89 STA-PQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 209 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE---YAMTGQ 265
I+RD KS+NI L E K+ DFGLA SH ++ G+ + APE +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 266 LTVKSDVYSFGVVFLELITGR 286
+ +SDVY+FG+V EL+TG+
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-57
Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 24/210 (11%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIGY 148
IG+G FG+VY G VA++ +D + + F EV+ H N+V +G
Sbjct: 41 IGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 149 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 208
C ++ +L + D K LD N +IA KG+ YLH +
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 209 IYRDFKSSNILLEEGFHPKLSDFGLAKL---GPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 265
+++D KS N+ + G ++DFGL + G + G + APE
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 266 L---------TVKSDVYSFGVVFLELITGR 286
+ SDV++ G ++ EL
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 5e-56
Identities = 68/302 (22%), Positives = 117/302 (38%), Gaps = 39/302 (12%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFL--VEVLMLSLLHHSNLVNLIGY 148
IG+G +G V+ G G+ VAVK + E+ L+ H N++ I
Sbjct: 45 IGKGRYGEVWMGKWR--GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 149 CADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH--- 201
G Q L+ ++ GSL D+L LD + +K+A + GL +LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 202 --DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH--VSTRVMGTYGYCA 257
+ P + +RD KS NIL+++ ++D GLA +GT Y
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 258 PE------YAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR----PHGEQNLVTWARPL 307
PE Q + +D+YSFG++ E+ + P+ + + + P
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD---LVPSDPS 271
Query: 308 FNDRRKF--SKLADPRLEGRYPIRGLYQALA-VASMCIQEQAATRPLIGDVVTALSYLAN 364
+ D R+ K P R+ + + + + C A+R V L+ ++
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
Query: 365 QT 366
Sbjct: 332 SQ 333
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 7e-55
Identities = 53/224 (23%), Positives = 94/224 (41%), Gaps = 29/224 (12%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFL--VEVLMLSLLHHSNLVNLIGY 148
+G+G +G V++G + G+ VAVK + + + E+ +L H N++ I
Sbjct: 16 VGKGRYGEVWRGSWQ--GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 149 CADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH--- 201
Q L+ + +GSL D+L LD + ++I A GL +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 202 --DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV--STRVMGTYGYCA 257
+ P + +RD KS NIL+++ ++D GLA + + +GT Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 258 PE------YAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPH 295
PE + D+++FG+V E+ + +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-53
Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 31/225 (13%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFL--VEVLMLSLLHHSNLVNLIGY 148
IG+G FG V++G G+ VAVK + R + E+ +L H N++ I
Sbjct: 50 IGKGRFGEVWRGKWR--GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 149 CADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH--- 201
+ Q LV ++ GSL D+L+ + + +K+A A GL +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 202 --DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG--DKSHVSTRVMGTYGYCA 257
+ P + +RD KS NIL+++ ++D GLA +GT Y A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 258 PEYAMTGQLTV-------KSDVYSFGVVFLELITGRKAIDSTRPH 295
PE + + + ++D+Y+ G+VF E+ +
Sbjct: 220 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-41
Identities = 73/202 (36%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 91 IGEGGFGRVYKG----WLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLI 146
+G+G FG V ++TG+VVAVK+L + + R+F E+ +L L H N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 147 GYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
G C +R L+ E++P GSL D+L KE +D ++ + KG+EYL K
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY--GYCAPEYAM 262
I+RD + NIL+E K+ DFGL K+ P DK + G + APE
Sbjct: 135 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWYAPESLT 190
Query: 263 TGQLTVKSDVYSFGVVFLELIT 284
+ +V SDV+SFGVV EL T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-41
Identities = 73/202 (36%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 91 IGEGGFGRVYKG----WLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLI 146
+G+G FG V ++TG+VVAVK+L + + R+F E+ +L L H N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 147 GYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
G C +R L+ E++P GSL D+L KE +D ++ + KG+EYL K
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR 165
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY--GYCAPEYAM 262
I+RD + NIL+E K+ DFGL K+ P DK + + G + APE
Sbjct: 166 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWYAPESLT 221
Query: 263 TGQLTVKSDVYSFGVVFLELIT 284
+ +V SDV+SFGVV EL T
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-41
Identities = 69/205 (33%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 91 IGEGGFGRVYKGWL----ESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLI 146
+G+G FG V ++TG +VAVKQL +G R+F E+ +L LH +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 147 GYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
G ++ LV E++P G L D L + LD + + ++ KG+EYL +
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG-----YCAPE 259
++RD + NIL+E H K++DFGLAKL P+ +V G + APE
Sbjct: 148 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQSPIFWYAPE 200
Query: 260 YAMTGQLTVKSDVYSFGVVFLELIT 284
+ +SDV+SFGVV EL T
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-41
Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 7/195 (3%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC 149
IG G FG V+ G L + +VAVK + +FL E +L H N+V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
+V E + G L + L T +++ AA G+EYL K I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVK 269
+RD + N L+ E K+SDFG+++ G + + APE G+ + +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 270 SDVYSFGVVFLELIT 284
SDV+SFG++ E +
Sbjct: 296 SDVWSFGILLWETFS 310
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-40
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 16/203 (7%)
Query: 91 IGEGGFGRVYKGWL----ESTGQVVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVNL 145
+GEG FG+V ++TG+ VAVK L +G + E+ +L L+H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 146 IGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
G C + L+ EF+P GSL+++L +K ++ ++K A KG++YL +
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY--GYCAPEYA 261
++RD + N+L+E K+ DFGL K DK + + + + APE
Sbjct: 146 Q---YVHRDLAARNVLVESEHQVKIGDFGLTKAIET-DKEYYTVKDDRDSPVFWYAPECL 201
Query: 262 MTGQLTVKSDVYSFGVVFLELIT 284
M + + SDV+SFGV EL+T
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLT 224
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 9e-40
Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 91 IGEGGFGRVYKGWLESTGQ----VVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVNL 145
+G G FG VYKG G+ VA+K+L + + N+E L E +++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
+G C L+ + MP G L D++ + K+ + + AKG+ YL D+
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 265
+++RD + N+L++ H K++DFGLAKL +K + + + A E +
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 266 LTVKSDVYSFGVVFLELIT-GRK 287
T +SDV+S+GV EL+T G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-39
Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 24/206 (11%)
Query: 91 IGEGGFGRVYKGWL----ESTGQVVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVNL 145
+GEG FG+V + TG++VAVK L G Q + E+ +L L+H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 146 IGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
G C D LV E++PLGSL D+L + ++ + A +G+ YLH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG-----YCAP 258
I+RD + N+LL+ K+ DFGLAK P G + + + G + AP
Sbjct: 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYAP 206
Query: 259 EYAMTGQLTVKSDVYSFGVVFLELIT 284
E + SDV+SFGV EL+T
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 61/204 (29%), Positives = 89/204 (43%), Gaps = 19/204 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIGY 148
IG G F VYKG T VA +L L + + F E ML L H N+V
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 149 CAD---GDQRLLVY-EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
G + +++ E M G+L+ +L + KGL++LH +
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR- 148
Query: 205 NPPVIYRDFKSSNILL--EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM 262
PP+I+RD K NI + G K+ D GLA L ++ + V+GT + APE
Sbjct: 149 TPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLK----RASFAKAVIGTPEFMAPEM-Y 202
Query: 263 TGQLTVKSDVYSFGVVFLELITGR 286
+ DVY+FG+ LE+ T
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSE 226
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 7/194 (3%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G G +G VY+G + VAVK L + EFL E ++ + H NLV L+G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210
++ EFM G+L D+L + +++ + + +A + +EYL K I+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 341
Query: 211 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKS 270
R+ + N L+ E K++DFGL++L GD + APE + ++KS
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 271 DVYSFGVVFLELIT 284
DV++FGV+ E+ T
Sbjct: 401 DVWAFGVLLWEIAT 414
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 63/203 (31%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 91 IGEGGFGRVYKGWLESTGQ----VVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVNL 145
+G G FG V+KG G+ V +K + D++G Q + +L + L H+++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
+G C G LV +++PLGSL DH+ + AL + AKG+ YL +
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG- 135
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 265
+++R+ + N+LL+ +++DFG+A L P DK + + + A E G+
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 266 LTVKSDVYSFGVVFLELIT-GRK 287
T +SDV+S+GV EL+T G +
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAE 216
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 55/232 (23%), Positives = 90/232 (38%), Gaps = 23/232 (9%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 142
K++ +GEGGF V G A+K++ + Q E E M L +H N+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 143 VNLIGYCADGDQR----LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 198
+ L+ YC L+ F G+L + + L L + + + G +GLE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 199 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM-------G 251
+H +RD K +NILL + P L D G + + +
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 252 TYGYCAPE------YAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE 297
T Y APE + + + ++DV+S G V ++ G D G+
Sbjct: 206 TISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-37
Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 91 IGEGGFGRVYKGWLESTGQ----VVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVNL 145
+G G FG VYKG G+ VA+K+L + + N+E L E +++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
+G C L+ + MP G L D++ + K+ + + AKG+ YL D+
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 265
+++RD + N+L++ H K++DFGLAKL +K + + + A E +
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 266 LTVKSDVYSFGVVFLELIT-GRK 287
T +SDV+S+GV EL+T G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 65/207 (31%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 91 IGEGGFGRVYKG-WLESTGQV--VAVKQL---DRNGLQGNREFLVEVLMLSLLHHSNLVN 144
+G+G FG V +G W +G+ VAVK L + + +F+ EV + L H NL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
L G +V E PLGSL D L + T + A A+G+ YL K
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---YGYCAPEYA 261
I+RD + N+LL K+ DFGL + P D +V + +CAPE
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESL 196
Query: 262 MTGQLTVKSDVYSFGVVFLELIT-GRK 287
T + SD + FGV E+ T G++
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-37
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 31/206 (15%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G G +G VY+G + VAVK L + EFL E ++ + H NLV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210
++ EFM G+L D+L + +++ + + +A + +EYL K I+
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 134
Query: 211 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY------------CAP 258
RD + N L+ E K++DFGL+ R+M Y AP
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLS-------------RLMTGDTYTAHAGAKFPIKWTAP 181
Query: 259 EYAMTGQLTVKSDVYSFGVVFLELIT 284
E + ++KSDV++FGV+ E+ T
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-37
Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
IG G FG V+ G+ + +V A+K + R G +F+ E ++ L H LV L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKV-AIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210
+ LV EFM G L D+L + T + + +G+ YL + VI+
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 211 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---YGYCAPEYAMTGQLT 267
RD + N L+ E K+SDFG+ + V D + T GT + +PE + +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRF--VLDDQY--TSSTGTKFPVKWASPEVFSFSRYS 183
Query: 268 VKSDVYSFGVVFLELIT-GRK 287
KSDV+SFGV+ E+ + G+
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKI 204
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 16/205 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQ---VVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLI 146
IG G G V G L GQ VA+K L + R +FL E ++ H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
G G ++V E+M GSL+ L + + G G+ YL D
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG-- 171
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---YGYCAPEYAMT 263
++RD + N+L++ K+SDFGL+++ + D + G + APE
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 264 GQLTVKSDVYSFGVVFLELIT-GRK 287
+ SDV+SFGVV E++ G +
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGER 253
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-36
Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 91 IGEGGFGRVYKGWLESTGQV-------VAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 143
+G+G F +++KG G V +K LD+ + F M+S L H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
G C GD+ +LV EF+ GSL+ +L +K ++ ++++A A + +L +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 204 ANPPVIYRDFKSSNILLEEGFHP--------KLSDFGLAKLGPVGDKSHVSTRVMGTYGY 255
+I+ + + NILL KLSD G++ V K + R+
Sbjct: 133 T---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDILQERIPWV--- 184
Query: 256 CAPEYAMTGQL-TVKSDVYSFGVVFLELIT-GRK 287
PE + + +D +SFG E+ + G K
Sbjct: 185 -PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 63/194 (32%), Positives = 97/194 (50%), Gaps = 9/194 (4%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G+G FG V+ G T +V A+K L + G FL E ++ L H LV L
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 248
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210
+ +V E+M GSL D L + L + +AA A G+ Y+ ++
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 303
Query: 211 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKS 270
RD +++NIL+ E K++DFGLA+L ++ + APE A+ G+ T+KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 271 DVYSFGVVFLELIT 284
DV+SFG++ EL T
Sbjct: 363 DVWSFGILLTELTT 376
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-36
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 88 ESFIGEGGFGRVYKG-WLESTGQV-VAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLV 143
+ +G G FG V +G + Q+ VA+K L + G + E + E ++ L + +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
LIG C + +LV E G L L +E + + ++ + G++YL +K
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY--GYCAPEYA 261
++RD + N+LL + K+SDFGL+K D S+ + R G + + APE
Sbjct: 130 N---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECI 185
Query: 262 MTGQLTVKSDVYSFGVVFLELIT-GRK 287
+ + +SDV+S+GV E ++ G+K
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 23/199 (11%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
IG+G FG V G G VAVK + + + FL E +++ L HSNLV L+G
Sbjct: 201 IGKGEFGDVMLGDYR--GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 151 DGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
+ L +V E+M GSL D+L + L + +K + + +EYL +
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 311
Query: 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV----MGTYGYCAPEYAMTGQ 265
+RD + N+L+ E K+SDFGL K + + ++ APE +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKK 362
Query: 266 LTVKSDVYSFGVVFLELIT 284
+ KSDV+SFG++ E+ +
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-36
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 91 IGEGGFGRVYKG-WLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC 149
+G G FG V G W VAVK + + G EF E + L H LV G C
Sbjct: 16 LGSGQFGVVKLGKWKGQY--DVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
+ +V E++ G L ++L + L+ + +++ +G+ +L I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FI 126
Query: 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---YGYCAPEYAMTGQL 266
+RD + N L++ K+SDFG+ + V D + +GT + APE +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQY--VSSVGTKFPVKWSAPEVFHYFKY 182
Query: 267 TVKSDVYSFGVVFLELIT-GRK 287
+ KSDV++FG++ E+ + G+
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKM 204
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-36
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 83 KNFRPESFIGEGGFGRVYKG-WLESTGQV---VAVKQLDRNGL--QGNREFLVEVLMLSL 136
+ IG G FG VYKG S+G+ VA+K L + G + +FL E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQ 102
Query: 137 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 196
H N++ L G + +++ E+M G+L+ L + + + G A G
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAG 159
Query: 197 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---Y 253
++YL + ++RD + NIL+ K+SDFGL+++ + D + G
Sbjct: 160 MKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPI 214
Query: 254 GYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRK 287
+ APE + T SDV+SFG+V E++T G +
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-36
Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQV--VAVKQL--DRNGLQGNREFLVEVLMLSLLHHSNLVNLI 146
+G G FG V KG+ + V VAVK L + N E L E ++ L + +V +I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
G C + + +LV E LG L +L + +++ + G++YL +
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN-- 137
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY--GYCAPEYAMTG 264
++RD + N+LL + K+SDFGL+K D+++ + G + + APE
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPVKWYAPECINYY 195
Query: 265 QLTVKSDVYSFGVVFLELIT-GRK 287
+ + KSDV+SFGV+ E + G+K
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 61/272 (22%), Positives = 100/272 (36%), Gaps = 22/272 (8%)
Query: 32 SNNISRLPSGRDRLRSRSNGVSKRELHLPKDGAGVNIAAQTFTFRELAAATKNFRPESFI 91
S L S S S + + + + E + +
Sbjct: 7 SGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRV 66
Query: 92 GEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD 151
G G FG V++ + TG AVK++ + E++ + L +V L G +
Sbjct: 67 GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVRE 121
Query: 152 GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 211
G + E + GSL + + E + A +GLEYLH + +++
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDR----ALYYLGQALEGLEYLHTRR---ILHG 174
Query: 212 DFKSSNILL-EEGFHPKLSDFGLAK-LGPVGDKSHVSTR--VMGTYGYCAPEYAMTGQLT 267
D K+ N+LL +G L DFG A L P G + T + GT + APE M
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 268 VKSDVYSFGVVFLELITGRKAIDSTRPHGEQN 299
K D++S + L ++ G P +
Sbjct: 235 AKVDIWSSCCMMLHMLNGC------HPWTQYF 260
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-35
Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 91 IGEGGFGRVYKGWLESTG-----QVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVN 144
+G+G FG VY+G + VA+K ++ R EFL E ++ + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHL------HDLPPDKEALDWNTRMKIAAGAAKGLE 198
L+G + G L++ E M G L+ +L P + +++A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 199 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--KSHVSTRV----MGT 252
YL+ ++RD + N ++ E F K+ DFG+ + D + + M
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207
Query: 253 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+PE G T SDV+SFGVV E+ T
Sbjct: 208 ----SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQ---VVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLI 146
+G G FG V G L+ + VA+K L + R +FL E ++ H N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
G ++V E+M GSL+ L + + G A G++YL D
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG-- 167
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---YGYCAPEYAMT 263
++RD + NIL+ K+SDFGL ++ + D + G + +PE
Sbjct: 168 -YVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 264 GQLTVKSDVYSFGVVFLELIT-GRK 287
+ T SDV+S+G+V E+++ G +
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGER 249
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-35
Identities = 63/194 (32%), Positives = 97/194 (50%), Gaps = 9/194 (4%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G+G FG V+ G T +V A+K L + G FL E ++ L H LV L
Sbjct: 275 LGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 331
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210
+ +V E+M GSL D L + L + +AA A G+ Y+ ++
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 386
Query: 211 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKS 270
RD +++NIL+ E K++DFGLA+L ++ + APE A+ G+ T+KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 271 DVYSFGVVFLELIT 284
DV+SFG++ EL T
Sbjct: 446 DVWSFGILLTELTT 459
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-35
Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
IG+G FG V G G VAVK + +N + FL E +++ L HSNLV L+G
Sbjct: 29 IGKGEFGDVMLGDYR--GNKVAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 151 DGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 209
+ L +V E+M GSL D+L + L + +K + + +EYL +
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 139
Query: 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV----MGTYGYCAPEYAMTGQ 265
+RD + N+L+ E K+SDFGL K + + ++ APE +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKK 190
Query: 266 LTVKSDVYSFGVVFLELIT-GRK 287
+ KSDV+SFG++ E+ + GR
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRV 213
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 91 IGEGGFGRVYKGWLESTGQ---VVAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNLI 146
IG+G FG VY G Q A+K L R +Q FL E L++ L+H N++ LI
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 147 GYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
G + ++ +M G L + + + A+G+EYL ++
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK- 144
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG--------TYGYCA 257
++RD + N +L+E F K++DFGLA+ + D+ + S + T A
Sbjct: 145 --FVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHARLPVKWT----A 196
Query: 258 PEYAMTGQLTVKSDVYSFGVVFLELIT 284
E T + T KSDV+SFGV+ EL+T
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-35
Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 15/197 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G G FG V G V A+K + + G EF+ E ++ L H LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDV-AIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210
++ E+M G L ++L + + +++ + +EYL K ++
Sbjct: 90 KQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLH 143
Query: 211 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---YGYCAPEYAMTGQLT 267
RD + N L+ + K+SDFGL++ T +G+ + PE M + +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 268 VKSDVYSFGVVFLELIT 284
KSD+++FGV+ E+ +
Sbjct: 200 SKSDIWAFGVLMWEIYS 216
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-35
Identities = 51/244 (20%), Positives = 94/244 (38%), Gaps = 25/244 (10%)
Query: 58 HLPKDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLD 117
H +GV++ + F+ ++ + + IG GG +V++ L Q+ A+K ++
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVN 61
Query: 118 RNGLQGN--REFLVEVLMLSLLHHSNL--VNLIGYCADGDQRLLVYEFMPLGSLEDHLHD 173
+ E+ L+ L + + L Y +V E L L
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK 120
Query: 174 LPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 233
K+++D R + + +H +++ D K +N L+ +G KL DFG+
Sbjct: 121 ----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGI 172
Query: 234 AKLGPVGDKSHVSTRVMGTYGYCAPE-----------YAMTGQLTVKSDVYSFGVVFLEL 282
A S V +GT Y PE +++ KSDV+S G + +
Sbjct: 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232
Query: 283 ITGR 286
G+
Sbjct: 233 TYGK 236
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-35
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 91 IGEGGFGRVYKGWLESTGQV---VAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVNLI 146
+GEG FG VY+G + VAVK ++ N+ +F+ E +++ L H ++V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
G + + ++ E P G L +L +K +L T + + K + YL
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN-- 133
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG------YCAPEY 260
++RD NIL+ KL DFGL++ + D+ + + +PE
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS-----VTRLPIKWMSPES 185
Query: 261 AMTGQLTVKSDVYSFGVVFLELIT-GRK 287
+ T SDV+ F V E+++ G++
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-35
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 91 IGEGGFGRVYKGWL---ESTGQVVAVKQL--DRNGLQGNREFLVEVLMLSLLHHSNLVNL 145
+GEG FG V +G L + T VAVK + D + + EFL E + H N++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 146 IGYCADGDQR-----LLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAAGAAKGLE 198
+G C + + +++ FM G L +L L + + T +K A G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 199 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--KSHVSTRV----MGT 252
YL ++ ++RD + N +L + ++DFGL+K GD + ++ +
Sbjct: 162 YLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI-- 216
Query: 253 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
A E T KSDV++FGV E+ T
Sbjct: 217 ----AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-35
Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 30/228 (13%)
Query: 77 ELAAATKNFRPE---------SFIGEGGFGRVYKGWLESTGQV---VAVKQLDRN-GLQG 123
EL A ++ IG G FG VY G L AVK L+R +
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 124 NREFLVEVLMLSLLHHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEALD 182
+FL E +++ H N+++L+G C + L+V +M G L + + + +
Sbjct: 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PT 126
Query: 183 WNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242
+ AKG++YL K ++RD + N +L+E F K++DFGLA+ +
Sbjct: 127 VKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE- 182
Query: 243 SHVSTRVMGTYGYC------APEYAMTGQLTVKSDVYSFGVVFLELIT 284
V G A E T + T KSDV+SFGV+ EL+T
Sbjct: 183 ---YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 91 IGEGGFGRVYKGWLESTG-----QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNL 145
+GEG FG+V+ + +VAVK L L ++F E +L+ L H ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEALDWNTRMKIAAGA 193
G C DGD ++V+E+M G L L K L + + IA+
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 194 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--KSHVSTRV-- 249
A G+ YL + ++RD + N L+ K+ DFG+++ D + T +
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 250 --MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
M PE M + T +SDV+SFGV+ E+ T
Sbjct: 200 RWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 15/197 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G G FG V+ G+ +V AVK L + G FL E ++ L H LV L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210
+ ++ E+M GSL D L P L N + +AA A+G+ ++ ++ I+
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 211 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---YGYCAPEYAMTGQLT 267
RD +++NIL+ + K++DFGLA+L + D + T G + APE G T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARL--IEDNEY--TAREGAKFPIKWTAPEAINYGTFT 188
Query: 268 VKSDVYSFGVVFLELIT 284
+KSDV+SFG++ E++T
Sbjct: 189 IKSDVWSFGILLTEIVT 205
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 91 IGEGGFGRVYKGWL---ESTGQVVAVKQLDRNGLQGNR--EFLVEVLMLSLLHHSNLVNL 145
+G+G FG V + L + + VAVK L + + + EFL E + H ++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 146 IGYCADGDQR------LLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAAGAAKGL 197
+G + +++ FM G L L + + L T ++ A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--KSHVSTRV----MG 251
EYL + I+RD + N +L E ++DFGL++ GD + ++++ +
Sbjct: 151 EYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL- 206
Query: 252 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
A E TV SDV++FGV E++T
Sbjct: 207 -----ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 15/197 (7%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G G FG V+ +V AVK + + G FL E ++ L H LV L
Sbjct: 196 LGAGQFGEVWMATYNKHTKV-AVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 210
+ ++ EFM GSL D L + + +A A+G+ ++ + I+
Sbjct: 254 -KEPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 307
Query: 211 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---YGYCAPEYAMTGQLT 267
RD +++NIL+ K++DFGLA++ + D + T G + APE G T
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARV--IEDNEY--TAREGAKFPIKWTAPEAINFGSFT 363
Query: 268 VKSDVYSFGVVFLELIT 284
+KSDV+SFG++ +E++T
Sbjct: 364 IKSDVWSFGILLMEIVT 380
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-34
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 88 ESFIGEGGFGRVYKG-WLESTGQV-VAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVN 144
+ +G G FG V +G + Q+ VA+K L E + E ++ L + +V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
LIG C + +LV E G L L +E + + ++ + G++YL +K
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY--CAPEYAM 262
++R+ + N+LL + K+SDFGL+K D S+ + R G + APE
Sbjct: 457 ---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECIN 512
Query: 263 TGQLTVKSDVYSFGVVFLELIT-GRK 287
+ + +SDV+S+GV E ++ G+K
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 65/293 (22%), Positives = 108/293 (36%), Gaps = 58/293 (19%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 142
+F+ IG GGFG+V+K G+ +K++ N N + EV L+ L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNI 66
Query: 143 VNLIGYCADGDQRL----------------LVYEFMPLGSLEDHLHD----LPPDKEALD 182
V+ G D + EF G+LE + AL+
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 183 WNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242
++ KG++Y+H K +I RD K SNI L + K+ DFGL
Sbjct: 127 LFEQI------TKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKN 174
Query: 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVT 302
TR GT Y +PE + + D+Y+ G++ EL+
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV----------------- 217
Query: 303 WARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDV 355
F + F+ L D + + + + + ++ RP ++
Sbjct: 218 -CDTAFETSKFFTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 91 IGEGGFGRVYKGWLESTGQV---VAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNLI 146
IG G FG VY G L AVK L+R + +FL E +++ H N+++L+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 147 GYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
G C + L+V +M G L + + + + + AKG+++L K
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFLASKK- 212
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG------TYGYCAPE 259
++RD + N +L+E F K++DFGLA+ + V + A E
Sbjct: 213 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----ALE 266
Query: 260 YAMTGQLTVKSDVYSFGVVFLELIT 284
T + T KSDV+SFGV+ EL+T
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-34
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 91 IGEGGFGRVYKGWLESTG-----QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNL 145
+GEG FG+V+ + +VAVK L ++F E +L++L H ++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTR-----------MKIAAGAA 194
G C +G L+V+E+M G L L PD + L + +A+ A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--KSHVSTRV--- 249
G+ YL ++RD + N L+ +G K+ DFG+++ D + T +
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 250 -MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
M PE + + T +SDV+SFGVV E+ T
Sbjct: 226 WM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 91 IGEGGFGRVYKGWL-----ESTGQVVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVN 144
+G G FG VY+G + + + VAVK L + Q +FL+E L++S +H N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE---ALDWNTRMKIAAGAAKGLEYLH 201
IG R ++ E M G L+ L + P +L + +A A G +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 202 DKANPPVIYRDFKSSNILLE---EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY--- 255
+ I+RD + N LL G K+ DFG+A+ D S G
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 209
Query: 256 --CAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
PE M G T K+D +SFGV+ E+ +
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 58/209 (27%), Positives = 87/209 (41%), Gaps = 27/209 (12%)
Query: 91 IGEGGFGRVYKGWLESTGQV---VAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNL 145
IGEG FG V++G S VA+K +N +FL E L + H ++V L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
IG + ++ E LG L L LD + + A + L YL K
Sbjct: 82 IGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR- 136
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG------YCAPE 259
++RD + N+L+ KL DFGL++ + D ++ + APE
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKAS-----KGKLPIKWMAPE 187
Query: 260 YAMTGQLTVKSDVYSFGVVFLELIT-GRK 287
+ T SDV+ FGV E++ G K
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 67/275 (24%), Positives = 112/275 (40%), Gaps = 34/275 (12%)
Query: 24 QKQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELHLPKDGAGVNIAAQTFTFRELAAATK 83
QK+G+ + + + + +RS + VS+ + + I + T+ +
Sbjct: 333 QKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAE-------IIDEEDTYTMPSTRDY 385
Query: 84 NFRPESF-----IGEGGFGRVYKGWLESTGQV---VAVKQL-DRNGLQGNREFLVEVLML 134
+ E IGEG FG V++G S VA+K + +FL E L +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 135 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAA 194
H ++V LIG + ++ E LG L L K +LD + + A +
Sbjct: 446 RQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLS 501
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 254
L YL K ++RD + N+L+ KL DFGL++ + D ++ G
Sbjct: 502 TALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASK----G 552
Query: 255 -----YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ APE + T SDV+ FGV E++
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 8/216 (3%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLV-EVLMLSLLHHS 140
+++ IG G +GR K +S G+++ K+LD + + ++ LV EV +L L H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 141 NLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 198
N+V D L V E+ G L + +++ LD +++ L+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 199 YLHDKANPP--VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 256
H +++ V++RD K +N+ L+ + KL DFGLA++ + + + +GT Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYM 183
Query: 257 APEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 292
+PE KSD++S G + EL +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 33/218 (15%)
Query: 91 IGEGGFGRVYKGWLESTG-----QVVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVN 144
+GE FG+VYKG L Q VA+K L D+ EF E ++ + L H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEALDWNTRMKIAAG 192
L+G +++ + G L + L D K AL+ + + A
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 193 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--KSHVSTRV- 249
A G+EYL V+++D + N+L+ + + K+SD GL + D K ++ +
Sbjct: 137 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 250 ---MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
M APE M G+ ++ SD++S+GVV E+ +
Sbjct: 194 IRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-33
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 91 IGEGGFGRVYKGWLESTGQV--VAVKQL-DRNGLQGNREFLVEV-LMLSLLHHSNLVNLI 146
IGEG FG+V K ++ G A+K++ + +R+F E+ ++ L HH N++NL+
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEALDWNTRMKIAAGAA 194
G C L E+ P G+L D L L + AA A
Sbjct: 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV----M 250
+G++YL K I+RD + NIL+ E + K++DFGL++ V K R+ M
Sbjct: 153 RGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-MGRLPVRWM 208
Query: 251 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
A E T SDV+S+GV+ E+++
Sbjct: 209 ------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 51/266 (19%), Positives = 97/266 (36%), Gaps = 25/266 (9%)
Query: 36 SRLPSGRDRLRSRSNGVSKRELHLPKDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGG 95
+P G + + ++ + P G + A + ++ + + IG GG
Sbjct: 9 GLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGG 68
Query: 96 FGRVYKGWLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNL--VNLIGYCAD 151
+V++ L Q+ A+K ++ + E+ L+ L + + L Y
Sbjct: 69 SSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127
Query: 152 GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 211
+V E L L K+++D R + + +H +++
Sbjct: 128 DQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHS 179
Query: 212 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE-----------Y 260
D K +N L+ +G KL DFG+A S V +G Y PE
Sbjct: 180 DLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENG 238
Query: 261 AMTGQLTVKSDVYSFGVVFLELITGR 286
+++ KSDV+S G + + G+
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 55/232 (23%), Positives = 105/232 (45%), Gaps = 21/232 (9%)
Query: 63 GAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL- 121
+GV++ + F+ + + + IGEG FG+ G+ +K+++ + +
Sbjct: 8 SSGVDLGTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS 63
Query: 122 QGNREFLV-EVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL----HDLPP 176
RE EV +L+ + H N+V + +V ++ G L + L
Sbjct: 64 SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ 123
Query: 177 DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236
+ + LDW ++ L+++HD+ +++RD KS NI L + +L DFG+A++
Sbjct: 124 EDQILDWFVQI------CLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARV 174
Query: 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 288
+ ++ +GT Y +PE KSD+++ G V EL T + A
Sbjct: 175 --LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-33
Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 39/233 (16%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN 141
+F + +G+G FG+V K + A+K++ + L EV++L+ L+H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 142 LVNLIGYCADGDQRL-------------LVYEFMPLGSLEDHLHD--LPPDKEALDWNTR 186
+V + + + E+ G+L D +H L ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY----- 118
Query: 187 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL---------- 236
++ + L Y+H + +I+RD K NI ++E + K+ DFGLAK
Sbjct: 119 WRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 237 ---GPVGDKSHVSTRVMGTYGYCAPE-YAMTGQLTVKSDVYSFGVVFLELITG 285
G ++++ + GT Y A E TG K D+YS G++F E+I
Sbjct: 176 DSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-33
Identities = 52/211 (24%), Positives = 83/211 (39%), Gaps = 20/211 (9%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN--GLQGNREFLVEV-LMLSLLHH 139
++F+ S +G G +G V+K + G++ AVK+ G + L EV + H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP---PDKEALDWNTRMKIAAGAAKG 196
V L +G L E SL+ H P+ + +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGY------LRDTLLA 169
Query: 197 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 256
L +LH + +++ D K +NI L KL DFGL +G + G Y
Sbjct: 170 LAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE-GDPRYM 223
Query: 257 APEYAMTGQLTVKSDVYSFGVVFLELITGRK 287
APE + G +DV+S G+ LE+ +
Sbjct: 224 APE-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-33
Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 91 IGEGGFGRVYKGWL-----ESTGQVVAVKQL-DRNGLQGNREFLVEVLMLSLLHHSNLVN 144
+G G FG VY+G + + + VAVK L + Q +FL+E L++S +H N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE---ALDWNTRMKIAAGAAKGLEYLH 201
IG R ++ E M G L+ L + P +L + +A A G +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 202 DKANPPVIYRDFKSSNILLE---EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY--- 255
+ I+RD + N LL G K+ DFG+A+ D G
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLPV 250
Query: 256 --CAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
PE M G T K+D +SFGV+ E+ +
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-33
Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 8/209 (3%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHH 139
NFR E IG G F VY+ G VA+K++ L + + E+ +L L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEY 199
N++ + ++ +V E G L + K + T K LE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 200 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE 259
+H + V++RD K +N+ + KL D GL + K+ + ++GT Y +PE
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPE 206
Query: 260 YAMTGQLTVKSDVYSFGVVFLELITGRKA 288
KSD++S G + E+ +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 48/219 (21%), Positives = 84/219 (38%), Gaps = 25/219 (11%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLL--H 138
+ + IG GG +V++ L Q+ A+K ++ + E+ L+ L H
Sbjct: 9 RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 139 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 198
++ L Y +V E L L K+++D R + +
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYWKNMLEAVH 122
Query: 199 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAP 258
+H +++ D K +N L+ +G KL DFG+A S V +GT Y P
Sbjct: 123 TIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 259 E-----------YAMTGQLTVKSDVYSFGVVFLELITGR 286
E +++ KSDV+S G + + G+
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 91 IGEGGFGRVYKGWL-------ESTGQVVAVKQL-DRNGLQGNREFLVEV-LMLSLLHHSN 141
+GEG FG+V VAVK L D + + + E+ +M + H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEALDWNTRMKI 189
++NL+G C ++ E+ G+L ++L +E + + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 190 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--KSHVST 247
A+G+EYL + I+RD + N+L+ E K++DFGLA+ D K +
Sbjct: 163 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 248 RV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
R+ M APE T +SDV+SFGV+ E+ T
Sbjct: 220 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 71/237 (29%), Positives = 109/237 (45%), Gaps = 31/237 (13%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
IG+G G VY +TGQ VA++Q++ + E+L++ + N+VN +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA---GAAKGLEYLHDKANPP 207
GD+ +V E++ GSL D + + D+ +IAA + LE+LH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEG--------QIAAVCRECLQALEFLHSNQ--- 136
Query: 208 VIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL 266
VI+RD KS NILL KL+DFG A++ P K T V GT + APE
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-GTPYWMAPEVVTRKAY 193
Query: 267 TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN-------LVTWARPLFNDRRKFSK 316
K D++S G++ +E+I G P+ +N + T P + K S
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEP------PYLNENPLRALYLIATNGTPELQNPEKLSA 244
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV----EVLMLSLLHHS 140
++ +G GG VY VA+K + + E L EV S L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 141 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 200
N+V++I + D LV E++ +L +++ L +T + G+++
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHA 127
Query: 201 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST-RVMGTYGYCAPE 259
HD +++RD K NIL++ K+ DFG+AK + + S T V+GT Y +PE
Sbjct: 128 HDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPE 182
Query: 260 YAMTGQLTVKSDVYSFGVVFLELITGR 286
A +D+YS G+V E++ G
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 4e-32
Identities = 40/339 (11%), Positives = 91/339 (26%), Gaps = 63/339 (18%)
Query: 24 QKQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELHLPKDGAGVNIAAQTFTFR-ELAAAT 82
Q G + +R+P R S + L Q F EL
Sbjct: 17 QGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNT----GQPFRVESELGERP 72
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE---------------- 126
+ + +G+ + + TG+ V +
Sbjct: 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 132
Query: 127 ------------FLVEVLMLSLLHHSNLVNLIGYCADGD--QRLLVYEFM--PLGSLEDH 170
F+ ++ ++ + D R +Y M L + +
Sbjct: 133 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 192
Query: 171 LHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSD 230
L ++L + R+++ + L LH +++ + +I+L++ L+
Sbjct: 193 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTG 249
Query: 231 FGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-----------GQLTVKSDVYSFGVVF 279
F + + G+ PE +T D ++ G+V
Sbjct: 250 FEHLV------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303
Query: 280 LELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318
+ P + + + +F + +
Sbjct: 304 YWIWCAD------LPITKDAALGGSEWIFRSCKNIPQPV 336
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-32
Identities = 51/225 (22%), Positives = 92/225 (40%), Gaps = 27/225 (12%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSN 141
+F P +G GGFG V++ + A+K++ + RE + EV L+ L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 142 LVNLIGYCADGD---------QRLLVY---EFMPLGSLEDHLHDLPPDKEALDWNTRMKI 189
+V + + ++ +Y + +L+D ++ +E + + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHI 123
Query: 190 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL----------GPV 239
A+ +E+LH K +++RD K SNI K+ DFGL
Sbjct: 124 FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
T +GT Y +PE + K D++S G++ EL+
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-32
Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 18/199 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
IGEG G V + +G+ VAVK +D Q EV+++ H N+V +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA---GAAKGLEYLHDKANPP 207
G++ ++ EF+ G+L D + + ++E +IA + L YLH +
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVRLNEE--------QIATVCEAVLQALAYLHAQG--- 161
Query: 208 VIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL 266
VI+RD KS +ILL KLSDFG A++ K + V GT + APE
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-GTPYWMAPEVISRSLY 218
Query: 267 TVKSDVYSFGVVFLELITG 285
+ D++S G++ +E++ G
Sbjct: 219 ATEVDIWSLGIMVIEMVDG 237
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 90 FIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC 149
+G+G +G VY G S +A+K++ + ++ E+ + L H N+V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLP---PDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
++ + E +P GSL L D E +I +GL+YLHD
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI----LEGLKYLHDNQ-- 142
Query: 207 PVIYRDFKSSNILL--EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE---YA 261
+++RD K N+L+ G K+SDFG +K + + + GT Y APE
Sbjct: 143 -IVHRDIKGDNVLINTYSG-VLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKG 198
Query: 262 MTGQLTVKSDVYSFGVVFLELITGR 286
G +D++S G +E+ TG+
Sbjct: 199 PRG-YGKAADIWSLGCTIIEMATGK 222
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 40/220 (18%), Positives = 88/220 (40%), Gaps = 33/220 (15%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-----------------EVLM 133
+ +G F ++ E + A+K+ +++ L+ R+F E+ +
Sbjct: 39 LNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 134 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA-- 191
++ + + + G + D+ ++YE+M S+ + +++
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 192 --GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 249
Y+H++ N + +RD K SNIL+++ KLSDFG ++ +
Sbjct: 157 IKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV---DKKIKG-S 210
Query: 250 MGTYGYCAPEYAMTGQLTV---KSDVYSFGVVFLELITGR 286
GTY + PE + + + K D++S G+ +
Sbjct: 211 RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 58/223 (26%), Positives = 89/223 (39%), Gaps = 44/223 (19%)
Query: 91 IGEGGFGRVYKGWL-----ESTGQVVAVKQL-DRNGLQGNREFLVEV-LMLSLLHHSNLV 143
+G G FG+V + E VAVK L + E+ +M L H N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTR----------MKIAAGA 193
NL+G C G L++ E+ G L + L E + ++
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 194 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 253
A+G+ +L K I+RD + N+LL G K+ DFGLA+ +M
Sbjct: 174 AQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARD------------IMNDS 218
Query: 254 GYC------------APEYAMTGQLTVKSDVYSFGVVFLELIT 284
Y APE TV+SDV+S+G++ E+ +
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR---EFLVEVLMLSLLHHSNLVNLIG 147
+G+G FG VY + + ++A+K L + L+ + EV + S L H N++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
Y D + L+ E+ PLG++ L L ++ A L Y H K
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT------ATYITELANALSYCHSKR- 129
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM-GTYGYCAPEYAMTG 264
VI+RD K N+LL K++DFG + P + GT Y PE
Sbjct: 130 --VIHRDIKPENLLLGSAGELKIADFGWSVHAP-----SSRRTDLCGTLDYLPPEMIEGR 182
Query: 265 QLTVKSDVYSFGVVFLELITGR 286
K D++S GV+ E + G+
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGK 204
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN 141
+ F +GEG +G VYK + TGQ+VA+KQ+ +E + E+ ++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKIAA---GAAKGL 197
+V G +V E+ GS+ D + E +IA KGL
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED-------EIATILQSTLKGL 138
Query: 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMGTYGYC 256
EYLH I+RD K+ NILL H KL+DFG+ +L K + V+GT +
Sbjct: 139 EYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPFWM 192
Query: 257 APEYAMTGQLTVKSDVYSFGVVFLELITG 285
APE +D++S G+ +E+ G
Sbjct: 193 APEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 32/216 (14%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 149
+G+G V++G + TG + A+K + + + E +L L+H N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 150 ADGDQRL--LVYEFMPLGSLEDHLHDLP-----PDKEALDWNTRMKIAAGAAKGLEYLHD 202
+ R L+ EF P GSL L + P+ E L + G+ +L +
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL------IVLRDVVGGMNHLRE 130
Query: 203 KANPPVIYRDFKSSNILLEEGFHP----KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAP 258
+++R+ K NI+ G KL+DFG A+ + D + GT Y P
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYLHP 184
Query: 259 E--------YAMTGQLTVKSDVYSFGVVFLELITGR 286
+ + D++S GV F TG
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 91 IGEGGFGRVYKGWL-------ESTGQVVAVKQL-DRNGLQGNREFLVEV-LMLSLLHHSN 141
+GEG FG+V VAVK L D + + + E+ +M + H N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEALDWNTRMKI 189
++NL+G C ++ E+ G+L ++L +E + + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 190 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--KSHVST 247
A+G+EYL + I+RD + N+L+ E K++DFGLA+ D K +
Sbjct: 209 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 248 RV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
R+ M APE T +SDV+SFGV+ E+ T
Sbjct: 266 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 73/250 (29%), Positives = 111/250 (44%), Gaps = 32/250 (12%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHS 140
+ F IG+G FG V+KG T +VVA+K +D + E + E+ +LS
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 141 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA---GAAKGL 197
+ G + ++ E++ GS D L P D+ +IA KGL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET--------QIATILREILKGL 132
Query: 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMGTYGYC 256
+YLH + I+RD K++N+LL E KL+DFG+ +L K + +GT +
Sbjct: 133 DYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWM 186
Query: 257 APEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316
APE K+D++S G+ +EL G PH E + + + LF K
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEP------PHSELHPM---KVLF----LIPK 233
Query: 317 LADPRLEGRY 326
P LEG Y
Sbjct: 234 NNPPTLEGNY 243
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-31
Identities = 62/221 (28%), Positives = 94/221 (42%), Gaps = 36/221 (16%)
Query: 91 IGEGGFGRVYKGWL-----ESTGQVVAVKQLDRNGLQGNR-EFLVEV-LMLSLLHHSNLV 143
+G G FG+V + VAVK L + R + E+ ++ L +H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHL--------------HDLPPDKEALDWNTRMKI 189
NL+G C G L++ E+ G L + L + D+ ALD +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 190 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--KSHVST 247
+ AKG+ +L K I+RD + NILL G K+ DFGLA+ +
Sbjct: 151 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 248 RV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
R+ M APE T +SDV+S+G+ EL +
Sbjct: 208 RLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 12/213 (5%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSN 141
++ + IG G V + + VA+K+++ Q + + L+ E+ +S HH N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWN-TRMKIAA---GAAKGL 197
+V+ D+ LV + + GS+ D + + E IA +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTR--VMGTYG 254
EYLH I+RD K+ NILL E +++DFG+ A L GD + R +GT
Sbjct: 135 EYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 255 YCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 286
+ APE + K+D++SFG+ +EL TG
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 91 IGEGGFGRVYKGWL-----ESTGQVVAVKQL-DRNGLQGNREFLVEV-LMLSLLHHSNLV 143
+G G FG+V + +T + VAVK L + +R + E+ +++ + HH N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 144 NLIGYCADGDQ-RLLVYEFMPLGSLEDHL------------HDLPPDKEALDWNTRMKIA 190
NL+G C +++ EF G+L +L K+ L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 191 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--KSHVSTR 248
AKG+E+L + I+RD + NILL E K+ DFGLA+ R
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 249 V----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ M APE T++SDV+SFGV+ E+ +
Sbjct: 212 LPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 41/226 (18%)
Query: 91 IGEGGFGRVYKGWL-----ESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVN 144
+GEG FG+V K + VAVK L N + L E +L ++H +++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHL--------------------HDLPPDKEALDWN 184
L G C+ LL+ E+ GSL L PD+ AL
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 185 TRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--K 242
+ A ++G++YL + +++RD + NIL+ EG K+SDFGL++ D
Sbjct: 151 DLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 243 SHVSTRV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
R+ M A E T +SDV+SFGV+ E++T
Sbjct: 208 KRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 91 IGEGGFGRVYKG-------WLESTGQVVAVKQL-DRNGLQGNREFLVEV-LMLSLLHHSN 141
+GEG FG+V + VAVK L + + + E+ +M + H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTR------------MKI 189
++NL+G C ++ E+ G+L ++L P +N +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 190 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--KSHVST 247
A A+G+EYL K I+RD + N+L+ E K++DFGLA+ D K +
Sbjct: 197 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 248 RV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
R+ M APE T +SDV+SFGV+ E+ T
Sbjct: 254 RLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-31
Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN 141
+ + +G+G FG+VYK + TG + A K ++ + +++VE+ +L+ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKIAA---GAAKGL 197
+V L+G + ++ EF P G+++ + +L E +I + L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------QIQVVCRQMLEAL 130
Query: 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMGTYGYC 256
+LH K +I+RD K+ N+L+ +L+DFG+ AK K +GT +
Sbjct: 131 NFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPYWM 184
Query: 257 APEYAMTGQLT-----VKSDVYSFGVVFLELITG 285
APE M + K+D++S G+ +E+
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-31
Identities = 59/226 (26%), Positives = 97/226 (42%), Gaps = 41/226 (18%)
Query: 91 IGEGGFGRVYKGWL-----ESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLLHHSNLVN 144
IGEG FGRV++ +VAVK L + +F E +++ + N+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHL--------------------HDLPPDKEALDWN 184
L+G CA G L++E+M G L + L P L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 185 TRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--K 242
++ IA A G+ YL ++ ++RD + N L+ E K++DFGL++ D K
Sbjct: 175 EQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 243 SHVSTRV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ + + M PE + T +SDV+++GVV E+ +
Sbjct: 232 ADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 32/216 (14%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 149
+G+G V++G + TG + A+K + + + E +L L+H N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 150 ADGDQRL--LVYEFMPLGSLEDHLHDLP-----PDKEALDWNTRMKIAAGAAKGLEYLHD 202
+ R L+ EF P GSL L + P+ E L + G+ +L +
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL------IVLRDVVGGMNHLRE 130
Query: 203 KANPPVIYRDFKSSNILLEEGFHP----KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAP 258
+++R+ K NI+ G KL+DFG A+ + D + GT Y P
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYLHP 184
Query: 259 E--------YAMTGQLTVKSDVYSFGVVFLELITGR 286
+ + D++S GV F TG
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 14/203 (6%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNG-LQGNREFLVEV-LMLSLLHHSNLVNLIGY 148
+G G +G V K +GQ++AVK++ Q + L+++ + + + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 149 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 208
+ E M SL+ + + + + KIA K LE+LH K + V
Sbjct: 75 LFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 209 IYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMGTYGYCAPE----YAMT 263
I+RD K SN+L+ K+ DFG+ L G Y APE
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 264 GQLTVKSDVYSFGVVFLELITGR 286
+VKSD++S G+ +EL R
Sbjct: 188 KGYSVKSDIWSLGITMIELAILR 210
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 32/293 (10%), Positives = 64/293 (21%), Gaps = 42/293 (14%)
Query: 27 GQPTVSNNISRLPSGRDRLRSRSNGVSKRELHLPKDGAGVNIAAQTFTFRELAAATKNFR 86
G + + + R R + + A+T L+ + +
Sbjct: 7 GDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATV-WPQNAETTVDSLLSQGERKLK 65
Query: 87 PESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHHSNLV 143
+ G V+ + A+K E + L +
Sbjct: 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPE 125
Query: 144 NLIGYC--------------------------ADGDQRLLVYEFMP--LGSLEDHLHDLP 175
LL+ L L L +
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVY 185
Query: 176 PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235
+ + A + L K +++ F N+ + L D
Sbjct: 186 VFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 236 LGPVGDKSHVSTRVMGTYGYCAPEYAM--TGQLTVKSDVYSFGVVFLELITGR 286
VG + S+ Y E+ T T + + G+ +
Sbjct: 243 --KVGTRGPASS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 3e-30
Identities = 50/221 (22%), Positives = 82/221 (37%), Gaps = 26/221 (11%)
Query: 82 TKNFRPESFIGEG--GFGRVYKGWLESTGQVVAVKQLD-RNGLQGNREFLV-EVLMLSLL 137
+ + IG+G V + TG+ V V++++ FL E+ + L
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 138 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD--KEALDWNTRMKIAA---G 192
+H N+V ++ +V FM GS +D + D E IA G
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-------IAYILQG 136
Query: 193 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG-LAKLGPVGDKSHV----ST 247
K L+Y+H ++R K+S+IL+ LS + G + V
Sbjct: 137 VLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193
Query: 248 RVMGTYGYCAPEYAMTGQL--TVKSDVYSFGVVFLELITGR 286
+ + +PE KSD+YS G+ EL G
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 27/211 (12%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLI--- 146
+G GGFG V + + TG+ VA+KQ + NRE E+ ++ L+H N+V+
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 147 ---GYCADGDQRLLVYEFMPLGSLEDHLHDLP-----PDKEALDWNTRMKIAAGAAKGLE 198
A D LL E+ G L +L+ + + + + L
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR------TLLSDISSALR 135
Query: 199 YLHDKANPPVIYRDFKSSNILLEEGFHP---KLSDFGLAKLGPVGDKSHVSTRVMGTYGY 255
YLH+ +I+RD K NI+L+ G K+ D G AK + + V GT Y
Sbjct: 136 YLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEFV-GTLQY 189
Query: 256 CAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
APE + TV D +SFG + E ITG
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 13/204 (6%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLV 143
F S +G G G V+K + +G V+A K + R ++ E+ +L + +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
G + + E M GSL+ L E K++ KGL YL +K
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIAVIKGLTYLREK 150
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVSTRVMGTYGYCAPEYAM 262
+++RD K SNIL+ KL DFG++ +L S ++ V GT Y +PE
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV-GTRSYMSPERLQ 203
Query: 263 TGQLTVKSDVYSFGVVFLELITGR 286
+V+SD++S G+ +E+ GR
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-30
Identities = 49/210 (23%), Positives = 75/210 (35%), Gaps = 21/210 (10%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV----EVLMLSLLHHS 140
+R +G GG G VY+ ++VA+K + L + F E L
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 141 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD---LPPDKEALDWNTRMKIAAGAAKGL 197
++V + + Q + + L L L P A+ I L
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPP-RAVA------IVRQIGSAL 147
Query: 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST-RVMGTYGYC 256
+ H +RD K NIL+ L DFG+A D+ +GT Y
Sbjct: 148 DAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASA--TTDEKLTQLGNTVGTLYYM 202
Query: 257 APEYAMTGQLTVKSDVYSFGVVFLELITGR 286
APE T ++D+Y+ V E +TG
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGS 232
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 41/226 (18%)
Query: 91 IGEGGFGRVYKGWL-----ESTGQVVAVKQL-DRNGLQGNREFLVEV-LMLSLLHHSNLV 143
+G G FG+V VAVK L ++ + E+ +M L H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHL-------------------HDLPPDKEALDWN 184
NL+G C L++E+ G L ++L + D L +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 185 TRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--K 242
+ A AKG+E+L K+ ++RD + N+L+ G K+ DFGLA+
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 243 SHVSTRV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 284
+ R+ M APE G T+KSDV+S+G++ E+ +
Sbjct: 230 VRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 20/202 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR---EFLVEVLMLSLLHHSNLVNLIG 147
+G+G FG VY + ++A+K L ++ L+ + E+ + S L H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
Y D + L+ EF P G L L ++ + A L Y H++
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS------ATFMEELADALHYCHERK- 134
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM-GTYGYCAPEYAMTG 264
VI+RD K N+L+ K++DFG + P + R M GT Y PE
Sbjct: 135 --VIHRDIKPENLLMGYKGELKIADFGWSVHAP-----SLRRRTMCGTLDYLPPEMIEGK 187
Query: 265 QLTVKSDVYSFGVVFLELITGR 286
K D++ GV+ E + G
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGM 209
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 23/214 (10%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV----EVLMLSLLHHS 140
+ +G GG V+ + VAVK L R L + F + E + L+H
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHP 72
Query: 141 NLVNL--IGYCADGDQRLLVY---EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK 195
+V + G A+ L Y E++ +L D +H + + +++ A A +
Sbjct: 73 AIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQ 127
Query: 196 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR---VMGT 252
L + H +I+RD K +NI++ K+ DFG+A+ + D + T+ V+GT
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGT 182
Query: 253 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
Y +PE A + +SDVYS G V E++TG
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-29
Identities = 63/278 (22%), Positives = 101/278 (36%), Gaps = 28/278 (10%)
Query: 17 PEKEPDDQKQGQPTVSNNISRLPS-GRDRLRSRSNGVSKRELHLPKDGAGVNIAAQTFTF 75
P+ +P + P V + + GR RS S E P G+ + Q
Sbjct: 16 PDIDPLEALMTNPVVPESKRFCWNCGRPVGRSDSETKGASEGWCPYCGSPYSFLPQLNPG 75
Query: 76 RELAAATKNFRPESFIGEGGFGRVYKGW-LESTGQVVAVKQLDRNGLQGNRE-FLVEVLM 133
+A + + I GG G +Y G+ V +K L +G + + E
Sbjct: 76 DIVAG---QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQF 132
Query: 134 LSLLHHSNLVNLIGYCADGDQRL-----LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 188
L+ + H ++V + + D+ +V E++ SL+ P EA+
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA------ 186
Query: 189 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 248
L YLH ++Y D K NI+L E KL D G + ++
Sbjct: 187 YLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINSFGYL--- 237
Query: 249 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
GT G+ APE TV +D+Y+ G L
Sbjct: 238 -YGTPGFQAPEIV-RTGPTVATDIYTVGRTLAALTLDL 273
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLM-----LSLLHHSNLVNL 145
IG G +G V K + +GQ++AVK++ + + ++LM + +V
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIR---STVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA-LDWNTRMKIAAGAAKGLEYLHDKA 204
G + E M S + + + + KI K L +L +
Sbjct: 87 YGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMGTYGYCAPE---- 259
+I+RD K SNILL+ + KL DFG+ +L S TR G Y APE
Sbjct: 146 K--IIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDAGCRPYMAPERIDP 199
Query: 260 YAMTGQLTVKSDVYSFGVVFLELITGR 286
A V+SDV+S G+ EL TGR
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 39/231 (16%), Positives = 71/231 (30%), Gaps = 26/231 (11%)
Query: 76 RELAAATKNFRPESFIGEGGFGRVYKG-----WLESTGQVVAVKQLDRNGLQGNREFLVE 130
E +K +GEG F +VY+ Q +K EF +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIG 114
Query: 131 VLMLSLL---HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDL-PPDKEALDWNTR 186
++ L + + +LV E G+L + ++ ++ +
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 187 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP-----------KLSDFGLAK 235
+ A +E +HD +I+ D K N +L GF L D G +
Sbjct: 175 ISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 236 LGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
+ K + T T G+ E + D + ++ G
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 23/225 (10%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEV-LMLSLLHHSN 141
R + EGGF VY+ +G+ A+K+L N + NR + EV M L H N
Sbjct: 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN 87
Query: 142 LVNLIGYCADGDQRLL--VYEFMPL-----GSLEDHLHDLPPDKEALDWNTRMKIAAGAA 194
+V + G + EF+ L G L + L + + L +T +KI
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTC 146
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA---KLGPVGDKSHVSTRVM- 250
+ ++++H + PP+I+RD K N+LL KL DFG A P S ++
Sbjct: 147 RAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 251 ------GTYGYCAPE-YAMTGQLTV--KSDVYSFGVVFLELITGR 286
T Y PE + + K D+++ G + L +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 53/301 (17%), Positives = 92/301 (30%), Gaps = 70/301 (23%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN--GLQGNREFLVEV-LMLSLLH 138
T F IG G FG V+K G + A+K+ + G + L EV L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 139 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 198
HS++V A+ D L+ E+ GSL D + + + +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 199 YLHDKANPPVIYRDFKSSNILL-------------------EEGFHPKLSDFGLAKLGPV 239
Y+H + +++ D K SNI + K+ D G
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR--- 183
Query: 240 GDKSHVSTRVMGTYGYCAPE-------YAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 292
S G + A E + K+D+++ + +
Sbjct: 184 --ISSPQVEE-GDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGA------- 227
Query: 293 RPHGEQNLVTWARPLFNDRRKFSKLAD---PRLEGRYPIRGLYQALAVASMCIQEQAATR 349
PL + ++ ++ PR+ + + + I R
Sbjct: 228 ------------EPLPRNGDQWHEIRQGRLPRIPQVLS----QEFTELLKVMIHPDPERR 271
Query: 350 P 350
P
Sbjct: 272 P 272
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 50/406 (12%), Positives = 105/406 (25%), Gaps = 88/406 (21%)
Query: 24 QKQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELHLPKDGAGVNIAAQTFTFRELAAATK 83
+ Q V + S D L S S L G + EL +
Sbjct: 34 NRIPQANVRTTSEYMQSAADSLVSTS---------LWNTGQPFRVE------SELGERPR 78
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE----------------- 126
+ +G+ + + TG+ V +
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 127 -----------FLVEVLMLSLLHHSNLVNLIGYCADGD--QRLLVYEFM--PLGSLEDHL 171
F+ ++ ++ + D R +Y M L + + L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 172 HDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDF 231
++L + R+++ + L LH +++ + +I+L++ L+ F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEY----------AMTGQLTVKSDVYSFGVVFLE 281
G S G+ PE +T D ++ G+
Sbjct: 256 EHLV--RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309
Query: 282 LITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMC 341
+ P+ + + + +F + + LEG
Sbjct: 310 IWCAD------LPNTDDAALGGSEWIFRSCKNIPQPVRALLEG----------------F 347
Query: 342 IQEQAATRPLIGDVVTALSYLANQTYDPNSHRGAGDKDDRRNRDGA 387
++ R L + Y +T + + GA
Sbjct: 348 LRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGA 393
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-28
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR---EFLVEVLMLSLLHH 139
+ + F+G+GGF + ++ T +V A K + ++ L + +E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAAGAAKGL 197
++V G+ D D +V E SL + + EA R G
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----R-YYLRQIVLGC 128
Query: 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVSTRVMGTYGYC 256
+YLH VI+RD K N+ L E K+ DFGLA K+ G++ V GT Y
Sbjct: 129 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYI 182
Query: 257 APEYAMTGQLTVKSDVYSFGVVFLELITGR 286
APE + + DV+S G + L+ G+
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 70/216 (32%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLH 138
K F IG G FG VY +VVA+K++ +G Q N ++ + EV L L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 139 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKIAA---GAA 194
H N + G LV E+ GS D L P +E +IAA GA
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEV-------EIAAVTHGAL 164
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR--VMGT 252
+GL YLH +I+RD K+ NILL E KL DFG A S ++ +GT
Sbjct: 165 QGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGT 213
Query: 253 YGYCAPEYAMTGQLT---VKSDVYSFGVVFLELITG 285
+ APE + K DV+S G+ +EL
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-28
Identities = 67/220 (30%), Positives = 97/220 (44%), Gaps = 28/220 (12%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLS-LLHHS 140
F +G G +G+VYKG TGQ+ A+K +D G E E+ ML HH
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81
Query: 141 NLVNLIG-----YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA--- 191
N+ G D +L LV EF GS+ D + + + +W IA
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICR 136
Query: 192 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVM 250
+GL +LH VI+RD K N+LL E KL DFG+ A+L + + +
Sbjct: 137 EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FI 190
Query: 251 GTYGYCAPEYAMTGQLT-----VKSDVYSFGVVFLELITG 285
GT + APE + KSD++S G+ +E+ G
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-28
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR---EFLVEVLMLSLLHH 139
+ + F+G+GGF + ++ T +V A K + ++ L + +E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAAGAAKGL 197
++V G+ D D +V E SL + + EA R G
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----R-YYLRQIVLGC 154
Query: 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVSTRVMGTYGYC 256
+YLH VI+RD K N+ L E K+ DFGLA K+ G++ V GT Y
Sbjct: 155 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYI 208
Query: 257 APEYAMTGQLTVKSDVYSFGVVFLELITGR 286
APE + + DV+S G + L+ G+
Sbjct: 209 APEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 22/237 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV---EVLMLSLLHHSNLVNLIG 147
+G G G+V+K TG V+AVKQ+ R+G + + ++ +V++ +V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVL-KSHDCPYIVQCFG 91
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 207
+ E M + + P E K+ K L YL +K
Sbjct: 92 TFITNTDVFIAMELMGTCAEKLKKRMQGPIPE----RILGKMTVAIVKALYYLKEKHG-- 145
Query: 208 VIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMGTYGYCAPE-----YA 261
VI+RD K SNILL+E KL DFG+ +L R G Y APE
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRL----VDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 262 MTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ--NLVTWARPLFNDRRKFSK 316
+++DV+S G+ +EL TG+ + + E ++ PL FS
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG 258
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 19/211 (9%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR---EFLVEVLMLSLLHH 139
++F+ + +G+G F VY+ TG VA+K +D+ + EV + L H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP---PDKEALDWNTRMKIAAGAAKG 196
+++ L Y D + LV E G + +L + + EA G
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR------HFMHQIITG 124
Query: 197 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVSTRVMGTYGY 255
+ YLH +++RD SN+LL + K++DFGLA +L +K + GT Y
Sbjct: 125 MLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNY 178
Query: 256 CAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
+PE A ++SDV+S G +F L+ GR
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHH 139
F +G GGFG V+ +++TG++ A K+L++ L+ + + +VE +L+ +H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 140 SNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGL 197
+V+L Y + L LV M G + H++++ D R A GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGL 302
Query: 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCA 257
E+LH + +IYRD K N+LL++ + ++SD GLA G GT G+ A
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMA 357
Query: 258 PEYAMTGQLTVKSDVYSFGVVFLELITGR 286
PE + + D ++ GV E+I R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 21/212 (9%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNL 142
+F P+ +G G G + + VAVK++ +RE V++L H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFADRE--VQLLR-ESDEHPNV 80
Query: 143 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
+ D + + E +L++++ L+ T ++ GL +LH
Sbjct: 81 IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQ---QTTSGLAHLHS 136
Query: 203 KANPPVIYRDFKSSNILLEE-----GFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYC 256
+++RD K NIL+ +SDFGL K VG S + V GT G+
Sbjct: 137 LN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 257 APEY---AMTGQLTVKSDVYSFGVVFLELITG 285
APE T D++S G VF +I+
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHH 139
FR +G+GGFG V + +TG++ A K+L++ ++ + L E +L ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 140 SNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPD--KEALDWNTRMKI-AAGAAK 195
+V+L Y + L LV M G L+ H++ + EA R AA
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA-----RAVFYAAEICC 297
Query: 196 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY 255
GLE LH + ++YRD K NILL++ H ++SD GLA P G RV GT GY
Sbjct: 298 GLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGY 351
Query: 256 CAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
APE + T D ++ G + E+I G+
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 58/236 (24%), Positives = 93/236 (39%), Gaps = 24/236 (10%)
Query: 60 PKDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN 119
+ F + ++ ++ +G G +G V + T A+K + +
Sbjct: 14 LYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKT 73
Query: 120 GLQGNREFLV--EVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD 177
+ + + EV +L LL H N++ L + D LV E G L D +
Sbjct: 74 SVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF 133
Query: 178 KEALDWNTRMKIAAGAAK----GLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSD 230
E AA K G+ YLH +++RD K N+LL E+ K+ D
Sbjct: 134 NE--------VDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVD 182
Query: 231 FGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
FGL+ V + +GT Y APE + + K DV+S GV+ L+ G
Sbjct: 183 FGLSA---VFENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 17/217 (7%)
Query: 79 AAATKNFRPESF-----IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVE 130
+ RPE F +GEG F V +T + A+K L++ + + E
Sbjct: 21 PPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE 80
Query: 131 VLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI- 189
++S L H V L D ++ + G L ++ K T +
Sbjct: 81 RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-----KIGSFDETCTRFY 135
Query: 190 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 249
A LEYLH K +I+RD K NILL E H +++DFG AK+ K +
Sbjct: 136 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 250 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
+GT Y +PE SD+++ G + +L+ G
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 71/213 (33%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHH 139
+F IG GGFG VY TG++ A+K LD+ ++ + L E +MLSL+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 140 SN---LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAA 194
+ +V + Y +L + + M G L HL EA M+ AA
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEII 302
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 254
GLE++H++ V+YRD K +NILL+E H ++SD GLA K H V GT+G
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--ASV-GTHG 355
Query: 255 YCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 286
Y APE G S D +S G + +L+ G
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHHSNLVNLIG 147
+G+G FG V + TGQ AVK + + ++ + L EV +L L H N++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 148 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK----GLEYLHDK 203
+ D LV E G L D + E AA + G+ Y+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSE--------VDAARIIRQVLSGITYMHKN 145
Query: 204 ANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEY 260
+++RD K N+LL + + ++ DFGL+ + S +GT Y APE
Sbjct: 146 K---IVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPE- 198
Query: 261 AMTGQLTVKSDVYSFGVVFLELITGR 286
+ G K DV+S GV+ L++G
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 66/258 (25%), Positives = 106/258 (41%), Gaps = 26/258 (10%)
Query: 39 PSGRDRLRSRSNGVSKRELHLPKDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGR 98
+ S + KDG+ V T ++ IG G FG
Sbjct: 13 SCKPVQQPSAFGSMKVSR---DKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGV 69
Query: 99 VYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGY-CADGDQRL- 156
VY+ L +G++VA+K++ LQ R E+ ++ L H N+V L + + G+++
Sbjct: 70 VYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125
Query: 157 ----LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 212
LV +++P ++ K+ L + L Y+H + +RD
Sbjct: 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFG--ICHRD 181
Query: 213 FKSSNILLEEGFHP-KLSDFGLAKLGPVGDK--SHVSTRVMGTYGYCAPEYAMTGQL-TV 268
K N+LL+ KL DFG AK G+ S++ +R Y Y APE T
Sbjct: 182 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR----Y-YRAPELIFGATDYTS 236
Query: 269 KSDVYSFGVVFLELITGR 286
DV+S G V EL+ G+
Sbjct: 237 SIDVWSAGCVLAELLLGQ 254
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 53/229 (23%), Positives = 82/229 (35%), Gaps = 34/229 (14%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSN 141
E +G G G V G+ VAVK++ + E +++L S H N
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALME--IKLLTESD-DHPN 70
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA---GAAKGLE 198
++ + E +L+D + E L + A G+
Sbjct: 71 VIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 199 YLHDKANPPVIYRDFKSSNILL-------------EEGFHPKLSDFGLAKLGPVGDKSHV 245
+LH +I+RD K NIL+ E +SDFGL K G S
Sbjct: 130 HLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 246 STR--VMGTYGYCAPE-------YAMTGQLTVKSDVYSFGVVFLELITG 285
+ GT G+ APE +LT D++S G VF +++
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 55/216 (25%), Positives = 84/216 (38%), Gaps = 35/216 (16%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-------------EVLMLSLL 137
+G G +G V ++ A+K + ++ R E+ +L L
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 138 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK-- 195
H N++ L D LV EF G L + + + E AA K
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDE--------CDAANIMKQI 155
Query: 196 --GLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 250
G+ YLH +++RD K NILL + K+ DFGL+ K + +
Sbjct: 156 LSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSKDYKLRDRL 209
Query: 251 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
GT Y APE + + K DV+S GV+ L+ G
Sbjct: 210 GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 60/205 (29%), Positives = 88/205 (42%), Gaps = 24/205 (11%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV--EVLMLSLLHHSNLVNLIGY 148
+G+G FG V K T Q AVK +++ + + EV +L L H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 149 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK----GLEYLHDKA 204
D +V E G L D + E AA K G+ Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSE--------HDAARIIKQVFSGITYMHKHN 141
Query: 205 NPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
+++RD K NILL E+ K+ DFGL+ + + R+ GT Y APE
Sbjct: 142 ---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRI-GTAYYIAPE-V 194
Query: 262 MTGQLTVKSDVYSFGVVFLELITGR 286
+ G K DV+S GV+ L++G
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSGT 219
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 38/231 (16%)
Query: 73 FTFRELAAATKNFRPESF---------IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG 123
F F +L ++ P++ +G G G V + T + VA++ + +
Sbjct: 116 FVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAI 175
Query: 124 NREFLV--------EVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HD 173
E+ +L L+H ++ + + D + +V E M G L D + +
Sbjct: 176 GSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNK 234
Query: 174 LPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSD 230
+ + +M ++YLH+ +I+RD K N+LL EE K++D
Sbjct: 235 RLKEATCKLYFYQM------LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285
Query: 231 FGLAKLGPVGDKSHVSTRVMGTYGYCAPE---YAMTGQLTVKSDVYSFGVV 278
FG +K+ +G+ S + T GT Y APE T D +S GV+
Sbjct: 286 FGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 70/257 (27%), Positives = 106/257 (41%), Gaps = 15/257 (5%)
Query: 35 ISRLPSGRDRLRSRSNGVSKRELHLPKDGAGVNIAAQTFTFRELAAATKNFRPESFIGEG 94
+ + + D L+ ++ P D +G + + F +G+G
Sbjct: 100 TTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKG 159
Query: 95 GFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLIGYCAD 151
FG+V ++TG+ A+K L + + E L E +L H L L Y
Sbjct: 160 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQ 218
Query: 152 GDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDKANPPVI 209
RL V E+ G L HL E R + A L+YLH + N V+
Sbjct: 219 THDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGAEIVSALDYLHSEKN--VV 271
Query: 210 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVK 269
YRD K N++L++ H K++DFGL K G + D + + T GT Y APE
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDNDYGRA 329
Query: 270 SDVYSFGVVFLELITGR 286
D + GVV E++ GR
Sbjct: 330 VDWWGLGVVMYEMMCGR 346
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 26/210 (12%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV----EVLMLSLLHHSNLVNL- 145
+GEG +G+V + T AVK L + L+ E+ +L L H N++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 146 -IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK------GLE 198
+ Y + + +V E+ G E + D P+K R + GLE
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK-------RFPVCQAHGYFCQLIDGLE 123
Query: 199 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAP 258
YLH + ++++D K N+LL G K+S G+A+ G+ + P
Sbjct: 124 YLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 259 EYAMTGQL--TVKSDVYSFGVVFLELITGR 286
E A K D++S GV + TG
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 57/244 (23%), Positives = 86/244 (35%), Gaps = 52/244 (21%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE-----FLVEVLMLSLLHHSNLVNL 145
IG+G +G V T + A+K +++N ++ EV ++ LHH N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG------------- 192
D LV E G L D L+ D +K
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 193 ----------------AAK-------GLEYLHDKANPPVIYRDFKSSNILLE--EGFHPK 227
+ L YLH++ + +RD K N L + F K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 228 LSDFGLAKL---GPVGDKSHVSTRVMGTYGYCAPE--YAMTGQLTVKSDVYSFGVVFLEL 282
L DFGL+K G+ ++T+ GT + APE K D +S GV+ L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 283 ITGR 286
+ G
Sbjct: 270 LMGA 273
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 68/237 (28%), Positives = 102/237 (43%), Gaps = 21/237 (8%)
Query: 62 DGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL 121
G+ +++ A F+ E G+G FG V G +STG VA+K++ ++
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 122 QGNREFLVEVLMLSLLHHSNLVNLI------GYCADGDQRL-LVYEFMPLGSLEDHLHDL 174
NRE L + L++LHH N+V L G D L +V E++P +L +
Sbjct: 62 FRNRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNY 119
Query: 175 PPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDFKSSNILLEEGFHP-KLSDFG 232
+ A + + LH N V +RD K N+L+ E KL DFG
Sbjct: 120 YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFG 177
Query: 233 LAK-LGPVGDKSH-VSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 286
AK L P + +R Y Y APE Q T D++S G +F E++ G
Sbjct: 178 SAKKLSPSEPNVAYICSR----Y-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 6e-22
Identities = 54/196 (27%), Positives = 81/196 (41%), Gaps = 19/196 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSNLVNLIGYC 149
+G G FG V+ S+G +K ++++ Q E E+ +L L H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK----GLEYLHDKAN 205
D +V E G L + + +AL A K L Y H +
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALS----EGYVAELMKQMMNALAYFHSQH- 144
Query: 206 PPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM 262
V+++D K NIL K+ DFGLA+L H + GT Y APE
Sbjct: 145 --VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHSTNAA-GTALYMAPE-VF 198
Query: 263 TGQLTVKSDVYSFGVV 278
+T K D++S GVV
Sbjct: 199 KRDVTFKCDIWSAGVV 214
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 7e-22
Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSLLH 138
+ + IGEG +G V+K T ++VA+K++ D G+ L E+ +L L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV--PSSALREICLLKELK 59
Query: 139 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK--- 195
H N+V L + LV+EF DL K+ D + + K
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCD--------QDL---KKYFD-SCNGDLDPEIVKSFL 107
Query: 196 -----GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKSHVSTR 248
GL + H + V++RD K N+L+ KL++FGLA+ PV S
Sbjct: 108 FQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---E 161
Query: 249 VMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGRKAI 289
V+ T Y P+ + D++S G +F EL + +
Sbjct: 162 VV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 62/277 (22%), Positives = 107/277 (38%), Gaps = 33/277 (11%)
Query: 16 NPEKEPDDQKQGQPTVS-NNISRLPSGRDRLRSRSNGVSKRELHLPKDGAGVNIAAQTFT 74
N + Q + S +N ++ L R SKR L D F
Sbjct: 18 NLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPA---PPAPFD 74
Query: 75 FRELAAATKNFR------PESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFL 128
R + A +G G FG+V+K +TG +A K + G++ E
Sbjct: 75 HRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK 134
Query: 129 VEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRM- 187
E+ +++ L H+NL+ L + +LV E++ G L D + +D + +
Sbjct: 135 NEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI---------IDESYNLT 185
Query: 188 -KIAAGAAK----GLEYLHDKANPPVIYRDFKSSNILL--EEGFHPKLSDFGLAKLGPVG 240
K G+ ++H +++ D K NIL + K+ DFGLA+
Sbjct: 186 ELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARR--YK 240
Query: 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGV 277
+ + GT + APE ++ +D++S GV
Sbjct: 241 PREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGV 276
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 48/195 (24%), Positives = 86/195 (44%), Gaps = 22/195 (11%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G G F V+ TG++ A+K + ++ + E+ +L + H N+V L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK----GLEYLHDKANP 206
LV + + G L D + + E K A+ + ++YLH+
Sbjct: 77 STTHYYLVMQLVSGGELFDRILERGVYTE--------KDASLVIQQVLSAVKYLHENG-- 126
Query: 207 PVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT 263
+++RD K N+L EE ++DFGL+K+ +++ + + GT GY APE
Sbjct: 127 -IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQ 181
Query: 264 GQLTVKSDVYSFGVV 278
+ D +S GV+
Sbjct: 182 KPYSKAVDCWSIGVI 196
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 51/298 (17%), Positives = 98/298 (32%), Gaps = 51/298 (17%)
Query: 9 SREDEKLNPEKEPDDQKQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELHLPKDGAGVNI 68
R ++ + +++ S S ++ ++ + +
Sbjct: 20 RRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGP 79
Query: 69 AAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFL 128
+ + + + P+ IG G V + +TG AVK ++ + + E L
Sbjct: 80 EDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQL 139
Query: 129 VEVL---------MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE 179
EV + + H +++ LI LV++ M G L D+L
Sbjct: 140 EEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-------- 191
Query: 180 ALDWNTRMKIAAG------AAK-------GLEYLHDKANPPVIYRDFKSSNILLEEGFHP 226
+ +LH +++RD K NILL++
Sbjct: 192 ---------TEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239
Query: 227 KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE------YAMTGQLTVKSDVYSFGVV 278
+LSDFG + + + GT GY APE + D+++ GV+
Sbjct: 240 RLSDFGFSCH--LEPGEKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 31/209 (14%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 149
+GEG +G V T + VAVK +D E + E+ + +L+H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 150 ADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMK----IAAGAAKGLEYLHDK 203
+G+ + L E+ G L D + P+ +A + +A + YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRFFHQLMAG-----VVYLHGI 124
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE---- 259
+ +RD K N+LL+E + K+SDFGLA + ++ + ++ GT Y APE
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 260 --YAMTGQLTVKSDVYSFGVVFLELITGR 286
+ + DV+S G+V ++ G
Sbjct: 182 REFH--AE---PVDVWSCGIVLTAMLAGE 205
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV--EVLMLSLLHHSNLVNLIGY 148
IG+G F +V TG+ VA+K +D+ L + EV ++ +L+H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 149 CADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMK---IAAGAAKGLEYLHDK 203
L+ E+ G + D+L H +KEA R K I + ++Y H K
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA-----RSKFRQIVS----AVQYCHQK 133
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE---- 259
+++RD K+ N+LL+ + K++DFG + VG K G Y APE
Sbjct: 134 R---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPELFQG 187
Query: 260 --YAMTGQLTVKSDVYSFGVVFLELITGR 286
Y G + DV+S GV+ L++G
Sbjct: 188 KKYD--GP---EVDVWSLGVILYTLVSGS 211
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSN 141
+ + +GEG + VYKG + T +VA+K++ +G + EV +L L H+N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK------ 195
+V L LV+E++ DL K+ LD + I K
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLD--------KDL---KQYLD-DCGNIINMHNVKLFLFQL 109
Query: 196 --GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKSHVSTRVMG 251
GL Y H + V++RD K N+L+ E KL+DFGLA+ P + V+
Sbjct: 110 LRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV- 162
Query: 252 TYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 286
T Y P+ + + + + D++ G +F E+ TGR
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 58/197 (29%), Positives = 84/197 (42%), Gaps = 24/197 (12%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV--EVLMLSLLHHSNLVNLIGY 148
+G+G FG V K T Q AVK +++ + + EV +L L H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 149 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK----GLEYLHDKA 204
D +V E G L D + E AA K G+ Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSE--------HDAARIIKQVFSGITYMHKHN 141
Query: 205 NPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
+++RD K NILL E+ K+ DFGL+ + + R+ GT Y APE
Sbjct: 142 ---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRI-GTAYYIAPE-V 194
Query: 262 MTGQLTVKSDVYSFGVV 278
+ G K DV+S GV+
Sbjct: 195 LRGTYDEKCDVWSAGVI 211
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 59/207 (28%), Positives = 89/207 (42%), Gaps = 25/207 (12%)
Query: 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEV-LMLSLLHHSNLVNLI 146
E +GEG RV T Q AVK +++ EV ++ H N++ LI
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPP--DKEALDWNTRMKIAAGAAKGLEYLHDKA 204
+ + D+ LV+E M GS+ H+H + EA ++ A A L++LH+K
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV---VQDVASA---LDFLHNKG 131
Query: 205 NPPVIYRDFKSSNILLEEGFHP---KLSDFGLAK-LGPVGDKSHVSTRVM----GTYGYC 256
+ +RD K NIL E K+ DF L + GD S +ST + G+ Y
Sbjct: 132 ---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 257 APEYAMTGQLTVKS-----DVYSFGVV 278
APE D++S GV+
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 50/194 (25%), Positives = 79/194 (40%), Gaps = 20/194 (10%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
IG G + + ++T AVK +D++ E +E+ +L H N++ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEI-LLRYGQHPNIITLKDVYD 86
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPP--DKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 208
DG +V E M G L D + ++EA + +EYLH + V
Sbjct: 87 DGKYVYVVTELMKGGELLDKILRQKFFSEREASAV---LFTITKT---VEYLHAQG---V 137
Query: 209 IYRDFKSSNILL---EEGFHP-KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG 264
++RD K SNIL ++ DFG AK + + T T + APE
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTPC-YTANFVAPEVLERQ 195
Query: 265 QLTVKSDVYSFGVV 278
D++S GV+
Sbjct: 196 GYDAACDIWSLGVL 209
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 58/237 (24%), Positives = 94/237 (39%), Gaps = 24/237 (10%)
Query: 60 PKDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN 119
P D I + + IG G FG V++ L + + VA+K++
Sbjct: 17 PLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV--- 72
Query: 120 GLQGNREFLVEVLMLSLLHHSNLVNLIGY-----CADGDQRL-LVYEFMPLGSLEDHLHD 173
LQ R E+ ++ ++ H N+V+L + + L LV E++P ++
Sbjct: 73 -LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRH 130
Query: 174 LPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP-KLSDFG 232
K+ + + L Y+H + +RD K N+LL+ KL DFG
Sbjct: 131 YAKLKQTMPMLLIKLYMYQLLRSLAYIH-SIG--ICHRDIKPQNLLLDPPSGVLKLIDFG 187
Query: 233 LAK-LGPVGDKSH-VSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 286
AK L + +R Y Y APE T D++S G V EL+ G+
Sbjct: 188 SAKILIAGEPNVSYICSR----Y-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 50/195 (25%), Positives = 75/195 (38%), Gaps = 22/195 (11%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
IG G +G V + T A K++ + ++ F E+ ++ L H N++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK----GLEYLHDKANP 206
D LV E G L + + +E AA K + Y H
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRE--------SDAARIMKDVLSAVAYCHKLN-- 126
Query: 207 PVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT 263
V +RD K N L KL DFGLA + T+V GT Y +P+ +
Sbjct: 127 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV-GTPYYVSPQ-VLE 181
Query: 264 GQLTVKSDVYSFGVV 278
G + D +S GV+
Sbjct: 182 GLYGPECDEWSAGVM 196
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 4e-21
Identities = 62/217 (28%), Positives = 90/217 (41%), Gaps = 34/217 (15%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSLLHH 139
+ IGEG +G V+K TGQ+VA+K+ D + + L E+ ML L H
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI--KKIALREIRMLKQLKH 61
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEY 199
NLVNL+ + LV+E+ ++ L + + I + + +
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ---RGVPEHLVKSITWQTLQAVNF 117
Query: 200 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKSH-VSTRVMGTYGYC 256
H I+RD K NIL+ + KL DFG A+L GP V+TR Y
Sbjct: 118 CHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYR 169
Query: 257 APEYAMTGQLTVKSDVYSFGV-------VFLELITGR 286
+PE L V Y V VF EL++G
Sbjct: 170 SPE------LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 5e-21
Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 42/226 (18%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL----DRNGLQGN-----REFLVEVL-M 133
+ P + IG G +G VYK +G VA+K + G G RE V +L
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE--VALLRR 67
Query: 134 LSLLHHSNLVNLI----GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 188
L H N+V L+ D + ++ LV+E + DL + LD
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--------QDL---RTYLDKAPPPG 116
Query: 189 IAAGAAK--------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240
+ A K GL++LH +++RD K NIL+ G KL+DFGLA+
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--IYS 171
Query: 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
+ ++ V+ T Y APE + D++S G +F E+ +
Sbjct: 172 YQMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 63/230 (27%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 65 GVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL----DRNG 120
GV++ + F+ + + + +GEG +G V K + TG++VA+K+ D
Sbjct: 11 GVDLGTENLYFQSM----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM 66
Query: 121 LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA 180
+ + + E+ +L L H NLVNL+ C + LV+EF+ ++ D L P
Sbjct: 67 V--KKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFP---NG 120
Query: 181 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GP 238
LD+ K G+ + H +I+RD K NIL+ + KL DFG A+ P
Sbjct: 121 LDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177
Query: 239 VGDKSH-VSTRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 286
V+TR Y APE + + DV++ G + E+ G
Sbjct: 178 GEVYDDEVATR-----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSLLHHSNLVNLIG 147
IG+G FG+V T ++ A+K +++ E E+ ++ L H LVNL
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 148 YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDKAN 205
Y ++ + +V + + G L HL + +K+ L+YL ++
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHL-----QQNVHFKEETVKLFICELVMALDYLQNQR- 135
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE--YAMT 263
+I+RD K NILL+E H ++DF +A + P + T + GT Y APE +
Sbjct: 136 --IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRK 190
Query: 264 GQLTVKS-DVYSFGVVFLELITGR 286
G + D +S GV EL+ GR
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 6e-21
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 37/219 (16%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSLLH 138
+ ++ +GEG +G VYK +S G++VA+K++ + G+ + E+ +L LH
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGI--PSTAIREISLLKELH 77
Query: 139 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK--- 195
H N+V+LI LV+EFM DL K+ LD + + K
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFME--------KDL---KKVLD-ENKTGLQDSQIKIYL 125
Query: 196 -----GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKSHVSTR 248
G+ + H +++RD K N+L+ KL+DFGLA+ PV +H
Sbjct: 126 YQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---E 179
Query: 249 VMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 286
V+ T Y AP+ M + + + D++S G +F E+ITG+
Sbjct: 180 VV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 8e-21
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 31/209 (14%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 149
+GEG +G V T + VAVK +D E + E+ + +L+H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 150 ADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMK----IAAGAAKGLEYLHDK 203
+G+ + L E+ G L D + P+ +A + +A + YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRFFHQLMAG-----VVYLHGI 124
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE---- 259
+ +RD K N+LL+E + K+SDFGLA + ++ + ++ GT Y APE
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 260 --YAMTGQLTVKSDVYSFGVVFLELITGR 286
+ + DV+S G+V ++ G
Sbjct: 182 REFH--AE---PVDVWSCGIVLTAMLAGE 205
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 9e-21
Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 49/225 (21%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSLLH 138
+ + IGEG +G VYK + G+ A+K++ + G+ + E+ +L L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGI--PSTTIREISILKELK 58
Query: 139 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK--- 195
HSN+V L + +LV+E + DL K+ LD + + AK
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLD--------QDL---KKLLD-VCEGGLESVTAKSFL 106
Query: 196 -----GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKSHVSTR 248
G+ Y HD+ V++RD K N+L+ K++DFGLA+ PV +H
Sbjct: 107 LQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---E 160
Query: 249 VMGTYGYCAPE-------YAMTGQLTVKSDVYSFGVVFLELITGR 286
++ T Y AP+ Y + D++S G +F E++ G
Sbjct: 161 IV-TLWYRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 62/224 (27%), Positives = 98/224 (43%), Gaps = 40/224 (17%)
Query: 84 NFRPESFIGEGGFGRVYKGW-LESTGQVVAVKQL----DRNGL--QGNREFLVEVL-MLS 135
+ + IGEG +G+V+K L++ G+ VA+K++ G+ RE V VL L
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE--VAVLRHLE 69
Query: 136 LLHHSNLVNLI----GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 190
H N+V L D + +L LV+E + DL LD +
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD--------QDL---TTYLDKVPEPGVP 118
Query: 191 AGAAK--------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242
K GL++LH V++RD K NIL+ KL+DFGLA+ +
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQ 173
Query: 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
+++ V+ T Y APE + D++S G +F E+ +
Sbjct: 174 MALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 49/227 (21%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE-----FLVEVLMLSLL 137
K + F+GEG F VYK ++T Q+VA+K++ ++ L E+ +L L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 138 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK-- 195
H N++ L+ LV++FM DL + + + + + K
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFME--------TDL---EVIIK-DNSLVLTPSHIKAY 117
Query: 196 ------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKSH-VS 246
GLEYLH +++RD K +N+LL+E KL+DFGLAK P +H V
Sbjct: 118 MLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV 174
Query: 247 TRVMGTYGYCAPE-------YAMTGQLTVKSDVYSFGVVFLELITGR 286
TR Y APE Y V D+++ G + EL+
Sbjct: 175 TR-----WYRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 44/194 (22%), Positives = 85/194 (43%), Gaps = 19/194 (9%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G G FG V++ ++TG+V K ++ E+ +++ LHH L+NL
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK----GLEYLHDKANP 206
D + +L+ EF+ G L D + + + + GL+++H+ +
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAA---EDYKMS----EAEVINYMRQACEGLKHMHEHS-- 169
Query: 207 PVIYRDFKSSNILLE--EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG 264
+++ D K NI+ E + K+ DFGLA + + T + APE
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDRE 225
Query: 265 QLTVKSDVYSFGVV 278
+ +D+++ GV+
Sbjct: 226 PVGFYTDMWAIGVL 239
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 55/228 (24%)
Query: 91 IGEGGFGRVYKGW--LESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIG- 147
+G G +G VYK + A+KQ++ G+ + E+ +L L H N+++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86
Query: 148 YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAA------------ 194
+ + D+++ L++++ HDL + ++ K
Sbjct: 87 FLSHADRKVWLLFDYAE--------HDL---WHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 195 ---KGLEYLHDKANPPVIYRDFKSSNILLEEGFHP----KLSDFGLAKL--GPVGDKSHV 245
G+ YLH V++RD K +NIL+ K++D G A+L P+ + +
Sbjct: 136 QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192
Query: 246 STRVMGTYGYCAPE-------YAMTGQLTVKSDVYSFGVVFLELITGR 286
V+ T+ Y APE Y T D+++ G +F EL+T
Sbjct: 193 DPVVV-TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 3e-20
Identities = 47/197 (23%), Positives = 79/197 (40%), Gaps = 23/197 (11%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV--EVLMLSLLHHSNLVNLIGY 148
+G+G F V + ++TG A K ++ L + E + L H N+V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 149 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK----GLEYLHDKA 204
+ LV++ + G L + + E A+ + + Y H
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSNG 125
Query: 205 NPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
+++R+ K N+LL +G KL+DFGLA V D GT GY +PE
Sbjct: 126 ---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFA-GTPGYLSPEVL 179
Query: 262 MTGQLTVKSDVYSFGVV 278
+ D+++ GV+
Sbjct: 180 KKDPYSKPVDIWACGVI 196
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 50/221 (22%), Positives = 95/221 (42%), Gaps = 38/221 (17%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL----DRNGLQGNREFLVEVLMLSLLHH 139
+R + +GEG +G VYK T + VA+K++ + G+ + EV +L L H
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV--PGTAIREVSLLKELQH 92
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAA----- 194
N++ L + L++E+ +DL K+ +D N + + +
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAE--------NDL---KKYMDKNPDVSMRVIKSFLYQL 141
Query: 195 -KGLEYLHDKANPPVIYRDFKSSNILLEEGFHP-----KLSDFGLAKL--GPVGDKSHVS 246
G+ + H + ++RD K N+LL K+ DFGLA+ P+ +H
Sbjct: 142 INGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH-- 196
Query: 247 TRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 286
++ T Y PE + + + D++S ++ E++
Sbjct: 197 -EII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 24/228 (10%)
Query: 69 AAQTFTFRELAAATKNFRPESF-----IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG 123
A + F + + + + F +G G FGRV + +G A+K LD+ +
Sbjct: 22 AKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK 81
Query: 124 NREF---LVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA 180
++ L E +L ++ LV L D +V E++ G + HL +
Sbjct: 82 LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-----RIG 136
Query: 181 LDWNTRMKI-AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239
+ AA EYLH +IYRD K N+L+++ + +++DFG AK V
Sbjct: 137 RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR--V 191
Query: 240 GDKSHVSTRVM-GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
+ T + GT APE ++ D ++ GV+ E+ G
Sbjct: 192 KGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 80 AATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL---DRNGLQGNREFLVEVLMLSL 136
+++ F+ +G G + VYKG ++TG VA+K++ G + E+ ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT--PSTAIREISLMKE 59
Query: 137 LHHSNLVNLIGYCADGDQRLLVYEFMP--LGSLEDHLHDLPPDKEALDWNTRMKIAAGAA 194
L H N+V L ++ LV+EFM L D + L+ N
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDS-RTVGNTPRGLELNLVKYFQWQLL 118
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKSHVSTRVMGT 252
+GL + H+ +++RD K N+L+ + KL DFGLA+ PV S V+ T
Sbjct: 119 QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-T 171
Query: 253 YGYCAPE-------YAMTGQLTVKSDVYSFGVVFLELITGR 286
Y AP+ Y + D++S G + E+ITG+
Sbjct: 172 LWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 5e-20
Identities = 69/227 (30%), Positives = 101/227 (44%), Gaps = 33/227 (14%)
Query: 77 ELAAATKNFRPESF-----IGEGGFGRVY---KGWLESTGQVVAVKQLDRNGLQGNREFL 128
+ + P F +G+G FG+V+ K Q+ A+K L + L+
Sbjct: 13 HVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR-- 70
Query: 129 VEVLM----LSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDW 183
V M L ++H +V L Y + +L L+ +F+ G L L E
Sbjct: 71 VRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE--- 126
Query: 184 NTRMKI-AAGAAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGD 241
+K A A L++LH +IYRD K NILL EEG H KL+DFGL+K +
Sbjct: 127 --DVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHE 180
Query: 242 KSHVSTRVM-GTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 286
K GT Y APE + + +S D +SFGV+ E++TG
Sbjct: 181 K---KAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 50/194 (25%), Positives = 78/194 (40%), Gaps = 20/194 (10%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEV-LMLSLLHHSNLVNLIGYC 149
+GEG F K + + Q AVK + + ++ E+ + H N+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPP--DKEALDWNTRMKIAAGAAKGLEYLHDKANPP 207
D LV E + G L + + + EA M+ A + ++HD
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI---MRKLVSA---VSHMHDVG--- 126
Query: 208 VIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG 264
V++RD K N+L + K+ DFG A+L P D + T T Y APE
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKTPC-FTLHYAAPELLNQN 184
Query: 265 QLTVKSDVYSFGVV 278
D++S GV+
Sbjct: 185 GYDESCDLWSLGVI 198
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 5e-20
Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR------EFLVEVLMLSLLHHSNLVN 144
+G G F V K + TG+ A K + + L +R E EV +L + H N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK----GLEYL 200
L + +L+ E + G L D L +KE+L T + A K G+ YL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFL----AEKESL---TEDE-ATQFLKQILDGVHYL 124
Query: 201 HDKANPPVIYRDFKSSNILL----EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 256
H K + + D K NI+L KL DFG+A + + GT +
Sbjct: 125 HSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNIF-GTPEFV 178
Query: 257 APEYAMTGQLTVKSDVYSFGVV 278
APE L +++D++S GV+
Sbjct: 179 APEIVNYEPLGLEADMWSIGVI 200
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 47/234 (20%), Positives = 90/234 (38%), Gaps = 27/234 (11%)
Query: 58 HLPKDGAGVNIAAQTFTFRELAAATKNFR-PESFIGEGGFGRVYKGWLESTGQVVAVKQL 116
H +GV++ + F+ + + +G G F V + +STGQ A K L
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFL 62
Query: 117 DRNGLQGNREFLV--EV-LMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD 173
+ + + E+ ++ ++NL + + +L+ E+ G +
Sbjct: 63 KKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP 122
Query: 174 LPPDK--EALDWNTRMKIAAGAAK----GLEYLHDKANPPVIYRDFKSSNILL---EEGF 224
+ E K G+ YLH +++ D K NILL
Sbjct: 123 ELAEMVSE--------NDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLG 171
Query: 225 HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 278
K+ DFG+++ +G + + GT Y APE +T +D+++ G++
Sbjct: 172 DIKIVDFGMSRK--IGHACELREIM-GTPEYLAPEILNYDPITTATDMWNIGII 222
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 7e-20
Identities = 51/195 (26%), Positives = 81/195 (41%), Gaps = 23/195 (11%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G G FG V++ +TG A K + E+ +S+L H LVNL
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRM--KIAAGAAK----GLEYLHDKA 204
D ++ +++YEFM G L + + D + +M A + GL ++H+
Sbjct: 225 DDNEMVMIYEFMSGGELFEKV---------ADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 205 NPPVIYRDFKSSNILL--EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM 262
++ D K NI+ + KL DFGL V GT + APE A
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAE 329
Query: 263 TGQLTVKSDVYSFGV 277
+ +D++S GV
Sbjct: 330 GKPVGYYTDMWSVGV 344
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 8e-20
Identities = 51/220 (23%), Positives = 86/220 (39%), Gaps = 32/220 (14%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV--------EVLML 134
+ + S +G G FG V+ + + V VK + + + + E+ +L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 135 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGS-LEDHL--HDLPPDKEALDWNTRMK--- 188
S + H+N++ ++ + LV E G L + H + A
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLA-----SYIFRQ 138
Query: 189 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 248
+ + + YL K +I+RD K NI++ E F KL DFG A G +
Sbjct: 139 LVSA----VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC- 190
Query: 249 VMGTYGYCAPEYAMTGQLTV--KSDVYSFGVVFLELITGR 286
GT YCAPE + G + +++S GV L+
Sbjct: 191 --GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 53/212 (25%), Positives = 83/212 (39%), Gaps = 45/212 (21%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV--------EVLMLSLLHHSNL 142
+G G G V + T + VA+K + + E+ +L L+H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 143 VNLIGYCADGDQRLLVYEFMPLGSLED------HLHDLPPDKEALDWNTRMKIAAGAAK- 195
+ + + D + +V E M G L D L KE
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRL------KE--------ATCKLYFYQ 122
Query: 196 ---GLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRV 249
++YLH+ +I+RD K N+LL EE K++DFG +K+ +G+ S + T
Sbjct: 123 MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC 177
Query: 250 MGTYGYCAPE---YAMTGQLTVKSDVYSFGVV 278
GT Y APE T D +S GV+
Sbjct: 178 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 50/223 (22%), Positives = 83/223 (37%), Gaps = 46/223 (20%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR--------NGLQGNREFL---VE 130
+N+ P+ +G G V + + T + AVK +D +Q RE V+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 131 VLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRM--- 187
+L + H N++ L LV++ M G L D+ T
Sbjct: 76 ILR-KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLTEKVTL 121
Query: 188 --KIAAGAAK----GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241
K + + LH +++RD K NILL++ + KL+DFG + +
Sbjct: 122 SEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDP 176
Query: 242 KSHVSTRVMGTYGYCAPE------YAMTGQLTVKSDVYSFGVV 278
+ GT Y APE + D++S GV+
Sbjct: 177 GEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 50/228 (21%), Positives = 85/228 (37%), Gaps = 23/228 (10%)
Query: 60 PKDGAGVNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN 119
G F + N+ + +G+G F V + ++TG A K ++
Sbjct: 6 SMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK 65
Query: 120 GLQGNREFLV--EVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD 177
L + E + L H N+V L + LV++ + G L + +
Sbjct: 66 KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY 125
Query: 178 KEALDWNTRMKIAAGAAK----GLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSD 230
E A+ + + Y H +++R+ K N+LL +G KL+D
Sbjct: 126 SE--------ADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD 174
Query: 231 FGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 278
FGLA V D GT GY +PE + D+++ GV+
Sbjct: 175 FGLAIE--VNDSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVI 219
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 62/250 (24%), Positives = 100/250 (40%), Gaps = 33/250 (13%)
Query: 56 ELHLPKDGAGVNIAAQTFTFRELAAATKNFR--PESF-----IGEGGFGRVYKGWLESTG 108
+L P NI +++ ++ R E + IG G FG V +ST
Sbjct: 35 DLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR 94
Query: 109 QVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHHSNLVNLIGYCA--DGDQRLLVYEFMP 163
+V A+K L + + + F E +++ + +V L + A D +V E+MP
Sbjct: 95 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMP 152
Query: 164 LGSLEDHL--HDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDKANPPVIYRDFKSSNILL 220
G L + + +D+P + A L+ +H I+RD K N+LL
Sbjct: 153 GGDLVNLMSNYDVPEK--------WARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLL 201
Query: 221 EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE----YAMTGQLTVKSDVYSFG 276
++ H KL+DFG T V GT Y +PE G + D +S G
Sbjct: 202 DKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVG 260
Query: 277 VVFLELITGR 286
V E++ G
Sbjct: 261 VFLYEMLVGD 270
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 51/204 (25%), Positives = 78/204 (38%), Gaps = 29/204 (14%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-----EVLMLSLLHHSNLVNL 145
IG+G F V + TGQ AVK +D + E + +L H ++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHL----HDLPPDKEALDWNTRMKIAAGAAK----GL 197
+ + +V+EFM L + E +A+ + L
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE--------AVASHYMRQILEAL 143
Query: 198 EYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 254
Y HD +I+RD K +LL E KL FG+A +G+ V+ +GT
Sbjct: 144 RYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPH 198
Query: 255 YCAPEYAMTGQLTVKSDVYSFGVV 278
+ APE DV+ GV+
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVI 222
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 85 FRPESF-----IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSL 136
F +G+G FG+V ++TG+ A+K L + + E + E +L
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 137 LHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAA 194
H L L Y RL V E+ G L HL E R + A
Sbjct: 62 TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFYGAEIV 115
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 254
LEYLH + V+YRD K N++L++ H K++DFGL K G + D + + T GT
Sbjct: 116 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPE 170
Query: 255 YCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 286
Y APE + ++ D + GVV E++ GR
Sbjct: 171 YLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 58/202 (28%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR------EFLVEVLMLSLLHHSNLVN 144
+G G F V K +STG A K + + + +R E EV +L + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK----GLEYL 200
L + +L+ E + G L D L KE+L + A K G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL----AQKESL----SEEEATSFIKQILDGVNYL 131
Query: 201 HDKANPPVIYRDFKSSNILLEEGFHP----KLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 256
H K + + D K NI+L + P KL DFGLA + D GT +
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GTPEFV 185
Query: 257 APEYAMTGQLTVKSDVYSFGVV 278
APE L +++D++S GV+
Sbjct: 186 APEIVNYEPLGLEADMWSIGVI 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 58/202 (28%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR------EFLVEVLMLSLLHHSNLVN 144
+G G F V K +STG A K + + + +R E EV +L + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK----GLEYL 200
L + +L+ E + G L D L KE+L + A K G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL----AQKESL----SEEEATSFIKQILDGVNYL 131
Query: 201 HDKANPPVIYRDFKSSNILLEEGFHP----KLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 256
H K + + D K NI+L + P KL DFGLA + D GT +
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GTPEFV 185
Query: 257 APEYAMTGQLTVKSDVYSFGVV 278
APE L +++D++S GV+
Sbjct: 186 APEIVNYEPLGLEADMWSIGVI 207
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 64/222 (28%), Positives = 95/222 (42%), Gaps = 31/222 (13%)
Query: 82 TKNFRPESF-----IGEGGFGRVY---KGWLESTGQVVAVKQLDRNGLQGNREFLVEVLM 133
+ RPE F +G+GG+G+V+ K +TG++ A+K L + + N +
Sbjct: 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK-DTAHTK 69
Query: 134 -----LSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRM 187
L + H +V+LI Y +L L+ E++ G L L E
Sbjct: 70 AERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED-----TA 123
Query: 188 KI-AAGAAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHV 245
A + L +LH K +IYRD K NI+L +G H KL+DFGL K
Sbjct: 124 CFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQG-HVKLTDFGLCKESIHDGT--- 176
Query: 246 STRVM-GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
T GT Y APE M D +S G + +++TG
Sbjct: 177 VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 69/250 (27%), Positives = 106/250 (42%), Gaps = 28/250 (11%)
Query: 51 GVSKRELHLPKDGAGVNIAAQTFTFRELAAATKNFRPESF-----IGEGGFGRVYKGWLE 105
G+S+ + + A + ++ + +P F IG+G FG+V +
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60
Query: 106 STGQVVAVKQLDRNGLQGNREF---LVE--VLMLSLLHHSNLVNLIGYCADGDQRL-LVY 159
+ AVK L + + +E + E VL+ ++ H LV L + +L V
Sbjct: 61 AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLH-FSFQTADKLYFVL 118
Query: 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDKANPPVIYRDFKSSNI 218
+++ G L HL E R + AA A L YLH ++YRD K NI
Sbjct: 119 DYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGYLHSLN---IVYRDLKPENI 170
Query: 219 LL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKS-DVYSFG 276
LL +G H L+DFGL K + S ST GT Y APE + Q ++ D + G
Sbjct: 171 LLDSQG-HIVLTDFGLCKEN-IEHNSTTST-FCGTPEYLAPE-VLHKQPYDRTVDWWCLG 226
Query: 277 VVFLELITGR 286
V E++ G
Sbjct: 227 AVLYEMLYGL 236
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 57/242 (23%), Positives = 88/242 (36%), Gaps = 36/242 (14%)
Query: 67 NIAAQTFTFRELAAATKNFR--PESF-----IGEGGFGRVYKGWLESTGQVVAVKQLDRN 119
NI + + K R E F IG G FG V L++ +V A+K L++
Sbjct: 51 NILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW 110
Query: 120 GLQGNRE---FLVEVLMLSLLHHSNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHL--- 171
+ E F E +L + L + A D + LV ++ G L L
Sbjct: 111 EMLKRAETACFREERDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKF 168
Query: 172 -HDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLS 229
LP + + A ++ +H ++RD K NIL++ H +L+
Sbjct: 169 EDRLPEE--------MARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLA 217
Query: 230 DFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKS-----DVYSFGVVFLELIT 284
DFG S V GT Y +PE + D +S GV E++
Sbjct: 218 DFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
Query: 285 GR 286
G
Sbjct: 277 GE 278
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 49/221 (22%), Positives = 89/221 (40%), Gaps = 34/221 (15%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV------EVLMLSL 136
++ +G GGFG VY G S VA+K ++++ + E EV++L
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 137 LHHS--NLVNLIGYCADGDQRLLVYEF-MPLGSLEDHL--HDLPPDKEALDWNTRMK--- 188
+ ++ L+ + D +L+ E P+ L D + ++ A R
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-----RSFFWQ 157
Query: 189 -IAAGAAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVS 246
+ A + + H+ V++RD K NIL+ KL DFG L + +
Sbjct: 158 VLEA-----VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYT 206
Query: 247 TRVMGTYGYCAPEYAMTGQLT-VKSDVYSFGVVFLELITGR 286
GT Y PE+ + + V+S G++ +++ G
Sbjct: 207 DFD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 83 KNFRPESF-----IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVE--VL 132
+ E F +G+G FG+V+ + T Q A+K L ++ + + + +VE VL
Sbjct: 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 133 MLSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-A 190
L+ H L ++ + L V E++ G L H+ + R A
Sbjct: 72 SLAW-EHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATFYA 124
Query: 191 AGAAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRV 249
A GL++LH K ++YRD K NILL ++G H K++DFG+ K + + +T
Sbjct: 125 AEIILGLQFLHSKG---IVYRDLKLDNILLDKDG-HIKIADFGMCKEN-MLGDAKTNT-F 178
Query: 250 MGTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 286
GT Y APE + GQ S D +SFGV+ E++ G+
Sbjct: 179 CGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 47/199 (23%), Positives = 80/199 (40%), Gaps = 28/199 (14%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G G G+V + + TGQ A+K L + +E V+ ++V ++
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR-QE--VD-HHWQASGGPHIVCILDVYE 92
Query: 151 DGDQR----LLVYEFMPLGSLEDHLHDLPPD----KEALDWNTRMKIAAGAAKGLEYLHD 202
+ L++ E M G L + + +EA + M+ A +++LH
Sbjct: 93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI---MRDIGTA---IQFLHS 146
Query: 203 KANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE 259
+ +RD K N+L E+ KL+DFG AK + T T Y APE
Sbjct: 147 HN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC-YTPYYVAPE 199
Query: 260 YAMTGQLTVKSDVYSFGVV 278
+ D++S GV+
Sbjct: 200 VLGPEKYDKSCDMWSLGVI 218
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 62/220 (28%), Positives = 94/220 (42%), Gaps = 42/220 (19%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE-F----LVEVLMLSLLHHSNLVNL 145
IG+G FG V+K TGQ VA+K++ ++ +E F L E+ +L LL H N+VNL
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 146 IGYCADGDQRL--------LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK-- 195
I C LV++F HDL L N +K K
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCE--------HDL---AGLLS-NVLVKFTLSEIKRV 129
Query: 196 ------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKSHVST 247
GL Y+H +++RD K++N+L+ KL+DFGLA+ + + T
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 248 RVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 286
+ T Y PE + D++ G + E+ T
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 34/196 (17%), Positives = 78/196 (39%), Gaps = 26/196 (13%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-EVLMLSLLHHSNLVNLIGYC 149
+G G FG V++ S+ + K + G ++ + E+ +L++ H N+++L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESF 70
Query: 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRM--KIAAGAAK----GLEYLHDK 203
++ ++++EF+ + + + + + L++LH
Sbjct: 71 ESMEELVMIFEFISGLDIFERI---------NTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 204 ANPPVIYRDFKSSNILL--EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
+ + D + NI+ K+ +FG A+ GD + + Y APE
Sbjct: 122 N---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVH 175
Query: 262 MTGQLTVKSDVYSFGV 277
++ +D++S G
Sbjct: 176 QHDVVSTATDMWSLGT 191
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 43/228 (18%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV--------------------- 129
IG+G +G V + E+ A+K L + L F
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 130 -----EVLMLSLLHHSNLVNL--IGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEAL 181
E+ +L L H N+V L + + D +V+E + G + + P + +A
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 182 DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241
+ + I G+EYLH + +I+RD K SN+L+ E H K++DFG++ G
Sbjct: 141 FY-FQDLIK-----GIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKGS 190
Query: 242 KSHVSTRVMGTYGYCAPEYAMTGQLTV---KSDVYSFGVVFLELITGR 286
+ +S V GT + APE + DV++ GV + G+
Sbjct: 191 DALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 28/202 (13%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR------EFLVEVLMLSLLHHSNLVN 144
+G G F V K +STG A K + + + +R + EV +L + H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK----GLEYL 200
L + +L+ E + G L D L +KE+L + A K G+ YL
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFL----AEKESLT----EEEATEFLKQILNGVYYL 130
Query: 201 HDKANPPVIYRDFKSSNILL----EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 256
H + + D K NI+L K+ DFGLA D + + GT +
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 257 APEYAMTGQLTVKSDVYSFGVV 278
APE L +++D++S GV+
Sbjct: 185 APEIVNYEPLGLEADMWSIGVI 206
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 56/255 (21%), Positives = 88/255 (34%), Gaps = 38/255 (14%)
Query: 56 ELHLPKDGAGVNIAAQTFTFRELAAATKNFR--PESF-----IGEGGFGRVYKGWLESTG 108
EL + +A + K R + F IG G F V ++ TG
Sbjct: 27 ELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTG 86
Query: 109 QVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHHSNLVNLIGYCA--DGDQRLLVYEFMP 163
QV A+K +++ + E F E +L + L + A D + LV E+
Sbjct: 87 QVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL--HFAFQDENYLYLVMEYYV 144
Query: 164 LGSLEDHL----HDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDKANPPVIYRDFKSSNI 218
G L L +P + + A ++ +H ++RD K NI
Sbjct: 145 GGDLLTLLSKFGERIPAE--------MARFYLAEIVMAIDSVHRLG---YVHRDIKPDNI 193
Query: 219 LLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVY----- 273
LL+ H +L+DFG V GT Y +PE + Y
Sbjct: 194 LLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECD 252
Query: 274 --SFGVVFLELITGR 286
+ GV E+ G+
Sbjct: 253 WWALGVFAYEMFYGQ 267
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 8e-19
Identities = 35/169 (20%), Positives = 64/169 (37%), Gaps = 27/169 (15%)
Query: 135 SLLHHSNLVNLIGYCADGDQRLLVY---EFMPLGSLEDHL-----HDLPPDKEALDWNTR 186
+ + N +G ++ +Y + +L+D + + L
Sbjct: 113 RRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHI--F 170
Query: 187 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK----------L 236
++IA + +E+LH K +++RD K SNI K+ DFGL +
Sbjct: 171 IQIA----EAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 285
T +GT Y +PE + K D++S G++ EL+
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 8e-19
Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 85 FRPESF-----IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVEVLMLSL 136
+ + F +G G FGRV+ G+ A+K L + + ++ E LMLS+
Sbjct: 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 137 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAK 195
+ H ++ + G D Q ++ +++ G L L K N K AA
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCL 117
Query: 196 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM-GTYG 254
LEYLH K +IYRD K NILL++ H K++DFG AK V D T + GT
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY--VPDV----TYTLCGTPD 168
Query: 255 YCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 286
Y APE ++ + KS D +SFG++ E++ G
Sbjct: 169 YIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 8e-19
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 40/213 (18%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV-----EVLMLSLLHHSNLVNL 145
+G G FG+V G + TG VAVK L+R ++ +V E+ L L H +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD--VVGKIKREIQNLKLFRHPHIIKL 76
Query: 146 IGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMK----IAAGAAKGLEY 199
+ +V E++ G L D++ H + EA R ++A ++Y
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA-----RRLFQQILSA-----VDY 126
Query: 200 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE 259
H V++RD K N+LL+ + K++DFGL+ + G+ S G+ Y APE
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE 180
Query: 260 ------YAMTGQLTVKSDVYSFGVVFLELITGR 286
YA G + D++S GV+ L+ G
Sbjct: 181 VISGRLYA--GP---EVDIWSCGVILYALLCGT 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 9e-19
Identities = 31/205 (15%), Positives = 58/205 (28%), Gaps = 41/205 (20%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLHHSN 141
+R F G + ++ + + VA+ +D G+ + +E L L LS +
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
+ ++ L+V E++ GSL++ P A+ A + H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR------AMQSLAAAADAAH 146
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
V S + +S G L
Sbjct: 147 RA---GVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA-- 179
Query: 262 MTGQLTVKSDVYSFGVVFLELITGR 286
+ D+ G L+ R
Sbjct: 180 -----NPQDDIRGIGASLYALLVNR 199
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 59/224 (26%), Positives = 90/224 (40%), Gaps = 33/224 (14%)
Query: 83 KNFRPESF-----IGEGGFGRVY---KGWLESTGQVVAVKQLDRNGLQGNREFLVEVLM- 133
+ E+F +G G +G+V+ K TG++ A+K L + + +
Sbjct: 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 108
Query: 134 ----LSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 188
+ LV L Y + +L L+ +++ G L HL + ++
Sbjct: 109 RQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLS-----QRERFTEHEVQ 162
Query: 189 I-AAGAAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVS 246
I LE+LH +IYRD K NILL G H L+DFGL+K +
Sbjct: 163 IYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNG-HVVLTDFGLSKEFVADETERAY 218
Query: 247 TRVMGTYGYCAPEYAMTGQL----TVKSDVYSFGVVFLELITGR 286
GT Y AP+ G V D +S GV+ EL+TG
Sbjct: 219 DFC-GTIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 67/232 (28%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 70 AQTFTFRELAAATKNFRPESF-----IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN 124
T + + + F +G+G FG+V + T ++ AVK L ++ + +
Sbjct: 2 TNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 61
Query: 125 REF---LVE--VLMLSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDK 178
+ +VE VL L L L C RL V E++ G L H+ + K
Sbjct: 62 DDVECTMVEKRVLALPG-KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK 119
Query: 179 EALDWNTRMKI-AAGAAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKL 236
E AA A GL +L K +IYRD K N++L EG H K++DFG+ K
Sbjct: 120 EP-----HAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEG-HIKIADFGMCKE 170
Query: 237 GPVGDKSHVSTRVM-GTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 286
+T+ GT Y APE + Q KS D ++FGV+ E++ G+
Sbjct: 171 NIWDGV---TTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 23/214 (10%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLH 138
K ++ IG G G V + + VA+K+L R N R E++++ ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA-YRELVLMKCVN 119
Query: 139 HSNLVNLIG-YCADGDQRL-----LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 192
H N+++L+ + LV E M + +L + + LD +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVI--QMELDHERMSYLLYQ 172
Query: 193 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 252
G+++LH A +I+RD K SNI+++ K+ DFGLA+ S + T + T
Sbjct: 173 MLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVT 226
Query: 253 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
Y APE + D++S G + E++ +
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 74/295 (25%), Positives = 115/295 (38%), Gaps = 30/295 (10%)
Query: 6 CFDSREDEKLNPEKEPDDQKQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELHLPKDGAG 65
F E +K + Q + N +P +R A
Sbjct: 261 SFGISELQKAGVDGWFKLLSQEEGEYFNV--PVPPEGSEGNEELRQKFERAKIGQGTKAP 318
Query: 66 VNIAAQTFTFRELAAATKNFRPESF-----IGEGGFGRVYKGWLESTGQVVAVKQLDRNG 120
A T + + + F +G+G FG+V + T ++ AVK L ++
Sbjct: 319 EEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDV 378
Query: 121 LQGNREF---LVE--VLMLSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDL 174
+ + + +VE VL L L L C RL V E++ G L H+ +
Sbjct: 379 VIQDDDVECTMVEKRVLALPGKPPF-LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQV 436
Query: 175 PPDKEALDWNTRMKI-AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 233
KE AA A GL +L K +IYRD K N++L+ H K++DFG+
Sbjct: 437 GRFKEP-----HAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGM 488
Query: 234 AKLGPVGDKSHVSTRVM-GTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 286
K +T+ GT Y APE + Q KS D ++FGV+ E++ G+
Sbjct: 489 CKENIWDGV---TTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 28/221 (12%)
Query: 80 AATKNFRPESF-----IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVE- 130
A + F IG G + +V L+ T ++ A+K + + + + + E
Sbjct: 1 GAMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEK 60
Query: 131 -VLMLSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 188
V + +H LV L C + RL V E++ G L H+ E +
Sbjct: 61 HVFEQAS-NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-----HAR 113
Query: 189 I-AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 247
+A + L YLH++ +IYRD K N+LL+ H KL+D+G+ K G +T
Sbjct: 114 FYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TT 167
Query: 248 RVM-GTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 286
GT Y APE + G+ S D ++ GV+ E++ GR
Sbjct: 168 STFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 45/197 (22%), Positives = 77/197 (39%), Gaps = 22/197 (11%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV--EVLMLSLLHHSNLVNLIGY 148
+G+G F V + GQ A ++ L + E + LL H N+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 149 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK----GLEYLHDKA 204
++ L+++ + G L + + E A+ + + + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSE--------ADASHCIQQILEAVLHCHQMG 130
Query: 205 NPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
V++R+ K N+LL +G KL+DFGLA V + GT GY +PE
Sbjct: 131 ---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGTPGYLSPEVL 185
Query: 262 MTGQLTVKSDVYSFGVV 278
D+++ GV+
Sbjct: 186 RKDPYGKPVDLWACGVI 202
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 79 AAATKNFRPESF-----IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---LVE 130
++ ++F +G+G FG+V ++ TG + AVK L ++ + + + + E
Sbjct: 14 VNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE 73
Query: 131 --VLMLSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRM 187
+L L+ +H L L C RL V EF+ G L H+ EA R
Sbjct: 74 KRILSLAR-NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----RA 126
Query: 188 KI-AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 246
+ AA L +LHDK +IYRD K N+LL+ H KL+DFG+ K G +
Sbjct: 127 RFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV---T 180
Query: 247 TRVM-GTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 286
T GT Y APE + L + D ++ GV+ E++ G
Sbjct: 181 TATFCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 54/270 (20%), Positives = 90/270 (33%), Gaps = 32/270 (11%)
Query: 20 EPDDQKQGQPTVSNNISRLPSGRDRLRSRSNGVSKRELHLPKDGAGVNIAAQTFTFRELA 79
Q P + P + P+ + + +
Sbjct: 4 NSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID-- 61
Query: 80 AATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH 139
+G G G+V + + + T + A+K L RE VE L
Sbjct: 62 ---DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-RE--VE-LHWRASQC 114
Query: 140 SNLVNLIGYCADGDQR----LLVYEFMPLGSLEDHLHDLPPD----KEALDWNTRMKIAA 191
++V ++ + L+V E + G L + D +EA + MK
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI---MKSIG 171
Query: 192 GAAKGLEYLHDKANPPVIYRDFKSSNILLE---EGFHPKLSDFGLAKLGPVGDKSHVSTR 248
A ++YLH + +RD K N+L KL+DFG AK + ++T
Sbjct: 172 EA---IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTP 223
Query: 249 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 278
T Y APE + D++S GV+
Sbjct: 224 C-YTPYYVAPEVLGPEKYDKSCDMWSLGVI 252
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 52/257 (20%), Positives = 99/257 (38%), Gaps = 75/257 (29%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN 141
+K + +G G FG V + + +G+ A+K++ ++ NRE + ++ +L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61
Query: 142 LVNLIGY-------------------------------------CADGDQRL-LVYEFMP 163
++ L+ Y ++ L ++ E++P
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 164 LGSLEDHLHDLPPDKEALDWNTRMKIAAGAA----------KGLEYLHDKANPPVIYRDF 213
+ LH + L R + + + ++H + +RD
Sbjct: 122 ----DT-LHKV------LKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLG--ICHRDI 167
Query: 214 KSSNILLEEGFHP-KLSDFGLAKLGPVGDK--SHVSTRVMGTYGYCAPEYAMTGQL-TVK 269
K N+L+ + KL DFG AK + +++ +R + Y APE + T
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEYTPS 222
Query: 270 SDVYSFGVVFLELITGR 286
D++S G VF ELI G+
Sbjct: 223 IDLWSIGCVFGELILGK 239
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 8e-18
Identities = 60/266 (22%), Positives = 96/266 (36%), Gaps = 77/266 (28%)
Query: 91 IGEGGFGRVYKG-----WLESTGQVVAVKQL-DRNGLQGNREFLVEV-LMLSLLHHSNLV 143
+G G FG+V + +T + VAVK L + +R + E+ +++ + HH N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 144 NLIG--------------YCADGDQRLLVY------------------------------ 159
NL+G +C G+ L Y
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 160 ---------------------EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 198
E L +E+ K+ L + + AKG+E
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 199 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAP 258
+L + I+RD + NILL E K+ DFGLA+ + AP
Sbjct: 208 FLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264
Query: 259 EYAMTGQLTVKSDVYSFGVVFLELIT 284
E T++SDV+SFGV+ E+ +
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 8e-18
Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 25/215 (11%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLH 138
K ++ IG G G V + + VA+K+L R N R + E++++ ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 82
Query: 139 HSNLVNLIG-YCADGDQRL-----LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK-IAA 191
H N++ L+ + +V E M + +L + + LD + RM +
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVI--QMELD-HERMSYLLY 134
Query: 192 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 251
G+++LH A +I+RD K SNI+++ K+ DFGLA S + T +
Sbjct: 135 QMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVV 188
Query: 252 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
T Y APE + D++S G + E+I G
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 63/248 (25%), Positives = 108/248 (43%), Gaps = 28/248 (11%)
Query: 53 SKRELHLPKDGAGVNIAAQTFTFRELAAATKNFRPESF-----IGEGGFGRVYKGWLEST 107
++ G+G+ + RE A+ + + F IG G + +V L+ T
Sbjct: 17 TENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKT 76
Query: 108 GQVVAVKQLDRNGLQGNREF---LVE--VLMLSLLHHSNLVNLIGYCADGDQRL-LVYEF 161
++ A++ + + + + + E V + +H LV L C + RL V E+
Sbjct: 77 DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVGLH-SCFQTESRLFFVIEY 134
Query: 162 MPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDKANPPVIYRDFKSSNILL 220
+ G L H+ E + +A + L YLH++ +IYRD K N+LL
Sbjct: 135 VNGGDLMFHMQRQRKLPEE-----HARFYSAEISLALNYLHERG---IIYRDLKLDNVLL 186
Query: 221 EEGFHPKLSDFGLAKLGPVGDKSHVSTRVM-GTYGYCAPEYAMTGQLTVKS-DVYSFGVV 278
+ H KL+D+G+ K G +T GT Y APE + G+ S D ++ GV+
Sbjct: 187 DSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVL 242
Query: 279 FLELITGR 286
E++ GR
Sbjct: 243 MFEMMAGR 250
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 52/195 (26%), Positives = 85/195 (43%), Gaps = 23/195 (11%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
+G G VY+ + T + A+K L + + E+ +L L H N++ L
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK----GLEYLHDKANP 206
+ LV E + G L D + + E + AA A K + YLH+
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSE--------RDAADAVKQILEAVAYLHENG-- 168
Query: 207 PVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT 263
+++RD K N+L K++DFGL+K+ V + + T GT GYCAPE
Sbjct: 169 -IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTVC-GTPGYCAPEILRG 224
Query: 264 GQLTVKSDVYSFGVV 278
+ D++S G++
Sbjct: 225 CAYGPEVDMWSVGII 239
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 52/212 (24%), Positives = 82/212 (38%), Gaps = 40/212 (18%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV--EVLMLSLLHHSNLVNLIGY 148
IG G FG + T ++VAVK ++R V E++ L H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN---VQREIINHRSLRHPNIVRFKEV 84
Query: 149 CADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMK----IAAGAAKGLEYLHD 202
++ E+ G L + + + EA R ++ + Y H
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEA-----RFFFQQLLSG-----VSYCHS 134
Query: 203 KANPPVIYRDFKSSNILLEEGFHP--KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE- 259
+ +RD K N LL+ P K+ DFG +K + + + V GT Y APE
Sbjct: 135 MQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPEV 188
Query: 260 -----YAMTGQLTVKSDVYSFGVVFLELITGR 286
Y G+ +DV+S GV ++ G
Sbjct: 189 LLRQEYD--GK---IADVWSCGVTLYVMLVGA 215
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV---EVLMLSLLHHSNLVNLIG 147
+GEG FG+V T Q VA+K + R L+ + + E+ L LL H +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 148 YCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMK----IAAGAAKGLEYLH 201
++V E+ G L D++ + E R I A +EY H
Sbjct: 77 VITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEG-----RRFFQQIICA-----IEYCH 125
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE-- 259
+++RD K N+LL++ + K++DFGL+ + G+ S G+ Y APE
Sbjct: 126 RHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVI 179
Query: 260 ----YAMTGQLTVKSDVYSFGVVFLELITGR 286
YA G + DV+S G+V ++ GR
Sbjct: 180 NGKLYA--GP---EVDVWSCGIVLYVMLVGR 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 36/211 (17%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV---EVLMLSLLHHSNLVNLIG 147
+G G FG+V G E TG VAVK L+R ++ E+ L L H +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 148 YCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMK----IAAGAAKGLEYLH 201
+ +V E++ G L D++ + +KE+ R ++ ++Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES-----RRLFQQILSG-----VDYCH 133
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE-- 259
V++RD K N+LL+ + K++DFGL+ + G+ S G+ Y APE
Sbjct: 134 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVI 187
Query: 260 ----YAMTGQLTVKSDVYSFGVVFLELITGR 286
YA G + D++S GV+ L+ G
Sbjct: 188 SGRLYA--GP---EVDIWSSGVILYALLCGT 213
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 50/220 (22%), Positives = 88/220 (40%), Gaps = 30/220 (13%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-------QGNREFLVEVLMLS 135
+R +G+GGFG V+ G + VA+K + RN + L EV +L
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLW 89
Query: 136 LLH----HSNLVNLIGYCADGDQRLLVYEF-MPLGSLEDHL--HDLPPDKEALDWNTRMK 188
+ H ++ L+ + + +LV E +P L D++ + + R
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS-----R-C 143
Query: 189 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVST 247
+++ H + V++RD K NIL+ KL DFG L +
Sbjct: 144 FFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTD 197
Query: 248 RVMGTYGYCAPEYAMTGQLT-VKSDVYSFGVVFLELITGR 286
GT Y PE+ Q + + V+S G++ +++ G
Sbjct: 198 FD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 26/215 (12%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLH 138
K + + +G G +G V + +G+ VA+K+L R + + R E+L+L +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA-YRELLLLKHMQ 81
Query: 139 HSNLVNLI-----GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 192
H N++ L+ LV FM + L + +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIM--GLKFSEEKIQYLVYQ 134
Query: 193 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 252
KGL+Y+H A V++RD K N+ + E K+ DFGLA+ +V TR
Sbjct: 135 MLKGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR---- 187
Query: 253 YGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 286
+ Y APE ++ D++S G + E++TG+
Sbjct: 188 W-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 61/215 (28%), Positives = 90/215 (41%), Gaps = 25/215 (11%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLH 138
+R +G G +G V TG VA+K+L R + L R E+ +L +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA-YRELRLLKHMR 82
Query: 139 HSNLVNLIG-YCADGDQRL-----LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 192
H N++ L+ + D LV FM L L E L + +
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLM-KHEKLGEDRIQFLVYQ 136
Query: 193 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 252
KGL Y+H A +I+RD K N+ + E K+ DFGLA+ +V TR
Sbjct: 137 MLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW--- 190
Query: 253 YGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 286
Y APE + T D++S G + E+ITG+
Sbjct: 191 --YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 55/255 (21%), Positives = 89/255 (34%), Gaps = 68/255 (26%)
Query: 66 VNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR--NGLQG 123
++ A+ + + FI G +G V G ++S G VA+K++ + +
Sbjct: 11 RDLIAELHAM------QSPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRT 63
Query: 124 NREF---------LVEVLMLSLLHHSNLVNL----IGYCADGDQRL-LVYEFMPLGSLED 169
L E+ +L+ HH N++ L + + +L LV E M
Sbjct: 64 VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RT 118
Query: 170 HLHDLPPDKEALDWNTRMKIAAGAA---------------KGLEYLHDKANPPVIYRDFK 214
L + I GL LH+ A V++RD
Sbjct: 119 DLAQV--------------IHDQRIVISPQHIQYFMYHILLGLHVLHE-AG--VVHRDLH 161
Query: 215 SSNILLEEGFHPKLSDFGLAKLGPVGDKS--HVSTRVMGTYGYCAPEYAMT-GQLTVKSD 271
NILL + + DF LA+ +V+ R Y APE M T D
Sbjct: 162 PGNILLADNNDITICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVD 216
Query: 272 VYSFGVVFLELITGR 286
++S G V E+ +
Sbjct: 217 MWSAGCVMAEMFNRK 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 53/231 (22%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLD--RNGLQGNREFLVEVLMLSLLHH 139
+ S+IGEG +G V + VA+K++ + R L E+ +L H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRH 84
Query: 140 SNLVNLIG----YCADGDQRL-LVYEFMPLGSLEDHLH------DLPPDK------EALD 182
N++ + + + + +V + M E L+ L D + L
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQIL- 138
Query: 183 WNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242
+GL+Y+H AN V++RD K SN+LL K+ DFGLA++
Sbjct: 139 ------------RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 243 S------HVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 286
+V+TR Y APE + + T D++S G + E+++ R
Sbjct: 184 HTGFLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLH 138
+ ++ S +G G +G V + TG VAVK+L R + + R E+ +L +
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-YRELRLLKHMK 86
Query: 139 HSNLVNLI-----GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 192
H N++ L+ + + LV M L+++ ++ D + + +
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQF-LIYQ 140
Query: 193 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 252
+GL+Y+H A+ +I+RD K SN+ + E K+ DFGLA+ +V+TR
Sbjct: 141 ILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW--- 194
Query: 253 YGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 286
Y APE + D++S G + EL+TGR
Sbjct: 195 --YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 57/233 (24%), Positives = 95/233 (40%), Gaps = 50/233 (21%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLD--RNGLQGNREFLVEVLMLSLLHH 139
+ +F+ +S +GEG +G V + TG++VA+K+++ L R L E+ +L H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFKH 68
Query: 140 SNLVNLIG-YCADGDQRL----LVYEFMPLGSLEDHLH------DLPPDK------EALD 182
N++ + D + ++ E M + LH L D + L
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQTL- 122
Query: 183 WNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA----KLGP 238
+ ++ LH +N VI+RD K SN+L+ K+ DFGLA +
Sbjct: 123 ------------RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 239 VGDKSHVSTRVMGTY----GYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 286
+ M + Y APE +T + DV+S G + EL R
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 45/221 (20%), Positives = 86/221 (38%), Gaps = 37/221 (16%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLML-SLLHHS 140
+++ +G G + V++ + + V VK L ++ E+ +L +L
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGP 91
Query: 141 NLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPD------KEALDWNTRMKIAAG 192
N++ L D R LV+E + + L E L
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL----------- 140
Query: 193 AAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDK--SHVSTRV 249
K L+Y H +++RD K N+++ E +L D+GLA+ G + V++R
Sbjct: 141 --KALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195
Query: 250 MGTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGRKAI 289
+ PE + Q+ S D++S G + +I ++
Sbjct: 196 -----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 52/235 (22%), Positives = 92/235 (39%), Gaps = 52/235 (22%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLD-RNGLQGNREFLVEVLMLSLLHHS 140
+ +G GG G V+ + VA+K++ + L E+ ++ L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA-LREIKIIRRLDHD 68
Query: 141 NLVNLIG-YCADGDQRL-------------LVYEFMPLGSLEDHLH------DLPPDK-- 178
N+V + G Q +V E+M E L L +
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHAR 123
Query: 179 ----EALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGL 233
+ L +GL+Y+H AN V++RD K +N+ + E K+ DFGL
Sbjct: 124 LFMYQLL-------------RGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGL 167
Query: 234 AK-LGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 286
A+ + P + + T Y +P ++ T D+++ G +F E++TG+
Sbjct: 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 46/158 (29%), Positives = 61/158 (38%), Gaps = 15/158 (9%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 143
NFR IG G FG + G T + VA+K L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ-LGSGDGIP 68
Query: 144 NLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
+ + G +V E LG SLED L DL +L T + IA +EY+H
Sbjct: 69 QVYYFGPCGKYNAMVLEL--LGPSLED-LFDLCDRTFSL--KTVLMIAIQLISRMEYVHS 123
Query: 203 KANPPVIYRDFKSSNILLEEGFHPK-----LSDFGLAK 235
K +IYRD K N L+ + + DF LAK
Sbjct: 124 KN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 22/214 (10%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 143
+R IG G FG +Y G + G+ VA+K + + +E + ++ +
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGI 67
Query: 144 -NLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
+ A+GD ++V E LG SLED L + K +L T + +A +EY+H
Sbjct: 68 PTIRWCGAEGDYNVMVMEL--LGPSLED-LFNFCSRKFSL--KTVLLLADQMISRIEYIH 122
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPK---LSDFGLAKL-GPVGDKSHVSTR----VMGTY 253
K I+RD K N L+ G + DFGLAK H+ R + GT
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 254 GYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGR 286
Y A G + + + D+ S G V + G
Sbjct: 180 RY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 9e-14
Identities = 56/330 (16%), Positives = 103/330 (31%), Gaps = 94/330 (28%)
Query: 36 SRLPSGRDRLRSRSNGVSKRELHLPKDGAGVNIAAQTFTFRELAAA---TKNFRPESFIG 92
S + + S + + + + T + + + IG
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62
Query: 93 EGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF---------LVEVLMLSLLHHSNLV 143
G +G V + + + +VVA+K++ R F L E+ +L+ L+H ++V
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKI-------LRVFEDLIDCKRILREIAILNRLNHDHVV 115
Query: 144 NL----IGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAA---- 194
+ I + L +V E + L
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKL--------------FRTPVYLTEL 156
Query: 195 ----------KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244
G++Y+H A +++RD K +N L+ + K+ DFGLA+ + +
Sbjct: 157 HIKTLLYNLLVGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 245 VSTRVMGTYG-------------------------YCAPEYAMTGQL-TVKSDVYSFGVV 278
+ Y APE + + T DV+S G +
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273
Query: 279 FLELITGRKAIDSTRPHGEQNLVTWARPLF 308
F EL+ K + PLF
Sbjct: 274 FAELLNMIKENVAYHADR--------GPLF 295
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 24/216 (11%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 143
+++ IGEG FG +++G Q VA+K R + E LL +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGI 68
Query: 144 -NLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
N+ + +G +LV + LG SLED L DL K T A ++ +H
Sbjct: 69 PNVYYFGQEGLHNVLVIDL--LGPSLED-LLDLCGRK--FSVKTVAMAAKQMLARVQSIH 123
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPK-----LSDFGLAKL-GPVGDKSHVSTR----VMG 251
+K+ ++YRD K N L+ + DFG+ K K H+ R + G
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 252 TYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGR 286
T Y G + + + D+ + G VF+ + G
Sbjct: 181 TARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 57/275 (20%), Positives = 98/275 (35%), Gaps = 84/275 (30%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLH 138
N+ + IG G +G VY + ++T + VA+K+++R + + R L E+ +L+ L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR-ILREITILNRLK 83
Query: 139 HSNLVNL----IGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 193
++ L I L +V E + L L
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKL--------------FKTPI 124
Query: 194 A--------------KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239
G ++H+ + +I+RD K +N LL + K+ DFGLA+
Sbjct: 125 FLTEEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181
Query: 240 GDKS-------------------------HVSTRVMGTYGYCAPEYAMTGQL-TVKSDVY 273
+ HV TR Y APE + + T D++
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTKSIDIW 236
Query: 274 SFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLF 308
S G +F EL+ ++ + + PLF
Sbjct: 237 STGCIFAELLNMLQSHINDPTNR--------FPLF 263
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 22/214 (10%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 143
FR IG G FG +Y G T + VA+K + + + L E + +L +
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGI 65
Query: 144 -NLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
N+ + +GD +LV + LG SLED L + K L T + +A +E++H
Sbjct: 66 PNVRWFGVEGDYNVLVMDL--LGPSLED-LFNFCSRK--LSLKTVLMLADQMINRVEFVH 120
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPK---LSDFGLAKL-GPVGDKSHVSTR----VMGTY 253
K+ ++RD K N L+ G + DFGLAK H+ R + GT
Sbjct: 121 SKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 254 GYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGR 286
Y A G + + + D+ S G V + + G
Sbjct: 178 RY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 37/157 (23%), Positives = 61/157 (38%), Gaps = 26/157 (16%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEV-LMLSLLHHSNLVNLIGYC 149
+G G G+V + + + T + A+K L EV L ++V ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVY 80
Query: 150 ADGDQR----LLVYEFMPLGSLEDHL----HDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
+ L+V E + G L + ++EA + MK A ++YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI---MKSIGEA---IQYLH 134
Query: 202 DKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAK 235
+ +RD K N+L KL+DFG AK
Sbjct: 135 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 61/244 (25%), Positives = 101/244 (41%), Gaps = 62/244 (25%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDR---NGLQGNREFLVEVLMLSLLH 138
+ + +G+G +G V+K TG+VVAVK++ N R E+++L+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT-FREIMILTELS 66
Query: 139 -HSNLVNLIG-YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAA- 194
H N+VNL+ AD D+ + LV+++M E LH + I A
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAV--------------IRANILE 107
Query: 195 ------------KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242
K ++YLH +++RD K SNILL H K++DFGL++ +
Sbjct: 108 PVHKQYVVYQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
Query: 243 SHVSTRVMGTYG-------------------YCAPEYAMTGQL-TVKSDVYSFGVVFLEL 282
+ + Y APE + T D++S G + E+
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
Query: 283 ITGR 286
+ G+
Sbjct: 225 LCGK 228
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 45/220 (20%), Positives = 86/220 (39%), Gaps = 34/220 (15%)
Query: 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH---------- 138
+G G F V+ VA+K + R E+ +L ++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 139 -HSNLVNLIGY----CADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAG 192
++++ L+ + +G ++V+E LG +L + + + +I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALIKKY--EHRGIPLIYVKQISKQ 139
Query: 193 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP------KLSDFGLAKLGPVGDKSHVS 246
GL+Y+H + +I+ D K N+L+E P K++D G A + +
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 247 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
TR Y +PE + +D++S + ELITG
Sbjct: 198 TRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 35/175 (20%), Positives = 68/175 (38%), Gaps = 29/175 (16%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQV--------VAVKQLDRNG-LQGNREFLV---- 129
+ ++ +SF G +Y+ ST ++K ++G L + F
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 130 --EVLMLSLLHHSNLV---NLIGY-CADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEALD 182
+V L+ + L+ +G+ R LV LG SL+ L P K L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQSALDVSP--KHVLS 157
Query: 183 WNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPK--LSDFGLAK 235
+ +++A LE+LH+ ++ + + NI ++ + L+ +G A
Sbjct: 158 ERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 7e-11
Identities = 42/264 (15%), Positives = 69/264 (26%), Gaps = 69/264 (26%)
Query: 71 QTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL--------DRNGLQ 122
F T+ + IGEG FG V++ VA+K + + + +
Sbjct: 9 GPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQK 65
Query: 123 GNREFLVEVLMLSLLH---------HSNLVNLIG-YCADG-------------------- 152
E L E+++ L + L +C G
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 153 ---------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
DQ +V EF G + + + T I L
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEAS 180
Query: 204 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV------STRVMGTYGYC- 256
+RD N+LL++ KL K + + + G
Sbjct: 181 LR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVV 238
Query: 257 -----APEYAMTGQLTVKSDVYSF 275
E TG + D+Y
Sbjct: 239 FCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 63.3 bits (153), Expect = 8e-11
Identities = 53/333 (15%), Positives = 99/333 (29%), Gaps = 79/333 (23%)
Query: 28 QPTVSNNISRLPSGRDRLRSRSNGVSKRELHLPKDGAGVNIAAQTFTFRELAAATKNFRP 87
QP S RDRL + + +K + + + +L A RP
Sbjct: 104 QP--SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQ------------PYLKLRQALLELRP 149
Query: 88 ESFI---GEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVN 144
+ G G G K W+ A+ +Q +F ++ L+L
Sbjct: 150 AKNVLIDGVLGSG---KTWV-------ALDVCLSYKVQCKMDF--KIFWLNL-------- 189
Query: 145 LIGYCADGDQRL-----LVYEFMP-LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 198
C + L L+Y+ P S DH ++ ++
Sbjct: 190 --KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH--SIQAELR---------R 236
Query: 199 YLHDKANPP--VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 256
L K ++ + +++ F + L K V+ +
Sbjct: 237 LLKSKPYENCLLVLLNVQNAKAW--NAF-----NLSCKILLTTRFKQ-VTDFLSAATTTH 288
Query: 257 APEYAMTGQLTVKSDVYSFGVVFLELITG--RKAIDSTRPH-----GE---QNLVTWARP 306
+ LT +V S + +L+ + + +T P E L TW
Sbjct: 289 ISLDHHSMTLT-PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNW 347
Query: 307 LFNDRRKFSKLADPRLEGRYP--IRGLYQALAV 337
+ K + + + L P R ++ L+V
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV 380
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 50/219 (22%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL------HHSNL 142
IG+G FG+V K + Q VA+K + RN + +R+ E+ +L L + N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 143 VNLIGY-------CADGDQRLLVYEFMPLGSLEDHLHDLPPDKE----ALDWNTRMKIAA 191
++++ C + +E + + +L + + K+ K A
Sbjct: 162 IHMLENFTFRNHIC-------MTFELLSM-NLYELI------KKNKFQGFSLPLVRKFAH 207
Query: 192 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP--KLSDFGLAKLGPVGDKSH--VST 247
+ L+ LH +I+ D K NILL++ K+ DFG + + + + +
Sbjct: 208 SILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYTYIQS 262
Query: 248 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
R Y APE + + + D++S G + EL+TG
Sbjct: 263 RF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 31/175 (17%), Positives = 61/175 (34%), Gaps = 32/175 (18%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVK----------QLDR-----NGLQGNREF 127
+ IG GGFG +Y + + + A L + ++
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAK-KDC 95
Query: 128 LVEVLMLSLLHHSNLVNLIGY----CADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEALD 182
+ + + L + + G R +V E LG L+
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER--LGIDLQKISGQNG----TFK 149
Query: 183 WNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPK--LSDFGLAK 235
+T +++ LEY+H+ ++ D K++N+LL + L+D+GL+
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 35/174 (20%), Positives = 65/174 (37%), Gaps = 27/174 (15%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQV-----VAVKQLDRNGLQGNREF-----LVEVL 132
++ IG+GGFG +Y + S+ V VK + E +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 133 MLSLLHHSNLVNLIG-----YCADGDQRLLVYEFM---PLG-SLEDHLHDLPPDKEALDW 183
+ + + +G D+ Y FM G L+ +++ +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK-IYEANAKR--FSR 151
Query: 184 NTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPK--LSDFGLAK 235
T ++++ LEY+H+ ++ D K+SN+LL + L D+GLA
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 50/259 (19%), Positives = 79/259 (30%), Gaps = 76/259 (29%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC- 149
+G G F V+ W + VA+K + ++ L E+ +L + +S+ N
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTETALDEIRLLKSVRNSD-PNDPNREM 102
Query: 150 ------------ADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 196
+G +V+E LG L + L KI +G
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQG--LPLPCVKKIIQQVLQG 158
Query: 197 LEYLHDKANPPVIYRDFKSSNILLE----------------------------------- 221
L+YLH K +I+ D K NILL
Sbjct: 159 LDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 222 --------------EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLT 267
E K++D G A + TR Y + E +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYN 271
Query: 268 VKSDVYSFGVVFLELITGR 286
+D++S + EL TG
Sbjct: 272 TPADIWSTACMAFELATGD 290
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 36/215 (16%)
Query: 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL------HHSNL 142
S IG+G FG+V K + + VA+K + +N + +EV +L L+ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 143 VNLIGY-------CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK 195
V+L + C LV+E + +L D L + + + N K A
Sbjct: 119 VHLKRHFMFRNHLC-------LVFEMLSY-NLYDLLRNT--NFRGVSLNLTRKFAQQMCT 168
Query: 196 GLEYLHDKANPPVIYRDFKSSNILLEEGFHP--KLSDFGLAKLGPVGDKSH--VSTRVMG 251
L +L +I+ D K NILL K+ DFG + +G + + + +R
Sbjct: 169 ALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRIYQYIQSRF-- 223
Query: 252 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
Y +PE + + D++S G + +E+ TG
Sbjct: 224 ---YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 55/248 (22%), Positives = 87/248 (35%), Gaps = 84/248 (33%)
Query: 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-----HHSNLV 143
+G+G FGRV + AVK + RN + R +E +L + +++N+V
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 144 NLIGY-------CADGDQRLLVYEFMPLGSLEDHLHD-----LPPDKEALDWNTRMKIAA 191
G C L++E + SL + + + + +
Sbjct: 100 KYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRNNYNGFHIE------DIK-LYCI 144
Query: 192 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP------------------------- 226
K L YL + + + D K NILL++ +
Sbjct: 145 EILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 227 KLSDFGLAKLGPVGDKSH---VSTRVMGTYGYCAPE------YAMTGQLTVKSDVYSFGV 277
KL DFG A H ++TR Y APE + + SD++SFG
Sbjct: 202 KLIDFGCATF---KSDYHGSIINTRQ-----YRAPEVILNLGWDV------SSDMWSFGC 247
Query: 278 VFLELITG 285
V EL TG
Sbjct: 248 VLAELYTG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 49/246 (19%), Positives = 84/246 (34%), Gaps = 84/246 (34%)
Query: 89 SFIGEGGFGRVYKGW-LESTGQVVAVKQLDRNGLQGNREF----LVEVLMLSLL------ 137
+GEG FG+V + ++ G+ VAVK + +N + E+ +L L
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIV-KN----VDRYCEAARSEIQVLEHLNTTDPN 74
Query: 138 HHSNLVNLIGY-------CADGDQRLLVYEFMPLG-SLEDHLHD-----LPPDKEALDWN 184
V ++ + C +V+E LG S D + + D +
Sbjct: 75 STFRCVQMLEWFEHHGHIC-------IVFE--LLGLSTYDFIKENGFLPFRLD------H 119
Query: 185 TRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244
R K+A K + +LH + + D K NIL + + + + + +
Sbjct: 120 IR-KMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 245 -------------------VSTRVMGTYGYCAPE------YAMTGQLTVKSDVYSFGVVF 279
VSTR Y APE ++ DV+S G +
Sbjct: 176 IKVVDFGSATYDDEHHSTLVSTRH-----YRAPEVILALGWSQ------PCDVWSIGCIL 224
Query: 280 LELITG 285
+E G
Sbjct: 225 IEYYLG 230
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 44/243 (18%), Positives = 76/243 (31%), Gaps = 78/243 (32%)
Query: 89 SFIGEGGFGRVYKGW-LESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH------SN 141
+GEG FG+V + VA+K + RN + +E+ +L +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKII-RNVGKYREAARLEINVLKKIKEKDKENKFL 83
Query: 142 LVNLIGY-------CADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAAG 192
V + + C + +E + + + L ++ P +A
Sbjct: 84 CVLMSDWFNFHGHMC-------IAFELLGK-NTFEFLKENNFQP----YPLPHVRHMAYQ 131
Query: 193 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP-------------------KLSDFGL 233
L +LH+ + + D K NIL +++DFG
Sbjct: 132 LCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 234 A-----KLGPVGDKSHVSTRVMGTYGYCAPE------YAMTGQLTVKSDVYSFGVVFLEL 282
A + V+TR Y PE +A DV+S G + E
Sbjct: 189 ATFDHEHHTTI-----VATRH-----YRPPEVILELGWAQ------PCDVWSIGCILFEY 232
Query: 283 ITG 285
G
Sbjct: 233 YRG 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 457 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.18 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.16 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.83 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.66 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.63 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.6 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.52 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.44 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.39 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.24 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.0 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.96 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.82 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.74 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.63 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.61 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.59 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.5 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.48 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.45 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.21 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.11 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.95 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.8 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.06 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.39 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.39 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.91 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.0 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-58 Score=447.70 Aligned_cols=263 Identities=27% Similarity=0.404 Sum_probs=215.2
Q ss_pred cCCCccceeeecCcEEEEEEEEC-----CCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLE-----STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
++|.+.+.||+|+||.||+|++. .++..||||+++.......++|.+|+.+|++|+|||||+++++|.+.+.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57888999999999999999875 3578999999987655556789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEE
Q 012761 158 VYEFMPLGSLEDHLHDLP---------PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKL 228 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL 228 (457)
|||||++|+|.++|+... .....|+|.+++.|+.||+.||.|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 23457999999999999999999999999 999999999999999999999
Q ss_pred eeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhh
Q 012761 229 SDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPL 307 (457)
Q Consensus 229 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 307 (457)
+|||+|+.....+.........||+.|||||++.+..|+.++|||||||+||||+| |+.||...... .+...+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i--- 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIECI--- 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHH---
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---
Confidence 99999986433333333344679999999999999999999999999999999999 89999765321 111111
Q ss_pred hhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 308 FNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 308 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.. ... +. .|.....++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 244 ~~-~~~------~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 244 TQ-GRV------LQ----RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HH-TCC------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Hc-CCC------CC----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11 110 11 1112234688999999999999999999999999988753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-57 Score=449.09 Aligned_cols=263 Identities=28% Similarity=0.444 Sum_probs=209.3
Q ss_pred cCCCccceeeecCcEEEEEEEEC-----CCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLE-----STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
++|.+.+.||+|+||.||+|++. .++..||||+++.......+.|.+|+.+|++|+|||||+++++|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56788899999999999999875 3578999999987655556789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCce
Q 012761 158 VYEFMPLGSLEDHLHDLPP-----------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP 226 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~ 226 (457)
|||||++|+|.++|+.... ...+++|.+++.|+.||+.||.|||+.+ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999976432 2357999999999999999999999999 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhh
Q 012761 227 KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWAR 305 (457)
Q Consensus 227 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~ 305 (457)
||+|||+++.....+........+||+.|||||++.+..|+.++|||||||+||||+| |+.||...... .+...+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i- 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAIDCI- 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHHHHH-
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHHHHH-
Confidence 9999999986544444444556789999999999999999999999999999999999 89999764321 111111
Q ss_pred hhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 306 PLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.... .+.. |.....++.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 274 ---~~g~------~~~~----p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 ---TQGR------ELER----PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ---HHTC------CCCC----CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---HcCC------CCCC----cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1111 1111 112234688999999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=440.28 Aligned_cols=260 Identities=27% Similarity=0.406 Sum_probs=212.0
Q ss_pred cCCCccceeeecCcEEEEEEEEC-----CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLE-----STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
.++++.+.||+|+||+||+|++. .+++.||||+++.... ...++|.+|+.++++|+|||||+++++|.+.+.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 35677889999999999999864 3578999999975432 33478999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC
Q 012761 157 LVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF 224 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~ 224 (457)
||||||++|+|.++|..... ....++|..++.|+.||+.||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999975321 1356999999999999999999999999 99999999999999999
Q ss_pred ceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhh
Q 012761 225 HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTW 303 (457)
Q Consensus 225 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~ 303 (457)
.+||+|||+++.....+........+||+.|||||++.++.|+.++|||||||+||||+| |+.||..... ..+...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~~~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVEM 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHHHH
Confidence 999999999986444333344455789999999999999999999999999999999998 8999976542 122221
Q ss_pred hhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 304 ARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 304 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
+ ..... + ..+......+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 260 i----~~~~~------~----~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 I----RNRQV------L----PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp H----HTTCC------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred H----HcCCC------C----CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 11110 0 11222335688999999999999999999999999754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=436.51 Aligned_cols=261 Identities=30% Similarity=0.446 Sum_probs=204.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.++|.+.+.||+|+||+||+|+++. .||||+++.... ...+.|.+|+.++++|+|||||++++++.+ +.++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 3578889999999999999998753 599999875432 223678999999999999999999998865 5689999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
|||++|+|.++|+. ....+++.+++.|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+....
T Consensus 111 Ey~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 111 QWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp ECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 99999999999975 3457999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCCccccccccccccccchhhhhc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMT---GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
..........+||+.|||||++.+ +.|+.++|||||||+||||+||+.||....... .+.......
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~----- 253 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRG----- 253 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTT-----
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcC-----
Confidence 333344556789999999999974 468999999999999999999999997644311 111111111
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
...|.+. ..+......+.+|+.+||+.+|++|||+.+|++.|+.+..
T Consensus 254 ~~~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 254 YASPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp CCCCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred CCCCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1122211 1122233568899999999999999999999999998864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-56 Score=442.73 Aligned_cols=250 Identities=24% Similarity=0.322 Sum_probs=211.4
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
..|++.+.||+|+||+||+|+++.+|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46999999999999999999999999999999998765556677899999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
+||+|.+++.. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.... .
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 223 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--E 223 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS--S
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCC--C
Confidence 99999999975 46999999999999999999999999 99999999999999999999999999986322 2
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCcc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
.......+||+.|||||++.+..|+.++|||||||+||||++|++||...... .+...+ .. ...+.+
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i---~~-------~~~~~~ 290 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMI---RD-------NLPPRL 290 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHH---HH-------SSCCCC
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHH---Hc-------CCCCCC
Confidence 23345678999999999999999999999999999999999999999754321 111111 11 011111
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
. ........+.+|+.+||+.||++|||+.|+++
T Consensus 291 ~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 K--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp S--CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 11123457889999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-56 Score=437.03 Aligned_cols=250 Identities=23% Similarity=0.295 Sum_probs=212.5
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|++.+.||+|+||+||+|+++.+++.||||++.+.. ....+.+.+|+.+|+.|+|||||+++++|.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 47999999999999999999999999999999997532 233467899999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
|||+||+|.++|.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999976 467999999999999999999999999 99999999999999999999999999987544
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
..........+||+.|||||++.+..|+.++|||||||+||||+||++||...+. ......+......
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~~~------ 252 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKIIKLEYD------ 252 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCC------
Confidence 4444445567999999999999999999999999999999999999999975432 1112222221111
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
++.....++.+|+.+||+.||++|||+.|++.
T Consensus 253 ------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 253 ------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ------CCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 11122346889999999999999999998753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=446.04 Aligned_cols=252 Identities=21% Similarity=0.330 Sum_probs=205.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.++|++.+.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.|+|||||++++++.+.+.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 36899999999999999999999999999999999865432 2356889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
|||+||+|.++|... ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+...
T Consensus 103 Ey~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~- 176 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN- 176 (350)
T ss_dssp ECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCC-
T ss_pred eCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeec-
Confidence 999999999999752 2456799999999999999999999999 9999999999999999999999999998532
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
.........+||+.|||||++.+..|+.++|||||||+||||+||+.||..... ......+.... +
T Consensus 177 -~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~--~----- 242 (350)
T 4b9d_A 177 -STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIISGS--F----- 242 (350)
T ss_dssp -HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTC--C-----
T ss_pred -CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCC--C-----
Confidence 112233456899999999999999999999999999999999999999975432 12222222211 0
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+.+.. ....++.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 PPVSL----HYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 22346889999999999999999999976
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-56 Score=438.91 Aligned_cols=258 Identities=20% Similarity=0.228 Sum_probs=211.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.+.|.+.+.||+|+||.||+|+++.+|+.||||+++..... .+|+.+++.|+|||||+++++|.+.+.+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45688889999999999999999999999999999865332 4699999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC-ceEEeeccccccCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF-HPKLSDFGLAKLGPVG 240 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~~~~~ 240 (457)
|+||+|.++|.. ...+++..+..|+.||+.||+|||+++ ||||||||+||||+.+| .+||+|||+|+.....
T Consensus 132 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999976 467999999999999999999999999 99999999999999887 6999999999864332
Q ss_pred CCc---cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 241 DKS---HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 241 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
... .....++||+.|||||++.+..|+.++|||||||+||||+||++||........ . ..+......+.
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~---~~i~~~~~~~~-- 276 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---C---LKIASEPPPIR-- 276 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---H---HHHHHSCCGGG--
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---H---HHHHcCCCCch--
Confidence 211 122346899999999999999999999999999999999999999976543221 1 11111111111
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
.++......+.+|+.+||+.||.+|||+.|+++.|.......
T Consensus 277 -------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 277 -------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp -------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 111222346889999999999999999999999998776543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-55 Score=444.99 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=211.9
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
+.|++.+.||+|+||.||+|+++.+|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999998776666778999999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
+||+|.+++.. ..+++..+..|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.... .
T Consensus 231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~ 300 (423)
T 4fie_A 231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--E 300 (423)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCS--S
T ss_pred CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCC--C
Confidence 99999999975 46999999999999999999999999 99999999999999999999999999986322 2
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCcc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
.......+||+.|||||++.+..|+.++|||||||+||||++|++||...... .+...+ .. ...+.+
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i---~~-------~~~~~~ 367 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMI---RD-------NLPPRL 367 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHH---HH-------SCCCCC
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHH---Hc-------CCCCCC
Confidence 23345678999999999999999999999999999999999999999754321 111111 11 011111
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.. .......+.+|+.+||+.||++|||+.|+++
T Consensus 368 ~~--~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 KN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SC--TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 1122346889999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-55 Score=425.84 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=199.3
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEec----CCeeeEE
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCAD----GDQRLLV 158 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lV 158 (457)
|++.+.||+|+||+||+|++..++..||||++...... ..+.|.+|+.+|+.|+|||||+++++|.+ .+.+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 36677899999999999999999999999999754322 23568999999999999999999999865 3568999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc-CCCceEEeeccccccC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE-EGFHPKLSDFGLAKLG 237 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~-~~~~~kL~DFGla~~~ 237 (457)
||||+||+|.++|.. ...+++..+..|+.||+.||+|||+++ ++||||||||+||||+ .++.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999976 467999999999999999999999975 4599999999999997 4799999999999853
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
.. ......+||+.|||||++.+ .|+.++|||||||+||||+||+.||...... ......+.. . .
T Consensus 183 ~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~~~~~~i~~-~-----~ 246 (290)
T 3fpq_A 183 RA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTS-G-----V 246 (290)
T ss_dssp CT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTT-T-----C
T ss_pred CC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----HHHHHHHHc-C-----C
Confidence 21 23445789999999998864 7999999999999999999999999654321 111111111 0 0
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..+.+... ...++.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~----~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 247 KPASFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCGGGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCcc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111111 1236789999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=417.81 Aligned_cols=246 Identities=24% Similarity=0.359 Sum_probs=194.0
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|++.+.||+|+||+||+|++..+|+.||||++.+... .....+.+|+.+++.++|||||++++++.+.+.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 689999999999999999999999999999999976432 22356899999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+ +|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 6899999976 467999999999999999999999999 99999999999999999999999999985332
Q ss_pred CCCccccccccccccccchhhhhcCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
. ......+||+.|||||++.+..| +.++|||||||++|||+||+.||..... ......+......
T Consensus 165 ~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~~i~~~~~~----- 230 (275)
T 3hyh_A 165 G---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFKNISNGVYT----- 230 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC-----
T ss_pred C---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCCCC-----
Confidence 2 23345789999999999998776 5899999999999999999999975321 1112222111111
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+ +......+.+|+.+||+.||++|||+.|+++
T Consensus 231 ---~----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 ---L----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---C----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---C----CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 1112346789999999999999999999976
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=433.44 Aligned_cols=266 Identities=25% Similarity=0.350 Sum_probs=215.3
Q ss_pred HHhcCCCccceeeecCcEEEEEEEECCC-----CeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCC-CCceeeEEEEecC
Q 012761 80 AATKNFRPESFIGEGGFGRVYKGWLEST-----GQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHH-SNLVNLIGYCADG 152 (457)
Q Consensus 80 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~ 152 (457)
...++|++.+.||+|+||.||+|.+..+ ++.||||++...... ..+.|.+|+.+|..+.| ||||+++++|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 3457899999999999999999997653 368999999765432 23568999999999965 9999999999764
Q ss_pred -CeeeEEEeccCCCCHHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeE
Q 012761 153 -DQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNIL 219 (457)
Q Consensus 153 -~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NIL 219 (457)
+.++||||||++|+|.++|+.... ....|++..++.|+.||+.||+|||+++ ||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCcccee
Confidence 568999999999999999975321 2356899999999999999999999999 999999999999
Q ss_pred EcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 012761 220 LEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQ 298 (457)
Q Consensus 220 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~ 298 (457)
|++++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||......
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~--- 294 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--- 294 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999986544433334455789999999999999999999999999999999998 99999765432
Q ss_pred cchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 299 NLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 299 ~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
..+...+..... +. .|.....++.+|+..||+.||++|||+.+|++.|+.+..
T Consensus 295 ---~~~~~~i~~g~~------~~----~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 295 ---EEFCRRLKEGTR------MR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp ---HHHHHHHHHTCC------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHcCCC------CC----CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 111111221111 11 111223468889999999999999999999999998864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=424.91 Aligned_cols=243 Identities=26% Similarity=0.315 Sum_probs=196.2
Q ss_pred cCCCccceeeecCcEEEEEEEEC---CCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLE---STGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
++|++.+.||+|+||+||+|++. .+++.||||++.+... .....+.+|+.+|+.|+|||||++++++.+.+.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999874 4678999999975432 123468889999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
|||||+||+|.++|.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999976 457999999999999999999999999 999999999999999999999999999853
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
... .......+||+.|||||++.+..|+.++|||||||+||||+||+.||...+. ......+......
T Consensus 177 ~~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~~~---- 244 (304)
T 3ubd_A 177 IDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTMILKAKLG---- 244 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC----
T ss_pred cCC--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHHHHcCCCC----
Confidence 222 2234457899999999999999999999999999999999999999975432 1112222221111
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCCh
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 352 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 352 (457)
++.....++.+|+.+||+.||++||++
T Consensus 245 --------~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 245 --------MPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred --------CCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 111223468899999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=422.69 Aligned_cols=272 Identities=25% Similarity=0.338 Sum_probs=203.0
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHH--HHHHHHHHhcCCCCceeeEEEEecCC----eee
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREF--LVEVLMLSLLHHSNLVNLIGYCADGD----QRL 156 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~--~~E~~~l~~l~hpniv~l~~~~~~~~----~~~ 156 (457)
++|.+.+.||+|+||+||+|+++ |+.||||++... ....+ ..|+..+..++|||||+++++|.+.+ .+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 56888899999999999999984 899999999754 23333 34566667889999999999998654 579
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeeccCCccCeEEcCCCceEEeec
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA-----NPPVIYRDFKSSNILLEEGFHPKLSDF 231 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----~~~iiHrDLkp~NILl~~~~~~kL~DF 231 (457)
||||||++|+|.++|+. ..++|..+++|+.|++.||+|||++. .++||||||||+||||+.++.+||+||
T Consensus 78 lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 99999999999999975 46999999999999999999999871 233999999999999999999999999
Q ss_pred cccccCCCCCCc--cccccccccccccchhhhhcC------CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCc--ccc-
Q 012761 232 GLAKLGPVGDKS--HVSTRVMGTYGYCAPEYAMTG------QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE--QNL- 300 (457)
Q Consensus 232 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~--~~l- 300 (457)
|+|+........ ......+||+.|||||++.+. .|+.++|||||||+||||+||.+||........ ..+
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 999864333221 122346899999999999754 467899999999999999999988754332111 000
Q ss_pred -hhhhhhhhhcccccccccCCccCCCC-ChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 301 -VTWARPLFNDRRKFSKLADPRLEGRY-PIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 301 -~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
..+....+.. .......+|.+...+ +......+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 233 ~~~~~~~~~~~-~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 233 PSDPSVEEMRK-VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHH-HHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccchHHHHHH-HHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 0000000000 001122233332222 223456788999999999999999999999999998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=410.33 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=190.0
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCC--------
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGD-------- 153 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-------- 153 (457)
++|++.+.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4699999999999999999999999999999999765432 2356889999999999999999999987644
Q ss_pred ----eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEe
Q 012761 154 ----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLS 229 (457)
Q Consensus 154 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~ 229 (457)
.+|||||||++|+|.+++.... .....++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999998632 2234567788999999999999999999 9999999999999999999999
Q ss_pred eccccccCCCCCCc----------cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 012761 230 DFGLAKLGPVGDKS----------HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN 299 (457)
Q Consensus 230 DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~ 299 (457)
|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||+||||++ ||.... .
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~ 232 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----E 232 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----H
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----H
Confidence 99999864332211 11234679999999999999999999999999999999996 664211 0
Q ss_pred chhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 300 LVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 300 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
........ . ...-|.. .......+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~-~------~~~~p~~----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 RVRTLTDV-R------NLKFPPL----FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHH-H------TTCCCHH----HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHH-h------cCCCCCC----CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00000000 0 0000100 0122335678999999999999999999876
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=408.32 Aligned_cols=263 Identities=22% Similarity=0.305 Sum_probs=202.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEec------CC
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCAD------GD 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~ 153 (457)
.++|++.+.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.|+|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36799999999999999999999999999999999754322 23567899999999999999999999764 36
Q ss_pred eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 233 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGl 233 (457)
.+|||||||. |+|.+++.. ...+++..+..|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecce
Confidence 7899999996 689999975 567999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCC--CccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhh-
Q 012761 234 AKLGPVGD--KSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN- 309 (457)
Q Consensus 234 a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~- 309 (457)
|+...... ........+||+.|||||++.+. .|+.++||||||||+|||++|++||.+.+.... ...+.....
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~---l~~I~~~~g~ 281 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ---LQLIMMVLGT 281 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH---HHHHHHHHCC
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhcCC
Confidence 98542221 22234557899999999998875 569999999999999999999999976542211 111100000
Q ss_pred cccc-cc-----------cccCCccCCCCC-----hHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 310 DRRK-FS-----------KLADPRLEGRYP-----IRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 310 ~~~~-~~-----------~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.... .. ..+.+. ...+ .....++.+|+.+||+.||++|||+.|+++
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPR--QPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCC--CCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CChHHhhhhhhhhhhhhhhcCCCc--CCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 00 000000 0001 012346889999999999999999999865
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=393.83 Aligned_cols=288 Identities=41% Similarity=0.693 Sum_probs=247.1
Q ss_pred ccHHHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecC
Q 012761 73 FTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADG 152 (457)
Q Consensus 73 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 152 (457)
+++.++..++++|.+.+.||+|+||.||+|++. ++..||||++........+.+.+|+.+++.++||||+++++++.+.
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 334455567899999999999999999999975 5899999998876555567899999999999999999999999999
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecc
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 232 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFG 232 (457)
+..++||||+++|+|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999999765444557999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccc
Q 012761 233 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 312 (457)
Q Consensus 233 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 312 (457)
++................||+.|+|||++.+..++.++|||||||++|||++|+.||....+.....+..|...... ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 263 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NG 263 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TT
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-cc
Confidence 99864433333334456789999999999999999999999999999999999999988776666666666654433 23
Q ss_pred ccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 313 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 313 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.+..++++.+....+......+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 45567777777777778888999999999999999999999999999988753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=400.18 Aligned_cols=204 Identities=25% Similarity=0.341 Sum_probs=174.0
Q ss_pred HHHHHhcCCCccceeeecCcEEEEEEEEC---CCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCceeeEEEEecC
Q 012761 77 ELAAATKNFRPESFIGEGGFGRVYKGWLE---STGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADG 152 (457)
Q Consensus 77 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 152 (457)
.+....+.|++.+.||+|+||+||+|+++ .+++.||||++.... ....+.+|+.+|..+ +||||++++++|.+.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 34445688999999999999999999875 457899999987542 345688999999988 699999999999999
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC-CceEEeec
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG-FHPKLSDF 231 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~-~~~kL~DF 231 (457)
+.+||||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+||||+.+ +.+||+||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred CEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcC
Confidence 99999999999999999984 3899999999999999999999999 9999999999999876 89999999
Q ss_pred cccccCCCCCC--------------------------ccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHh
Q 012761 232 GLAKLGPVGDK--------------------------SHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELIT 284 (457)
Q Consensus 232 Gla~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~ellt 284 (457)
|+|+....... ....+..+||+.|+|||++.+. .|+.++||||+|||+|||++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 99975322110 0112345799999999999875 58999999999999999999
Q ss_pred CCCCCCCC
Q 012761 285 GRKAIDST 292 (457)
Q Consensus 285 G~~p~~~~ 292 (457)
|+.||...
T Consensus 243 G~~Pf~~~ 250 (361)
T 4f9c_A 243 GRYPFYKA 250 (361)
T ss_dssp TCSSSSCC
T ss_pred CCCCCCCC
Confidence 99999654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=420.06 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=210.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||.||+|+++.+|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46899999999999999999999999999999999876555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC--CceEEeeccccccCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG--FHPKLSDFGLAKLGPV 239 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~--~~~kL~DFGla~~~~~ 239 (457)
|+||+|.++|.. ....+++.++..++.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+|+....
T Consensus 236 ~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999965 2457999999999999999999999999 9999999999999754 8999999999986432
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
. ......+||+.|||||++.+..|+.++|||||||+||||++|++||.+.... .....+......+ .
T Consensus 310 ~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~i~~~~~~~----~ 376 (573)
T 3uto_A 310 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCDWNM----D 376 (573)
T ss_dssp T---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCCCC----C
T ss_pred C---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHhCCCCC----C
Confidence 2 2334568999999999999999999999999999999999999999764321 1111111111111 1
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+.... .....+.+|+.+||+.||.+||++.|+++
T Consensus 377 ~~~~~----~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 377 DSAFS----GISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp SGGGT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccccc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 12346789999999999999999999876
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=419.87 Aligned_cols=250 Identities=26% Similarity=0.334 Sum_probs=201.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHH---HHHHHHhcCCCCceeeEEEEecCCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLV---EVLMLSLLHHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~---E~~~l~~l~hpniv~l~~~~~~~~~~ 155 (457)
.++|.+.+.||+|+||.||+|+++.+|+.||||++.+... .....+.. ++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 4689999999999999999999999999999999975321 12233333 45666777899999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
|||||||+||+|.++|.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999976 467999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 236 LGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
..... .....+||+.|||||++.. ..|+.++||||||||||||++|++||......... ...........
T Consensus 341 ~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---~i~~~i~~~~~-- 411 (689)
T 3v5w_A 341 DFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLTMAV-- 411 (689)
T ss_dssp ECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---HHHHHHHHCCC--
T ss_pred ecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHhhcCCCC--
Confidence 64322 2345689999999999975 57999999999999999999999999754332211 11111111111
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCC-----hHHHHH
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVT 357 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ev~~ 357 (457)
. ++.....++.+|+.+||+.||.+|++ +.||++
T Consensus 412 ------~----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 ------E----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ------C----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ------C----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1 12222346889999999999999998 566653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=383.40 Aligned_cols=288 Identities=43% Similarity=0.744 Sum_probs=244.7
Q ss_pred cccccHHHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEE
Q 012761 70 AQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGY 148 (457)
Q Consensus 70 ~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~ 148 (457)
...|++.++..+.++|.+.+.||+|+||.||+|++. ++..||||++...... ....+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 456888999999999999999999999999999864 5899999999765332 23468999999999999999999999
Q ss_pred EecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCeeeccCCccCeEEcCCCc
Q 012761 149 CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK---ANPPVIYRDFKSSNILLEEGFH 225 (457)
Q Consensus 149 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~~~~iiHrDLkp~NILl~~~~~ 225 (457)
+.+.+..++||||+++|+|.+++.........+++..++.|+.||+.||.|||+. + |+||||||+|||++.++.
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFE 172 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCC
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCC
Confidence 9999999999999999999999988666667799999999999999999999999 7 999999999999999999
Q ss_pred eEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCC--CCCcccchhh
Q 012761 226 PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR--PHGEQNLVTW 303 (457)
Q Consensus 226 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~--~~~~~~l~~~ 303 (457)
+||+|||++....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||+... ......+..|
T Consensus 173 ~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp EEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred EEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 9999999998643222 223344569999999999999899999999999999999999999996321 1233445566
Q ss_pred hhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 304 ARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 304 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
....... ..+..+.+..+...++......+.+++..||+.+|.+|||+.+|++.|+...
T Consensus 252 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 252 VKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp HTTTTSS-CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHHhhc-hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 6655443 3456777888888888888999999999999999999999999999997643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=372.89 Aligned_cols=263 Identities=25% Similarity=0.359 Sum_probs=215.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||.||+|.+..++..||+|++........+.+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 45799999999999999999999999999999998765555567799999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999986 2457999999999999999999999999 9999999999999999999999999997643222
Q ss_pred Ccc------------ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhh
Q 012761 242 KSH------------VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN 309 (457)
Q Consensus 242 ~~~------------~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 309 (457)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||....+....... .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-~~~~~~~ 241 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-NVRGFLD 241 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB-CHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh-hhhcccc
Confidence 111 112457999999999999999999999999999999999999998764432211111 1111110
Q ss_pred cccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 310 DRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 310 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
......+ ...+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 242 ----------~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 242 ----------RYCPPNC----PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ----------HTCCTTC----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------ccCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0011111 12477899999999999999999999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=369.99 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=210.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999999999999999999866555667889999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++|+|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999975 36899999999999999999999999 9999999999999999999999999987543222
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. .......... ..+
T Consensus 171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~--~~~---- 236 (297)
T 3fxz_A 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGT--PEL---- 236 (297)
T ss_dssp --CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCS--CCC----
T ss_pred --cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC--CCC----
Confidence 23344679999999999999999999999999999999999999996543211 1111111100 011
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..+......+.+++.+||+.||.+||++.|+++
T Consensus 237 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 ---QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp ---SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 112223456889999999999999999999976
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=362.46 Aligned_cols=285 Identities=39% Similarity=0.633 Sum_probs=232.2
Q ss_pred ccccccHHHHHHHhcCCCcc------ceeeecCcEEEEEEEECCCCeEEEEEEeccCCC----cChHHHHHHHHHHHhcC
Q 012761 69 AAQTFTFRELAAATKNFRPE------SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL----QGNREFLVEVLMLSLLH 138 (457)
Q Consensus 69 ~~~~~~~~~~~~~~~~f~~~------~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~----~~~~~~~~E~~~l~~l~ 138 (457)
....|++.++..++++|... +.||+|+||.||+|.+ ++..||||++..... ...+.+.+|+.+++.++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 34578999999999999887 8999999999999986 478999999875321 22356889999999999
Q ss_pred CCCceeeEEEEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCe
Q 012761 139 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNI 218 (457)
Q Consensus 139 hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NI 218 (457)
||||+++++++.+.+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Ni 164 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANI 164 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHE
Confidence 9999999999999999999999999999999997421 2356999999999999999999999999 99999999999
Q ss_pred EEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 012761 219 LLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 298 (457)
Q Consensus 219 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~ 298 (457)
|++.++.+||+|||++................||+.|+|||++.+ .++.++|||||||++|+|++|..||...... .
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~ 241 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP--Q 241 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS--S
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch--H
Confidence 999999999999999976443333333345679999999998764 5899999999999999999999999765432 2
Q ss_pred cchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 299 NLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 299 ~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
.+..+..........+...+++.+. ..+......+.+++..||+.+|.+||++.+|++.|+.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 242 LLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp BTTHHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 2233333333333333444454442 345556778999999999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=373.92 Aligned_cols=273 Identities=26% Similarity=0.341 Sum_probs=210.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCC----eeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD----QRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~l 157 (457)
.++|.+.+.||+|+||.||+|++. ++.||||++.... .....+..|+.++..++||||+++++++.+.. .+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 468999999999999999999876 7999999997542 22344566888999999999999999998754 3699
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeeeccCCccCeEEcCCCceE
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK----------ANPPVIYRDFKSSNILLEEGFHPK 227 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~----------~~~~iiHrDLkp~NILl~~~~~~k 227 (457)
||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+|
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence 9999999999999975 4599999999999999999999998 8 99999999999999999999
Q ss_pred EeeccccccCCCCCCccccccccccccccchhhhhcC-----CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchh
Q 012761 228 LSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-----QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVT 302 (457)
Q Consensus 228 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~ 302 (457)
|+|||+++...............||+.|+|||++.+. .++.++|||||||++|||+||+.||.............
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 9999999764443333334446799999999999863 45678999999999999999999997654322211111
Q ss_pred hhhhhhhcc----cccccccCCccCCCC-ChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 303 WARPLFNDR----RKFSKLADPRLEGRY-PIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 303 ~~~~~~~~~----~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
......... ........+.+...+ .......+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 100000000 000111122222111 123456789999999999999999999999999998753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=376.73 Aligned_cols=264 Identities=25% Similarity=0.379 Sum_probs=214.1
Q ss_pred hcCCCccceeeecCcEEEEEEEEC-------CCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhc-CCCCceeeEEEEecC
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLE-------STGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLL-HHSNLVNLIGYCADG 152 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 152 (457)
.++|.+.+.||+|+||.||+|++. .++..||||++...... ....+.+|+.+++.+ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467999999999999999999874 34568999999765322 235688999999999 899999999999999
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL 220 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl 220 (457)
+.+++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999986432 1346899999999999999999999999 9999999999999
Q ss_pred cCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 012761 221 EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQN 299 (457)
Q Consensus 221 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~ 299 (457)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 9999999999999986443333233344567889999999999999999999999999999999 99999764321 1
Q ss_pred chhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 300 LVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 300 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
+... +.... .+. .+......+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 314 ~~~~----~~~~~------~~~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 314 LFKL----LKEGH------RMD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp HHHH----HHTTC------CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH----HhcCC------CCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111 11110 011 1122334688999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=365.96 Aligned_cols=265 Identities=24% Similarity=0.316 Sum_probs=217.2
Q ss_pred ccccccHHHHHHHhcC----------CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC
Q 012761 69 AAQTFTFRELAAATKN----------FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH 138 (457)
Q Consensus 69 ~~~~~~~~~~~~~~~~----------f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~ 138 (457)
....+++.++..+++. |...+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+++.++
T Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 100 (321)
T 2c30_A 21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100 (321)
T ss_dssp ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence 3356788888888865 677789999999999999999899999999998766666678999999999999
Q ss_pred CCCceeeEEEEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCe
Q 012761 139 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNI 218 (457)
Q Consensus 139 hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NI 218 (457)
||||+++++++...+..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NI 172 (321)
T 2c30_A 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSI 172 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGE
T ss_pred CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHE
Confidence 99999999999999999999999999999999864 46999999999999999999999999 99999999999
Q ss_pred EEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 012761 219 LLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 298 (457)
Q Consensus 219 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~ 298 (457)
|++.++.+||+|||++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--- 247 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--- 247 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---
T ss_pred EECCCCcEEEeeeeeeeecccC--ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence 9999999999999998753322 12234567999999999999989999999999999999999999999754321
Q ss_pred cchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 299 NLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 299 ~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.....+.. ...+.+.. .......+.+++.+||+.||++||++.++++.
T Consensus 248 ---~~~~~~~~-------~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 ---QAMKRLRD-------SPPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ---HHHHHHHH-------SSCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---HHHHHHhc-------CCCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111 11111111 11223467899999999999999999999863
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=366.43 Aligned_cols=263 Identities=31% Similarity=0.439 Sum_probs=203.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.++|.+.+.||+|+||.||+|++ ++..||||++....... .+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 56899999999999999999987 47899999997654322 256889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 114 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp ECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred ecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 9999999999997621 1224899999999999999999999986 4599999999999999999999999999975322
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... +...+ ... ...
T Consensus 192 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~~---~~~------~~~ 257 (309)
T 3p86_A 192 T--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVAAV---GFK------CKR 257 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHHHH---HHS------CCC
T ss_pred c--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---Hhc------CCC
Confidence 1 122334679999999999999999999999999999999999999997543211 11100 000 001
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
..+ +......+.+|+..||+.+|.+||++.+|++.|+.+....
T Consensus 258 ~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 258 LEI----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 111 1122346889999999999999999999999999987654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=369.09 Aligned_cols=248 Identities=23% Similarity=0.355 Sum_probs=207.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.++|.+.+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 5689999999999999999999999999999999976432 22356889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999975 356999999999999999999999999 99999999999999999999999999975433
Q ss_pred CCCccccccccccccccchhhhhcCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLT-VKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.. .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||..... ......+......
T Consensus 167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~----- 232 (328)
T 3fe3_A 167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRERVLRGKYR----- 232 (328)
T ss_dssp SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC-----
T ss_pred CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC-----
Confidence 22 33456899999999999988775 799999999999999999999975432 1111111111111
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+......+.+|+.+||+.||.+|||+.++++
T Consensus 233 -------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 233 -------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11122346789999999999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=375.22 Aligned_cols=273 Identities=25% Similarity=0.364 Sum_probs=216.3
Q ss_pred ccHHHHHHHhcCCCccceeeecCcEEEEEEE-----ECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhc-CCCCceee
Q 012761 73 FTFRELAAATKNFRPESFIGEGGFGRVYKGW-----LESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLL-HHSNLVNL 145 (457)
Q Consensus 73 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l 145 (457)
+.........++|.+.+.||+|+||.||+|+ ...+++.||||++...... ..+.+.+|+.++..+ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 3344444557899999999999999999998 4556789999999764332 235689999999999 79999999
Q ss_pred EEEEecCCe-eeEEEeccCCCCHHHhhhcCCCC-----------------------------------------------
Q 012761 146 IGYCADGDQ-RLLVYEFMPLGSLEDHLHDLPPD----------------------------------------------- 177 (457)
Q Consensus 146 ~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~~----------------------------------------------- 177 (457)
++++.+.+. .++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 89999999999999999864321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 178 ---------------KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 178 ---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122899999999999999999999999 99999999999999999999999999986433333
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
........||+.|+|||++.+..++.++|||||||++|||++ |..||....... .....+.... ...
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~------~~~ 316 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGT------RMR 316 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTC------CCC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCC------CCC
Confidence 333445678999999999999999999999999999999998 999997644321 1111111110 111
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
. +......+.+++..||+.+|.+||++.+|++.|+.+..
T Consensus 317 ~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 317 A----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1 11123468899999999999999999999999998865
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=369.29 Aligned_cols=262 Identities=25% Similarity=0.397 Sum_probs=210.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCC---eEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTG---QVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
.++|.+.+.||+|+||.||+|++..++ ..||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 457899999999999999999997544 4699999976432 233568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++++|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...
T Consensus 128 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999975 2457999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCC-ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 238 PVGDK-SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 238 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
..... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .+...+ ...
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~----~~~---- 270 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVISSV----EEG---- 270 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHH----HTT----
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH----HcC----
Confidence 33221 112223456788999999999999999999999999999999 99999654321 111111 000
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
.... .+......+.+|+..||+.+|.+||++.+|++.|+.+....
T Consensus 271 --~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 271 --YRLP----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp --CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred --CCCC----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 0111 11122346889999999999999999999999999998643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=368.54 Aligned_cols=260 Identities=27% Similarity=0.447 Sum_probs=204.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeE----EEEEEeccCC-CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQV----VAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
.++|++.+.||+|+||.||+|++..++.. ||+|.+.... ......+.+|+.+++.++||||++++++|.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 35799999999999999999998877764 5888775432 234567999999999999999999999998765 78
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+|+||+.+|+|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 89999999999999976 3457999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
..............||+.|+|||++.+..++.++|||||||++|||++ |+.||....... +... +....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~----~~~~~--- 236 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LEKGE--- 236 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTC---
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHH----HHcCC---
Confidence 544433333444567889999999999999999999999999999999 999997654321 1111 11110
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
....+......+.+++.+||+.+|.+||++.+|++.|+.+...
T Consensus 237 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 237 -------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 0011222345688999999999999999999999999988753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=368.27 Aligned_cols=250 Identities=24% Similarity=0.318 Sum_probs=208.3
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccC---CCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN---GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|+||.||+|+++.+++.||||++.+. .......+..|+.++..++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 46899999999999999999999999999999999753 123346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999975 457899999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+......
T Consensus 157 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~~----- 223 (337)
T 1o6l_A 157 SD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEEIR----- 223 (337)
T ss_dssp CT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC-----
T ss_pred cC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHHcCCCC-----
Confidence 21 2233456899999999999998999999999999999999999999965331 1111111111111
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCC-----ChHHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 358 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~~ 358 (457)
++......+.+|+.+||+.||.+|| ++.+|++.
T Consensus 224 -------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 -------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1112234688999999999999999 88888753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=368.40 Aligned_cols=254 Identities=25% Similarity=0.372 Sum_probs=206.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 46899999999999999999999999999999999754332 23568899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999999975 456999999999999999999999999 999999999999999999999999999764333
Q ss_pred CCccccccccccccccchhhhhcCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
..........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... .....|... . ....
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~----~----~~~~ 229 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK----K----TYLN 229 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHHTT----C----TTST
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhcc----c----ccCC
Confidence 33333445689999999999987765 789999999999999999999997654321 111111110 0 0001
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+ .......+.+|+.+||+.||.+|||+.|+++
T Consensus 230 ~------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 230 P------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp T------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c------cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 0122346789999999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=360.42 Aligned_cols=262 Identities=23% Similarity=0.308 Sum_probs=208.3
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|++.+.||+|+||.||+|++..++..||||++....... .+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999999999999999986543332 25688999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++++|.+++.. ..++++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999976 357999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ......+... ....
T Consensus 163 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~--~~~~- 232 (294)
T 4eqm_A 163 ETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDS--VPNV- 232 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSC--CCCH-
T ss_pred ccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhcc--CCCc-
Confidence 221 12233457999999999999999999999999999999999999999764321 1111111110 0000
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCC-ChHHHHHHHHhhhh
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRP-LIGDVVTALSYLAN 364 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~ev~~~L~~l~~ 364 (457)
...+... ....+.+++.+||+.+|.+|| ++.++.+.|..+..
T Consensus 233 ~~~~~~~----~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 233 TTDVRKD----IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHSCTT----SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred chhcccC----CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 0011111 234688899999999999999 89999999987754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=368.82 Aligned_cols=252 Identities=24% Similarity=0.287 Sum_probs=207.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc------ChHHHHHHHHHHHhcCCCCceeeEEEEecCCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ------GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 155 (457)
.+.|.+.+.||+|+||.||+|+++.+|..||||++...... ..+.+.+|+.++..++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 46799999999999999999999999999999999765332 236789999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC----ceEEeec
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF----HPKLSDF 231 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~----~~kL~DF 231 (457)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999965 457999999999999999999999999 99999999999998776 7999999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 311 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 311 (457)
|++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+....
T Consensus 164 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~~~~i~~~~ 234 (361)
T 2yab_A 164 GLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITAVS 234 (361)
T ss_dssp SSCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTC
T ss_pred CCceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcC
Confidence 999864332 1234467999999999999889999999999999999999999999754321 1111111111
Q ss_pred cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 312 RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 312 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.. +++.... .....+.+|+..||+.||.+|||+.++++
T Consensus 235 ~~----~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 YD----FDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC----CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC----CCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0111111 12346789999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=378.55 Aligned_cols=261 Identities=25% Similarity=0.388 Sum_probs=210.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.++|.+.+.||+|+||.||+|++..++..||||++...... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 46788999999999999999999988999999998754221 22457889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999975 2346899999999999999999999999 999999999999999999999999999753221
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
..........+++.|+|||++..+.++.++|||||||++|||++ |..||...... .+.. .+.... .+
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~----~~~~~~---~~-- 334 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTRE----FVEKGG---RL-- 334 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHH----HHHTTC---CC--
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCC---CC--
Confidence 11111112235778999999999899999999999999999998 99999754321 1111 111111 01
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
. .+......+.+|+..||+.+|.+|||+.+|++.|+.+..+
T Consensus 335 -~----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 335 -P----CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -C----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1 1111234678899999999999999999999999998753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=364.76 Aligned_cols=268 Identities=29% Similarity=0.427 Sum_probs=208.9
Q ss_pred hcCCCccceeeecCcEEEEEEE----ECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecC--Cee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGW----LESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 155 (457)
.++|++.+.||+|+||.||+|+ +..+++.||||++........+.+.+|+.++..++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 4689999999999999999998 5567899999999866544456789999999999999999999998653 568
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 999999999999999976 2446999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCc-cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCC---------Ccccchhhhh
Q 012761 236 LGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPH---------GEQNLVTWAR 305 (457)
Q Consensus 236 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~---------~~~~l~~~~~ 305 (457)
........ .......++..|+|||++.+..++.++|||||||++|||++|..|+...... ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 64332211 1223345788899999999999999999999999999999999988542110 0000000111
Q ss_pred hhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 306 PLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
..+... .....+......+.+|+..||+.+|++|||+.+|++.|+.+...
T Consensus 243 ~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 243 ELLKNN----------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHTT----------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHhcc----------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 111110 01111222345688999999999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=370.94 Aligned_cols=249 Identities=27% Similarity=0.383 Sum_probs=202.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 157 (457)
.++|++.+.||+|+||.||+|+++.+++.||||++.... ......+..|..++..+ +||||+++++++.+.+.+||
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 578999999999999999999999999999999997531 22345678899999988 69999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999976 467999999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+......
T Consensus 175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~~---- 242 (353)
T 3txo_A 175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDEVV---- 242 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC----
T ss_pred ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCC----
Confidence 222 2234456899999999999988999999999999999999999999975432 1111222221111
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCCh------HHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI------GDVVT 357 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~ev~~ 357 (457)
++......+.+|+..||+.+|.+||++ .++++
T Consensus 243 --------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 --------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111223467899999999999999998 66654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=361.67 Aligned_cols=264 Identities=27% Similarity=0.398 Sum_probs=213.6
Q ss_pred hcCCCccceeeecCcEEEEEEEEC-----CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLE-----STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 155 (457)
.++|.+.+.||+|+||.||+|.+. .++..||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 568999999999999999999873 4568999999975432 2235688999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPP--------------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKS 215 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp 215 (457)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999986432 1235899999999999999999999999 99999999
Q ss_pred cCeEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCC
Q 012761 216 SNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRP 294 (457)
Q Consensus 216 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~ 294 (457)
+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999976433332223334567889999999999899999999999999999999 9999976543
Q ss_pred CCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 295 HGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 295 ~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
. .+.... .... .+.. +......+.+++.+||+.||.+||++.+|++.|+.+..+
T Consensus 259 ~---~~~~~~----~~~~------~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 E---RLFNLL----KTGH------RMER----PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp G---GHHHHH----HTTC------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred H---HHHHHh----hcCC------cCCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 1 111111 1110 1111 112234688999999999999999999999999988753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=371.84 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=203.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 157 (457)
.++|.+.+.||+|+||.||+|+++.+++.||||++.+... .....+..|..++..+ +||||+++++++.+.+.++|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4689999999999999999999999999999999976432 2234578899999877 79999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999975 457999999999999999999999999 999999999999999999999999999752
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCc--ccchhhhh-hhhhccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE--QNLVTWAR-PLFNDRRKF 314 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~--~~l~~~~~-~~~~~~~~~ 314 (457)
.. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+.. .+.....
T Consensus 204 ~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 279 (396)
T 4dc2_A 204 LR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 279 (396)
T ss_dssp CC--TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--
T ss_pred cc--CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--
Confidence 22 22234557899999999999999999999999999999999999999975432211 11111111 1111111
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCCh
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 352 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 352 (457)
.++......+.+|+.+||+.||.+||++
T Consensus 280 ----------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 ----------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ----------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1122233468899999999999999996
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=352.57 Aligned_cols=258 Identities=25% Similarity=0.395 Sum_probs=212.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||.||+|++.. +..||||++.... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 3578999999999999999999874 7889999998653 3457799999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 87 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999999975 3456899999999999999999999999 9999999999999999999999999997532211
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... .....+... ..+
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~~~~~-------~~~ 226 (269)
T 4hcu_A 161 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTG-------FRL 226 (269)
T ss_dssp -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTT-------CCC
T ss_pred -cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhcC-------ccC
Confidence 112233457888999999999999999999999999999999 99999754321 111111110 011
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.. +......+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 227 ~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 227 YK----PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CC----CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11 111234688999999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=366.73 Aligned_cols=266 Identities=25% Similarity=0.420 Sum_probs=213.0
Q ss_pred HHhcCCCccceeeecCcEEEEEEEEC-----CCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCC
Q 012761 80 AATKNFRPESFIGEGGFGRVYKGWLE-----STGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGD 153 (457)
Q Consensus 80 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 153 (457)
...++|.+.+.||+|+||.||+|++. .++..||||++...... ....+.+|+.+++.++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34678999999999999999999987 34589999999764322 2356889999999999999999999999999
Q ss_pred eeeEEEeccCCCCHHHhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPPD--------------------KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 213 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDL 213 (457)
..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 999999999999999999763221 267999999999999999999999999 999999
Q ss_pred CccCeEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 012761 214 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 292 (457)
Q Consensus 214 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~ 292 (457)
||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999975332222222334568899999999999999999999999999999999 99999754
Q ss_pred CCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 293 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 293 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.. ..+. ..+ .... . +.+ +......+.+|+..||+.+|.+||++.+|++.|+.+...
T Consensus 281 ~~---~~~~---~~~-~~~~-~-----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 281 AH---EEVI---YYV-RDGN-I-----LAC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp CH---HHHH---HHH-HTTC-C-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred Ch---HHHH---HHH-hCCC-c-----CCC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 32 1111 111 1110 0 011 112234688999999999999999999999999988754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=364.71 Aligned_cols=265 Identities=25% Similarity=0.389 Sum_probs=210.9
Q ss_pred hcCCCccceeeecCcEEEEEEEE-----CCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhc-CCCCceeeEEEEecCCe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWL-----ESTGQVVAVKQLDRNG-LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~i~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 154 (457)
.++|.+.+.||+|+||.||+|.+ ..++..||||++.... ......+.+|+.++..+ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 57899999999999999999997 3456789999997542 23446789999999999 89999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPD-------------------KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKS 215 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp 215 (457)
.++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 99999999999999999863221 134899999999999999999999999 99999999
Q ss_pred cCeEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCC
Q 012761 216 SNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRP 294 (457)
Q Consensus 216 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~ 294 (457)
+||||+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|+| |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999975433332233344567889999999999999999999999999999998 9999976542
Q ss_pred CCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 295 HGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 295 ~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.. .+. ..+... ..+. .+......+.+|+..||+.+|.+||++.+|++.|..+...
T Consensus 281 ~~--~~~----~~~~~~------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 281 DA--NFY----KLIQNG------FKMD----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp SH--HHH----HHHHTT------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HH--HHH----HHHhcC------CCCC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11 111 111111 0111 1112234688999999999999999999999999988654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=361.96 Aligned_cols=268 Identities=23% Similarity=0.340 Sum_probs=196.7
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCe---EEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCee
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQ---VVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 155 (457)
..++|.+.+.||+|+||.||+|++..++. .||||++..... ...+.+.+|+.+++.++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 35689999999999999999999877664 899999976432 2346789999999999999999999999887665
Q ss_pred ------eEEEeccCCCCHHHhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceE
Q 012761 156 ------LLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPK 227 (457)
Q Consensus 156 ------~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~k 227 (457)
++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 99999999999999986422 12336999999999999999999999999 99999999999999999999
Q ss_pred EeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhh
Q 012761 228 LSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARP 306 (457)
Q Consensus 228 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~ 306 (457)
|+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |..||....... +. ..
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~---~~ 251 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IY---NY 251 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH---HH
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HH---HH
Confidence 999999976433333233334567889999999999999999999999999999999 999997644211 11 11
Q ss_pred hhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcCCC
Q 012761 307 LFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYD 368 (457)
Q Consensus 307 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~ 368 (457)
+.... ... .+......+.+|+.+||+.||.+||++.++++.|+.+......
T Consensus 252 ~~~~~-------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 252 LIGGN-------RLK----QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp HHTTC-------CCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred HhcCC-------CCC----CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 11100 001 1112234688999999999999999999999999999987643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=362.95 Aligned_cols=265 Identities=20% Similarity=0.229 Sum_probs=214.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ....+..|+.+++.| +||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 468999999999999999999999999999999987553 234688999999999 89999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc-----eEEeeccccc
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH-----PKLSDFGLAK 235 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~-----~kL~DFGla~ 235 (457)
|+ +++|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+++
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 99999999862 457999999999999999999999999 999999999999998887 9999999998
Q ss_pred cCCCCCCcc-----ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhc
Q 012761 236 LGPVGDKSH-----VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND 310 (457)
Q Consensus 236 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 310 (457)
......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............. .+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~---~i~~~ 235 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ---KIGDT 235 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHH---HHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHH---HHHhh
Confidence 643322111 1245679999999999999999999999999999999999999998764432211111 11111
Q ss_pred ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 311 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 311 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
... .....+...+ . .+.+++..||+.+|.+||++.+|++.|+.+....
T Consensus 236 ~~~---~~~~~~~~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 236 KRA---TPIEVLCENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHH---SCHHHHTTTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hcc---CCHHHHhccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 100 0000011111 1 7889999999999999999999999999887654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=374.98 Aligned_cols=264 Identities=27% Similarity=0.387 Sum_probs=209.9
Q ss_pred hcCCCccceeeecCcEEEEEEEE-----CCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWL-----ESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 155 (457)
.++|.+.+.||+|+||.||+|++ ..++..||||++..... .....+.+|+.++..++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 46799999999999999999994 45678999999975422 2335688999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC---ceEEe
Q 012761 156 LLVYEFMPLGSLEDHLHDLP---PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF---HPKLS 229 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~---~~kL~ 229 (457)
++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997532 12346999999999999999999999999 99999999999998554 59999
Q ss_pred eccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhh
Q 012761 230 DFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLF 308 (457)
Q Consensus 230 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 308 (457)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||..... ..+...+ .
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~~~~i---~ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFV---T 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHH---H
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---H
Confidence 9999974322222222334568999999999999999999999999999999998 9999975432 1111111 1
Q ss_pred hcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 309 NDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 309 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
. .. .+.. +......+.+|+..||+.+|.+||++.+|++.|+.+...
T Consensus 301 ~-~~------~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 301 S-GG------RMDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp T-TC------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred c-CC------CCCC----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 1 00 0111 112234688999999999999999999999999988764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=360.85 Aligned_cols=253 Identities=17% Similarity=0.248 Sum_probs=208.3
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||.||+|.+..++..||+|++.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999999999999999997543 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC--CCceEEeeccccccCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE--GFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~--~~~~kL~DFGla~~~~~ 239 (457)
+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999975 2357999999999999999999999999 999999999999987 78999999999986433
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+......+ +
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~----~ 223 (321)
T 1tki_A 157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAEYTF----D 223 (321)
T ss_dssp TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCCC----C
T ss_pred CC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHcCCCCC----C
Confidence 22 23446799999999999988899999999999999999999999975432 11111111111110 0
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
+.... .....+.+|+.+||+.||.+|||+.|+++.
T Consensus 224 ~~~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 224 EEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00001 113468899999999999999999999873
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=372.32 Aligned_cols=261 Identities=25% Similarity=0.401 Sum_probs=200.7
Q ss_pred hcCCCccceeeecCcEEEEEEEEC---CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLE---STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
.++|.+.+.||+|+||.||+|++. .++..||||++..... ...+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 458999999999999999999886 4577899999976432 223578999999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999975 3457999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCcc-ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 238 PVGDKSH-VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 238 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+...+ .....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i----~~~~~-- 268 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAV----DEGYR-- 268 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHH----HTTEE--
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCCC--
Confidence 3222111 1122345778999999999999999999999999999998 9999965432 1111111 11100
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
...+......+.+++..||+.+|.+||++.+|++.|+.+...
T Consensus 269 --------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 269 --------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp --------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 011112235688999999999999999999999999998764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=365.98 Aligned_cols=260 Identities=27% Similarity=0.452 Sum_probs=207.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeE----EEEEEeccCC-CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQV----VAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
.++|++.+.||+|+||.||+|++..++.. ||+|.+.... ......+.+|+.++..++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 35799999999999999999999877765 7888775432 233356788999999999999999999986 45688
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 99999999999999976 2457899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
..............||+.|+|||++.+..++.++|||||||++|+|++ |+.||....... +.... ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~--- 234 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDLL----EKGE--- 234 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHHH----HTTC---
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHHH----HcCC---
Confidence 554444444455678889999999999999999999999999999999 999997654321 11111 1110
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
....+. .....+.+++..||+.+|.+||++.++++.|..+...
T Consensus 235 ~~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 235 RLAQPQ-------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp BCCCCT-------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CCCCCC-------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011111 1112467899999999999999999999999988753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=363.58 Aligned_cols=252 Identities=23% Similarity=0.286 Sum_probs=206.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc------ChHHHHHHHHHHHhcCCCCceeeEEEEecCCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ------GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 155 (457)
.+.|.+.+.||+|+||.||+|++..++..||||++...... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 45799999999999999999999999999999999764322 346789999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC----ceEEeec
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF----HPKLSDF 231 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~----~~kL~DF 231 (457)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999965 467999999999999999999999999 99999999999998877 8999999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 311 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 311 (457)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+....
T Consensus 163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~ 233 (326)
T 2y0a_A 163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVSAVN 233 (326)
T ss_dssp TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHTC
T ss_pred CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHHhcC
Confidence 9998643222 233467999999999999889999999999999999999999999654321 1111111100
Q ss_pred cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 312 RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 312 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.. ..+.... .....+.+|+..||+.||.+|||+.++++
T Consensus 234 ~~----~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 YE----FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CC----CCHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CC----cCccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0000001 11346789999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=368.31 Aligned_cols=265 Identities=26% Similarity=0.373 Sum_probs=215.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECC-------CCeEEEEEEeccCCCc-ChHHHHHHHHHHHhc-CCCCceeeEEEEecC
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLES-------TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLL-HHSNLVNLIGYCADG 152 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 152 (457)
.++|.+.+.||+|+||.||+|++.. .+..||||++...... ....+.+|+.+++.+ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4689999999999999999999753 3368999999765322 235688999999999 899999999999999
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL 220 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl 220 (457)
+..++||||+++|+|.+++..... ....+++..++.|+.||+.||.|||+.+ |+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999986432 1246999999999999999999999999 9999999999999
Q ss_pred cCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 012761 221 EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQN 299 (457)
Q Consensus 221 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~ 299 (457)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... ..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---~~ 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EE 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HH
Confidence 9999999999999986544333333444567899999999999999999999999999999999 9999965432 11
Q ss_pred chhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 300 LVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 300 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
+...+ .... .+.. +......+.+|+..||+.+|.+||++.+|++.|+.+....
T Consensus 302 ~~~~~----~~~~------~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 302 LFKLL----KEGH------RMDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHHH----HTTC------CCCC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHH----HcCC------CCCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 11111 1110 1111 1122346889999999999999999999999999998654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=358.49 Aligned_cols=265 Identities=26% Similarity=0.385 Sum_probs=214.3
Q ss_pred hcCCCccceeeecCcEEEEEEEE-----CCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCceeeEEEEecCCe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWL-----ESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 154 (457)
.++|.+.+.||+|+||.||+|.+ ..++..||||++..... ...+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999985 45678999999986533 2346788999999999 89999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPP--------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL 220 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl 220 (457)
.++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999976321 1235899999999999999999999999 9999999999999
Q ss_pred cCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 012761 221 EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQN 299 (457)
Q Consensus 221 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~ 299 (457)
+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||....... .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~ 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--H
Confidence 9999999999999986443333223334567889999999999999999999999999999999 999997643211 1
Q ss_pred chhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 300 LVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 300 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
........ ..+.. +......+.+++.+||+.+|.+||++.+|++.|+.+...
T Consensus 257 ----~~~~~~~~------~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 257 ----FYKMIKEG------FRMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp ----HHHHHHHT------CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHhccC------CCCCC----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11111111 11111 111234688999999999999999999999999988764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=350.19 Aligned_cols=258 Identities=22% Similarity=0.347 Sum_probs=211.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|++.+.||+|+||.||+|.+.. +..||||++..... ....+.+|+.++..++||||+++++++.+....++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4679999999999999999998864 77899999976543 457799999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999975 2346999999999999999999999999 9999999999999999999999999997643322
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... .......... ....+
T Consensus 159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~----~~~~~ 227 (268)
T 3sxs_A 159 -YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVSQGH----RLYRP 227 (268)
T ss_dssp -EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTC----CCCCC
T ss_pred -hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHHHHcCC----CCCCC
Confidence 122233456788999999998899999999999999999999 99999654321 1111111100 11111
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
. .....+.+++..||+.+|.+||++.++++.|+.+..+
T Consensus 228 ---~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 228 ---H----LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ---T----TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ---C----cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 1 1124688999999999999999999999999988654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=363.78 Aligned_cols=260 Identities=27% Similarity=0.445 Sum_probs=204.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeE----EEEEEeccC-CCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQV----VAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~----vavK~i~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
.++|++.+.||+|+||.||+|++..++.. ||+|.+... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 46899999999999999999999877764 477777543 2334578999999999999999999999998765 78
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+|++|+.+|+|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 93 ~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 89999999999999976 2456999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
..............+|+.|+|||++.+..++.++|||||||++|||++ |..||....... +.... ....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~----~~~~--- 236 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL----EKGE--- 236 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTTC---
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcCC---
Confidence 433333333344567889999999999999999999999999999999 999997654321 11111 1110
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
....+......+.+|+..||+.+|.+||++.++++.|+.+...
T Consensus 237 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 -------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0011112334688999999999999999999999999999854
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=357.87 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=198.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--------------------------ChHHHHHHHHHHH
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--------------------------GNREFLVEVLMLS 135 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--------------------------~~~~~~~E~~~l~ 135 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999999999999999999754321 1246889999999
Q ss_pred hcCCCCceeeEEEEec--CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC
Q 012761 136 LLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 213 (457)
Q Consensus 136 ~l~hpniv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDL 213 (457)
.++||||+++++++.+ .+..++||||+++++|.+++. ...+++..++.++.||+.||.|||+.+ |+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 9999999999999987 568899999999999988654 357999999999999999999999999 999999
Q ss_pred CccCeEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCC---CCccchHHHHHHHHHHHHhCCCCCC
Q 012761 214 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ---LTVKSDVYSFGVVFLELITGRKAID 290 (457)
Q Consensus 214 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvil~elltG~~p~~ 290 (457)
||+|||++.++.+||+|||++...... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999764322 22234467999999999987655 3788999999999999999999996
Q ss_pred CCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 291 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 291 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.... ..+...+...... .+. ... ....+.+|+.+||+.||++||++.|+++
T Consensus 242 ~~~~------~~~~~~~~~~~~~-----~~~-~~~----~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERI------MCLHSKIKSQALE-----FPD-QPD----IAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSH------HHHHHHHHHCCCC-----CCS-SSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccH------HHHHHHHhcccCC-----CCC-ccc----cCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 5321 1111111111100 010 111 2346889999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=367.10 Aligned_cols=256 Identities=22% Similarity=0.248 Sum_probs=206.3
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccC-----CCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN-----GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
.+.|.+.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35799999999999999999999999999999998642 1123567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc---eEEeeccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH---PKLSDFGL 233 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~---~kL~DFGl 233 (457)
+||||+++++|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999888653233456899999999999999999999999 999999999999976554 99999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccc
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRK 313 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 313 (457)
+...... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+ ...+.....
T Consensus 180 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~---~~~i~~~~~- 249 (351)
T 3c0i_A 180 AIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RL---FEGIIKGKY- 249 (351)
T ss_dssp CEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HH---HHHHHHTCC-
T ss_pred eeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HH---HHHHHcCCC-
Confidence 9764322 2223446799999999999998999999999999999999999999975321 11 111111110
Q ss_pred cccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 314 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 314 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...+..... ....+.+|+.+||+.||++||++.++++
T Consensus 250 ---~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 ---KMNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp ---CCCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---CCCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011110011 1346889999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=349.82 Aligned_cols=266 Identities=18% Similarity=0.223 Sum_probs=214.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.++..+ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 467999999999999999999999999999999987543 335688899999999 79999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc-----eEEeeccccc
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH-----PKLSDFGLAK 235 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~-----~kL~DFGla~ 235 (457)
|+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++.
T Consensus 87 ~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 87 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99 99999999862 346999999999999999999999999 999999999999987766 9999999998
Q ss_pred cCCCCCCc-----cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhc
Q 012761 236 LGPVGDKS-----HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND 310 (457)
Q Consensus 236 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 310 (457)
........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.. .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~---~ 236 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE---K 236 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH---H
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh---h
Confidence 64332221 123446799999999999999999999999999999999999999987544322211111110 0
Q ss_pred ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 311 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 311 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
.. ....+.+...+ ...+.+++..||+.+|.+||++.+|++.|+.+....
T Consensus 237 ~~---~~~~~~~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 237 KQ---STPLRELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HH---HSCHHHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cc---CccHHHHHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 00 00001111112 246889999999999999999999999999988653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=366.02 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=205.9
Q ss_pred HHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhc-CCCCceeeEEEEecCCee
Q 012761 80 AATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 80 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 155 (457)
...++|.+.+.||+|+||.||+|+++.+++.||||++.... ......+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34678999999999999999999999999999999997532 22345678899999876 899999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999975 357999999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 236 LGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... . .....+....
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~---~~~~~i~~~~---- 234 (345)
T 1xjd_A 167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---E---ELFHSIRMDN---- 234 (345)
T ss_dssp CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHHCC----
T ss_pred hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---H---HHHHHHHhCC----
Confidence 532222 224456899999999999999999999999999999999999999975432 1 1111111111
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChH-HHH
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIG-DVV 356 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ev~ 356 (457)
+.+ +......+.+|+.+||+.+|.+||++. +|+
T Consensus 235 ----~~~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 ----PFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ----CCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----CCC----CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111 111234688999999999999999997 554
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=361.37 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=202.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 157 (457)
.++|.+.+.||+|+||.||+|+++.+++.||||++....... ...+..|+.++..+ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357999999999999999999999999999999998653322 24577899999887 89999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999975 357999999999999999999999999 999999999999999999999999999752
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc--cchhhhhh-hhhccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ--NLVTWARP-LFNDRRKF 314 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~--~l~~~~~~-~~~~~~~~ 314 (457)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ........ +.....
T Consensus 161 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 236 (345)
T 3a8x_A 161 LRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 236 (345)
T ss_dssp CCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--
T ss_pred cCC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--
Confidence 221 22344568999999999999999999999999999999999999999754322111 11111111 111110
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCCh
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 352 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 352 (457)
.++......+.+|+.+||+.||.+||++
T Consensus 237 ----------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ----------RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1122233468899999999999999996
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=349.32 Aligned_cols=254 Identities=29% Similarity=0.438 Sum_probs=197.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc----ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ----GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
.++|.+.+.||+|+||.||+|.+. +..||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 468999999999999999999975 789999998754322 23678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC--------CCceEEe
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE--------GFHPKLS 229 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~--------~~~~kL~ 229 (457)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+..+|+||||||+|||++. ++.+||+
T Consensus 84 v~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 9999999999999864 57999999999999999999999988556889999999999986 7789999
Q ss_pred eccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhh
Q 012761 230 DFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN 309 (457)
Q Consensus 230 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 309 (457)
|||++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ........
T Consensus 159 Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~ 228 (271)
T 3dtc_A 159 DFGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVAM 228 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHT
T ss_pred cCCcccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhhc
Confidence 99999753222 122457899999999999999999999999999999999999999754321 00000000
Q ss_pred cccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 310 DRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 310 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
. ......+......+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 229 ~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 N----------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp S----------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred C----------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 011111222235688999999999999999999999999754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=354.60 Aligned_cols=273 Identities=19% Similarity=0.246 Sum_probs=214.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCC--eeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGD--QRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lV 158 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 3579999999999999999999999999999999975432 33467889999999999999999999998765 77999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE----cCCCceEEeecccc
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL----EEGFHPKLSDFGLA 234 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl----~~~~~~kL~DFGla 234 (457)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999997632 1234999999999999999999999999 9999999999999 78888999999999
Q ss_pred ccCCCCCCccccccccccccccchhhhh--------cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhh
Q 012761 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAM--------TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP 306 (457)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~ 306 (457)
....... ......||+.|+|||++. +..++.++|||||||++|||++|+.||........ .......
T Consensus 164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~ 238 (319)
T 4euu_A 164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYK 238 (319)
T ss_dssp EECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHH
T ss_pred eecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHH
Confidence 8643322 223457999999999987 46889999999999999999999999975433211 1111111
Q ss_pred hhhccc--c---ccccc--------CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 307 LFNDRR--K---FSKLA--------DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 307 ~~~~~~--~---~~~~~--------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
+..... . +.... +......+.......+.+++..||+.||++||++.|+++...+.+
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 111100 0 00000 001112334455667889999999999999999999999887654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=359.01 Aligned_cols=246 Identities=28% Similarity=0.392 Sum_probs=206.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+.+..|+.++..++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999999999999999997532 23346688899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999976 457999999999999999999999999 9999999999999999999999999998532
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+......
T Consensus 158 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~----- 221 (318)
T 1fot_A 158 D-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAELR----- 221 (318)
T ss_dssp S-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCCC-----
T ss_pred C-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC-----
Confidence 2 23346899999999999999999999999999999999999999965432 1111122221111
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCC-----ChHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVT 357 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~ 357 (457)
++......+.+++.+||+.+|.+|| ++.++++
T Consensus 222 -------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 -------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1112234688999999999999999 8888874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=364.08 Aligned_cols=254 Identities=19% Similarity=0.269 Sum_probs=207.0
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
..++|.+.+.||+|+||.||+|.+..++..||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 356899999999999999999999999999999999765432 235688999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC---CceEEeeccccc
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG---FHPKLSDFGLAK 235 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~---~~~kL~DFGla~ 235 (457)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999999875 457999999999999999999999999 9999999999999764 459999999997
Q ss_pred cCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 236 LGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... . .....+......+
T Consensus 180 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~---~~~~~i~~~~~~~- 249 (362)
T 2bdw_A 180 EVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---H---RLYAQIKAGAYDY- 249 (362)
T ss_dssp CCTTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHHTCCCC-
T ss_pred EecCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---H---HHHHHHHhCCCCC-
Confidence 54322 223346799999999999998999999999999999999999999965432 1 1111111111100
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
..+.. ......+.+|+..||+.||.+||++.++++.
T Consensus 250 --~~~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 --PSPEW-----DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp --CTTGG-----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --Ccccc-----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00100 1123468899999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=352.90 Aligned_cols=264 Identities=21% Similarity=0.280 Sum_probs=202.5
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
++|++.+.||+|+||.||+|++..+++.||||++....... ...+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999999999999999997654332 3668899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++ +|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9975 56555543 2467999999999999999999999999 999999999999999999999999999764222
Q ss_pred CCccccccccccccccchhhhhcCC-CCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhc--ccc---c
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQ-LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND--RRK---F 314 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~---~ 314 (457)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... ......+...... ... .
T Consensus 155 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp --CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTG
T ss_pred --cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCChhhhhhh
Confidence 22334457899999999998765 899999999999999999998886433211 1111111000000 000 0
Q ss_pred ccccC---------CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 315 SKLAD---------PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 315 ~~~~d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..+.+ ..............+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000 00001111223456789999999999999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=372.74 Aligned_cols=254 Identities=19% Similarity=0.253 Sum_probs=206.6
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 357899999999999999999999999999999999865432 235688999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc---CCCceEEeeccccc
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE---EGFHPKLSDFGLAK 235 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~ 235 (457)
|||+.+|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999976 456999999999999999999999999 99999999999998 46789999999997
Q ss_pred cCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 236 LGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|.+||..... ......+......
T Consensus 162 ~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~-- 231 (444)
T 3soa_A 162 EVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ------HRLYQQIKAGAYD-- 231 (444)
T ss_dssp CCCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCCC--
T ss_pred EecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHhCCCC--
Confidence 53322 2233456899999999999998999999999999999999999999965432 1111111111111
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...+.. . .....+.+|+..||+.||.+||++.++++
T Consensus 232 -~~~~~~-~----~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 -FPSPEW-D----TVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -CCTTTT-T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -CCcccc-c----cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111111 1 12346889999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=380.12 Aligned_cols=264 Identities=21% Similarity=0.215 Sum_probs=211.5
Q ss_pred cHHHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEe
Q 012761 74 TFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150 (457)
Q Consensus 74 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 150 (457)
.+.++....++|.+.+.||+|+||.||+|+++.+++.||||++.+.. ......+..|+.++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34455566789999999999999999999999999999999997521 112234888999999999999999999999
Q ss_pred cCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEee
Q 012761 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSD 230 (457)
Q Consensus 151 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~D 230 (457)
+.+.++|||||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcc
Confidence 99999999999999999999975 2457999999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCccccccccccccccchhhhh-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhh
Q 012761 231 FGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWAR 305 (457)
Q Consensus 231 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~ 305 (457)
||+++..... ........+||+.|+|||++. ...|+.++|||||||++|||++|+.||...... ....
T Consensus 219 FGla~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~------~~~~ 291 (437)
T 4aw2_A 219 FGSCLKLMED-GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYG 291 (437)
T ss_dssp CTTCEECCTT-SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH
T ss_pred hhhhhhcccC-CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh------HHHH
Confidence 9999753322 222334468999999999997 457899999999999999999999999754321 1111
Q ss_pred hhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCC--CCChHHHHH
Q 012761 306 PLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAAT--RPLIGDVVT 357 (457)
Q Consensus 306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ev~~ 357 (457)
.++..... +.-|..... ....+.+|+.+||+.+|++ ||++.|+++
T Consensus 292 ~i~~~~~~---~~~p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 292 KIMNHKER---FQFPTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHTHHHH---CCCCSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhhhcccc---ccCCccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 11111110 111111111 2346889999999988888 999999876
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=351.18 Aligned_cols=258 Identities=22% Similarity=0.346 Sum_probs=209.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||.||++.+. ++..||||++.... ...+.+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 568999999999999999999887 47889999998653 3457799999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 101 MANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999975 2456999999999999999999999999 9999999999999999999999999997532211
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... .....+.. ....
T Consensus 175 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~~~~~-------~~~~ 240 (283)
T 3gen_A 175 -YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIAQ-------GLRL 240 (283)
T ss_dssp -HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHT-------TCCC
T ss_pred -cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHHHHhc-------ccCC
Confidence 112233456788999999999999999999999999999998 99999754321 11111111 0011
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.. +......+.+++..||+.+|.+||++.++++.|..+...
T Consensus 241 ~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 241 YR----PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC----CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 11 111224688999999999999999999999999988764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=351.51 Aligned_cols=256 Identities=30% Similarity=0.506 Sum_probs=206.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcCh-------HHHHHHHHHHHhcCCCCceeeEEEEecCCe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN-------REFLVEVLMLSLLHHSNLVNLIGYCADGDQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~-------~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 154 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++........ +.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 4689999999999999999999999999999999976433222 56889999999999999999999997665
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc-----eEEe
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH-----PKLS 229 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~-----~kL~ 229 (457)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||||+|||++.++. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999998875 3457999999999999999999999986 45999999999999988776 9999
Q ss_pred eccccccCCCCCCccccccccccccccchhhhh--cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhh
Q 012761 230 DFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM--TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL 307 (457)
Q Consensus 230 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 307 (457)
|||++..... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||........ .+....
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~ 242 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINMI 242 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHHHH
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHHHH
Confidence 9999974221 234467999999999984 45678999999999999999999999976543211 111111
Q ss_pred hhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 308 FNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 308 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
.. ....+.+.. .....+.+++..||+.||.+||++.+|++.|+.+
T Consensus 243 ~~------~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 RE------EGLRPTIPE----DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HH------SCCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hc------cCCCCCCCc----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11 111112222 2234688999999999999999999999999764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=353.39 Aligned_cols=261 Identities=23% Similarity=0.354 Sum_probs=201.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHh--cCCCCceeeEEEEec----CCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSL--LHHSNLVNLIGYCAD----GDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~----~~~~ 155 (457)
.++|.+.+.||+|+||.||+|++ +++.||||++... ....+..|.+++.. ++||||+++++++.+ ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 56899999999999999999988 4899999999653 34556667777666 789999999998654 3568
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeccCCccCeEEcCCCceE
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH--------DKANPPVIYRDFKSSNILLEEGFHPK 227 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~~~~iiHrDLkp~NILl~~~~~~k 227 (457)
++||||+++|+|.+++.. ..+++..++.++.||+.||.||| +.+ |+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence 999999999999999964 46999999999999999999999 888 99999999999999999999
Q ss_pred EeeccccccCCCCCCc--cccccccccccccchhhhhcC------CCCccchHHHHHHHHHHHHhC----------CCCC
Q 012761 228 LSDFGLAKLGPVGDKS--HVSTRVMGTYGYCAPEYAMTG------QLTVKSDVYSFGVVFLELITG----------RKAI 289 (457)
Q Consensus 228 L~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSlGvil~elltG----------~~p~ 289 (457)
|+|||++......... .......||+.|+|||++.+. .++.++|||||||++|||++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 9999999753322211 112334799999999999876 455799999999999999999 7777
Q ss_pred CCCCCCCcccchhhhhhhhhcccccccccCCccC-CCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 290 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLE-GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 290 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
....+.... ... ....... ....+.+. ..++......+.+|+..||+.||.+|||+.+|++.|+.+
T Consensus 234 ~~~~~~~~~-~~~-~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPS-FED-MRKVVCV-----DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCC-HHH-HHHHHTT-----SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcc-hhh-hhHHHhc-----cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 554332211 111 1111110 11111111 112234567899999999999999999999999999876
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=367.29 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=206.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ......+.+|+.++..++||||++++++|.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999999999999999986432 22346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+.+|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999976 457999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCccccccccccccccchhhhhc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMT---GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
.. ......+||+.|+|||++.. ..|+.++|||||||++|||++|+.||..........+... +.....
T Consensus 167 ~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---~~~~~~--- 237 (384)
T 4fr4_A 167 RE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT---FETTVV--- 237 (384)
T ss_dssp TT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH---HHHCCC---
T ss_pred CC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH---Hhhccc---
Confidence 22 23345689999999999874 4589999999999999999999999976543322211111 111100
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCC-hHHHH
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-IGDVV 356 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~ev~ 356 (457)
.++......+.+|+..||+.+|.+||+ +.+|+
T Consensus 238 ---------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 238 ---------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred ---------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 111122356889999999999999999 55554
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=368.27 Aligned_cols=253 Identities=21% Similarity=0.261 Sum_probs=208.3
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.++..++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46899999999999999999999999999999999866444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC--CCceEEeeccccccCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE--GFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~--~~~~kL~DFGla~~~~~ 239 (457)
+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++.....
T Consensus 130 ~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999975 2346899999999999999999999999 999999999999974 57899999999986432
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+..... ..+
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~~~~~----~~~ 270 (387)
T 1kob_A 204 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCDW----EFD 270 (387)
T ss_dssp TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCCC----CCC
T ss_pred Cc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC----CCC
Confidence 21 23345799999999999998999999999999999999999999975432 111111111111 111
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+.... .....+.+|+..||+.||.+||++.++++
T Consensus 271 ~~~~~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 271 EDAFS----SVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp SSTTT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 11111 12346889999999999999999999976
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=363.08 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=205.9
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeee
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 156 (457)
..++|.+.+.||+|+||.||+|+++.+++.||||++.... ......+..|..++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999999999999999999999999997532 23346678899999887 7999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+||||++||+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999975 356999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+......
T Consensus 171 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~~--- 239 (353)
T 2i0e_A 171 NIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNVA--- 239 (353)
T ss_dssp CCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---
T ss_pred cccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCCCC---
Confidence 2221 2234456899999999999999999999999999999999999999975432 1112222221111
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCCh-----HHHHH
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI-----GDVVT 357 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~ev~~ 357 (457)
++......+.+|+.+||+.+|.+||++ .+|++
T Consensus 240 ---------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 ---------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 112223468899999999999999964 56553
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=375.57 Aligned_cols=260 Identities=22% Similarity=0.270 Sum_probs=209.5
Q ss_pred HHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecC
Q 012761 76 RELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG 152 (457)
Q Consensus 76 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 152 (457)
.++....++|.+.+.||+|+||.||+|+++.+++.||||++.+.. ......+..|+.++..++||||++++++|.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344445689999999999999999999999999999999996521 12234578899999999999999999999999
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecc
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 232 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFG 232 (457)
+.+||||||++||+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 999999999999999999975 35899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccchhhhhcCC----CCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhh
Q 012761 233 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ----LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLF 308 (457)
Q Consensus 233 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~ 308 (457)
+++...... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ......+.
T Consensus 214 ~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~ 286 (410)
T 3v8s_A 214 TCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIM 286 (410)
T ss_dssp TCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHH
T ss_pred eeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------hhHHHHHH
Confidence 997643221 12234568999999999998765 78999999999999999999999975432 11112222
Q ss_pred hcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCC--CCChHHHHHH
Q 012761 309 NDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAAT--RPLIGDVVTA 358 (457)
Q Consensus 309 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~ev~~~ 358 (457)
.....+ .-|.. . .....+.+|+.+||+.+|.+ ||++.||++.
T Consensus 287 ~~~~~~---~~p~~-~----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 287 NHKNSL---TFPDD-N----DISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp THHHHC---CCCTT-C----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred hccccc---cCCCc-c----cccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 111110 01100 0 12346889999999999998 9999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=360.93 Aligned_cols=248 Identities=23% Similarity=0.297 Sum_probs=205.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999986431 22345788999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+ +|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 7899998875 457999999999999999999999999 9999999999999999999999999997533
Q ss_pred CCCCccccccccccccccchhhhhcCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......... .+
T Consensus 160 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------~i 220 (336)
T 3h4j_B 160 DG---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------KV 220 (336)
T ss_dssp TS---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------CC
T ss_pred CC---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------HH
Confidence 22 22344679999999999987776 789999999999999999999997643221100 00
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.... ...+......+.+|+.+||+.||.+|||+.|+++.
T Consensus 221 ~~~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 221 NSCV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CSSC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HcCC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0000 01111223467899999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=380.71 Aligned_cols=258 Identities=25% Similarity=0.398 Sum_probs=213.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
..+|.+.+.||+|+||.||+|.+..++..||||++.... ...+.|.+|+.+++.++||||++++++|.+.+..+|||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 467889999999999999999999889999999997653 3467899999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++|+|.+++... ....+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 298 MTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred cCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 9999999999752 2456899999999999999999999999 9999999999999999999999999998643221
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
........+++.|+|||++....++.++|||||||+||||++ |..||...... .+... +....
T Consensus 373 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~-------- 436 (495)
T 1opk_A 373 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL----LEKDY-------- 436 (495)
T ss_dssp -EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH----HHTTC--------
T ss_pred -eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCC--------
Confidence 122233456788999999999999999999999999999999 99999764321 11111 11110
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
....+......+.+|+.+||+.+|.+||++.+|++.|+.+.
T Consensus 437 --~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 --RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 01111222356889999999999999999999999998774
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=351.45 Aligned_cols=261 Identities=25% Similarity=0.395 Sum_probs=215.9
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
..++|.+.+.||+|+||.||+|.+..++..||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 3578999999999999999999999999999999997643 345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 90 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999999763 3456899999999999999999999999 999999999999999999999999999864322
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
. ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... .+.... ... ..
T Consensus 165 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~----~~~------~~ 230 (288)
T 3kfa_A 165 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL----EKD------YR 230 (288)
T ss_dssp S-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH----HTT------CC
T ss_pred c-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----hcc------CC
Confidence 2 222334567889999999999999999999999999999999 99999764321 111111 100 11
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
... +......+.+|+..||+.+|.+||++.+|++.|+.+...
T Consensus 231 ~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 231 MER----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC----CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 111 112234688999999999999999999999999887653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=354.76 Aligned_cols=263 Identities=23% Similarity=0.331 Sum_probs=200.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.++|++.+.||+|+||.||+|++.. ++.||||++....... ...+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 4789999999999999999999864 8999999997543222 356889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||++ ++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 99 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFME-KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCS-EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCC-CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 9997 588888865 3456999999999999999999999999 99999999999999999999999999986332
Q ss_pred CCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc--ccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR--RKFSK 316 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~~~ 316 (457)
. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ...+...+... ..+..
T Consensus 172 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 172 P--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp C--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGG
T ss_pred C--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhh
Confidence 2 222344578999999999876 5689999999999999999999999976544321 11110000000 00000
Q ss_pred -------------ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 317 -------------LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 317 -------------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
................++.+|+.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000001112346789999999999999999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=361.15 Aligned_cols=246 Identities=24% Similarity=0.303 Sum_probs=206.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 368999999999999999999999999999999996532 23346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999975 356999999999999999999999999 9999999999999999999999999998532
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.....
T Consensus 193 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~------ 255 (350)
T 1rdq_E 193 G-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGKV------ 255 (350)
T ss_dssp S-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC------
T ss_pred C-----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHHcCCC------
Confidence 2 12346799999999999999999999999999999999999999975432 111111111111
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCC-----hHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVT 357 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ev~~ 357 (457)
. ++......+.+|+.+||+.||.+||+ +.+|++
T Consensus 256 --~----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 --R----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --C----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --C----CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1 11122346889999999999999998 777764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=362.05 Aligned_cols=264 Identities=25% Similarity=0.380 Sum_probs=211.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCe-----EEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCceeeEEEEecCCe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQ-----VVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~-----~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 154 (457)
.++|.+.+.||+|+||.||+|.+..++. .||+|++..... .....+.+|+.++..+ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 5789999999999999999999876654 799999976532 2335688999999999 89999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPP----------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF 224 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~ 224 (457)
.++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence 9999999999999999874210 1346899999999999999999999999 99999999999999999
Q ss_pred ceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhh
Q 012761 225 HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTW 303 (457)
Q Consensus 225 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~ 303 (457)
.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~ 275 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS------K 275 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH------H
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH------H
Confidence 999999999975433322222334567889999999999999999999999999999998 999997543211 1
Q ss_pred hhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 304 ARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 304 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
......... .+.. +......+.+++..||+.+|.+||++.+|++.|+.+..
T Consensus 276 ~~~~~~~~~------~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 276 FYKLVKDGY------QMAQ----PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHHTC------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCC------CCCC----CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 111111110 0111 11123467899999999999999999999999988765
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=364.01 Aligned_cols=254 Identities=22% Similarity=0.279 Sum_probs=198.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||.||++++..+++.||||++.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999999999999999997653 3346788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc--eEEeeccccccCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH--PKLSDFGLAKLGPV 239 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~~~~ 239 (457)
+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999975 456999999999999999999999999 999999999999987765 99999999874222
Q ss_pred CCCccccccccccccccchhhhhcCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVK-SDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... .+......+......+ .
T Consensus 171 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~~~---~ 242 (361)
T 3uc3_A 171 H---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSVKYSI---P 242 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTTCCCC---C
T ss_pred c---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcCCCCC---C
Confidence 1 22334579999999999988887665 899999999999999999997644321 1111121111111110 0
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
+ .......+.+|+.+||+.+|.+|||+.++++.
T Consensus 243 ~-------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 D-------DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp T-------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred C-------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0 00123467899999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=355.89 Aligned_cols=271 Identities=25% Similarity=0.375 Sum_probs=214.5
Q ss_pred HHHHHHhcCCCccceeeecCcEEEEEEEE-----CCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhc-CCCCceeeEEE
Q 012761 76 RELAAATKNFRPESFIGEGGFGRVYKGWL-----ESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLL-HHSNLVNLIGY 148 (457)
Q Consensus 76 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~ 148 (457)
.+.....++|.+.+.||+|+||.||+|++ ..+++.||||++...... ..+.+.+|+.++..+ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 33444567899999999999999999985 346789999999765332 235688999999999 69999999999
Q ss_pred EecCC-eeeEEEeccCCCCHHHhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCc
Q 012761 149 CADGD-QRLLVYEFMPLGSLEDHLHDLPPD------------KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKS 215 (457)
Q Consensus 149 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp 215 (457)
+...+ ..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp 176 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 176 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCcc
Confidence 88754 589999999999999999864321 223899999999999999999999999 99999999
Q ss_pred cCeEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCC
Q 012761 216 SNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRP 294 (457)
Q Consensus 216 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~ 294 (457)
+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999999976433332233344568899999999999999999999999999999998 9999976442
Q ss_pred CCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 295 HGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 295 ~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.. .+. ..+.... ...... .....+.+++..||+.+|.+||++.+|++.|+.+...
T Consensus 257 ~~--~~~----~~~~~~~------~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 257 DE--EFC----RRLKEGT------RMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp SH--HHH----HHHHHTC------CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hH--HHH----HHhccCc------cCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 21 111 1111110 011111 1234688999999999999999999999999988753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=349.52 Aligned_cols=253 Identities=24% Similarity=0.388 Sum_probs=205.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCC-------eEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTG-------QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 154 (457)
.++|.+.+.||+|+||.||+|++..++ ..||+|++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 467999999999999999999988766 5799999976655556789999999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc--------e
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH--------P 226 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~--------~ 226 (457)
.++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999986 2345999999999999999999999999 999999999999988887 9
Q ss_pred EEeeccccccCCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhh
Q 012761 227 KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWAR 305 (457)
Q Consensus 227 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~ 305 (457)
||+|||++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|..|+...... ....
T Consensus 161 kl~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~~---- 228 (289)
T 4fvq_A 161 KLSDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRKL---- 228 (289)
T ss_dssp EECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHH----
T ss_pred eeccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--HHHH----
Confidence 999999986421 1223468899999999987 67999999999999999999965544322110 0000
Q ss_pred hhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 306 PLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
........+. ... ...+.+|+..||+.||.+||++.++++.|+.+..
T Consensus 229 ~~~~~~~~~~--------~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 229 QFYEDRHQLP--------APK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHTTCCCC--------CCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHhhccCCCC--------CCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111111110 111 1246789999999999999999999999988865
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=358.08 Aligned_cols=252 Identities=23% Similarity=0.291 Sum_probs=192.5
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
..+.|.+.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999999999999999997643 34568889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC---CCceEEeeccccccC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE---GFHPKLSDFGLAKLG 237 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~---~~~~kL~DFGla~~~ 237 (457)
|+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++...
T Consensus 129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999975 456999999999999999999999999 999999999999975 889999999999753
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
.. ........||+.|+|||++.+..++.++|||||||++|||++|..||....... .+ ...+..... ..
T Consensus 202 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~---~~~i~~~~~---~~ 270 (349)
T 2w4o_A 202 EH---QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FM---FRRILNCEY---YF 270 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HH---HHHHHTTCC---CC
T ss_pred Cc---ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HH---HHHHHhCCC---cc
Confidence 22 122344679999999999999899999999999999999999999996543211 01 111111110 01
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..+ . .......+.+|+.+||+.||++||++.++++
T Consensus 271 ~~~-~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 271 ISP-W----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CTT-T----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCc-h----hhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 1 1122346889999999999999999999876
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=357.18 Aligned_cols=265 Identities=25% Similarity=0.378 Sum_probs=211.6
Q ss_pred hcCCCccceeeecCcEEEEEEEEC-------CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCceeeEEEEecC
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLE-------STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLL-HHSNLVNLIGYCADG 152 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~-------~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 152 (457)
.++|.+.+.||+|+||.||+|++. .++..||||++..... .....+.+|+.++..+ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468999999999999999999975 3567899999976532 2235688999999999 899999999999999
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL 220 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl 220 (457)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+||||
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999986432 1235899999999999999999999999 9999999999999
Q ss_pred cCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 012761 221 EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQN 299 (457)
Q Consensus 221 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~ 299 (457)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... ..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~ 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---HH
Confidence 9999999999999986433332223334567889999999998899999999999999999999 9999965432 11
Q ss_pred chhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 300 LVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 300 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
+.. .+.. .. .+.. +......+.+++..||+.+|.+||++.+|++.|+.+....
T Consensus 268 ~~~---~~~~-~~------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 268 LFK---LLKE-GH------RMDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HHH---HHHH-TC------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHH---HHhc-CC------CCCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 111 1111 10 0111 1122346889999999999999999999999999997643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=352.79 Aligned_cols=267 Identities=22% Similarity=0.327 Sum_probs=204.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|++.+.||+|+||.||+|.+..++..||||++...... ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999999989999999999764322 235688999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++++|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999998753334567999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|..||...... .......+.. ..+
T Consensus 188 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~--~~~---- 255 (310)
T 2wqm_A 188 SK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQ--CDY---- 255 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHHHT--TCS----
T ss_pred CC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHhhc--ccC----
Confidence 21 12223457899999999999989999999999999999999999999653321 1111111111 001
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcCC
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTY 367 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~~ 367 (457)
.+..... ....+.+++..||+.||.+||++.+|++.|+.+....-
T Consensus 256 ~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 256 PPLPSDH----YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp CCCCTTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCCcccc----cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 0111111 23468899999999999999999999999999987653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=355.43 Aligned_cols=266 Identities=22% Similarity=0.323 Sum_probs=192.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4689999999999999999999999999999999976432 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 161 FMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|++ ++|.+++.... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999886421 22346899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhh--------
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN-------- 309 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~-------- 309 (457)
.. ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....+.....
T Consensus 160 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCG
T ss_pred CC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhh
Confidence 22 1223345789999999999764 68999999999999999999999997643211 1111100000
Q ss_pred cccccccccCCccCCC------------CChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 310 DRRKFSKLADPRLEGR------------YPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 310 ~~~~~~~~~d~~l~~~------------~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
....+. ...+.+... ........+.+|+.+||+.||++|||+.++++
T Consensus 235 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 235 SVTKLP-KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGCT-TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhh-hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000 000000000 00012346889999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=344.05 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=211.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||.||+|.+. ++..||||++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 357899999999999999999986 478999999986543 457899999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~- 157 (267)
T 3t9t_A 85 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD- 157 (267)
T ss_dssp CTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-
T ss_pred CCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc-
Confidence 999999999976 2356899999999999999999999999 999999999999999999999999999753221
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
.........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... .....+... ..+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~i~~~-------~~~ 224 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTG-------FRL 224 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTT-------CCC
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHHHHHhcC-------CcC
Confidence 1112233457889999999998999999999999999999999 89999754321 111111110 000
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.. +......+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus 225 ~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 225 YK----PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CC----CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11 111234678999999999999999999999999998753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=348.39 Aligned_cols=259 Identities=25% Similarity=0.358 Sum_probs=198.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCC---CeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLEST---GQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
.++|.+.+.||+|+||.||+|++..+ +..||||++..... ...+.+.+|+.+++.++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 46899999999999999999998653 56799999875432 22356889999999999999999999984 467899
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 93 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 9999999999999975 2346999999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.... ........+|+.|+|||++....++.++|||||||++|||++ |..||...... .+...+ .. ..
T Consensus 167 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i---~~-~~---- 234 (281)
T 1mp8_A 167 EDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI---EN-GE---- 234 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH---HT-TC----
T ss_pred Cccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHH---Hc-CC----
Confidence 3221 112233457789999999999999999999999999999997 99999764321 111111 11 00
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.+.+ +......+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 235 --~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 235 --RLPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0111 112234688999999999999999999999999988653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=354.32 Aligned_cols=265 Identities=27% Similarity=0.388 Sum_probs=207.4
Q ss_pred cCCCccceeeecCcEEEEEEE----ECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecC--Cee
Q 012761 83 KNFRPESFIGEGGFGRVYKGW----LESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQR 155 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 155 (457)
+.|++.+.||+|+||.||+|+ +..+++.||||++..... .....+.+|+.+++.++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 468999999999999999999 466799999999975432 3346789999999999999999999999876 668
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 999999999999999965 2456999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCc-cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCC--------CCCcccchhhhhh
Q 012761 236 LGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR--------PHGEQNLVTWARP 306 (457)
Q Consensus 236 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~--------~~~~~~l~~~~~~ 306 (457)
........ .......||..|+|||++.+..++.++|||||||++|+|++|..|+.... +............
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 64333221 22334568889999999999999999999999999999999999864321 0000000000000
Q ss_pred hhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 307 LFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 307 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
.... ... ...+......+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus 255 ~~~~------~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKE------GKR----LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHT------TCC----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhc------cCC----CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0000 001 1112223356889999999999999999999999998774
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=373.97 Aligned_cols=249 Identities=25% Similarity=0.319 Sum_probs=198.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccC---CCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN---GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++... .......+..|+.+++.++||||+++++++.+.+..+||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999999999999999999753 222335677899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999975 4579999999999999999999998 88 999999999999999999999999999753
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+......
T Consensus 300 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~~---- 367 (446)
T 4ejn_A 300 IKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEEIR---- 367 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC----
T ss_pred cCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCC----
Confidence 222 2233457899999999999999999999999999999999999999965432 1111111111111
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCC-----ChHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVT 357 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~ 357 (457)
++......+.+|+..||+.||.+|| ++.++++
T Consensus 368 --------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 --------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1112234688999999999999999 9999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=344.83 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=205.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecC--CeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADG--DQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 157 (457)
.++|.+.+.||+|+||.||+|++. +..||||++...... ..+.+.+|+.+++.++||||+++++++.+. ...++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 457999999999999999999985 789999999865322 235688999999999999999999999887 78899
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999999862 2336999999999999999999999975 45999999999999999999999999887532
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCc---cchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTV---KSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
. .....||+.|+|||++.+..++. ++|||||||++|||++|+.||...... .........
T Consensus 164 ~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~---- 226 (271)
T 3kmu_A 164 Q-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALE---- 226 (271)
T ss_dssp S-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHS----
T ss_pred c-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhc----
Confidence 1 22346899999999998765444 899999999999999999999754321 111111111
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
...+.+.. .....+.+++..||+.+|.+||++.++++.|+.+..
T Consensus 227 --~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 --GLRPTIPP----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --CCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --CCCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11111212 223468899999999999999999999999998854
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=353.64 Aligned_cols=262 Identities=22% Similarity=0.280 Sum_probs=199.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcCh---HHHHHHHHHHHhcCCCCceeeEEEEecCCe----
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLHHSNLVNLIGYCADGDQ---- 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---- 154 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++........ ..+.+|+.++..++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4689999999999999999999999999999999986543332 467889999999999999999999876543
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999975 357999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCC-ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccc
Q 012761 235 KLGPVGDK-SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRK 313 (457)
Q Consensus 235 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 313 (457)
........ ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCC
Confidence 75332221 12233457999999999999999999999999999999999999999654321 111111111100
Q ss_pred cccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHH-HHHHHHhhhh
Q 012761 314 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGD-VVTALSYLAN 364 (457)
Q Consensus 314 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e-v~~~L~~l~~ 364 (457)
. ...... .....+.+|+.+||+.||.+||+..+ +...|..+..
T Consensus 238 ~----~~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 238 P----PSARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp C----HHHHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred C----cccccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 0 000011 12346789999999999999997655 4455655544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=354.47 Aligned_cols=249 Identities=26% Similarity=0.366 Sum_probs=196.2
Q ss_pred hcCCCccceeeecCcEEEEEEEEC---CCCeEEEEEEeccCCC----cChHHHHHHHHHHHhcCCCCceeeEEEEecCCe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLE---STGQVVAVKQLDRNGL----QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 154 (457)
.++|.+.+.||+|+||.||+|++. .+++.||||++..... .....+..|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 468999999999999999999985 5789999999986432 223457789999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999975 456899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
+..... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+.....
T Consensus 169 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~-- 238 (327)
T 3a62_A 169 KESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKILKCKL-- 238 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCC--
T ss_pred cccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCC--
Confidence 742221 1223446799999999999998999999999999999999999999975432 111111111111
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCC-----ChHHHHH
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVT 357 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~ 357 (457)
.++......+.+++.+||+.+|.+|| ++.++++
T Consensus 239 ----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11112234688999999999999999 6667764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=357.84 Aligned_cols=246 Identities=22% Similarity=0.216 Sum_probs=194.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|+||+||+|++..+++.||||++....... ...+..|+..+..+ +||||++++++|.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999999899999999987543222 23445555555554 899999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+ +++|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 136 ~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 67999988752 456999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.. .......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... ..... .. ...
T Consensus 209 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~~-----~~-----~~~ 269 (311)
T 3p1a_A 209 TA---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----GWQQL-----RQ-----GYL 269 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----HHHHH-----TT-----TCC
T ss_pred cC---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHH-----hc-----cCC
Confidence 22 22334569999999998875 79999999999999999999977664321 00000 00 001
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+.+.. .....+.+|+.+||+.||++||++.++++
T Consensus 270 ~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 PPEFTA----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Cccccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111111 12346889999999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=368.74 Aligned_cols=254 Identities=28% Similarity=0.403 Sum_probs=208.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCC-eeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD-QRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lV~E 160 (457)
.++|.+.+.||+|+||.||+|.+. +..||||+++... ..+.|.+|+.+++.++||||+++++++...+ ..++|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 467889999999999999999885 7899999998653 4578999999999999999999999987765 7899999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 99999999999862 2334799999999999999999999999 999999999999999999999999999753211
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
.....+++.|+|||++.+..++.++|||||||+||||++ |+.||....... +... +.... .
T Consensus 343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~----i~~~~------~ 404 (450)
T 1k9a_A 343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGY------K 404 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHH----HHTTC------C
T ss_pred -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCC------C
Confidence 122357889999999999999999999999999999998 999997654321 1111 11110 0
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
.. .+......+.+|+..||+.+|.+||++.+|++.|+.+....
T Consensus 405 ~~----~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 405 MD----APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CC----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 11 11122346889999999999999999999999999987643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=348.15 Aligned_cols=261 Identities=29% Similarity=0.450 Sum_probs=195.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.++|.+.+.||+|+||.||+|++.. .||||++...... ..+.+.+|+.+++.++||||+++++++ .....++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 4679999999999999999998753 5999999754322 235688999999999999999999965 456789999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 99 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 99 QWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp ECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999999965 3467999999999999999999999999 99999999999999999999999999975433
Q ss_pred CCCccccccccccccccchhhhh---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
...........||+.|+|||++. ...++.++|||||||++|+|++|+.||...... ..+.... ...
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~----~~~----- 241 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMV----GRG----- 241 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHH----HHT-----
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHh----ccc-----
Confidence 33333344567999999999986 567899999999999999999999999764321 1111111 111
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
...+.+. .........+.+|+..||+.+|.+||++.++++.|+.+..
T Consensus 242 ~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 242 SLSPDLS-KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SCCCCTT-SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccCcchh-hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0111111 0111223568899999999999999999999999998864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=359.40 Aligned_cols=253 Identities=21% Similarity=0.304 Sum_probs=198.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCC--CCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHH--SNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~l 157 (457)
.+.|.+.+.||+|+||.||++.+. +++.||||++...... ....+.+|+.++..++| |||+++++++.+.+..++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 467999999999999999999885 5899999999765332 22568899999999986 999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
|||+ .+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||++...
T Consensus 87 v~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9995 57899999986 457999999999999999999999999 99999999999997 578999999999864
Q ss_pred CCCCCccccccccccccccchhhhhc-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhh
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMT-----------GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP 306 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~ 306 (457)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~--- 229 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISK--- 229 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHH---
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHH---
Confidence 43333333445679999999999875 6789999999999999999999999964321 0111
Q ss_pred hhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 307 LFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 307 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
+..++++.....++......+.+|+..||+.||.+|||+.++++.-
T Consensus 230 -------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 230 -------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp -------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -------HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 1112222222222222234688999999999999999999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=362.52 Aligned_cols=247 Identities=22% Similarity=0.284 Sum_probs=199.0
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCCCCH
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL 167 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~gsL 167 (457)
.+.||+|+||.||+|.+..+|..||||++........+.+.+|+.++..++||||+++++++.+.+..+|||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56799999999999999999999999999876555567899999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE--cCCCceEEeeccccccCCCCCCccc
Q 012761 168 EDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL--EEGFHPKLSDFGLAKLGPVGDKSHV 245 (457)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl--~~~~~~kL~DFGla~~~~~~~~~~~ 245 (457)
.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++....... .
T Consensus 174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~ 244 (373)
T 2x4f_A 174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K 244 (373)
T ss_dssp HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence 998875 2456999999999999999999999999 9999999999999 567899999999998643322 2
Q ss_pred cccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCC
Q 012761 246 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGR 325 (457)
Q Consensus 246 ~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 325 (457)
.....||+.|+|||++....++.++|||||||++|||++|+.||...... .....+......+ .+.....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~~----~~~~~~~ 314 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRWDL----EDEEFQD 314 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCS----CSGGGTT
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCCC----Chhhhcc
Confidence 23457999999999999889999999999999999999999999754321 1111111111110 0111111
Q ss_pred CChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 326 YPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 326 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
....+.+|+..||+.+|.+||++.|+++
T Consensus 315 ----~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ----ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2346889999999999999999999987
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=349.11 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=199.0
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
++|.+.+.||+|+||.||+|++ .+++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5799999999999999999998 5689999999975432 223678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 81 HLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 9975 99998875 2456899999999999999999999999 999999999999999999999999999753221
Q ss_pred CCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc--cccc--
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR--RKFS-- 315 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~~-- 315 (457)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+..... ..... ..+.
T Consensus 154 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~-~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 154 --VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFR-ILGTPNSKNWPNV 228 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHH-HHCCCCTTTSTTG
T ss_pred --ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-HHCCCChhhchhh
Confidence 1223345789999999999764 58999999999999999999999997543211 0110000 00000 0000
Q ss_pred ---cccCCccC-------CCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 316 ---KLADPRLE-------GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 316 ---~~~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...++.+. ..+.......+.+|+.+||+.||++|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00111110 0011122356789999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=349.39 Aligned_cols=267 Identities=26% Similarity=0.341 Sum_probs=201.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++....... .+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 368999999999999999999999999999999987653322 356788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 82 EYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp ECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999998875 456999999999999999999999999 99999999999999999999999999976332
Q ss_pred CCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchh-h-------hhhhhhc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVT-W-------ARPLFND 310 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~-~-------~~~~~~~ 310 (457)
. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............. . ....+..
T Consensus 155 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 155 P--SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred c--ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 2 222334578999999999976 578999999999999999999999997654321111000 0 0000010
Q ss_pred ccccc--cccCCccCCCC---ChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 311 RRKFS--KLADPRLEGRY---PIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 311 ~~~~~--~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...+. .+.++...... .......+.+|+..||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 10000 11111100000 0112346889999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=359.92 Aligned_cols=277 Identities=28% Similarity=0.390 Sum_probs=212.3
Q ss_pred hcCCCccceeeecCcEEEEEEE----ECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEe--cCCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGW----LESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA--DGDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~----~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~ 155 (457)
.++|++.+.||+|+||.||+|+ ...++..||||++........+.+.+|+.+++.++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 4689999999999999999999 46678999999998765555567899999999999999999999987 45678
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++||||+++++|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 999999999999999975 2346999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCc-cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 236 LGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 236 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ...+.... .....+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~-~~~~~~ 253 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDV-PALSRL 253 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----C-CHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hccccccc-ccHHHH
Confidence 64333221 1223356888999999999989999999999999999999999998643210000 00000000 000000
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
...+........+......+.+|+..||+.+|.+||++.+|++.|+.+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 0011111111122233456889999999999999999999999999887543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=353.96 Aligned_cols=253 Identities=22% Similarity=0.318 Sum_probs=199.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCC-------
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGD------- 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------- 153 (457)
.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|+.+++.++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 46799999999999999999999999999999999754332 3467899999999999999999999986543
Q ss_pred --------------------------------------------------eeeEEEeccCCCCHHHhhhcCCCCCCCCCH
Q 012761 154 --------------------------------------------------QRLLVYEFMPLGSLEDHLHDLPPDKEALDW 183 (457)
Q Consensus 154 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~ 183 (457)
..++||||+++++|.+++.... .....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence 3799999999999999998643 2345677
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCc----------cccccccccc
Q 012761 184 NTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS----------HVSTRVMGTY 253 (457)
Q Consensus 184 ~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~----------~~~~~~~gt~ 253 (457)
..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 889999999999999999999 999999999999999999999999999864433211 1223457999
Q ss_pred cccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHH
Q 012761 254 GYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQ 333 (457)
Q Consensus 254 ~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 333 (457)
.|+|||++.+..++.++|||||||++|||++|..|+... ....... .....+.. .......
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~~~~~~~-------~~~~~~~~----~~~~~~~ 301 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------VRIITDV-------RNLKFPLL----FTQKYPQ 301 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------HHHHHHH-------HTTCCCHH----HHHHCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------HHHHHHh-------hccCCCcc----cccCChh
Confidence 999999999999999999999999999999987654210 0000000 00000000 1122346
Q ss_pred HHHHHHHcchhhcCCCCChHHHHH
Q 012761 334 ALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 334 l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+.+|+..||+.||.+||++.++++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCCCCcCCCHHHHhh
Confidence 788999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=372.62 Aligned_cols=263 Identities=23% Similarity=0.238 Sum_probs=208.1
Q ss_pred cHHHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEe
Q 012761 74 TFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCA 150 (457)
Q Consensus 74 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 150 (457)
.+.++....++|.+.+.||+|+||.||+|+++.+++.||||++.+... .....+..|..++..++||||++++++|.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 344555567899999999999999999999999999999999975321 12234788999999999999999999999
Q ss_pred cCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEee
Q 012761 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSD 230 (457)
Q Consensus 151 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~D 230 (457)
+.+.+||||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999752 347999999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCccccccccccccccchhhhh-------cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhh
Q 012761 231 FGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-------TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTW 303 (457)
Q Consensus 231 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~ 303 (457)
||+++...... .......+||+.|+|||++. ...|+.++|||||||++|||++|+.||...... ..
T Consensus 206 FGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~ 278 (412)
T 2vd5_A 206 FGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------ET 278 (412)
T ss_dssp CTTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HH
T ss_pred chhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH------HH
Confidence 99997643222 12233468999999999997 356899999999999999999999999754321 11
Q ss_pred hhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCC---CChHHHHH
Q 012761 304 ARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATR---PLIGDVVT 357 (457)
Q Consensus 304 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~ev~~ 357 (457)
...+..... .+.-|.+...+ ...+.+|+.+||+ +|.+| |++.|+++
T Consensus 279 ~~~i~~~~~---~~~~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 279 YGKIVHYKE---HLSLPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHTHHH---HCCCC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHhccc---CcCCCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 111111110 01111111122 3468899999999 99998 58888764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=358.83 Aligned_cols=253 Identities=23% Similarity=0.284 Sum_probs=202.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.++|.+.+.||+|+||.||+|+++.+++.||||++..... ....|+.++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 5679999999999999999999999999999999976533 234678888877 79999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC----CceEEeecccccc
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG----FHPKLSDFGLAKL 236 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~----~~~kL~DFGla~~ 236 (457)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+.+. +.+||+|||++..
T Consensus 97 ~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 97 LMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999975 456999999999999999999999999 9999999999998432 3599999999986
Q ss_pred CCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||..........+. ..+......
T Consensus 170 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~---~~i~~~~~~--- 241 (342)
T 2qr7_A 170 LRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL---ARIGSGKFS--- 241 (342)
T ss_dssp CBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH---HHHHHCCCC---
T ss_pred CcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH---HHHccCCcc---
Confidence 43222 2234467999999999998888999999999999999999999999754322211111 111111110
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
+...+.......+.+|+..||+.||++||++.++++.
T Consensus 242 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 -----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp -----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111111233568899999999999999999998863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=364.45 Aligned_cols=248 Identities=25% Similarity=0.304 Sum_probs=197.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHH-HHhcCCCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLM-LSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
.++|.+.+.||+|+||.||+|+++.++..||||++.+.... ....+..|..+ ++.++||||+++++++.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 46899999999999999999999999999999999764322 22345666665 567899999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999975 457899999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
... .......+||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+......
T Consensus 190 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~~---- 257 (373)
T 2r5t_A 190 IEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKPLQ---- 257 (373)
T ss_dssp BCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHSCCC----
T ss_pred ccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhcccC----
Confidence 222 2234456899999999999999999999999999999999999999965321 1111222221111
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVV 356 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~ 356 (457)
++......+.+|+..||+.||.+||++.+.+
T Consensus 258 --------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 258 --------LKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp --------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred --------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 1111234688999999999999999986443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=357.90 Aligned_cols=250 Identities=21% Similarity=0.264 Sum_probs=181.2
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCceeeEEEEecCCeeeEEEeccCCCC
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGS 166 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~E~~~~gs 166 (457)
.+.||+|+||.||+|++..+++.||||++... ....+.+|+.++..+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 37899999999999999999999999999653 3467788999999997 9999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC---ceEEeeccccccCCCCCCc
Q 012761 167 LEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF---HPKLSDFGLAKLGPVGDKS 243 (457)
Q Consensus 167 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~---~~kL~DFGla~~~~~~~~~ 243 (457)
|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++...... .
T Consensus 93 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~ 163 (325)
T 3kn6_A 93 LFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--N 163 (325)
T ss_dssp HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC--C
Confidence 9999986 467999999999999999999999999 99999999999997665 8999999999854322 2
Q ss_pred cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCc-ccchhhhhhhhhcccccccccCCcc
Q 012761 244 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE-QNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .........+...... .....
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~----~~~~~ 239 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS----FEGEA 239 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC----CCSHH
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC----CCccc
Confidence 223445789999999999999999999999999999999999999976543211 1111111111111100 00000
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.......+.+|+..||+.||.+||++.++++
T Consensus 240 ----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 240 ----WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp ----HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ----ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0112356889999999999999999998853
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=361.65 Aligned_cols=270 Identities=20% Similarity=0.227 Sum_probs=205.7
Q ss_pred hcCCCccceeeec--CcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEG--GFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G--~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
.++|++.+.||+| +||.||+|++..+++.||||++...... ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 5689999999999 9999999999999999999999764322 23567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...
T Consensus 104 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999762 2356999999999999999999999999 999999999999999999999999987642
Q ss_pred CCCC-----Cccccccccccccccchhhhhc--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhh-
Q 012761 238 PVGD-----KSHVSTRVMGTYGYCAPEYAMT--GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN- 309 (457)
Q Consensus 238 ~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~- 309 (457)
.... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +.........
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~ 256 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPC 256 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC-------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCc
Confidence 1111 0111223478999999999987 5799999999999999999999999976443221 1110000000
Q ss_pred --cccc------------------ccccc---CCc------cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 310 --DRRK------------------FSKLA---DPR------LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 310 --~~~~------------------~~~~~---d~~------l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
+... +.... .+. ....++......+.+|+.+||+.||.+|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000 00000 000 0001112234568899999999999999999999853
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=353.43 Aligned_cols=266 Identities=25% Similarity=0.369 Sum_probs=201.4
Q ss_pred HhcCCCccceeeecCcEEEEEEEECC---CCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCCe-
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLES---TGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ- 154 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~- 154 (457)
..++|.+.+.||+|+||.||+|.+.. ++..||||++...... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 35689999999999999999998765 4568999999765322 23568899999999999999999999987653
Q ss_pred ----eeEEEeccCCCCHHHhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEE
Q 012761 155 ----RLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKL 228 (457)
Q Consensus 155 ----~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL 228 (457)
.++||||+++++|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 499999999999999985322 23467999999999999999999999999 999999999999999999999
Q ss_pred eeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhh
Q 012761 229 SDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPL 307 (457)
Q Consensus 229 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 307 (457)
+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||...... .+.. ..
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~---~~ 262 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYD---YL 262 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH---HH
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHH---HH
Confidence 99999975433322223334567889999999999999999999999999999999 88898654321 1111 11
Q ss_pred hhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 308 FNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 308 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
.... .+.. +......+.+++..||+.+|.+||++.++++.|+.+....
T Consensus 263 ~~~~-------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 263 LHGH-------RLKQ----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HTTC-------CCCC----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HcCC-------CCCC----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1100 0111 1122346889999999999999999999999999987643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=341.95 Aligned_cols=265 Identities=22% Similarity=0.296 Sum_probs=212.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEE-ecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC-ADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~lV~E 160 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ....+..|+.++..++|++++..+.++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 578999999999999999999999999999999987653 345688999999999988877666655 66778899999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE---cCCCceEEeeccccccC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~ 237 (457)
|+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 8999999974 2457999999999999999999999999 9999999999999 58899999999999864
Q ss_pred CCCCCc-----cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhh-hhhhhcc
Q 012761 238 PVGDKS-----HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWA-RPLFNDR 311 (457)
Q Consensus 238 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~-~~~~~~~ 311 (457)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+ .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 333221 1123467999999999999999999999999999999999999999875543322222111 1111100
Q ss_pred cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 312 RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 312 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
.+.+...++ ..+.+++..||+.+|.+||++.+|++.|+.+....
T Consensus 239 -------~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 239 -------IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp -------HHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -------hHHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 001111122 45889999999999999999999999999987654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=341.79 Aligned_cols=266 Identities=21% Similarity=0.294 Sum_probs=208.7
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEE-ecCCeeeEEE
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYC-ADGDQRLLVY 159 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~lV~ 159 (457)
..++|.+.+.||+|+||.||+|++..+++.||||++..... ...+..|+.++..++|++++..+.++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 45789999999999999999999999999999998765432 34578899999999988877766655 6678889999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE---cCCCceEEeecccccc
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKL 236 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~ 236 (457)
||+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 9999999974 2456999999999999999999999999 9999999999999 7899999999999986
Q ss_pred CCCCCCc-----cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhh-hhhhhc
Q 012761 237 GPVGDKS-----HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWA-RPLFND 310 (457)
Q Consensus 237 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~-~~~~~~ 310 (457)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 4333221 1223467999999999999999999999999999999999999999875543332222111 111000
Q ss_pred ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 311 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 311 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
. .+.+...++ ..+.+++..||+.+|++||++.+|++.|+.+....
T Consensus 238 ~-------~~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 238 P-------IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp C-------HHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred h-------hhhhhccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 0 000111122 46889999999999999999999999999988643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=345.03 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=185.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 467999999999999999999998899999999996432 12236788999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999975 3467999999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .... ..
T Consensus 164 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~--------~~ 227 (278)
T 3cok_A 164 MPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------NKVV--------LA 227 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC--------SS
T ss_pred CCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------HHHh--------hc
Confidence 221 1223457899999999999888999999999999999999999999764322110 0000 00
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+..+ +......+.+++.+||+.||.+||++.++++
T Consensus 228 ~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 DYEM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccCC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1111 1122346789999999999999999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=349.98 Aligned_cols=252 Identities=24% Similarity=0.281 Sum_probs=206.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc------ChHHHHHHHHHHHhcCCCCceeeEEEEecCCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ------GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 155 (457)
.++|.+.+.||+|+||.||+|++..++..||||++...... ....+.+|+.++..++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 46799999999999999999999999999999999764322 246789999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC----ceEEeec
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF----HPKLSDF 231 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~----~~kL~DF 231 (457)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999975 457899999999999999999999999 99999999999999887 7999999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 311 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 311 (457)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+....
T Consensus 164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~ 234 (321)
T 2a2a_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITSVS 234 (321)
T ss_dssp TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTC
T ss_pred ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcc
Confidence 9997543221 223457999999999999889999999999999999999999999654321 1111111100
Q ss_pred cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 312 RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 312 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
. ..++.+... ....+.+|+..||+.||.+||++.++++
T Consensus 235 ~----~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 Y----DFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C----CCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c----ccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 011111111 1246789999999999999999999976
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=363.96 Aligned_cols=252 Identities=21% Similarity=0.301 Sum_probs=198.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcC--CCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLH--HSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~l 157 (457)
.++|.+.+.||+|+||.||+|.+.. ++.||||++...... ....+.+|+.++..|. ||||+++++++...+..+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 3569999999999999999999875 899999999765332 2356889999999996 5999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||| +.+++|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+++..
T Consensus 134 v~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 999 568899999986 357899999999999999999999999 99999999999995 579999999999864
Q ss_pred CCCCCccccccccccccccchhhhhc-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhh
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMT-----------GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP 306 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~ 306 (457)
............+||+.|+|||++.+ ..++.++|||||||+||||++|+.||..... ......
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~- 278 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLH- 278 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHH-
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHH-
Confidence 43332333445679999999999875 3689999999999999999999999965321 011111
Q ss_pred hhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 307 LFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 307 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.++++.....++......+.+|+..||+.||.+||++.+|++.
T Consensus 279 ---------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 279 ---------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1122221111222223468899999999999999999999865
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=353.02 Aligned_cols=262 Identities=27% Similarity=0.423 Sum_probs=209.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEE--EEEEeccCC-CcChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVV--AVKQLDRNG-LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~v--avK~i~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 157 (457)
.++|.+.+.||+|+||.||+|++..++..+ |||.+.... ....+.+.+|+.++..+ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 368999999999999999999998888765 999987532 22345788999999999 89999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc
Q 012761 158 VYEFMPLGSLEDHLHDLP------------PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH 225 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~ 225 (457)
||||+++++|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999998632 22357999999999999999999999999 999999999999999999
Q ss_pred eEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhh
Q 012761 226 PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWA 304 (457)
Q Consensus 226 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~ 304 (457)
+||+|||++..... ........+++.|+|||++.+..++.++|||||||++|+|++ |+.||...... ...
T Consensus 181 ~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~ 251 (327)
T 1fvr_A 181 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELY 251 (327)
T ss_dssp EEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHH
T ss_pred EEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------HHH
Confidence 99999999874221 112233457889999999998889999999999999999998 99999654321 111
Q ss_pred hhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 305 RPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 305 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
..+.. . ..+. .+......+.+|+.+||+.+|.+||++.++++.|..+....
T Consensus 252 ~~~~~-~------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 252 EKLPQ-G------YRLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HHGGG-T------CCCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHhhc-C------CCCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 11100 0 0111 11122346889999999999999999999999999988653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=344.07 Aligned_cols=254 Identities=25% Similarity=0.375 Sum_probs=207.3
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 4689999999999999999999998999999999975432 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999865 457999999999999999999999999 999999999999999999999999999754333
Q ss_pred CCccccccccccccccchhhhhcCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
..........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... ..+..|... . ....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~----~----~~~~ 229 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK----K----TYLN 229 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHHTT----C----TTST
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhhhc----c----cccC
Confidence 22223345679999999999987665 789999999999999999999997654321 111111110 0 0000
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+ .......+.+++..||+.||.+||++.++++
T Consensus 230 ~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 P------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp T------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0 0112346788999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=359.47 Aligned_cols=211 Identities=26% Similarity=0.314 Sum_probs=182.9
Q ss_pred ccccHHHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-----CCCceee
Q 012761 71 QTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-----HSNLVNL 145 (457)
Q Consensus 71 ~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-----hpniv~l 145 (457)
..+++.+.....++|.+.+.||+|+||.||+|++..+++.||||++... ......+..|+.++..+. ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 3445555555678999999999999999999999999999999999743 223456778999999986 9999999
Q ss_pred EEEEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC---
Q 012761 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE--- 222 (457)
Q Consensus 146 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~--- 222 (457)
++++...+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 99999999999999999 89999999863 2345899999999999999999999999 999999999999975
Q ss_pred ----------------------CCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHH
Q 012761 223 ----------------------GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 280 (457)
Q Consensus 223 ----------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ 280 (457)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 78999999999975322 123457899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCC
Q 012761 281 ELITGRKAIDSTR 293 (457)
Q Consensus 281 elltG~~p~~~~~ 293 (457)
+|++|+.||....
T Consensus 251 ell~g~~pf~~~~ 263 (360)
T 3llt_A 251 ELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHSSCSCCCSS
T ss_pred HHHHCCCCCCCCc
Confidence 9999999997643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=355.64 Aligned_cols=266 Identities=24% Similarity=0.393 Sum_probs=211.7
Q ss_pred HHHhcCCCccceeeecCcEEEEEEEEC-----CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecC
Q 012761 79 AAATKNFRPESFIGEGGFGRVYKGWLE-----STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADG 152 (457)
Q Consensus 79 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 152 (457)
....++|.+.+.||+|+||.||+|++. .++..||||++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 344678999999999999999999876 3578999999975432 2234688999999999999999999999999
Q ss_pred CeeeEEEeccCCCCHHHhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCce
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLP------PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP 226 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~ 226 (457)
+..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence 99999999999999999987421 11246799999999999999999999999 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhh
Q 012761 227 KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWAR 305 (457)
Q Consensus 227 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~ 305 (457)
||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||..... ..+. .
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~---~ 251 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVL---R 251 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHH---H
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHHH---H
Confidence 9999999975332222222333467889999999999999999999999999999999 8899865432 1111 1
Q ss_pred hhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 306 PLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
.+.... . +.. +......+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 252 ~~~~~~-----~--~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 252 FVMEGG-----L--LDK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHTTC-----C--CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHcCC-----c--CCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111100 0 001 11223468899999999999999999999999987754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=343.90 Aligned_cols=261 Identities=26% Similarity=0.345 Sum_probs=205.3
Q ss_pred CCCccceeeecCcEEEEEEEECCCCe---EEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCee-eEE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQ---VVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR-LLV 158 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~-~lV 158 (457)
.|.+.+.||+|+||.||+|.+..++. .||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999999755443 899999975432 2235688999999999999999999999876665 999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+.+++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999976 3467899999999999999999999999 9999999999999999999999999997532
Q ss_pred CCC--CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 239 VGD--KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 239 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
... .........+|+.|+|||.+.+..++.++|||||||++|+|++|..|+..... ...+..... ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~----~~~---- 245 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHFLA----QGR---- 245 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHHHH----TTC----
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHHhh----cCC----
Confidence 221 11122335678999999999999999999999999999999996655433211 111111111 000
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
.... +......+.+++..||+.+|.+|||+.++++.|+.+....
T Consensus 246 --~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 246 --RLPQ----PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp --CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --CCCC----CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 0111 1112346889999999999999999999999999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=361.00 Aligned_cols=271 Identities=16% Similarity=0.173 Sum_probs=208.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCC-----CeEEEEEEeccCCCcC-----------hHHHHHHHHHHHhcCCCCceee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLEST-----GQVVAVKQLDRNGLQG-----------NREFLVEVLMLSLLHHSNLVNL 145 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~~vavK~i~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~l 145 (457)
.++|.+.+.||+|+||.||+|.+..+ ++.||||++....... ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 56899999999999999999998764 5789999987643211 1223456667778889999999
Q ss_pred EEEEecC----CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc
Q 012761 146 IGYCADG----DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE 221 (457)
Q Consensus 146 ~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~ 221 (457)
++++... ...+|||||+ +++|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 9998764 4589999999 9999999976 3467999999999999999999999999 99999999999998
Q ss_pred --CCCceEEeeccccccCCCCCCc-----cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 012761 222 --EGFHPKLSDFGLAKLGPVGDKS-----HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRP 294 (457)
Q Consensus 222 --~~~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~ 294 (457)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999754322111 112335699999999999998999999999999999999999999975332
Q ss_pred CCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 295 HGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 295 ~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
. ..+..+...... ..+..++++.+... .....+.+++..||+.+|.+||++.+|++.|..+....
T Consensus 267 ~--~~~~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 267 D--PKYVRDSKIRYR--ENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp C--HHHHHHHHHHHH--HCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred C--HHHHHHHHHHhh--hhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 1 111211111111 11223333322111 11246788999999999999999999999999887643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=373.63 Aligned_cols=252 Identities=24% Similarity=0.372 Sum_probs=207.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|+||.||+|+++.+|+.||||++.... ......+..|+.++..++||||+++++++.+.+.+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999999999999999997532 12346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||++||+|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999875444567999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... ........+.....
T Consensus 341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~~~~------ 410 (543)
T 3c4z_A 341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLEQAV------ 410 (543)
T ss_dssp TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHHCCC------
T ss_pred CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhhccc------
Confidence 222 22334589999999999999999999999999999999999999997653211 11112222221111
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCCh
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 352 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 352 (457)
.++......+.+|+..||+.||.+||++
T Consensus 411 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 ------TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ------CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 1122223468899999999999999976
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=358.75 Aligned_cols=263 Identities=24% Similarity=0.235 Sum_probs=203.4
Q ss_pred HHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccC-----CCcChHHHHHHHHHHHhcCCCCceeeEEEEecC
Q 012761 78 LAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN-----GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADG 152 (457)
Q Consensus 78 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 152 (457)
+....++|.+.+.||+|+||.||+|++..++..||||++... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345678999999999999999999999999999999998643 223346789999999999999999999999999
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCC------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPP------------------------------------DKEALDWNTRMKIAAGAAKG 196 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------~~~~l~~~~~~~i~~qi~~~ 196 (457)
+..++||||+++|+|.+++..... ....+++..++.|+.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999852110 01234677888999999999
Q ss_pred HHHHHhCCCCCeeeccCCccCeEEcCCC--ceEEeeccccccCCCCC--Cccccccccccccccchhhhhc--CCCCccc
Q 012761 197 LEYLHDKANPPVIYRDFKSSNILLEEGF--HPKLSDFGLAKLGPVGD--KSHVSTRVMGTYGYCAPEYAMT--GQLTVKS 270 (457)
Q Consensus 197 L~yLH~~~~~~iiHrDLkp~NILl~~~~--~~kL~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~ks 270 (457)
|.|||+.+ |+||||||+||||+.++ .+||+|||++....... .........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999 99999999999998766 89999999997532211 1112345679999999999975 6789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCC
Q 012761 271 DVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP 350 (457)
Q Consensus 271 DvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 350 (457)
|||||||++|||++|+.||...... .....+...... ...+.. ......+.+|+..||+.+|.+||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~---~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLC---FENPNY-----NVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC---TTSGGG-----GGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccc---cCCccc-----ccCCHHHHHHHHHHcCCChhHCC
Confidence 9999999999999999999754321 111111111110 111110 01234688999999999999999
Q ss_pred ChHHHHH
Q 012761 351 LIGDVVT 357 (457)
Q Consensus 351 t~~ev~~ 357 (457)
++.++++
T Consensus 324 s~~~~l~ 330 (345)
T 3hko_A 324 DAMRALQ 330 (345)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9999987
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=342.33 Aligned_cols=252 Identities=21% Similarity=0.235 Sum_probs=207.1
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
..++|.+.+.||+|+||.||+|.+..++..||+|++........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 35679999999999999999999999999999999987655667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE---cCCCceEEeeccccccC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~ 237 (457)
|+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.++|+|||++...
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999999875 456899999999999999999999999 9999999999999 78899999999999754
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...... .....+......+..
T Consensus 160 ~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~- 228 (277)
T 3f3z_A 160 KPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVMLKIREGTFTFPE- 228 (277)
T ss_dssp CTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCCH-
T ss_pred cCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCCCCc-
Confidence 3222 2334579999999998865 5999999999999999999999999754321 111111111000000
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.... .....+.+++..||+.+|.+||++.++++
T Consensus 229 ---~~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 ---KDWL----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ---HHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---hhhh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 11346889999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=353.93 Aligned_cols=265 Identities=24% Similarity=0.312 Sum_probs=208.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEe----cCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA----DGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~----~~~~~~l 157 (457)
.++|.+.+.||+|+||.||++++..+++.||||++........+.+.+|+.+++.++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 468999999999999999999999999999999997654445567899999999999999999999987 3457899
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++|+|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999999764444577999999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCcc-------ccccccccccccchhhhhcCC---CCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhh
Q 012761 238 PVGDKSH-------VSTRVMGTYGYCAPEYAMTGQ---LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL 307 (457)
Q Consensus 238 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 307 (457)
....... ......||+.|+|||++.... ++.++|||||||++|+|++|+.||........ .+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~---- 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALA---- 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHH----
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHH----
Confidence 2111100 012345799999999987543 68999999999999999999999853211100 01100
Q ss_pred hhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 308 FNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 308 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
...... -+ . +......+.+++..||+.||.+||++.+|++.|+.+..
T Consensus 260 ~~~~~~-----~~-~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 VQNQLS-----IP-Q----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHCC-------CC-C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hhccCC-----CC-c----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 000000 00 0 11123468899999999999999999999999998864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=371.76 Aligned_cols=258 Identities=24% Similarity=0.407 Sum_probs=209.2
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
..++|.+.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+++.++||||+++++++. .+..++|||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred chHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 45688999999999999999999864 6889999998654 35678999999999999999999999986 567899999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 263 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 263 FMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred ecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 99999999999752 1236889999999999999999999999 999999999999999999999999999863221
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
. ........+|+.|+|||++....++.++|||||||+||||+| |+.||...... .+.. .+ .... .+..
T Consensus 338 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~---~i-~~~~---~~~~ 406 (454)
T 1qcf_A 338 E-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIR---AL-ERGY---RMPR 406 (454)
T ss_dssp H-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH---HH-HHTC---CCCC
T ss_pred c-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH---HH-HcCC---CCCC
Confidence 1 111223456788999999999999999999999999999999 99999754321 1111 11 1110 0111
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
+......+.+|+.+||+.+|++|||+.+|++.|+.+..
T Consensus 407 -------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 407 -------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred -------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 11223468899999999999999999999999988754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=360.59 Aligned_cols=255 Identities=20% Similarity=0.236 Sum_probs=195.2
Q ss_pred hcCCCcc-ceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHH-hcCCCCceeeEEEEec----CCee
Q 012761 82 TKNFRPE-SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLS-LLHHSNLVNLIGYCAD----GDQR 155 (457)
Q Consensus 82 ~~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~----~~~~ 155 (457)
.++|.+. +.||+|+||.||+|++..+++.||||++.. ...+.+|+.++. .++||||++++++|.. ...+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567776 789999999999999999999999999863 356778888874 4589999999999875 5678
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC---CCceEEeecc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE---GFHPKLSDFG 232 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~---~~~~kL~DFG 232 (457)
||||||+++|+|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence 9999999999999999862 2346999999999999999999999999 999999999999987 7899999999
Q ss_pred ccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccc
Q 012761 233 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 312 (457)
Q Consensus 233 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 312 (457)
+++..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......... ......+.....
T Consensus 210 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~i~~~~~ 284 (400)
T 1nxk_A 210 FAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMKTRIRMGQY 284 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC--CSHHHHHHHTCC
T ss_pred cccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc--HHHHHHHHcCcc
Confidence 99853221 2234567999999999999899999999999999999999999999765432211 001111111111
Q ss_pred ccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 313 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 313 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
....+.. . .....+.+|+..||+.||.+|||+.+|++.-
T Consensus 285 ---~~~~~~~-~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 285 ---EFPNPEW-S----EVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp ---CCCTTTT-T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ---cCCCccc-c----cCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0111110 1 1234688999999999999999999998753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=348.14 Aligned_cols=261 Identities=24% Similarity=0.299 Sum_probs=201.0
Q ss_pred hcCCCcc-ceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPE-SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.+.|.+. +.||+|+||.||+|++..+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3568774 7899999999999999999999999999876555567899999999885 7999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc---eEEeecccccc
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH---PKLSDFGLAKL 236 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~---~kL~DFGla~~ 236 (457)
||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999976 357899999999999999999999999 999999999999987766 99999999875
Q ss_pred CCCCCC-----ccccccccccccccchhhhhc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhh---
Q 012761 237 GPVGDK-----SHVSTRVMGTYGYCAPEYAMT-----GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTW--- 303 (457)
Q Consensus 237 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~--- 303 (457)
...... .......+||+.|+|||++.. ..++.++|||||||++|||++|+.||..............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 322111 111223569999999999875 4688999999999999999999999976543321000000
Q ss_pred --hhhhhhcccccccccCCccCCCCCh----HhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 304 --ARPLFNDRRKFSKLADPRLEGRYPI----RGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 304 --~~~~~~~~~~~~~~~d~~l~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...++. .+..... .++. .....+.+|+.+||+.||.+||++.|+++
T Consensus 244 ~~~~~~~~------~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFE------SIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHH------HHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHH------HHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000000 0000000 0111 11346889999999999999999999976
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=347.55 Aligned_cols=267 Identities=25% Similarity=0.331 Sum_probs=202.5
Q ss_pred HHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc--CCCCceeeEEEEecC----
Q 012761 79 AAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL--HHSNLVNLIGYCADG---- 152 (457)
Q Consensus 79 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~~~---- 152 (457)
....++|++.+.||+|+||.||+|++. +..||||++... ....+..|.+++..+ +||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 334578999999999999999999885 899999998643 234455566665554 899999999999887
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeeeccCCccCeEEcCCC
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK--------ANPPVIYRDFKSSNILLEEGF 224 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--------~~~~iiHrDLkp~NILl~~~~ 224 (457)
...++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. + |+||||||+|||++.++
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNG 179 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTS
T ss_pred CceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCC
Confidence 789999999999999999975 4689999999999999999999998 7 99999999999999999
Q ss_pred ceEEeeccccccCCCCCCcc--ccccccccccccchhhhhcCCCCcc------chHHHHHHHHHHHHhC----------C
Q 012761 225 HPKLSDFGLAKLGPVGDKSH--VSTRVMGTYGYCAPEYAMTGQLTVK------SDVYSFGVVFLELITG----------R 286 (457)
Q Consensus 225 ~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k------sDvwSlGvil~elltG----------~ 286 (457)
.+||+|||++.......... ......||+.|+|||++.+..++.+ +|||||||++|||++| .
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999999997533222111 1224579999999999987766655 9999999999999999 4
Q ss_pred CCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCC-ChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 287 KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRY-PIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 287 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.||....+.... ......... .....+.+...+ +......+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus 260 ~p~~~~~~~~~~--~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 260 LPYHDLVPSDPS--YEDMREIVC-----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CTTTTTSCSSCC--HHHHHHHHT-----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccHhhhcCCCCc--hhhhHHHHh-----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 455433221110 000000000 011111111111 124566789999999999999999999999999998864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=340.81 Aligned_cols=253 Identities=20% Similarity=0.279 Sum_probs=205.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.++|.+.+.||+|+||.||+|.+..++..||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999999999999999999754322 2356788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc---eEEeecccccc
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH---PKLSDFGLAKL 236 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~---~kL~DFGla~~ 236 (457)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999998875 456999999999999999999999999 999999999999976655 99999999975
Q ss_pred CCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+..... .
T Consensus 158 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~---~ 225 (284)
T 3kk8_A 158 VNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGAY---D 225 (284)
T ss_dssp CCSS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCC---C
T ss_pred cccC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------HHHHHHHhccc---c
Confidence 3322 2223467999999999999999999999999999999999999999654321 11111111110 0
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
...+.. . .....+.+++..||+.+|.+||++.++++.
T Consensus 226 ~~~~~~-~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 226 YPSPEW-D----TVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CCTTTT-T----TSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCchhh-c----ccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111110 1 123467899999999999999999999873
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=344.21 Aligned_cols=254 Identities=24% Similarity=0.284 Sum_probs=201.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.++|.+.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 4679999999999999999999999999999999976432 345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE---cCCCceEEeeccccccC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~ 237 (457)
|+++++|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999998653223467999999999999999999999999 9999999999999 45688999999999753
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
... .......||+.|+|||++. +.++.++|||||||++|+|++|+.||...... .............
T Consensus 178 ~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~--- 244 (285)
T 3is5_A 178 KSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQKATYKEPNY--- 244 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCC---
T ss_pred CCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhhhccCCccc---
Confidence 322 2234467999999999875 57899999999999999999999999754321 1111110000000
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+..... ....+.+|+.+||+.||++||++.||++
T Consensus 245 --~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 --AVECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --CC--CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --ccccCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000011 1246789999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=360.53 Aligned_cols=276 Identities=18% Similarity=0.244 Sum_probs=215.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCC--eeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGD--QRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lV 158 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 3579999999999999999999999999999999975432 33467889999999999999999999998765 77999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE----cCCCceEEeecccc
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL----EEGFHPKLSDFGLA 234 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl----~~~~~~kL~DFGla 234 (457)
|||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999997522 1233999999999999999999999999 9999999999999 77888999999999
Q ss_pred ccCCCCCCccccccccccccccchhhhhc--------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhh
Q 012761 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAMT--------GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP 306 (457)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~ 306 (457)
+..... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||........ .......
T Consensus 164 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~ 238 (396)
T 4eut_A 164 RELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYK 238 (396)
T ss_dssp EECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHH
T ss_pred eEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHH
Confidence 763322 22334679999999999875 5678899999999999999999999975433221 1111111
Q ss_pred hhhcccc-----ccccc--------CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 307 LFNDRRK-----FSKLA--------DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 307 ~~~~~~~-----~~~~~--------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
+...... +.... +..............+.+++..||+.||++||++.++++.|..+..+.
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 1111000 00000 001112233455667889999999999999999999999999988754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=356.53 Aligned_cols=247 Identities=30% Similarity=0.413 Sum_probs=202.3
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
+.|.+.+.||+|+||.||+|++..++..||||++....... .+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45899999999999999999999999999999997653322 246889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+. |+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 688888754 2467999999999999999999999999 99999999999999999999999999975322
Q ss_pred CCCccccccccccccccchhhhh---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+....
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~----- 269 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE----- 269 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC-----
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcC-----
Confidence 23457999999999985 46789999999999999999999999965432 11111111111
Q ss_pred ccCCcc-CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHH
Q 012761 317 LADPRL-EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359 (457)
Q Consensus 317 ~~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L 359 (457)
.+.+ ...+ ...+.+|+..||+.+|++||++.++++..
T Consensus 270 --~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 270 --SPALQSGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp --CCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred --CCCCCCCCC----CHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 1111 1112 24578899999999999999999998754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=368.80 Aligned_cols=196 Identities=24% Similarity=0.358 Sum_probs=156.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEec-----CCe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCAD-----GDQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~ 154 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4689999999999999999999999999999999975422 223568899999999999999999999844 357
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
+|+||||+ +++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 5799999875 467999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCc-------------------------cccccccccccccchhhhh-cCCCCccchHHHHHHHHHHHHhC
Q 012761 235 KLGPVGDKS-------------------------HVSTRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITG 285 (457)
Q Consensus 235 ~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvil~elltG 285 (457)
+........ ...+..+||+.|+|||++. ...|+.++||||||||||||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 864322110 1234467899999999864 56799999999999999999993
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=345.85 Aligned_cols=262 Identities=19% Similarity=0.213 Sum_probs=202.3
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
..++|.+.+.||+|+||.||+|++..+++.||||++....... .+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999999999999999997543322 2568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 112 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999999975 356999999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
.... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+........
T Consensus 185 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~- 255 (309)
T 2h34_A 185 TDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPRPS- 255 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCCGG-
T ss_pred cccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCCcc-
Confidence 3221 12223457899999999999889999999999999999999999999653211 11111111100000
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCC-ChHHHHHHHHhhhhc
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-LIGDVVTALSYLANQ 365 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~ev~~~L~~l~~~ 365 (457)
.+...+ ...+.+++.+||+.+|++|| ++.++++.|+.+...
T Consensus 256 ---~~~~~~----~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 256 ---TVRPGI----PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp ---GTSTTC----CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred ---ccCCCC----CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 111112 23578899999999999999 999999999877643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=363.45 Aligned_cols=204 Identities=27% Similarity=0.425 Sum_probs=165.9
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcC-CCCceeeEEEEecCC--ee
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGD--QR 155 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~--~~ 155 (457)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4678999999999999999999999999999999986532 222356788999999997 999999999997644 68
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
|+||||+. ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999997 689999875 46899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCC-------------------CCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 012761 236 LGPVG-------------------DKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTR 293 (457)
Q Consensus 236 ~~~~~-------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~ 293 (457)
..... ......+..+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 53221 11122344689999999999986 579999999999999999999999997643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=345.36 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=205.4
Q ss_pred hcCCCccc-eeeecCcEEEEEEEE--CCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 82 TKNFRPES-FIGEGGFGRVYKGWL--ESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 82 ~~~f~~~~-~lG~G~~g~Vy~~~~--~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
.++|.+.+ .||+|+||.||+|.+ ..++..||||++....... .+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45788887 999999999999954 5567899999997653222 46788999999999999999999999 567789
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 94 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999986 356999999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCc-cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 237 GPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 237 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... .+...+ ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~----~~~~-- 237 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAML----EKGE-- 237 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH----HTTC--
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----HcCC--
Confidence 4332221 11222456789999999998889999999999999999999 99999764321 111111 1110
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.+.+ +......+.+++..||+.+|.+||++.+|++.|+.+-..
T Consensus 238 ----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 238 ----RMGC----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp ----CCCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ----CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111 112234688999999999999999999999999988653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=347.32 Aligned_cols=265 Identities=25% Similarity=0.308 Sum_probs=200.5
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-----cChHHHHHHHHHHHhcC---CCCceeeEEEEecC
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-----QGNREFLVEVLMLSLLH---HSNLVNLIGYCADG 152 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-----~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~ 152 (457)
..++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+|+.+++.+. ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 46799999999999999999999999999999999874321 12346777887777665 99999999999876
Q ss_pred C-----eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceE
Q 012761 153 D-----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPK 227 (457)
Q Consensus 153 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~k 227 (457)
. ..++||||+. ++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 5 5799999996 6999999863 2344999999999999999999999999 99999999999999999999
Q ss_pred EeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhh
Q 012761 228 LSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL 307 (457)
Q Consensus 228 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 307 (457)
|+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|++||....... ....+...
T Consensus 161 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~ 234 (308)
T 3g33_A 161 LADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDL 234 (308)
T ss_dssp ECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHH
T ss_pred EeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHH
Confidence 9999999754322 22345679999999999999999999999999999999999999997543211 11111000
Q ss_pred hhc--cccccc-------ccCCccC---CCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 308 FND--RRKFSK-------LADPRLE---GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 308 ~~~--~~~~~~-------~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+.. ...+.. .+.+... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 000 000000 0000000 0000112356789999999999999999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=341.50 Aligned_cols=253 Identities=25% Similarity=0.393 Sum_probs=205.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|+||.||+|.+..++..||||++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 568999999999999999999999999999999986432 12345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999975 356899999999999999999999999 9999999999999999999999999986432
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......+...
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-------- 222 (279)
T 3fdn_A 161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISRV-------- 222 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHT--------
T ss_pred cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH------HHHHHHHHhC--------
Confidence 21 22345789999999999998999999999999999999999999965321 1111111110
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
... ++......+.+|+..||+.+|.+||++.+|++. ..+..
T Consensus 223 ~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h-~~~~~ 263 (279)
T 3fdn_A 223 EFT----FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH-PWITA 263 (279)
T ss_dssp CCC----CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC-HHHHH
T ss_pred CCC----CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC-ccccC
Confidence 011 111123467899999999999999999999975 34443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=344.11 Aligned_cols=258 Identities=23% Similarity=0.339 Sum_probs=204.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECC---CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLES---TGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
.++|.+.+.||+|+||.||+|++.. ++..||||++..... ...+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 5689999999999999999998653 345799999976532 234678899999999999999999999865 45689
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999999975 2456899999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.... ........+|+.|+|||++.+..++.++|||||||++|+|++ |+.||....... +.... ....
T Consensus 164 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~----~~~~---- 231 (281)
T 3cc6_A 164 EDED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVL----EKGD---- 231 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHH----HHTC----
T ss_pred cccc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHH----hcCC----
Confidence 3222 112233457889999999999999999999999999999998 999997543211 11111 1110
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
...... .....+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 232 --~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 232 --RLPKPD----LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp --CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCC----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 001111 122468899999999999999999999999998865
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=354.86 Aligned_cols=265 Identities=20% Similarity=0.297 Sum_probs=195.5
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
..++|.+.+.||+|+||.||+|++..+++.||||++....... ...+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4578999999999999999999999999999999997543322 34577899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE-----cCCCceEEeeccc
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL-----EEGFHPKLSDFGL 233 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl-----~~~~~~kL~DFGl 233 (457)
|||++ |+|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+
T Consensus 112 ~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 99997 599999976 346999999999999999999999999 9999999999999 4556699999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhh-hcc
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLF-NDR 311 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~-~~~ 311 (457)
+...... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.......- ...
T Consensus 184 a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 184 ARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFEVLGLPDD 259 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCT
T ss_pred ccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHHHhCCCch
Confidence 9753222 1223445789999999999875 58999999999999999999999997543211 1111100000 000
Q ss_pred cccc------ccc--CCccCCC-----CChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 312 RKFS------KLA--DPRLEGR-----YPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 312 ~~~~------~~~--d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..+. ... .+..... .+......+.+|+.+||+.||.+|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 000 0000000 00012356789999999999999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=367.98 Aligned_cols=248 Identities=25% Similarity=0.366 Sum_probs=206.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|+||.||+|++..+|+.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999999999999999997532 12345788999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999975 467999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCccccccccccccccchhhhhcCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ......+.....
T Consensus 168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~----- 233 (476)
T 2y94_A 168 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------PTLFKKICDGIF----- 233 (476)
T ss_dssp TTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------HHHHHHHHTTCC-----
T ss_pred ccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcCCc-----
Confidence 222 2334679999999999988765 7899999999999999999999975432 111111111110
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
. .+......+.+|+.+||+.||.+|||+.++++
T Consensus 234 ~-------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 Y-------TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp C-------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C-------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0 11112246789999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=354.83 Aligned_cols=244 Identities=24% Similarity=0.332 Sum_probs=204.2
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--------ChHHHHHHHHHHHhcCCCCceeeEEEEecC
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--------GNREFLVEVLMLSLLHHSNLVNLIGYCADG 152 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 152 (457)
..++|.+.+.||+|+||.||+|++..++..||||++...... ....+..|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999999999999999999865322 223577899999999999999999999999
Q ss_pred CeeeEEEeccCCC-CHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeec
Q 012761 153 DQRLLVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDF 231 (457)
Q Consensus 153 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DF 231 (457)
+..++||||+.+| +|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999776 99999976 456999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhcCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhc
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND 310 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 310 (457)
|++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ..
T Consensus 175 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~~- 238 (335)
T 3dls_A 175 GSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------VE- 238 (335)
T ss_dssp TTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------TT-
T ss_pred ccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------Hh-
Confidence 9998643322 2334679999999999988776 88999999999999999999999642110 00
Q ss_pred ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 311 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 311 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
....+ +......+.+|+..||+.+|.+||++.++++.
T Consensus 239 -----~~~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 -----AAIHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----TCCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----hccCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 11123468899999999999999999999773
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=356.26 Aligned_cols=258 Identities=16% Similarity=0.163 Sum_probs=209.1
Q ss_pred HhcCCCccceeeecCcEEEEEEE-----ECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC---CCCceeeEEEEecC
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGW-----LESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH---HSNLVNLIGYCADG 152 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~ 152 (457)
..++|.+.+.||+|+||.||+|. ...+++.||||++... ...++..|+.++..++ |+||+.+++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 35789999999999999999994 5667899999999754 3567888888888887 99999999999999
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC---------
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPP-DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE--------- 222 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~--------- 222 (457)
+..+|||||+++|+|.+++..... ....+++..++.|+.||+.||+|||+.+ |+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 999999999999999999974221 2467999999999999999999999999 999999999999988
Q ss_pred --CCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccc
Q 012761 223 --GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNL 300 (457)
Q Consensus 223 --~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l 300 (457)
++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence 89999999999975433333344556789999999999999999999999999999999999999985432210
Q ss_pred hhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCC-CChHHHHHHHHhhhhcC
Q 012761 301 VTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATR-PLIGDVVTALSYLANQT 366 (457)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~ev~~~L~~l~~~~ 366 (457)
.. ....+.. ++ ....+.+++..||+.+|.+| |++.++.+.|+.+....
T Consensus 293 -----------~~----~~~~~~~-~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 -----------CK----PEGLFRR-LP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp -----------EE----ECSCCTT-CS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -----------ee----echhccc-cC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 00 1111111 11 23456789999999999998 57889999998877653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=351.88 Aligned_cols=261 Identities=26% Similarity=0.420 Sum_probs=203.3
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCC----eEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTG----QVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
.++|.+.+.||+|+||.||+|.+..++ ..||||++...... ....+.+|+.++..++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 357888899999999999999986543 46999999764322 2346889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 123 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999975 2457999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCc-cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 237 GPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 237 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+.. . +....
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~---~-~~~~~-- 267 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMK---A-INDGF-- 267 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---H-HHTTC--
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHH---H-HHCCC--
Confidence 4322111 11222346788999999998999999999999999999999 99999654321 1111 1 11110
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.... +......+.+++.+||+.+|.+||++.+|++.|+.+...
T Consensus 268 ----~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 268 ----RLPT----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ----CCCC----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----cCCC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0011 112234688999999999999999999999999988754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=352.58 Aligned_cols=264 Identities=27% Similarity=0.394 Sum_probs=205.3
Q ss_pred hcCCCccceeeecCcEEEEEEE-----ECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGW-----LESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~-----~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 155 (457)
.++|.+.+.||+|+||.||+|+ ...++..||||++..... .....+.+|+.+++.++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 4689999999999999999998 455678999999975422 2335688999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC---CCceEEe
Q 012761 156 LLVYEFMPLGSLEDHLHDLPP---DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE---GFHPKLS 229 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~---~~~~kL~ 229 (457)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999986432 2246899999999999999999999999 999999999999984 4569999
Q ss_pred eccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhh
Q 012761 230 DFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLF 308 (457)
Q Consensus 230 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 308 (457)
|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||..... ..+...+ .
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~---~ 259 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFV---T 259 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHH---H
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHHHH---h
Confidence 9999874322222222334568899999999999999999999999999999998 9999865432 1111111 1
Q ss_pred hcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 309 NDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 309 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
. .. .+.... .....+.+++..||+.+|.+||++.+|++.|..+...
T Consensus 260 ~-~~------~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 260 S-GG------RMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp T-TC------CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred c-CC------CCCCCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 1 00 011111 1234678999999999999999999999999988763
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=342.23 Aligned_cols=260 Identities=24% Similarity=0.346 Sum_probs=208.0
Q ss_pred cCCCccc-eeeecCcEEEEEEEEC--CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 83 KNFRPES-FIGEGGFGRVYKGWLE--STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 83 ~~f~~~~-~lG~G~~g~Vy~~~~~--~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
++|.+.. .||+|+||.||+|.+. .++..||||++..... ...+.+.+|+.++..++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566666 8999999999999864 4678999999986432 2346688999999999999999999999 45678999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 999999999999965 3456999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCc-cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 239 VGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 239 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
..... .......||+.|+|||++.+..++.++|||||||++|+|++ |+.||...... .+...+ ...
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~i----~~~----- 229 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFI----EQG----- 229 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHH----HTT-----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH----hcC-----
Confidence 32211 11223457899999999998899999999999999999998 99999764321 111111 100
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
..+. .+......+.+++..||+.+|.+||++.+|++.|..+....
T Consensus 230 -~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 230 -KRME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp -CCCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CcCC----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0011 11222346889999999999999999999999999887643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=342.80 Aligned_cols=262 Identities=28% Similarity=0.409 Sum_probs=204.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCC---CeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEe-cCCeee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLEST---GQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCA-DGDQRL 156 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~ 156 (457)
..+|.+.+.||+|+||.||+|.+..+ ...||+|.+..... .....+.+|+.+++.++||||+++++++. ..+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 35688899999999999999997543 34689999876432 22356889999999999999999999865 456789
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 104 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999999975 3456899999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCC--ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccc
Q 012761 237 GPVGDK--SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRK 313 (457)
Q Consensus 237 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 313 (457)
...... ........||+.|+|||.+.+..++.++|||||||++|+|++ |.+||....... +.. ......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~---~~~~~~-- 249 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV---YLLQGR-- 249 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHH---HHHTTC--
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHH---HHhcCC--
Confidence 432221 112233567889999999999999999999999999999999 555665433221 111 111110
Q ss_pred cccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 314 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 314 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
.... ...+ ...+.+++..||+.+|.+||++.++++.|+.+....
T Consensus 250 --~~~~---~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 250 --RLLQ---PEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp --CCCC---CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred --CCCC---CccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0111 1111 246889999999999999999999999999988644
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=346.94 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=205.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEec--CCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l 157 (457)
.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46899999999999999999999999999999999765332 23568899999999999999999998754 678999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA--NPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
||||+++++|.+++.........+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999764333456999999999999999999999976 2349999999999999999999999999997
Q ss_pred cCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 236 LGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
..... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ..+. ..+....
T Consensus 165 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~---~~i~~~~---- 232 (279)
T 2w5a_A 165 ILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELA---GKIREGK---- 232 (279)
T ss_dssp HC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH---HHHHHTC----
T ss_pred eeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHH---HHHhhcc----
Confidence 53222 1222345789999999999998999999999999999999999999975432 1111 1111110
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
.+.+.. .....+.+++.+||+.+|.+||++.+|++.+.
T Consensus 233 ---~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 233 ---FRRIPY----RYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp ---CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ---cccCCc----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 011111 22346889999999999999999999988663
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=351.56 Aligned_cols=268 Identities=26% Similarity=0.324 Sum_probs=199.6
Q ss_pred HHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC-----hHHHHHHHHHHHhcCCCCceeeEEEEecCCe
Q 012761 80 AATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG-----NREFLVEVLMLSLLHHSNLVNLIGYCADGDQ 154 (457)
Q Consensus 80 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 154 (457)
...++|.+.+.||+|+||.||+|++..+|+.||||++....... .+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34678999999999999999999999999999999997532211 2468899999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
.++||||+++ +|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999975 88888865 3456888999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhc-cc
Q 012761 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND-RR 312 (457)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~ 312 (457)
..... .........||+.|+|||++.+. .++.++|||||||++|||++|.+||....... .+.......... ..
T Consensus 160 ~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 160 KSFGS--PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEE 235 (346)
T ss_dssp STTTS--CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTT
T ss_pred eeccC--CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHcCCCChh
Confidence 75322 22233456789999999999764 58999999999999999999999987543211 111111000000 00
Q ss_pred ccc---cccCCccCC---CCC-----hHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 313 KFS---KLADPRLEG---RYP-----IRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 313 ~~~---~~~d~~l~~---~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.+. .+.+..... ..+ ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 000000000 011 1123578899999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=341.12 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=207.0
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEec---------
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD--------- 151 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--------- 151 (457)
..++|.+.+.||+|+||.||+|++..+++.||||++.... ..+.+|+.++..++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467999999999999999999999889999999997542 457789999999999999999998864
Q ss_pred -------CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC
Q 012761 152 -------GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF 224 (457)
Q Consensus 152 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~ 224 (457)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence 34579999999999999999752 2357999999999999999999999999 99999999999999999
Q ss_pred ceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhh
Q 012761 225 HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWA 304 (457)
Q Consensus 225 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~ 304 (457)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..|+.... .+.
T Consensus 160 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~ 228 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFF 228 (284)
T ss_dssp EEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHH
T ss_pred CEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHH
Confidence 99999999987643322 2234568999999999999899999999999999999999998864210 111
Q ss_pred hhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 305 RPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 305 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
. .+.+..+...++ ..+.+++..||+.||.+||++.++++.|..+...
T Consensus 229 ~----------~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 229 T----------DLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp H----------HHHTTCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred H----------HhhcccccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1 011111112222 3577899999999999999999999999988653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=344.07 Aligned_cols=252 Identities=27% Similarity=0.389 Sum_probs=209.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.+.|.+.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 3568999999999999999999999999999999976543 334778999999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999964 56999999999999999999999999 999999999999999999999999999753322
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .+... + .. ...+
T Consensus 173 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~---~-~~------~~~~ 237 (303)
T 3a7i_A 173 --QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLFL---I-PK------NNPP 237 (303)
T ss_dssp --BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH---H-HH------SCCC
T ss_pred --ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHHH---h-hc------CCCC
Confidence 12233457899999999999989999999999999999999999999654321 11110 0 00 0111
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
.+...++ ..+.+|+..||+.+|.+||++.++++..-
T Consensus 238 ~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 238 TLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp CCCSSCC----HHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred CCccccC----HHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 2222222 45889999999999999999999987543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=353.35 Aligned_cols=268 Identities=30% Similarity=0.436 Sum_probs=210.7
Q ss_pred hcCCCccceeeecCcEEEEEEEE----CCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCC--ee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWL----ESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD--QR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~ 155 (457)
.++|++.+.||+|+||.||+|++ ..++..||||++........+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45789999999999999999984 5679999999998765545567899999999999999999999987654 78
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999999862 356999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCc-cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCC---------CCcccchhhhh
Q 012761 236 LGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRP---------HGEQNLVTWAR 305 (457)
Q Consensus 236 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~---------~~~~~l~~~~~ 305 (457)
........ .......++..|+|||++.+..++.++|||||||++|||++|..||..... ...........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 64333221 112234577889999999998899999999999999999999998753210 00000000001
Q ss_pred hhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 306 PLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
..+.... .. ..+......+.+|+.+||+.+|.+||++.+|++.|+.+...
T Consensus 274 ~~~~~~~------~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 274 ELLKNNG------RL----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHTTC------CC----CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhhcCC------CC----CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111100 01 11122335688999999999999999999999999988753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=365.93 Aligned_cols=257 Identities=27% Similarity=0.400 Sum_probs=204.3
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||.||+|.+.. +..||||++.... ...+.|.+|+.+++.++||||+++++++.+ +..++||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 5678899999999999999999975 5779999998654 345789999999999999999999999876 678999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 260 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 260 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 9999999999641 1345899999999999999999999999 9999999999999999999999999997543221
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
........+++.|+|||++....++.++|||||||++|||++ |+.||...... .+.. . +.... ..
T Consensus 335 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~---~-i~~~~------~~ 400 (452)
T 1fmk_A 335 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD---Q-VERGY------RM 400 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH---H-HHTTC------CC
T ss_pred -eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH---H-HHcCC------CC
Confidence 112233457889999999999999999999999999999999 99999754321 1111 1 11110 00
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
..+......+.+|+.+||+.+|++|||+.+|++.|+.+..
T Consensus 401 ----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 401 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 1111223468899999999999999999999999988764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=342.46 Aligned_cols=259 Identities=23% Similarity=0.293 Sum_probs=206.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc------ChHHHHHHHHHHHhcCCCCceeeEEEEecCCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ------GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 155 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 35799999999999999999999999999999998754322 246789999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC----ceEEeec
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF----HPKLSDF 231 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~----~~kL~DF 231 (457)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999975 457999999999999999999999999 99999999999998877 8999999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 311 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 311 (457)
|++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... .....+....
T Consensus 157 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~ 227 (283)
T 3bhy_A 157 GIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------ETLTNISAVN 227 (283)
T ss_dssp TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTC
T ss_pred ccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------HHHHHhHhcc
Confidence 9997533221 223456899999999999889999999999999999999999999754321 1111110000
Q ss_pred cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH--HHHhhhh
Q 012761 312 RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT--ALSYLAN 364 (457)
Q Consensus 312 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~--~L~~l~~ 364 (457)
. ...+.... .....+.+++.+||+.+|.+||++.++++ .+..+..
T Consensus 228 ~----~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 228 Y----DFDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp C----CCCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred c----CCcchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 0 00100101 12346789999999999999999999997 3455443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=344.23 Aligned_cols=251 Identities=21% Similarity=0.296 Sum_probs=204.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++..........+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 46799999999999999999999999999999999876544556788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE---cCCCceEEeeccccccCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~~ 238 (457)
+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.++|+|||++....
T Consensus 88 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999875 356899999999999999999999999 9999999999999 788999999999987532
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..+ ...+...... .
T Consensus 161 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~---~~~i~~~~~~----~ 226 (304)
T 2jam_A 161 N----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKL---FEKIKEGYYE----F 226 (304)
T ss_dssp C----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH---HHHHHHCCCC----C
T ss_pred C----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH---HHHHHcCCCC----C
Confidence 1 122345689999999999998999999999999999999999999965432 111 1111111100 0
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.... .......+.+++..||+.||.+||++.++++
T Consensus 227 ~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 ESPF----WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CTTT----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred Cccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 1122346889999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=351.15 Aligned_cols=262 Identities=24% Similarity=0.313 Sum_probs=192.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCceeeEEEEe--------cC
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCA--------DG 152 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~--------~~ 152 (457)
..+|++.+.||+|+||.||+|++..+++.||||++..........+.+|+.++..+. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457999999999999999999999999999999997665455567889999999996 999999999994 34
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecc
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 232 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFG 232 (457)
...++||||+. |+|.+++.... ....+++..++.|+.||+.||.|||+.+ ++|+||||||+||||+.++.+||+|||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred ceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 45799999995 79988886421 2356999999999999999999999975 349999999999999999999999999
Q ss_pred ccccCCCCCCcc----------ccccccccccccchhhh---hcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 012761 233 LAKLGPVGDKSH----------VSTRVMGTYGYCAPEYA---MTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN 299 (457)
Q Consensus 233 la~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~ 299 (457)
++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--- 260 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--- 260 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---
Confidence 997643322111 11134689999999998 56678999999999999999999999996533211
Q ss_pred chhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 300 LVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 300 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
+. ... ......... ...+.+|+..||+.+|.+||++.++++.|..+....
T Consensus 261 ~~-------~~~------~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 261 IV-------NGK------YSIPPHDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp ------------------CCCCTTCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred hh-------cCc------ccCCccccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 00 000 000001111 124678999999999999999999999999998643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=371.98 Aligned_cols=255 Identities=28% Similarity=0.382 Sum_probs=208.6
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
..++|.+.+.||+|+||.||+|++..+|+.||||++.... ......+.+|+.+|..++||||+++++++.+.+.++|
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999999999999999996532 2234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||++||+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 262 VmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence 99999999999999762 2345999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......+....
T Consensus 337 ~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~i~~~i~~~~------ 405 (576)
T 2acx_A 337 PEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKEVP------ 405 (576)
T ss_dssp CTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHHHHHHHHHCC------
T ss_pred ccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHHHHHHhhccc------
Confidence 3222 23345899999999999998999999999999999999999999976543211 111111111111
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCC-----ChHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVT 357 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~ 357 (457)
. .++......+.+|+.+||+.||.+|| ++.||++
T Consensus 406 --~----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 --E----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --C----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --c----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1 11122235688999999999999999 6788764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=354.64 Aligned_cols=267 Identities=16% Similarity=0.160 Sum_probs=200.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECC---CCeEEEEEEeccCCCc-----------ChHHHHHHHHHHHhcCCCCceeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLES---TGQVVAVKQLDRNGLQ-----------GNREFLVEVLMLSLLHHSNLVNLIG 147 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~i~~~~~~-----------~~~~~~~E~~~l~~l~hpniv~l~~ 147 (457)
.++|.+.+.||+|+||.||+|.+.. ++..||||++...... ....+..|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4679999999999999999999987 7889999998765321 1234667888999999999999999
Q ss_pred EEec----CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC
Q 012761 148 YCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG 223 (457)
Q Consensus 148 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~ 223 (457)
++.. ....++||||+ +++|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 9987 77899999999 9999999976 347999999999999999999999999 9999999999999887
Q ss_pred C--ceEEeeccccccCCCCCC-----ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCC
Q 012761 224 F--HPKLSDFGLAKLGPVGDK-----SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHG 296 (457)
Q Consensus 224 ~--~~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~ 296 (457)
+ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999975422111 111244579999999999999899999999999999999999999996432111
Q ss_pred cccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 297 EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 297 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
..+.......... +......... .......+.+++..||+.+|.+||++.+|++.|+.+.
T Consensus 268 -~~~~~~~~~~~~~---~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 268 -VAVQTAKTNLLDE---LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp -HHHHHHHHHHHHT---TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred -HHHHHHHHhhccc---ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1111111111000 0000000000 0012246889999999999999999999999997654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=339.98 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=208.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||.||+|.+. ++..||||++.... ...+.+.+|+.+++.++||||+++++++.+ +..++||||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 467999999999999999999986 46789999997653 345789999999999999999999999864 568999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 89 MENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp CTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999999641 1236899999999999999999999999 9999999999999999999999999998643222
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
........+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .+. ..+.. . ..+
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~---~~~~~-~------~~~ 229 (279)
T 1qpc_A 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVI---QNLER-G------YRM 229 (279)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH---HHHHT-T------CCC
T ss_pred -cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHH---HHHhc-c------cCC
Confidence 112233457889999999998899999999999999999999 99999654321 111 11111 0 011
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.... .....+.+++..||+.+|++||++.++++.|+.+...
T Consensus 230 ~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 230 VRPD----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcc----cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 1111 2234688999999999999999999999999988754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=349.99 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=207.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|+||.||++++..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 46899999999999999999999999999999998754322 235688899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999875 457999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+.....
T Consensus 193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~------ 258 (335)
T 2owb_A 193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNEY------ 258 (335)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCC------
T ss_pred cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHhcCCC------
Confidence 221 223345799999999999998999999999999999999999999965321 111111111111
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.+... ....+.+|+.+||+.||.+||++.++++.
T Consensus 259 --~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 --SIPKH----INPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp --CCCTT----SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CCCcc----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111 22457889999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=352.76 Aligned_cols=267 Identities=25% Similarity=0.415 Sum_probs=204.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.++|++.+.||+|+||.||+|++..+++.||||++....... .+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 468999999999999999999999999999999986543322 245778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999888764 456999999999999999999999999 99999999999999999999999999975322
Q ss_pred CCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc-cch-------hhhhhhhhc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-NLV-------TWARPLFND 310 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~-~l~-------~~~~~~~~~ 310 (457)
. ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||......... .+. ......+..
T Consensus 177 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 177 P--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred C--ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 2 2223345789999999999875 7899999999999999999999999764321110 000 000111111
Q ss_pred ccccccccCCccCCCCCh-----HhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 311 RRKFSKLADPRLEGRYPI-----RGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 311 ~~~~~~~~d~~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...+.....+.+....+. .....+.+|+.+||+.||.+||++.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111112222222222111 22457889999999999999999999886
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=345.39 Aligned_cols=270 Identities=25% Similarity=0.361 Sum_probs=211.0
Q ss_pred HHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHh--cCCCCceeeEEEEecCC-
Q 012761 77 ELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSL--LHHSNLVNLIGYCADGD- 153 (457)
Q Consensus 77 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~~- 153 (457)
......++|.+.+.||+|+||.||+|++. ++.||||++... ....+..|+.++.. ++||||+++++++....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 33455689999999999999999999884 899999999643 34667888888887 78999999999998876
Q ss_pred ---eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeccCCccCeEEcC
Q 012761 154 ---QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH--------DKANPPVIYRDFKSSNILLEE 222 (457)
Q Consensus 154 ---~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~~~~iiHrDLkp~NILl~~ 222 (457)
..++||||+++|+|.+++.. ..+++..++.++.||+.||.||| +.+ |+||||||+||||+.
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK 182 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred ccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence 78999999999999999975 46899999999999999999999 777 999999999999999
Q ss_pred CCceEEeeccccccCCCCCCcc--ccccccccccccchhhhhcC------CCCccchHHHHHHHHHHHHhC---------
Q 012761 223 GFHPKLSDFGLAKLGPVGDKSH--VSTRVMGTYGYCAPEYAMTG------QLTVKSDVYSFGVVFLELITG--------- 285 (457)
Q Consensus 223 ~~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSlGvil~elltG--------- 285 (457)
++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 9999999999997543322111 22345799999999999865 233789999999999999999
Q ss_pred -CCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCC-ChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 286 -RKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRY-PIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 286 -~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
..||........ ....+...... ....+.+...+ .......+.+|+.+||+.+|.+||++.+|++.|+.+.
T Consensus 263 ~~~p~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 263 YQLPYYDLVPSDP-SVEEMRKVVCE------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CCCTTTTTSCSSC-CHHHHHHHHTT------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCccccCcCcc-cHHHHHHHHHH------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 667755432211 11111111111 11122222111 2245668899999999999999999999999999997
Q ss_pred hcC
Q 012761 364 NQT 366 (457)
Q Consensus 364 ~~~ 366 (457)
.+.
T Consensus 336 ~~~ 338 (342)
T 1b6c_B 336 QQE 338 (342)
T ss_dssp HTT
T ss_pred HHh
Confidence 653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=340.81 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=207.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|+||.||+|.+..+++.||+|++...... ..+.+..|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 46799999999999999999999999999999998754322 235688899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999999875 357999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+....
T Consensus 167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~------- 231 (294)
T 2rku_A 167 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNE------- 231 (294)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTC-------
T ss_pred cCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhhcc-------
Confidence 221 223345789999999999988899999999999999999999999965431 11111111111
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
..+ +......+.+++.+||+.+|++||++.++++.
T Consensus 232 -~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 -YSI----PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -CCC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -CCC----ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 011 11122467889999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=351.97 Aligned_cols=263 Identities=22% Similarity=0.341 Sum_probs=196.6
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC-hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
++|.+.+.||+|+||.||+|++..+++.||||++....... ...+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999999999999999997543221 12355799999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~- 153 (324)
T 3mtl_A 82 LD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP- 153 (324)
T ss_dssp CS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC-
Confidence 97 689998876 2456999999999999999999999999 999999999999999999999999999753222
Q ss_pred Cccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc--cccc---
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR--RKFS--- 315 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~~--- 315 (457)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+...+... ..+.
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 154 -TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGG
T ss_pred -ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhh
Confidence 222334578999999999876 568999999999999999999999997643211 111111110000 0000
Q ss_pred ------cccCCccCCCC----ChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 316 ------KLADPRLEGRY----PIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 316 ------~~~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
....+...... .......+.+|+.+||+.||.+|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000000 0112346789999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=369.97 Aligned_cols=264 Identities=24% Similarity=0.287 Sum_probs=197.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecC------C
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADG------D 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 153 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999999999999999997542 22235688999999999999999999999655 4
Q ss_pred eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 233 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGl 233 (457)
..||||||+++ +|.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 57999999975 56666643 4899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCccc-ch-----------
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN-LV----------- 301 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~-l~----------- 301 (457)
++.... ....+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+........ +.
T Consensus 211 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 211 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp C--------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 975322 223345689999999999999999999999999999999999999997643211000 00
Q ss_pred ----hhhhhhhhcccc-----cccccCCccCCCCC---hHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 302 ----TWARPLFNDRRK-----FSKLADPRLEGRYP---IRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 302 ----~~~~~~~~~~~~-----~~~~~d~~l~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
..+..++..... +...+...+..... ......+.+|+.+||+.||++|||+.|+++.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000100000 00000000000000 0114578899999999999999999999863
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=344.55 Aligned_cols=255 Identities=30% Similarity=0.442 Sum_probs=199.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||.||+|++. +..||||++... ...+.+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 357899999999999999999885 689999999754 234678999999999999999999998874 48999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCeeeccCCccCeEEcCCCc-eEEeeccccccC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD---KANPPVIYRDFKSSNILLEEGFH-PKLSDFGLAKLG 237 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~---~~~~~iiHrDLkp~NILl~~~~~-~kL~DFGla~~~ 237 (457)
+++++|.+++.... ....+++..++.++.|++.||.|||+ .+ |+||||||+|||++.++. +||+|||++...
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 81 AEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp CTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred CCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 99999999998632 12357899999999999999999999 66 999999999999988886 799999998743
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...|. ... .
T Consensus 157 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~--~~~-------~ 220 (307)
T 2eva_A 157 QT-----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWA--VHN-------G 220 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHH--HHT-------T
T ss_pred cc-----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHH--Hhc-------C
Confidence 21 12234689999999999998999999999999999999999999975432110 01111 000 0
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
..+.+...+ ...+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus 221 ~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 221 TRPPLIKNL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp CCCCCBTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred CCCCccccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 111111222 245788999999999999999999999999987643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=350.10 Aligned_cols=271 Identities=25% Similarity=0.373 Sum_probs=198.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHH--HHhcCCCCceeeEEEEec-----CCe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLM--LSLLHHSNLVNLIGYCAD-----GDQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~--l~~l~hpniv~l~~~~~~-----~~~ 154 (457)
.++|.+.+.||+|+||.||+|++ +++.||||++... ....+..|..+ +..++||||+++++++.. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46899999999999999999977 4799999999753 23444445544 445899999999986532 235
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeeeccCCccCeEEcCCCc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK---------ANPPVIYRDFKSSNILLEEGFH 225 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~---------~~~~iiHrDLkp~NILl~~~~~ 225 (457)
+++||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. + |+||||||+||||+.++.
T Consensus 87 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSC
T ss_pred EEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCc
Confidence 7899999999999999975 3458999999999999999999998 7 999999999999999999
Q ss_pred eEEeeccccccCCCCC------Cccccccccccccccchhhhhc-------CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 012761 226 PKLSDFGLAKLGPVGD------KSHVSTRVMGTYGYCAPEYAMT-------GQLTVKSDVYSFGVVFLELITGRKAIDST 292 (457)
Q Consensus 226 ~kL~DFGla~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwSlGvil~elltG~~p~~~~ 292 (457)
+||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999997543221 1122234579999999999976 35667999999999999999998777543
Q ss_pred CCCCcccchhh--h--hhhhhccc--ccccccCCccCCCC--ChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 293 RPHGEQNLVTW--A--RPLFNDRR--KFSKLADPRLEGRY--PIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 293 ~~~~~~~l~~~--~--~~~~~~~~--~~~~~~d~~l~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
........... . .+...... .......+.+...+ .......+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 32221111000 0 00000000 00011111121111 12245578999999999999999999999999999986
Q ss_pred c
Q 012761 365 Q 365 (457)
Q Consensus 365 ~ 365 (457)
.
T Consensus 319 ~ 319 (336)
T 3g2f_A 319 I 319 (336)
T ss_dssp C
T ss_pred H
Confidence 4
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=340.74 Aligned_cols=254 Identities=28% Similarity=0.405 Sum_probs=201.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecC-CeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADG-DQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~lV~E 160 (457)
.++|++.+.||+|+||.||++.+. +..||||++.... ..+.+.+|+.+++.++||||+++++++.+. +..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 468999999999999999999875 7899999997543 456789999999999999999999997654 47899999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999999752 1224889999999999999999999999 999999999999999999999999998743221
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
.....+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... .+.. .+ ... ..
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~---~~-~~~------~~ 232 (278)
T 1byg_A 171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP---RV-EKG------YK 232 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHH---HH-TTT------CC
T ss_pred -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---HH-hcC------CC
Confidence 123357889999999999999999999999999999998 99999754321 1111 11 100 01
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
+.. +......+.+++..||+.+|.+||++.++++.|+.+....
T Consensus 233 ~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 233 MDA----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCC----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 111 1122346889999999999999999999999999987654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=340.27 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=206.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|+||.||+|++..++..||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999999999999999986431 22346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999975 356899999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... .....+...
T Consensus 166 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~-------- 227 (284)
T 2vgo_A 166 SL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRRIVNV-------- 227 (284)
T ss_dssp SS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTT--------
T ss_pred cc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHHHhcc--------
Confidence 21 123457899999999999989999999999999999999999999654311 111111111
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
+.. ++......+.+++..||+.+|.+||++.++++.
T Consensus 228 ~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 228 DLK----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ccC----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 111 111223467899999999999999999999863
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=344.67 Aligned_cols=254 Identities=24% Similarity=0.316 Sum_probs=189.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC-h-HHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG-N-REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-~-~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.++|++.+.||+|+||.||+|++..+++.||||++....... . +.+..+...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 468999999999999999999999999999999997643221 1 23444555688889999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
||++ |+|.+++.........+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 588887764333456799999999999999999999998 8 9999999999999999999999999997532
Q ss_pred CCCCccccccccccccccchhhh----hcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYA----MTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
.. .......||+.|+|||++ .+..++.++|||||||++|+|++|+.||...... ... ........
T Consensus 162 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~--- 230 (290)
T 3fme_A 162 DD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----FQQ-LKQVVEEP--- 230 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH----HHH-HHHHHHSC---
T ss_pred cc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch----HHH-HHHHhccC---
Confidence 22 122334699999999996 4567899999999999999999999999653221 011 11111110
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+... .......+.+++.+||+.+|++|||+.++++
T Consensus 231 ----~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 ----SPQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ----CCCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 01110 1112346889999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=357.33 Aligned_cols=266 Identities=21% Similarity=0.292 Sum_probs=199.6
Q ss_pred HHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEec-------
Q 012761 79 AAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD------- 151 (457)
Q Consensus 79 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------- 151 (457)
....++|.+.+.||+|+||.||+|++..+++.||||++...... ..+|+.+++.++||||++++++|..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999999999999999998754322 2369999999999999999999844
Q ss_pred -------------------------------CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 012761 152 -------------------------------GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 200 (457)
Q Consensus 152 -------------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yL 200 (457)
....++||||++ ++|.+.+.........+++..+..++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334889999998 588777764333456799999999999999999999
Q ss_pred HhCCCCCeeeccCCccCeEEc-CCCceEEeeccccccCCCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHH
Q 012761 201 HDKANPPVIYRDFKSSNILLE-EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVV 278 (457)
Q Consensus 201 H~~~~~~iiHrDLkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvi 278 (457)
|+.+ |+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9999 99999999999997 68999999999998543222 23345789999999998865 58999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcccchhhhhhh--------hhcccccccccCCccC-----CCCChHhHHHHHHHHHHcchhh
Q 012761 279 FLELITGRKAIDSTRPHGEQNLVTWARPL--------FNDRRKFSKLADPRLE-----GRYPIRGLYQALAVASMCIQEQ 345 (457)
Q Consensus 279 l~elltG~~p~~~~~~~~~~~l~~~~~~~--------~~~~~~~~~~~d~~l~-----~~~~~~~~~~l~~li~~cl~~d 345 (457)
+|||++|+.||......+ .+...+... ......+....-+.+. ..++......+.+|+.+||+.+
T Consensus 232 l~ell~g~~pf~~~~~~~--~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 232 FGELILGKPLFSGETSID--QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 999999999997643211 111111100 0000000111111111 1112223456889999999999
Q ss_pred cCCCCChHHHHH
Q 012761 346 AATRPLIGDVVT 357 (457)
Q Consensus 346 P~~RPt~~ev~~ 357 (457)
|.+|||+.|+++
T Consensus 310 P~~R~t~~e~l~ 321 (383)
T 3eb0_A 310 PDLRINPYEAMA 321 (383)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=350.77 Aligned_cols=273 Identities=27% Similarity=0.398 Sum_probs=208.2
Q ss_pred CCCccceeeecCcEEEEEEEE----CCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEec--CCeee
Q 012761 84 NFRPESFIGEGGFGRVYKGWL----ESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQRL 156 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~ 156 (457)
.|++.+.||+|+||.||++.. ..+++.||||++..... .....+.+|+.+++.++||||+++++++.+ ....+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 348999999999999988754 34789999999986532 223568899999999999999999999987 46789
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 112 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccc
Confidence 99999999999999975 34999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCc-cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 237 GPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 237 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
....... .......||..|+|||++.+..++.++|||||||++|+|++|..||...... ...+..+....... ..+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~-~~~~ 261 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-FLELIGIAQGQMTV-LRLT 261 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-HHHHHCSCCHHHHH-HHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh-hhhhhcccccchhH-HHHH
Confidence 4433221 2233456888999999999989999999999999999999999998642210 00000010000000 0000
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
..+........+......+.+|+..||+.+|.+||++.+|++.|+.+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 111111111122223457889999999999999999999999999987643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=349.96 Aligned_cols=262 Identities=20% Similarity=0.233 Sum_probs=206.2
Q ss_pred cHHHHHHHhcCCCcc-ceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcC-CCCceeeEEEE
Q 012761 74 TFRELAAATKNFRPE-SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLH-HSNLVNLIGYC 149 (457)
Q Consensus 74 ~~~~~~~~~~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~-hpniv~l~~~~ 149 (457)
.+.......+.|.+. +.||+|+||.||+|++..+++.||||++.... ......+.+|+.++..+. ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 334445556778887 89999999999999999999999999997532 233567889999999985 69999999999
Q ss_pred ecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC---CCce
Q 012761 150 ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE---GFHP 226 (457)
Q Consensus 150 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~---~~~~ 226 (457)
.+.+..++||||+++|+|.+++.. .....+++..++.++.||+.||.|||+.+ |+||||||+||||+. ++.+
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence 999999999999999999999864 23467999999999999999999999999 999999999999987 7899
Q ss_pred EEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhh
Q 012761 227 KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP 306 (457)
Q Consensus 227 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~ 306 (457)
||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....
T Consensus 174 kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~ 244 (327)
T 3lm5_A 174 KIVDFGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ------ETYLN 244 (327)
T ss_dssp EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH
T ss_pred EEeeCccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HHHHH
Confidence 99999999864322 1223457999999999999999999999999999999999999999654321 11111
Q ss_pred hhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 307 LFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 307 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+...... ..... .......+.+|+..||+.+|.+||++.++++
T Consensus 245 i~~~~~~----~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 245 ISQVNVD----YSEET----FSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHTCCC----CCTTT----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHhcccc----cCchh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1110000 00111 1122346789999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=360.52 Aligned_cols=254 Identities=20% Similarity=0.297 Sum_probs=194.6
Q ss_pred HHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--------cChHHHHHHHHHHHhcCCCCceeeEEEEec
Q 012761 80 AATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--------QGNREFLVEVLMLSLLHHSNLVNLIGYCAD 151 (457)
Q Consensus 80 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 151 (457)
...++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 456899999999999999999999999999999999875321 112347899999999999999999999854
Q ss_pred CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC---CceEE
Q 012761 152 GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG---FHPKL 228 (457)
Q Consensus 152 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~---~~~kL 228 (457)
+..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.+ +.+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence 568999999999999998865 467999999999999999999999999 9999999999999654 45999
Q ss_pred eeccccccCCCCCCccccccccccccccchhhhhc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhh
Q 012761 229 SDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT---GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWAR 305 (457)
Q Consensus 229 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~ 305 (457)
+|||+++.... .......+||+.|+|||++.. ..++.++|||||||++|+|++|+.||....... .+...+.
T Consensus 284 ~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i~ 358 (419)
T 3i6u_A 284 TDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT 358 (419)
T ss_dssp CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHHH
T ss_pred eecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHHh
Confidence 99999986322 223345679999999999863 578899999999999999999999997543211 1111110
Q ss_pred hhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 306 PLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..... ..+.... .....+.+|+.+||+.||.+||++.++++
T Consensus 359 ---~~~~~----~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 359 ---SGKYN----FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp ---TTCCC----CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---cCCCC----CCchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000 0000001 12346889999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=341.00 Aligned_cols=247 Identities=20% Similarity=0.238 Sum_probs=199.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++..... .....+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 5689999999999999999999998999999999986432 2345688899999998 899999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC----------------
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE---------------- 222 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~---------------- 222 (457)
|||+++++|.+++.........+++..++.|+.||+.||.|||+.+ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999753222366899999999999999999999999 999999999999984
Q ss_pred ---CCceEEeeccccccCCCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 012761 223 ---GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 298 (457)
Q Consensus 223 ---~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~ 298 (457)
...+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 447999999998763321 223589999999999865 56789999999999999999988764221
Q ss_pred cchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 299 NLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 299 ~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.... +.. ...+.+... ....+.+++..||+.||.+||++.++++
T Consensus 236 ~~~~----~~~-------~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 QWHE----IRQ-------GRLPRIPQV----LSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHH----HHT-------TCCCCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH----HHc-------CCCCCCCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 0100 000 001111112 2346889999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=339.98 Aligned_cols=254 Identities=23% Similarity=0.310 Sum_probs=201.5
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
++|....+||+|+||.||+|.+..++..||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34566668999999999999999999999999998765555678999999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC-CCceEEeeccccccCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE-GFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~-~~~~kL~DFGla~~~~~~~ 241 (457)
++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+|+||||+|||++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 9999999997631 2345678999999999999999999999 999999999999987 8999999999997533221
Q ss_pred CccccccccccccccchhhhhcCC--CCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQ--LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....... ...+.... ....
T Consensus 178 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~--------~~~~ 244 (295)
T 2clq_A 178 --PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---AAMFKVGM--------FKVH 244 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---HHHHHHHH--------HCCC
T ss_pred --CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---HHHHhhcc--------cccc
Confidence 2233457899999999997653 8899999999999999999999996432110 00000000 0111
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+.+.. .....+.+++.+||+.+|++||++.+++.
T Consensus 245 ~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 245 PEIPE----SMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCT----TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22222 22346789999999999999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=361.57 Aligned_cols=201 Identities=25% Similarity=0.356 Sum_probs=169.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecC-----Ce
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADG-----DQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 154 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4689999999999999999999999999999999975422 2235688999999999999999999999776 57
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
.|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999996 699999975 456999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCc--------------------cccccccccccccchhhh-hcCCCCccchHHHHHHHHHHHHhCCCCCC
Q 012761 235 KLGPVGDKS--------------------HVSTRVMGTYGYCAPEYA-MTGQLTVKSDVYSFGVVFLELITGRKAID 290 (457)
Q Consensus 235 ~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDvwSlGvil~elltG~~p~~ 290 (457)
+........ ...+..+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 864332211 123557899999999986 45579999999999999999998655553
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=349.18 Aligned_cols=256 Identities=28% Similarity=0.421 Sum_probs=200.6
Q ss_pred HHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCceeeEEEEec----
Q 012761 77 ELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCAD---- 151 (457)
Q Consensus 77 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~---- 151 (457)
++....++|.+.+.||+|+||.||+|++..+++.||||++.... .....+.+|+.++..+ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34445788999999999999999999999899999999997543 3457889999999999 79999999999977
Q ss_pred --CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEe
Q 012761 152 --GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLS 229 (457)
Q Consensus 152 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~ 229 (457)
.+..++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEe
Confidence 46789999999999999999762 2357899999999999999999999999 9999999999999999999999
Q ss_pred eccccccCCCCCCccccccccccccccchhhhh-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhh
Q 012761 230 DFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWA 304 (457)
Q Consensus 230 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~ 304 (457)
|||++...... ........||+.|+|||++. +..++.++|||||||++|+|++|..||....... . .
T Consensus 172 Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~---~ 243 (326)
T 2x7f_A 172 DFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---A---L 243 (326)
T ss_dssp CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---H
T ss_pred eCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---H---H
Confidence 99998753221 11223457899999999987 5678999999999999999999999996543210 0 0
Q ss_pred hhhhhcccccccccCCcc-CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 305 RPLFNDRRKFSKLADPRL-EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 305 ~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..+... ..+.+ ...+ ...+.+++..||+.+|.+||++.++++
T Consensus 244 ~~~~~~-------~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 244 FLIPRN-------PAPRLKSKKW----SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHS-------CCCCCSCSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhhcC-------ccccCCcccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 001110 01111 1112 246889999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=354.66 Aligned_cols=260 Identities=28% Similarity=0.419 Sum_probs=197.4
Q ss_pred CCCccceeeecCcEEEEEEEECCC---CeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEec-CCeeeEE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLEST---GQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCAD-GDQRLLV 158 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lV 158 (457)
.|.+.+.||+|+||.||+|.+..+ +..||||.+..... ...+.+.+|+.+++.++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 467788999999999999987543 24689999875322 234678999999999999999999998755 4578999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999975 3456889999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCc--cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 239 VGDKS--HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 239 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||....... +.... ....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~---~~~~---- 313 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL---LQGR---- 313 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHH---HTTC----
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHH---HcCC----
Confidence 22211 12233567889999999999999999999999999999999 677776543321 11111 1110
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
....+ . .....+.+++..||+.+|.+||++.++++.|+.+....
T Consensus 314 ~~~~p---~----~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 314 RLLQP---E----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp CCCCC---T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCCC---C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11111 1 12246889999999999999999999999999988654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=356.91 Aligned_cols=200 Identities=27% Similarity=0.369 Sum_probs=176.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.++|.+.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 3579999999999999999999999999999999976532 223568899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+||||+.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999976 35699999999999999999999996 8 99999999999999999999999999864211
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 292 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~ 292 (457)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 185 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 185 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1223457999999999999999999999999999999999999999754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=348.64 Aligned_cols=259 Identities=23% Similarity=0.342 Sum_probs=207.4
Q ss_pred HHHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--------hHHHHHHHHHHHhc-CCCCceee
Q 012761 75 FRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--------NREFLVEVLMLSLL-HHSNLVNL 145 (457)
Q Consensus 75 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--------~~~~~~E~~~l~~l-~hpniv~l 145 (457)
+.......++|.+.+.||+|+||.||+|++..+|+.||||++....... .+.+..|+.++..+ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444556678999999999999999999999889999999997643211 24577899999999 79999999
Q ss_pred EEEEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc
Q 012761 146 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH 225 (457)
Q Consensus 146 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~ 225 (457)
++++......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence 9999999999999999999999999975 457999999999999999999999999 999999999999999999
Q ss_pred eEEeeccccccCCCCCCccccccccccccccchhhhhc------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 012761 226 PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT------GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN 299 (457)
Q Consensus 226 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~ 299 (457)
++|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .
T Consensus 239 ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~ 312 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---L 312 (365)
T ss_dssp EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---H
T ss_pred EEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---H
Confidence 9999999987643322 2334679999999999864 35889999999999999999999999653211 1
Q ss_pred chhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 300 LVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 300 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+. ..+...... ...+.. . .....+.+++.+||+.||++||++.++++
T Consensus 313 ~~---~~i~~~~~~---~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 313 ML---RMIMEGQYQ---FSSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HH---HHHHHTCCC---CCHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HH---HHHHhCCCC---CCCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 111110000 000000 0 11245889999999999999999999976
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=374.00 Aligned_cols=258 Identities=24% Similarity=0.348 Sum_probs=203.0
Q ss_pred CCCccc-eeeecCcEEEEEEEEC--CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 84 NFRPES-FIGEGGFGRVYKGWLE--STGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 84 ~f~~~~-~lG~G~~g~Vy~~~~~--~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++.+.. .||+|+||.||+|.+. .++..||||+++.... ...+.+.+|+.+|+.++||||+++++++.. +..+|||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 444444 7999999999999875 3467899999986532 345789999999999999999999999976 5689999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|+|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 415 E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp ECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 99999999999975 3457999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCc-cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 240 GDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 240 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
.... .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...... .+...+ ....
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i----~~~~----- 556 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFI----EQGK----- 556 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHH----HTTC-----
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HcCC-----
Confidence 2211 11122345688999999999999999999999999999998 99999765431 111111 1110
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.. ..+......+.+|+..||+.+|.+||++.+|++.|+.+...
T Consensus 557 -~~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 557 -RM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp -CC----CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -CC----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 00 11122335688999999999999999999999999987643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=338.89 Aligned_cols=250 Identities=27% Similarity=0.391 Sum_probs=199.8
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEec----CCeee
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCAD----GDQRL 156 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~ 156 (457)
+.|.+.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 357888899999999999999999999999999875432 223568899999999999999999999865 45689
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc-CCCceEEeeccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE-EGFHPKLSDFGLAK 235 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~-~~~~~kL~DFGla~ 235 (457)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++|+||||||+|||++ .++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999975 356899999999999999999999975 3499999999999997 78999999999997
Q ss_pred cCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 236 LGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
..... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||...... ......... .
T Consensus 181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~-~---- 245 (290)
T 1t4h_A 181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTS-G---- 245 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTT-T----
T ss_pred ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHHHHHhc-c----
Confidence 53221 233457999999999876 46999999999999999999999999654321 111111110 0
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.....+.. .....+.+|+..||+.+|.+||++.+|++
T Consensus 246 -~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 246 -VKPASFDK----VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -CCCGGGGG----CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCccccCC----CCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00011111 11246889999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=346.33 Aligned_cols=267 Identities=23% Similarity=0.304 Sum_probs=202.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEec--------
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCAD-------- 151 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~-------- 151 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++...... ....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999999999999999998654322 24578899999999999999999999977
Q ss_pred CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeec
Q 012761 152 GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDF 231 (457)
Q Consensus 152 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DF 231 (457)
.+..++||||+. ++|.+.+.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccC-CCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 446899999997 477777765 2456999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCC--Cccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhh
Q 012761 232 GLAKLGPVGD--KSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLF 308 (457)
Q Consensus 232 Gla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~ 308 (457)
|++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+....
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~ 245 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLC 245 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHh
Confidence 9997643222 1122344678999999999876 4689999999999999999999999976432111 11110000
Q ss_pred h--------cccc--cccccCCccCCCCCh-Hh------HHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 309 N--------DRRK--FSKLADPRLEGRYPI-RG------LYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 309 ~--------~~~~--~~~~~d~~l~~~~~~-~~------~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
. .... ............... .. ...+.+|+.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 0000 000000000000011 11 2357899999999999999999999873
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=342.80 Aligned_cols=252 Identities=26% Similarity=0.360 Sum_probs=202.2
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
..++|.+.+.||+|+||.||+|.+..+|..||||++.... ....+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3568999999999999999999999999999999997643 45778999999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 105 ~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999863 2457999999999999999999999999 999999999999999999999999999753221
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ......... ..+
T Consensus 179 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-------~~~ 243 (314)
T 3com_A 179 --MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMIPTN-------PPP 243 (314)
T ss_dssp --BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-------CCC
T ss_pred --ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcC-------CCc
Confidence 12233457899999999999889999999999999999999999999754321 000000000 001
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+ ..+......+.+++..||+.+|.+||++.++++
T Consensus 244 ~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 244 TF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00 011112346889999999999999999999976
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=366.32 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=206.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 4679999999999999999999999999999999975432 3456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE---cCCCceEEeeccccc
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAK 235 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~ 235 (457)
|||+.+|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++.
T Consensus 105 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999975 457999999999999999999999999 9999999999999 567899999999997
Q ss_pred cCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 236 LGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||...... .+. ..+......
T Consensus 178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---~~i~~~~~~-- 245 (484)
T 3nyv_A 178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DIL---KKVEKGKYT-- 245 (484)
T ss_dssp HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHCCCC--
T ss_pred Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHHcCCCC--
Confidence 543222 2344579999999999865 7999999999999999999999999764321 111 111111100
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
...+.. ......+.+|+..||+.+|.+|||+.++++.
T Consensus 246 -~~~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 246 -FELPQW-----KKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -CCSGGG-----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 000100 1123468899999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=350.84 Aligned_cols=267 Identities=17% Similarity=0.203 Sum_probs=209.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCC--------CeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCcee---------
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLEST--------GQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVN--------- 144 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~--------~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~--------- 144 (457)
.++|.+.+.||+|+||.||+|++..+ ++.||||++... ..+.+|+.++..++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 36899999999999999999999874 789999998754 46888999999999999987
Q ss_pred ------eEEEEec-CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccC
Q 012761 145 ------LIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 217 (457)
Q Consensus 145 ------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~N 217 (457)
+++++.. ....++||||+ +++|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 6777766 77899999999 99999999862 2367999999999999999999999999 9999999999
Q ss_pred eEEcCCC--ceEEeeccccccCCCCCC-----ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCC
Q 012761 218 ILLEEGF--HPKLSDFGLAKLGPVGDK-----SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 290 (457)
Q Consensus 218 ILl~~~~--~~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~ 290 (457)
||++.++ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||+||||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 999999999975332211 111233579999999999999899999999999999999999999997
Q ss_pred CCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 291 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 291 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
...... ..+......+.... ..+.+.... .......+.+|+..||+.||.+||++.+|++.|+.+....
T Consensus 270 ~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 270 NCLPNT-EDIMKQKQKFVDKP---GPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp GGTTCH-HHHHHHHHHHHHSC---CCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCCcCH-HHHHHHHHhccCCh---hhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 654221 11222222111111 111111110 0011246889999999999999999999999999998654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=345.13 Aligned_cols=253 Identities=21% Similarity=0.357 Sum_probs=200.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.+.|++.+.||+|+||.||+|++..++..||+|++..........+..|+.++..++||||+++++++.+.+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 46899999999999999999999999999999999876666668899999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 169 (302)
T 2j7t_A 98 CPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK-- 169 (302)
T ss_dssp CTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--
T ss_pred CCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc--
Confidence 999999998865 2356999999999999999999999999 99999999999999999999999998753110
Q ss_pred Cccccccccccccccchhhhh-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.........||+.|+|||++. ...++.++|||||||++|+|++|..||...... ........... ..
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~--~~ 241 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSDP--PT 241 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC--CC
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhccCC--cc
Confidence 011122356899999999984 567899999999999999999999999754321 11111111100 00
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.. .+......+.+++..||+.+|.+||++.++++
T Consensus 242 ~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 LL-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CS-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cC-------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 11122346889999999999999999998865
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=378.80 Aligned_cols=245 Identities=24% Similarity=0.338 Sum_probs=204.8
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccC---CCcChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeee
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN---GLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 156 (457)
..++|.+.+.||+|+||.||+|+++.+++.||||++.+. .......+..|..++..+ +||||+.+++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 356899999999999999999999999999999999753 123346678899999887 6999999999999999999
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
|||||+++|+|.+++.. ...+++..++.|+.||+.||+|||+.+ ||||||||+||||+.++++||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999986 357999999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.... .......+||+.|+|||++.+..|+.++|||||||+||||++|+.||..... ......+.....
T Consensus 492 ~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~---- 559 (674)
T 3pfq_A 492 NIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNV---- 559 (674)
T ss_dssp CCCT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHSSCC----
T ss_pred cccC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCCC----
Confidence 3222 2234457899999999999999999999999999999999999999976432 111222222111
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCCh
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 352 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 352 (457)
.++.....++.+|+..||+.||.+||++
T Consensus 560 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 560 --------AYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred --------CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 1222234578899999999999999998
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=351.01 Aligned_cols=256 Identities=25% Similarity=0.336 Sum_probs=204.4
Q ss_pred hcCCCccceeeecCcEEEEEEEEC---CCCeEEEEEEeccCC----CcChHHHHHHHHHHHhc-CCCCceeeEEEEecCC
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLE---STGQVVAVKQLDRNG----LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGD 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~---~~~~~vavK~i~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 153 (457)
.++|.+.+.||+|+||.||+|++. .+++.||||++.... ......+..|+.++..+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 468999999999999999999984 478999999987532 12335577899999999 6999999999999999
Q ss_pred eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 233 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGl 233 (457)
..+|||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999975 356999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhcC--CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG--QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 311 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 311 (457)
++..... ........+||+.|+|||++.+. .++.++|||||||+||||++|+.||....... .............
T Consensus 206 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~ 282 (355)
T 1vzo_A 206 SKEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE 282 (355)
T ss_dssp EEECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHCC
T ss_pred CeecccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhccC
Confidence 9753221 12233446799999999999853 57899999999999999999999997543221 1112222211111
Q ss_pred cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCC-----ChHHHHHHH
Q 012761 312 RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTAL 359 (457)
Q Consensus 312 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~~L 359 (457)
+. ++......+.+|+.+||+.||.+|| ++.++++..
T Consensus 283 --------~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 --------PP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --------CC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --------CC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11 1122234678899999999999999 899988654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=366.63 Aligned_cols=253 Identities=22% Similarity=0.282 Sum_probs=203.0
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-------------cChHHHHHHHHHHHhcCCCCceeeEE
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-------------QGNREFLVEVLMLSLLHHSNLVNLIG 147 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-------------~~~~~~~~E~~~l~~l~hpniv~l~~ 147 (457)
..++|.+.+.||+|+||.||+|++..++..||||++..... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999999999999999999975432 22457889999999999999999999
Q ss_pred EEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC---
Q 012761 148 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF--- 224 (457)
Q Consensus 148 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~--- 224 (457)
++.+....++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999999875 456999999999999999999999999 99999999999998765
Q ss_pred ceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhh
Q 012761 225 HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWA 304 (457)
Q Consensus 225 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~ 304 (457)
.+||+|||++...... .......||+.|+|||++. +.++.++|||||||++|+|++|..||...... ...
T Consensus 187 ~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~ 256 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ------DII 256 (504)
T ss_dssp SEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH
T ss_pred cEEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------HHH
Confidence 6999999999864322 2234457999999999986 57999999999999999999999999764321 111
Q ss_pred hhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 305 RPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 305 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
..+...... .+...... ....+.+|+..||+.||.+|||+.++++.
T Consensus 257 ~~i~~~~~~----~~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 257 KKVEKGKYY----FDFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHHCCCC----CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCCC----CCccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111111000 00000011 13468899999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=363.74 Aligned_cols=252 Identities=24% Similarity=0.305 Sum_probs=201.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.+.|.+.+.||+|+||.||+|++..++..||||++.... ......+.+|+.+++.++||||++++++|.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999999999999999997643 233567899999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC---CCceEEeecccccc
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE---GFHPKLSDFGLAKL 236 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~---~~~~kL~DFGla~~ 236 (457)
||+++|+|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999998875 456999999999999999999999999 999999999999975 45599999999976
Q ss_pred CCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.... ......+||+.|+|||++. +.|+.++|||||||++|+|++|..||...... .....+......
T Consensus 189 ~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~--- 255 (494)
T 3lij_A 189 FENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------EILRKVEKGKYT--- 255 (494)
T ss_dssp CBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCC---
T ss_pred CCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC---
Confidence 4322 2234467999999999886 57999999999999999999999999764321 111111111110
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.+...... ....+.+|+..||+.+|.+|||+.++++.
T Consensus 256 -~~~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 256 -FDSPEWKN----VSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp -CCSGGGTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -CCchhccc----CCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11111111 23468899999999999999999999853
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=350.25 Aligned_cols=264 Identities=19% Similarity=0.222 Sum_probs=204.3
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC--------CCCceeeEEEEe---
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH--------HSNLVNLIGYCA--- 150 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~--------hpniv~l~~~~~--- 150 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 368999999999999999999999999999999997542 23466888999999986 788999999987
Q ss_pred -cCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCccCeEEcCCC----
Q 012761 151 -DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDFKSSNILLEEGF---- 224 (457)
Q Consensus 151 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLkp~NILl~~~~---- 224 (457)
+....++||||+ +++|.+++... ....+++..++.|+.||+.||.|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 566899999999 56776666542 235699999999999999999999998 8 99999999999998775
Q ss_pred ---------------------------------------------ceEEeeccccccCCCCCCccccccccccccccchh
Q 012761 225 ---------------------------------------------HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE 259 (457)
Q Consensus 225 ---------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 259 (457)
.+||+|||++..... ......||+.|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCCh
Confidence 799999999975322 133457899999999
Q ss_pred hhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhh---------------------hhccccccccc
Q 012761 260 YAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL---------------------FNDRRKFSKLA 318 (457)
Q Consensus 260 ~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~---------------------~~~~~~~~~~~ 318 (457)
++.+..++.++|||||||+||||++|+.||..........-......+ +.....+..+.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 999999999999999999999999999999865543321111111000 11111111111
Q ss_pred CCcc---------CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 319 DPRL---------EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 319 d~~l---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+... .-.++......+.+|+.+||+.||++|||+.||++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 1000 01234455678899999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=333.58 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=197.3
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999999899999999986432 22346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999975 356899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCccccccccccccccchhhhhcCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||..... ......+....
T Consensus 163 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~------ 227 (276)
T 2h6d_A 163 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PTLFKKIRGGV------ 227 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC------
T ss_pred CCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHhhcCc------
Confidence 221 2234568999999999987765 6899999999999999999999965321 11111111100
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
..+ +......+.+++.+||+.+|.+||++.++++.
T Consensus 228 --~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 --FYI----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --ccC----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 001 11122467889999999999999999999873
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=360.09 Aligned_cols=244 Identities=14% Similarity=0.169 Sum_probs=191.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHH---HHHHhcCCCCceeeE-------EE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEV---LMLSLLHHSNLVNLI-------GY 148 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~---~~l~~l~hpniv~l~-------~~ 148 (457)
.++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+ .+++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467899999999999999999998889999999997532 22346788999 455556899999998 77
Q ss_pred EecCCe-----------------eeEEEeccCCCCHHHhhhcC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 012761 149 CADGDQ-----------------RLLVYEFMPLGSLEDHLHDL---PPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 208 (457)
Q Consensus 149 ~~~~~~-----------------~~lV~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i 208 (457)
+.+.+. .+|||||+ +|+|.+++... ......+++..++.|+.||+.||.|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 766542 78999999 68999999752 111234556889999999999999999999 9
Q ss_pred eeccCCccCeEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcC-----------CCCccchHHHHHH
Q 012761 209 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-----------QLTVKSDVYSFGV 277 (457)
Q Consensus 209 iHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDvwSlGv 277 (457)
+||||||+||||+.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999998521 12344567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 278 VFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 278 il~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
++|||++|+.||........ ..+ +... ...+ ...+.+|+.+||+.||.+||++.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~---~~~-------------~~~~--~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG---SEW-------------IFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CC---SGG-------------GGSS--CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccc---hhh-------------hhhh--ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999975443211 110 0000 0112 246789999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=354.93 Aligned_cols=255 Identities=10% Similarity=-0.015 Sum_probs=184.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhc--CCCCceeeE-------EEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---GNREFLVEVLMLSLL--HHSNLVNLI-------GYC 149 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~E~~~l~~l--~hpniv~l~-------~~~ 149 (457)
..+|.+.+.||+|+||.||+|++..+++.||||++...... ....+..|+.++..| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 44689999999999999999999999999999999875432 224567775555555 699988755 454
Q ss_pred ecC-----------------CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCC
Q 012761 150 ADG-----------------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTR------MKIAAGAAKGLEYLHDKANP 206 (457)
Q Consensus 150 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~qi~~~L~yLH~~~~~ 206 (457)
... ...+|||||++ |+|.+++... ...+++..+ +.++.||+.||.|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 432 33799999998 8999999752 223455556 788899999999999999
Q ss_pred CeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhc--CCCCccchHHHHHHHHHHHHh
Q 012761 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT--GQLTVKSDVYSFGVVFLELIT 284 (457)
Q Consensus 207 ~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvil~ellt 284 (457)
|+||||||+||||+.++.+||+|||+++... . ......+|+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~--~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG--T---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETT--C---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecC--C---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 9999999999999999999999999998532 1 1213467799999999987 679999999999999999999
Q ss_pred CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 285 GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 285 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
|+.||....+.......... .. ......+.-.........+.+|+.+||+.||++||++.++++
T Consensus 289 g~~Pf~~~~~~~~~~~~~~~---~~------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWKRPS---LR------VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTTCCCBCC---TT------SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCcccccchhhhh---hh------hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999876443211111000 00 000001110111122356889999999999999999999974
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=371.22 Aligned_cols=257 Identities=27% Similarity=0.395 Sum_probs=207.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||.||+|.+.. +..||||++.... ...+.|.+|+.+|+.|+||||+++++++.+ +..+|||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 4678889999999999999999976 5779999998654 345789999999999999999999999876 678999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+.+|+|.++|... ....+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 343 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 416 (535)
T 2h8h_A 343 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN- 416 (535)
T ss_dssp CTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-
T ss_pred hcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC-
Confidence 9999999999641 1245899999999999999999999999 999999999999999999999999999753211
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
.........++..|+|||++....++.++|||||||+||||++ |+.||...... .+... +.... ..
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~~----i~~~~------~~ 483 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQ----VERGY------RM 483 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHHH----HHTTC------CC
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCC------CC
Confidence 1111223456788999999999999999999999999999999 99999654321 11111 11110 00
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
. .+......+.+|+.+||+.+|++||++.+|++.|+.+..
T Consensus 484 ~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 484 P----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred C----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 1 111223468899999999999999999999999988754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=336.53 Aligned_cols=254 Identities=20% Similarity=0.264 Sum_probs=200.9
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC----CcChHHHHHHHHHHHhcCCCCceeeEEEEe--cCCe
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG----LQGNREFLVEVLMLSLLHHSNLVNLIGYCA--DGDQ 154 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~ 154 (457)
..++|.+.+.||+|+||.||+|.+..++..||||++.... ......+.+|+.+++.++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3578999999999999999999999999999999997532 223467899999999999999999999984 4567
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
.++||||++++ |.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence 89999999876 77777653 2457999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccccccchhhhhcCC--CCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccc
Q 012761 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ--LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 312 (457)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 312 (457)
................||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..... ......+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i~~~~- 229 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLFENIGKGS- 229 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCC-
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHHHHHhcCC-
Confidence 7643332233334457999999999987644 37899999999999999999999975321 11111111111
Q ss_pred ccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 313 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 313 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
..+... ....+.+++.+||+.||.+||++.++++.
T Consensus 230 -------~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 -------YAIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -------CCCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------CCCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011111 23467899999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=357.38 Aligned_cols=264 Identities=21% Similarity=0.275 Sum_probs=210.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC-CCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH-SNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lV~E 160 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++..... ...+..|+.++..|.| ++|..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4689999999999999999999999999999999875432 3458889999999987 566666677778889999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE---cCCCceEEeeccccccC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~ 237 (457)
|+ +++|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++..
T Consensus 84 ~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 9999999975 2457999999999999999999999999 9999999999999 68899999999999864
Q ss_pred CCCCCc-----cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccc
Q 012761 238 PVGDKS-----HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 312 (457)
Q Consensus 238 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 312 (457)
...... .......||+.|+|||++.+..++.++||||||||||||++|+.||..............+... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~---~- 232 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---K- 232 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH---H-
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc---c-
Confidence 332221 1123567999999999999999999999999999999999999999876543322222111110 0
Q ss_pred ccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 313 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 313 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
+...+. .+...+ ..++.+|+..||+.+|.+||++.+|++.|+.+..
T Consensus 233 -~~~~~~-~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 233 -VATSIE-ALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp -HHSCHH-HHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred -ccccHH-HHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 000000 011122 2468899999999999999999999999988854
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=362.36 Aligned_cols=252 Identities=24% Similarity=0.314 Sum_probs=203.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999999999999999986432 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc---CCCceEEeecccccc
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE---EGFHPKLSDFGLAKL 236 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~ 236 (457)
||+.+|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||++..
T Consensus 101 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999998875 357999999999999999999999999 99999999999995 456799999999975
Q ss_pred CCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...... .....+......+
T Consensus 174 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~-- 241 (486)
T 3mwu_A 174 FQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKYAF-- 241 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCS--
T ss_pred CCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCC--
Confidence 3322 22334579999999999875 6999999999999999999999999754321 1111111111000
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
..+.. ......+.+|+..||+.+|.+|||+.++++.
T Consensus 242 -~~~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 -DLPQW-----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -CSGGG-----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -CCccc-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00100 1123468899999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=375.02 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=198.8
Q ss_pred ceeeecCcEEEEEEEE--CCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWL--ESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~--~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.||+|+||.||+|.+ ..++..||||++..... ...+.+.+|+.++..++|||||++++++.. +..+|||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999955 45678999999975432 234679999999999999999999999965 558899999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC-c
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK-S 243 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~-~ 243 (457)
|+|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++....... .
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999975 457999999999999999999999999 99999999999999999999999999986433221 1
Q ss_pred cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCcc
Q 012761 244 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
.......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...... .+... +.... ..
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~----i~~~~------~~-- 591 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAM----LEKGE------RM-- 591 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----HHTTC------CC--
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCC------CC--
Confidence 22233457889999999999999999999999999999998 99999764321 11111 11110 01
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
..+......+.+|+..||+.||++||++.+|++.|+.+-.
T Consensus 592 --~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 592 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1112223568899999999999999999999999987754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=341.84 Aligned_cols=261 Identities=28% Similarity=0.385 Sum_probs=197.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECC-CC--eEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCceeeEEEEecCCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLES-TG--QVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~--~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 155 (457)
.++|++.+.||+|+||.||+|++.. ++ ..||||++..... ...+.+.+|+.++..++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4689999999999999999998643 23 3699999875432 22357889999999999999999999998765 8
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 899999999999999975 2356899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCc-cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccc
Q 012761 236 LGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRK 313 (457)
Q Consensus 236 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 313 (457)
........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... .....+.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~- 242 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGE- 242 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCC-
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCC-
Confidence 64333221 12233567889999999998889999999999999999999 99999754321 11111111110
Q ss_pred cccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 314 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 314 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.... +......+.+++..||+.+|.+||++.++++.|..+...
T Consensus 243 -----~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 243 -----RLPR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -----CCCC----CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 0111 112234688999999999999999999999999888654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=350.11 Aligned_cols=259 Identities=24% Similarity=0.311 Sum_probs=196.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCC------
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGD------ 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 153 (457)
.++|.+.+.||+|+||.||+|++..+|+.||||++...... ....+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999999999999999999654322 2356789999999999999999999997753
Q ss_pred eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 233 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGl 233 (457)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 8899999975 46899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc-
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR- 311 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~- 311 (457)
++.... ..+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+...... +.......-...
T Consensus 175 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 175 ARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPA 247 (367)
T ss_dssp CEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCH
T ss_pred cccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCH
Confidence 986321 2334578999999999887 6899999999999999999999999976432111 000000000000
Q ss_pred ---------------cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 312 ---------------RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 312 ---------------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..+.......+. .........+.+|+.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000011111111 011122456889999999999999999999876
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=342.30 Aligned_cols=253 Identities=21% Similarity=0.297 Sum_probs=199.1
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--------cChHHHHHHHHHHHhcCCCCceeeEEEEecC
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--------QGNREFLVEVLMLSLLHHSNLVNLIGYCADG 152 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 152 (457)
..++|.+.+.||+|+||.||+|++..+++.||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 35689999999999999999999999999999999975422 1123478999999999999999999999766
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc---eEEe
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH---PKLS 229 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~---~kL~ 229 (457)
+ .++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 8999999999999999865 457999999999999999999999999 999999999999987654 9999
Q ss_pred eccccccCCCCCCccccccccccccccchhhhh---cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhh
Q 012761 230 DFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP 306 (457)
Q Consensus 230 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~ 306 (457)
|||++..... ........||+.|+|||++. ...++.++|||||||++|+|++|..||....... .+...+.
T Consensus 160 Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~- 233 (322)
T 2ycf_A 160 DFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT- 233 (322)
T ss_dssp CCTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHH-
T ss_pred cCccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHH-
Confidence 9999975322 12223457999999999975 4578999999999999999999999997644321 1111111
Q ss_pred hhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 307 LFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 307 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..... ..+..... ....+.+|+.+||+.||.+||++.++++
T Consensus 234 --~~~~~----~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 --SGKYN----FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --HTCCC----CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --hCccc----cCchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000 00111111 2346889999999999999999999984
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=342.26 Aligned_cols=259 Identities=17% Similarity=0.259 Sum_probs=201.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCceeeEEEEec--CCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCAD--GDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~--~~~~~lV 158 (457)
.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+|+.++..+. ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999999999999999999743 3577899999999997 9999999999988 6678999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC-ceEEeeccccccC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF-HPKLSDFGLAKLG 237 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~~ 237 (457)
|||+.+++|.+++.. +++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++...
T Consensus 112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 999999999999853 889999999999999999999999 99999999999999766 8999999999864
Q ss_pred CCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhh--------h
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL--------F 308 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~--------~ 308 (457)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ...+....... +
T Consensus 182 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 182 HPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp CTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHHHHH
T ss_pred CCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHHhcCCchhhhHH
Confidence 3322 2234578999999999987 67899999999999999999999999543221 11111110000 0
Q ss_pred hc-c----ccccccc--------CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 309 ND-R----RKFSKLA--------DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 309 ~~-~----~~~~~~~--------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.. . ..+..+. ........+......+.+|+..||+.||.+|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0 0000000 000011111113457889999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=342.02 Aligned_cols=265 Identities=26% Similarity=0.405 Sum_probs=187.9
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
..++|.+.+.||+|+||.||+|.+..++..||||++..... .....+.+|+.++..++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 35789999999999999999999988899999999875432 23466889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 160 EFMPLGSLEDHLHDL----PPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 160 E~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
||+++++|.+++... ......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998631 112456999999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCC---ccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc
Q 012761 236 LGPVGDK---SHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 311 (457)
Q Consensus 236 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 311 (457)
....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ .. .......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~--~~~~~~~ 244 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---LM--LTLQNDP 244 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HH--HHHTSSC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---HH--HHhccCC
Confidence 5432211 112234579999999999876 5789999999999999999999999976543211 10 0000000
Q ss_pred ccc-ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 312 RKF-SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 312 ~~~-~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
... ....++.+...+ ...+.+++..||+.||.+||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Cccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000 011112222222 246789999999999999999999976
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=336.97 Aligned_cols=253 Identities=25% Similarity=0.299 Sum_probs=205.0
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc---------ChHHHHHHHHHHHhcC-CCCceeeEEEEe
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ---------GNREFLVEVLMLSLLH-HSNLVNLIGYCA 150 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---------~~~~~~~E~~~l~~l~-hpniv~l~~~~~ 150 (457)
..++|.+.+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.++..+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 357899999999999999999999999999999999764311 1245778999999996 999999999999
Q ss_pred cCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEee
Q 012761 151 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSD 230 (457)
Q Consensus 151 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~D 230 (457)
+....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999975 457999999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCccccccccccccccchhhhh------cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhh
Q 012761 231 FGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM------TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWA 304 (457)
Q Consensus 231 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~ 304 (457)
||++....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||..... ....
T Consensus 168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~ 238 (298)
T 1phk_A 168 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLML 238 (298)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH
T ss_pred ccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHHH
Confidence 99997543222 233457899999999985 45688999999999999999999999965321 1111
Q ss_pred hhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 305 RPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 305 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..+...... ...+. .......+.+++.+||+.+|.+||++.++++
T Consensus 239 ~~~~~~~~~---~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 RMIMSGNYQ---FGSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHTCCC---CCTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhcCCcc---cCccc-----ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111111100 00110 1122346889999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=358.29 Aligned_cols=262 Identities=24% Similarity=0.314 Sum_probs=196.8
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecC------Ceee
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADG------DQRL 156 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~~ 156 (457)
.+|.+.+.||+|+||.||+|++..+++.||||++..... .+.+|+.+++.|+||||++++++|... ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 468999999999999999999999999999999865422 234699999999999999999998542 2367
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC-CceEEeeccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG-FHPKLSDFGLAK 235 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~-~~~kL~DFGla~ 235 (457)
+||||+++ +|.+.+.........+++..++.++.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 666665432223567999999999999999999999999 9999999999999954 678999999998
Q ss_pred cCCCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhh-------
Q 012761 236 LGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL------- 307 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~------- 307 (457)
...... .....+||+.|+|||++.+. .++.++||||||||||||++|+.||...... ..+...+..+
T Consensus 206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHH
T ss_pred hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHH
Confidence 643222 22345789999999999765 7999999999999999999999999764321 1121111110
Q ss_pred h-hcccccccccCCccCCC-----CChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 308 F-NDRRKFSKLADPRLEGR-----YPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 308 ~-~~~~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+ .....+.....+.+... ++......+.+|+.+||+.||.+||++.|+++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0 00001111111111110 11122357889999999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=348.40 Aligned_cols=264 Identities=21% Similarity=0.295 Sum_probs=202.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecC-----Cee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADG-----DQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 155 (457)
.++|.+.+.||+|+||.||+|++..++..||||++...... ....+.+|+.++..++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 46899999999999999999999999999999999754322 225688999999999999999999999765 368
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 699999875 46999999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCC-ccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc--
Q 012761 236 LGPVGDK-SHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR-- 311 (457)
Q Consensus 236 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-- 311 (457)
....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ...+...+...
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQ 253 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCH
Confidence 6432211 112344689999999998764 4589999999999999999999999976543221 11110000000
Q ss_pred ------------cccccccCCccC--CCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 312 ------------RKFSKLADPRLE--GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 312 ------------~~~~~~~d~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.....+..+... ..........+.+|+.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000 0000112346889999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=345.74 Aligned_cols=272 Identities=24% Similarity=0.273 Sum_probs=194.1
Q ss_pred HHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCe-
Q 012761 76 RELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ- 154 (457)
Q Consensus 76 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~- 154 (457)
.......++|.+.+.||+|+||.||+|++..++..||||++.... .....+..++..+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345567889999999999999999999999999999999986543 234566788888999999999999999865433
Q ss_pred ------eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeeeccCCccCeEEcC-CCc
Q 012761 155 ------RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH--DKANPPVIYRDFKSSNILLEE-GFH 225 (457)
Q Consensus 155 ------~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--~~~~~~iiHrDLkp~NILl~~-~~~ 225 (457)
.++||||+++ +|...+.........+++..+..++.||+.||.||| +.+ |+||||||+||||+. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 7899999975 555544432234567899999999999999999999 888 999999999999996 899
Q ss_pred eEEeeccccccCCCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhh
Q 012761 226 PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWA 304 (457)
Q Consensus 226 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~ 304 (457)
+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .+....
T Consensus 171 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~~~ 245 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--QLHEIV 245 (360)
T ss_dssp EEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH
T ss_pred EEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--HHHHHH
Confidence 9999999998543222 23345789999999998765 48999999999999999999999997643211 111111
Q ss_pred hhhhhccccc----------ccccCC------ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 305 RPLFNDRRKF----------SKLADP------RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 305 ~~~~~~~~~~----------~~~~d~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.......... ....+. .+...........+.+|+.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1000000000 000000 0001112224567899999999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=347.13 Aligned_cols=264 Identities=24% Similarity=0.290 Sum_probs=194.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCC------
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGD------ 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 153 (457)
.++|.+.+.||+|+||.||+|++..++..||||++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4689999999999999999999999999999999975432 22356789999999999999999999997765
Q ss_pred eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 233 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGl 233 (457)
..++||||++ ++|.+++.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 7899999997 578888853 4899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcc-cch-----------
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-NLV----------- 301 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~-~l~----------- 301 (457)
+..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .+.
T Consensus 174 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred cccccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 975322 12233467999999999999989999999999999999999999999764321100 000
Q ss_pred ----hhhhhhhhcccc-----cccccCCccCCCC---ChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 302 ----TWARPLFNDRRK-----FSKLADPRLEGRY---PIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 302 ----~~~~~~~~~~~~-----~~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
............ +..+....+.... .......+.+|+.+||+.||.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000000 0000000000000 01124578899999999999999999999873
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=346.13 Aligned_cols=275 Identities=22% Similarity=0.268 Sum_probs=200.4
Q ss_pred cccHHHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC-----------hHHHHHHHHHHHhcCCC
Q 012761 72 TFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG-----------NREFLVEVLMLSLLHHS 140 (457)
Q Consensus 72 ~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-----------~~~~~~E~~~l~~l~hp 140 (457)
...+.++....++|.+.+.||+|+||.||+|.+.. +..||||++....... .+.+.+|+.+++.++||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 89 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCT
T ss_pred HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCc
Confidence 34567888899999999999999999999999865 8999999986532211 16788999999999999
Q ss_pred CceeeEEEEec-----CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCc
Q 012761 141 NLVNLIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKS 215 (457)
Q Consensus 141 niv~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp 215 (457)
||+++++++.. ....++||||+. |+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||
T Consensus 90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 162 (362)
T 3pg1_A 90 NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHP 162 (362)
T ss_dssp TBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCG
T ss_pred CccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCCh
Confidence 99999999854 346899999997 688888875 3457999999999999999999999999 99999999
Q ss_pred cCeEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 012761 216 SNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRP 294 (457)
Q Consensus 216 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~ 294 (457)
+|||++.++.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 163 GNILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp GGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HHEEEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999743222 22334578999999999887 6789999999999999999999999976432
Q ss_pred CCc-ccchhhhhhh-hh-----cccccccccCCccC----C---CCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 295 HGE-QNLVTWARPL-FN-----DRRKFSKLADPRLE----G---RYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 295 ~~~-~~l~~~~~~~-~~-----~~~~~~~~~d~~l~----~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
... ..+....... .. ............+. . .........+.+|+..||+.||.+|||+.++++
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 110 0000000000 00 00000000000000 0 001112346889999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=343.11 Aligned_cols=255 Identities=21% Similarity=0.308 Sum_probs=197.1
Q ss_pred HHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcC--CCCceeeEEEEecCCe
Q 012761 79 AAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLH--HSNLVNLIGYCADGDQ 154 (457)
Q Consensus 79 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~ 154 (457)
....++|.+.+.||+|+||.||++.+.. ++.||||++...... ....+.+|+.++..++ ||||+++++++.+.+.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 3346789999999999999999999864 889999999754322 2356889999999997 5999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
.++||| +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||+++ +.+||+|||++
T Consensus 103 ~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred EEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccc
Confidence 999999 558899999986 357899999999999999999999999 999999999999965 89999999999
Q ss_pred ccCCCCCCccccccccccccccchhhhhc-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhh
Q 012761 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAMT-----------GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTW 303 (457)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~ 303 (457)
................||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ...
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~ 248 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISK 248 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHH
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHH
Confidence 76433322223334579999999999875 47889999999999999999999999653211 111
Q ss_pred hhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 304 ARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 304 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.. .+.++.....++......+.+++.+||+.+|.+||++.++++.
T Consensus 249 ~~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 249 LH----------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HH----------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH----------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11 1111111111221223468899999999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=355.56 Aligned_cols=200 Identities=23% Similarity=0.319 Sum_probs=174.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc------CCCCceeeEEEEecCCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL------HHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l------~hpniv~l~~~~~~~~~~ 155 (457)
..+|.+.+.||+|+||.||+|++..+++.||||++.... .....+..|+.++..+ +|+||+.+++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457999999999999999999999999999999997542 2235677888888877 577999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc--eEEeeccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH--PKLSDFGL 233 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~--~kL~DFGl 233 (457)
++||||+. ++|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999995 6999998762 2345899999999999999999999999 999999999999999887 99999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 293 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~ 293 (457)
+..... .....+||+.|+|||++.+..++.++|||||||+||||++|.+||....
T Consensus 249 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 975322 1234578999999999999999999999999999999999999997653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=341.97 Aligned_cols=263 Identities=21% Similarity=0.300 Sum_probs=199.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecC-----Cee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADG-----DQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 155 (457)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 5689999999999999999999999999999999975322 1234678999999999999999999998654 678
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 699999875 46999999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcc--------ccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhh
Q 012761 236 LGPVGDKSH--------VSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP 306 (457)
Q Consensus 236 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~ 306 (457)
......... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||....... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHH
Confidence 643221110 1223578999999998765 678999999999999999999999997643211 0000000
Q ss_pred hhhcc------------------cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 307 LFNDR------------------RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 307 ~~~~~------------------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..... ..+.......+. .........+.+|+.+||+.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 000000000000 000112346789999999999999999999876
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=337.96 Aligned_cols=265 Identities=20% Similarity=0.298 Sum_probs=195.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEe-----------
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA----------- 150 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~----------- 150 (457)
.++|.+.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999999999999999998665444567889999999999999999999874
Q ss_pred ---cCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc-CCCce
Q 012761 151 ---DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE-EGFHP 226 (457)
Q Consensus 151 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~-~~~~~ 226 (457)
+....++||||+. |+|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 699999864 56899999999999999999999999 99999999999997 57799
Q ss_pred EEeeccccccCCCCC-Cccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhh
Q 012761 227 KLSDFGLAKLGPVGD-KSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWA 304 (457)
Q Consensus 227 kL~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~ 304 (457)
||+|||++....... .........+|..|+|||++.. ..++.++|||||||++|||++|+.||........ +....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~ 238 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--MQLIL 238 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHH
Confidence 999999997532211 1112233467999999998875 6789999999999999999999999976432110 00000
Q ss_pred hhh--hh--cccccc---------cccCCccC-CCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 305 RPL--FN--DRRKFS---------KLADPRLE-GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 305 ~~~--~~--~~~~~~---------~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
... .. ....+. ....+... ..........+.+++.+||+.||.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000 00 000000 00000000 0000112346889999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=344.44 Aligned_cols=260 Identities=18% Similarity=0.250 Sum_probs=203.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcCh-----------------HHHHHHHHHHHhcCCCCcee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN-----------------REFLVEVLMLSLLHHSNLVN 144 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~-----------------~~~~~E~~~l~~l~hpniv~ 144 (457)
.++|.+.+.||+|+||.||+|.+ ++..||||++........ ..+.+|+.++..++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999998 699999999875322111 78999999999999999999
Q ss_pred eEEEEecCCeeeEEEeccCCCCHHHh------hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCccC
Q 012761 145 LIGYCADGDQRLLVYEFMPLGSLEDH------LHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFKSSN 217 (457)
Q Consensus 145 l~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLkp~N 217 (457)
+++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+ .+ |+||||||+|
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSN 182 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGG
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHh
Confidence 99999999999999999999999998 443 225679999999999999999999999 88 9999999999
Q ss_pred eEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcC-CCCc-cchHHHHHHHHHHHHhCCCCCCCCCCC
Q 012761 218 ILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTV-KSDVYSFGVVFLELITGRKAIDSTRPH 295 (457)
Q Consensus 218 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDvwSlGvil~elltG~~p~~~~~~~ 295 (457)
||++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||......
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999999763222 23446799999999999877 6666 999999999999999999999764431
Q ss_pred Ccccchhhhhhhhhccccccc----ccCCccC---CCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 296 GEQNLVTWARPLFNDRRKFSK----LADPRLE---GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 296 ~~~~l~~~~~~~~~~~~~~~~----~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..+... +......+.. ...+... ..........+.+|+.+||+.||.+||++.++++
T Consensus 259 --~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 --VELFNN---IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --HHHHHH---HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHHHHH---HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111 1111100000 0000000 0000122356889999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=348.91 Aligned_cols=258 Identities=23% Similarity=0.322 Sum_probs=184.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecC------C
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADG------D 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 153 (457)
.++|.+.+.||+|+||.||+|++..+|+.||||++..... .....+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4789999999999999999999999999999999975422 2235678999999999999999999999754 5
Q ss_pred eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 233 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGl 233 (457)
..++|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 7899988864 46999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc-
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR- 311 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~- 311 (457)
++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..... ....+...+...
T Consensus 179 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~ 250 (367)
T 2fst_X 179 ARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPG 250 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCC
T ss_pred cccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCC
Confidence 975321 1334679999999999887 678999999999999999999999997643211 111110000000
Q ss_pred c-ccccc--------cC--CccCCCCC-----hHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 312 R-KFSKL--------AD--PRLEGRYP-----IRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 312 ~-~~~~~--------~d--~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
. .+..+ +. +.. ...+ ......+.+|+.+||+.||.+|||+.+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQM-PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCC-CCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhhHHHHHHHhccCCC-CCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0 00000 00 000 0000 012346789999999999999999999976
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=338.08 Aligned_cols=264 Identities=19% Similarity=0.258 Sum_probs=202.3
Q ss_pred hcCCCccceeeecCcEEEEEEEE-CCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCC------CceeeEEEEecCCe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWL-ESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHS------NLVNLIGYCADGDQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hp------niv~l~~~~~~~~~ 154 (457)
.++|++.+.||+|+||.||+|.+ ..+++.||||++.... .....+..|+.++..++|+ +|+++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999998 5578999999997532 2345688899999988765 49999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC------------
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE------------ 222 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~------------ 222 (457)
.++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999 89999999762 2346899999999999999999999999 999999999999987
Q ss_pred -------CCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCC
Q 012761 223 -------GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPH 295 (457)
Q Consensus 223 -------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~ 295 (457)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 67899999999975322 123457899999999999989999999999999999999999999764321
Q ss_pred Ccccchhhhhh-----hhhcccc----------c----------ccccCCcc-CCCCChHhHHHHHHHHHHcchhhcCCC
Q 012761 296 GEQNLVTWARP-----LFNDRRK----------F----------SKLADPRL-EGRYPIRGLYQALAVASMCIQEQAATR 349 (457)
Q Consensus 296 ~~~~l~~~~~~-----~~~~~~~----------~----------~~~~d~~l-~~~~~~~~~~~l~~li~~cl~~dP~~R 349 (457)
........... +...... + .....+.. ...........+.+|+.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 11100000000 0000000 0 00000000 001122345678899999999999999
Q ss_pred CChHHHHH
Q 012761 350 PLIGDVVT 357 (457)
Q Consensus 350 Pt~~ev~~ 357 (457)
||+.||++
T Consensus 321 pt~~ell~ 328 (339)
T 1z57_A 321 ITLREALK 328 (339)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=335.97 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=180.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHH-HHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVL-MLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.++|.+.+.||+|+||.||+|.+..+++.||||++...... ....+..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 46899999999999999999999999999999999764322 2234555555 777789999999999999999999999
Q ss_pred eccCCCCHHHhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 160 EFMPLGSLEDHLHDL-PPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 160 E~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||+.+ +|.+++... ......+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99974 887776521 11246789999999999999999999998 8 999999999999999999999999999753
Q ss_pred CCCCCccccccccccccccchhhh----hcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYA----MTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRK 313 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 313 (457)
... .......||+.|+|||++ .+..++.++|||||||++|+|++|+.||........ .......
T Consensus 177 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~---- 244 (327)
T 3aln_A 177 VDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVVK---- 244 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCC----
T ss_pred ccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHhc----
Confidence 221 122334789999999998 456789999999999999999999999975432110 0000000
Q ss_pred cccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 314 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 314 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...+.+...........+.+|+..||+.||.+||++.+|++
T Consensus 245 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 ---GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ---SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00111111111122346889999999999999999999976
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=334.22 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=200.8
Q ss_pred HhcCCCccceeeecCcEEEEEEEEC-CCCeEEEEEEeccCCC--cChHHHHHHHHHHHhc---CCCCceeeEEEEe----
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLE-STGQVVAVKQLDRNGL--QGNREFLVEVLMLSLL---HHSNLVNLIGYCA---- 150 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~~---- 150 (457)
+.++|.+.+.||+|+||.||+|++. .+++.||||++..... .....+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999995 6789999999874322 1234566777777766 8999999999987
Q ss_pred -cCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEe
Q 012761 151 -DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLS 229 (457)
Q Consensus 151 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~ 229 (457)
.....++||||+. |+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999997 6999999763 2345899999999999999999999999 9999999999999999999999
Q ss_pred eccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhh
Q 012761 230 DFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN 309 (457)
Q Consensus 230 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 309 (457)
|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+...+.
T Consensus 163 Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~ 236 (326)
T 1blx_A 163 DFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIG 236 (326)
T ss_dssp SCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred cCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcC
Confidence 9999975321 122344678999999999999899999999999999999999999997643211 1111100000
Q ss_pred -------------cccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 310 -------------DRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 310 -------------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
....+.......+ ..+.......+.+|+.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCcccCccccccchhhhcccCcchh-hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000000 0111122346789999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=344.50 Aligned_cols=264 Identities=19% Similarity=0.248 Sum_probs=200.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-----------CCCceeeEEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-----------HSNLVNLIGYCA 150 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~~~ 150 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++.... .....+..|+.++..+. ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 468999999999999999999999999999999997532 23456788999998886 899999999987
Q ss_pred cCC----eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCccCeEEc----
Q 012761 151 DGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDFKSSNILLE---- 221 (457)
Q Consensus 151 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLkp~NILl~---- 221 (457)
..+ ..++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 654 789999999 89999999763 234599999999999999999999998 8 99999999999994
Q ss_pred --CCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 012761 222 --EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN 299 (457)
Q Consensus 222 --~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~ 299 (457)
..+.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 445899999999975322 1234578999999999999999999999999999999999999997654322111
Q ss_pred chhhhhhh---------------------hhcccccccccCCcc---------CCCCChHhHHHHHHHHHHcchhhcCCC
Q 012761 300 LVTWARPL---------------------FNDRRKFSKLADPRL---------EGRYPIRGLYQALAVASMCIQEQAATR 349 (457)
Q Consensus 300 l~~~~~~~---------------------~~~~~~~~~~~d~~l---------~~~~~~~~~~~l~~li~~cl~~dP~~R 349 (457)
.......+ +.....+..+..... ...++......+.+|+.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 11111000 010000000000000 112344556788999999999999999
Q ss_pred CChHHHHH
Q 012761 350 PLIGDVVT 357 (457)
Q Consensus 350 Pt~~ev~~ 357 (457)
||+.||++
T Consensus 326 pt~~ell~ 333 (373)
T 1q8y_A 326 ADAGGLVN 333 (373)
T ss_dssp BCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999976
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=343.72 Aligned_cols=258 Identities=22% Similarity=0.321 Sum_probs=197.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEecCCee----
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQR---- 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~---- 155 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++....... ...+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 478999999999999999999999999999999997643222 35688999999999999999999999887655
Q ss_pred --eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccc
Q 012761 156 --LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 233 (457)
Q Consensus 156 --~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGl 233 (457)
++||||+. ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 68888874 34999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccc
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 312 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 312 (457)
+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+.......-....
T Consensus 191 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 191 ARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGT 263 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCH
T ss_pred cccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCcH
Confidence 975321 2334578999999999987 689999999999999999999999997643211 00000000000000
Q ss_pred c-------------cccccCCccCCC---CChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 313 K-------------FSKLADPRLEGR---YPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 313 ~-------------~~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
. ...+.. ..... ........+.+|+..||+.||.+|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQ-TPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCC-CCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhhhhhhhhhhccCC-CcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0 000000 00000 01112357889999999999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=327.65 Aligned_cols=253 Identities=23% Similarity=0.287 Sum_probs=203.8
Q ss_pred HHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 80 AATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG--LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 80 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
...++|.+.+.||+|+||.||+|++..+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999999899999999987532 2345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC---CceEEeecccc
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG---FHPKLSDFGLA 234 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~---~~~kL~DFGla 234 (457)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999998875 356999999999999999999999999 9999999999999654 47999999998
Q ss_pred ccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...... .....+......
T Consensus 172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~- 240 (287)
T 2wei_A 172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKYA- 240 (287)
T ss_dssp GTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC-
T ss_pred eeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCC-
Confidence 7533221 2233468999999998865 5899999999999999999999999754321 111111111100
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.+...... ....+.+++..||+.+|.+||++.++++
T Consensus 241 ---~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 ---FDLPQWRT----ISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ---CCSGGGTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCchhhhh----cCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00000011 1346889999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=350.40 Aligned_cols=262 Identities=22% Similarity=0.288 Sum_probs=192.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCC------ee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGD------QR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------~~ 155 (457)
..+|.+.+.||+|+||.||+|++..++. ||+|++...... ..+|+.+++.++||||++++++|.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3469999999999999999999987655 888887543222 236899999999999999999985533 37
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc-CCCceEEeecccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE-EGFHPKLSDFGLA 234 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~-~~~~~kL~DFGla 234 (457)
++||||++++ +...+.........+++..+..++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||++
T Consensus 114 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 8999999864 43333321123567999999999999999999999999 99999999999998 7999999999999
Q ss_pred ccCCCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhh-----
Q 012761 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLF----- 308 (457)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~----- 308 (457)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+......+-
T Consensus 190 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 190 KILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIKVLGTPSRE 264 (394)
T ss_dssp EECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHH
T ss_pred ccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHH
Confidence 8643322 22345789999999998765 58999999999999999999999997643211 1111111000
Q ss_pred ---hccc-----ccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 309 ---NDRR-----KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 309 ---~~~~-----~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.... .+..+....+...++......+.+|+.+||+.||.+||++.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000 000000000001111123357889999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=332.10 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=193.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEec----------
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD---------- 151 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---------- 151 (457)
.++|++.+.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 567999999999999999999999899999999996431 234668899999999999999999998865
Q ss_pred ---CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEE
Q 012761 152 ---GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKL 228 (457)
Q Consensus 152 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL 228 (457)
....++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 3567999999999999999975 2456788999999999999999999999 999999999999999999999
Q ss_pred eeccccccCCCCC------------CccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCC
Q 012761 229 SDFGLAKLGPVGD------------KSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPH 295 (457)
Q Consensus 229 ~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~ 295 (457)
+|||++....... .........||+.|+|||++.+. .++.++|||||||++|+|++ ||...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--- 231 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--- 231 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---
Confidence 9999997532211 01122345789999999999864 78999999999999999998 44211
Q ss_pred CcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 296 GEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 296 ~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.........+... ...+...++......+.+++..||+.||.+||++.++++
T Consensus 232 --~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 --MERVNILKKLRSV--------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp --HHHHHHHHHHHST--------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --hhHHHHHHhcccc--------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0111111111110 111112223333456789999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=340.87 Aligned_cols=258 Identities=23% Similarity=0.332 Sum_probs=199.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.++|.+.+.||+|+||.||+|.+.. .||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 5689999999999999999999864 499999875422 22355778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||++.....
T Consensus 109 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp BCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 99999999999975 2356899999999999999999999999 99999999999998 67999999999875322
Q ss_pred CC---Cccccccccccccccchhhhhc---------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhh
Q 012761 240 GD---KSHVSTRVMGTYGYCAPEYAMT---------GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL 307 (457)
Q Consensus 240 ~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 307 (457)
.. .........||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ......
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~ 255 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------AIIWQM 255 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------HHHHHH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHh
Confidence 11 1122233568999999999874 35789999999999999999999999754321 111111
Q ss_pred hhcccccccccCCccC-CCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 308 FNDRRKFSKLADPRLE-GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 308 ~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
.. ...+.+. ..+ ...+.+++..||+.+|.+||++.+|++.|+.+....
T Consensus 256 ~~-------~~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 256 GT-------GMKPNLSQIGM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HT-------TCCCCCCCSSC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred cc-------CCCCCCCcCCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 11 0111111 011 124788999999999999999999999998887643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=345.92 Aligned_cols=205 Identities=24% Similarity=0.338 Sum_probs=157.6
Q ss_pred cCCCc-cceeeecCcEEEEEEEEC--CCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEec--CCeeeE
Q 012761 83 KNFRP-ESFIGEGGFGRVYKGWLE--STGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQRLL 157 (457)
Q Consensus 83 ~~f~~-~~~lG~G~~g~Vy~~~~~--~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l 157 (457)
+.|.+ .++||+|+||.||+|+++ .++..||||++.... ....+.+|+.+|+.|+||||+++++++.. ....+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34665 457999999999999976 468899999997543 34678899999999999999999999954 678999
Q ss_pred EEeccCCCCHHHhhhcC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE----cCCCceEE
Q 012761 158 VYEFMPLGSLEDHLHDL-----PPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL----EEGFHPKL 228 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~-----~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl----~~~~~~kL 228 (457)
||||+. ++|.+++... ......+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 5888777531 112235999999999999999999999999 9999999999999 67899999
Q ss_pred eeccccccCCCCC-CccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 012761 229 SDFGLAKLGPVGD-KSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTR 293 (457)
Q Consensus 229 ~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~ 293 (457)
+|||+++...... ........+||+.|+|||++.+. .++.++|||||||++|||++|++||....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999997643221 11223446799999999999874 58999999999999999999999997544
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=341.71 Aligned_cols=201 Identities=24% Similarity=0.324 Sum_probs=172.8
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CC-----CceeeEEEEecCCe
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HS-----NLVNLIGYCADGDQ 154 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~l~~~~~~~~~ 154 (457)
..++|.+.+.||+|+||.||+|++..+++.||||++.... .....+..|+.++..+. |+ +|+.+++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578999999999999999999999999999999997432 22356777888888885 55 49999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeeeccCCccCeEEc--CCCceEEee
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD--KANPPVIYRDFKSSNILLE--EGFHPKLSD 230 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~--~~~~~iiHrDLkp~NILl~--~~~~~kL~D 230 (457)
.+|||||+. ++|.+++... ....+++..+..++.||+.||.|||. .+ |+||||||+||||+ .++.+||+|
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECC
T ss_pred eEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEe
Confidence 999999996 5999999763 23468999999999999999999994 56 99999999999994 578899999
Q ss_pred ccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 012761 231 FGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 293 (457)
Q Consensus 231 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~ 293 (457)
||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 205 FG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 205 FGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999976422 1234678999999999999999999999999999999999999997643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=335.75 Aligned_cols=257 Identities=23% Similarity=0.337 Sum_probs=197.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEecCCe-----
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQ----- 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 154 (457)
.++|.+.+.||+|+||.||+|++..+|+.||||++....... ...+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999999999999999997643222 3567899999999999999999999987654
Q ss_pred -eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccc
Q 012761 155 -RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 233 (457)
Q Consensus 155 -~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGl 233 (457)
.++||||+. ++|.+++.. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 688887742 4899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhh---
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN--- 309 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~--- 309 (457)
+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+.....
T Consensus 173 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~ 244 (353)
T 3coi_A 173 ARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPG 244 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCC
T ss_pred ccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCC
Confidence 975321 1234578999999999887 678999999999999999999999997643211 0100000000
Q ss_pred --------cc------cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 310 --------DR------RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 310 --------~~------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+. ..+.....+.+. .........+.+|+.+||+.||.+||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 000000001111 111223457889999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=336.02 Aligned_cols=254 Identities=20% Similarity=0.233 Sum_probs=175.5
Q ss_pred hcCCCccc-eeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEec----CCeee
Q 012761 82 TKNFRPES-FIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD----GDQRL 156 (457)
Q Consensus 82 ~~~f~~~~-~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~ 156 (457)
.++|.+.+ +||+|+||.||+|++..+++.||||++... ..........+..+.||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 56898854 699999999999999999999999998643 2222233344667789999999999876 45589
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC---CCceEEeeccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE---GFHPKLSDFGL 233 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~---~~~~kL~DFGl 233 (457)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+
T Consensus 103 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 999999999999999862 2357999999999999999999999999 999999999999975 45599999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccc
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRK 313 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 313 (457)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ......+.....
T Consensus 178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~- 250 (336)
T 3fhr_A 178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--PGMKRRIRLGQY- 250 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh--hhHHHhhhcccc-
Confidence 9753221 223457899999999998888999999999999999999999999754432110 000000000000
Q ss_pred cccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 314 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 314 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
....+. .......+.+|+..||+.||.+|||+.++++.
T Consensus 251 --~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 251 --GFPNPE-----WSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp --CCCTTT-----STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --ccCchh-----hccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000110 01223468899999999999999999999873
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=332.79 Aligned_cols=244 Identities=24% Similarity=0.407 Sum_probs=193.0
Q ss_pred HHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC------hHHHHHHHHHHHhc----CCCCceeeEEE
Q 012761 79 AAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG------NREFLVEVLMLSLL----HHSNLVNLIGY 148 (457)
Q Consensus 79 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~------~~~~~~E~~~l~~l----~hpniv~l~~~ 148 (457)
....++|.+.+.||+|+||.||+|++..+++.||||++....... ...+..|+.++..+ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344678999999999999999999999999999999997653321 23356789999888 89999999999
Q ss_pred EecCCeeeEEEec-cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc-CCCce
Q 012761 149 CADGDQRLLVYEF-MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE-EGFHP 226 (457)
Q Consensus 149 ~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~-~~~~~ 226 (457)
+.+.+..++|||| +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 9999999999999 789999999976 356999999999999999999999999 99999999999999 89999
Q ss_pred EEeeccccccCCCCCCccccccccccccccchhhhhcCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhh
Q 012761 227 KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLT-VKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWAR 305 (457)
Q Consensus 227 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~ 305 (457)
||+|||++...... ......||+.|+|||++.+..+. .++|||||||++|+|++|+.||....
T Consensus 180 kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------ 243 (312)
T 2iwi_A 180 KLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------ 243 (312)
T ss_dssp EECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------
T ss_pred EEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------
Confidence 99999999764322 22345689999999999877664 58999999999999999999995421
Q ss_pred hhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 306 PLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
....... . ++......+.+++.+||+.+|++||++.++++
T Consensus 244 ~~~~~~~--------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 EILEAEL--------H----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHHTCC--------C----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHhhhcc--------C----CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011000 0 11122346788999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=364.03 Aligned_cols=259 Identities=25% Similarity=0.355 Sum_probs=204.9
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCC---CeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLEST---GQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
..++|.+.+.||+|+||.||+|.+..+ +..||||.+...... ..+.+.+|+.+++.++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 356799999999999999999998643 568999998754322 2367889999999999999999999985 45689
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 467 lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 99999999999999975 2346899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccc
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 315 (457)
..... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .+...+ .. ..
T Consensus 541 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i---~~-~~--- 609 (656)
T 2j0j_A 541 MEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI---EN-GE--- 609 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH---HH-TC---
T ss_pred cCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH---Hc-CC---
Confidence 43221 122233457889999999999999999999999999999997 99999754321 111111 11 10
Q ss_pred cccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 316 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
.+.+ +......+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus 610 ---~~~~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 610 ---RLPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ---CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCC----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 0111 11223468899999999999999999999999998864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=334.50 Aligned_cols=261 Identities=18% Similarity=0.247 Sum_probs=200.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCC-eEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC------ceeeEEEEecCCe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTG-QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN------LVNLIGYCADGDQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~-~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~~~~~ 154 (457)
.++|.+.+.||+|+||.||+|.+..++ ..||||++.... .....+..|+.+++.+.|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999998776 799999997532 23456788999999997765 8999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE--------------
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL-------------- 220 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl-------------- 220 (457)
.++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 99999999 67777777652 2356999999999999999999999999 9999999999999
Q ss_pred -----cCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCC
Q 012761 221 -----EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPH 295 (457)
Q Consensus 221 -----~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~ 295 (457)
+.++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 5688999999999975322 123457999999999999999999999999999999999999999754321
Q ss_pred Ccccchhhhhhhhhc--------ccc--------------------cccccCCcc-CCCCChHhHHHHHHHHHHcchhhc
Q 012761 296 GEQNLVTWARPLFND--------RRK--------------------FSKLADPRL-EGRYPIRGLYQALAVASMCIQEQA 346 (457)
Q Consensus 296 ~~~~l~~~~~~~~~~--------~~~--------------------~~~~~d~~l-~~~~~~~~~~~l~~li~~cl~~dP 346 (457)
. ........... ... ......+.. ...........+.+|+.+||+.||
T Consensus 246 ~---~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 246 E---HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp H---HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred H---HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 1 11110000000 000 000000000 001112335578899999999999
Q ss_pred CCCCChHHHHH
Q 012761 347 ATRPLIGDVVT 357 (457)
Q Consensus 347 ~~RPt~~ev~~ 357 (457)
.+|||+.++++
T Consensus 323 ~~Rpt~~e~l~ 333 (355)
T 2eu9_A 323 AQRITLAEALL 333 (355)
T ss_dssp TTSCCHHHHTT
T ss_pred hhCcCHHHHhc
Confidence 99999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=336.88 Aligned_cols=244 Identities=22% Similarity=0.372 Sum_probs=201.2
Q ss_pred HHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc------ChHHHHHHHHHHHhcC--CCCceeeEEEEe
Q 012761 79 AAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ------GNREFLVEVLMLSLLH--HSNLVNLIGYCA 150 (457)
Q Consensus 79 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~------~~~~~~~E~~~l~~l~--hpniv~l~~~~~ 150 (457)
....++|.+.+.||+|+||.||+|++..+++.||||++...... ....+..|+.+++.+. ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 33467899999999999999999999999999999999754322 2245678999999996 599999999999
Q ss_pred cCCeeeEEEeccCC-CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc-CCCceEE
Q 012761 151 DGDQRLLVYEFMPL-GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE-EGFHPKL 228 (457)
Q Consensus 151 ~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~-~~~~~kL 228 (457)
+.+..++|||++.+ ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+ +++.+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEE
Confidence 99999999999976 899999975 457899999999999999999999999 99999999999999 7899999
Q ss_pred eeccccccCCCCCCccccccccccccccchhhhhcCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhh
Q 012761 229 SDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL 307 (457)
Q Consensus 229 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 307 (457)
+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .
T Consensus 192 ~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~ 255 (320)
T 3a99_A 192 IDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------I 255 (320)
T ss_dssp CCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------H
T ss_pred eeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------h
Confidence 999999764321 2334579999999999987765 6889999999999999999999954210 0
Q ss_pred hhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 308 FNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 308 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.... .. +...+ ...+.+|+.+||+.+|.+||++.+|++
T Consensus 256 ~~~~----~~----~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 IRGQ----VF----FRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHCC----CC----CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hccc----cc----ccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0100 00 11112 246789999999999999999999976
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=327.88 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=182.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcCh--HHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~--~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++........ +.+..+..++..++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 5689999999999999999999998999999999976533221 23444556788889999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
||+ ++.+..++.. ....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 5566655543 245789999999999999999999995 8 9999999999999999999999999987532
Q ss_pred CCCCccccccccccccccchhhhh-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRK 313 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 313 (457)
.. .......||+.|+|||++. ...++.++|||||||++|+|++|+.||...... ............
T Consensus 177 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~- 247 (318)
T 2dyl_A 177 DD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEP- 247 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCC-
T ss_pred CC---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCC-
Confidence 22 1223457899999999984 457899999999999999999999999753221 111111111110
Q ss_pred cccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 314 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 314 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+.+... ......+.+++..||+.||.+||++.++++
T Consensus 248 ------~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 ------PLLPGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ------CCCCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------CCCCcc--CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111100 011246789999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=339.83 Aligned_cols=254 Identities=23% Similarity=0.267 Sum_probs=186.1
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEEEec
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
+.|.+.+.||+|+||+||.+.. .+|+.||||++... ..+.+.+|+.++..+ +||||+++++++.+.+..+|||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 3456678899999999987543 56899999998653 245678899999876 899999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC-------------Cc
Q 012761 162 MPLGSLEDHLHDLPPDKEA---LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG-------------FH 225 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~-------------~~ 225 (457)
+. |+|.+++......... .++..++.++.||+.||.|||+.+ |+||||||+||||+.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 95 6999999864322221 133456789999999999999999 9999999999999654 48
Q ss_pred eEEeeccccccCCCCCCcc--ccccccccccccchhhhhc-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCCCC
Q 012761 226 PKLSDFGLAKLGPVGDKSH--VSTRVMGTYGYCAPEYAMT-------GQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPH 295 (457)
Q Consensus 226 ~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~ 295 (457)
+||+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999998643322111 1234579999999999975 578999999999999999999 99999643221
Q ss_pred CcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 296 GEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 296 ~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
. . .+......+ +.+....+......+.+|+.+||+.||.+||++.+|++
T Consensus 247 ~----~----~i~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 E----S----NIIRGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H----H----HHHHTCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H----H----HHhcCCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0 0 111111111 11111122344568899999999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=315.49 Aligned_cols=235 Identities=14% Similarity=0.107 Sum_probs=187.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++....... .+.+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 357999999999999999999999999999999998654332 26788999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||++|++|.+++.. . ....++..|+.||+.||.|||+.+ |+||||||+||||+.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence 999999999999954 2 355578999999999999999999 9999999999999999999998543
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
|++ .++.++|||||||++|||+||+.||.......... .+............
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~-- 226 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA---PAERDTAGQPIEPA-- 226 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---ECCBCTTSCBCCHH--
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---HHHHHhccCCCChh--
Confidence 333 36899999999999999999999998654322110 00000000000000
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
.+... ....+.+|+.+||+.||.+| |+.++++.|..+....
T Consensus 227 --~~~~~----~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 227 --DIDRD----IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp --HHCTT----SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred --hcccC----CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 01111 12458899999999999999 9999999999987643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=336.04 Aligned_cols=250 Identities=24% Similarity=0.270 Sum_probs=184.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~E 160 (457)
..+|.+.+.||+|+||.||.. ...+++.||||++..... ..+.+|+.+|+.+ +||||+++++++.+....+||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 356889999999999986543 334689999999975432 3356799999999 79999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC-----CCceEEeeccccc
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE-----GFHPKLSDFGLAK 235 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~-----~~~~kL~DFGla~ 235 (457)
|+. |+|.+++... ...+.+..++.++.||+.||.|||+.+ |+||||||+||||+. ...+||+|||+++
T Consensus 99 ~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 99 LCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp CCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred CCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 996 6999999763 233444567899999999999999999 999999999999943 3358899999998
Q ss_pred cCCCCCCc-cccccccccccccchhhhh---cCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhc
Q 012761 236 LGPVGDKS-HVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFND 310 (457)
Q Consensus 236 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 310 (457)
........ .......||+.|+|||++. ...++.++|||||||++|||++ |..||...... ..... ..
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~-~~ 243 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANIL-LG 243 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHH-TT
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHH-hc
Confidence 64332211 2234467999999999997 4577889999999999999999 89998543211 00000 00
Q ss_pred ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 311 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 311 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.... ..+. ........+.+|+.+||+.||.+||++.+|++
T Consensus 244 ~~~~-----~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 244 ACSL-----DCLH--PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCC-----TTSC--TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCc-----cccC--ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0000 0000 11123445788999999999999999999983
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=353.07 Aligned_cols=241 Identities=22% Similarity=0.321 Sum_probs=193.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECC-CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEecCCe-----
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLES-TGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ----- 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 154 (457)
.++|.+.+.||+|+||.||+|++.. +++.||||++..... .....+..|+.++..++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4789999999999999999999976 689999999875432 223567899999999999999999999987665
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
.||||||+++++|.+++.. .+++..++.|+.||+.||.|||+++ ||||||||+||||+.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999887743 6999999999999999999999999 9999999999999886 9999999999
Q ss_pred ccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
+..... ....||+.|+|||++.++ ++.++|||||||++|+|++|.+||.......
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------ 283 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------ 283 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS------------------
T ss_pred hhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc------------------
Confidence 863221 345799999999998775 4899999999999999999998876421100
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCC-hHHHHHHHHhhh
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-IGDVVTALSYLA 363 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~ev~~~L~~l~ 363 (457)
+.. ..........+.+|+.+||+.||.+||+ +.++...|..+.
T Consensus 284 --~~~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 --LPE----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp --CCT----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --ccc----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000 0000112346788999999999999995 666767666553
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.53 Aligned_cols=272 Identities=24% Similarity=0.308 Sum_probs=206.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCceeeEEEEec------CCe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-QGNREFLVEVLMLSLLHHSNLVNLIGYCAD------GDQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~~ 154 (457)
.++|.+.+.||+|+||.||+|.+..+|..||||++..... .....+..|+.++..++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 4689999999999999999999999999999999875422 223568899999999999999999999765 677
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCc---eEEeec
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH---PKLSDF 231 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~---~kL~DF 231 (457)
.++||||+++|+|.+++.... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999998632 2336889999999999999999999999 999999999999987664 999999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 311 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 311 (457)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...|........
T Consensus 169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~ 240 (676)
T 3qa8_A 169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKS 240 (676)
T ss_dssp CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC---
T ss_pred cccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhccc
Confidence 9998643222 23446799999999999999999999999999999999999999965321 112221111100
Q ss_pred cccccccCC------------ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHH-----HHHHHHhhhhcC
Q 012761 312 RKFSKLADP------------RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGD-----VVTALSYLANQT 366 (457)
Q Consensus 312 ~~~~~~~d~------------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e-----v~~~L~~l~~~~ 366 (457)
.. ...... .............+.+++..||+.||++||++.+ +.+.+..+....
T Consensus 241 ~~-~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 241 NE-HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred ch-hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 00 000000 0112233345678899999999999999999988 557777666543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=310.57 Aligned_cols=229 Identities=19% Similarity=0.272 Sum_probs=181.0
Q ss_pred hcCCCcc-ceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHH-HhcCCCCceeeEEEEec----CCee
Q 012761 82 TKNFRPE-SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLML-SLLHHSNLVNLIGYCAD----GDQR 155 (457)
Q Consensus 82 ~~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~----~~~~ 155 (457)
.++|.+. +.||+|+||.||+|.+..+++.||||++.. ...+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4577777 789999999999999999999999999853 35677888887 56689999999999876 6778
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC---CCceEEeecc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE---GFHPKLSDFG 232 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~---~~~~kL~DFG 232 (457)
++||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 9999999999999999862 2346999999999999999999999999 999999999999987 7899999999
Q ss_pred ccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccc
Q 012761 233 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 312 (457)
Q Consensus 233 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 312 (457)
++.... +..++.++|||||||++|||++|+.||.......... ....
T Consensus 166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--~~~~------- 212 (299)
T 3m2w_A 166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKT------- 212 (299)
T ss_dssp TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--CSCC-------
T ss_pred cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--HHHH-------
Confidence 986421 2346789999999999999999999997543321100 0000
Q ss_pred ccccccCCccCCCCC----hHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 313 KFSKLADPRLEGRYP----IRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 313 ~~~~~~d~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.+..... .++ ......+.+|+..||+.||.+||++.|+++.
T Consensus 213 ---~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 ---RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp ---SSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000 011 1123468899999999999999999999873
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=329.15 Aligned_cols=245 Identities=16% Similarity=0.169 Sum_probs=183.4
Q ss_pred HhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCC-CCc---------ee---
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHH-SNL---------VN--- 144 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~E~~~l~~l~h-pni---------v~--- 144 (457)
.+++|...++||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.++..+.| +|. +.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34568888999999999999999999999999999984322 224678999999999987 221 11
Q ss_pred ---------eEEEEec-----CCeeeEEEeccCCCCHHHhhhcC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 012761 145 ---------LIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDL---PPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 207 (457)
Q Consensus 145 ---------l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ 207 (457)
++.++.. ...++++|+++ +++|.+++... ......+++..++.|+.||+.||.|||+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1111111 12356777765 68999888521 123456889999999999999999999999
Q ss_pred eeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhh----------hcCCCCccchHHHHHH
Q 012761 208 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA----------MTGQLTVKSDVYSFGV 277 (457)
Q Consensus 208 iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDvwSlGv 277 (457)
|+||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++ ....++.++|||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 99999999999999999999999999875221 1344577 999999999 4446888999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 278 VFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 278 il~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
++|||++|+.||........ ... ++... ..++ ..+.+|+..||+.+|.+||++.++++
T Consensus 306 il~elltg~~Pf~~~~~~~~------~~~----------~~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGG------SEW----------IFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSC------SGG----------GGSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHCCCCCCCcchhhh------HHH----------HHhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999999975432111 111 11100 1122 46889999999999999999877754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=314.57 Aligned_cols=242 Identities=17% Similarity=0.141 Sum_probs=183.8
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--------cChHHHHHHHHHHHhcC---------CCCcee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--------QGNREFLVEVLMLSLLH---------HSNLVN 144 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--------~~~~~~~~E~~~l~~l~---------hpniv~ 144 (457)
.++|.+.+.||+|+||.||+|++ +|+.||||++..... ...+.+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46799999999999999999998 589999999986532 12367889999998886 888888
Q ss_pred eEEEEe------------------------------cCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 012761 145 LIGYCA------------------------------DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAA 194 (457)
Q Consensus 145 l~~~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~ 194 (457)
+.+++. +.+..+|||||+++|++.+.+.. ..+++..++.|+.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 777643 26789999999999977776643 5689999999999999
Q ss_pred HHHHHHH-hCCCCCeeeccCCccCeEEcCCC--------------------ceEEeeccccccCCCCCCccccccccccc
Q 012761 195 KGLEYLH-DKANPPVIYRDFKSSNILLEEGF--------------------HPKLSDFGLAKLGPVGDKSHVSTRVMGTY 253 (457)
Q Consensus 195 ~~L~yLH-~~~~~~iiHrDLkp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~ 253 (457)
.||.||| +.+ |+||||||+||||+.++ .+||+|||+++.... ...+||+
T Consensus 172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~ 241 (336)
T 2vuw_A 172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCD 241 (336)
T ss_dssp HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCC
T ss_pred HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEee
Confidence 9999999 899 99999999999999887 899999999985321 2347999
Q ss_pred cccchhhhhcCCCCccchHHHHHHH-HHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCccCCCCChHhHH
Q 012761 254 GYCAPEYAMTGQLTVKSDVYSFGVV-FLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLY 332 (457)
Q Consensus 254 ~y~aPE~~~~~~~~~ksDvwSlGvi-l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 332 (457)
.|+|||++.+.. +.++|||||+++ .+++++|..||... .|.......-.. ..................
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTDKMLK-QMTFKTKCNTPAMKQIKR 310 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHHHHHH-TCCCSSCCCSHHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHHhhhh-hhccCcccchhhhhhcCH
Confidence 999999998655 899999998777 77888999888421 121111100000 000011111111223466
Q ss_pred HHHHHHHHcchhhcCCCCChHHHH
Q 012761 333 QALAVASMCIQEQAATRPLIGDVV 356 (457)
Q Consensus 333 ~l~~li~~cl~~dP~~RPt~~ev~ 356 (457)
.+.+|+.+||+.+ |+.|++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHhccC-----CHHHHH
Confidence 8899999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-33 Score=293.17 Aligned_cols=185 Identities=18% Similarity=0.118 Sum_probs=132.8
Q ss_pred eeecCcEEEEEEEECCCCeEEEEEEeccCCCcC----------hHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEEE
Q 012761 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG----------NREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 91 lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~----------~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++.|++|.+..++....|+.|+||++....... .++|.+|+.+|+++ .|+||+++++++.++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 566777777776666678999999997643211 24689999999999 6999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||++|++|.++|.. ..+++.. +|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999986 4566653 58999999999999999 99999999999999999999999999986432
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 288 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p 288 (457)
. .......+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 392 ~--~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 D--CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred C--CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 2 233445789999999999865 577889999999999888766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.3e-29 Score=261.09 Aligned_cols=186 Identities=18% Similarity=0.227 Sum_probs=145.6
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--------hHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--------NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--------~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
+...+.||+|+||.||+|.. .+..+++|++....... .+.+.+|+.+++.++||||+++..++...+..+
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ----------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred CCCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence 34567899999999999954 36889999876533221 134789999999999999997666666778889
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
|||||+++++|.+++.. ++.++.||+.||.|||+++ |+||||||+|||++. .+||+|||+++.
T Consensus 416 lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp EEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEE
Confidence 99999999999999964 4689999999999999999 999999999999998 999999999986
Q ss_pred CCCCCCcc-----ccccccccccccchhhhhc--CCCCccchHHHHHHHHHHHHhCCCCC
Q 012761 237 GPVGDKSH-----VSTRVMGTYGYCAPEYAMT--GQLTVKSDVYSFGVVFLELITGRKAI 289 (457)
Q Consensus 237 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvil~elltG~~p~ 289 (457)
........ ......||+.|||||++.. ..|+..+|+|+..+-.++.+.++.+|
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 43321111 1235689999999999986 56888899999999999988887765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=214.81 Aligned_cols=152 Identities=14% Similarity=0.048 Sum_probs=121.5
Q ss_pred HHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc------------------ChHHHHHHHHHHHhcC
Q 012761 77 ELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ------------------GNREFLVEVLMLSLLH 138 (457)
Q Consensus 77 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~------------------~~~~~~~E~~~l~~l~ 138 (457)
.+......|.+.+.||+|+||.||+|.+ .+|+.||||++...... ....+.+|+.+++.++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 3444456677889999999999999999 77999999999743211 1345889999999998
Q ss_pred CCCceeeEEEEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCe
Q 012761 139 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNI 218 (457)
Q Consensus 139 hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NI 218 (457)
| +++.+++.. +..++||||++|++|.+ +.. .....++.||+.||.|||+.+ |+||||||+||
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 4 555555433 56799999999999998 422 124579999999999999999 99999999999
Q ss_pred EEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhc
Q 012761 219 LLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT 263 (457)
Q Consensus 219 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 263 (457)
|++ ++.+||+|||++.. +..|+|||++..
T Consensus 225 Ll~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp EEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 999 99999999999863 344789998754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4.6e-21 Score=183.07 Aligned_cols=137 Identities=17% Similarity=0.079 Sum_probs=107.6
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeE--EEEEEeccCCCcC------------------------hHHHHHHHHHHHhc
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQV--VAVKQLDRNGLQG------------------------NREFLVEVLMLSLL 137 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~--vavK~i~~~~~~~------------------------~~~~~~E~~~l~~l 137 (457)
-|.+.+.||+|+||.||+|.+..+|.. ||||+++...... ...+..|+.+|..|
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999998667888 9999976432110 12578899999999
Q ss_pred CCCCc--eeeEEEEecCCeeeEEEeccCC-C----CHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCee
Q 012761 138 HHSNL--VNLIGYCADGDQRLLVYEFMPL-G----SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH-DKANPPVI 209 (457)
Q Consensus 138 ~hpni--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~~~~ii 209 (457)
.|+++ +.++.+ +..+|||||+.+ | +|.+++.. +++..+..++.||+.+|.||| +.+ |+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 88764 444442 356899999942 3 67666532 224467889999999999999 898 99
Q ss_pred eccCCccCeEEcCCCceEEeecccccc
Q 012761 210 YRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 210 HrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
||||||+|||++. .++|+|||+|..
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred eCCCCHHHEEEcC--cEEEEECccccc
Confidence 9999999999998 999999999974
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=8.6e-18 Score=168.18 Aligned_cols=136 Identities=15% Similarity=0.105 Sum_probs=99.5
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--------------ChHH--------HHHHHHHHHhcCCCC
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--------------GNRE--------FLVEVLMLSLLHHSN 141 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--------------~~~~--------~~~E~~~l~~l~hpn 141 (457)
-|.+...||.|+||.||+|.+. +|+.||||+++..... .... ...|...|.+|.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3899999999999999999985 5899999998642110 0011 234667777775554
Q ss_pred ceeeEEEEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc
Q 012761 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE 221 (457)
Q Consensus 142 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~ 221 (457)
+....-+... ..+|||||++|++|..+... .....++.||+.+|.|||+.+ ||||||||.||||+
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 4222212111 23799999999888765431 124578899999999999999 99999999999998
Q ss_pred CCC----------ceEEeeccccc
Q 012761 222 EGF----------HPKLSDFGLAK 235 (457)
Q Consensus 222 ~~~----------~~kL~DFGla~ 235 (457)
+++ .+.|+||+-+.
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCE
T ss_pred CCCCcccccccccceEEEEeCCcc
Confidence 776 38999998664
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=3.4e-13 Score=128.09 Aligned_cols=147 Identities=16% Similarity=0.068 Sum_probs=115.3
Q ss_pred HHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCceeeEEEEecCCeeeE
Q 012761 79 AAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 79 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l 157 (457)
......|.+...++.|+++.||++... +..+++|+...........+..|+.+++.|. +..+.++++++.+.+..|+
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 445568988888999999999998754 6789999987532223346888999999885 6778899999998889999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA--------------------------------- 204 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--------------------------------- 204 (457)
||||++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 88 v~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 9999999999876421 1123478899999999999811
Q ss_pred -----------------------CCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 205 -----------------------NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 205 -----------------------~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
.+.++|+|++|.|||++++..+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13389999999999998765667999987753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.29 E-value=3.8e-12 Score=119.99 Aligned_cols=138 Identities=17% Similarity=0.094 Sum_probs=100.7
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC--ceeeEEEEecCCeeeEEEe
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN--LVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~lV~E 160 (457)
.+|.+..+.+.|..+.||++.. .+|..++||+.... ....+..|+.+++.+.+.+ +.+++++....+..++|||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3455444344566699999965 44678999997654 2345778999998886544 4568888888888999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA------------------------------------ 204 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~------------------------------------ 204 (457)
|++|.+|. ... .+ ...++.+++..|..||+..
T Consensus 96 ~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 96 EVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp CCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred ecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 99998884 221 11 2357778888888888743
Q ss_pred -------------------CCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 205 -------------------NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 205 -------------------~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
...++|+|++|.|||+++++.+.|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.18 E-value=7.9e-11 Score=117.16 Aligned_cols=143 Identities=15% Similarity=0.202 Sum_probs=107.0
Q ss_pred CccceeeecCcEEEEEEEECCCCeEEEEEEec--cCCC-cChHHHHHHHHHHHhcC--CCCceeeEEEEecC---CeeeE
Q 012761 86 RPESFIGEGGFGRVYKGWLESTGQVVAVKQLD--RNGL-QGNREFLVEVLMLSLLH--HSNLVNLIGYCADG---DQRLL 157 (457)
Q Consensus 86 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~--~~~~-~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~---~~~~l 157 (457)
...+.|+.|.++.||++... +..+++|+.. .... .....+..|+.+++.|. +..+++++.++.+. ...++
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 34567899999999998764 4678898876 3221 22346788999999997 45678899988776 34799
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA--------------------------------- 204 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--------------------------------- 204 (457)
||||++|..+.+.. ...++...+..++.++++.|..||...
T Consensus 119 vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 99999988775422 124678888999999999999999731
Q ss_pred ----------------------CCCeeeccCCccCeEEcCCCc--eEEeecccccc
Q 012761 205 ----------------------NPPVIYRDFKSSNILLEEGFH--PKLSDFGLAKL 236 (457)
Q Consensus 205 ----------------------~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~ 236 (457)
.+.++|+|+++.|||++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 234999999999999987653 68999998875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.16 E-value=3e-11 Score=117.45 Aligned_cols=187 Identities=19% Similarity=0.184 Sum_probs=122.9
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCC--ceeeEEEEecCC---eeeEEEec
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSN--LVNLIGYCADGD---QRLLVYEF 161 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~l~~~~~~~~---~~~lV~E~ 161 (457)
.+.|+.|....||++. ..+++|+.... .....+..|..+|+.+. +.. +..++.+....+ ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4568999999999862 45889986532 23456888999998884 333 344554443333 34889999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA------------------------------------- 204 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~------------------------------------- 204 (457)
++|.+|.+... ..++..++..++.+++..|..||+..
T Consensus 98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99988875432 23677788888899999988888621
Q ss_pred ------------------CCCeeeccCCccCeEEcC--CCceEEeeccccccCCCCCCcccccc------------cccc
Q 012761 205 ------------------NPPVIYRDFKSSNILLEE--GFHPKLSDFGLAKLGPVGDKSHVSTR------------VMGT 252 (457)
Q Consensus 205 ------------------~~~iiHrDLkp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~~------------~~gt 252 (457)
.+.++|+|++|.|||+++ +..+.|+||+.+.............. +...
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 134899999999999988 55678999999875432110000000 0011
Q ss_pred ccccc-hhhhhcCCCCccchHHHHHHHHHHHHhCCCCC
Q 012761 253 YGYCA-PEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 289 (457)
Q Consensus 253 ~~y~a-PE~~~~~~~~~ksDvwSlGvil~elltG~~p~ 289 (457)
+++.. |+.... .....+.|+++.++|.+.+|..+|
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11222 222211 122368999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=1.8e-07 Score=88.69 Aligned_cols=143 Identities=18% Similarity=0.180 Sum_probs=101.9
Q ss_pred hcCCCccceeeecCcE-EEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFG-RVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g-~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~ 159 (457)
...|+.. .+..|..| .||+......+..++||+-... ....+..|..+|+.|. +--+.++++++.+.+..++||
T Consensus 24 l~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 24 LYGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp HTTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ccCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 3344433 34555554 6999887766778999986532 2456788999998885 334678899999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA----------------------------------- 204 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~----------------------------------- 204 (457)
|+++|.++.+..... ......++.+++..|.-||...
T Consensus 100 e~l~G~~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDER 171 (272)
T ss_dssp ECCCSEEHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGG
T ss_pred EeeCCccccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccc
Confidence 999998887765431 1123456666777777777431
Q ss_pred --------------------CCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 205 --------------------NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 205 --------------------~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
.+.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 172 ~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 172 NGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 01279999999999999877777999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=3.1e-07 Score=89.17 Aligned_cols=136 Identities=18% Similarity=0.147 Sum_probs=95.3
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCC---CceeeEEEEe-cCCeeeEEEeccC
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHS---NLVNLIGYCA-DGDQRLLVYEFMP 163 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~-~~~~~~lV~E~~~ 163 (457)
.+.++.|....||+. +..++||+... ......+..|..+|..|.+. .+..++.++. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456888998999987 45688887532 12235688999999999752 3556666664 4456789999999
Q ss_pred CCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 012761 164 LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA--------------------------------------- 204 (457)
Q Consensus 164 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--------------------------------------- 204 (457)
|..|.+... ..++......++.++...|..||+..
T Consensus 97 G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 988876321 12445555666666666666666432
Q ss_pred ------------------CCCeeeccCCccCeEEcC---CCc-eEEeecccccc
Q 012761 205 ------------------NPPVIYRDFKSSNILLEE---GFH-PKLSDFGLAKL 236 (457)
Q Consensus 205 ------------------~~~iiHrDLkp~NILl~~---~~~-~kL~DFGla~~ 236 (457)
.+.++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 224799999999999987 455 48999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=4.9e-07 Score=89.35 Aligned_cols=82 Identities=9% Similarity=-0.015 Sum_probs=55.9
Q ss_pred ccee-eecCcEEEEEEEEC---C---CCeEEEEEEeccCC---CcChHHHHHHHHHHHhcC-C--CCceeeEEEEecC--
Q 012761 88 ESFI-GEGGFGRVYKGWLE---S---TGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLH-H--SNLVNLIGYCADG-- 152 (457)
Q Consensus 88 ~~~l-G~G~~g~Vy~~~~~---~---~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~~-- 152 (457)
.+.| +.|....+|+.... . ++..+++|+..... ......+..|+.+++.|. + ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78888999988653 0 15678999865432 112245778888888875 3 3567788887665
Q ss_pred -CeeeEEEeccCCCCHHH
Q 012761 153 -DQRLLVYEFMPLGSLED 169 (457)
Q Consensus 153 -~~~~lV~E~~~~gsL~~ 169 (457)
...++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999876543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=1.8e-06 Score=86.74 Aligned_cols=76 Identities=17% Similarity=0.113 Sum_probs=49.8
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccCCC-------cChHHHHHHHHHHHhcCC--CCce-eeEEEEecCCeeeE
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL-------QGNREFLVEVLMLSLLHH--SNLV-NLIGYCADGDQRLL 157 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-------~~~~~~~~E~~~l~~l~h--pniv-~l~~~~~~~~~~~l 157 (457)
.+.||.|.++.||++....++..|+||....... .....+..|..++..+.. +.++ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4579999999999997665578899998653211 123456778888887742 4444 45543 3455789
Q ss_pred EEeccCCC
Q 012761 158 VYEFMPLG 165 (457)
Q Consensus 158 V~E~~~~g 165 (457)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.24 E-value=8.2e-06 Score=79.56 Aligned_cols=142 Identities=18% Similarity=0.316 Sum_probs=79.5
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-----CCCceeeE-E--EEecCCeeeEEEe
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-----HSNLVNLI-G--YCADGDQRLLVYE 160 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-----hpniv~l~-~--~~~~~~~~~lV~E 160 (457)
+.|+.|..+.||++... +..+++|+.... ...+..|..++..|. .|.++... + +....+..++||+
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34666778899998764 345899998752 234444555555543 24443310 0 1234567899999
Q ss_pred ccCCCCHH--------------HhhhcCC-----CCC-----CCCCHHHH------------------------------
Q 012761 161 FMPLGSLE--------------DHLHDLP-----PDK-----EALDWNTR------------------------------ 186 (457)
Q Consensus 161 ~~~~gsL~--------------~~l~~~~-----~~~-----~~l~~~~~------------------------------ 186 (457)
|++|..+. ..+|... ... ..-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 1122110 000 01123211
Q ss_pred -HHHHHHHHHHHHHHHh----------CCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 187 -MKIAAGAAKGLEYLHD----------KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 187 -~~i~~qi~~~L~yLH~----------~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
..+...+..++.+|++ .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223445667763 1234499999999999998888999999997753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.00 E-value=3.5e-05 Score=74.86 Aligned_cols=140 Identities=17% Similarity=0.164 Sum_probs=92.0
Q ss_pred ccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC---CCCceeeEEEEecCCeeeEEEeccC
Q 012761 87 PESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH---HSNLVNLIGYCADGDQRLLVYEFMP 163 (457)
Q Consensus 87 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lV~E~~~ 163 (457)
..+.|+.|.+..+|+... ++..++||+.... ....+..|...|+.|. ...+++++.+....+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 345689999999999875 3568889987643 2456888999888884 3567888888888888999999999
Q ss_pred CCCHH-----------HhhhcCCC-CC-----------------CCCCHHHHH---HHH----------------HHHHH
Q 012761 164 LGSLE-----------DHLHDLPP-DK-----------------EALDWNTRM---KIA----------------AGAAK 195 (457)
Q Consensus 164 ~gsL~-----------~~l~~~~~-~~-----------------~~l~~~~~~---~i~----------------~qi~~ 195 (457)
+..+. ..||.... .. -.-+|.... ++. ..++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87642 12333221 00 011454322 111 11111
Q ss_pred H-HHHHHh-CCCCCeeeccCCccCeEEcCCCceEEeecc
Q 012761 196 G-LEYLHD-KANPPVIYRDFKSSNILLEEGFHPKLSDFG 232 (457)
Q Consensus 196 ~-L~yLH~-~~~~~iiHrDLkp~NILl~~~~~~kL~DFG 232 (457)
. ...|.. ...+.++|+|+.+.||+++.++ +.|.||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 223322 1245699999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.96 E-value=4.1e-05 Score=77.41 Aligned_cols=77 Identities=16% Similarity=0.199 Sum_probs=48.0
Q ss_pred CCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCccccccccc--cccccchhhhhcC---CCCccchHHHHHHHHH
Q 012761 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG--TYGYCAPEYAMTG---QLTVKSDVYSFGVVFL 280 (457)
Q Consensus 206 ~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~ksDvwSlGvil~ 280 (457)
+.++|+|++|.|||++.++ +.|+||+.+..++..-.- ....+ ...|++|+..... .-....++..+...+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 3499999999999998876 999999998754321110 00011 2346666654311 1122355667888888
Q ss_pred HHHhCC
Q 012761 281 ELITGR 286 (457)
Q Consensus 281 elltG~ 286 (457)
+++++.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.0002 Score=68.39 Aligned_cols=80 Identities=21% Similarity=0.208 Sum_probs=57.9
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC---CCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH---SNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h---pniv~l~~~~~~~~~~~lV~ 159 (457)
....-.+.+|.|..+.||+.... +|+.|+||+...........|..|+..|+.|.- -.+++++++. .-++||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 45566677999999999999875 488999998765544445668889999998852 1344555442 237899
Q ss_pred eccCCCCH
Q 012761 160 EFMPLGSL 167 (457)
Q Consensus 160 E~~~~gsL 167 (457)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00016 Score=69.50 Aligned_cols=139 Identities=9% Similarity=0.030 Sum_probs=75.7
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCc-eeeEEEEecCCeeeEEEecc-CCC
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL-VNLIGYCADGDQRLLVYEFM-PLG 165 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~E~~-~~g 165 (457)
.+.|+.|....+|++ ..+++|+....... ......|+.+++.+..-++ .+++++ +.+.-++|+||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 677999999999998 35889987643211 1123457777777653233 455544 344457899999 654
Q ss_pred CHHH------------------hhhcCCCC-CCCCCH-HHHHHHHH--------------HHHHHHH----HHHh-CCCC
Q 012761 166 SLED------------------HLHDLPPD-KEALDW-NTRMKIAA--------------GAAKGLE----YLHD-KANP 206 (457)
Q Consensus 166 sL~~------------------~l~~~~~~-~~~l~~-~~~~~i~~--------------qi~~~L~----yLH~-~~~~ 206 (457)
+|.. .||..... ....+. .....+.. .+...+. .|.. ..++
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 4421 11221110 011111 11111110 0111111 1111 1223
Q ss_pred CeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 207 ~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
.++|+|+.+.||| ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5566789999998865
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00057 Score=65.98 Aligned_cols=160 Identities=14% Similarity=0.112 Sum_probs=88.2
Q ss_pred cccHHHHHHHhcCCCcc-----ceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC--cee
Q 012761 72 TFTFRELAAATKNFRPE-----SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN--LVN 144 (457)
Q Consensus 72 ~~~~~~~~~~~~~f~~~-----~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn--iv~ 144 (457)
.++..++......|.+. +.|+.|....+|+..... + .+++|+.... .....+..|+.++..|...+ +.+
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCc
Confidence 35556666666667652 346678888999987643 3 6889988753 12345566777776664212 223
Q ss_pred eEEE------EecCCeeeEEEeccCCCCHHH--------------hhhcC----CCCC-CCC---CHHHHHH--------
Q 012761 145 LIGY------CADGDQRLLVYEFMPLGSLED--------------HLHDL----PPDK-EAL---DWNTRMK-------- 188 (457)
Q Consensus 145 l~~~------~~~~~~~~lV~E~~~~gsL~~--------------~l~~~----~~~~-~~l---~~~~~~~-------- 188 (457)
++.. ....+..+++|+|++|..+.. .+|.. .... ... .|...+.
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3311 122356789999998865321 12211 1110 011 1222111
Q ss_pred ----HHHHHHHHHHHHHhC----CCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 189 ----IAAGAAKGLEYLHDK----ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 189 ----i~~qi~~~L~yLH~~----~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
+...+...+.+|+.. .+..++|+|+++.|||++.+..+.|+||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234455666532 12349999999999999887666899998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.61 E-value=0.0002 Score=72.76 Aligned_cols=74 Identities=19% Similarity=0.231 Sum_probs=50.6
Q ss_pred cceeeecCcEEEEEEEECC-------CCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCc-eeeEEEEecCCeeeEEE
Q 012761 88 ESFIGEGGFGRVYKGWLES-------TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL-VNLIGYCADGDQRLLVY 159 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~ 159 (457)
.+.|+.|-...||++.... .+..+++|+.... .....+..|..++..|...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4568888889999998753 2578999988432 122556689999888864344 566766543 3899
Q ss_pred eccCCCCH
Q 012761 160 EFMPLGSL 167 (457)
Q Consensus 160 E~~~~gsL 167 (457)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00052 Score=70.19 Aligned_cols=75 Identities=15% Similarity=0.006 Sum_probs=48.3
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCc-eeeEEEEecCCeeeEEEeccCCCC
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL-VNLIGYCADGDQRLLVYEFMPLGS 166 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~E~~~~gs 166 (457)
.+.|+.|-...+|++.....+..+++|+..... ...-....|..++..|...++ .++++++. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 345788888999999876445789999875432 111112578888888875555 56777663 2 25999998754
Q ss_pred H
Q 012761 167 L 167 (457)
Q Consensus 167 L 167 (457)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.0009 Score=64.75 Aligned_cols=143 Identities=15% Similarity=0.108 Sum_probs=80.3
Q ss_pred ceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCC--CceeeEEE-----EecCCeeeEEEec
Q 012761 89 SFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHS--NLVNLIGY-----CADGDQRLLVYEF 161 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~-----~~~~~~~~lV~E~ 161 (457)
..|+ |....||++... +|..+++|+..... .....+..|..++..|... .+++++.. ....+..++||+|
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 3466 778899987653 36679999986432 2345677788888777522 23444432 1224556789999
Q ss_pred cCCCCHH-----H---------hhhc----CCC-CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhC
Q 012761 162 MPLGSLE-----D---------HLHD----LPP-DKEALDWNTR----MKI---------------AAGAAKGLEYLHDK 203 (457)
Q Consensus 162 ~~~gsL~-----~---------~l~~----~~~-~~~~l~~~~~----~~i---------------~~qi~~~L~yLH~~ 203 (457)
++|..+. . .+|. ... ....+++... ..+ ...+...+..|...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 9875432 1 0121 111 0112222211 001 01111223333221
Q ss_pred ----CCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 204 ----ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 204 ----~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
.+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 233489999999999999 4 899999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.0012 Score=64.28 Aligned_cols=144 Identities=15% Similarity=0.089 Sum_probs=72.1
Q ss_pred ceeeecCcEE-EEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC--CCceeeEEEEecCCeeeEEEeccCCC
Q 012761 89 SFIGEGGFGR-VYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH--SNLVNLIGYCADGDQRLLVYEFMPLG 165 (457)
Q Consensus 89 ~~lG~G~~g~-Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lV~E~~~~g 165 (457)
+.|+.|.... +|+.... ++..+++|....... ..+..|+.++..|.. -.+.+++.+..+. -+++||++.+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~ 97 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA 97 (333)
T ss_dssp CC--------CCEEEECT-TCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred eECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence 3465554444 6676532 256777776543321 233456666666542 2345666654333 37899999776
Q ss_pred CHHHhhhc---------------------CCCC-CCCCCHHHHH-------H-H------------HHHHHHHHHHHHh-
Q 012761 166 SLEDHLHD---------------------LPPD-KEALDWNTRM-------K-I------------AAGAAKGLEYLHD- 202 (457)
Q Consensus 166 sL~~~l~~---------------------~~~~-~~~l~~~~~~-------~-i------------~~qi~~~L~yLH~- 202 (457)
.+.+++.. .... ...++..... . + ...+...+..|-.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 66543321 1100 0112221110 0 0 0111222333311
Q ss_pred --CCCCCeeeccCCccCeEEcCC----CceEEeeccccccCC
Q 012761 203 --KANPPVIYRDFKSSNILLEEG----FHPKLSDFGLAKLGP 238 (457)
Q Consensus 203 --~~~~~iiHrDLkp~NILl~~~----~~~kL~DFGla~~~~ 238 (457)
...+.++|+|+.+.|||++.+ +.+.|+||+.+..++
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 123459999999999999874 689999999887643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00057 Score=68.12 Aligned_cols=142 Identities=18% Similarity=0.192 Sum_probs=83.5
Q ss_pred ceeeecCcEEEEEEEECC-------CCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCceeeEEEEecCCeeeEEEe
Q 012761 89 SFIGEGGFGRVYKGWLES-------TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~-------~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~E 160 (457)
+.|..|-...+|++.... ++..|++|+.... ......+.+|..+++.|. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 457677778899987642 3478999986332 234456678999998885 3223566666643 28999
Q ss_pred ccCCCCHHH-----------------hhhcCCC-CCCCC--CHHHHHHHHHHHHH-------------------HHHHHH
Q 012761 161 FMPLGSLED-----------------HLHDLPP-DKEAL--DWNTRMKIAAGAAK-------------------GLEYLH 201 (457)
Q Consensus 161 ~~~~gsL~~-----------------~l~~~~~-~~~~l--~~~~~~~i~~qi~~-------------------~L~yLH 201 (457)
|++|.+|.. .||.... ..... -+.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999765431 1222211 11122 24555555544322 233333
Q ss_pred ----hC-CCCCeeeccCCccCeEEcCC----CceEEeeccccc
Q 012761 202 ----DK-ANPPVIYRDFKSSNILLEEG----FHPKLSDFGLAK 235 (457)
Q Consensus 202 ----~~-~~~~iiHrDLkp~NILl~~~----~~~kL~DFGla~ 235 (457)
.. .+..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22 12348999999999999876 789999998775
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00097 Score=65.90 Aligned_cols=75 Identities=11% Similarity=0.004 Sum_probs=43.9
Q ss_pred cceeeecCcEEEEEEEECC--------CCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC-ceeeEEEEecCCeeeEE
Q 012761 88 ESFIGEGGFGRVYKGWLES--------TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN-LVNLIGYCADGDQRLLV 158 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~--------~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lV 158 (457)
.+.|+.|....+|++.... .+..+++|+...... .......|..++..|...+ ..++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3457778888999987653 126788998754321 1112356788887775333 34666554 2 3689
Q ss_pred EeccCCCCH
Q 012761 159 YEFMPLGSL 167 (457)
Q Consensus 159 ~E~~~~gsL 167 (457)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0027 Score=62.04 Aligned_cols=31 Identities=16% Similarity=0.151 Sum_probs=27.4
Q ss_pred CCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 206 ~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3499999999999999888899999987764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0039 Score=56.64 Aligned_cols=100 Identities=14% Similarity=0.083 Sum_probs=66.5
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCCcc
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 244 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 244 (457)
.+|.+.|.. ...+|++.++|.++.|.+.+|.-+-....+ ..+=+.|..|+|..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---------
Confidence 478999886 468999999999999999988776221111 2333567999999999998764 1110
Q ss_pred ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhC
Q 012761 245 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 285 (457)
Q Consensus 245 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG 285 (457)
.....+.|||... ...+.+.=|||||++||.-+-=
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 0122366888753 3456788999999999988753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.06 E-value=0.022 Score=57.42 Aligned_cols=143 Identities=16% Similarity=0.172 Sum_probs=83.9
Q ss_pred cceeeecCcEEEEEEEECCC-------CeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC-ceeeEEEEecCCeeeEEE
Q 012761 88 ESFIGEGGFGRVYKGWLEST-------GQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN-LVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~-------~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lV~ 159 (457)
.+.|..|-...+|+...... +..|++|+..... ...-...+|..+++.|.--+ ..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 34577788888999887521 4789999865432 11122356788887775323 345565432 27899
Q ss_pred eccCCCCHHH-----------------hhhcC-------CC--CCCCCCHHHHHHHHHHH-------------------H
Q 012761 160 EFMPLGSLED-----------------HLHDL-------PP--DKEALDWNTRMKIAAGA-------------------A 194 (457)
Q Consensus 160 E~~~~gsL~~-----------------~l~~~-------~~--~~~~l~~~~~~~i~~qi-------------------~ 194 (457)
||++|.+|.. .||.. +. ...+.-+.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999865421 01111 11 12222344444444332 2
Q ss_pred HHHHHHHh---------------------CCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 195 KGLEYLHD---------------------KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 195 ~~L~yLH~---------------------~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
..+.+|.+ ..+..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333331 11234899999999999 7788999999988753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.39 E-value=0.23 Score=49.43 Aligned_cols=29 Identities=31% Similarity=0.348 Sum_probs=24.7
Q ss_pred eeeccCCccCeEE------cCCCceEEeecccccc
Q 012761 208 VIYRDFKSSNILL------EEGFHPKLSDFGLAKL 236 (457)
Q Consensus 208 iiHrDLkp~NILl------~~~~~~kL~DFGla~~ 236 (457)
++|+|+.+.|||+ +++..+.|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999988754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.39 E-value=0.45 Score=42.91 Aligned_cols=115 Identities=8% Similarity=0.081 Sum_probs=79.9
Q ss_pred CCCCceeeEEEEecCCeeeEEEeccCCC-CHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCcc
Q 012761 138 HHSNLVNLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 216 (457)
Q Consensus 138 ~hpniv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~ 216 (457)
.||+++.. .+-.+.+.+.|.++.-+.+ ++.. +. .++...+++++..|+....+++. =+|--|.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 58999977 5666777777777765433 3333 33 47788999999999988865543 277889999
Q ss_pred CeEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCC
Q 012761 217 NILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 290 (457)
Q Consensus 217 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~ 290 (457)
||+++.++.++|.-.|+-...++. =+.+|-+ +-.+=|++..+++++..|+
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~P~--------------~~~ee~f----------L~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVDPL--------------PVSEAEF----------LTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBSCC--------------CCCHHHH----------HHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCCCCC--------------CCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 999999999999887764321110 0112222 2366789999999988774
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.91 E-value=0.76 Score=41.57 Aligned_cols=115 Identities=11% Similarity=0.052 Sum_probs=78.2
Q ss_pred CCCCceeeEEEEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeeeccCCcc
Q 012761 138 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE-YLHDKANPPVIYRDFKSS 216 (457)
Q Consensus 138 ~hpniv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~-yLH~~~~~~iiHrDLkp~ 216 (457)
.||++ -...-.+.+.+.|.++.-+++.-...+. .++...+++++.+|+.... +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 58888 4444577788888888664443333443 3678899999999887766 5543 477789999
Q ss_pred CeEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCC
Q 012761 217 NILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 290 (457)
Q Consensus 217 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~ 290 (457)
||+++.++.++|.-.|+-...+ |.=+.+|.+ +-.+=|++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~lp--------------P~e~~ee~f----------l~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESLP--------------PDEWDDERL----------LREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTTBS--------------SCSCCHHHH----------HHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcccCC--------------CCCCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 9999999999999887643211 101122222 2266788889999887764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.00 E-value=0.13 Score=52.34 Aligned_cols=61 Identities=5% Similarity=0.035 Sum_probs=17.8
Q ss_pred ccceeeecCcEEEEEEEECCCCeEEEE------EEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEe
Q 012761 87 PESFIGEGGFGRVYKGWLESTGQVVAV------KQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCA 150 (457)
Q Consensus 87 ~~~~lG~G~~g~Vy~~~~~~~~~~vav------K~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 150 (457)
+.+.|| ||.||+|.+.....+||| |....... .....+..|..++..++|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 445666 999999998765568888 66553222 12245788889999999999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 457 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-47 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-44 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (578), Expect = 5e-72
Identities = 79/285 (27%), Positives = 125/285 (43%), Gaps = 27/285 (9%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSN 141
IG G FG VYKG VAVK L+ Q + F EV +L H N
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
++ +GY Q +V ++ SL HLH + + + + IA A+G++YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLH 121
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
K +I+RD KS+NI L E K+ DFGLA + SH ++ G+ + APE
Sbjct: 122 AK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 262 MT---GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318
+ +SDVY+FG+V EL+TG+ + + + L D K
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363
++ + + C++++ RPL ++ ++ LA
Sbjct: 239 PKAMK------------RLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-65
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 11/218 (5%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSNL 142
+F S +G G G V+K + +G V+A K + R + E+ +L + +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 143 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
V G + + E M GSL+ L + K++ KGL YL +
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM 262
K +++RD K SNIL+ KL DFG++ ++ +GT Y +PE
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQ 176
Query: 263 TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNL 300
+V+SD++S G+ +E+ GR I + +
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (532), Expect = 6e-65
Identities = 77/316 (24%), Positives = 123/316 (38%), Gaps = 41/316 (12%)
Query: 72 TFTFRELAAATKNFRPE---------SFIGEGGFGRVYKGWLESTGQ---VVAVKQLDRN 119
FTF + A + F E IG G FG V G L+ G+ VA+K L
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 120 GLQGN-REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 178
+ R+FL E ++ H N+++L G +++ EFM GSL+ L
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125
Query: 179 EALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238
+ + G A G++YL + ++RD + NIL+ K+SDFGL++
Sbjct: 126 ---TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 239 VGDKSHVSTRV---MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPH 295
T + APE + T SDV+S+G+V E+++ + RP+
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPY 234
Query: 296 GEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDV 355
+ + D R P+ + C Q+ RP G +
Sbjct: 235 WDMTNQDVINAIEQDYRL-----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 356 VTALSYLANQTYDPNS 371
V L + +PNS
Sbjct: 284 VNTLDKMIR---NPNS 296
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 3e-64
Identities = 72/279 (25%), Positives = 121/279 (43%), Gaps = 29/279 (10%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 142
+ + +G G FG V+ G+ VAVK L + G FL E ++ L H L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 143 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
V L + ++ E+M GSL D L P L N + +AA A+G+ ++ +
Sbjct: 71 VRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM 262
+ I+RD +++NIL+ + K++DFGLA+L ++ + APE
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAIN 183
Query: 263 TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE--QNLVTWARPLFNDRRKFSKLADP 320
G T+KSDV+SFG++ E++T + + E QNL R + D +
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--NCPE---- 237
Query: 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359
+ + +C +E+ RP + + L
Sbjct: 238 ------------ELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 1e-63
Identities = 74/281 (26%), Positives = 116/281 (41%), Gaps = 25/281 (8%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 142
IG G FG V+ G+ VA+K + R G +F+ E ++ L H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 143 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
V L G C + LV+EFM G L D+L T + + +G+ YL +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF---AAETLLGMCLDVCEGMAYLEE 119
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM 262
VI+RD + N L+ E K+SDFG+ + D+ ST + +PE
Sbjct: 120 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFS 175
Query: 263 TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322
+ + KSDV+SFGV+ E+ + K R + E + D +L PRL
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL 226
Query: 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363
+ + C +E+ RP ++ L+ +A
Sbjct: 227 AST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 9e-63
Identities = 60/279 (21%), Positives = 112/279 (40%), Gaps = 25/279 (8%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSN 141
++ IG G +GR K +S G+++ K+LD + + + EV +L L H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 142 LVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEY 199
+V D L V E+ G L + +++ LD +++ L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 200 LHDK--ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCA 257
H + V++RD K +N+ L+ + KL DFGLA++ + + + +GT Y +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMS 182
Query: 258 PEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317
PE KSD++S G + EL P + A + +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKIREGKF----- 231
Query: 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVV 356
R+ RY + + + + + RP + +++
Sbjct: 232 --RRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-62
Identities = 69/297 (23%), Positives = 115/297 (38%), Gaps = 31/297 (10%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCA 150
IG+G FG V++G G+ VAVK + + E+ +L H N++ I
Sbjct: 11 IGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 151 DGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA-- 204
+ Q LV ++ GSL D+L+ + + +K+A A GL +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 205 ---NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK--SHVSTRVMGTYGYCAPE 259
P + +RD KS NIL+++ ++D GLA +GT Y APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 260 YAMT------GQLTVKSDVYSFGVVFLELITGRKAIDST----RPHGEQNLVTWARPLFN 309
+ ++D+Y+ G+VF E+ P+ + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 310 DRRKFSKLADPRLEGRYPIRGLYQALA-VASMCIQEQAATRPLIGDVVTALSYLANQ 365
KL P + R+ + +A + C A R + LS L+ Q
Sbjct: 243 KVVCEQKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 202 bits (514), Expect = 2e-62
Identities = 68/296 (22%), Positives = 122/296 (41%), Gaps = 23/296 (7%)
Query: 71 QTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVE 130
+ + + + + +G G +G VY+G + VAVK L + ++ EFL E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKE 63
Query: 131 VLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 190
++ + H NLV L+G C ++ EFM G+L D+L + + + + +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMA 121
Query: 191 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 250
+ +EYL K I+RD + N L+ E K++DFGL++L GD
Sbjct: 122 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 177
Query: 251 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND 310
+ APE + ++KSDV++FGV+ E+ T + D
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------ID 221
Query: 311 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366
+ +L + P + + C Q + RP ++ A + ++
Sbjct: 222 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 3e-62
Identities = 61/277 (22%), Positives = 107/277 (38%), Gaps = 25/277 (9%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 142
K+ +G G FG V G VA+K + EF+ E ++ L H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKL 61
Query: 143 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
V L G C ++ E+M G L ++L + +++ + +EYL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM 262
K ++RD + N L+ + K+SDFGL++ D+ S + PE M
Sbjct: 119 K---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLM 174
Query: 263 TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322
+ + KSD+++FGV+ E+ + K + E + +L P L
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---------TAEHIAQGLRLYRPHL 225
Query: 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359
+ + C E+A RP +++ +
Sbjct: 226 ASE-------KVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-61
Identities = 68/277 (24%), Positives = 109/277 (39%), Gaps = 32/277 (11%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLHH 139
++F +G+G FG VY + + ++A+K L + L+ + EV + S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEY 199
N++ L GY D + L+ E+ PLG++ L L D A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121
Query: 200 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE 259
H K VI+RD K N+LL K++DFG + P S T + GT Y PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPE 174
Query: 260 YAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319
K D++S GV+ E + G+ P + + F
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYKRISRVEFTFPDFVT 228
Query: 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVV 356
A + S ++ + RP++ +V+
Sbjct: 229 E------------GARDLISRLLKHNPSQRPMLREVL 253
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-61
Identities = 63/276 (22%), Positives = 110/276 (39%), Gaps = 26/276 (9%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHSN 141
+++ +GEG +G V T + VAVK +D E E+ + +L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
+V G+ +G+ + L E+ G L D + + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
+ +RD K N+LL+E + K+SDFGLA + ++ + ++ GT Y APE
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 262 MTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-NLVTWARPLFNDRRKFSKLAD 319
+ DV+S G+V ++ G D ++ + + N +K
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS--- 234
Query: 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDV 355
LA+ + E + R I D+
Sbjct: 235 -------------APLALLHKILVENPSARITIPDI 257
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 3e-61
Identities = 72/284 (25%), Positives = 113/284 (39%), Gaps = 31/284 (10%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 142
K + IG+G FG V G G VAVK + + + FL E +++ L HSNL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNL 62
Query: 143 VNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
V L+G + L +V E+M GSL D+L + L + +K + + +EYL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
++RD + N+L+ E K+SDFGL K + S + APE
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL 172
Query: 262 MTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321
+ + KSDV+SFG++ E+ + + P+ L + +
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVVPRVEKGYK-------MD 220
Query: 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365
P V C AA RP + L ++
Sbjct: 221 APDGCPP----AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 6e-61
Identities = 72/304 (23%), Positives = 112/304 (36%), Gaps = 39/304 (12%)
Query: 84 NFRPESFIGEGGFGRVYKGWL-----ESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLS-L 136
+G G FG+V + VAVK L + RE + E+ +LS L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 137 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD--------------LPPDKEALD 182
+H N+VNL+G C G L++ E+ G L + L + D+ ALD
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 183 WNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242
+ + AKG+ +L K I+RD + NILL G K+ DFGLA+
Sbjct: 144 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVT 302
V + APE T +SDV+S+G+ EL + + P +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---- 256
Query: 303 WARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362
F K+ P + + C RP +V +
Sbjct: 257 -----------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
Query: 363 ANQT 366
+++
Sbjct: 306 ISES 309
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-60
Identities = 76/287 (26%), Positives = 120/287 (41%), Gaps = 29/287 (10%)
Query: 91 IGEGGFGRVYKGWL---ESTGQVVAVKQLDRNGLQGN-REFLVEVLMLSLLHHSNLVNLI 146
IG G FG VY G L + AVK L+R G +FL E +++ H N+++L+
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 147 GYCADGDQR-LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
G C + L+V +M G L + + + + AKG+++L +
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLA---S 148
Query: 206 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKSHVSTRVMGTYGYCAPEYAMT 263
++RD + N +L+E F K++DFGLA+ D H T + A E T
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 264 GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLE 323
+ T KSDV+SFGV+ EL+T P+ + N L RR L P
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQGRR----LLQPEYC 259
Query: 324 GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPN 370
V C +A RP ++V+ +S + + +
Sbjct: 260 PD-------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-60
Identities = 70/302 (23%), Positives = 110/302 (36%), Gaps = 44/302 (14%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQ-----VVAVKQLDRNGLQGNRE-FLVEV-LMLSL 136
N +G G FG+V + VAVK L RE + E+ +M L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 137 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH-------------------DLPPD 177
H N+VNL+G C L++E+ G L ++L + D
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 178 KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237
L + + A AKG+E+L K ++RD + N+L+ G K+ DFGLA+
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE 297
V + APE G T+KSDV+S+G++ E+ + P
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 298 QNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357
F KL + P + + C + RP ++ +
Sbjct: 275 N---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 358 AL 359
L
Sbjct: 320 FL 321
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 3e-60
Identities = 59/249 (23%), Positives = 103/249 (41%), Gaps = 20/249 (8%)
Query: 82 TKNFRPESF------IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLS 135
T++ PE F +G+G FG+VYK + T + A K +D + +++VE+ +L+
Sbjct: 5 TRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILA 64
Query: 136 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK 195
H N+V L+ + ++ EF G+++ + +L + L + +
Sbjct: 65 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLD 121
Query: 196 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY 255
L YLHD +I+RD K+ NIL KL+DFG++ +GT +
Sbjct: 122 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYW 176
Query: 256 CAPEYAMTGQL-----TVKSDVYSFGVVFLELITGRKAIDSTRPHGE-QNLVTWARPLFN 309
APE M K+DV+S G+ +E+ P + P
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236
Query: 310 DRRKFSKLA 318
++S
Sbjct: 237 QPSRWSSNF 245
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (498), Expect = 6e-60
Identities = 66/305 (21%), Positives = 107/305 (35%), Gaps = 45/305 (14%)
Query: 84 NFRPESFIGEGGFGRVYKGWL-----ESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSLL 137
N IGEG FGRV++ +VAVK L + +F E +++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 138 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD--------------------LPPD 177
+ N+V L+G CA G L++E+M G L + L P
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 178 KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237
L ++ IA A G+ YL ++RD + N L+ E K++DFGL++
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE 297
D + PE + T +SDV+++GVV E+ + H E
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 298 QNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357
+ + L + +C + A RP +
Sbjct: 251 ----VIYYVRDGNILACPENCPLEL------------YNLMRLCWSKLPADRPSFCSIHR 294
Query: 358 ALSYL 362
L +
Sbjct: 295 ILQRM 299
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 6e-60
Identities = 66/281 (23%), Positives = 108/281 (38%), Gaps = 32/281 (11%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHS 140
+ + + IG G F VYKG T VA +L L + + F E ML L H
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 141 NLVNLIGYCADGDQR----LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 196
N+V + +LV E M G+L+ +L + KG
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKG 124
Query: 197 LEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY 255
L++LH + PP+I+RD K NI + K+ D GLA L ++ + V+GT +
Sbjct: 125 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEF 179
Query: 256 CAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315
APE + DVY+FG+ LE+ T + + +
Sbjct: 180 MAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------YR 223
Query: 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVV 356
++ + + + + CI++ R I D++
Sbjct: 224 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 4e-59
Identities = 71/299 (23%), Positives = 121/299 (40%), Gaps = 38/299 (12%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTG--QVVAVKQLDRNGL-QGNREFLVEV-LMLSLLH 138
+ + + IGEG FG+V K ++ G A+K++ +R+F E+ ++ L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 139 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD------------LPPDKEALDWNTR 186
H N++NL+G C L E+ P G+L D L L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 187 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 246
+ AA A+G++YL K I+RD + NIL+ E + K++DFGL++ V K
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---K 183
Query: 247 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP 306
T + A E T SDV+S+GV+ E+++ P+
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCAELYEK 238
Query: 307 LFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365
L R P+ + + C +E+ RP ++ +L+ + +
Sbjct: 239 LPQGYR-----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 8e-59
Identities = 66/290 (22%), Positives = 113/290 (38%), Gaps = 30/290 (10%)
Query: 76 RELAAATKNFRPESF-IGEGGFGRVYKGWLEST--GQVVAVKQLDRNGLQGNRE-FLVEV 131
++L N +G G FG V +G VA+K L + + + E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 132 LMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 191
++ L + +V LIG C + +LV E G L L +E + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 192 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVM 250
+ G++YL +K ++RD + N+LL + K+SDFGL+K LG +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 251 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRP-HGEQNLVTWARPLFN 309
+ APE + + +SDV+S+GV E ++ + +P + A
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMAFIEQG 228
Query: 310 DRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359
R + P L A+ S C + RP V +
Sbjct: 229 KRMECPPECPPELY------------ALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-58
Identities = 72/292 (24%), Positives = 121/292 (41%), Gaps = 33/292 (11%)
Query: 82 TKNFRPESF-----IGEGGFGRVYKGWLESTGQ----VVAVKQLDRNGLQGNR-EFLVEV 131
T P IG G FG VYKG L+++ VA+K L + R +FL E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 132 LMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 191
++ H N++ L G + +++ E+M G+L+ L + + +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLR 117
Query: 192 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVM 250
G A G++YL N ++RD + NIL+ K+SDFGL++ L + ++ ++
Sbjct: 118 GIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 251 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND 310
+ APE + T SDV+SFG+V E++T + + E
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------------- 221
Query: 311 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362
K + P+ + C Q++ A RP D+V+ L L
Sbjct: 222 ---VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 4e-58
Identities = 63/238 (26%), Positives = 104/238 (43%), Gaps = 11/238 (4%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSN 141
K + IG+G G VY +TGQ VA++Q++ + E+L++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
+VN + GD+ +V E++ GSL D + + D + + LE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-----DEGQIAAVCRECLQALEFLH 133
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
VI+RD KS NILL KL+DFG + + + ++GT + APE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEVV 188
Query: 262 MTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE-QNLVTWARPLFNDRRKFSKLA 318
K D++S G++ +E+I G + P + T P + K S +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-57
Identities = 65/274 (23%), Positives = 107/274 (39%), Gaps = 29/274 (10%)
Query: 91 IGEGGFGRVYKGWLE--STGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSNLVNLI 146
+G G FG V KG+ + + VAVK L E L E ++ L + +V +I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 147 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 206
G C + + +LV E LG L +L + +++ + G++YL +
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES--- 126
Query: 207 PVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 265
++RD + N+LL + K+SDFGL+K L + T + APE +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 266 LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGR 325
+ KSDV+SFGV+ E + + +P+ L R
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSEVTAMLEKGER-------MGCPAG 234
Query: 326 YPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359
P + + ++C RP V L
Sbjct: 235 CPR----EMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (481), Expect = 3e-57
Identities = 69/281 (24%), Positives = 105/281 (37%), Gaps = 35/281 (12%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLH 138
K F IG G FG VY +VVA+K++ +G Q N ++ + EV L L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 139 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 198
H N + G LV E+ + + K+ L + GA +GL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLA 129
Query: 199 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAP 258
YLH +I+RD K+ NILL E KL DFG A + + +GT + AP
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVGTPYWMAP 180
Query: 259 EYAMT---GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315
E + GQ K DV+S G+ +EL + + + + +S
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240
Query: 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVV 356
+ C+Q+ RP ++
Sbjct: 241 E----------------YFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-56
Identities = 73/277 (26%), Positives = 116/277 (41%), Gaps = 25/277 (9%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL 142
++ R E +G+G FG V+ G T +V A+K L + G FL E ++ L H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 143 VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 202
V L + +V E+M GSL D L + L + +AA A G+ Y+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 203 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM 262
++RD +++NIL+ E K++DFGLA+L ++ + APE A+
Sbjct: 132 M---NYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAAL 187
Query: 263 TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322
G+ T+KSDV+SFG++ EL T + G N + R L
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLDQVERGYRMPCPPECPESL 243
Query: 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359
+ C +++ RP + L
Sbjct: 244 ------------HDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-55
Identities = 69/286 (24%), Positives = 124/286 (43%), Gaps = 28/286 (9%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQV----VAVKQLDR-NGLQGNREFLVEVLMLSLLHH 139
F+ +G G FG VYKG G+ VA+K+L + N+E L E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEY 199
++ L+G C +L + + MP G L D++ + K+ + + AKG+ Y
Sbjct: 71 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNY 126
Query: 200 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE 259
L D+ +++RD + N+L++ H K++DFGLAKL +K + + + A E
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 260 YAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319
+ T +SDV+S+GV EL+T +P+ + S + +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGS-----KPYDG-----------IPASEISSILE 227
Query: 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365
P + C A +RP +++ S +A
Sbjct: 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-54
Identities = 73/284 (25%), Positives = 110/284 (38%), Gaps = 29/284 (10%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLEST---GQVVAVKQLDRNGL---QGNREFLVEVLMLSL 136
K+ R +G+G FG V +G ++ VAVK L + L + +F+ EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 137 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 196
L H NL+ L G ++ V E PLGSL D L + T + A A+G
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEG 123
Query: 197 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV-STRVMGTYGY 255
+ YL K I+RD + N+LL K+ DFGL + P D +V + +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 256 CAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315
CAPE T + SD + FGV E+ T + P N + + +
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERLP 235
Query: 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359
+ D + V C + RP + L
Sbjct: 236 RPEDCPQD----------IYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-54
Identities = 56/242 (23%), Positives = 92/242 (38%), Gaps = 16/242 (6%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLHHS 140
+F+ +GEG F V +T + A+K L++ + E ++S L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 141 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 200
V L D ++ + G L ++ + D A LEYL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYL 124
Query: 201 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEY 260
H +I+RD K NILL E H +++DFG AK+ K + +GT Y +PE
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 261 AMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320
SD+++ G + +L+ G P N + + F + P
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQKIIKLEYDFPEKFFP 235
Query: 321 RL 322
+
Sbjct: 236 KA 237
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 8e-54
Identities = 69/299 (23%), Positives = 115/299 (38%), Gaps = 38/299 (12%)
Query: 84 NFRPESFIGEGGFGRVYKGWL-----ESTGQVVAVKQLDRNGLQG-NREFLVEV-LMLSL 136
+ +G G FG+V + +T + VAVK L +R + E+ +++ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 137 LHHSNLVNLIGYCA-DGDQRLLVYEFMPLGSLEDHLHD------------LPPDKEALDW 183
HH N+VNL+G C G +++ EF G+L +L K+ L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 184 NTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS 243
+ + AKG+E+L + I+RD + NILL E K+ DFGLA+
Sbjct: 134 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 244 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTW 303
+ APE T++SDV+SFGV+ E+ + P+ +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEE 245
Query: 304 ARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362
+ + R P + C + + RP ++V L L
Sbjct: 246 FCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 8e-53
Identities = 63/289 (21%), Positives = 115/289 (39%), Gaps = 31/289 (10%)
Query: 83 KNFRPESFIGEGGFGRVYKGWL-----ESTGQVVAVKQLDRNGLQGNR-EFLVEVLMLSL 136
+ +G+G FG VY+G + VA+K ++ R EFL E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 137 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA------LDWNTRMKIA 190
+ ++V L+G + G L++ E M G L+ +L L P + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 191 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 250
A G+ YL+ ++RD + N ++ E F K+ DFG+ + D + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 251 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND 310
+ +PE G T SDV+SFGVV E+ T + ++
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---------------QPYQGLSN 241
Query: 311 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 359
+ + + L P + MC Q RP ++++++
Sbjct: 242 EQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-52
Identities = 68/286 (23%), Positives = 109/286 (38%), Gaps = 28/286 (9%)
Query: 84 NFRPESFIGEGGFGRVYKGWL---ESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHH 139
IGEG FG V++G E+ VA+K RE FL E L + H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEY 199
++V LIG + + ++ E LG L L K +LD + + A + L Y
Sbjct: 68 PHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAY 123
Query: 200 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE 259
L K ++RD + N+L+ KL DFGL++ + +++ + APE
Sbjct: 124 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 179
Query: 260 YAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319
+ T SDV+ FGV E++ G +N R +R
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV----KPFQGVKNNDVIGRIENGERLPMPPNCP 235
Query: 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365
P L ++ + C + RP ++ LS + +
Sbjct: 236 PTLY------------SLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 173 bits (439), Expect = 1e-50
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 11/205 (5%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 143
++ +G G FG V++ +TG A K + E+ +S+L H LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
NL D ++ +++YEFM G L + + D + + + ++ KGL ++H+
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 204 ANPPVIYRDFKSSNILL--EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
++ D K NI+ + KL DFGL D GT + APE A
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVA 197
Query: 262 MTGQLTVKSDVYSFGVVFLELITGR 286
+ +D++S GV+ L++G
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-50
Identities = 70/304 (23%), Positives = 114/304 (37%), Gaps = 40/304 (13%)
Query: 84 NFRPESFIGEGGFGRVYKGWLEST-------GQVVAVKQLDRNGLQGN-REFLVEV-LML 134
+GEG FG+V VAVK L + + + + + E+ +M
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 135 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEALD 182
+ H N++NL+G C ++ E+ G+L ++L P +E L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 183 WNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242
+ A A+G+EYL K I+RD + N+L+ E K++DFGLA+ D
Sbjct: 134 SKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVT 302
+T + APE T +SDV+SFGV+ E+ T P+ +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG-----SPYPGVPVEE 245
Query: 303 WARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362
+ L R P + + C + RP +V L +
Sbjct: 246 LFKLLKEGHR-----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
Query: 363 ANQT 366
T
Sbjct: 295 VALT 298
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 172 bits (436), Expect = 5e-50
Identities = 67/225 (29%), Positives = 99/225 (44%), Gaps = 18/225 (8%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLVEVLMLSLLH-- 138
+F IG GGFG VY TG++ A+K LD+ + QG L E +MLSL+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 139 -HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGL 197
+V + D+ + + M G L HL EA AA GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYAAEIILGL 120
Query: 198 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCA 257
E++H++ V+YRD K +NILL+E H ++SD GLA +GT+GY A
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 258 PEYAMTGQ-LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV 301
PE G +D +S G + +L+ G + + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 170 bits (432), Expect = 1e-49
Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 11/205 (5%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 143
+ +G G FG V++ ++TG+V K ++ E+ +++ LHH L+
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
NL D + +L+ EF+ G L D + + + + A +GL+++H+
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 204 ANPPVIYRDFKSSNILLE--EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
+++ D K NI+ E + K+ DFGLA + + T + APE
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIV 200
Query: 262 MTGQLTVKSDVYSFGVVFLELITGR 286
+ +D+++ GV+ L++G
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 2e-49
Identities = 52/242 (21%), Positives = 89/242 (36%), Gaps = 14/242 (5%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHS 140
+ +G G F V + T ++VA+K + + L+G E+ +L + H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 141 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 200
N+V L G L+ + + G L D + +K ++ ++YL
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYL 123
Query: 201 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEY 260
HD + L+E +SDFGL+K+ D V + GT GY APE
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEV 180
Query: 261 AMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320
+ D +S GV+ L+ G P ++N + +F
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKAEYEFDSPYWD 234
Query: 321 RL 322
+
Sbjct: 235 DI 236
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-49
Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 13/231 (5%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSL-LHH 139
+F +G+G FG+V+ + T Q A+K L ++ + + + +VE +LSL H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEY 199
L ++ + V E++ G L H+ D + AA GL++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQF 118
Query: 200 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE 259
LH K ++YRD K NILL++ H K++DFG+ K +GD GT Y APE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPE 173
Query: 260 YAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND 310
+ + D +SFGV+ E++ G+ + + P +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR 224
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 165 bits (418), Expect = 2e-48
Identities = 61/277 (22%), Positives = 105/277 (37%), Gaps = 29/277 (10%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLH 138
+ + +G GG V+ + VAVK L + + F E + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 139 HSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAA 194
H +V + G +V E++ +L D +H P + +++ A A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 121
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVMGTY 253
+ L + H +I+RD K +NI++ K+ DFG+A+ + G+ + V+GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 254 GYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRK 313
Y +PE A + +SDVYS G V E++TG P + V+ A +
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVREDPI 232
Query: 314 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP 350
L AV + + R
Sbjct: 233 PPSARHEGLSA--------DLDAVVLKALAKNPENRY 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 164 bits (415), Expect = 5e-48
Identities = 62/288 (21%), Positives = 102/288 (35%), Gaps = 40/288 (13%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---------QGNREFLVEV-LM 133
N+ P+ +G G V + + T + AVK +D G + L EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 134 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 193
+ H N++ L LV++ M G L D+L +K L KI
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRAL 119
Query: 194 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 253
+ + LH +++RD K NILL++ + KL+DFG + D V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTP 173
Query: 254 GYCAPEYAMTGQL------TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL 307
Y APE + D++S GV+ L+ G P + + R +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQMLMLRMI 227
Query: 308 FNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDV 355
+ +F + S + Q R +
Sbjct: 228 MSGNYQFGSPEWDDYSD--------TVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 164 bits (415), Expect = 2e-47
Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 15/232 (6%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHH 139
++F+ +G G FGRV+ G+ A+K L + + ++ E LMLS++ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEY 199
++ + G D Q ++ +++ L L + AA LEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIE----GGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 200 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE 259
LH K +IYRD K NILL++ H K++DFG AK P V+ + GT Y APE
Sbjct: 120 LHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPE 171
Query: 260 YAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 311
T D +SFG++ E++ G + + A F
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF 223
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-47
Identities = 39/230 (16%), Positives = 90/230 (39%), Gaps = 12/230 (5%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 143
+ +G G FG V++ S+ + K + G E+ +L++ H N++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNIL 64
Query: 144 NLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
+L ++ ++++EF+ + + ++ L+ + + L++LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 204 ANPPVIYRDFKSSNILL--EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
+ + D + NI+ K+ +FG A+ GD + + Y APE
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVH 175
Query: 262 MTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 311
++ +D++S G + L++G + + A F++
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE 225
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 3e-46
Identities = 68/258 (26%), Positives = 108/258 (41%), Gaps = 17/258 (6%)
Query: 90 FIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG-----NREFLVEVLMLSLLHHSNLVN 144
F+GEG F VYK ++T Q+VA+K++ NR L E+ +L L H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 145 LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 204
L+ LV++FM D + + L + +GLEYLH
Sbjct: 65 LLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG 264
+++RD K +N+LL+E KL+DFGLAK G + T + T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 265 QL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV--TWARPLFNDRRKFSKLADPR 321
++ V D+++ G + EL+ + + + T P L D
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 322 LEGRYPIRGLYQALAVAS 339
+P L+ + A
Sbjct: 236 TFKSFPGIPLHHIFSAAG 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-44
Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 7/208 (3%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE-FLVEVLMLSLLHHS 140
+ S+IGEG +G V + VA+K++ Q + L E+ +L H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 141 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 200
N++ + + ++ + L+ L + L + +GL+Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKL-LKTQHLSNDHICYFLYQILRGLKYI 125
Query: 201 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVMGTYGYCAPE 259
H V++RD K SN+LL K+ DFGLA+ P D + T + T Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 260 YAMTGQLTVKS-DVYSFGVVFLELITGR 286
+ + KS D++S G + E+++ R
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-44
Identities = 52/210 (24%), Positives = 86/210 (40%), Gaps = 17/210 (8%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV 143
++ IG G FG VY+ L +G++VA+K++ ++ NR E+ ++ L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 144 NLIGYCADGDQR------LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGL 197
L + ++ LV +++P H K+ L + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 198 EYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 256
Y+H + +RD K N+LL + KL DFG AK + + + Y
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRYYRA 190
Query: 257 APEYAMTGQLTVKSDVYSFGVVFLELITGR 286
T DV+S G V EL+ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 6e-44
Identities = 55/237 (23%), Positives = 91/237 (38%), Gaps = 20/237 (8%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNR------EFLVEVLMLSLLH 138
+ +G G F V K +STG A K + + + +R + EV +L +
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 139 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 198
H N++ L + +L+ E + L D +KE+L + G+
Sbjct: 72 HPNVITLHEVYENKTDVILILELVA----GGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 199 YLHDKANPPVIYRDFKSSNILL----EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 254
YLH + + D K NI+L K+ DFGLA D + + GT
Sbjct: 128 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 181
Query: 255 YCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 311
+ APE L +++D++S GV+ L++G V+ F D
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE 238
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (383), Expect = 3e-43
Identities = 52/305 (17%), Positives = 97/305 (31%), Gaps = 39/305 (12%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLL-HHSN 141
+++ IGEG FG +++G Q VA+K R + E LL +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
+ N+ + +G +LV + + L T A ++ +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLG----PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 202 DKANPPVIYRDFKSSNILLEEGFHP-----KLSDFGLAKLGPVGDKS-----HVSTRVMG 251
+K ++YRD K N L+ + DFG+ K + G
Sbjct: 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 252 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 311
T Y + + + + + D+ + G VF+ + G + + +R
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY--------ER 227
Query: 312 RKFSKLADPRLEGRYPI-RGLYQALAVASMCIQEQAATRP-------LIGDVVTALSYLA 363
K + P E Y+ P L V+ L+
Sbjct: 228 IGEKKQSTPLRELCAGFPEEFYK---YMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284
Query: 364 NQTYD 368
++ +D
Sbjct: 285 DENFD 289
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 5e-43
Identities = 54/237 (22%), Positives = 93/237 (39%), Gaps = 26/237 (10%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE------FLVEVLMLSLLH 138
++ +G GGFG VY G S VA+K ++++ + E +EV++L +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 139 --HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 196
S ++ L+ + D +L+ E L D ++ AL +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEA 122
Query: 197 LEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY 255
+ + H+ V++RD K NIL+ KL DFG L K V T GT Y
Sbjct: 123 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVY 175
Query: 256 CAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 311
PE+ + + V+S G++ +++ G P + + F R
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------IPFEHDEEIIRGQVFFRQR 226
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-42
Identities = 54/246 (21%), Positives = 99/246 (40%), Gaps = 9/246 (3%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSN 141
NF+ IGEG +G VYK + TG+VVA+K++ + + E+ +L L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
+V L+ ++ LV+EF+ + + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
V++RD K N+L+ KL+DFGLA+ V + + V+ +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILL 175
Query: 262 MTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321
+ D++S G +F E++T R + + ++ + P
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 322 LEGRYP 327
+ +P
Sbjct: 236 YKPSFP 241
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-42
Identities = 62/293 (21%), Positives = 110/293 (37%), Gaps = 25/293 (8%)
Query: 81 ATKNFRPESFIGEGGFGRVYKGW-LESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLL 137
A + + + IGEG +G+V+K L++ G+ VA+K++ + + EV +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 138 ---HHSNLVNLIGYCADGDQRLLVYEFMPLGSL--EDHLHDLPPDKEALDWNTRMKIAAG 192
H N+V L C + + + + + + T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 193 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 252
+GL++LH V++RD K NIL+ KL+DFGLA++ T V+ T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 253 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPH----------GEQNLVT 302
Y APE + D++S G +F E+ + + G
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 303 WARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDV 355
W R + R+ F + +E ++ + C+ A R
Sbjct: 239 WPRDVALPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-42
Identities = 62/243 (25%), Positives = 92/243 (37%), Gaps = 18/243 (7%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHH 139
+F +G+G FG+V ++TG+ A+K L + + E + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEY 199
L L D+ V E+ G L HL A LEY
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEY 120
Query: 200 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE 259
LH + V+YRD K N++L++ H K++DFGL K G GT Y APE
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKTFCGTPEYLAPE 175
Query: 260 YAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319
D + GVV E++ GR P Q+ + + +F +
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILMEEIRFPRTLS 229
Query: 320 PRL 322
P
Sbjct: 230 PEA 232
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (375), Expect = 6e-42
Identities = 53/275 (19%), Positives = 95/275 (34%), Gaps = 28/275 (10%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVN 144
+R IG G FG +Y G + G+ VA+K + + +E + ++ +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIP 66
Query: 145 LIGYC-ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 203
I +C A+GD ++V E + + T + +A +EY+H K
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIHSK 122
Query: 204 ANPPVIYRDFKSSNIL---LEEGFHPKLSDFGLAKL-----GPVGDKSHVSTRVMGTYGY 255
I+RD K N L ++G + DFGLAK + + GT Y
Sbjct: 123 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 256 CAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 315
+ + + + + D+ S G V + G + ++ K
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY------ERISEKKM 233
Query: 316 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP 350
L YP + + C + +P
Sbjct: 234 STPIEVLCKGYPS----EFATYLNFCRSLRFDDKP 264
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-41
Identities = 46/204 (22%), Positives = 75/204 (36%), Gaps = 21/204 (10%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEV-LMLSLLHHSNLVNLIGYC 149
+G G G+V + + + T + A+K L + EV L ++V ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 150 ----ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 205
A L+V E + G L + D +I + ++YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYLHSIN- 131
Query: 206 PPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM 262
+ +RD K N+L KL+DFG AK + T Y APE
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLG 186
Query: 263 TGQLTVKSDVYSFGVVFLELITGR 286
+ D++S GV+ L+ G
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGY 210
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 144 bits (364), Expect = 1e-40
Identities = 48/248 (19%), Positives = 99/248 (39%), Gaps = 11/248 (4%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQL--DRNGLQGNREFLVEVLMLSLLHHSN 141
+ IGEG +G VYK + G+ A+K++ ++ + E+ +L L HSN
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 142 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 201
+V L + +LV+E + + + L+ T G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCH 117
Query: 202 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 261
D+ V++RD K N+L+ K++DFGLA+ + + + ++ +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLM 173
Query: 262 MTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321
+ + + D++S G +F E++ G + + N + + P+
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 322 LEGRYPIR 329
+ + +
Sbjct: 234 YDPNFTVY 241
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 2e-40
Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 20/216 (9%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHSN 141
+ + IG+G FG V+K TGQ VA+K++ + L E+ +L LL H N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 142 LVNLIGYCADGDQR--------LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 193
+VNLI C LV++F + L + ++
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQML 126
Query: 194 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS--TRVMG 251
GL Y+H +++RD K++N+L+ KL+DFGLA+ + S + T +
Sbjct: 127 LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 252 TYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 286
T Y PE + + D++ G + E+ T
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (357), Expect = 2e-39
Identities = 54/266 (20%), Positives = 98/266 (36%), Gaps = 10/266 (3%)
Query: 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHHS 140
+ + IGEG +G V+K T ++VA+K++ + L E+ +L L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 141 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 200
N+V L + LV+EF +D LD KGL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 201 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEY 260
H + V++RD K N+L+ KL++FGLA+ + + + S V+ +
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVL 173
Query: 261 AMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320
+ D++S G +F EL + + +Q + ++ +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 321 RLEGRYPIRGLYQALAVASMCIQEQA 346
YP+ +L +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATG 259
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-38
Identities = 48/220 (21%), Positives = 83/220 (37%), Gaps = 13/220 (5%)
Query: 73 FTFRELAAAT----KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN--RE 126
F +E+ +R +G G +G V TG VA+K+L R +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 127 FLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTR 186
E+ +L + H N++ L+ + +F + E L +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 187 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 246
+ KGL Y+H +RD K N+ + E K+ DFGLA+ S ++
Sbjct: 124 QFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA----DSEMT 176
Query: 247 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
V+ + + T D++S G + E+ITG+
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 5e-38
Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 15/231 (6%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNRE---FLVEVLMLSLLHHS 140
F +G G FGRV + +G A+K LD+ + ++ L E +L ++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 141 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 200
LV L D +V E++ G + HL + AA EYL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYL 157
Query: 201 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEY 260
H +IYRD K N+L+++ + +++DFG AK + + GT APE
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209
Query: 261 AMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 311
++ D ++ GV+ E+ G + +P + + F
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 133 bits (335), Expect = 5e-36
Identities = 40/220 (18%), Positives = 84/220 (38%), Gaps = 21/220 (9%)
Query: 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEV-LMLSLLHHSNL 142
+++ +G G + V++ + + V VK L + + E+ ++ +L N+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNI 92
Query: 143 VNLIGYCADGDQRL--LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 200
+ L D R LV+E + + L K L+Y
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT-------DYDIRFYMYEILKALDYC 145
Query: 201 HDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE 259
H +++RD K N+++ E +L D+GLA+ G + + + + PE
Sbjct: 146 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPE 199
Query: 260 YAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 298
+ Q+ D++S G + +I ++ + +Q
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-33
Identities = 57/214 (26%), Positives = 88/214 (41%), Gaps = 18/214 (8%)
Query: 83 KNFRPESFIGEGGFGRVYKGWL---ESTGQVVAVKQLDRNGL----QGNREFLVEVLMLS 135
+NF +G G +G+V+ TG++ A+K L + + + E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 136 LL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAA 194
+ LV L + L+ +++ G L HL +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIV 139
Query: 195 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 254
LE+LH +IYRD K NILL+ H L+DFGL+K V D++ + GT
Sbjct: 140 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIE 195
Query: 255 YCAPEYAMTGQ--LTVKSDVYSFGVVFLELITGR 286
Y AP+ G D +S GV+ EL+TG
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-33
Identities = 45/207 (21%), Positives = 80/207 (38%), Gaps = 9/207 (4%)
Query: 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN--REFLVEVLMLSLLHH 139
+ ++ S +G G +G V + TG VAVK+L R + E+ +L + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 140 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEY 199
N++ L+ + + L + + L + + +GL+Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 200 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE 259
+H +RD K SN+ + E K+ DFGLA+ ++ V +
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEI 189
Query: 260 YAMTGQLTVKSDVYSFGVVFLELITGR 286
D++S G + EL+TGR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 3e-33
Identities = 60/298 (20%), Positives = 113/298 (37%), Gaps = 43/298 (14%)
Query: 66 VNIAAQTFTFRELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QG 123
V + TFT K ++ IG G G V + + VA+K+L R
Sbjct: 6 VEVGDSTFTV------LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 59
Query: 124 NREFLVEVLMLSLLHHSNLVNLIGYCA------DGDQRLLVYEFMPLGSLEDHLHDLPPD 177
+ E++++ ++H N+++L+ + LV E M + +
Sbjct: 60 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---- 115
Query: 178 KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237
LD + G+++LH + +I+RD K SNI+++ K+ DFGLA+
Sbjct: 116 ---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART- 168
Query: 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR----------- 286
S + T + T Y APE + D++S G + E++ +
Sbjct: 169 --AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
Query: 287 -----KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVAS 339
+ + + P + L R +R K++ L P+L + + +
Sbjct: 227 WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 284
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (297), Expect = 2e-30
Identities = 40/215 (18%), Positives = 76/215 (35%), Gaps = 16/215 (7%)
Query: 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVN 144
+ +G G F V+ VA+K + + + E+ +L ++ ++
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTK 73
Query: 145 LIGYCADGDQRLL-VYEFMPLGSLEDHLHDLPPDKEALD-----------WNTRMKIAAG 192
A+ +LL + + + + L +I+
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 193 AAKGLEYLHDKANPPVIYRDFKSSNILLE-EGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 251
GL+Y+H + +I+ D K N+L+E L +A LG T +
Sbjct: 134 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 252 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 286
T Y +PE + +D++S + ELITG
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.5 bits (190), Expect = 3e-17
Identities = 21/159 (13%), Positives = 44/159 (27%), Gaps = 30/159 (18%)
Query: 91 IGEGGFGRVYKGWLESTGQVVAVKQLDRNGL----------QGNREFLVEVLMLSLLHHS 140
+GEG V+ + E VK G+ F V + +
Sbjct: 8 MGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 141 NLVNLIGYCA----DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 196
L L G + ++ E + L ++ +
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-----------RVENPDEVLDMILEE 115
Query: 197 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235
+ + + +++ D N+L+ E + DF +
Sbjct: 116 VAKFY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 457 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.77 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.13 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.1 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.17 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.12 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.83 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=423.86 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=207.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.++|++.+.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+++.++|||||++++++.+.+..|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 46799999999999999999999999999999999765332 33568899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 9999999999975 467999999999999999999999999 999999999999999999999999999865444
Q ss_pred CCccccccccccccccchhhhhcCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
.........+||+.|||||++.+..+ +.++|||||||++|||+||++||........ .+..+. .... ...
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~~~-----~~~~---~~~ 227 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK-----EKKT---YLN 227 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHHHH-----TTCT---TST
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHHHHh-----cCCC---CCC
Confidence 44444556789999999999988776 5789999999999999999999976443211 111110 0000 000
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
........+.+|+.+||+.||++|||+.|+++
T Consensus 228 ------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 ------PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01112346788999999999999999999854
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=420.56 Aligned_cols=250 Identities=26% Similarity=0.365 Sum_probs=210.4
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
++|++.+.||+|+||+||+|++..+|+.||||++........+.+.+|+.+++.++|||||++++++.+.+..||||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999999999999999998765556678999999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++|+|.+++.. ..+++.++..|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-- 169 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc--
Confidence 99999998865 46999999999999999999999999 999999999999999999999999999864322
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCcc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...... .......... .+.+
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~-------~~~~ 236 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNG-------TPEL 236 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHC-------SCCC
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCC-------CCCC
Confidence 22344568999999999999999999999999999999999999999654321 1111111111 0011
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..+......+.+|+.+||+.||.+|||+.|+++
T Consensus 237 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp --SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111222356889999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=415.89 Aligned_cols=261 Identities=30% Similarity=0.443 Sum_probs=204.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
.++|.+.+.||+|+||.||+|+++ ..||||+++.... ...+.|.+|+.++++++|||||++++++.+ +.++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 467999999999999999999864 3599999975432 234678999999999999999999998754 5689999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|+|.+++.. ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 83 Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp ECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred ecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999999975 2456999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCCccccccccccccccchhhhhc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMT---GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
...........||+.|||||++.+ ..|+.++|||||||+||||+||+.||....... .+.......
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~----- 225 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRG----- 225 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHT-----
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcC-----
Confidence 444444556789999999999864 358999999999999999999999997654321 111111111
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
...|.+. ..+......+.+|+.+||+.+|++|||+.+|++.|+.++.
T Consensus 226 ~~~p~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 226 YLSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp SCCCCGG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111111 0111223468899999999999999999999999998875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-54 Score=411.82 Aligned_cols=246 Identities=26% Similarity=0.398 Sum_probs=207.8
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccC---CCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN---GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|++.+.||+|+||.||+|+++.+++.||||++.+. .......+.+|+.+++.++|||||++++++.+.+..+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999998643 2233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999975 457999999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
. ......||+.|+|||++.+..|+.++|||||||+||||++|+.||...... .....+....
T Consensus 159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~-------- 220 (263)
T d2j4za1 159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVE-------- 220 (263)
T ss_dssp C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTC--------
T ss_pred C----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH------HHHHHHHcCC--------
Confidence 2 234467999999999999999999999999999999999999999754321 1111111111
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+. ++.....++.+|+.+||+.||++|||+.|+++
T Consensus 221 ~~----~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 FT----FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC----CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11 11122346889999999999999999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8e-55 Score=422.10 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=214.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|++.+.||+|+||.||+|+++.+++.||||++..+. ...+.|.+|+.+|+.++|||||+++++|.+.+..+|||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 457889999999999999999999999999999997654 3467899999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++|+|.+++... ....+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 95 ~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (287)
T d1opja_ 95 MTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD- 168 (287)
T ss_dssp CTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-
T ss_pred ccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC-
Confidence 9999999999752 3467999999999999999999999999 999999999999999999999999999864322
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
.........||+.|+|||++.+..|+.++|||||||++|||++|..||..... ...+.. .+... ..+
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~~----~i~~~------~~~- 235 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYE----LLEKD------YRM- 235 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHH----HHHTT------CCC-
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHHH----HHhcC------CCC-
Confidence 22233445689999999999999999999999999999999998777643221 111111 11111 011
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
..+......+.+|+..||+.||++|||+.+|++.|+.+..
T Consensus 236 ---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 236 ---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1122233468899999999999999999999999987753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-54 Score=420.58 Aligned_cols=259 Identities=26% Similarity=0.416 Sum_probs=199.5
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCe---EEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQ---VVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~---~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
++|++.++||+|+||+||+|+++.++. .||||.+...... ..+.|.+|+.+|+.++|||||+++++|.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 346677899999999999999976654 6899988754332 335799999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++|+|.+++.. ....+++.+++.|+.||++||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998875 3457999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCcc---ccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 239 VGDKSH---VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 239 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
...... ......||+.|||||++.++.++.++|||||||+||||+| |+.||..... ..+...+. . ..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i~---~-~~-- 250 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAIE---Q-DY-- 250 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHH---T-TC--
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHHH---c-CC--
Confidence 322211 1223457999999999999999999999999999999998 8999976432 11221111 1 10
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
.+ ..+......+.+|+.+||+.+|++|||+.+|++.|+++..
T Consensus 251 ----~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 251 ----RL----PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ----CC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CC----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 01 1122233568899999999999999999999999998765
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-55 Score=418.66 Aligned_cols=256 Identities=23% Similarity=0.362 Sum_probs=196.8
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEec--CCeeeEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCAD--GDQRLLV 158 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lV 158 (457)
++|++.+.||+|+||.||+|+++.+|+.||||++....... .+.+.+|+.+++.++|||||++++++.+ .+.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999999999999999998654322 3458899999999999999999999865 4568999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA--NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
|||+++|+|.+++.........+++..++.++.||+.||.|||+.+ ..+||||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998753333567999999999999999999999864 23499999999999999999999999999986
Q ss_pred CCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
... ........+||+.|||||++.+..|+.++|||||||++|||+||+.||..... ..+. ..+... .+
T Consensus 164 ~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~---~~i~~~--~~-- 231 (269)
T d2java1 164 LNH--DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELA---GKIREG--KF-- 231 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH---HHHHHT--CC--
T ss_pred ccc--CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHH---HHHHcC--CC--
Confidence 432 22234457899999999999999999999999999999999999999975432 1111 111111 01
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+.+...+ ..++.+|+.+||+.||.+|||+.|+++
T Consensus 232 ---~~~~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 ---RRIPYRY----SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCCccc----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1111222 346889999999999999999999874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-54 Score=410.59 Aligned_cols=256 Identities=27% Similarity=0.412 Sum_probs=201.6
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
++|.+.+.||+|+||.||+|++.+ +..||||++.... ...++|.+|+.+++.++|||||+++++|.+.+..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 578999999999999999999864 6889999997643 35678999999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++|+|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 83 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~- 155 (263)
T d1sm2a_ 83 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 155 (263)
T ss_dssp TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC-
Confidence 99999999876 3467899999999999999999999999 9999999999999999999999999998643222
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCC-CCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA-IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
........||+.|+|||++.+..|+.++|||||||++|||+|+..| |..... ..+...+ .. . .....|.
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~i---~~-~---~~~~~p~ 225 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDI---ST-G---FRLYKPR 225 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHHH---HH-T---CCCCCCT
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHHHH---Hh-c---CCCCCcc
Confidence 2223345789999999999999999999999999999999996444 433211 1111111 11 1 0111121
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
....++.+|+..||+.||++|||+++|++.|++++.
T Consensus 226 -------~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 226 -------LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp -------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 123468899999999999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-54 Score=417.54 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=208.6
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
+.|++.+.||+|+||.||+|++..++..||||++........+.+.+|+.+|+.++|||||++++++.+.+..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999999999999999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.... .
T Consensus 92 ~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~ 163 (288)
T d2jfla1 92 AGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--T 163 (288)
T ss_dssp TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH--H
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC--C
Confidence 99999999764 2457999999999999999999999999 99999999999999999999999999874211 1
Q ss_pred ccccccccccccccchhhhh-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 243 SHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
.......+||+.|+|||++. ...|+.++|||||||++|||+||+.||....+.. + ...+.....
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~---~~~i~~~~~----- 232 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---V---LLKIAKSEP----- 232 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---H---HHHHHHSCC-----
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---H---HHHHHcCCC-----
Confidence 12234568999999999984 4568999999999999999999999997654321 1 111111110
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+.+ ..+......+.+|+.+||+.||++|||+.|+++
T Consensus 233 --~~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 --PTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --CCC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011 111223457889999999999999999999865
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-54 Score=415.20 Aligned_cols=251 Identities=23% Similarity=0.294 Sum_probs=206.9
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|++.+.||+|+||+||+|+++.+++.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999997532 223467899999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999875 467999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
..........+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... .....+.....
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~~------- 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------LIFQKIIKLEY------- 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHTTCC-------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------HHHHHHHcCCC-------
Confidence 44344445578999999999999999999999999999999999999999754321 11111111111
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
. ++.....++.+|+.+||+.||++|||++|++..
T Consensus 228 -~----~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 -D----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp -C----CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred -C----CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1 111223468899999999999999999998653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-53 Score=417.65 Aligned_cols=259 Identities=26% Similarity=0.402 Sum_probs=208.1
Q ss_pred cCCCccceeeecCcEEEEEEEECCCC-----eEEEEEEeccCC-CcChHHHHHHHHHHHhc-CCCCceeeEEEEecCCee
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTG-----QVVAVKQLDRNG-LQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~i~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 155 (457)
++|++.+.||+|+||+||+|++..++ ..||||.+.... ......+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 57999999999999999999986544 379999987542 23446789999999998 899999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCcc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPP-------------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 216 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~ 216 (457)
+|||||+++|+|.++|+.... ....+++..++.|+.||+.||.|||+++ ||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999976321 1246899999999999999999999999 999999999
Q ss_pred CeEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCC
Q 012761 217 NILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPH 295 (457)
Q Consensus 217 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~ 295 (457)
|||++.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986444433334445678999999999999999999999999999999998 89999765432
Q ss_pred CcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHH
Q 012761 296 GEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 360 (457)
Q Consensus 296 ~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~ 360 (457)
. .+. ..+.... .+ ..+......+.+|+.+||+.||++|||+.||++.|.
T Consensus 274 ~--~~~----~~~~~~~------~~----~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 A--NFY----KLIQNGF------KM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp H--HHH----HHHHTTC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H--HHH----HHHhcCC------CC----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 111 1111111 11 112222356889999999999999999999999984
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-54 Score=421.50 Aligned_cols=264 Identities=22% Similarity=0.286 Sum_probs=206.9
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC-hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.++|++.+.||+|+||+||+|++..+|+.||||+++...... ...+.+|+.+|+.++|||||+++++|.+.+.++||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 468999999999999999999999999999999997653322 3578899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+ ++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999975 4579999999999999999999997 48 99999999999999999999999999985321
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccc-------
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR------- 312 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------- 312 (457)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||........... +.........
T Consensus 158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM--FGCQVEGDAAETPPRPR 231 (322)
T ss_dssp ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHH--C----------------
T ss_pred ----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH--HHHHhcCCcccCCcccc
Confidence 223456899999999999999999999999999999999999999976443211000 0000000000
Q ss_pred ---------------------ccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 313 ---------------------KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 313 ---------------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
....+...............++.+|+.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000000000000001123568899999999999999999999873
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=405.61 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=206.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|++.+.||+|+||.||+|+++ ++..||||++.... ...+.|.+|+.++++++|||||++++++.+ +..++||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 357889999999999999999986 47899999997653 345789999999999999999999998754 567999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++|+|.+++... ....+++..++.|+.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+......
T Consensus 89 ~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 9999999987641 2346999999999999999999999999 9999999999999999999999999998643322
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCc
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPR 321 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 321 (457)
........||+.|+|||++.++.++.++|||||||++|||+||..|+..... ...+...+ ... ..+.
T Consensus 164 -~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i----~~~------~~~~ 230 (272)
T d1qpca_ 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNL----ERG------YRMV 230 (272)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHH----HTT------CCCC
T ss_pred -cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHHH----Hhc------CCCC
Confidence 2233446789999999999999999999999999999999997665543221 11111111 111 1111
Q ss_pred cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 322 LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 322 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
.... ....+.+|+.+||+.+|++|||+.+|++.|+.+-
T Consensus 231 ~p~~----~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 231 RPDN----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Cccc----ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 1112 2346889999999999999999999999998653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-53 Score=403.75 Aligned_cols=248 Identities=27% Similarity=0.402 Sum_probs=198.6
Q ss_pred CCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEec----CCeeeEE
Q 012761 85 FRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCAD----GDQRLLV 158 (457)
Q Consensus 85 f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lV 158 (457)
|++.+.||+|+||+||+|++..++..||+|++...... ..+.+.+|+.+|+.++|||||++++++.+ ...++||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 36677899999999999999999999999998754322 23568899999999999999999999865 3568999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc-CCCceEEeeccccccC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE-EGFHPKLSDFGLAKLG 237 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~-~~~~~kL~DFGla~~~ 237 (457)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ ++|+||||||+||||+ +++.+||+|||+++..
T Consensus 91 mE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999999975 467999999999999999999999975 4599999999999996 5789999999999853
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
.. ......+||+.|||||++.+ .|+.++|||||||++|||++|+.||...... ..+. ..+.. . .
T Consensus 166 ~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~~---~~i~~-~-----~ 229 (270)
T d1t4ha_ 166 RA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIY---RRVTS-G-----V 229 (270)
T ss_dssp CT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHH---HHHTT-T-----C
T ss_pred cC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHHH---HHHHc-C-----C
Confidence 22 22345689999999998865 6999999999999999999999999654321 1111 11111 0 0
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..+.+.. ....++.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~----~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 230 KPASFDK----VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CCGGGGG----CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcccCc----cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0011111 12335789999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=397.80 Aligned_cols=255 Identities=23% Similarity=0.375 Sum_probs=212.3
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|++.+.||+|+||+||+|+++ ++..||||+++.... ..++|.+|+.+++.++||||++++++|.+.+..++||||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 368999999999999999999986 578999999987543 467899999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 241 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 241 (457)
+++|+|.+++.. ....+++..+++++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 999999999765 3567899999999999999999999999 9999999999999999999999999997543322
Q ss_pred CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 242 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 242 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+. ..+ .... .+..|
T Consensus 155 -~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~---~~i-~~~~---~~~~p 223 (258)
T d1k2pa_ 155 -YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETA---EHI-AQGL---RLYRP 223 (258)
T ss_dssp -CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHH---HHH-HTTC---CCCCC
T ss_pred -ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHH---HHH-HhCC---CCCCc
Confidence 223334679999999999999999999999999999999998 89999765321 111 111 1110 11112
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
. .....+.+|+.+||+.||++|||+.+|++.|.+|
T Consensus 224 ~-------~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 H-------LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp T-------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred c-------cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1 1234688999999999999999999999998653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-53 Score=413.07 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=193.3
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC-hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.+.|++.+.||+|+||+||+|+++.+++.||||++....... ...+.+|+.+|+.++|||||++++++.+.+.+|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999999999999999997654332 3457889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc---CCCceEEeeccccccC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE---EGFHPKLSDFGLAKLG 237 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~~ 237 (457)
|++||+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999975 467999999999999999999999999 99999999999994 5789999999999853
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .+. ..+......
T Consensus 161 ~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~---~~i~~~~~~---- 227 (307)
T d1a06a_ 161 DPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLF---EQILKAEYE---- 227 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH---HHHHTTCCC----
T ss_pred cCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHH---HHHhccCCC----
Confidence 222 2234567999999999999999999999999999999999999999754321 111 111111111
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..... .......+.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 FDSPY----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCTTT----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCcc----ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11111 1122346889999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=405.53 Aligned_cols=261 Identities=26% Similarity=0.387 Sum_probs=203.1
Q ss_pred cCCCccceeeecCcEEEEEEEECCCC----eEEEEEEeccCCCcC-hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTG----QVVAVKQLDRNGLQG-NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~----~~vavK~i~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
+.|++.++||+|+||.||+|.++.++ ..||||++....... ...|.+|+.+++.++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 56888999999999999999987654 479999997643322 3468899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+.+++|.+++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999998875 3467999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCC-ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 238 PVGDK-SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 238 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
..... ........||+.|+|||++.++.++.++|||||||++|||++|..|+..... ...+...+ ...
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~~i----~~~----- 229 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKAI----NDG----- 229 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHH----HTT-----
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHHHHH----hcc-----
Confidence 33221 2223345689999999999999999999999999999999997666543221 11111111 111
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
..+ ..+......+.+|+.+||+.+|++||++.+|++.|+.+...
T Consensus 230 -~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 -FRL----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -CCC----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -CCC----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 111 11222335688999999999999999999999999988753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.4e-52 Score=415.30 Aligned_cols=253 Identities=22% Similarity=0.270 Sum_probs=210.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|++.+.||+|+||.||+|+++.+|+.||||++........+.+.+|+.+|+.|+|||||++++++.+.+.+||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45899999999999999999999999999999999876555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc--CCCceEEeeccccccCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE--EGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~--~~~~~kL~DFGla~~~~~ 239 (457)
|+||+|.+++.. ....+++..++.|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+++....
T Consensus 105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999965 2457999999999999999999999999 99999999999995 468899999999986432
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
. .......||+.|||||++.+..|+.++|||||||++|||++|+.||..... ......+......+ .
T Consensus 179 ~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~----~ 245 (350)
T d1koaa2 179 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDWNM----D 245 (350)
T ss_dssp T---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCS----C
T ss_pred c---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCC----C
Confidence 2 233456899999999999999999999999999999999999999975432 11111111111111 1
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+.. .......+.+|+.+||+.||++|||+.|+++
T Consensus 246 ~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 246 DSA----FSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CGG----GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 1112346889999999999999999999976
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-53 Score=411.80 Aligned_cols=245 Identities=28% Similarity=0.375 Sum_probs=202.9
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcCh---HHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
.|+..+.||+|+||+||+|++..+++.||||++........ +.+.+|+.+|+.++|||||++++++.+.+..|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 48999999999999999999999999999999986544332 458899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
||++|+|..++.. ..++++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|.....
T Consensus 96 ~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp CCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999877654 467999999999999999999999999 99999999999999999999999999975321
Q ss_pred CCccccccccccccccchhhhhc---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccc
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMT---GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKL 317 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 317 (457)
....+||+.|||||++.+ +.|+.++|||||||++|||++|+.||...... .......... ...+
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~~--~~~~ 234 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE--SPAL 234 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC--CCCC
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCC--CCCC
Confidence 234679999999999864 46899999999999999999999999654321 1111111111 0011
Q ss_pred cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 318 ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 318 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
. ...+ ...+.+|+.+||+.||.+|||+.|+++
T Consensus 235 ~----~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 Q----SGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp S----CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C----CCCC----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 1112 346889999999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=404.30 Aligned_cols=257 Identities=24% Similarity=0.363 Sum_probs=206.7
Q ss_pred cCCCccce-eeecCcEEEEEEEECC--CCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 83 KNFRPESF-IGEGGFGRVYKGWLES--TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 83 ~~f~~~~~-lG~G~~g~Vy~~~~~~--~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
++|.+... ||+|+||.||+|.++. ++..||||+++..... ..+.|.+|+.+|+.++|||||++++++.+ +.++||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45667774 9999999999998754 4568999999764322 23678999999999999999999999865 568999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++|+|.+++.. ....+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999999865 3467999999999999999999999999 9999999999999999999999999998644
Q ss_pred CCCC-ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 239 VGDK-SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 239 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.... ........||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+... +....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~----i~~~~---- 229 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQGK---- 229 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH----HHTTC----
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCC----
Confidence 3322 222334578999999999999999999999999999999998 99999765431 11111 11111
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
.+.+ +.....++.+|+..||+.+|++||++.+|++.|+.+.
T Consensus 230 --~~~~----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 230 --RMEC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp --CCCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCC----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111 1122346789999999999999999999999997654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-52 Score=416.02 Aligned_cols=253 Identities=21% Similarity=0.274 Sum_probs=210.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|++.+.||+|+||.||+|++..+|+.||||++..........+.+|+.+|+.|+|||||+++++|.+.+.+||||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999999999999999999876554556788999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc--CCCceEEeeccccccCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE--EGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~--~~~~~kL~DFGla~~~~~ 239 (457)
|+||+|.+++.. ...++++..++.|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+|.....
T Consensus 108 ~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999988765 3457999999999999999999999999 99999999999997 678999999999986433
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
. .......||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.... .+ ...+......+ .
T Consensus 182 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~---~~~i~~~~~~~----~ 248 (352)
T d1koba_ 182 D---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ET---LQNVKRCDWEF----D 248 (352)
T ss_dssp T---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH---HHHHHHCCCCC----C
T ss_pred C---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHhCCCCC----C
Confidence 2 2344567999999999999999999999999999999999999999754321 11 11111111111 1
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
... ......++.+|+.+||+.||.+|||+.|+++
T Consensus 249 ~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 249 EDA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp SST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 1122346889999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=400.90 Aligned_cols=249 Identities=25% Similarity=0.402 Sum_probs=197.8
Q ss_pred ceeeecCcEEEEEEEECC--CCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEeccCC
Q 012761 89 SFIGEGGFGRVYKGWLES--TGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFMPL 164 (457)
Q Consensus 89 ~~lG~G~~g~Vy~~~~~~--~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~~~ 164 (457)
+.||+|+||.||+|.+.. +++.||||++...... ..+.|.+|+.+|++++|||||+++++|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 569999999999998653 4578999999754322 23579999999999999999999999965 467899999999
Q ss_pred CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC-c
Q 012761 165 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK-S 243 (457)
Q Consensus 165 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~-~ 243 (457)
|+|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....... .
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999976 467999999999999999999999999 99999999999999999999999999986433322 2
Q ss_pred cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccCCcc
Q 012761 244 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 244 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+... +.... .+.+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~~----i~~~~------~~~~ 231 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAM----LEKGE------RMGC 231 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----HHTTC------CCCC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHHH----HHcCC------CCCC
Confidence 22334578999999999999999999999999999999998 89999764321 11111 11111 0111
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
+......+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 232 ----p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 ----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 112234678999999999999999999999988654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=400.21 Aligned_cols=252 Identities=23% Similarity=0.297 Sum_probs=207.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc------ChHHHHHHHHHHHhcCCCCceeeEEEEecCCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ------GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 155 (457)
.+.|++.+.||+|+||+||+|+++.+|+.||||++.+.... ..+.+.+|+.+|+.|+|||||+++++|.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36799999999999999999999999999999999754322 246789999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC----ceEEeec
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF----HPKLSDF 231 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~----~~kL~DF 231 (457)
|||||||++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 999999999999999976 457999999999999999999999999 99999999999998766 5999999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 311 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 311 (457)
|++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .+ ...+....
T Consensus 162 G~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~---~~~i~~~~ 232 (293)
T d1jksa_ 162 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ET---LANVSAVN 232 (293)
T ss_dssp TTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHTTC
T ss_pred hhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---HH---HHHHHhcC
Confidence 9998643322 234567999999999999989999999999999999999999999754321 11 11111111
Q ss_pred cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 312 RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 312 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
..+. +.. +......+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~----~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 YEFE----DEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCCC----HHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCC----chh----cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1000 000 0112346789999999999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=407.01 Aligned_cols=249 Identities=25% Similarity=0.317 Sum_probs=209.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV 158 (457)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+.. ......+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 468999999999999999999999999999999997532 22346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||++||+|.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999986 567999999999999999999999999 9999999999999999999999999998533
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.. .......+||+.|+|||++.+..|+.++|||||||++|||++|++||..... ......+.....
T Consensus 157 ~~--~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------~~~~~~i~~~~~------ 222 (337)
T d1o6la_ 157 SD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEEI------ 222 (337)
T ss_dssp CT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC------
T ss_pred cC--CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH------HHHHHHHhcCCC------
Confidence 22 2234457899999999999999999999999999999999999999976432 111111111111
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCC-----hHHHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVT 357 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ev~~ 357 (457)
. ++.....++.+|+.+||+.||.+||+ +.++++
T Consensus 223 --~----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 --R----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --C----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --C----CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1 11122346789999999999999995 777765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=404.37 Aligned_cols=258 Identities=28% Similarity=0.470 Sum_probs=205.1
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCe----EEEEEEeccC-CCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQ----VVAVKQLDRN-GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~i~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
.+|++.+.||+|+||+||+|++..+|+ .||+|.+... .....+.|.+|+.+++.++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999999987775 5888888653 233457899999999999999999999999875 5677
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
++||+.+|+|.+++.. ....+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 8899999999998876 3567999999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.............||+.|+|||++.++.|+.++|||||||+||||+| |.+||....... +.. .+.....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~----~i~~~~~--- 231 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGER--- 231 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHH----HHHHTCC---
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCC---
Confidence 44444444445678999999999999999999999999999999998 788887654221 111 1111110
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
. ..+......+.+|+.+||+.+|.+|||+.+|++.|..+..
T Consensus 232 ~-------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 232 L-------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp C-------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1 1112233468899999999999999999999999988864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.2e-51 Score=394.65 Aligned_cols=262 Identities=23% Similarity=0.290 Sum_probs=206.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcCh---HHHHHHHHHHHhcCCCCceeeEEEEecCC----e
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGN---REFLVEVLMLSLLHHSNLVNLIGYCADGD----Q 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~---~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~ 154 (457)
.++|++.+.||+|+||.||+|++..+|+.||||++........ ..+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4679999999999999999999999999999999986544332 46889999999999999999999987654 3
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
.||||||++|++|.+++.. ...+++.+++.|+.||+.||+|||+++ |+||||||+||||+.++.++|+|||++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 7899999999999999875 467999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCC-CccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccc
Q 012761 235 KLGPVGD-KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRK 313 (457)
Q Consensus 235 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 313 (457)
....... ........+||+.|+|||++.+..++.++|||||||++|||+||++||....+ .......+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCC
Confidence 7533222 22234456899999999999999999999999999999999999999975432 1111122222111
Q ss_pred cccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCC-ChHHHHHHHHhhhh
Q 012761 314 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-LIGDVVTALSYLAN 364 (457)
Q Consensus 314 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~ev~~~L~~l~~ 364 (457)
......+ . ....+.+++.+||+.||.+|| ++.+++..|.++.+
T Consensus 233 ~~~~~~~----~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 233 PPSARHE----G----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp CGGGTSS----S----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred CCchhcc----C----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 1111111 1 224688999999999999999 89999999988753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.3e-51 Score=400.30 Aligned_cols=245 Identities=29% Similarity=0.400 Sum_probs=207.2
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccC---CCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRN---GLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|++.+.||+|+||+||+|+++.+|+.||||++.+. .....+.+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999999999999999999743 2234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||++||+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999876 567889999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
.....+||+.|||||++.+..|+.++|||||||++|||+||+.||..... ......+......
T Consensus 157 -----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~~~------ 219 (316)
T d1fota_ 157 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAELR------ 219 (316)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCCCC------
T ss_pred -----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHHcCCCC------
Confidence 23456899999999999999999999999999999999999999975432 1111122221111
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCC-----ChHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVT 357 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~ 357 (457)
++......+.+++.+||+.||.+|| +++++++
T Consensus 220 ------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 ------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1112234688999999999999996 8999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-51 Score=401.80 Aligned_cols=263 Identities=25% Similarity=0.418 Sum_probs=211.0
Q ss_pred HhcCCCccceeeecCcEEEEEEEECC-----CCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCe
Q 012761 81 ATKNFRPESFIGEGGFGRVYKGWLES-----TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQ 154 (457)
Q Consensus 81 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 154 (457)
..++|++.+.||+|+||+||+|+++. ++..||||++...... ..+.|.+|+.+++.++||||++++++|.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 46789999999999999999999753 4679999999764332 23568999999999999999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 012761 155 RLLVYEFMPLGSLEDHLHDLP--------------------PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFK 214 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLk 214 (457)
.++||||+++|+|.+++.... .....+++..++.|+.||+.||+|||+++ |||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 999999999999999996421 12345899999999999999999999999 9999999
Q ss_pred ccCeEEcCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCC-CCCCCCC
Q 012761 215 SSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR-KAIDSTR 293 (457)
Q Consensus 215 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~-~p~~~~~ 293 (457)
|+||||+.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++|. +||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999997543333333445567899999999999999999999999999999999996 5665543
Q ss_pred CCCcccchhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhh
Q 012761 294 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 363 (457)
Q Consensus 294 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~ 363 (457)
.. .+...+ .... . +.+ +.....++.+|+..||+.+|++|||+.||+++|+++.
T Consensus 248 ~~---e~~~~v----~~~~-~-----~~~----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HE---EVIYYV----RDGN-I-----LAC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HH---HHHHHH----HTTC-C-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HH---HHHHHH----HcCC-C-----CCC----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 21 111111 1111 0 111 1122346889999999999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-51 Score=394.74 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=202.5
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
++|++.+.||+|+||.||+|+++.+ ..||||++.... ...+.|.+|+.++++++|||||+++++|.+ +..++||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 5799999999999999999999764 679999997653 356789999999999999999999999854 5689999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++|+|..++... ....++|.+++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 94 ~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~- 167 (285)
T d1fmka3 94 SKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 167 (285)
T ss_dssp TTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC-
Confidence 999999988652 2346999999999999999999999999 9999999999999999999999999998643222
Q ss_pred ccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCCcc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL 322 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 322 (457)
........||+.|+|||++..+.++.++|||||||++|||++|..|+..... ...+..++. . . ..+..
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~---~-~------~~~~~ 235 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVE---R-G------YRMPC 235 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH---T-T------CCCCC
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHH---h-c------CCCCC
Confidence 2233446789999999999999999999999999999999997666543221 111222111 1 1 01111
Q ss_pred CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 323 EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 323 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
.. ....++.+|+.+||+.||++||++.+|+++|+..-.
T Consensus 236 ~~----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 236 PP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred Cc----ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 11 223468899999999999999999999999987654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-51 Score=396.58 Aligned_cols=264 Identities=26% Similarity=0.351 Sum_probs=200.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECC-----CCeEEEEEEeccCCCc-ChHHHHHHHHHHHhc-CCCCceeeEEEEecC-C
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLES-----TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLL-HHSNLVNLIGYCADG-D 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~ 153 (457)
.++|++.+.||+|+||.||+|++.. +++.||||++...... ..+.+..|..++.++ +|+||+.+++++... .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 3679999999999999999999754 4578999999754332 235677788877776 689999999998764 5
Q ss_pred eeeEEEeccCCCCHHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE 221 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~ 221 (457)
.+++||||+++|+|.++|..... ....+++..++.++.||+.||.|||+++ ||||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 68999999999999999975321 2346899999999999999999999999 99999999999999
Q ss_pred CCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCC-CCCCCCCCCCcccc
Q 012761 222 EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR-KAIDSTRPHGEQNL 300 (457)
Q Consensus 222 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~-~p~~~~~~~~~~~l 300 (457)
.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. +||......
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~----- 243 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----- 243 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-----
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-----
Confidence 99999999999998654444334445578999999999999999999999999999999999975 567544321
Q ss_pred hhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 301 VTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
......+.... .+.+ +.....++.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 244 -~~~~~~~~~~~------~~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 244 -EEFCRRLKEGT------RMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp -HHHHHHHHHTC------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHhcCC------CCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111112111 1111 11223468899999999999999999999999998753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-51 Score=390.85 Aligned_cols=259 Identities=24% Similarity=0.363 Sum_probs=199.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCC---CeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeE
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLEST---GQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLL 157 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~---~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 157 (457)
.++|++.+.||+|+||.||+|++..+ +..||||.++..... ..+.+.+|+.+++.++|||||++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 35799999999999999999998654 357899998654332 2356899999999999999999999996 467899
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999998765 3467999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccccc
Q 012761 238 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 316 (457)
Q Consensus 238 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 316 (457)
.... ........||+.|+|||++.+..|+.++|||||||++|||+| |.+||...... .+...+ ....
T Consensus 159 ~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~i----~~~~---- 226 (273)
T d1mp8a_ 159 EDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI----ENGE---- 226 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH----HTTC----
T ss_pred cCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHHH----HcCC----
Confidence 3222 223345678999999999999999999999999999999998 89999765432 111111 1110
Q ss_pred ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 317 LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 317 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.+.+ +......+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 227 --~~~~----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 227 --RLPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCC----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0111 112234688999999999999999999999999887643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-51 Score=390.38 Aligned_cols=253 Identities=28% Similarity=0.404 Sum_probs=201.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEec-CCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCAD-GDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lV~E 160 (457)
.++|++.+.||+|+||.||+|+++ |..||||+++... ..+.+.+|+.++++++||||++++++|.+ .+.+++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 357889999999999999999985 7899999997643 45779999999999999999999999865 456899999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+++|+|.++|... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 y~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~- 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 155 (262)
T ss_dssp CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC-
Confidence 99999999999751 2345899999999999999999999999 99999999999999999999999999975321
Q ss_pred CCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
......+|..|+|||++.++.++.++|||||||++|||+| |++||..... ..+..++.. . ..
T Consensus 156 ----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i~~----~------~~ 218 (262)
T d1byga_ 156 ----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEK----G------YK 218 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHTT----T------CC
T ss_pred ----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHc----C------CC
Confidence 1223467899999999999999999999999999999998 6777765432 222222211 1 11
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
+.+ +......+.+|+.+||+.||.+|||+.+|+++|+++...
T Consensus 219 ~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 219 MDA----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 111 222234678999999999999999999999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.7e-50 Score=386.30 Aligned_cols=251 Identities=25% Similarity=0.301 Sum_probs=206.3
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC---------hHHHHHHHHHHHhcC-CCCceeeEEEEecC
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG---------NREFLVEVLMLSLLH-HSNLVNLIGYCADG 152 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---------~~~~~~E~~~l~~l~-hpniv~l~~~~~~~ 152 (457)
++|++.+.||+|+||+||+|++..+++.||||++.+..... .+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999999999999999998654322 134788999999997 99999999999999
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecc
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 232 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFG 232 (457)
+..||||||+++|+|.++|.. ...+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999975 467999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCccccccccccccccchhhhhc------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhh
Q 012761 233 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT------GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP 306 (457)
Q Consensus 233 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~ 306 (457)
+++...... ..+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .+ ...
T Consensus 156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~---~~---~~~ 226 (277)
T d1phka_ 156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LM---LRM 226 (277)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHH
T ss_pred heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH---HH---HHH
Confidence 998643322 2345689999999999863 35788999999999999999999999764321 11 111
Q ss_pred hhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 307 LFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 307 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+......+ ..........++.+|+.+||+.+|++||++.||++
T Consensus 227 i~~~~~~~--------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 227 IMSGNYQF--------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHTCCCC--------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhCCCCC--------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111110 01111123357889999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=393.73 Aligned_cols=264 Identities=26% Similarity=0.377 Sum_probs=209.5
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCC-------eEEEEEEeccCCCc-ChHHHHHHHHHHHhc-CCCCceeeEEEEecC
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTG-------QVVAVKQLDRNGLQ-GNREFLVEVLMLSLL-HHSNLVNLIGYCADG 152 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~-------~~vavK~i~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 152 (457)
.++|.+.+.||+|+||.||+|++..++ ..||||+++..... ...++..|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 357889999999999999999876544 47999999765432 236788899988888 799999999999999
Q ss_pred CeeeEEEeccCCCCHHHhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE
Q 012761 153 DQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL 220 (457)
Q Consensus 153 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl 220 (457)
+..++||||+++|+|.++|..... ....+++.+++.++.||+.||+|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999975421 2356999999999999999999999999 9999999999999
Q ss_pred cCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 012761 221 EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQN 299 (457)
Q Consensus 221 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~ 299 (457)
+.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |.+||..... ..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~~ 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EE 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---HH
Confidence 9999999999999986544444444556789999999999999999999999999999999998 6888865432 11
Q ss_pred chhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 300 LVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 300 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
+.. .+.... .+..... ....+.+|+.+||+.||++|||+.||++.|+++...
T Consensus 246 ~~~----~i~~~~------~~~~p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 246 LFK----LLKEGH------RMDKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHH----HHHTTC------CCCCCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH----HHHcCC------CCCCCcc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 111 111111 1111112 234688999999999999999999999999998653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=394.82 Aligned_cols=252 Identities=16% Similarity=0.243 Sum_probs=207.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEec
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~ 161 (457)
.++|.+.+.||+|+||+||+|+++.+++.||||++..... ....+.+|+.+|+.++|||||++++++.+.+.+||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 4689999999999999999999999999999999986542 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC--CCceEEeeccccccCCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE--GFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~--~~~~kL~DFGla~~~~~ 239 (457)
|+||+|.+++.. ....+++.++..|+.||+.||+|||+++ |+||||||+|||++. .+.+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999975 2347999999999999999999999999 999999999999974 45899999999986432
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
. .......||+.|+|||.+.+..|+.++|||||||++|+|++|..||...... .....+......+.....
T Consensus 157 ~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~~~~~~~~~~ 227 (321)
T d1tkia_ 157 G---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYTFDEEAF 227 (321)
T ss_dssp T---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCCCHHHH
T ss_pred C---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCChhhc
Confidence 2 2234467899999999999999999999999999999999999999764321 111112211111111000
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
+ .....+.+|+.+||+.||.+|||+.|+++
T Consensus 228 ~--------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 228 K--------EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp T--------TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c--------CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 11246789999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-50 Score=399.84 Aligned_cols=245 Identities=24% Similarity=0.302 Sum_probs=206.4
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~ 159 (457)
++|++.+.||+|+||.||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999999999999999996432 233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 239 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 239 (457)
||+.+|+|..++.. ...+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999976 457999999999999999999999999 99999999999999999999999999986422
Q ss_pred CCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccC
Q 012761 240 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLAD 319 (457)
Q Consensus 240 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 319 (457)
......||+.|||||++.+..|+.++|||||||++|||+||+.||..... ......+.....
T Consensus 194 -----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~~------- 255 (350)
T d1rdqe_ 194 -----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGKV------- 255 (350)
T ss_dssp -----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC-------
T ss_pred -----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHHhcCCC-------
Confidence 23346799999999999999999999999999999999999999975432 111111111111
Q ss_pred CccCCCCChHhHHHHHHHHHHcchhhcCCCC-----ChHHHHH
Q 012761 320 PRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVT 357 (457)
Q Consensus 320 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~ 357 (457)
.+ +......+.+|+..||+.||.+|+ ++.++++
T Consensus 256 -~~----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 -RF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CC----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CC----CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11 112234688999999999999994 8999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.6e-50 Score=399.85 Aligned_cols=250 Identities=26% Similarity=0.339 Sum_probs=201.0
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC---cChHHHHH---HHHHHHhcCCCCceeeEEEEecCCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL---QGNREFLV---EVLMLSLLHHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~~~~~~~---E~~~l~~l~hpniv~l~~~~~~~~~~ 155 (457)
.++|++.+.||+|+||.||+|++..+|+.||||++.+... .....+.. ++.+++.++|||||++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 4689999999999999999999999999999999864321 12233444 46667777899999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
||||||+++|+|.++|.. ...+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+
T Consensus 83 ~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999999976 467899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 236 LGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 236 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
..... .....+||+.|+|||++.. ..|+.++|||||||+||||+||+.||..........+. ......
T Consensus 156 ~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~---~~~~~~---- 224 (364)
T d1omwa3 156 DFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLTM---- 224 (364)
T ss_dssp ECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH---HHSSSC----
T ss_pred ecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcccC----
Confidence 54322 2344679999999999975 46899999999999999999999999765432211111 110000
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCC-----hHHHHH
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVT 357 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ev~~ 357 (457)
.+.+.. ....++.+|+.+||+.||++||+ +.|+++
T Consensus 225 ----~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 ----AVELPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----CCCCCS----SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----CCCCCC----CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111111 12346889999999999999999 577764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=393.36 Aligned_cols=265 Identities=25% Similarity=0.359 Sum_probs=212.9
Q ss_pred hcCCCccceeeecCcEEEEEEEEC-----CCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhc-CCCCceeeEEEEecCCe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLE-----STGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 154 (457)
.++|.+.+.||+|+||.||+|++. .++..||||+++..... ....+.+|+.++..+ +|||||+++++|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 368889999999999999999863 45679999999865432 335688999999999 69999999999999999
Q ss_pred eeEEEeccCCCCHHHhhhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEE
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPP--------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL 220 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl 220 (457)
.++||||+++|+|.++++.... ....+++..++.++.||+.||+|||+++ ||||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 9999999999999999975321 2346999999999999999999999999 9999999999999
Q ss_pred cCCCceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhC-CCCCCCCCCCCccc
Q 012761 221 EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG-RKAIDSTRPHGEQN 299 (457)
Q Consensus 221 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG-~~p~~~~~~~~~~~ 299 (457)
+.++.+||+|||+++...............||+.|+|||++..+.++.++|||||||++|||+|+ .+||.......
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~--- 255 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--- 255 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH---
Confidence 99999999999999875544444444557899999999999999999999999999999999995 55554433211
Q ss_pred chhhhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 300 LVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 300 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
-+..++.... .+.. +......+.+|+.+||+.||++|||+.+|+++|+++...
T Consensus 256 ---~~~~~i~~~~------~~~~----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 256 ---KFYKMIKEGF------RMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp ---HHHHHHHHTC------CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHHhcCC------CCCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 1111111111 1111 112234688999999999999999999999999876543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=395.83 Aligned_cols=248 Identities=26% Similarity=0.399 Sum_probs=204.4
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCC---CcChHHHHHHHHHHH-hcCCCCceeeEEEEecCCeeeEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNG---LQGNREFLVEVLMLS-LLHHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~---~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~lV 158 (457)
++|.+.+.||+|+||+||+|+++.+++.||||++++.. ....+.+..|..++. .++|||||++++++.+.+..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999999999999999997532 223455667777665 68999999999999999999999
Q ss_pred EeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCC
Q 012761 159 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 238 (457)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999976 467899999999999999999999999 9999999999999999999999999998533
Q ss_pred CCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccccccccc
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 318 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 318 (457)
.. ....+...||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.... .+ ...+...
T Consensus 155 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~---~~~i~~~-------- 218 (320)
T d1xjda_ 155 LG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---EL---FHSIRMD-------- 218 (320)
T ss_dssp CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHC--------
T ss_pred cc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HH---HHHHHcC--------
Confidence 22 22344568999999999999999999999999999999999999999764321 11 1111111
Q ss_pred CCccCCCCChHhHHHHHHHHHHcchhhcCCCCChH-HHHH
Q 012761 319 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIG-DVVT 357 (457)
Q Consensus 319 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ev~~ 357 (457)
.+.+... ....+.+|+.+||+.||.+||++. ++++
T Consensus 219 ~~~~p~~----~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 NPFYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCCCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCCcc----CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1111111 234688999999999999999985 6653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-50 Score=392.25 Aligned_cols=260 Identities=27% Similarity=0.412 Sum_probs=207.6
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCe--EEEEEEeccC-CCcChHHHHHHHHHHHhc-CCCCceeeEEEEecCCeeeEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQ--VVAVKQLDRN-GLQGNREFLVEVLMLSLL-HHSNLVNLIGYCADGDQRLLV 158 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~--~vavK~i~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV 158 (457)
++|++.+.||+|+||.||+|+++.++. .||||.+... .....+.|.+|+.+|+.+ +|||||+++++|.+.+.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 689999999999999999999988876 4677877543 223446799999999998 699999999999999999999
Q ss_pred EeccCCCCHHHhhhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCce
Q 012761 159 YEFMPLGSLEDHLHDLP------------PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP 226 (457)
Q Consensus 159 ~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~ 226 (457)
|||+++|+|.++|+... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999997531 23467999999999999999999999999 9999999999999999999
Q ss_pred EEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCC-CCCCCCCCCcccchhhhh
Q 012761 227 KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK-AIDSTRPHGEQNLVTWAR 305 (457)
Q Consensus 227 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~-p~~~~~~~~~~~l~~~~~ 305 (457)
||+|||+++..... .......||..|+|||.+.++.++.++|||||||++|||++|.. ||..... ..+...+.
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~~i~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLP 240 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHGG
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHHHHHH
Confidence 99999999753221 12234568999999999999999999999999999999999765 5654321 11111111
Q ss_pred hhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 306 PLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.. ..+.. +......+.+|+.+||+.||++|||+.||++.|+++...
T Consensus 241 ----~~------~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 241 ----QG------YRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp ----GT------CCCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----hc------CCCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11 01111 122335788999999999999999999999999998764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=388.91 Aligned_cols=257 Identities=28% Similarity=0.390 Sum_probs=196.3
Q ss_pred cCCCccceeeecCcEEEEEEEECCC-C--eEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCceeeEEEEecCCeee
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLEST-G--QVVAVKQLDRNGLQ---GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRL 156 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~-~--~~vavK~i~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 156 (457)
++|++.+.||+|+||.||+|++..+ + ..||||++...... ..+.|.+|+.+|+.++||||++++++|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5799999999999999999986532 2 47899998764322 23578999999999999999999999976 4678
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999998875 3456999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCc-cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCCCcccchhhhhhhhhccccc
Q 012761 237 GPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKF 314 (457)
Q Consensus 237 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 314 (457)
....... .......|+..|+|||++.+..++.++|||||||++|||+| |+.||..... ..+..+ +.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~---~~~~~~---i~~~~~-- 232 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHK---IDKEGE-- 232 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHH---HHTSCC--
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH---HHHHHH---HHhCCC--
Confidence 4333222 22334568889999999999999999999999999999998 8999965432 112111 111111
Q ss_pred ccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhh
Q 012761 315 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 362 (457)
Q Consensus 315 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l 362 (457)
.+.....+ ...+.+|+..||+.||++|||+.+|++.|.+.
T Consensus 233 ----~~~~~~~~----~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 ----RLPRPEDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCcccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11111122 24688999999999999999999999999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-50 Score=388.64 Aligned_cols=258 Identities=25% Similarity=0.294 Sum_probs=196.1
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC-----hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEecc
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG-----NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYEFM 162 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E~~ 162 (457)
+++||+|+||+||+|+++.+|+.||||++....... .+.+.+|+.+++.++|||||++++++.+.+..+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 568999999999999999999999999997543221 246889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
.++++..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-- 153 (299)
T d1ua2a_ 83 ETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-- 153 (299)
T ss_dssp SEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--
T ss_pred cchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC--
Confidence 98877766643 567889999999999999999999999 999999999999999999999999999753322
Q ss_pred ccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhc--cccc---cc
Q 012761 243 SHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND--RRKF---SK 316 (457)
Q Consensus 243 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~---~~ 316 (457)
.......+||+.|+|||++... .|+.++|||||||++|||+||.+||......+ ....+...+.. ...+ ..
T Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTS
T ss_pred cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhc
Confidence 2233446799999999998754 67999999999999999999999997543211 11111000000 0000 00
Q ss_pred ccCCccCC---CCCh-----HhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 317 LADPRLEG---RYPI-----RGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 317 ~~d~~l~~---~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
........ ..+. .....+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000000 0111 12346889999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=393.41 Aligned_cols=252 Identities=20% Similarity=0.223 Sum_probs=200.1
Q ss_pred hcCCCccc-eeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHh-cCCCCceeeEEEEec----CCee
Q 012761 82 TKNFRPES-FIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSL-LHHSNLVNLIGYCAD----GDQR 155 (457)
Q Consensus 82 ~~~f~~~~-~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~----~~~~ 155 (457)
.++|.+.. .||+|+||+||+|++..+++.||||+++. ...+.+|+.++.+ ++|||||+++++|.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46898764 69999999999999999999999999863 3567889988655 479999999999875 4668
Q ss_pred eEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC---CCceEEeecc
Q 012761 156 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE---GFHPKLSDFG 232 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~---~~~~kL~DFG 232 (457)
|||||||+||+|.++|... ....+++.++..|+.||+.||+|||+.+ |+||||||+|||++. .+.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 9999999999999999752 2357999999999999999999999999 999999999999975 5679999999
Q ss_pred ccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhccc
Q 012761 233 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 312 (457)
Q Consensus 233 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 312 (457)
+|+...... .....+||+.|+|||++.+..|+.++|||||||+||+|+||+.||.......... ....
T Consensus 160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~------ 227 (335)
T d2ozaa1 160 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKT------ 227 (335)
T ss_dssp TCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred eeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHH------
Confidence 998643322 2345679999999999999899999999999999999999999997654321110 0000
Q ss_pred ccccccCCcc--CCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 313 KFSKLADPRL--EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 313 ~~~~~~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.+..... ...........+.+|+.+||+.||++|||+.|++..
T Consensus 228 ---~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 ---RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000000 000011224578899999999999999999999763
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=385.39 Aligned_cols=266 Identities=23% Similarity=0.302 Sum_probs=201.1
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
++|++.+.||+|+||+||+|++..+|+.||||++..... .....+.+|+.+|+.++|||||++++++.+.+..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 589999999999999999999999999999999975432 234678999999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+.++ +.+++.. .....+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~-~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCc-hhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 99754 4444433 13567999999999999999999999999 999999999999999999999999999864322
Q ss_pred CCccccccccccccccchhhhhcCC-CCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhh----------hhh
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQ-LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP----------LFN 309 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~----------~~~ 309 (457)
........||+.|+|||++.... ++.++|||||||++|+|++|+.||...+.... +...... ...
T Consensus 156 --~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 156 --VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp --SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGG
T ss_pred --cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcCCCchhhccccc
Confidence 22334457999999999987665 58899999999999999999999975432110 0000000 000
Q ss_pred cccccccccCCccCCCC---ChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 310 DRRKFSKLADPRLEGRY---PIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 310 ~~~~~~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
................+ .......+.+|+.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000000000000 01123568899999999999999999999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=384.81 Aligned_cols=256 Identities=28% Similarity=0.424 Sum_probs=203.6
Q ss_pred cceeeecCcEEEEEEEECCCC---eEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCceeeEEEEec-CCeeeEEEecc
Q 012761 88 ESFIGEGGFGRVYKGWLESTG---QVVAVKQLDRNG-LQGNREFLVEVLMLSLLHHSNLVNLIGYCAD-GDQRLLVYEFM 162 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~---~~vavK~i~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lV~E~~ 162 (457)
.++||+|+||+||+|++..++ ..||||+++... ......|.+|+.+|++++||||+++++++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 467999999999999986543 469999997532 2233679999999999999999999999875 46889999999
Q ss_pred CCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCCCC
Q 012761 163 PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 242 (457)
Q Consensus 163 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 242 (457)
++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999886 3556788999999999999999999999 99999999999999999999999999986433322
Q ss_pred c--cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcccccccccCC
Q 012761 243 S--HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 320 (457)
Q Consensus 243 ~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 320 (457)
. .......||+.|+|||++....++.++|||||||++|||+||..||..... ...+..++ .... ....|
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i---~~g~----~~~~p 256 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYL---LQGR----RLLQP 256 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---HTTC----CCCCC
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHH---HcCC----CCCCc
Confidence 1 223345789999999999999999999999999999999998888754321 11122221 1111 11111
Q ss_pred ccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 321 RLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 321 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
......+.+|+.+||+.||++||++.||++.|+.+...
T Consensus 257 -------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 257 -------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11224688999999999999999999999999999764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=387.70 Aligned_cols=273 Identities=25% Similarity=0.335 Sum_probs=203.2
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHH--HHHHHHhcCCCCceeeEEEEecCC----eee
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLV--EVLMLSLLHHSNLVNLIGYCADGD----QRL 156 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~--E~~~l~~l~hpniv~l~~~~~~~~----~~~ 156 (457)
++|.+.+.||+|+||.||+|++ +|+.||||+++.. ....+.. |+..+..++||||+++++++.+.+ .++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 5688889999999999999987 4799999999754 2334444 555556789999999999997654 579
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeeccCCccCeEEcCCCceEEeec
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA-----NPPVIYRDFKSSNILLEEGFHPKLSDF 231 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----~~~iiHrDLkp~NILl~~~~~~kL~DF 231 (457)
+||||+++|+|.++|+. ..++|..++.++.|++.||.|||+.. .++|+||||||+||||+.++.+||+||
T Consensus 78 lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 99999999999999986 46999999999999999999999741 123999999999999999999999999
Q ss_pred cccccCCCCCCc--cccccccccccccchhhhhcCC------CCccchHHHHHHHHHHHHhCCCCCCCCCCCCc--ccc-
Q 012761 232 GLAKLGPVGDKS--HVSTRVMGTYGYCAPEYAMTGQ------LTVKSDVYSFGVVFLELITGRKAIDSTRPHGE--QNL- 300 (457)
Q Consensus 232 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~ksDvwSlGvil~elltG~~p~~~~~~~~~--~~l- 300 (457)
|+++........ .......||+.|+|||++.+.. ++.++|||||||+||||+||..||........ ...
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 999864333221 1234568999999999987542 57789999999999999999988754332211 000
Q ss_pred -hhhhhhhhhcccccccccCCccCCCC-ChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhcC
Q 012761 301 -VTWARPLFNDRRKFSKLADPRLEGRY-PIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 366 (457)
Q Consensus 301 -~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 366 (457)
..+....... .......+|.+...+ +......+.+|+.+||+.||++|||+.||++.|+++..+.
T Consensus 233 ~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 233 PSDPSVEEMRK-VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CSSCCHHHHHH-HHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccchHHHHHH-HHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 0011111110 001122233332222 2234567889999999999999999999999999998643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=380.13 Aligned_cols=241 Identities=22% Similarity=0.368 Sum_probs=198.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc------ChHHHHHHHHHHHhcC--CCCceeeEEEEecCC
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ------GNREFLVEVLMLSLLH--HSNLVNLIGYCADGD 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~------~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~ 153 (457)
.++|++.+.||+|+||.||+|++..+|+.||||++...... ....+.+|+.+++.++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999999999999999999999754222 1234678999999997 899999999999999
Q ss_pred eeeEEEeccCC-CCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC-CCceEEeec
Q 012761 154 QRLLVYEFMPL-GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE-GFHPKLSDF 231 (457)
Q Consensus 154 ~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~-~~~~kL~DF 231 (457)
..++||||+.+ +++.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence 99999999976 578888765 467999999999999999999999999 999999999999985 579999999
Q ss_pred cccccCCCCCCccccccccccccccchhhhhcCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhc
Q 012761 232 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND 310 (457)
Q Consensus 232 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 310 (457)
|+|+.... ...+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... . +...
T Consensus 156 G~a~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~-------i~~~ 219 (273)
T d1xwsa_ 156 GSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E-------IIRG 219 (273)
T ss_dssp TTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H-------HHHC
T ss_pred ccceeccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H-------Hhhc
Confidence 99986322 23345689999999999987765 577999999999999999999996421 0 1111
Q ss_pred ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 311 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 311 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.. .+...+ ..++.+|+.+||+.||++|||+.|+++
T Consensus 220 ~~--------~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 QV--------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CC--------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc--------CCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 10 111122 246889999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-49 Score=385.39 Aligned_cols=263 Identities=24% Similarity=0.367 Sum_probs=210.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECC-----CCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCCee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLES-----TGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGDQR 155 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 155 (457)
.++|.+.+.||+|+||.||+|.++. ++..||||+++..... ....|.+|+.++++++||||++++++|...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 3678899999999999999998853 3578999999754322 224588999999999999999999999999999
Q ss_pred eEEEeccCCCCHHHhhhcC------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEe
Q 012761 156 LLVYEFMPLGSLEDHLHDL------PPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLS 229 (457)
Q Consensus 156 ~lV~E~~~~gsL~~~l~~~------~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~ 229 (457)
++||||+++|+|.+++... ......+++..+..++.|+++||.|||+++ |+||||||+||||+.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999988642 112345799999999999999999999998 9999999999999999999999
Q ss_pred eccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCC-CCCCCCCCCCcccchhhhhhhh
Q 012761 230 DFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR-KAIDSTRPHGEQNLVTWARPLF 308 (457)
Q Consensus 230 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~-~p~~~~~~~~~~~l~~~~~~~~ 308 (457)
|||+++...............||+.|+|||.+.+..++.++|||||||++|||+||. +||..... ..+...+.
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~~~i~ 249 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRFVM 249 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHHHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHHHHHH
Confidence 999998643333333344557899999999999999999999999999999999985 66644321 11111111
Q ss_pred hcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 309 NDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 309 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
. .. . +.. +......+.+|+.+||+.+|++|||+.+|+++|+....
T Consensus 250 ~-~~----~--~~~----p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 E-GG----L--LDK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp T-TC----C--CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred h-CC----C--CCC----cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1 11 0 111 11123468899999999999999999999999976643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=380.18 Aligned_cols=266 Identities=23% Similarity=0.316 Sum_probs=198.4
Q ss_pred hcCCCccceeeecCcEEEEEEEECCC-CeEEEEEEeccCCC--cChHHHHHHHHHHHhc---CCCCceeeEEEEec----
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLEST-GQVVAVKQLDRNGL--QGNREFLVEVLMLSLL---HHSNLVNLIGYCAD---- 151 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~---- 151 (457)
.++|++.+.||+|+||+||+|++..+ ++.||||++..... .....+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999655 67899999865322 2234566777777665 79999999999853
Q ss_pred -CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEee
Q 012761 152 -GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSD 230 (457)
Q Consensus 152 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~D 230 (457)
....+++|||+.++.+...... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 3468999999988777655543 3567899999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCccc-chh-------
Q 012761 231 FGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN-LVT------- 302 (457)
Q Consensus 231 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~-l~~------- 302 (457)
||++.... .........||+.|+|||++.+..|+.++|||||||++|||++|++||.......... +..
T Consensus 160 fg~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 99987532 2233455789999999999999999999999999999999999999997654211100 000
Q ss_pred --hhhhhhhcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 303 --WARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 303 --~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
|..........+...... ....+.......+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQ-PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCC-CGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcccccccchhhhhcccccc-chhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000000000000 000111122346788999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-47 Score=370.97 Aligned_cols=263 Identities=22% Similarity=0.283 Sum_probs=199.4
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
++|.+.+.||+|+||+||+|+++ +|+.||||++..... .....+.+|+.+|+.++||||+++++++.+.+..+++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 58999999999999999999986 689999999976532 224678999999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
|+.++.+..+... ...+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||++......
T Consensus 81 ~~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 81 HLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CCSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred eehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9987766666654 567999999999999999999999999 999999999999999999999999999763322
Q ss_pred CCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhh-------hhhccc
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP-------LFNDRR 312 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~-------~~~~~~ 312 (457)
. .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||......+. +...... ......
T Consensus 154 ~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 154 V--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGG
T ss_pred c--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCChhhccchh
Confidence 2 223345689999999998754 579999999999999999999999975432111 0000000 000000
Q ss_pred cccc------ccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 313 KFSK------LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 313 ~~~~------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.... ...+.............+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000001111122356889999999999999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-46 Score=361.46 Aligned_cols=262 Identities=21% Similarity=0.272 Sum_probs=202.1
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCce-eeEEEEecCCeeeEEEec
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLV-NLIGYCADGDQRLLVYEF 161 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~lV~E~ 161 (457)
++|++.+.||+|+||.||+|++..+|+.||||++.... ....+..|+.+++.++|+|++ .+..++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999999999999999987653 234578899999999876655 555666778899999999
Q ss_pred cCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEc---CCCceEEeeccccccCC
Q 012761 162 MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE---EGFHPKLSDFGLAKLGP 238 (457)
Q Consensus 162 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~~~ 238 (457)
+ +++|.+.+.. ....+++..++.++.|++.||+|||+++ ||||||||+|||++ .+..++|+|||+|+...
T Consensus 85 ~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 L-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp C-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred c-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9 5677666654 3467999999999999999999999999 99999999999985 45679999999998643
Q ss_pred CCCCc-----cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccch-hhhhhhhhccc
Q 012761 239 VGDKS-----HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV-TWARPLFNDRR 312 (457)
Q Consensus 239 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~-~~~~~~~~~~~ 312 (457)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||............ .+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-- 235 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-- 235 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS--
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC--
Confidence 32211 1234568999999999999999999999999999999999999999765543222111 111110000
Q ss_pred ccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhh
Q 012761 313 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 364 (457)
Q Consensus 313 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~ 364 (457)
..+.+...++ .++.+++..||+.+|++||++.++.+.|+.+..
T Consensus 236 -----~~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 236 -----PIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -----CHHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -----ChhHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0011112222 357889999999999999999999998887643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=366.15 Aligned_cols=266 Identities=23% Similarity=0.288 Sum_probs=197.3
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCceeeEEEEec--------
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGL--QGNREFLVEVLMLSLLHHSNLVNLIGYCAD-------- 151 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-------- 151 (457)
.++|++.+.||+|+||+||+|++..+|+.||||++..... .....+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 4689999999999999999999999999999999865432 234678899999999999999999999855
Q ss_pred CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeec
Q 012761 152 GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDF 231 (457)
Q Consensus 152 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DF 231 (457)
.+..++||||+.++.+..+... ...++...+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 3467999999987766655443 567899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCc--cccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhh
Q 012761 232 GLAKLGPVGDKS--HVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLF 308 (457)
Q Consensus 232 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~ 308 (457)
|++......... ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||........ ........
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~---~~~i~~~~ 238 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLC 238 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH---HHHHHHhc
Confidence 999754332211 122335799999999998765 689999999999999999999999975432111 11110100
Q ss_pred h-cccc-cccc--------cCCccCCCCChH-------hHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 309 N-DRRK-FSKL--------ADPRLEGRYPIR-------GLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 309 ~-~~~~-~~~~--------~d~~l~~~~~~~-------~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
. .... .... .........+.. ....+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0 0000 0000 000000011111 1235678999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=374.46 Aligned_cols=261 Identities=25% Similarity=0.302 Sum_probs=194.6
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCceeeEEEEecC------CeeeE
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNLVNLIGYCADG------DQRLL 157 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~~l 157 (457)
+|...++||+|+||+||+|++..+|+.||||++...... +.+|+.+|+.++||||++++++|... .+++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 588889999999999999999999999999999765322 34699999999999999999998542 35789
Q ss_pred EEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCC-ceEEeecccccc
Q 012761 158 VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF-HPKLSDFGLAKL 236 (457)
Q Consensus 158 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~ 236 (457)
||||++++.+..+.. .......+++..+..|+.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 999998664433332 1123567999999999999999999999999 99999999999999765 899999999986
Q ss_pred CCCCCCccccccccccccccchhhhhc-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhh-----------
Q 012761 237 GPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWA----------- 304 (457)
Q Consensus 237 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~----------- 304 (457)
..... .....+||+.|+|||.+.+ ..|+.++|||||||++|||++|++||........ +....
T Consensus 173 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 173 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQI 247 (350)
T ss_dssp CCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHHH
T ss_pred ccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHHhh
Confidence 43322 2334679999999998875 4789999999999999999999999975432111 11100
Q ss_pred hhhhhc--ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 305 RPLFND--RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 305 ~~~~~~--~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...... ...+.......+...........+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 00000110000111111123446889999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=373.76 Aligned_cols=260 Identities=24% Similarity=0.315 Sum_probs=195.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEecCC------
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGD------ 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 153 (457)
.++|++.+.||+|+||+||+|+++.+|+.||||++....... .+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999999999999999998643322 346889999999999999999999997654
Q ss_pred eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 233 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGl 233 (457)
.+++||||+ +.+|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 579999999 6678887764 56999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhh----
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLF---- 308 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~---- 308 (457)
++.... ..+...||+.|+|||++.+. .++.++|||||||++|+|++|++||........ +........
T Consensus 168 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 168 ARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPA 240 (346)
T ss_dssp CEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCH
T ss_pred eeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHHHHhccCCCcH
Confidence 986322 23456799999999998764 578999999999999999999999976432111 000000000
Q ss_pred ------------hcccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHH
Q 012761 309 ------------NDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 358 (457)
Q Consensus 309 ------------~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~ 358 (457)
.....+.......+.. ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhcchhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000111111110 011123467899999999999999999999863
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.9e-46 Score=359.35 Aligned_cols=265 Identities=19% Similarity=0.233 Sum_probs=211.2
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC-CCceeeEEEEecCCeeeEEEe
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH-SNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lV~E 160 (457)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ....+..|++.+..|.| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999999999999999986543 23457789999999975 899999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcC-----CCceEEeeccccc
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE-----GFHPKLSDFGLAK 235 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~-----~~~~kL~DFGla~ 235 (457)
|+ +++|.+++.. ....+++.++..++.|++.||+|||+.+ |+||||||+||||+. ++.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 7899999876 3457999999999999999999999999 999999999999964 5789999999998
Q ss_pred cCCCCCCc-----cccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhc
Q 012761 236 LGPVGDKS-----HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND 310 (457)
Q Consensus 236 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 310 (457)
........ ......+||+.|||||++.+..++.++|||||||++|||+||+.||..............+.... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~-~ 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-Q 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-H
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc-C
Confidence 64322211 12334679999999999999999999999999999999999999997655432221111111100 0
Q ss_pred ccccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHHHHHhhhhc
Q 012761 311 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 365 (457)
Q Consensus 311 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~ 365 (457)
.... +.+...+| .++.+++..|++.+|++||++..+.+.|+++...
T Consensus 234 ~~~~-----~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 234 STPL-----RELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HSCH-----HHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCh-----HHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 0000 11112223 3578899999999999999999999999887653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-46 Score=359.98 Aligned_cols=264 Identities=20% Similarity=0.239 Sum_probs=205.2
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCceeeEEEEecCCeeeEEEe
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQG--NREFLVEVLMLSLLHHSNLVNLIGYCADGDQRLLVYE 160 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~E 160 (457)
++|++++.||+|+||+||+|++..+++.||||+++...... ...+.+|+.+|+.++||||+++++++.+.+..++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999999999999999997653322 3678899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccccccCCCC
Q 012761 161 FMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 240 (457)
Q Consensus 161 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 240 (457)
++.+++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999999888765 567899999999999999999999999 999999999999999999999999999864332
Q ss_pred CCccccccccccccccchhhhhcCC-CCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhh--------cc
Q 012761 241 DKSHVSTRVMGTYGYCAPEYAMTGQ-LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN--------DR 311 (457)
Q Consensus 241 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~--------~~ 311 (457)
. .......+++.|+|||++.... ++.++|||||||++|||++|+.||....... ....-+..... ..
T Consensus 155 ~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 155 V--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp C--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTG
T ss_pred C--ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhh
Confidence 2 2233346788999999988664 6999999999999999999999975432211 11110000000 00
Q ss_pred cccccc------cCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 312 RKFSKL------ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 312 ~~~~~~------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...... ....-...........+.+|+.+||+.||++|||+.||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0000001112223456789999999999999999999865
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=373.96 Aligned_cols=265 Identities=22% Similarity=0.294 Sum_probs=197.1
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCceeeEEEEecCC----eee
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-GNREFLVEVLMLSLLHHSNLVNLIGYCADGD----QRL 156 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~ 156 (457)
+.+|++++.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.|+||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999999999999999999764322 2356889999999999999999999997643 234
Q ss_pred EEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 157 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 157 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||++..
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 55566779999999975 46999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCC-ccccccccccccccchhhhh-cCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhh------
Q 012761 237 GPVGDK-SHVSTRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLF------ 308 (457)
Q Consensus 237 ~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~------ 308 (457)
...... .......+||+.|+|||++. ...++.++||||+||++|||++|+.||......+............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 433221 12234467999999999985 4567899999999999999999999997643211100000000000
Q ss_pred -----hcccccccccCCccCCCCCh-----HhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 309 -----NDRRKFSKLADPRLEGRYPI-----RGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 309 -----~~~~~~~~~~d~~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
...... ...+.. ...+. ....++.+|+.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 239 CIINLKARNYL--LSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp TCCCHHHHHHH--HTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhccc--ccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 000000 00110 11236889999999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.3e-46 Score=365.13 Aligned_cols=259 Identities=16% Similarity=0.236 Sum_probs=198.6
Q ss_pred cCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCceeeEEEEec--CCeeeEEE
Q 012761 83 KNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCAD--GDQRLLVY 159 (457)
Q Consensus 83 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~--~~~~~lV~ 159 (457)
++|++.+.||+|+||+||+|++..+++.||||+++.. ..+.+.+|+.+|..++ ||||++++++|.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999999999999999999753 3567889999999996 9999999999974 45689999
Q ss_pred eccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCC-CceEEeeccccccCC
Q 012761 160 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG-FHPKLSDFGLAKLGP 238 (457)
Q Consensus 160 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~ 238 (457)
||+.+++|..+. ..+++..+..++.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+|+...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 999999997764 35899999999999999999999999 9999999999999865 469999999998643
Q ss_pred CCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCccc--ch---------hhhhh
Q 012761 239 VGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN--LV---------TWARP 306 (457)
Q Consensus 239 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~--l~---------~~~~~ 306 (457)
... .....+||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......... +. .|...
T Consensus 182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 322 23446789999999998865 57999999999999999999999997543311100 00 00000
Q ss_pred h-hhcccccccccCCc--------cCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 307 L-FNDRRKFSKLADPR--------LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 307 ~-~~~~~~~~~~~d~~--------l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
. ......+....... ...........++.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000000111000 000111122356889999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=364.39 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=202.3
Q ss_pred hcCCCccceeeecCcEEEEEEEE---CCCCeEEEEEEeccCCC----cChHHHHHHHHHHHhcCC-CCceeeEEEEecCC
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWL---ESTGQVVAVKQLDRNGL----QGNREFLVEVLMLSLLHH-SNLVNLIGYCADGD 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~---~~~~~~vavK~i~~~~~----~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~ 153 (457)
.++|++.+.||+|+||+||+|++ +.+|+.||||++.+... ...+.+.+|+.++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 36799999999999999999987 44689999999975422 234567889999999976 89999999999999
Q ss_pred eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 233 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGl 233 (457)
..++||||+.+|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred ceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999999976 456788999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhcC--CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccchhhhhhhhhcc
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG--QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 311 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 311 (457)
++...... ........|++.|+|||.+.+. .++.++|||||||+||||++|+.||......... ..........
T Consensus 176 a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~--~~i~~~~~~~- 251 (322)
T d1vzoa_ 176 SKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS- 251 (322)
T ss_dssp EEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC-
T ss_pred hhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcccC-
Confidence 97543222 2223446799999999999754 4788999999999999999999999765443211 1111111110
Q ss_pred cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCC-----hHHHHH
Q 012761 312 RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVT 357 (457)
Q Consensus 312 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ev~~ 357 (457)
.+. ++.....++.+|+.+||+.||.+||+ ++|+++
T Consensus 252 -------~~~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 -------EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCC----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111 11223457889999999999999995 677764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-45 Score=363.44 Aligned_cols=263 Identities=23% Similarity=0.268 Sum_probs=191.6
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEec------CC
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCAD------GD 153 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~ 153 (457)
.++|++.+.||+|+||+||+|++..+|+.||||++...... ....+.+|+.+++.++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 46899999999999999999999999999999999765332 22458899999999999999999999964 46
Q ss_pred eeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeeccc
Q 012761 154 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 233 (457)
Q Consensus 154 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGl 233 (457)
.+|+||||+.++.+ +.+. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchHHH-Hhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhh
Confidence 88999999976544 4443 35899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCccc-c------------
Q 012761 234 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN-L------------ 300 (457)
Q Consensus 234 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~-l------------ 300 (457)
++.... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.......... +
T Consensus 166 ~~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 166 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhcccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 875332 223345679999999999999999999999999999999999999996543211000 0
Q ss_pred ---hhhhhhhhhccc-----ccccccCCccCCCC---ChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 301 ---VTWARPLFNDRR-----KFSKLADPRLEGRY---PIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 301 ---~~~~~~~~~~~~-----~~~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
............ ....+......... .......+.+|+.+||+.||++|||++||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000001000 00001111111111 1123557889999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-45 Score=362.41 Aligned_cols=262 Identities=22% Similarity=0.314 Sum_probs=195.7
Q ss_pred hcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCceeeEEEEecC-----Ce
Q 012761 82 TKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ--GNREFLVEVLMLSLLHHSNLVNLIGYCADG-----DQ 154 (457)
Q Consensus 82 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 154 (457)
.++|++.+.||+|+||+||+|++..+|+.||||++...... ..+.+.+|+.+|+.|+|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999999999999999999865332 234678999999999999999999998643 34
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceEEeecccc
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 234 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~kL~DFGla 234 (457)
.+++|+|+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 4667778889999999964 46999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccccccchhhhhcC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccch-hhh----hhhh
Q 012761 235 KLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV-TWA----RPLF 308 (457)
Q Consensus 235 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~-~~~----~~~~ 308 (457)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.......... ... ....
T Consensus 169 ~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 169 RHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp -CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 6421 223446789999999987765 4689999999999999999999999754321110000 000 0000
Q ss_pred hc-----c----cccccccCCccCCCCChHhHHHHHHHHHHcchhhcCCCCChHHHHH
Q 012761 309 ND-----R----RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 357 (457)
Q Consensus 309 ~~-----~----~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~ 357 (457)
.. . ..+.......+... .......+.+|+.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00 0 00000000000000 0012346789999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-40 Score=329.14 Aligned_cols=264 Identities=19% Similarity=0.206 Sum_probs=189.9
Q ss_pred CCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-----------CCCceeeEEEEec-
Q 012761 84 NFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-----------HSNLVNLIGYCAD- 151 (457)
Q Consensus 84 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~~~~- 151 (457)
+|++.+.||+|+||+||+|++..+|+.||||+++.... ..+.+.+|+.+++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 49999999999999999999999999999999976532 2356788888888775 5789999988754
Q ss_pred -CCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCccCeEEcCCC-----
Q 012761 152 -GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFKSSNILLEEGF----- 224 (457)
Q Consensus 152 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~iiHrDLkp~NILl~~~~----- 224 (457)
....+++|+++..+........ ......+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred cccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 4566777776655543322221 1235678999999999999999999998 77 99999999999997655
Q ss_pred -ceEEeeccccccCCCCCCccccccccccccccchhhhhcCCCCccchHHHHHHHHHHHHhCCCCCCCCCCCCcccch--
Q 012761 225 -HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV-- 301 (457)
Q Consensus 225 -~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvil~elltG~~p~~~~~~~~~~~l~-- 301 (457)
.++|+|||.+..... .....+||+.|+|||++....++.++|||||||++++|++|+.||............
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 399999999875321 223467999999999999999999999999999999999999999754432211111
Q ss_pred --hhhhh-----------------hhhcccccccccCCc---------cCCCCChHhHHHHHHHHHHcchhhcCCCCChH
Q 012761 302 --TWARP-----------------LFNDRRKFSKLADPR---------LEGRYPIRGLYQALAVASMCIQEQAATRPLIG 353 (457)
Q Consensus 302 --~~~~~-----------------~~~~~~~~~~~~d~~---------l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 353 (457)
..+.. .+........+.... ............+.+|+.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 00000 000000000000000 01123345567889999999999999999999
Q ss_pred HHHH
Q 012761 354 DVVT 357 (457)
Q Consensus 354 ev~~ 357 (457)
|+++
T Consensus 324 e~L~ 327 (362)
T d1q8ya_ 324 GLVN 327 (362)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9865
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.1e-24 Score=196.54 Aligned_cols=163 Identities=13% Similarity=0.071 Sum_probs=118.9
Q ss_pred CccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCc-----C-------------hHHHHHHHHHHHhcCCCCceeeEE
Q 012761 86 RPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQ-----G-------------NREFLVEVLMLSLLHHSNLVNLIG 147 (457)
Q Consensus 86 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-----~-------------~~~~~~E~~~l~~l~hpniv~l~~ 147 (457)
.+.+.||+|+||.||+|++. +|+.||||+++..... . ......|...+..+.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46788999999999999985 5899999987642110 0 012456888899999999999887
Q ss_pred EEecCCeeeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCccCeEEcCCCceE
Q 012761 148 YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPK 227 (457)
Q Consensus 148 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iiHrDLkp~NILl~~~~~~k 227 (457)
+.. .+++|||+++..+.+ ++......++.|++.+|.|||+.+ |+||||||+|||++++ .++
T Consensus 82 ~~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEE
T ss_pred ecC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEE
Confidence 642 379999998765543 223345789999999999999999 9999999999999865 589
Q ss_pred EeeccccccCCCCCCccccccccccccccc------hhhhhcCCCCccchHHHHHHHH
Q 012761 228 LSDFGLAKLGPVGDKSHVSTRVMGTYGYCA------PEYAMTGQLTVKSDVYSFGVVF 279 (457)
Q Consensus 228 L~DFGla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~ksDvwSlGvil 279 (457)
|+|||+|........ ..|.. .+.+ ...|+.++|+||+.--+
T Consensus 143 liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGW----------REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTH----------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCc----------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999999875321111 01111 1222 35788999999976444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.77 E-value=2e-08 Score=92.56 Aligned_cols=150 Identities=16% Similarity=0.064 Sum_probs=105.7
Q ss_pred HHHHHHhcCCCccceeeecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCceeeEEEEecCCe
Q 012761 76 RELAAATKNFRPESFIGEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLH-HSNLVNLIGYCADGDQ 154 (457)
Q Consensus 76 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 154 (457)
.++......|++.+..+.++.+.||+... ++..++||+...........+..|...+..|. +--+.+++.+..+++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 35666677888777655556678998753 35678899887654444456778888888775 4346778888888889
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-----------------------------
Q 012761 155 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN----------------------------- 205 (457)
Q Consensus 155 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~----------------------------- 205 (457)
.++||++++|.++.+..... . ....++.+++..|..||+...
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred eEEEEEeccccccccccccc------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 99999999998886654320 1 123355566666666664310
Q ss_pred ---------------------------CCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 206 ---------------------------PPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 206 ---------------------------~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
+.++|+|+.|.|||+++++.+-|.||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1278999999999999876667999988753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.13 E-value=7e-06 Score=74.46 Aligned_cols=130 Identities=19% Similarity=0.125 Sum_probs=83.3
Q ss_pred eeecC-cEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC--CCceeeEEEEecCCeeeEEEeccCCCCH
Q 012761 91 IGEGG-FGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHH--SNLVNLIGYCADGDQRLLVYEFMPLGSL 167 (457)
Q Consensus 91 lG~G~-~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lV~E~~~~gsL 167 (457)
+..|. .+.||+.... ++..+++|...... ...+..|...++.|.. -.+.+++.+..+.+..++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECT-TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeC-CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 44444 3678988764 46678899876543 2346677777777653 3356788888888889999999988665
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q 012761 168 EDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH---------------------------------------------- 201 (457)
Q Consensus 168 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~yLH---------------------------------------------- 201 (457)
.+.. +.. ..++.++...|.-||
T Consensus 94 ~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 3211 010 111222333333333
Q ss_pred -----hCC----CCCeeeccCCccCeEEcCCCceEEeecccccc
Q 012761 202 -----DKA----NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 236 (457)
Q Consensus 202 -----~~~----~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 236 (457)
... .+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 211 11279999999999999876678999987753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.10 E-value=6.4e-06 Score=80.35 Aligned_cols=77 Identities=16% Similarity=0.101 Sum_probs=48.1
Q ss_pred cceeeecCcEEEEEEEECCCCeEEEEEEecc------CCC-cChHHHHHHHHHHHhcC-C-C-CceeeEEEEecCCeeeE
Q 012761 88 ESFIGEGGFGRVYKGWLESTGQVVAVKQLDR------NGL-QGNREFLVEVLMLSLLH-H-S-NLVNLIGYCADGDQRLL 157 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~i~~------~~~-~~~~~~~~E~~~l~~l~-h-p-niv~l~~~~~~~~~~~l 157 (457)
.+.||.|....||++....+++.|+||.-.. ... ........|...|..+. + | .+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3468999999999998877788999997532 111 12234556787777663 2 3 34445543 4556789
Q ss_pred EEeccCCCC
Q 012761 158 VYEFMPLGS 166 (457)
Q Consensus 158 V~E~~~~gs 166 (457)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.17 E-value=0.00068 Score=63.60 Aligned_cols=140 Identities=16% Similarity=0.136 Sum_probs=78.4
Q ss_pred cCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCc--eeeE-----EEEecCCeeeEEEeccCCCC
Q 012761 94 GGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL--VNLI-----GYCADGDQRLLVYEFMPLGS 166 (457)
Q Consensus 94 G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpni--v~l~-----~~~~~~~~~~lV~E~~~~gs 166 (457)
+..-.||++... +|..|++|+.+.. .....++..|...+..|....| +..+ ..+......+.++++++|..
T Consensus 33 s~EN~vy~v~~~-dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 33 SYENRVYQFQDE-DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp CSSSEEEEECCT-TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cccceeEEEEcC-CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 334579999875 4888999988654 3356778888888877753222 1111 11234566788999987643
Q ss_pred HH-----H---------hhh----cCC-CCCCCCCHHH-------------------HHHHHHHHHHHHHHHHh----CC
Q 012761 167 LE-----D---------HLH----DLP-PDKEALDWNT-------------------RMKIAAGAAKGLEYLHD----KA 204 (457)
Q Consensus 167 L~-----~---------~l~----~~~-~~~~~l~~~~-------------------~~~i~~qi~~~L~yLH~----~~ 204 (457)
+. . .+| ... .....+++.. ...+...+...++.+.. ..
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 21 0 011 111 1112222211 11112222223333332 12
Q ss_pred CCCeeeccCCccCeEEcCCCceEEeeccccccC
Q 012761 205 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 237 (457)
Q Consensus 205 ~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 237 (457)
+..+||+|+.+.|||++++ ..++||+.+..+
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~g 221 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARNG 221 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhcccC
Confidence 3348999999999999743 458999988753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.12 E-value=0.0013 Score=63.34 Aligned_cols=74 Identities=19% Similarity=0.231 Sum_probs=50.0
Q ss_pred cceeeecCcEEEEEEEECC-------CCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCc-eeeEEEEecCCeeeEEE
Q 012761 88 ESFIGEGGFGRVYKGWLES-------TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL-VNLIGYCADGDQRLLVY 159 (457)
Q Consensus 88 ~~~lG~G~~g~Vy~~~~~~-------~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~ 159 (457)
++.|+.|-.-.+|++.... ....|++++.... .......+|..+++.+.-.++ .++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3467878888999998753 2356778876532 233456678888888863344 567777643 5899
Q ss_pred eccCCCCH
Q 012761 160 EFMPLGSL 167 (457)
Q Consensus 160 E~~~~gsL 167 (457)
||++|.+|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.83 E-value=0.0055 Score=56.56 Aligned_cols=159 Identities=14% Similarity=0.061 Sum_probs=82.0
Q ss_pred ccHHHHHHHhcCCCcccee-----eecCcEEEEEEEECCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCc--eee
Q 012761 73 FTFRELAAATKNFRPESFI-----GEGGFGRVYKGWLESTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHSNL--VNL 145 (457)
Q Consensus 73 ~~~~~~~~~~~~f~~~~~l-----G~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~E~~~l~~l~hpni--v~l 145 (457)
++..++.....+|.+.++. ..|---+.|+..... | .+++|++.... ...++..|+.++..|...++ ...
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence 5667888888999876554 355557789987654 4 58999986532 23445556666666642221 111
Q ss_pred EE------EEecCCeeeEEEeccCCCCHHH--------------hhh----cCC-CCCCCCCHH----------------
Q 012761 146 IG------YCADGDQRLLVYEFMPLGSLED--------------HLH----DLP-PDKEALDWN---------------- 184 (457)
Q Consensus 146 ~~------~~~~~~~~~lV~E~~~~gsL~~--------------~l~----~~~-~~~~~l~~~---------------- 184 (457)
+. +.........++.++.+..... .++ ... .........
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 11 1122344556666665532210 111 000 000000000
Q ss_pred --HHHHHHHHHHHHHHHHHhC-CCCCeeeccCCccCeEEcCCCceEEeeccccc
Q 012761 185 --TRMKIAAGAAKGLEYLHDK-ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 235 (457)
Q Consensus 185 --~~~~i~~qi~~~L~yLH~~-~~~~iiHrDLkp~NILl~~~~~~kL~DFGla~ 235 (457)
.....+..+...+.-.+.. .+.++||+|+.++||+++.+...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1111222222222222221 12349999999999999988777899999875
|